Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,maintenance of blood-brain barrier (GO:0035633),-0.6634629235148362,-2.3102874346023654,0.0,0.0034192587270074986,0.003,15/30,7.43%,TJP1;CDH5;GJB6;OCLN;DMD;PECAM1;CLDN5;ESAM;LAMA2;SLC12A2;F11R;LSR;TJP2;ACTB;GJA1
prerank,dopaminergic neuron differentiation (GO:0071542),0.8401949789460932,1.9156541048560618,0.0,0.10390030193442186,0.082,5/19,4.03%,LMX1A;LRP6;WNT2;VEGFA;LMX1B
prerank,ethanol metabolic process (GO:0006067),-0.7188559887064899,-1.9126373963168022,0.0,0.7699030900311884,0.678,5/12,15.00%,ALDH1A1;ACSS1;ACSS2;ADH1A;SULT1A1
prerank,superoxide anion generation (GO:0042554),0.8968378982982755,1.900806930730961,0.0,0.07671143787681614,0.114,3/13,0.90%,NOX4;DUOX1;NCF4
prerank,protein localization to cell-cell junction (GO:0150105),-0.6708007367536877,-1.882234004151162,0.00819672131147541,0.6918300157645172,0.793,7/15,5.66%,TJP1;CGNL1;CDH5;F11R;LSR;TJP2;ACTB
prerank,collagen fibril organization (GO:0030199),0.6836864164305031,1.8743376832547347,0.0,0.09742676287308719,0.209,37/88,12.07%,COL14A1;PLOD2;COL3A1;P4HA3;COL5A2;COL6A3;COL1A2;DDR2;COL1A1;LOXL2;COL17A1;COL5A1;BMP1;COL8A1;COL11A1;COL5A3;ADAMTS2;COL6A2;TGFB2;COL8A2;P4HA1;ADAMTS3;DPT;DST;COL12A1;COL15A1;P4HA2;COL6A1;TLL1;PLOD3;LOXL1;COL9A3;COL2A1;SERPINH1;COLGALT1;TLL2;COL20A1
prerank,regulation of cell junction assembly (GO:1901888),-0.5496259770029811,-1.803334357029498,0.006060606060606061,1.0,0.963,8/27,3.19%,TJP1;RAPGEF2;PRKCH;OCLN;PDLIM5;CLDN5;MEF2C;F11R
prerank,regulation of multicellular organismal development (GO:2000026),-0.5580097476049508,-1.7999669571052594,0.005291005291005291,0.9113464260383987,0.966,10/25,18.56%,PTN;INSR;TRIP12;MYSM1;SOX17;OAS2;SPAAR;TDG;DUSP6;RACGAP1
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.6955214099210788,-1.7933611136854228,0.010380622837370242,0.8092245653917746,0.972,4/11,4.05%,TJP1;RAPGEF2;F11R;TJP2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.8780534568877563,1.7901518691238718,0.0028089887640449437,0.4944974650477041,0.775,3/11,0.75%,LMX1A;LRP6;WNT2
prerank,protein homotrimerization (GO:0070207),0.8354852794712834,1.7862357360474184,0.002628120893561104,0.3553972944672748,0.802,5/14,4.41%,SCARA5;SLC1A5;DISP1;MIF;P2RX3
prerank,protein trimerization (GO:0070206),0.8354852794712834,1.7862357360474184,0.002628120893561104,0.3553972944672748,0.802,5/14,4.41%,SCARA5;SLC1A5;DISP1;MIF;P2RX3
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.7924561972640715,1.7819565442472334,0.0,0.3311215229872697,0.822,9/19,11.65%,GFPT2;UAP1;UGDH;UGP2;GFPT1;GNPNAT1;NAGK;GMPPB;SLC35D1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.678820012073589,-1.7805881605899871,0.011152416356877323,0.7681934606676846,0.98,9/12,21.95%,ATP1B3;DMD;WNK4;FXYD1;NOS1;ATP1B1;GLRX;ANK3;ATP1B2
prerank,regulation of transmembrane transport (GO:0034762),-0.5160089768969022,-1.7773075638634006,0.006756756756756757,0.6936821142416462,0.98,8/31,5.66%,NEDD4L;OCLN;SLC2A1;BCL2;CTTNBP2NL;SNCA;WWP2;ACTB
prerank,positive regulation of protein processing (GO:0010954),0.7753644157184365,1.7762624093181003,0.0012755102040816326,0.3221394875396678,0.852,6/19,7.21%,GSN;CCBE1;HPN;CLEC3B;KLKB1;MELTF
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.6072032196641374,-1.7736626126389896,0.0051813471502590676,0.63281614292061,0.983,6/19,4.01%,TJP1;PRKCH;OCLN;CLDN5;F11R;NPHP1
prerank,skin development (GO:0043588),0.6577395990800341,1.7682399586214455,0.0,0.33252412311722557,0.88,13/65,4.80%,COL3A1;COL5A2;COL1A2;COL1A1;LORICRIN;COL5A1;ANXA1;COL5A3;SCEL;ADAM9;PKD1;KRT10;DACT2
prerank,positive regulation of vascular permeability (GO:0043117),-0.6656857954449809,-1.7636767111453107,0.003861003861003861,0.619683656624659,0.989,8/12,12.32%,TJP1;BMP6;OCLN;PDE3A;TJP2;PDE2A;TGFB1;TRPV4
prerank,regulation of interleukin-2 production (GO:0032663),0.6696738780919519,1.7602789310294473,0.0,0.3452014704456727,0.912,7/43,3.81%,CD34;CD80;IRF4;ANXA1;GLMN;RUNX1;HDAC7
prerank,amino acid import (GO:0043090),-0.5628973701767775,-1.7599516335406207,0.005405405405405406,0.5804450723847274,0.991,6/21,4.74%,SLC6A13;SLC1A3;SLC16A2;SLC6A1;SLC7A5;SLC22A4
prerank,heart process (GO:0003015),0.8110817326637412,1.7594590791710347,0.0026845637583892616,0.3180567441543942,0.913,3/14,3.25%,NOX4;FYN;TNNI3
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.8359937398240264,1.7587158799773361,0.0013869625520110957,0.29559797738819554,0.916,5/13,6.73%,GFPT2;UAP1;GFPT1;GNPNAT1;NAGK
prerank,cation transmembrane transport (GO:0098655),-0.46748129179770814,-1.7547842943763263,0.0,0.5545847696387995,0.993,10/44,9.08%,ATP1A2;TRPM3;SLC7A2;TRPM6;SLC7A5;SLC6A9;ABCC9;SLC3A2;SLC25A20;SLC38A5
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.496810843953564,-1.7538299774300903,0.0,0.5176231672885198,0.993,13/35,7.41%,PDE7B;IRAG1;RAPGEF2;ADCY1;RAPGEF3;ADGRG6;PDE3A;APOE;NUDT4;KSR1;GUCY1B1;AHR;CAP2
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.49426419953494183,-1.7466857833918898,0.007407407407407408,0.50556182606468,0.994,12/35,13.03%,TJP1;RAPGEF3;ESAM;F11R;IQGAP2;NRP1;NTRK3;TEK;MDK;CDK5;ABL1;ABI3
prerank,eye morphogenesis (GO:0048592),0.7510089106432274,1.7462564699865084,0.0025157232704402514,0.33911385390530213,0.952,7/19,5.07%,MFAP5;COL5A2;FBN1;COL5A1;VEGFA;SKI;TENM3
prerank,macrophage activation involved in immune response (GO:0002281),0.8225187587322782,1.7419726196350536,0.0,0.3386123324725284,0.959,2/13,0.27%,LBP;SYK
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.8490126482246148,1.737469010715697,0.001402524544179523,0.3383718867359645,0.973,5/11,6.73%,GFPT2;UAP1;GFPT1;GNPNAT1;NAGK
prerank,amino sugar biosynthetic process (GO:0046349),0.8411541806854322,1.735381965556734,0.002777777777777778,0.32869394583926914,0.973,5/12,6.73%,GFPT2;UAP1;GFPT1;GNPNAT1;NAGK
prerank,C21-steroid hormone metabolic process (GO:0008207),0.7445810206500107,1.7331090204522586,0.0012755102040816326,0.32169681170679715,0.98,2/20,0.75%,AKR1B1;DHRS9
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.7555531955693434,1.7304908625249449,0.007471980074719801,0.3168797370523334,0.982,6/17,8.79%,SYK;LIF;TGFB2;ADAM9;RET;FOXC2
prerank,superoxide metabolic process (GO:0006801),0.7083573100033986,1.7293780883571546,0.0011947431302270011,0.30613025508469605,0.983,3/29,0.90%,NOX4;DUOX1;NCF4
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.7763253021784816,1.7275944907291965,0.0,0.2996115716062231,0.983,5/17,6.47%,SFRP4;FSTL1;PCSK6;SLIT2;SULF1
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.8575669541726442,1.7237076204228594,0.0028129395218002813,0.3037477006707687,0.987,3/10,3.16%,GFPT2;PFKP;GFPT1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.753270661877133,1.7229558802551168,0.002484472049689441,0.2933395950111163,0.987,2/18,0.27%,LBP;SYK
prerank,bicellular tight junction assembly (GO:0070830),-0.46045588604548604,-1.7223426514169704,0.0,0.5764870213734642,0.998,10/46,4.13%,CDH5;PARD6G;OCLN;PECAM1;CLDN5;PATJ;ESAM;F11R;DLG1;STRN
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.7979444598307747,1.7186838552761363,0.00395778364116095,0.3003440666239241,0.991,4/14,8.29%,SYK;CD55;TGFBR2;CD81
prerank,transition metal ion transport (GO:0000041),-0.48017225184260093,-1.7172901237271807,0.0,0.563394109831298,0.998,15/35,14.62%,CP;IREB2;ATP2C1;SLC30A10;SLC39A8;FTH1;TRPC5;SLC30A1;TRPC6;TRPC4;CUTC;TFRC;TRPC7;TRPC3;COX17
prerank,response to interleukin-4 (GO:0070670),-0.669292555012655,-1.715050871336413,0.013071895424836602,0.5384326830705337,0.998,2/10,4.75%,LEF1;TCF7
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.6790622424050344,-1.7145744700525634,0.020338983050847456,0.5108625816573426,0.998,3/10,13.30%,ACTN2;SEMA5A;WDR1
prerank,extracellular matrix organization (GO:0030198),0.5957594707851263,1.7118921942182228,0.0,0.32153259325266764,0.995,84/276,12.51%,COL14A1;PLOD2;MFAP5;COL3A1;COMP;DCN;P4HA3;ADAMTS5;COL5A2;COL6A3;COL1A2;TIMP2;DDR2;FBN1;HAS2;GSN;COL1A1;HAS1;LOXL2;COL17A1;COL5A1;BMP1;COL8A1;POSTN;FLRT2;COL11A1;COL5A3;ADAMTS2;SPARC;ITGA11;VIT;COL6A2;CD44;MMP2;ITGB3;CAPN2;FGF2;TGFB2;COL8A2;P4HA1;KLKB1;ELN;SMOC2;ADAM19;ADAMTS3;ACAN;SCUBE3;ITGB5;DPT;ITGA2;ADAMTSL1;ITGA5;CREB3L1;VCAN;DST;ADAMTSL4;COL12A1;JAM3;COL15A1;P4HA2;TGFBI;COL6A1;TLL1;MMP11;GAS6;CAPN1;ADAMTSL5;PLOD3;ADAMTS18;ADAMTSL3;LOXL1;ITGAV;COL9A3;COL2A1;CD47;SERPINH1;COLGALT1;HSPG2;TLL2;PAPLN;ST7;COL20A1;RECK;ITGA9
prerank,extracellular matrix disassembly (GO:0022617),0.645262130133389,1.7065958642560464,0.0010976948408342481,0.33690886690810296,0.995,13/53,8.16%,ADAMTS5;TIMP2;GSN;BMP1;HPN;CD44;MMP2;CAPN2;KLKB1;SCUBE3;TLL1;MMP11;CAPN1
prerank,response to iron ion (GO:0010039),-0.6358265511935526,-1.7063342592185886,0.025179856115107913,0.5149283668882871,1.0,5/12,6.91%,BMP6;BCL2;SNCA;ACO1;B2M
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.7805775311130143,1.7026559695303807,0.005249343832020997,0.34456656565311866,0.995,2/15,0.51%,SYK;CD55
prerank,tight junction assembly (GO:0120192),-0.4469286498433287,-1.7012004806310894,0.0,0.5094125626786671,1.0,11/49,4.13%,CDH5;PARD6G;OCLN;PECAM1;CLDN5;PATJ;ESAM;F11R;LSR;DLG1;STRN
prerank,smooth muscle cell differentiation (GO:0051145),-0.651497330177904,-1.6992981606539794,0.019305019305019305,0.4923732566890798,1.0,9/12,22.93%,MEF2C;TBX18;MRTFB;TMEM204;EDNRB;MYOCD;APLNR;HEY1;HEY2
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.6832674031676265,-1.6971983279037817,0.017921146953405017,0.477763696673684,1.0,4/10,5.82%,ENG;ENPP1;ERRFI1;CAV1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.7358423143160776,1.6939300196315226,0.0012330456226880395,0.3773713631699165,0.998,6/21,7.89%,DCN;UGDH;CSGALNACT2;VCAN;CHST12;CHSY3
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.7696971085826089,1.6934731596413302,0.0,0.365835876203677,0.998,3/17,2.82%,SFRP4;TMEM100;FGF2
prerank,embryonic eye morphogenesis (GO:0048048),0.8180894360091313,1.6905875172787204,0.00823045267489712,0.36745147065044975,0.998,3/11,0.48%,MFAP5;FBN1;LRP6
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.6227370004938517,-1.6896167777246358,0.03383458646616541,0.48087661865044584,1.0,6/13,8.54%,PLXNA2;NRP2;PLXNA4;PLXND1;NRP1;PLXNB1
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.6406289141759535,-1.6857425767999088,0.02422145328719723,0.4747545763040828,1.0,5/11,9.74%,MLLT3;WNT5B;RSPO3;NKD1;SFRP1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7716225721648207,1.6727914413017662,0.013333333333333334,0.4568700192536962,0.999,6/15,8.73%,DCN;CSGALNACT2;VCAN;CHST12;CHST14;B3GAT3
prerank,smooth muscle contraction (GO:0006939),-0.5931986832588022,-1.672133752742967,0.026717557251908396,0.5018560008919806,1.0,5/14,11.32%,MYLK;EDNRA;MYH11;SMTN;ACTA2
prerank,myoblast fusion (GO:0007520),0.7866866023560601,1.6711689542068235,0.014824797843665768,0.45237508608288235,1.0,4/12,8.29%,ADAMTS5;CD9;PTGFRN;CD81
prerank,actin filament bundle assembly (GO:0051017),-0.48589556485581764,-1.6693469793886135,0.014814814814814815,0.4918472168849248,1.0,5/33,2.07%,PAWR;MYO1B;SHROOM2;CALD1;EPS8
prerank,response to glucagon (GO:0033762),-0.5498656692900308,-1.668808903182439,0.019138755980861243,0.47531917612474595,1.0,9/19,15.86%,ADCY5;ADCY1;PRKAR1B;CRY1;ADCY4;ADCY9;PRKAR2B;CYSLTR2;PRKACB
prerank,smooth muscle tissue development (GO:0048745),-0.6664260202150565,-1.6668607318572848,0.014234875444839857,0.46432719403541106,1.0,4/10,8.16%,MYLK;ENG;PTCH1;STRA6
prerank,muscle tissue morphogenesis (GO:0060415),-0.5985062524970266,-1.6667762456946018,0.03333333333333333,0.448866137024743,1.0,5/16,10.58%,MYLK;NOTCH1;TGFBR3;TBX1;BMP2
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.6916564941451401,1.6557942660821465,0.006038647342995169,0.5389221268561134,1.0,8/27,9.19%,DCN;UGDH;CSGALNACT2;VCAN;CHST12;CHSY3;B3GAT3;XYLT1
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5742688940732887,-1.6553212100239931,0.03211009174311927,0.4705659843634986,1.0,5/16,8.50%,PRKAG2;LONP2;PPARA;ACADL;APPL2
prerank,cellular component disassembly (GO:0022411),0.6266492295452099,1.654039213043096,0.0011013215859030838,0.5357736328581006,1.0,12/53,8.16%,ADAMTS5;TIMP2;GSN;BMP1;CD44;MMP2;CAPN2;KLKB1;SCUBE3;TLL1;MMP11;CAPN1
prerank,establishment of endothelial barrier (GO:0061028),-0.4767438409974616,-1.647437527361928,0.0,0.48251990895963875,1.0,13/29,17.30%,TJP1;RAPGEF2;RAPGEF3;PECAM1;PPP1R16B;F11R;TJP2;PDE2A;ROBO4;ICAM1;AFDN;SOX18;RAPGEF6
prerank,cellular response to interleukin-4 (GO:0071353),-0.6452047035553693,-1.6472648327346695,0.013333333333333334,0.4678329518671197,1.0,2/10,4.75%,LEF1;TCF7
prerank,presynaptic endocytosis (GO:0140238),0.6862365311889709,1.6448045235248292,0.010843373493975903,0.5836752255727817,1.0,5/24,3.32%,STON2;SNCB;CEL;SYT2;STX1A
prerank,actin filament bundle organization (GO:0061572),-0.4793838959532172,-1.6438421540365422,0.028368794326241134,0.46533002857547506,1.0,5/33,2.07%,PAWR;MYO1B;SHROOM2;CALD1;EPS8
prerank,B cell homeostasis (GO:0001782),-0.6697137393265917,-1.640178515377367,0.029411764705882353,0.4645163547072834,1.0,2/10,1.97%,LYN;MEF2C
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.7096478992652192,1.6385150680711387,0.01282051282051282,0.614523815179558,1.0,7/20,7.63%,NPTN;SULF2;FGF2;SMOC2;CREB3L1;SULF1;PRKD2
prerank,carbohydrate catabolic process (GO:0016052),-0.45743152836308015,-1.6362328538085973,0.015151515151515152,0.46221865115375643,1.0,18/38,20.40%,ENO1;HK2;PGAM1;PGAM4;DERA;MAN2B1;PGK1;PFKM;ALDOC;PFKL;GAPDH;MANBA;TPI1;MAN2B2;GAPDHS;NEU3;ENO3;GPI
prerank,heart trabecula morphogenesis (GO:0061384),-0.5412709705904336,-1.6338153887894367,0.028169014084507043,0.45533128714649845,1.0,8/18,6.34%,BMP5;ENG;ADGRG6;BMP7;RBP4;NOTCH1;TGFBR3;S1PR1
prerank,positive regulation of protein depolymerization (GO:1901881),-0.6402244070409553,-1.6329201472555404,0.03832752613240418,0.4454585626239228,1.0,5/11,19.29%,SEMA5A;NES;TRPV4;WDR1;KATNB1
prerank,modified amino acid transport (GO:0072337),-0.5704548920269297,-1.6327594570122397,0.013452914798206279,0.43445581281318957,1.0,5/15,11.02%,SLC6A13;SLC16A12;PDPN;CTNS;MGST1
prerank,cGMP-mediated signaling (GO:0019934),-0.6420144641662651,-1.6310645876735834,0.029661016949152543,0.4280502784143489,1.0,5/13,9.53%,IRAG1;PDE3A;APOE;GUCY1B1;PDE2A
prerank,vasoconstriction (GO:0042310),-0.6243749761534878,-1.629531588158456,0.03676470588235294,0.42128116899004886,1.0,5/11,16.91%,EDNRA;ACTA2;EDNRB;EDN1;EDN3
prerank,positive regulation of interleukin-10 production (GO:0032733),0.6663928202523794,1.6262176620083737,0.00589622641509434,0.6949074451548574,1.0,3/30,1.17%,CD34;SYK;IRF4
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.6307313182857179,1.6260860854340062,0.004464285714285714,0.6772809022535048,1.0,12/41,17.16%,CD34;LBP;IRAK3;SYT11;GAS6;TLR4;SIRPA;ZC3H12A;IL4;SELENOS;ILRUN;CHRNA7
prerank,positive regulation of interleukin-2 production (GO:0032743),0.6796829713098317,1.6259252316137318,0.004956629491945477,0.6605309652491076,1.0,6/25,7.63%,CD80;IRF4;ANXA1;GLMN;RUNX1;PRKD2
prerank,peptide cross-linking (GO:0018149),0.6835029425976434,1.6255303413162823,0.007290400972053463,0.6467314504544951,1.0,4/25,4.74%,COL3A1;LORICRIN;ANXA1;KRT10
prerank,regulation of interleukin-1 production (GO:0032652),0.7420955656409738,1.623233730370892,0.014627659574468085,0.6490613020608966,1.0,6/15,9.99%,ANXA1;FOXP1;F2R;GAS6;TLR4;SIRPA
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.4801945572851657,-1.621427695307689,0.006756756756756757,0.43355088704397515,1.0,8/29,12.28%,TPM1;ENG;NOTCH1;TGFBR3;S1PR1;FGFR2;BMP2;TGFB1
prerank,negative regulation of hormone secretion (GO:0046888),0.7973749728648045,1.6177826166977207,0.014084507042253521,0.6758137943238496,1.0,2/10,1.05%,LIF;RAB11FIP5
prerank,vascular transport (GO:0010232),-0.4083664226731507,-1.6170987928857659,0.0,0.43576552887528897,1.0,21/81,4.64%,ATP1A2;SLC24A3;SLC7A2;SLC6A13;SLC1A3;SLC16A12;ABCC4;SLC13A3;SLC22A8;SLC16A2;INSR;ABCG2;SLCO2B1;SLC2A1;SLCO1C1;SLC12A2;SLC6A1;SLC5A3;SLC7A5;SLC6A9;ABCC9
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.549188941132837,-1.6169385561560352,0.01652892561983471,0.42602903503249234,1.0,11/17,11.60%,MAML3;NOTCH3;CREBBP;NOTCH1;PLXND1;WWC1;HEYL;NOTCH4;MAML2;STAT1;EP300
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.6245394479956944,-1.616304843476721,0.04285714285714286,0.41813389675268964,1.0,6/11,14.89%,EFNB2;SOX6;MEF2C;BMP2;TGFB1;MYOCD
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.6237436906103134,1.615743946791304,0.0066298342541436465,0.6761149153916852,1.0,12/43,17.16%,CD34;LBP;IRAK3;SYT11;GAS6;TLR4;SIRPA;ZC3H12A;IL4;SELENOS;ILRUN;CHRNA7
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.7203402788532006,1.6155930769923708,0.009296148738379814,0.6614978362453857,1.0,7/16,13.85%,ZFP36L1;TRIM71;TARDBP;RC3H1;ZFP36L2;ZFP36;ZC3H12A
prerank,regulation of spindle organization (GO:0090224),0.7167558825870389,1.6151091460773825,0.006369426751592357,0.650215504650355,1.0,6/18,5.73%,PARP3;GPSM2;DCTN1;CLTC;PSRC1;FSD1
prerank,diol biosynthetic process (GO:0034312),-0.5628390298168686,-1.6114772191426363,0.032407407407407406,0.4213033308521683,1.0,8/15,23.87%,ACER2;GCH1;QDPR;SPR;SPHK1;SPTLC2;SPHK2;ABCA2
prerank,bone morphogenesis (GO:0060349),0.7428106340855763,1.6109645823015455,0.01045751633986928,0.6689971050618653,1.0,3/14,4.22%,SFRP4;LRP6;SKI
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6449811706568342,-1.6092591368867617,0.034013605442176874,0.4182149858924606,1.0,5/10,25.63%,LYN;KIT;CD40;BTLA;FGR
prerank,renal water homeostasis (GO:0003091),-0.503807365601945,-1.6078833690676901,0.014218009478672985,0.4130270541729908,1.0,9/23,15.86%,ADCY5;ADCY1;PRKAR1B;ADCY4;ADCY9;RAB11A;MYO5B;PRKAR2B;PRKACB
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.4892182948191848,-1.607824785221554,0.011494252873563218,0.40465977240042905,1.0,8/27,3.43%,TJP1;CGNL1;PHLDB2;ARHGAP28;ARHGAP6;F11R;SHANK3;RHPN2
prerank,homocysteine metabolic process (GO:0050667),0.7810749830818988,1.6074470093813742,0.016042780748663103,0.6814314601269956,1.0,1/11,0.01%,NOX4
prerank,transport across blood-brain barrier (GO:0150104),-0.40260107215809104,-1.6070033116893903,0.0,0.3984715731453432,1.0,21/83,4.64%,ATP1A2;SLC24A3;SLC7A2;SLC6A13;SLC1A3;SLC16A12;ABCC4;SLC13A3;SLC22A8;SLC16A2;INSR;ABCG2;SLCO2B1;SLC2A1;SLCO1C1;SLC12A2;SLC6A1;SLC5A3;SLC7A5;SLC6A9;ABCC9
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5475235931797392,-1.606301661395393,0.030973451327433628,0.39241692656956056,1.0,10/18,29.85%,SLC39A8;ITGA4;VCAM1;GCNT1;ROCK1;JAM2;PODXL2;SELPLG;SELP;ITGB7
prerank,positive regulation of bone mineralization (GO:0030501),-0.45293022137520006,-1.6047726269349665,0.023622047244094488,0.3885216533923226,1.0,14/35,12.28%,PTN;BMP6;WNT4;ADGRV1;MEF2C;BMP7;OSR1;KL;ATRAID;NELL1;BMPR2;BMP2;PKDCC;TGFB1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.7194083856876681,1.6044498598886594,0.013422818791946308,0.690774825050188,1.0,5/17,4.97%,MID1;STK25;TGFB2;TAOK3;KLHDC10
prerank,renal absorption (GO:0070293),0.7878827627616454,1.6039609763590825,0.018387553041018388,0.6803487255367099,1.0,2/10,0.45%,HAS2;GSN
prerank,external encapsulating structure organization (GO:0045229),0.5636325509419409,1.6039193223085861,0.0,0.6668802137511282,1.0,52/205,10.32%,COL14A1;MFAP5;COL3A1;COMP;DCN;ADAMTS5;COL5A2;COL6A3;COL1A2;DDR2;FBN1;COL1A1;COL17A1;COL5A1;COL8A1;POSTN;COL11A1;COL5A3;ADAMTS2;SPARC;ITGA11;VIT;COL6A2;CD44;MMP2;ITGB3;FGF2;COL8A2;ELN;SMOC2;ADAM19;ADAMTS3;ACAN;ITGB5;ITGA2;ADAMTSL1;ITGA5;VCAN;ADAMTSL4;JAM3;COL15A1;TGFBI;COL6A1;MMP11;ADAMTSL5;ADAMTS18;ADAMTSL3;LOXL1;ITGAV;COL9A3;COL2A1;CD47
prerank,regulation of mast cell activation (GO:0033003),-0.6450538449299055,-1.6033351656832888,0.05338078291814947,0.38446934186178544,1.0,4/10,12.12%,LYN;PLSCR1;NECTIN2;CD84
prerank,positive regulation of cell adhesion (GO:0045785),0.5820876413065456,1.6010880437487096,0.005230125523012552,0.674847026526958,1.0,19/74,10.32%,SYK;LIF;FBLN2;PRKCA;VIT;VEGFA;TGFB2;ADAM9;PTPRJ;ZFHX3;C1QBP;RET;FLCN;PRKD2;TNFRSF18;FOXC2;STX4;ITGAV;CD47
prerank,sulfur amino acid metabolic process (GO:0000096),0.6730627438876337,1.5998609584675372,0.016646848989298454,0.6703349698012079,1.0,2/24,0.81%,NOX4;GCLC
prerank,extracellular structure organization (GO:0043062),0.5621871436395255,1.5994425899902234,0.0,0.6608985417079545,1.0,52/204,10.32%,COL14A1;MFAP5;COL3A1;COMP;DCN;ADAMTS5;COL5A2;COL6A3;COL1A2;DDR2;FBN1;COL1A1;COL17A1;COL5A1;COL8A1;POSTN;COL11A1;COL5A3;ADAMTS2;SPARC;ITGA11;VIT;COL6A2;CD44;MMP2;ITGB3;FGF2;COL8A2;ELN;SMOC2;ADAM19;ADAMTS3;ACAN;ITGB5;ITGA2;ADAMTSL1;ITGA5;VCAN;ADAMTSL4;JAM3;COL15A1;TGFBI;COL6A1;MMP11;ADAMTSL5;ADAMTS18;ADAMTSL3;LOXL1;ITGAV;COL9A3;COL2A1;CD47
prerank,apical junction assembly (GO:0043297),-0.40918562865645214,-1.5963609370298142,0.010526315789473684,0.39409644925244913,1.0,10/53,4.13%,CDH5;PARD6G;OCLN;PECAM1;CLDN5;PATJ;ESAM;F11R;DLG1;STRN
prerank,synaptic vesicle membrane organization (GO:0048499),0.7166253234923712,1.5958388373188184,0.02313624678663239,0.6744816990678553,1.0,11/17,18.19%,STX2;STX1A;STX11;AP3D1;STX1B;STX4;TOR1A;SNAP23;SNAP25;SNAP47;STX3
prerank,regulation of protein neddylation (GO:2000434),-0.6286087733796583,-1.5943830674423614,0.02631578947368421,0.3916739765251737,1.0,7/10,25.11%,EPAS1;DCUN1D4;RPL5;DCUN1D3;DCUN1D5;HIF1A;DCUN1D2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.6913360625969165,1.5923968892015468,0.02998696219035202,0.6874359021549002,1.0,7/19,15.09%,SYK;AXL;ZMIZ1;GAS6;ZBTB1;CD27;IL4
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.6690392438127681,1.589466146738138,0.015132408575031526,0.6961055403008303,1.0,8/25,10.81%,HAS2;HAS1;B3GALNT1;CSGALNACT2;EXT1;HS2ST1;FUT9;B3GNT8
prerank,response to glucocorticoid (GO:0051384),0.6511909990598662,1.5876945079811258,0.019464720194647202,0.6962638057200894,1.0,10/26,20.76%,ANXA1;SLIT3;SLIT2;ADAM9;ZFP36L1;ZFP36L2;ZFP36;IL6;PDCD7;GOT1
prerank,positive regulation of dendrite development (GO:1900006),-0.6245272154986119,-1.5848885195900788,0.07236842105263158,0.4088604526294421,1.0,4/10,3.54%,PTN;BMP5;BMP7;DAB2IP
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.7203606545130723,1.5846411012152262,0.015727391874180863,0.7078133538405139,1.0,3/15,2.88%,TGFB3;IRAK3;TGFB2
prerank,regulation of actin nucleation (GO:0051125),0.7377162041605778,1.5841534640478758,0.025956284153005466,0.6993431215605334,1.0,3/12,9.87%,GSN;SCIN;ARF1
prerank,regulation of protein localization to membrane (GO:1905475),0.6467206919336784,1.5835034855386108,0.019115890083632018,0.6920652140570949,1.0,6/28,5.54%,AR;GSN;GPC6;GPC3;FYN;ZDHHC7
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.7652291570235568,1.5826823822551797,0.018055555555555554,0.6864540820639311,1.0,4/12,7.75%,DCN;VCAN;CHST12;CHST14
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.4287014843749614,-1.5825680382864913,0.0,0.4077262504651262,1.0,15/40,12.28%,PTN;BMP6;WNT4;ADGRV1;MEF2C;WNT6;BMP7;OSR1;KL;ATRAID;NELL1;BMPR2;BMP2;PKDCC;TGFB1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.5031288618970537,-1.5824229226153899,0.028169014084507043,0.40083310199761585,1.0,5/22,7.67%,EPHA4;LYN;SP1;ABCG1;CASP3
prerank,secretion (GO:0046903),-0.5580386913278959,-1.5820223409402068,0.030534351145038167,0.3949440338815902,1.0,5/14,16.38%,SLC22A6;SLC22A4;FBLN5;NPR1;SLC22A2
prerank,regulation of cellular component biogenesis (GO:0044087),-0.4323173394945196,-1.5750759431503432,0.0,0.4058486248344663,1.0,10/39,9.80%,TJP1;RAPGEF2;SNCAIP;APOE;NOTCH1;DAB2IP;TIE1;PINK1;GFAP;PARP10
prerank,gas transport (GO:0015669),0.770836471645137,1.5735396102961938,0.01881331403762663,0.7450990397800651,1.0,1/10,0.43%,CYGB
prerank,cellular defense response (GO:0006968),0.6123236649824255,1.5714656291916005,0.01888888888888889,0.7497924411830739,1.0,4/40,4.77%,LBP;LSP1;KIR3DL2;RAB23
prerank,endothelial cell proliferation (GO:0001935),0.7059176157675241,1.5707388479016455,0.021383647798742137,0.7437325722061502,1.0,3/17,1.62%,CD34;LOXL2;ANGPT4
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.6191461279832308,-1.5700152686655813,0.04633204633204633,0.41177373014078633,1.0,4/11,11.60%,CRY1;C1QTNF3;SIK1;EP300
prerank,negative regulation of actin filament polymerization (GO:0030837),0.6654487825326645,1.5643577963824025,0.029556650246305417,0.7816646692989896,1.0,8/22,10.62%,GSN;SCIN;SLIT2;MYADM;PFN2;KANK1;TWF1;SSH1
prerank,synaptic vesicle recycling (GO:0036465),0.6269531231324023,1.5638185867961925,0.017321016166281754,0.7738369001010861,1.0,5/31,3.32%,STON2;SNCB;CEL;SYT2;STX1A
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.4122036032467681,-1.5631675860404328,0.010416666666666666,0.42083040605677535,1.0,14/46,17.81%,ATP1A2;MEF2C;GRM3;SHANK3;DGKZ;CACNG4;GRM7;OPHN1;CACNG8;CDK5;UNC13A;GRM8;CDH2;CLN3
prerank,bone development (GO:0060348),0.6125240889452948,1.562341446101696,0.022701475595913734,0.774279409501957,1.0,9/39,6.47%,SFRP4;MYOC;LRP6;GNAS;AKAP13;SULF2;SKI;LRRC17;SULF1
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.7515925410883246,1.562055610747617,0.02119205298013245,0.7650998520602685,1.0,4/13,8.29%,SYK;CD9;ABCA1;CD81
prerank,angiogenesis involved in wound healing (GO:0060055),0.766384270359137,1.5618076804878933,0.03591160220994475,0.7559903634840887,1.0,4/11,6.24%,CD34;ITGB3;VEGFA;PRCP
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.4406650706305592,-1.5616802747823442,0.029197080291970802,0.4175723762579318,1.0,7/32,3.20%,NEDD4L;RAPGEF2;TNIK;CUX1;PTPRD;CDKL5;YWHAH
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.657445949928612,1.5614175676981938,0.016352201257861635,0.7475530324741284,1.0,6/24,12.24%,GFPT2;GFPT1;COQ10B;PID1;ACADVL;NDUFS1
prerank,embryonic appendage morphogenesis (GO:0035113),0.7355070077592838,1.560971433151917,0.02312925170068027,0.7405497488343273,1.0,5/12,9.49%,LRP6;MBNL1;TGFB2;SKI;FBXW4
prerank,gliogenesis (GO:0042063),0.7125541860187089,1.559580740663314,0.030666666666666665,0.7408008101329333,1.0,4/15,6.14%,ANXA1;CD9;TGFB2;NFIB
prerank,cell junction maintenance (GO:0034331),0.7347692004498247,1.5591282190179785,0.03580901856763926,0.7339374910788212,1.0,5/14,8.34%,DCTN1;CD177;F2R;MYADM;PARD6A
prerank,central nervous system neuron differentiation (GO:0021953),0.6281194774732561,1.5589694986642557,0.015240328253223915,0.7252669392744102,1.0,3/33,0.75%,LMX1A;LRP6;WNT2
prerank,regulation of sensory perception of pain (GO:0051930),0.7661251854014581,1.558846459830969,0.021246458923512748,0.7163845773942698,1.0,4/11,8.41%,MGLL;TMEM100;F2R;SPX
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.5716107163160511,1.5588318064409874,0.005246589716684155,0.7069363596539942,1.0,20/86,8.29%,GHR;LIF;CD80;FGF7;EGFR;EFNA5;ANGPT4;CD44;ITGB3;FYN;VEGFA;DGKQ;MIF;THBS4;ACVR1;ITGA5;PTPRJ;SRC;BANK1;CD81
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.7476448558379459,1.5582268225750564,0.014804845222072678,0.7020936413672426,1.0,3/12,3.52%,AR;TMEFF2;CLTC
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.7495364595343657,1.5558495963692325,0.028493894165535955,0.7096974501715572,1.0,9/12,18.19%,STX2;STX1A;STX11;STX1B;STX4;SNAP23;SNAP25;SNAP47;STX3
prerank,regulation of interleukin-12 production (GO:0032655),0.5951068318582042,1.554717562033576,0.014606741573033709,0.7085786467174005,1.0,11/47,11.97%,SYK;IL16;IRAK3;FOXP1;MAPK14;C1QBP;TIRAP;TLR4;MAPK11;CD47;PIBF1
prerank,regulation of protein processing (GO:0070613),0.6706874666158407,1.5539590929401337,0.03427172582619339,0.7053248581453839,1.0,3/21,2.75%,CCBE1;GAS1;RUNX1
prerank,B cell proliferation (GO:0042100),-0.5157441945895986,-1.5531517982666831,0.004608294930875576,0.43281664436469514,1.0,3/17,2.80%,MEF2C;BCL2;CTPS1
prerank,regulation of coagulation (GO:0050818),0.7603323844769625,1.552284681952917,0.028965517241379312,0.7088889408733693,1.0,4/11,11.57%,EPHB2;F2R;PROCR;HS3ST5
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.7496593523671858,1.5515888533510065,0.03155006858710562,0.7046447268262817,1.0,3/10,8.29%,CD55;TGFBR2;CD81
prerank,cellular response to glucagon stimulus (GO:0071377),-0.5378231161590616,-1.5498014793520212,0.05701754385964912,0.43428147560835856,1.0,8/17,15.86%,ADCY5;ADCY1;PRKAR1B;ADCY4;ADCY9;PRKAR2B;CYSLTR2;PRKACB
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.5501174551004624,1.5481441293842977,0.003051881993896236,0.7199128055392345,1.0,25/121,9.03%,NOX4;GHR;LIF;CD80;FGF7;EFNA5;ANGPT4;CTF1;CD44;ITGB3;VEGFA;DGKQ;DLG4;MIF;THBS4;ACVR1;ITGA5;CLCF1;PTPRJ;SRC;BANK1;GAS6;TNFRSF18;CD81;SRCIN1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.5535483499167382,1.5478091128590505,0.005159958720330237,0.7132397148330176,1.0,26/95,12.56%,DCN;HAS2;HAS1;ST3GAL2;GPC6;UGDH;B4GALT3;B4GALT1;GPC3;OGN;CHST1;CSGALNACT2;EXT1;ACAN;VCAN;CHST12;CHST14;CHSY3;B3GAT3;XYLT1;HS2ST1;HSPG2;HS3ST6;HS3ST5;ST3GAL4;GLCE
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.6563613299631382,1.5469364426668424,0.028500619578686492,0.710725229587464,1.0,8/23,11.74%,DPP4;SLIT2;THBS4;JAM3;C1QBP;TIRAP;MCU;MPP1
prerank,regulation of epithelial cell migration (GO:0010632),-0.40685383559220395,-1.546876947399262,0.0,0.4358941163829712,1.0,18/51,13.93%,PTN;PTPRG;SASH1;DOCK5;GLUL;PLCG1;DAB2IP;DUSP10;PRKCE;BMPR2;EMP2;RAB11A;MACF1;EVL;CEACAM1;PPM1F;PTK2;PFN1
prerank,iron ion transmembrane transport (GO:0034755),0.7631195330675533,1.5439488364785612,0.0339943342776204,0.7227668282338651,1.0,3/10,6.64%,SCARA5;SLC39A14;SLC11A2
prerank,extracellular matrix assembly (GO:0085029),0.6459080108050639,1.5423138368795586,0.028395061728395062,0.7259471867606737,1.0,5/23,7.80%,HAS2;TNXB;HAS1;NTN4;GAS6
prerank,regulation of immune response (GO:0050776),0.54555271526969,1.541447760769976,0.0010111223458038423,0.7236077317662948,1.0,19/135,11.23%,CD34;COL3A1;SYK;COL1A2;COL1A1;COL17A1;IRF4;KIR3DL2;NPDC1;TGFB2;FOXP1;CD160;CSK;TIRAP;CD81;SAMHD1;BCL6;COL2A1;SPPL2B
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.7739059611569249,1.5412591642705806,0.0335195530726257,0.7169628417787872,1.0,2/10,0.75%,LRP6;WNT2
prerank,regulation of B cell differentiation (GO:0045577),0.6940110829945456,1.5410397194745784,0.03259452411994785,0.7104563647026934,1.0,5/17,12.41%,SYK;ZFP36L1;INHA;ZFP36L2;CD27
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.7099143042245308,1.5402121890199902,0.0274869109947644,0.708582796421927,1.0,6/15,7.63%,FGF18;FGFR1;VEGFA;FGF2;SMOC2;PRKD2
prerank,amino sugar metabolic process (GO:0006040),0.7660895436037058,1.5388372890903126,0.02142857142857143,0.7102503848266462,1.0,2/10,3.16%,GFPT2;GFPT1
prerank,limb morphogenesis (GO:0035108),0.6629459190942267,1.5386934304206608,0.030226700251889168,0.7034063106580264,1.0,7/20,10.97%,LRP6;MBNL1;PCSK5;TGFB2;SKI;FBXW4;GLI3
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.70903858973111,1.5380692579246273,0.027308192457737322,0.7002907497479325,1.0,6/15,7.21%,DDR2;DPP4;LRP1;FAP;FSCN1;MELTF
prerank,spinal cord development (GO:0021510),0.746115429346133,1.5377264276889102,0.023876404494382022,0.6951754542631591,1.0,5/12,7.64%,VIT;ZPR1;PKD1;GLI2;PKD2
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.546199326116229,-1.5376807554439957,0.06521739130434782,0.4528618225103265,1.0,4/15,6.15%,PLTP;APOE;SCARB1;ABCG1
prerank,positive regulation of bone resorption (GO:0045780),0.7308410450130292,1.5370249839019456,0.03905160390516039,0.6925187660266553,1.0,2/11,1.22%,SYK;PRKCA
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.5477821413497117,-1.5366383693599166,0.024793388429752067,0.44877345511037214,1.0,5/15,12.26%,SORT1;ZFYVE27;CASP3;NTRK2;BDNF
prerank,synaptic vesicle endocytosis (GO:0048488),0.6134786030021406,1.5366176207360396,0.026436781609195402,0.6881169724103116,1.0,6/33,3.32%,STON2;SNCB;CEL;SYT2;DNM1;STX1A
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.6007626356877235,1.533955718395531,0.011428571428571429,0.6986416872534255,1.0,9/41,10.98%,NOX4;AREG;BTC;FYN;DLG4;SRC;GAS6;SRCIN1;EGF
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.7060399772178788,1.5338172657239473,0.0280970625798212,0.6925728976073132,1.0,8/16,16.92%,AR;ESR1;TRIP4;EGLN2;RBFOX2;DDX17;PADI2;DDX5
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.5240728174415245,-1.533388798930952,0.05069124423963134,0.45062142586076764,1.0,3/18,1.80%,PRKAG2;OCLN;SLC2A1
prerank,embryonic digit morphogenesis (GO:0042733),-0.4986373522289651,-1.5311096558077004,0.038461538461538464,0.45021891721408874,1.0,7/18,9.65%,MAP3K20;CREBBP;OSR1;TBX3;SALL1;TBX2;INTU
prerank,chondroitin sulfate metabolic process (GO:0030204),0.6287063426486036,1.5308053202708316,0.022458628841607566,0.7051155296671059,1.0,6/30,7.89%,DCN;UGDH;CSGALNACT2;VCAN;CHST12;CHSY3
prerank,negative regulation of interleukin-2 production (GO:0032703),0.671296595165848,1.5302161951858302,0.04225352112676056,0.7021329936704838,1.0,2/18,3.81%,CD34;HDAC7
prerank,embryonic skeletal system development (GO:0048706),0.606602011966635,1.529766334484945,0.02824858757062147,0.6983057861018658,1.0,14/35,14.91%,COL1A1;HOXA3;PCSK5;SULF2;WNT9A;SULF1;HOXA4;UCMA;XYLT1;SLC2A10;PDGFRA;SIX1;HOXC4;HOXA9
prerank,early endosome to Golgi transport (GO:0034498),0.7397094349080161,1.5273529434591724,0.051675977653631286,0.7074816601208078,1.0,5/11,8.49%,RAB6A;STX5;SNX1;SURF4;LMAN1
prerank,positive regulation of immune system process (GO:0002684),0.707237639917583,1.5219125269505165,0.03768506056527591,0.7374460864001707,1.0,5/16,8.24%,ANXA1;VEGFA;TGFB2;MIA3;TNFRSF18
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.6058809002483896,1.5199747291885433,0.02937720329024677,0.7438376486529105,1.0,9/33,8.79%,SYK;LIF;DPP4;TGFB2;ADAM9;JAM3;MUC1;RET;FOXC2
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.549623819139012,1.519779315970577,0.0030991735537190084,0.7380851800345477,1.0,23/90,16.92%,EBF2;IL4R;SYK;UCP1;GNAS;IRF4;GADD45G;GRB10;VEGFA;PRKAB2;ADCYAP1;ALMS1;HDAC3;CEBPB;HCRT;TSHR;CNOT3;DYNC1H1;IL4;OGT;DIO2;CXCR4;FABP5
prerank,response to laminar fluid shear stress (GO:0034616),0.7593823445304845,1.5192987921645686,0.0420899854862119,0.7343833102783283,1.0,6/10,14.55%,MAPK7;NFE2L2;KLF2;ABCA1;SMAD6;KLF4
prerank,regulation of epidermal cell differentiation (GO:0045604),0.655025959389564,1.519007363741264,0.03656998738965952,0.7295345770116376,1.0,6/21,12.93%,SFRP4;RUNX1;ZFP36L1;MAFF;SFN;ZFP36
prerank,nucleotide-sugar metabolic process (GO:0009225),0.7182382749769415,1.5183954565546889,0.038303693570451436,0.7270054096673085,1.0,3/12,3.16%,GFPT2;UGP2;GFPT1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.7104528248688566,1.5170172193888247,0.03783783783783784,0.7295025229191408,1.0,3/13,10.12%,GNAI3;RAB23;RHOQ
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.4771494653751967,-1.5163748280402776,0.04081632653061224,0.4822783023522004,1.0,7/24,3.43%,TJP1;CGNL1;PHLDB2;ARHGAP28;ARHGAP6;F11R;RHPN2
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.6469181429559763,1.5162500437732453,0.028967254408060455,0.7276728707781023,1.0,6/24,9.55%,CDON;MAPK12;MAPK14;RBM4;BOC;MAPK11
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.6155614607409117,1.5156177340073602,0.029411764705882353,0.7250188788179689,1.0,5/30,4.01%,SFRP4;FSTL1;PCSK6;SMAD4;SMURF2
prerank,phosphate ion homeostasis (GO:0055062),0.7586634308569452,1.5149450656981165,0.04101838755304102,0.7232272518996665,1.0,1/10,0.14%,SFRP4
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.572989346637048,-1.5146719875000796,0.051587301587301584,0.48025334899475736,1.0,7/12,21.07%,INSR;IGF1R;UVRAG;JMJD4;ADRB2;IRGM;BNIP3
prerank,renal filtration (GO:0097205),0.7475584416559692,1.5114839299143596,0.05316091954022988,0.7400372262253311,1.0,4/10,9.63%,CD34;SULF2;SULF1;XPNPEP3
prerank,cardiac muscle cell contraction (GO:0086003),0.6737055128170903,1.509652232506066,0.03164556962025317,0.7455387545018973,1.0,5/19,8.60%,GSN;ATP1A1;CAMK2D;KCNJ2;PIK3CA
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.5139741665793744,-1.50916130998261,0.04522613065326633,0.48898565776510006,1.0,5/20,11.60%,WNT4;CRY1;C1QTNF3;SIK1;EP300
prerank,regulation of leukocyte migration (GO:0002685),0.6794928584776231,1.5088134732988137,0.05519053876478318,0.7446877877939376,1.0,6/16,14.73%,ANXA1;VEGFA;MIA3;TNFRSF18;CD81;HOXA7
prerank,dermatan sulfate metabolic process (GO:0030205),0.7222855645559173,1.5072963398531831,0.026499302649930265,0.7485643409751644,1.0,4/13,7.75%,DCN;VCAN;CHST12;CHST14
prerank,regulation of mitochondrial depolarization (GO:0051900),0.7450212747475685,1.5071618092851145,0.04564315352697095,0.7431705836502761,1.0,3/10,6.79%,DCN;MYOC;SRC
prerank,skeletal system development (GO:0001501),0.5323847851121953,1.5064272702508739,0.004044489383215369,0.7417852856781765,1.0,30/148,9.19%,COMP;COL1A2;FBN1;MYOC;COL1A1;TRPS1;GNAS;BMP1;FGFR1;PAX1;AKAP13;PAPSS2;EIF2AK3;PCSK5;CD44;SULF2;TGFB2;EXT1;PKD1;ACAN;VCAN;SULF1;TNFRSF11B;INHA;GLI2;TLL1;UCMA;BPNT2;SOX5;XYLT1
prerank,hippo signaling (GO:0035329),-0.46092151335846404,-1.5062539498744099,0.03680981595092025,0.48970342453237525,1.0,14/26,17.60%,TJP1;FAT4;TEAD4;TJP2;TEAD1;AMOT;WWC1;TEAD2;CASP3;YAP1;AMOTL1;TEAD3;SAV1;NPHP4
prerank,regulation of cell communication (GO:0010646),0.5924365337856052,1.5058814894503645,0.026018099547511313,0.7389055243122363,1.0,9/35,7.01%,MGLL;ANXA1;ANK2;SRI;CAMK2D;MTCH1;SOCS2;SCG5;YWHAG
prerank,positive regulation of ossification (GO:0045778),-0.41627562516988215,-1.5048335362369916,0.008695652173913044,0.48699793553716253,1.0,15/39,12.28%,PTN;BMP6;WNT4;ADGRV1;MEF2C;BMP7;OSR1;KL;WNT5A;ATRAID;NELL1;BMPR2;BMP2;PKDCC;TGFB1
prerank,response to fatty acid (GO:0070542),0.674370600855145,1.5037135457368696,0.03810775295663601,0.7470383157541972,1.0,5/17,8.49%,UCP1;IRS1;FOXO1;PID1;PPP5C
prerank,toxin transport (GO:1901998),0.7485277509385977,1.5025273434693198,0.034334763948497854,0.7490820949613609,1.0,2/10,1.03%,ANTXR1;ANTXR2
prerank,potassium ion export across plasma membrane (GO:0097623),0.6965018883955344,1.5019875543120444,0.05319148936170213,0.7463645636047604,1.0,2/13,1.12%,KCNK5;KCNT2
prerank,urogenital system development (GO:0001655),0.7316444336018084,1.5012434177589546,0.046413502109704644,0.7453332881947196,1.0,3/11,1.29%,EPHB2;AMH;ANXA1
prerank,cyclooxygenase pathway (GO:0019371),-0.603611201845081,-1.5008090735988362,0.06885245901639345,0.4906256355619426,1.0,7/10,23.47%,PTGDS;PTGS2;PTGIS;PTGES3;TBXAS1;CBR1;PTGS1
prerank,endoplasmic reticulum organization (GO:0007029),0.5428745631693066,1.500278177104426,0.014814814814814815,0.745665560031473,1.0,33/72,26.07%,SEC16B;TLE6;MOSPD3;EIF2AK3;STX1A;STX5;UBE2J2;SEC31A;TOR1AIP2;GET4;REEP3;MIA3;ALDH3A2;WDR83OS;LMAN1;TRAM2;LNPK;SGTA;RTN3;TRAM1;SEC61A1;REEP5;SHTN1;VAMP2;RAB10;TMEM33;BNIP1;EMD;RTN4;SEC61B;RAB18;ATL1;LPCAT3
prerank,osteoclast differentiation (GO:0030316),0.6434938237841489,1.4991909717690777,0.03567035670356704,0.7470023876124069,1.0,6/22,7.46%,ANXA2;FOXP1;MAPK14;FARP2;SRC;OSTM1
prerank,DNA dealkylation (GO:0035510),0.7329935430197948,1.4981577967557158,0.04033379694019471,0.742089307884994,1.0,1/10,0.11%,MPG
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.7329935430197948,1.4981577967557158,0.04033379694019471,0.742089307884994,1.0,1/10,0.11%,MPG
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.6077105324003421,1.4978765695439515,0.03103448275862069,0.7380062115279178,1.0,20/33,24.61%,AR;ESR1;RUNX1;AXIN1;PRMT2;HDAC6;RNF14;TRIM68;DDX5;UFL1;GPAM;UFM1;KCTD6;CARM1;RNF6;NCOA2;KDM4C;LATS1;UFSP2;CALR
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.6025940390852929,-1.4978647558449276,0.08503401360544217,0.49223828594985575,1.0,4/10,4.51%,ATP1A2;NEDD4L;OSR1;PRKCE
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.6554937539580599,1.4972020759876763,0.05597964376590331,0.7370350042459597,1.0,8/18,16.92%,ESR1;EGFR;NCOR2;NCOR1;ZC3H12A;MAP2K2;IL6;DDX5
prerank,positive regulation of interleukin-12 production (GO:0032735),0.6109760092375969,1.4971699022587488,0.040145985401459854,0.7315522409169909,1.0,6/31,9.55%,SYK;IL16;MAPK14;TIRAP;TLR4;MAPK11
prerank,glycine transport (GO:0015816),-0.6018725732310019,-1.496151435874169,0.03571428571428571,0.49052300846017954,1.0,3/10,10.73%,SLC6A9;SLC38A5;SLC6A17
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6971300147670495,1.494607511306651,0.04722222222222222,0.7426829458527121,1.0,5/14,7.94%,SEC24D;SEC31A;MIA3;SEC24A;SEC23A
prerank,negative regulation of cell communication (GO:0010648),0.6449099047434699,1.4942579371238582,0.042767295597484274,0.7394032178090162,1.0,3/21,4.31%,LIF;SRMS;ACVR1
prerank,positive regulation of actin nucleation (GO:0051127),0.7407626756409724,1.4942558918678268,0.03008595988538682,0.7338583970865304,1.0,3/11,5.99%,GSN;SCIN;WASF1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.6424405930465145,1.4933815982660659,0.05089058524173028,0.7341210690522023,1.0,5/20,11.86%,PLOD2;GCLC;HAGH;CNDP2;GAMT
prerank,limb development (GO:0060173),0.6163305224395117,1.4929939291202192,0.04116222760290557,0.7312293939048295,1.0,7/28,12.17%,RSPO2;COMP;PCSK5;KREMEN1;KAT2B;GLI3;LNPK
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.5225398650787206,1.490899377681612,0.0010050251256281408,0.7392543610284615,1.0,56/173,17.93%,AREG;SEC16B;CD55;COPA;DCTN1;SEC24D;BET1L;ANK2;CNIH3;DYNC1LI2;TMED1;STX5;SEC31A;SPTAN1;SPTA1;ZW10;KDELR3;MIA3;PREB;SEC24A;KDELR1;ARF4;SEC22B;COPB1;TFG;GAS6;SEC23A;USO1;DYNC1LI1;LMAN1;ARFGAP3;ARFGAP1;CUL3;DYNC1I1;SCFD1;NRBP2;RAB2A;COPB2;MPPE1;NAPA;STX17;GOSR1;CNIH1;TRAPPC2L;KDELR2;COG6;DYNC1H1;COPZ2;SPTBN1;NSF;ANK1;SEC24B;ARCN1;RAB1B;GOPC;BCAP31
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.6847744324299556,1.4902043603414796,0.05142083897158322,0.7384512488805292,1.0,2/13,0.36%,FSTL1;FBN1
prerank,leukocyte tethering or rolling (GO:0050901),-0.5164642923467407,-1.4889248989691741,0.06956521739130435,0.5033908681427706,1.0,9/17,29.85%,ITGA4;VCAM1;GCNT1;ROCK1;JAM2;PODXL2;SELPLG;SELP;ITGB7
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.569829352017493,-1.4846031781140518,0.06181818181818182,0.509339705056003,1.0,4/12,13.76%,LYN;IL34;MAPK3;PTK2
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.540807801845936,-1.4838136194826685,0.07851239669421488,0.5054804151426086,1.0,6/14,17.87%,OSR1;CAV1;NOTCH4;SPRED3;SPRED2;SPRY1
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.687690516132238,1.4835949491374008,0.05182072829131653,0.7765924843286157,1.0,3/12,5.48%,UMPS;TK2;TK1
prerank,granulocyte chemotaxis (GO:0071621),0.5615179848419962,1.482947224552955,0.03036876355748373,0.7752389031512539,1.0,8/55,9.08%,SYK;CCL8;ANXA1;TGFB2;S100A8;S100A9;CXCL10;CCL25
prerank,anion transport (GO:0006820),-0.41920751823687946,-1.4827411318939694,0.034013605442176874,0.5022933283044718,1.0,7/33,7.39%,SLC13A4;SLC13A3;ABCG2;SLCO2B1;SLC26A7;SLC22A6;LRRC8B
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6643411973729352,1.481646680748931,0.04804045512010114,0.7781425149547924,1.0,7/17,13.57%,EGFR;PSRC1;PKD1;MAPRE3;PKD2;AKT1;CCND1
prerank,regulation of muscle cell differentiation (GO:0051147),0.6013759679020693,1.4799624967682483,0.03477218225419664,0.7839386935839494,1.0,8/31,9.55%,CDON;MAPK12;HDAC9;MAPK14;RBM4;BOC;CDK9;MAPK11
prerank,regulation of tumor necrosis factor production (GO:0032680),0.5256210873426949,1.4789470200744619,0.007121057985757884,0.78557764158394,1.0,26/112,17.16%,CD34;LBP;SYK;EPHB2;IRAK3;FOXP1;MIF;TMEM106A;SYT11;PTPRJ;IL33;GAS6;TIRAP;PSEN1;TLR4;SIRPA;CD47;ZFP36;TWIST1;ZC3H12A;CD14;IL4;SELENOS;ILRUN;IL6;CHRNA7
prerank,regulation of hormone secretion (GO:0046883),0.6712541718409251,1.478914634665172,0.04736842105263158,0.7803149661128133,1.0,3/15,6.86%,LIF;ANXA1;SCG5
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5506150220237136,1.4779652338645792,0.026058631921824105,0.7811673531471423,1.0,16/65,13.43%,ASPN;FBN1;HTRA3;LDLRAD4;SKIL;PMEPA1;TGFBR2;SMURF2;SKI;STUB1;SMAD6;PEG10;SLC2A10;VASN;UBA52;PIN1
prerank,androgen receptor signaling pathway (GO:0030521),0.7321258839954653,1.4757937394216958,0.04667609618104668,0.7899838296934628,1.0,7/11,16.92%,AR;ZMIZ1;PMEPA1;PLPP1;DDX17;RNF14;DDX5
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.588374581843518,1.4754812634310601,0.0319634703196347,0.7867877300114094,1.0,9/35,10.44%,MYOC;EPHB2;ARHGAP44;HEG1;TGFB2;ABL2;FLCN;CUL3;KANK1
prerank,hyaluronan metabolic process (GO:0030212),0.6185679751055573,1.4743514768607626,0.04773561811505508,0.788886608100977,1.0,4/23,2.82%,HAS2;HAS1;CD44;FGF2
prerank,regulation of mitotic spindle organization (GO:0060236),0.5918664050225355,1.4740708335941246,0.03460207612456748,0.7854786718418194,1.0,10/35,14.86%,PARP3;GPSM2;DCTN1;CLTC;PSRC1;VPS4B;FSD1;CCSAP;CEP97;DYNC1H1
prerank,actin filament capping (GO:0051693),0.6567930051041533,1.4738147511730562,0.0494148244473342,0.7765463251805261,1.0,7/18,14.80%,GSN;SCIN;SVIL;ADD3;TWF1;AVIL;TRIOBP
prerank,barbed-end actin filament capping (GO:0051016),0.6567930051041533,1.4738147511730562,0.0494148244473342,0.7765463251805261,1.0,7/18,14.80%,GSN;SCIN;SVIL;ADD3;TWF1;AVIL;TRIOBP
prerank,regulation of interleukin-10 production (GO:0032653),0.5716203397730043,1.473646358598436,0.030303030303030304,0.7726254611942183,1.0,3/44,1.17%,CD34;SYK;IRF4
prerank,ganglioside metabolic process (GO:0001573),-0.4953754258529772,-1.473234086687069,0.049019607843137254,0.5231465852321473,1.0,15/20,38.43%,ST8SIA4;ST6GALNAC3;ST6GALNAC5;ST8SIA2;ST8SIA6;NEU3;ST6GALNAC6;ABCA2;ST3GAL5;GM2A;NEU2;B4GALNT1;ST8SIA3;NEU4;B3GALT4
prerank,chondroitin sulfate catabolic process (GO:0030207),0.6983659223121317,1.471839739753435,0.04806408544726302,0.7795908476367011,1.0,2/13,4.92%,DCN;VCAN
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5045127585769411,-1.4717729277553493,0.06926406926406926,0.5207984196003469,1.0,11/17,26.29%,NRP1;NTRK3;TEK;CDK5;ABL1;BAIAP2L1;FES;HRAS;NTF3;HCK;HCLS1
prerank,regulation of Wnt signaling pathway (GO:0030111),0.5277363000284846,1.47117443290061,0.00411522633744856,0.7786969364024123,1.0,26/108,10.44%,RSPO2;SFRP4;ESR1;LRP1;GPC3;GRB10;SULF2;DACT3;RUNX1;CDK14;AMER3;KREMEN1;SKI;AXIN1;DACT1;ZRANB1;NFATC1;SULF1;DAAM2;MDFIC;FOXL1;FZD7;PSEN1;GSKIP;TSKU;KANK1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.4519529787583333,-1.4708754211015926,0.02962962962962963,0.5171628824598842,1.0,8/30,12.35%,FLT1;MLLT3;KDR;KIT;SFRP1;INHBA;TGFB1;FLT4
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.49988002118741237,-1.4683773451534088,0.08968609865470852,0.5179037218507357,1.0,8/18,12.83%,ACSL1;ELOVL7;ACSL4;HACD1;ACSL3;HACD2;ACSL6;ELOVL1
prerank,COPII vesicle coating (GO:0048208),0.55070809708545,1.467704165499066,0.02043010752688172,0.785719579012709,1.0,22/61,17.57%,AREG;SEC16B;SEC24D;CNIH3;STX5;SEC31A;PREB;SEC24A;SEC22B;TFG;SEC23A;USO1;LMAN1;CUL3;SCFD1;SEC23IP;NAPA;CNIH1;TRAPPC2L;NSF;SEC24B;RAB1B
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.55070809708545,1.467704165499066,0.02043010752688172,0.785719579012709,1.0,22/61,17.57%,AREG;SEC16B;SEC24D;CNIH3;STX5;SEC31A;PREB;SEC24A;SEC22B;TFG;SEC23A;USO1;LMAN1;CUL3;SCFD1;SEC23IP;NAPA;CNIH1;TRAPPC2L;NSF;SEC24B;RAB1B
prerank,vesicle coating (GO:0006901),0.55070809708545,1.467704165499066,0.02043010752688172,0.785719579012709,1.0,22/61,17.57%,AREG;SEC16B;SEC24D;CNIH3;STX5;SEC31A;PREB;SEC24A;SEC22B;TFG;SEC23A;USO1;LMAN1;CUL3;SCFD1;SEC23IP;NAPA;CNIH1;TRAPPC2L;NSF;SEC24B;RAB1B
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.7341210219891088,1.4674114380990726,0.07845934379457917,0.7777096775103207,1.0,4/10,18.81%,MAPK7;MYADM;KLF4;MBP
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.7341210219891088,1.4674114380990726,0.07845934379457917,0.7777096775103207,1.0,4/10,18.81%,MAPK7;MYADM;KLF4;MBP
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.7089392067481859,1.4673418090037522,0.050546448087431695,0.7732214910901754,1.0,5/11,21.27%,ANXA1;RC3H1;ZC3H12A;IL4;RC3H2
prerank,gastrulation (GO:0007369),0.6672765225721142,1.4670974704908053,0.04768211920529802,0.7700214024028921,1.0,2/15,2.24%,UGDH;GPC3
prerank,ERBB2 signaling pathway (GO:0038128),0.592418506177534,1.4666273551703635,0.0455607476635514,0.7682663470545419,1.0,10/31,16.45%,MYOC;PRKCA;EGFR;BTC;SRC;STUB1;PIK3CA;EGF;HSP90AA1;SOS1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.6832633695969699,1.4664015253696918,0.05131761442441054,0.7649745144673313,1.0,2/14,1.29%,CD80;ANXA1
prerank,regulation of blood coagulation (GO:0030193),0.6149962969579615,1.4655208474352694,0.04481132075471698,0.7657203835469785,1.0,4/27,3.29%,CD34;EPHB2;FAP;F2R
prerank,Notch signaling pathway (GO:0007219),-0.36643556985974574,-1.465325569782635,0.013513513513513514,0.5200586500251986,1.0,19/59,12.09%,SORBS2;ADAM10;GMDS;MAML3;NOTCH3;CREBBP;NOTCH1;PLXND1;WWC1;HEYL;DTX3L;JAG2;NOTCH4;MAML2;BMP2;STAT1;MDK;EP300;GALNT11
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5239650534394552,-1.4643115633228332,0.061611374407582936,0.5173954182545369,1.0,10/16,23.67%,APOE;SCARB1;PIK3CB;NPR3;GCH1;TERT;S100A1;HIF1A;TERF2;NOS1AP
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5135529757536883,-1.4640056504512386,0.04477611940298507,0.5124484499726465,1.0,6/16,12.95%,APOE;NOS3;GUCY1B1;NDNF;NOS1;GUCY1A1
prerank,focal adhesion assembly (GO:0048041),-0.46475080286527537,-1.4635374805926933,0.059113300492610835,0.5079968358911364,1.0,5/21,6.00%,PTPRK;SORBS1;ACTN2;THSD1;PIP5K1A
prerank,positive regulation of interleukin-4 production (GO:0032753),0.6482478483694445,1.4632560185731533,0.04967320261437908,0.7754747176290804,1.0,2/17,1.17%,SYK;IRF4
prerank,mammary gland development (GO:0030879),0.6283256754187118,1.4631340771686379,0.05137844611528822,0.7714457649037454,1.0,5/21,6.96%,WNT2;TGFB3;GPAT4;VEGFA;GLI2
prerank,cAMP biosynthetic process (GO:0006171),-0.5820216701241648,-1.4618571436911154,0.07308970099667775,0.5071520527424788,1.0,4/10,8.72%,ADCY5;ADCY1;ADCY4;ADCY9
prerank,organelle transport along microtubule (GO:0072384),0.5905165506401017,1.4614416274722373,0.04739336492890995,0.7777723198854071,1.0,15/31,25.47%,ARHGAP21;RAB6A;NDEL1;TRAK2;BICD1;DYNC1I1;MAPT;PAFAH1B1;UXT;COPG1;MAP1S;FBXW11;TMEM201;RHOT2;RAB1A
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.5315828597740053,1.4613123106164931,0.010582010582010581,0.7739232238946492,1.0,37/80,23.16%,COPA;RAB6A;KLC1;PLPP3;RAB6B;ZW10;KDELR3;ATP9A;RINT1;KDELR1;ARF4;SEC22B;COPB1;SURF4;ARFGAP3;ARFGAP1;RER1;ATP9B;KIF2A;SCFD1;COPB2;NAPA;KIF3A;SCYL1;KIF3B;KDELR2;COPZ2;NSF;ARCN1;RAB1B;CENPE;TMED2;COPG1;USE1;GOLPH3L;BNIP1;PICK1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.7216714707218665,1.4610476512440247,0.06515580736543909,0.7709291428578765,1.0,3/10,6.69%,ESR1;PSMC4;PSMC6
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.5098795141930458,-1.4603036766387834,0.06538461538461539,0.5061880639267694,1.0,8/14,24.38%,WNT5A;SEMA7A;KIT;MAVS;SIRT1;CD74;NR4A3;GPRC5B
prerank,positive regulation of metabolic process (GO:0009893),0.5206006714415984,1.4601333837357973,0.006122448979591836,0.7722970405137153,1.0,24/103,16.92%,EBF2;IL4R;SYK;UCP1;GNAS;IRF4;GADD45G;GRB10;VEGFA;ACLY;PRKAB2;ADCYAP1;ALMS1;HDAC3;CEBPB;HCRT;TSHR;CNOT3;DYNC1H1;IL4;OGT;DIO2;CXCR4;FABP5
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5403671155353208,1.4598926476734635,0.02267818574514039,0.7692392227659408,1.0,10/68,9.36%,LBP;SYK;IL16;RAB7B;F2R;TMEM106A;IL33;IL17RA;TIRAP;TLR4
prerank,glycolytic process (GO:0006096),-0.4388275383798299,-1.4594568347188794,0.0658682634730539,0.502928359715929,1.0,13/28,20.40%,ENO1;HK2;PGAM1;PGAM4;PGK1;PFKM;ALDOC;PFKL;GAPDH;TPI1;GAPDHS;ENO3;GPI
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.601040739556795,1.4590150880105355,0.04425837320574163,0.770004757173617,1.0,8/27,13.19%,DDR2;WNT2;MIF;CDK4;GAS6;S100A6;PDGFRA;CDKN1A
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.6288020913438402,1.458312696426335,0.049019607843137254,0.7698806876112319,1.0,9/21,12.56%,UGDH;SULF2;EXT1;SULF1;B3GAT3;XYLT1;HS2ST1;HS3ST5;GLCE
prerank,cytoplasmic sequestering of protein (GO:0051220),0.6884053843178626,1.457847686061139,0.06301369863013699,0.768461473601734,1.0,9/13,24.18%,DBN1;PKD1;GET4;PKD2;KEAP1;GOPC;FLNA;YWHAB;LATS1
prerank,positive regulation of superoxide anion generation (GO:0032930),0.6893391859079867,1.4569303671720044,0.04842931937172775,0.7696479880214769,1.0,2/13,2.55%,SYK;CD177
prerank,ribosomal small subunit assembly (GO:0000028),0.6549707050116486,1.4563882336758596,0.05643044619422572,0.768623638160747,1.0,8/16,17.71%,RPSA;MRPS11;ABT1;XRCC5;RPS27L;RPS5;RRP7A;PWP2
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.7184058013104744,1.4545011436220519,0.06611570247933884,0.7759915870207361,1.0,5/10,15.80%,DGKQ;ZNF692;USP7;SELENOS;OGT
prerank,regulation of synapse organization (GO:0050807),-0.45450264857883266,-1.454270373650939,0.04294478527607362,0.5113936493210355,1.0,8/26,12.49%,EPHA4;PDLIM5;MEF2C;CDKL5;WNT5A;ABHD17C;CAMK2B;ABL1
prerank,transition metal ion homeostasis (GO:0055076),-0.4283359902479456,-1.4533225777624579,0.050955414012738856,0.5085844230649982,1.0,10/28,18.77%,CP;IREB2;XIAP;SLC40A1;B2M;CUTC;HFE;FTL;MT3;CYBRD1
prerank,peptidyl-proline hydroxylation (GO:0019511),0.7124877353040413,1.4532323321430738,0.06722689075630252,0.7798036125383879,1.0,4/11,7.06%,P4HA3;P4HA1;EGLN2;P4HA2
prerank,chordate embryonic development (GO:0043009),0.5469583454730057,1.45204025666161,0.024096385542168676,0.7827381561881019,1.0,18/55,9.19%,COL1A1;TGFB3;FGFR1;MBNL1;PCSK5;SIX4;SULF2;VEGFA;LMX1B;PKD1;DACT1;TRIM71;SULF1;UCMA;FLCN;PKD2;SOX8;XYLT1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.5500255394735354,-1.4517097926068006,0.06614785992217899,0.5076339482706711,1.0,6/13,17.09%,NAMPT;PTGS2;PTGIS;PARP10;NUDT12;PARP9
prerank,COPII-coated vesicle budding (GO:0090114),0.5373295759908499,1.4514279860580348,0.022269353128313893,0.7821246714352394,1.0,23/68,17.57%,AREG;SEC16B;SEC24D;CNIH3;STX5;SEC31A;MIA3;PREB;SEC24A;SEC22B;TFG;SEC23A;USO1;LMAN1;CUL3;SCFD1;SEC23IP;NAPA;CNIH1;TRAPPC2L;NSF;SEC24B;RAB1B
prerank,positive regulation of viral life cycle (GO:1903902),0.6104031928372425,1.450786376310361,0.05949367088607595,0.7818524693644668,1.0,7/22,20.60%,AXL;KPNA2;LGALS1;TRIM11;DDB1;VPS37B;TYRO3
prerank,skeletal system morphogenesis (GO:0048705),0.5694289458837267,1.4495684365262478,0.030269058295964126,0.7847753378205763,1.0,14/42,19.46%,SFRP4;LRP6;HOXA3;FGFR1;SKI;HOXA4;PDGFRA;SIX1;HOXC4;HOXA9;RAB33B;TGFBR1;DYNC2I1;RFLNA
prerank,histone H4 deacetylation (GO:0070933),0.7052173726090185,1.4486087737894735,0.07225433526011561,0.7864069479267766,1.0,4/10,14.10%,HDAC9;SIRT2;HDAC3;HDAC4
prerank,protein heterooligomerization (GO:0051291),0.6523897900363993,1.447884603344874,0.06565656565656566,0.7868480605461153,1.0,8/17,14.97%,PKD1;KRT10;PKD2;CPSF6;MAT2A;TMEM120A;HSD17B8;KCNC2
prerank,atrioventricular valve morphogenesis (GO:0003181),0.6309276922660036,1.44718031305477,0.07934508816120907,0.7870099566985135,1.0,7/19,10.07%,TGFB2;SLIT3;TGFBR2;SMAD4;ACVR1;MDM4;SMAD6
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.5556984701632556,1.4469191298022657,0.03982300884955752,0.7843672351691943,1.0,15/47,18.49%,MID1;EGFR;STK25;TGFB2;TAOK3;COPS5;KLHDC10;FOXO1;TAOK2;MAP2K2;NBR1;PER1;PPIA;QARS1;EPHB1
prerank,regulation of plasminogen activation (GO:0010755),0.6802348195229335,1.4455424051640544,0.06408544726301736,0.7887485286634607,1.0,4/12,7.21%,HPN;CLEC3B;RUNX1;MELTF
prerank,positive regulation of T cell proliferation (GO:0042102),0.5489897351875994,1.445353472961113,0.030735455543358946,0.7857612868718402,1.0,4/55,1.29%,TNFSF9;SYK;CD80;ANXA1
prerank,melanocyte differentiation (GO:0030318),-0.5583549530688452,-1.445258169595315,0.09634551495016612,0.5196442195221916,1.0,6/11,13.78%,LRMDA;MEF2C;ENPP1;KIT;SLC24A5;MREG
prerank,regulation of glucose import (GO:0046324),-0.41505312911993036,-1.4422729084799826,0.03546099290780142,0.5221948328029802,1.0,7/30,3.32%,PRKAG2;SORBS1;OCLN;INSR;IGF1;ENPP1;OSBPL8
prerank,neutrophil activation (GO:0042119),0.6884927044667073,1.441918560807101,0.07620320855614973,0.8036313371434032,1.0,1/12,0.27%,SYK
prerank,PERK-mediated unfolded protein response (GO:0036499),0.7049443283435464,1.4417718823026995,0.07454289732770746,0.80030924851045,1.0,5/10,13.91%,EIF2AK3;NFE2L2;HERPUD1;QRICH1;EIF2S1
prerank,sphingosine biosynthetic process (GO:0046512),-0.5620149813162798,-1.4414949809678737,0.104,0.5137983088471975,1.0,7/11,33.25%,ACER2;SPHK1;SPTLC2;SPHK2;ABCA2;SPTLC3;SPTLC1
prerank,sphingoid biosynthetic process (GO:0046520),-0.5620149813162798,-1.4414949809678737,0.104,0.5137983088471975,1.0,7/11,33.25%,ACER2;SPHK1;SPTLC2;SPHK2;ABCA2;SPTLC3;SPTLC1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.6968341576166679,1.4401411453889799,0.06495263870094722,0.8061089337981485,1.0,2/11,1.22%,SYK;PRKCA
prerank,cellular response to fatty acid (GO:0071398),0.6876950186899835,1.43935685165031,0.07565337001375516,0.8067893778529699,1.0,4/12,13.85%,UCP1;IRS1;PID1;ZC3H12A
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.6737700048273784,1.4391792552830862,0.06602475928473177,0.8037758511553609,1.0,6/13,17.93%,SEC16B;EDEM1;CD81;EDEM2;TMEM30A;BCAP31
prerank,neurogenesis (GO:0022008),0.561479783338669,1.4391283408267246,0.039727582292849034,0.7999734592937394,1.0,16/43,20.22%,WNT2;ANXA1;SIX4;TGFB2;LPAR1;TRAK2;DAGLA;MAPT;SIX1;THOC2;DAGLB;CDK5RAP2;CXCR4;EPHB1;CIT;WDR62
prerank,regulation of translational initiation (GO:0006446),0.5394883966484032,1.436426354611723,0.029094827586206896,0.8131382383060269,1.0,31/63,26.80%,EIF2AK3;EIF3B;DAZL;CTIF;RBM4;PAIP2B;AGO2;EIF1;NPM1;CEBPB;LARP1;POLR2D;POLR2G;CDC123;EIF3E;NCK1;YTHDF2;YTHDF1;PAIP2;MTIF2;YTHDF3;ATF4;EIF4G3;TPR;NCK2;EIF4H;DNAJC3;EIF4G1;EIF2B2;EIF4EBP2;DDX1
prerank,negative regulation of T cell activation (GO:0050868),0.573692346196447,1.4346784666866876,0.053409090909090906,0.8201625415530834,1.0,3/35,1.41%,CD80;LAX1;GLMN
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.6181447409567215,1.4346463174561888,0.07663782447466007,0.8161712541140821,1.0,5/22,12.94%,ESR1;PSMC4;PSMC6;MED24;MED13
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.6048553325201075,1.4341513196174647,0.06755126658624849,0.815380034470133,1.0,8/23,13.67%,LIF;SIX4;VEGFA;FGF2;SOX8;EGF;GDNF;SIX1
prerank,regulation of superoxide anion generation (GO:0032928),0.6685341086873593,1.4340920498117227,0.06829896907216494,0.8116984269549748,1.0,2/14,2.55%,SYK;CD177
prerank,cellular sodium ion homeostasis (GO:0006883),-0.5081908847740497,-1.4339830269363323,0.06018518518518518,0.5293582385862108,1.0,4/15,2.72%,ATP1A2;NEDD4L;ATP1B3;SLC12A2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.672739954073481,1.43393447343555,0.09153005464480875,0.8086930418397441,1.0,3/13,10.97%,RUNX1;TGFBR2;GLI3
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.5569783678628161,1.4330290484132422,0.05983889528193326,0.8102767004596105,1.0,12/38,14.68%,CD34;KLF2;ATP2B4;PKD2;TLR4;SIRPA;CD47;AKT1;GLA;ZC3H12A;KLF4;HSP90AA1
prerank,glutathione biosynthetic process (GO:0006750),0.687845980988246,1.4317388724310773,0.07913669064748201,0.8141683119453257,1.0,3/11,9.60%,GCLC;HAGH;CNDP2
prerank,aggrephagy (GO:0035973),0.5874104069848378,1.4317335644396523,0.06643356643356643,0.8101666182483448,1.0,9/27,14.86%,DYNC1LI2;HDAC6;ARL13B;UBE2N;DYNC1LI1;DYNC1I1;SQSTM1;UBA52;DYNC1H1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.6316590025156041,1.4317309709522688,0.06086956521739131,0.8061852164920398,1.0,8/19,18.67%,HNRNPA1;CTC1;GNL3L;SRC;ACD;TERF1;TENT4B;TINF2
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6178990716855137,1.4313817531266395,0.07770700636942675,0.8045466663992911,1.0,3/20,3.98%,SFRP4;GSN;CD160
prerank,negative regulation of interleukin-8 production (GO:0032717),0.6375676195961445,1.4313198068011037,0.07712418300653595,0.8010246710657921,1.0,7/17,22.60%,ANXA1;OTUD7B;BCL3;KLF4;ANXA4;ARRB1;SSC5D
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.6673210543990684,1.4302489092368216,0.07162534435261708,0.803933417803175,1.0,4/14,6.47%,SULF2;FGF2;CREB3L1;SULF1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.629914178443547,1.4286357297773418,0.07426376440460948,0.8099147920983193,1.0,5/19,8.09%,AR;ZC3H8;MTOR;MAF1;BRF2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.6956608578456859,1.4285224116518813,0.07565337001375516,0.8066278652694621,1.0,3/11,1.88%,GHR;IRS1;EIF2AK3
prerank,cAMP-mediated signaling (GO:0019933),-0.44319418604262406,-1.427222710212647,0.040229885057471264,0.5424433919093182,1.0,10/24,9.53%,PDE7B;RAPGEF2;ADCY1;RAPGEF3;ADGRG6;PDE3A;KSR1;AHR;CAP2;PDE2A
prerank,membrane repolarization (GO:0086009),-0.4927122900600864,-1.4267694110263534,0.07258064516129033,0.5382538983004941,1.0,3/15,2.65%,ATP1A2;ATP1B3;KCND3
prerank,actin filament polymerization (GO:0030041),0.5791529497598251,1.4263114587212837,0.05680473372781065,0.8162792043760876,1.0,7/29,5.99%,GSN;PSTPIP1;ANG;DIAPH3;COBL;MSRB1;WASF1
prerank,GTP metabolic process (GO:0046039),0.6479619878178768,1.426115227509621,0.0703851261620186,0.8136683725321028,1.0,3/15,10.12%,GNAI3;RAB23;RHOQ
prerank,regulation of BMP signaling pathway (GO:0030510),0.5242300049117938,1.4260496040594308,0.03477344573234984,0.8102493183097896,1.0,10/73,6.77%,SFRP4;FSTL1;HTRA3;PCSK6;SKIL;SMAD4;SMURF2;SKI;SULF1;SMAD5
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5432935213368588,1.42568964625988,0.046275395033860044,0.8086030463277627,1.0,17/48,11.24%,FGF18;PRKCA;ANXA1;FGFR1;ANGPT4;VEGFA;FGF2;HDAC7;HDAC9;MAPK14;MAP2K3;PRKD2;STAT5A;FOXC2;AKT3;RHOJ;AKT1
prerank,regulation of hemopoiesis (GO:1903706),-0.5720825655842363,-1.4252668128940689,0.11578947368421053,0.5369342757624104,1.0,4/10,5.44%,PTN;CREBBP;PURB;MYSM1
prerank,negative regulation of translational initiation (GO:0045947),0.6728259950114208,1.424745959089014,0.07260273972602739,0.8106785613527492,1.0,8/13,26.36%,RBM4;PAIP2B;AGO2;LARP1;EIF3E;PAIP2;TPR;EIF4EBP2
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.48275155969270334,-1.4246338891158985,0.07488986784140969,0.5335468305267951,1.0,8/18,7.99%,FLT1;COL4A3;MEF2C;PLCG1;SP1;HMGB1;ITGA4;IGF2
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.5432355260859841,1.4242670558408226,0.034782608695652174,0.8098034363539348,1.0,8/51,6.77%,FSTL1;FBN1;HTRA3;SKIL;SMAD4;SMURF2;SKI;SMAD5
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.6243747578427381,1.4241703146537672,0.07702020202020202,0.8065111331160841,1.0,6/18,10.44%,MYOC;HEG1;ABL2;FLCN;CUL3;KANK1
prerank,mesonephros development (GO:0001823),-0.5694763695061551,-1.4231742928348925,0.09056603773584905,0.5330678629352738,1.0,4/11,13.79%,BMP7;OSR1;FGF1;PAX8
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6576697036627125,1.4228335207389313,0.08137931034482758,0.811089489252867,1.0,6/13,20.04%,PDE8A;NFE2L2;GPR37L1;GPR37;HGF;PYCR1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.6013890447762115,1.4225749780120478,0.07855361596009976,0.8089358276625629,1.0,18/23,31.71%,SYVN1;PREB;SURF4;LMAN1;HERPUD1;SELENOS;AUP1;DERL1;SEL1L;TECPR2;SEC61B;HSP90B1;UFD1;RANGRF;NPLOC4;SEC13;DERL2;TMEM129
prerank,cellular response to estradiol stimulus (GO:0071392),0.6255363960064777,1.4217706185578414,0.0779874213836478,0.8104009745925083,1.0,3/18,6.36%,ESR1;EGFR;NCOA3
prerank,supramolecular fiber organization (GO:0097435),0.4926411557721677,1.4212476871204203,0.0,0.8099195473285212,1.0,81/333,14.86%,COL14A1;PLOD2;COL3A1;P4HA3;COL5A2;COL6A3;COL1A2;DDR2;DBN1;TNXB;GSN;COL1A1;KRT20;LOXL2;COL17A1;COL5A1;BMP1;COL8A1;TLE6;COL11A1;COL5A3;DCTN1;ADAMTS2;CCDC88C;COL6A2;FGF13;TGFB2;CDC42EP2;COL8A2;P4HA1;HOOK2;MYO1A;CLIP1;ADAMTS3;DPT;SPTA1;DST;VPS4B;MARCKS;FSD1;COL12A1;COL15A1;NEFL;P4HA2;TGFBI;COL6A1;MYO5A;TLL1;SLK;CLIP2;SIAH1;PLOD3;KIF2A;GGA1;LOXL1;COL9A3;COL2A1;CALCA;SERPINH1;CLIP4;CAMSAP1;COLGALT1;HSPG2;AVIL;MAPT;TPPP3;TLL2;COL20A1;NAT8;UBA52;SLAIN2;RHOA;PIN1;P3H1;CRIPT;WDR73;RND3;GGA2;TRIOBP;TMOD2;DYNC1H1
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.4564381366721345,-1.4207108526961285,0.0748663101604278,0.5344150856909644,1.0,9/21,15.10%,PLTP;PTCH1;APOE;NR1H3;CAV1;SIRT1;ABCA3;NFKBIA;EEPD1
prerank,regulation of transforming growth factor beta production (GO:0071634),0.6210055080550281,1.4201150828225202,0.07944514501891552,0.8131412414942513,1.0,3/18,3.71%,CD34;TGFB2;SMAD4
prerank,positive regulation of vasculogenesis (GO:2001214),0.7109885869558811,1.419178965093051,0.0791268758526603,0.8151606341770042,1.0,2/10,0.97%,CD34;TMEM100
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.6589614554277612,1.4184666159541233,0.08111702127659574,0.8158058901403087,1.0,3/14,5.41%,DDX18;URB1;ZNHIT6
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.5914199585466442,1.4184607390394803,0.06755126658624849,0.8121736941538283,1.0,10/25,10.98%,AR;EGFR;GLMN;ANG;MIF;SRC;FZD7;PSEN1;DSCAM;EGF
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.6809844952009294,1.4180311750960717,0.08795669824086604,0.811075199942935,1.0,4/11,6.50%,TRIAP1;CD44;MIF;MUC1
prerank,receptor internalization (GO:0031623),0.5411253549857746,1.4176950987222336,0.05228031145717464,0.809688687328206,1.0,8/44,8.29%,ACKR3;SYK;LRP1;CD9;DNM1;CLTC;SNX1;CD81
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.6201102253965194,1.4174344778118204,0.08849557522123894,0.8076398790512426,1.0,8/18,9.40%,ANXA1;VEGFA;FGF2;HDAC7;HDAC9;FOXC2;AKT3;RHOJ
prerank,adipose tissue development (GO:0060612),-0.5441690191460617,-1.4172211867889295,0.11151079136690648,0.5386131387262746,1.0,6/11,17.16%,ARID5B;NAMPT;SH3PXD2B;SPTLC2;DYRK1B;PGRMC2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.6448446329773597,1.4164487943446094,0.07779171894604768,0.8098739579248365,1.0,4/16,4.74%,TGFB3;RUNX1;F2R;CREB3L1
prerank,positive regulation of protein maturation (GO:1903319),0.6885315980276181,1.4163551257684701,0.08203677510608204,0.8069053494589838,1.0,1/11,0.64%,CCBE1
prerank,protein import into peroxisome membrane (GO:0045046),0.6116390434516048,1.4162839789496493,0.0661764705882353,0.8037718537803265,1.0,13/22,23.90%,PXMP2;PEX16;GDAP1;ALDH3A2;PXMP4;PEX12;SLC25A17;PEX3;PEX5;ATAD1;ABCD3;PEX2;FIS1
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.5995977695187097,1.4150599993955357,0.07376058041112454,0.8073910500584657,1.0,9/24,18.67%,HNRNPA1;CTC1;GNL3L;SRC;ACD;ERCC4;TERF1;TENT4B;TINF2
prerank,actin filament-based transport (GO:0099515),-0.4566168973219988,-1.415002950454842,0.09359605911330049,0.5395358099328961,1.0,5/21,6.08%,SYNE2;MYO1B;FNBP1L;SUN2;MYO1D
prerank,vasculogenesis (GO:0001570),0.5692416629324599,1.4145068425835106,0.066429418742586,0.8073091713035396,1.0,6/32,3.25%,HAS2;GLMN;WT1;VEGFA;TGFBR2;TNNI3
prerank,protein insertion into membrane (GO:0051205),0.5636625262493752,1.4144879778261592,0.08246225319396051,0.8038963580382106,1.0,10/32,14.34%,EGFR;STX1A;STX5;UBE2J2;GET4;ALDH3A2;WDR83OS;TRAM2;SGTA;TRAM1
prerank,keratinocyte differentiation (GO:0030216),0.5739862558756884,1.4139767486478796,0.05748502994011976,0.8037093228653159,1.0,6/29,8.47%,LORICRIN;ANXA1;SCEL;ADAM9;KRT10;JAG1
prerank,miRNA metabolic process (GO:0010586),0.6233014982843653,1.4125653546292645,0.09136420525657071,0.80863217255576,1.0,6/20,12.61%,DIS3L2;TARBP2;TRIM71;DGCR8;AGO2;DDX17
prerank,DNA modification (GO:0006304),0.6140785296780213,1.411628673715516,0.06041923551171394,0.8108727481253112,1.0,2/22,0.87%,MPG;PARP3
prerank,positive regulation of collagen metabolic process (GO:0010714),0.6381445518967921,1.4109007327283305,0.07759699624530664,0.8117200802282861,1.0,4/17,4.74%,TGFB3;RUNX1;F2R;CREB3L1
prerank,negative regulation of neurogenesis (GO:0050768),-0.4028540042242957,-1.410777331505778,0.04827586206896552,0.5462344239759777,1.0,7/34,10.39%,PTN;RAPGEF2;YWHAH;NOTCH1;B2M;APPL2;SORL1
prerank,RNA catabolic process (GO:0006401),0.54813916005414,1.4105311596984513,0.047619047619047616,0.810569034011526,1.0,17/46,19.51%,DIS3L2;ZPR1;ZFP36L2;HNRNPD;NUDT16L1;EXOSC7;SIDT2;ERN1;NUDT16;DNA2;RNASE6;ZFP36;CNOT10;AGO4;YTHDF2;SUPV3L1;AGO3
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5928546844412721,1.4098862655379012,0.07942238267148015,0.810888286702443,1.0,11/26,16.23%,EGFR;PDE8A;ZPR1;ZFP36L1;ZFP36L2;SYAP1;IQGAP1;INPP5K;ZFP36;SNAI2;STAT5B
prerank,regulation of lymphocyte proliferation (GO:0050670),0.6296965125317938,1.4098482204917695,0.0915032679738562,0.8077107818858538,1.0,1/16,0.19%,TNFSF9
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.6696145285010028,1.4087148779174552,0.08263305322128851,0.8112558232426373,1.0,6/12,25.20%,TIPIN;NBN;GMNN;BLM;WDR18;KAT7
prerank,atrial septum development (GO:0003283),0.6680336391985726,1.4080922696380629,0.0922266139657444,0.811584368780579,1.0,3/13,6.84%,ANK2;TGFB2;MDM4
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.3435104688885674,-1.4080726276636508,0.016666666666666666,0.5487184959541306,1.0,23/66,12.28%,PTPRK;NR2F2;ROBO1;MTSS1;APOE;THBS1;DAB2IP;CDK6;DUSP10;PTPRM;TGFBR3;CAV1;RGCC;FGFR2;BRCA2;B2M;AQP11;CAV2;SFRP1;STAT1;CEACAM1;CDKN1C;TGFB1
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.45194220195457835,-1.4077797038838302,0.05829596412556054,0.5446786739724917,1.0,7/19,14.57%,TJP1;BMP6;NOTCH1;RGCC;NOTCH4;PPM1F;AFDN
prerank,intracellular lipid transport (GO:0032365),-0.44374096456098544,-1.4070753635849826,0.07537688442211055,0.5416675700034378,1.0,6/21,11.27%,PRKAG2;PLEKHA8;CERT1;PRKAA2;SLC25A20;ACACB
prerank,regulation of vasculogenesis (GO:2001212),0.6622898097994991,1.4060639296424533,0.07772020725388601,0.8204929883546918,1.0,2/14,0.97%,CD34;TMEM100
prerank,activation of protein kinase A activity (GO:0034199),-0.4896269945064562,-1.4049967387460693,0.09016393442622951,0.5425324709941189,1.0,7/16,15.86%,ADCY5;ADCY1;PRKAR1B;ADCY4;ADCY9;PRKAR2B;PRKACB
prerank,negative regulation of signaling (GO:0023057),0.5914889292455833,1.4038390570913504,0.08455882352941177,0.8306429738280992,1.0,3/25,4.31%,LIF;SRMS;ACVR1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.6641775823413245,1.4035684068826426,0.09563994374120956,0.8290016775034991,1.0,1/12,0.38%,AKR1B1
prerank,negative regulation of macroautophagy (GO:0016242),0.5844977278428793,1.4035078684937776,0.07272727272727272,0.8260301898784107,1.0,19/26,31.05%,USP36;MTOR;SEC22B;PIK3CA;SCFD1;NRBP2;AKT1;SMCR8;NUPR1;QSOX1;UBQLN4;TSC2;MTM1;TMEM39A;TSC1;LZTS1;CHMP4A;CHMP4B;RUBCN
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.695403009476163,1.402435430736502,0.08913649025069638,0.8293629830347763,1.0,3/10,11.38%,LBP;TIRAP;WDFY1
prerank,positive regulation of glucose import (GO:0046326),-0.4369015304360768,-1.4014352856787224,0.08900523560209424,0.5476012836130255,1.0,5/21,3.32%,SORBS1;OCLN;INSR;IGF1;OSBPL8
prerank,amino acid import across plasma membrane (GO:0089718),-0.42635626989716746,-1.4008647249169468,0.06707317073170732,0.5444748309727853,1.0,8/24,6.69%,SLC7A2;SLC6A13;SLC1A3;SLC16A2;SLC7A5;SLC6A9;SLC22A4;SLC3A2
prerank,regulation of cell killing (GO:0031341),0.6326129859734148,1.4008457563244872,0.08507853403141362,0.8354167680302845,1.0,4/16,8.23%,CD55;CFH;TGFB2;FZD7
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.6320342630066795,1.400163740448811,0.11096774193548387,0.8360105844072211,1.0,4/15,5.30%,PIEZO2;HPN;COL11A1;PDZD7
prerank,negative regulation of peptidase activity (GO:0010466),0.5368911684739157,1.4001440110181331,0.04746136865342163,0.8327389060718603,1.0,10/47,11.56%,TIMP2;LRP1;SERPINB8;ECM1;SERPINE3;SERPINF1;SERPINH1;CSTB;AKT1;SERPING1
prerank,integrated stress response signaling (GO:0140467),0.6446751152422586,1.399844373377549,0.08211920529801324,0.831280097944111,1.0,5/14,13.91%,EIF2AK3;NFE2L2;HERPUD1;QRICH1;EIF2S1
prerank,positive regulation of vasoconstriction (GO:0045907),0.6592581314088307,1.3993151255185492,0.09264305177111716,0.8312062841242164,1.0,2/13,3.29%,AVPR1A;F2R
prerank,protein ADP-ribosylation (GO:0006471),0.5727912852018697,1.398281602068657,0.07821901323706378,0.8337764179116677,1.0,8/28,10.90%,PARP3;ART4;PARP11;ARF4;PARP6;SIRT2;PARP14;ZC3HAV1
prerank,telomere maintenance via recombination (GO:0000722),0.6729281792797219,1.397521890576052,0.09766162310866575,0.8347871697144779,1.0,9/11,26.75%,XRCC3;SMC5;ERCC4;SMC6;RAD50;TEP1;ERCC1;NSMCE2;RAD51D
prerank,neutrophil chemotaxis (GO:0030593),0.5306379060929687,1.397246801847996,0.052060737527114966,0.8330756639832809,1.0,7/53,9.08%,SYK;CCL8;TGFB2;S100A8;S100A9;CXCL10;CCL25
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.5833110215674461,1.39721783760539,0.0748792270531401,0.8299495952687991,1.0,12/26,23.97%,FYN;MAPK7;PDE8A;NFE2L2;AKT1;GPR37L1;GPR37;HTRA2;PPIA;PYCR1;ATF4;BAG5
prerank,nuclear membrane disassembly (GO:0051081),0.6442639009003797,1.3958494224336653,0.11096605744125326,0.8347375746971507,1.0,2/14,1.79%,PRKCA;DCTN1
prerank,circulatory system development (GO:0072359),0.4942438773024777,1.394923804805505,0.023445463812436288,0.8368963590738757,1.0,32/118,13.19%,COL3A1;FBN1;AKAP13;WT1;PCSK5;PLCE1;ZDHHC16;HEG1;TGFB2;TGFBR2;TNNI3;BORCS8;HDAC9;CRIP1;PKD1;ACVR1;TCF25;PDLIM7;GLI2;ZFPM2;PKD2;FOXL1;PIK3CA;FOXC2;ECE1;KAT2B;EEF1AKMT4-ECE2;HSPG2;MICAL2;PDLIM1;FLRT3;CDKN1A
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.587291946223694,1.3948952210510743,0.07776427703523693,0.8338332316404174,1.0,5/24,6.50%,ACKR3;TRIAP1;CD44;MIF;MUC1
prerank,natural killer cell activation (GO:0030101),0.5949621660567354,1.3946155531764823,0.07151515151515152,0.8321547005650926,1.0,3/23,2.94%,AXL;ELF4;PBX1
prerank,positive regulation of heart rate (GO:0010460),-0.4688472714267526,-1.3942035088049118,0.10572687224669604,0.5579286998689476,1.0,8/17,20.19%,TPM1;ADRA1B;KCNQ1;RYR2;EDN1;ADM;EDN3;SCN3B
prerank,actin polymerization or depolymerization (GO:0008154),0.528893336095825,1.3930604673162281,0.05953693495038589,0.8381676945230995,1.0,18/50,18.74%,GSN;PSTPIP1;SCIN;ANG;DIAPH3;COBL;SVIL;MSRB1;WASF1;ABI1;TWF1;MICAL2;AVIL;DIAPH1;WASHC3;CORO7;GAS7;MICAL1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.5554466345236941,1.392515550576802,0.07286995515695067,0.8381893731519189,1.0,13/35,16.92%,AR;ESR1;ZMIZ1;PMEPA1;SRC;TRIP4;EGLN2;PLPP1;RBFOX2;DDX17;RNF14;PADI2;DDX5
prerank,regulation of lymphocyte activation (GO:0051249),-0.531646705164088,-1.3920989927509306,0.09398496240601503,0.5587029794018833,1.0,8/12,38.09%,PAG1;DCAF15;LAT;IKZF3;THEMIS2;CCL5;CRTAM;LCK
prerank,regulation of cholesterol storage (GO:0010885),-0.4934285646716611,-1.391946197046281,0.09663865546218488,0.5544028599230971,1.0,5/15,6.15%,SCARB1;TTC39B;PPARA;NR1H3;ABCG1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.6109909832250623,1.391630485075734,0.09529860228716645,0.8403642028186685,1.0,7/18,15.32%,NXF1;DDX19B;NUP93;MCM3AP;POLDIP3;THOC2;ZC3H11A
prerank,positive regulation of translational initiation (GO:0045948),0.6162554972489307,1.3914449680247831,0.07653061224489796,0.8382580807678905,1.0,9/18,21.82%,DAZL;MTOR;LARP1;POLR2D;POLR2G;CDC123;YTHDF2;YTHDF1;YTHDF3
prerank,neutrophil migration (GO:1990266),0.5250895619629277,1.3913219490423043,0.05064655172413793,0.8357338928183091,1.0,10/58,13.15%,SYK;CCL8;CD177;TGFB2;S100A8;S100A9;CXCL10;CCL25;IRAK4;CCL13
prerank,aminoglycan biosynthetic process (GO:0006023),0.5281237288347387,1.3906887256614693,0.06961325966850829,0.836445982115056,1.0,13/49,11.57%,HAS1;GPC6;UGDH;GPC3;B3GALNT1;EXT1;B3GAT3;XYLT1;HS2ST1;B3GNT8;HSPG2;HS3ST6;HS3ST5
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.5254870088421111,1.390585737588604,0.06345733041575492,0.8339366339473334,1.0,18/52,17.38%,DCTN1;GFPT1;LMNA;SEC31A;CXXC1;SYVN1;KDELR3;EDEM1;PREB;TPP1;ARFGAP1;CTDSP2;ACADVL;ERN1;DDX11;DNAJB11;KLHDC3;PPP2R5B
prerank,proteoglycan metabolic process (GO:0006029),0.5876628105130279,1.3904835106486766,0.08869987849331713,0.8313697091814544,1.0,9/26,9.19%,SULF2;CSGALNACT2;CHST10;SULF1;GAL3ST3;CHST12;CHST14;FOXL1;XYLT1
prerank,response to UV-A (GO:0070141),0.6424977075763129,1.3901062560356212,0.10158311345646438,0.8304016773414823,1.0,4/14,13.57%,EGFR;MMP2;AKT1;CCND1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6090858389493198,1.3898370106982076,0.09124537607891492,0.8287946921181759,1.0,7/20,13.57%,EGFR;PSRC1;PKD1;MAPRE3;PKD2;AKT1;CCND1
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.54066248382168,-1.3898133417911667,0.11705685618729098,0.5556055987498739,1.0,2/11,1.15%,NEDD4L;ACTN2
prerank,negative regulation of T cell proliferation (GO:0042130),0.5645260676994289,1.389688440753747,0.08492822966507177,0.8265954135100584,1.0,5/28,11.49%,CD80;GLMN;RC3H1;CEBPB;GPNMB
prerank,positive regulation of multicellular organismal process (GO:0051240),0.4797682875967073,1.3894042243829685,0.001002004008016032,0.8253045675261369,1.0,59/308,13.89%,EBF2;IL4R;GHR;LBP;SYK;COL1A1;AVPR1A;UCP1;LOXL2;GNAS;IRF4;LRP1;BMP1;TGFB3;GLMN;TMEM119;TLE6;GADD45G;SIX4;GRB10;VEGFA;FGF2;TGFB2;TGFBR2;F2R;MIF;SMAD4;SMURF2;WWTR1;ACVR1;MTOR;IL33;PRKAB2;ABCA1;NCOA3;C1QBP;SCAMP5;ADCYAP1;GAS6;HMCES;SOX8;CYP27B1;VDR;SOX5;AGO2;ALMS1;HDAC3;INPP5K;TSKU;EGF;FBXO5;CEBPB;HCRT;TSHR;GDNF;CNOT3;TWIST1;SIX1;NME2
prerank,response to cAMP (GO:0051591),0.5505227566485392,1.3892218269029752,0.07964601769911504,0.8232877999796145,1.0,10/37,11.54%,IGFBP5;DUOX1;WT1;DGKQ;ZFP36L1;RAP1B;PKD2;HCN4;INPP5K;SLC26A6
prerank,protein insertion into ER membrane (GO:0045048),0.5466580587174714,1.388739834565858,0.07790697674418605,0.822971772954535,1.0,18/37,24.77%,STX1A;STX5;UBE2J2;GET4;ALDH3A2;WDR83OS;EMC1;TRAM2;EMC10;EMC8;SGTA;TRAM1;EMC3;VAMP2;EMC2;EMD;EMC6;SEC61B
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.6676515431862171,1.3887369518520025,0.0938722294654498,0.8199753141544033,1.0,6/13,20.32%,SYK;CD177;STX4;IL4;ITGAM;GAB2
prerank,regulation of T cell proliferation (GO:0042129),0.5201119476565874,1.3879516714516555,0.04121475054229935,0.8214567966703111,1.0,11/61,18.30%,TNFSF9;CD80;ANXA1;GLMN;CEBPB;GPNMB;TNFRSF1B;IL4;NCK1;IL6;VTCN1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.5070393413069338,1.3876035664737587,0.039790575916230364,0.8204858937466654,1.0,16/72,14.84%,FGF18;FGF7;POLR2H;FGFR1;FLRT2;HNRNPA1;FGF2;TRIM71;HNRNPH1;RBFOX2;SHOC2;FLRT3;POLR2D;POLR2G;CBL;GTF2F1
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.5390579376515362,-1.3872504167723905,0.0944055944055944,0.5574341519113057,1.0,6/11,31.68%,AHR;CEACAM1;HFE;PTPRC;LILRB1;IL4I1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.6777283363949771,1.3868524546568615,0.10465116279069768,0.8216218113663708,1.0,6/10,20.42%,PDE8A;NFE2L2;GPR37L1;GPR37;PYCR1;STK26
prerank,cellular response to hormone stimulus (GO:0032870),0.515561380513297,1.3864759576788612,0.051118210862619806,0.8208913252007023,1.0,19/69,14.41%,GHR;AR;UCP1;WT1;SLIT3;SLIT2;SFR1;ZFP36L1;ATP1A3;ATP1A1;SOCS2;NCOA3;SRC;GAS2L1;INPP5K;URI1;NSMF;BCAS3;LHCGR
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.6105119987039754,1.3860067908972586,0.10440251572327044,0.8205663211896552,1.0,4/19,4.32%,DCN;CCBE1;SMOC2;ADAMTS3
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.45551902377777853,-1.3857077646525011,0.10476190476190476,0.5569152974534196,1.0,7/20,16.41%,IGF1;NIBAN2;FOXC1;LAMTOR5;EP300;TGFB1;GTF2B
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.670630944311507,1.385655652987588,0.09353507565337002,0.8197650591409383,1.0,1/11,0.11%,CD34
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.6644903975033334,1.3855993930946067,0.1006896551724138,0.8171241958298886,1.0,8/13,25.62%,DESI2;DESI1;UBA6;UBA2;SENP6;SAE1;ATG10;UBA7
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6551943513116799,1.3838975503384836,0.09103260869565218,0.8237165250927464,1.0,6/12,21.97%,EPHB2;MYCBP2;HSP90AA1;EPHB1;PTEN;SPTBN4
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.46005554272480953,-1.383605919880205,0.09417040358744394,0.5581239204067814,1.0,3/18,4.64%,PTN;LYN;IL6R
prerank,hematopoietic stem cell proliferation (GO:0071425),0.6798385859017595,1.3834173924824915,0.09483960948396095,0.8236331784598426,1.0,3/11,2.75%,CD34;WNT10B;RUNX1
prerank,axonal transport (GO:0098930),0.5537009966545093,1.3832292626593252,0.06974128233970754,0.8218066661757899,1.0,15/36,22.09%,DCTN1;DST;DTNBP1;NEFL;AP3D1;SYBU;MAPT;KIF3A;KIF3B;BLOC1S2;DYNC1H1;SNAPIN;PAFAH1B1;AP3B2;FBXW11
prerank,regulation of interleukin-6 production (GO:0032675),0.4986278066670278,1.3832050562995775,0.029227557411273485,0.8190526047949962,1.0,20/96,16.45%,LBP;SYK;IL16;RAB7B;IRAK3;F2R;TMEM106A;SYT11;IL33;IL17RA;GAS6;TIRAP;TLR4;SIRPA;CD47;TWIST1;CD200R1;ZC3H12A;SELENOS;IL6
prerank,regulation of cholesterol esterification (GO:0010872),-0.5592937693283697,-1.3822859650487627,0.11447811447811448,0.5574040364889135,1.0,3/10,6.23%,APOE;ABCG1;AGTR1
prerank,positive regulation of cell projection organization (GO:0031346),-0.30703986999841254,-1.3822333352993466,0.0,0.5530559075377451,1.0,36/115,14.26%,PLXNA2;PTN;ROBO1;LYN;RAPGEF2;PTK7;CUX1;ITGA6;SCARB2;PLXNA4;APOE;PTPRD;CDKL5;PRKD1;WNT5A;DAB2IP;PLXND1;SNX3;ROBO2;NDNF;PLPPR5;DVL3;NTRK3;MAP3K13;PLXNB1;CX3CL1;CAMK2B;MDK;EP300;NTRK2;SS18L1;BDNF;SLITRK1;PLK5;TOX;CUX2
prerank,regulation of extracellular matrix organization (GO:1903053),0.6368027222493841,1.3820589714881593,0.08496732026143791,0.822704197850976,1.0,4/15,2.75%,DDR2;LRP1;FAP;RUNX1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.5459102216585603,1.3814236984817574,0.09207459207459208,0.8233123668215252,1.0,11/33,14.55%,CDK2AP2;FHL1;DACT1;CDK4;PRMT2;PKD2;BRD7;GPNMB;CDKN1A;NACC2;KLF4
prerank,response to hydrogen peroxide (GO:0042542),0.5373503278348379,1.3808504415289966,0.066006600660066,0.8234206820620622,1.0,14/45,16.45%,ANXA1;STK25;FYN;MAPK7;ADAM9;NFE2L2;HDAC6;ANKZF1;SIRPA;GPX1;PLEKHA1;OSER1;STK24;IL6
prerank,heart development (GO:0007507),0.48622722979515576,1.3799857698690412,0.017034068136272545,0.8253963901303994,1.0,37/150,13.19%,COL3A1;FBN1;AKAP13;WT1;FLRT2;PCSK5;PLCE1;GPC3;ZDHHC16;HEG1;VEGFA;TGFB2;TGFBR2;TNNI3;BORCS8;HDAC9;CRIP1;MEF2D;PKD1;ACVR1;TCF25;PDLIM7;GLI2;ZFPM2;PKD2;FOXL1;NDRG4;FOXC2;ECE1;KAT2B;EEF1AKMT4-ECE2;ALPK2;MICAL2;PDLIM1;FLRT3;SGCZ;CDKN1A
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.5573227720421923,-1.3795891255034178,0.13962264150943396,0.5557891085459787,1.0,7/11,32.57%,ALG10B;LRRC38;AKAP6;NOS1AP;LRRC55;TREM2;RNF207
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6699837605842826,1.3794832141498063,0.10972222222222222,0.8252590369406151,1.0,3/12,18.11%,CD80;PAEP;IL18
prerank,regulation of cholesterol efflux (GO:0010874),-0.4170332792553609,-1.379137385749745,0.0851063829787234,0.5527439782341803,1.0,11/30,16.65%,PLTP;PTCH1;APOE;TTC39B;NR1H3;CAV1;SIRT1;ABCA3;NFKBIA;EEPD1;ABCA5
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.43174963196347266,-1.3787980708096426,0.0851063829787234,0.5493250044097874,1.0,11/25,19.57%,EPHA4;RPS7;PSMF1;PDCL3;OPHN1;PSME3IP1;RPL5;HIPK2;HFE;CSNK2A1;TAF1
prerank,peroxisomal membrane transport (GO:0015919),0.5753776469721184,1.378152552539393,0.08484848484848485,0.8300345089436909,1.0,14/27,23.90%,PXMP2;PEX16;GDAP1;ALDH3A2;PXMP4;PEX12;PEX1;SLC25A17;PEX3;PEX5;ATAD1;ABCD3;PEX2;FIS1
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.604714660871006,1.377733808538252,0.08227848101265822,0.8295130878162185,1.0,8/18,18.71%,RAB23;MDFIC;FLCN;OTUD7B;CABP1;CHP1;ILRUN;UFM1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6562292462213872,1.377715576372995,0.11172413793103449,0.8267681516883105,1.0,6/12,13.60%,GPAA1;KDELR3;KDELR1;INSIG2;RER1;KDELR2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.6535175920079218,1.3775555332408227,0.10228802153432032,0.8249138346729356,1.0,4/12,6.50%,TRIAP1;CD44;MIF;MUC1
prerank,regulation of platelet aggregation (GO:0090330),0.6198919069265155,1.3768211903540848,0.10643889618922471,0.8263143448790621,1.0,4/17,1.30%,SYK;C1QTNF1;PRKCA;CD9
prerank,positive regulation of embryonic development (GO:0040019),-0.47021261800751196,-1.3765887856695787,0.08755760368663594,0.5513287567711543,1.0,5/19,4.70%,WNT4;TENM4;NIBAN2;OSR1;PLCB1
prerank,regulation of cellular pH (GO:0030641),0.5677495722160046,1.3764441811004084,0.08136792452830188,0.8256747566991847,1.0,12/29,16.13%,SLC4A10;SLC4A8;ATP1A4;SLC4A3;SLC9A9;SLC4A4;SLC9A1;SLC26A6;ATP6AP1;CHP1;SLC9A6;SLC9A7
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.6214148477668664,1.3763103354177801,0.10596026490066225,0.8236434143088064,1.0,3/16,5.29%,SEC16B;ANK2;MIA3
prerank,regulation of Rho protein signal transduction (GO:0035023),0.5044830711341838,1.3762999246457845,0.04942166140904311,0.8209251291333701,1.0,16/72,10.44%,COL3A1;MYOC;ARHGEF28;AKAP13;HEG1;F2R;LPAR1;ABCA1;RIT2;ARHGEF3;ABL2;FLCN;MYO9B;CUL3;GPR20;KANK1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.4959213116059681,1.3761717916948986,0.03419689119170984,0.8188095935398967,1.0,20/87,14.84%,FGF18;FGF7;POLR2H;FGFR1;FLRT2;HNRNPA1;CD44;FGF2;ZFP36L1;TRIM71;ZFP36L2;HNRNPH1;RBFOX2;SHOC2;FLRT3;POLR2D;ZFP36;POLR2G;CBL;GTF2F1
prerank,catecholamine metabolic process (GO:0006584),-0.4935564855794481,-1.375667731689736,0.1125,0.5495022668410965,1.0,3/14,11.25%,SNCAIP;DDC;RNF180
prerank,plasma membrane repair (GO:0001778),0.6415180164574387,1.3756103496545535,0.12283044058744993,0.8192296049814365,1.0,2/13,4.44%,AHNAK2;SYT11
prerank,carbohydrate transport (GO:0008643),0.6556577861980164,1.3745809268477205,0.11944444444444445,0.8223470011614064,1.0,4/11,13.12%,SLC50A1;SLC26A6;SLC23A1;SLC23A2
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.39694547594209284,-1.3743051256026733,0.07633587786259542,0.5489751396161577,1.0,9/35,6.66%,FLT1;NR2F2;COL4A3;MEF2C;APOE;THBS1;PTPRM;CAV1;RGCC
prerank,regulation of chondrocyte differentiation (GO:0032330),0.5867482161274123,1.3740634482045955,0.08946078431372549,0.8226013971033203,1.0,9/24,18.08%,TRPS1;LOXL2;SCIN;WNT9A;CHADL;SOX5;SNAI2;EFEMP1;TGFBR1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.5679693556489462,1.3736321652776005,0.08904933814681107,0.8222516260702721,1.0,11/27,17.17%,ANK2;FGF13;SRI;DSC2;CAMK2D;HCN4;JUP;PDE4D;ATP2A2;STC1;AKAP9
prerank,regulation of cardiac muscle contraction (GO:0055117),0.5504909101435114,1.3724968821673365,0.09111880046136102,0.8258393864865686,1.0,11/34,15.66%,ANK2;TNNI3;SRI;TNNI3K;HCN4;SLC9A1;PDE4D;CALM2;ATP2A2;ZC3H12A;STC1
prerank,positive regulation of macrophage differentiation (GO:0045651),0.6603585585603847,1.372461774823608,0.10764872521246459,0.8233291062465156,1.0,2/11,1.22%,LIF;PRKCA
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6841981365965198,1.3724060176433868,0.11357340720221606,0.8209050457430067,1.0,3/10,14.55%,MAPK7;IRAK3;KLF4
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.47115407302001255,-1.372056617152123,0.08695652173913043,0.5508312703958568,1.0,8/17,12.28%,PTN;IL34;TENM4;NOTCH1;PTPRZ1;BMP2;MDK;TGFB1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.6323931927123418,1.371814505201375,0.128099173553719,0.821292839964384,1.0,4/15,6.86%,SFRP4;GPC3;DACT1;DAAM2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.4237366236443671,-1.3715930836930785,0.0718562874251497,0.5479189420194819,1.0,9/23,16.55%,EFNB2;IGF1;MEF2C;NIBAN2;AKAP6;TGFB1;EDN1;MYOCD;MAML1
prerank,cardiac ventricle development (GO:0003231),-0.44555790015794083,-1.3714278840654819,0.0851063829787234,0.5442362988340657,1.0,7/20,9.53%,ENG;NOTCH1;SALL1;HEYL;STRA6;HECTD1;PDE2A
prerank,protein polymerization (GO:0051258),0.5204685890428054,1.3713915008719348,0.058693244739756366,0.8211263939623754,1.0,18/55,17.94%,GSN;PSTPIP1;ANG;DIAPH3;FGF13;COBL;MSRB1;WASF1;MAPT;TPPP3;PIN1;CASQ1;DIAPH1;WASHC3;CORO7;MAP7D3;CKAP5;GAS7
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.5482447760901178,1.3709198287582587,0.09761904761904762,0.8210521576267773,1.0,10/31,14.55%,CDK2AP2;FHL1;DACT1;CDK4;PRMT2;PKD2;BRD7;GPNMB;CDKN1A;KLF4
prerank,membrane depolarization during action potential (GO:0086010),-0.4099677242998483,-1.3704230890670999,0.08287292817679558,0.5427095082971155,1.0,4/26,4.89%,ATP1A2;YWHAH;CACNA1D;SCN3A
prerank,stress granule assembly (GO:0034063),0.5845183526930358,1.3693239231336736,0.09938650306748466,0.8273120273233535,1.0,12/20,24.48%,UBAP2L;BICD1;ATXN2;MAPT;ATXN2L;EIF2S1;DYNC1H1;YTHDF2;YTHDF1;YTHDF3;OGFOD1;G3BP1
prerank,membrane raft organization (GO:0031579),0.6252028124875845,1.3689788353820374,0.11979166666666667,0.8266189000370923,1.0,6/15,16.19%,ANXA2;S100A10;RFTN1;MYADM;FA2H;FLOT2
prerank,response to ketone (GO:1901654),0.5697227277881453,1.3688861238466505,0.08780487804878048,0.8244861186992402,1.0,5/24,3.72%,TGFB3;TGFB2;SLIT3;SLIT2;CATSPERB
prerank,cellular glucan metabolic process (GO:0006073),-0.5291397086231119,-1.3685774519758136,0.14429530201342283,0.5436368097517699,1.0,4/11,5.19%,PRKAG2;PHKB;PYGM;GBE1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.62359114268037,1.368268088056132,0.121251629726206,0.8252707509297176,1.0,3/15,2.88%,FGFR1;SCEL;TGFB2
prerank,regulation of integrin activation (GO:0033623),0.6220529553785762,1.3679321053253497,0.10888610763454318,0.8244082919159392,1.0,4/15,6.79%,RAP1B;FARP2;JAM3;SRC
prerank,renal system development (GO:0072001),0.5202593321138266,1.3676745215412236,0.06652126499454744,0.823381763761753,1.0,10/52,6.96%,HAS2;WT1;PCSK5;SULF2;VEGFA;TGFB2;C1GALT1;PKD1;SULF1;GLI2
prerank,sulfur compound biosynthetic process (GO:0044272),0.4880489252076153,1.3676294972705698,0.042224510813594233,0.821074194868021,1.0,28/104,18.07%,DCN;GCLC;ST3GAL2;UGDH;B4GALT3;PAPSS2;B4GALT1;OGN;CHST1;CSGALNACT2;ACAN;VCAN;CHST12;CHST14;CHSY3;HAGH;CNDP2;GSTM2;MAT2A;ST3GAL4;MAT2B;GLCE;GGT7;SLC26A1;ST3GAL3;ST3GAL1;MPST;GSTO2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5519607607609248,1.3675066453367972,0.0859465737514518,0.8191548938058658,1.0,4/33,4.06%,LIF;PRKCA;RUNX1;ZFP36L1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.5650679957334012,1.36738263111989,0.09307875894988067,0.8172537709318953,1.0,4/29,3.59%,DBN1;EPHB2;SLC4A10;DLG4
prerank,sulfur compound transport (GO:0072348),-0.4099841968147823,-1.3673232587687167,0.10975609756097561,0.5430419779231174,1.0,9/27,11.53%,SLC6A13;SLC13A4;ABCG2;SLC26A7;SLC25A26;SLC35F3;SLC25A11;MGST1;SLC6A6
prerank,embryonic organ morphogenesis (GO:0048562),0.5296017724862777,1.3671757935842512,0.08508287292817679,0.8158424727934809,1.0,13/42,18.66%,MFAP5;FBN1;HOXA3;ACVR1;HOXA4;ALDH1A3;PDGFRA;SIX1;HOXC4;HOXA9;EFEMP1;NIPBL;DYNC2I1
prerank,negative regulation of cation channel activity (GO:2001258),0.5584437644345209,1.3665522144142255,0.09585798816568047,0.8166976420160719,1.0,6/26,12.36%,EPHB2;SRI;PKD2;CRHR1;GSTM2;CALM2
prerank,endodermal cell differentiation (GO:0035987),0.5543877321317211,1.3651079217499447,0.10440835266821345,0.8221243356982416,1.0,9/31,11.66%,COL8A1;COL11A1;MMP2;ITGB5;ITGA5;COL12A1;COL6A1;ITGAV;SETD2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5631858393330256,1.3650556974855275,0.0989522700814901,0.8198817637814696,1.0,9/29,16.55%,GHR;PKD1;CLCF1;SOCS2;PKD2;STAT5A;FER;STAT5B;SOCS6
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.6290203084000682,1.364980582075228,0.10618279569892473,0.8177252286586736,1.0,6/15,13.89%,SFRP4;NCOA3;CYP27B1;VDR;SFN;NME2
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.6258335102461802,1.3649267074107814,0.12631578947368421,0.8155220653045865,1.0,12/15,31.71%,SYVN1;HERPUD1;SELENOS;AUP1;DERL1;SEL1L;SEC61B;HSP90B1;UFD1;NPLOC4;DERL2;TMEM129
prerank,receptor signaling pathway via STAT (GO:0097696),0.5721079665515718,1.364419511007854,0.09778812572759023,0.8156987873880215,1.0,6/25,7.92%,GHR;PKD1;CLCF1;SOCS2;PKD2;STAT5A
prerank,integrin-mediated signaling pathway (GO:0007229),0.5015015507235236,1.3643652919586038,0.052521008403361345,0.8134855702283724,1.0,19/73,13.89%,COL3A1;SYK;ITGA11;PRAM1;ITGBL1;ITGB3;ADAM9;PLPP3;ITGB5;ITGA2;ITGA5;DST;SRC;CUL3;ITGAV;CD47;FYB2;ADAM15;NME2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.38569776479754114,-1.364096879396654,0.07017543859649122,0.547347615978777,1.0,13/35,25.13%,CDH5;ATP2C1;CDH6;CDH7;CDH13;PCDHB14;PCDHGC3;CDH19;DCHS1;CDH20;PCDHGB4;CDH11;CDH24
prerank,peptidyl-amino acid modification (GO:0018193),0.677385196087531,1.36401831923457,0.11047345767575323,0.8129488170304097,1.0,5/10,21.63%,FKBP10;METAP2;METAP1;METAP1D;FKBP7
prerank,epithelial cell morphogenesis (GO:0003382),0.6075480440570803,1.363760966664542,0.11182519280205655,0.8118765330093417,1.0,4/17,6.22%,TNMD;CCDC88C;DACT2;COL15A1
prerank,response to peptide hormone (GO:0043434),0.5273867555343823,1.3637036167609267,0.08444444444444445,0.809698066417221,1.0,12/43,16.23%,IGFBP5;ANXA1;IRS1;ZFP36L1;MEAK7;SRC;STAT5A;EPM2AIP1;AKT1;EIF6;OGT;STAT5B
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5024205479039474,1.36340463201008,0.0669500531349628,0.8089069584445874,1.0,10/69,9.36%,LBP;SYK;EPHB2;MIF;TMEM106A;PTPRJ;IL33;TIRAP;PSEN1;TLR4
prerank,negative regulation of calcium ion transport (GO:0051926),-0.48617278266513286,-1.3632150788261865,0.12264150943396226,0.5457351664359287,1.0,4/15,11.88%,ATP1A2;SLC30A1;ADRA2A;NOS1
prerank,camera-type eye morphogenesis (GO:0048593),0.6823877030248003,1.3631825497443897,0.10632183908045977,0.8076893872684575,1.0,4/10,5.07%,LRP6;VEGFA;SKI;TENM3
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6689638218846912,1.3631168984345396,0.11706629055007052,0.8031562448934303,1.0,3/10,8.25%,CLTC;AP2A2;MYLIP
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6689638218846912,1.3631168984345396,0.11706629055007052,0.8031562448934303,1.0,3/10,8.25%,CLTC;AP2A2;MYLIP
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.5601147610580487,1.3630896095960585,0.09036860879904875,0.8008795057105302,1.0,12/29,16.99%,COPA;RAB6A;RAB6B;COPB1;COPB2;NAPA;GOSR1;COG6;COPZ2;RAB33B;NSF;NAPG
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.6072084092317217,1.3629872712454896,0.11421319796954314,0.7990192643419426,1.0,6/17,18.11%,CD55;JAG1;TLR4;BACH2;BTN3A3;IL18
prerank,positive regulation of DNA replication (GO:0045740),0.6033862480084978,1.3620536683127966,0.11387434554973822,0.8019327710051973,1.0,5/16,12.18%,EGFR;CTC1;GLI2;EGF;DNA2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.49123211903214953,-1.3619356624541945,0.12549019607843137,0.5451626755966918,1.0,6/14,12.43%,KMT5B;SHLD1;KMT5C;NECTIN2;TFRC;RIF1
prerank,intestinal lipid absorption (GO:0098856),0.655364832030649,1.3616986591833944,0.0993103448275862,0.8014836846688739,1.0,1/11,1.40%,CEL
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.5637437409069095,1.3610092218317327,0.1097708082026538,0.802579988107885,1.0,13/26,26.58%,CUL3;HECW2;CDC23;FBXO5;ANAPC5;CDC27;CDK5RAP2;ANAPC4;CENPE;RIOK2;ANAPC15;NSMCE2;DUSP1
prerank,regulation of T cell activation (GO:0050863),0.5367318987632909,1.3604779777516023,0.07352941176470588,0.8032115200296394,1.0,9/42,21.01%,TNFSF9;LAX1;SIRPA;CD47;GPNMB;TNFRSF1B;VTCN1;PRELID1;PYCARD
prerank,regulation of tissue remodeling (GO:0034103),0.6009971498042537,1.35994988025406,0.12435897435897436,0.8037765056491998,1.0,3/18,4.22%,DDR2;RUNX1;THBS4
prerank,membrane assembly (GO:0071709),0.536699193278897,1.3596295320104654,0.09278350515463918,0.8031649672651544,1.0,8/34,9.23%,CEL;STX2;ANXA2;S100A10;RFTN1;CHMP7;TLCD2;STX4
prerank,positive regulation of natural killer cell activation (GO:0032816),0.6398509059503958,1.3592714599057438,0.11973684210526316,0.8027983432080099,1.0,3/13,8.46%,AXL;GAS6;ZBTB1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.6747790707696466,1.3590150848717164,0.13067400275103164,0.8017600803859227,1.0,1/10,0.17%,DCN
prerank,muscle cell differentiation (GO:0042692),-0.3930307597564046,-1.3587294395537979,0.08284023668639054,0.5496376992742481,1.0,8/32,8.90%,NEBL;DMD;WNT5B;MEF2C;SPEG;TBX18;TBX1;MRTFB
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.6463082898237876,1.358373453332377,0.13592233009708737,0.8027235482123782,1.0,3/11,8.47%,TGFB2;ZFPM2;JAG1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.6178615669128108,1.3574697662810742,0.10621761658031088,0.8052013051064142,1.0,5/15,13.67%,SIX4;VEGFA;SOX8;GDNF;SIX1
prerank,import into cell (GO:0098657),-0.36112449352894993,-1.3569676192037317,0.04716981132075472,0.5505168217561364,1.0,9/41,4.74%,ATP1A2;SLC6A13;SLC1A3;SLC16A2;SLC12A7;GLUL;SLC5A3;SLC7A5;SLC22A4
prerank,odontogenesis (GO:0042476),0.5379684603215035,1.3563165645829336,0.09828571428571428,0.8089192217700293,1.0,5/35,6.96%,COL1A2;LRP6;TGFB3;TGFB2;GLI2
prerank,secretory granule organization (GO:0033363),0.6785633933557089,1.3557819215560265,0.11697574893009986,0.8094843448752229,1.0,6/10,21.11%,F2R;DTNBP1;ABCA1;BLOC1S2;VPS33B;LYST
prerank,acylglycerol catabolic process (GO:0046464),0.550424959756285,1.355384527397727,0.09154113557358054,0.8093625920990531,1.0,6/30,18.79%,MGLL;FABP12;DAGLA;FABP5;LIPC;LIPH
prerank,response to interleukin-1 (GO:0070555),0.49348456564247334,1.3552825005564435,0.06092436974789916,0.8074942379646445,1.0,17/73,14.10%,HAS2;CCL8;PRKCA;ANXA1;IRAK3;USP10;NR1D1;SRC;RC3H1;CCL25;MAPK11;SIRPA;CD47;IRAK1;CCL13;ZC3H12A;HDAC4
prerank,regulation of fibroblast migration (GO:0010762),0.5797266158345851,1.3545095381809111,0.1259351620947631,0.8094263548643394,1.0,3/20,2.82%,DDR2;HAS1;FGF2
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.5300664251984055,1.3541639255985247,0.08646188850967008,0.8089599992133533,1.0,16/41,20.91%,MGLL;DAGLA;SCP2;PTGR1;GPX1;GSTM2;PNPLA8;ELOVL5;FADS1;DAGLB;ACOX1;EPHX1;FADS3;CYP1B1;SCD5;HSD17B4
prerank,negative regulation of interleukin-6 production (GO:0032715),0.5639665728076015,1.3536517371070917,0.1087216248506571,0.8095418066502613,1.0,8/27,15.59%,IRAK3;SYT11;GAS6;TLR4;SIRPA;CD200R1;ZC3H12A;SELENOS
prerank,skeletal muscle organ development (GO:0060538),0.5601499229843504,1.3534314241070693,0.11177884615384616,0.8083845656819877,1.0,7/26,13.67%,WT1;DISP1;SIX4;SVIL;MYH14;LARGE1;SIX1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.6351598971776604,1.3530406590924076,0.1394700139470014,0.8081143738316233,1.0,4/12,16.73%,GCLC;HAGH;CNDP2;BDH2
prerank,regulation of cartilage development (GO:0061035),0.5953568611313796,1.351438134255089,0.11892583120204604,0.814402213962114,1.0,3/18,1.37%,TRPS1;BMP1;SCIN
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.6073030897326093,1.3512731611772968,0.13020833333333334,0.8130719600790162,1.0,4/15,12.93%,ANXA1;ZFP36L1;ZFP36L2;ZFP36
prerank,cellular response to interleukin-2 (GO:0071352),0.6678885926523866,1.3512613127199546,0.11279229711141678,0.8085811937833925,1.0,2/11,7.92%,SYK;STAT5A
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.6678885926523866,1.3512613127199546,0.11279229711141678,0.8085811937833925,1.0,2/11,7.92%,SYK;STAT5A
prerank,cellular response to interleukin-7 (GO:0098761),0.6128077779303837,1.3512572545639308,0.10955414012738854,0.804107957195747,1.0,6/17,16.23%,IRS1;SOCS2;STAT5A;IRS2;SMARCA4;STAT5B
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.6128077779303837,1.3512572545639308,0.10955414012738854,0.804107957195747,1.0,6/17,16.23%,IRS1;SOCS2;STAT5A;IRS2;SMARCA4;STAT5B
prerank,protein auto-ADP-ribosylation (GO:0070213),0.6474933164709737,1.3511941541447052,0.12378303198887343,0.8022812969210243,1.0,3/12,7.41%,PARP3;PARP11;PARP6
prerank,regulation of collagen biosynthetic process (GO:0032965),0.5918374811881484,1.3511280494568074,0.11383108935128519,0.800389621332743,1.0,4/19,4.74%,TGFB3;RUNX1;F2R;CREB3L1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.6102594570654336,1.351049311629309,0.10997442455242967,0.798572568586879,1.0,7/17,21.89%,MPG;ACD;TERF1;ERCC5;TINF2;OGG1;TERF2IP
prerank,eye development (GO:0001654),0.5133702189889816,1.3509819452205343,0.08205689277899343,0.7966774666298556,1.0,9/54,5.28%,COL5A2;FBN1;COL5A1;WT1;ZDHHC16;TGFB2;PBX1;SKI;MEIS2
prerank,positive regulation of behavior (GO:0048520),-0.5502665243868591,-1.350863306760419,0.16025641025641027,0.5624680605927335,1.0,5/10,21.45%,MEF2C;STRA6;SGIP1;CFAP20;NR4A3
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.5470397914331164,1.3507336532181229,0.11428571428571428,0.7958994579367813,1.0,6/30,9.15%,COL3A1;AKAP13;F2R;LPAR1;ARHGEF3;GPR20
prerank,cellular response to virus (GO:0098586),0.5418334878366318,1.3506720779516592,0.10887573964497041,0.7940246683989474,1.0,15/30,29.53%,MAPK14;CXCL10;CHUK;MAPK11;ARF1;ZC3H12A;HSP90AA1;VWCE;IL6;RRP1B;LGALS8;GBF1;RIOK3;BAX;LGALS9
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5339887931646645,1.3506181770858712,0.10253456221198157,0.7921415746732697,1.0,6/36,10.98%,AREG;EPHB2;BTC;NCOA3;HDAC6;EGF
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5957771761259509,1.3498963691465224,0.1282051282051282,0.793685793855515,1.0,4/18,12.93%,ANXA1;ZFP36L1;ZFP36L2;ZFP36
prerank,calcium-ion regulated exocytosis (GO:0017156),0.5593157156229835,1.349542148666495,0.1111111111111111,0.7933874738853832,1.0,10/27,21.44%,SCIN;SYT2;SYT12;SYT11;SYT13;SYT1;VAMP2;RIMS2;PPP3CB;ARHGAP17
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.5173378339122261,1.3493919077875605,0.0737073707370737,0.7919780175791419,1.0,15/49,17.51%,LDLRAD4;PMEPA1;DACT1;AIDA;JAM3;SRC;HDAC6;TFIP11;SMAD6;ULK1;NLRP2B;NOP53;ANKRD27;IAPP;PEX5
prerank,ion homeostasis (GO:0050801),0.5511488174072263,1.3472071624241158,0.1038961038961039,0.8011475708495098,1.0,9/30,13.03%,SLC4A10;FHL1;SLC4A8;SLC4A3;CAMK2D;AP3D1;HCN4;SLC4A4;SLC12A5
prerank,chemokine-mediated signaling pathway (GO:0070098),0.5225280565520234,1.3467526821188227,0.10123734533183353,0.8013562680450117,1.0,6/42,13.15%,ACKR3;CCL8;CXCL10;CCL25;STK39;CCL13
prerank,aminoglycan metabolic process (GO:0006022),0.6616606270543123,1.3465560315539673,0.12693935119887165,0.8002726094749523,1.0,5/10,21.80%,GAL3ST3;B3GAT3;XYLT1;XYLT2;B3GAT2
prerank,positive regulation of phospholipase C activity (GO:0010863),0.5273239378278612,1.3456606081280238,0.08258928571428571,0.8026816294103636,1.0,7/40,3.89%,AVPR1A;ESR1;EGFR;FGFR1;ANG;FGF2;LPAR1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.6678244758910699,1.3450717101950864,0.1481994459833795,0.8036846956334535,1.0,4/10,12.45%,GAP43;F2R;PLPP1;PRKD3
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.4957424720932751,1.3449327199612375,0.06468716861081654,0.8022858395964795,1.0,22/79,17.38%,DCTN1;SEC24D;DYNC1LI2;ACTR1B;CLTC;KLC1;SEC31A;AP1M1;SEC24A;AP2A2;SEC23A;DYNC1LI1;DYNC1I1;KIF2A;ARF1;AP1S2;KIF3A;KIF3B;DYNC1H1;CTSD;MFSD6;SEC24B
prerank,protein import (GO:0017038),0.49175111650738174,1.3441988323598788,0.06645898234683281,0.8037405294785778,1.0,39/84,27.08%,SYK;PXMP2;PEX16;SPRN;NUP93;GDAP1;ALDH3A2;NUP107;PXMP4;AKT1;IPO9;PEX12;TNPO2;HSP90AA1;SLC25A17;E2F3;PEX3;PEX5;IPO5;NXT2;NUP50;ATAD1;ABCD3;PEX2;RANBP6;TPR;IPO11;FIS1;IPO13;TSC2;TNPO1;NUP85;NUP133;NUP188;KPNB1;FAM53C;SNX33;RAB8B;NUP88
prerank,positive regulation of DNA recombination (GO:0045911),-0.4045978447021146,-1.343299028042148,0.11627906976744186,0.5782054180670372,1.0,11/27,19.44%,WDR48;KMT5B;SHLD1;KMT5C;ARID2;MRNIP;TFRC;RIF1;FANCB;TIMELESS;MAD2L2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.5120625399903257,1.343083018558847,0.09565217391304348,0.8073761953190737,1.0,12/49,18.11%,GHR;LIF;CTF1;VEGFA;CLCF1;TNFRSF18;PARP14;PIBF1;FLT3;IL4;IL6;IL18
prerank,protein targeting to membrane (GO:0006612),0.492348969164611,1.3430802243388842,0.05783385909568875,0.8052536013804418,1.0,48/83,32.63%,PXMP2;PEX16;GDAP1;ZDHHC7;ALDH3A2;VPS37D;SRP19;PXMP4;TAOK2;VPS37C;ZDHHC2;SGTA;PEX12;SEC63;TRAM1;SLC25A17;SEC61A1;ZDHHC4;PEX3;ZDHHC24;PEX5;ZDHHC21;VPS37B;ZDHHC20;NACA;ATAD1;ABCD3;ATG3;ZDHHC18;PEX2;ICMT;SDCBP;FIS1;RAB8B;MICALL1;SSR1;PRKCI;ZDHHC15;PARD3;MYO1C;GOLGA7B;PIKFYVE;CHMP4A;CHMP4B;ARL6;ZDHHC3;CHM;PEX19
prerank,lipid translocation (GO:0034204),0.5848606980192297,1.3430013622004344,0.12700369913686807,0.8035791428754954,1.0,7/21,12.66%,ATP8B1;ATP9A;ABCA1;ATP11A;ATP9B;TMEM30A;ABCC1
prerank,regulation of hydrolase activity (GO:0051336),-0.320616835909049,-1.3428796811033146,0.047619047619047616,0.5753694303265812,1.0,14/71,5.82%,PLXNA2;PRKG1;EPHA4;CHN2;SCARB2;PLXNA4;FGD4;CHN1;FGD5;DAB2IP;PLXND1;SIPA1L1;RASIP1;CAV1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5454758916871376,-1.342870969667229,0.12681159420289856,0.5714249463845152,1.0,6/11,10.42%,LYN;RAPGEF2;MEF2C;PIK3CB;PIK3CD;SIRT1
prerank,cytoplasmic microtubule organization (GO:0031122),0.5100124289158249,1.3421503834245252,0.07874865156418555,0.8058230839900321,1.0,27/54,26.17%,DCTN1;CCDC88C;HOOK2;CLIP1;DST;VPS4B;FSD1;SLK;CLIP2;CLIP4;CAMSAP1;MAPT;SLAIN2;RHOA;CRIPT;WDR73;DYNC1H1;CHP1;CLIP3;NUMA1;PCM1;TUBGCP5;CCDC88A;KATNA1;CEP126;CCDC88B;KPNB1
prerank,cellular response to fluid shear stress (GO:0071498),0.6405233419910714,1.3413381141725698,0.14325842696629212,0.80784683554257,1.0,7/12,14.55%,HAS2;MAPK7;NFE2L2;KLF2;PKD2;HDAC3;KLF4
prerank,regulation of wound healing (GO:0061041),0.5268869925118661,1.3411384855579604,0.09875141884222474,0.8067162117203996,1.0,6/42,3.29%,EPHB2;DUOX1;ANXA1;SRSF6;FGF2;F2R
prerank,regulation of receptor internalization (GO:0002090),0.534684515618972,1.3411383232575005,0.10630841121495327,0.8046153882523777,1.0,15/35,24.73%,SFRP4;VEGFA;DLG4;ATXN2;ARF1;EGF;MAGI2;AHI1;MKLN1;ATAD1;ARRB1;SDCBP;FLOT1;PICK1;RSPO1
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.6356313763444901,1.3409270195218825,0.12876712328767123,0.8035746959125724,1.0,5/12,13.67%,SIX4;VEGFA;SOX8;GDNF;SIX1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.47402923482573445,1.3407213129677202,0.029233870967741934,0.8025720988728944,1.0,23/150,8.60%,AREG;MYOC;CD80;FGF18;ESR1;AXL;FGF7;EGFR;IRS1;FGFR1;BTC;FYN;FGF2;MST1R;PIK3R2;TCF7L2;PTPRJ;C1QBP;SRC;RET;GAS6;FLT3LG;PIK3CA
prerank,telomere maintenance via telomere trimming (GO:0090737),0.6548060953343617,1.340247029978529,0.1297071129707113,0.798816414531253,1.0,7/10,23.30%,XRCC3;DNA2;TERF1;NBN;BLM;SMARCAL1;ERCC1
prerank,t-circle formation (GO:0090656),0.6548060953343617,1.340247029978529,0.1297071129707113,0.798816414531253,1.0,7/10,23.30%,XRCC3;DNA2;TERF1;NBN;BLM;SMARCAL1;ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.6548060953343617,1.340247029978529,0.1297071129707113,0.798816414531253,1.0,7/10,23.30%,XRCC3;DNA2;TERF1;NBN;BLM;SMARCAL1;ERCC1
prerank,wound healing (GO:0042060),0.5014969640597833,1.3394545600902965,0.08459869848156182,0.800774292064386,1.0,12/62,8.23%,COL3A1;AHNAK2;DCBLD2;ITGB3;FGF2;TGFB2;SYT11;DST;MIA3;PPL;PRCP;FZD7
prerank,positive regulation of macrophage activation (GO:0043032),0.5960854622756101,1.3377529319317298,0.14416775884665792,0.8075400573514375,1.0,3/17,9.36%,LBP;IL33;TLR4
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.6480682230370512,1.3377444446158444,0.12921348314606743,0.805532025695039,1.0,2/11,4.41%,NEUROD2;P2RX3
prerank,muscle contraction (GO:0006936),-0.27919506572014197,-1.3370648494837425,0.0,0.5828040628389767,1.0,30/126,19.00%,SORBS1;TPM1;MYLK;CALD1;ACTN2;ITGA1;DMD;DTNA;DYSF;TMOD3;MYOF;EDNRA;MYL9;MYH11;SMTN;FXYD1;KCNJ12;ACTA2;NOS1;DES;MYOM1;MYL12A;MYBPC1;CLCN1;MYL6;UTRN;GJC1;TNNT3;ROCK1;SNTA1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.5406286780210521,1.3369343057998582,0.11971830985915492,0.8076011768822952,1.0,6/31,7.35%,SYT2;STX1A;SYT12;SYT11;SYT13;SCAMP5
prerank,signal peptide processing (GO:0006465),0.6464327009268415,1.3357525931638154,0.1490857946554149,0.8116930746595657,1.0,3/11,9.14%,PCSK5;SPCS1;SEC11C
prerank,vasculature development (GO:0001944),-0.4656635951452096,-1.3354925902400931,0.13168724279835392,0.5832278457209933,1.0,8/16,15.90%,CDH5;ERRFI1;BMPR2;STRA6;NOTCH4;PDGFRB;FLT4;SOX18
prerank,regulation of dendrite development (GO:0050773),-0.36927050829760527,-1.334773281383659,0.07692307692307693,0.5813201897902883,1.0,8/37,3.54%,PTN;NEDD4L;BMP5;MARK1;TNIK;BMP7;CDKL5;DAB2IP
prerank,regulation of lipase activity (GO:0060191),0.6291085102530583,1.3343664391973167,0.1410958904109589,0.8166467858112626,1.0,5/13,18.98%,PCSK6;PCSK5;RHOA;LIPC;ANGPTL3
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.5266580301195176,1.334241069687328,0.11751412429378531,0.8151656937097959,1.0,9/39,7.64%,LRP6;WT1;VEGFA;FGF2;SLIT2;TGFBR2;PKD1;GLI2;PKD2
prerank,lipoprotein transport (GO:0042953),0.6565187103172924,1.333627543066208,0.15450643776824036,0.8161624438047904,1.0,2/10,5.29%,LRP1;MIA3
prerank,regulation of RNA metabolic process (GO:0051252),0.5009403890619626,1.3335712770756833,0.10400866738894908,0.8143704006572288,1.0,19/59,22.30%,AHNAK2;AHNAK;AFF2;MBNL1;USP36;CLK1;RC3H1;MBNL2;SON;MITF;HNRNPH1;IGF2BP1;TNFRSF1B;YTHDF2;NOVA1;PTBP1;RASA1;RC3H2;PTBP2
prerank,positive regulation of cell killing (GO:0031343),0.6286413272280486,1.332938997711524,0.11966987620357634,0.8155904782278328,1.0,2/13,8.23%,SYK;FZD7
prerank,muscle cell migration (GO:0014812),0.6576964514328147,1.332759619134866,0.16033755274261605,0.8144230022283955,1.0,5/10,14.09%,ITGB3;THBS4;SIX1;AAMP;DDR1
prerank,JNK cascade (GO:0007254),-0.3702816947165232,-1.3325488667489958,0.08547008547008547,0.5834540478803063,1.0,21/40,26.21%,MAP4K3;TNFRSF19;CRKL;IRAK2;MAP3K13;IKBKG;MAPK8;MAPK10;NOD1;MAP3K5;TAB1;UBE2V1;MAPK9;MINK1;MAP2K7;MAP3K10;NOD2;TAB3;RIPK2;ARHGEF6;SH2D3C
prerank,fatty acid transmembrane transport (GO:1902001),-0.4465218442742592,-1.3325365361357377,0.11904761904761904,0.5795947476386777,1.0,5/19,11.27%,PRKAG2;SLC2A1;PRKAA2;SLC25A20;ACACB
prerank,receptor metabolic process (GO:0043112),0.49906071071907304,1.331865112031041,0.08686210640608034,0.816949329098187,1.0,9/53,8.29%,ACKR3;SYK;LRP1;CD9;DNM1;CLTC;MVB12A;SNX1;CD81
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6590626321994367,1.331424661274868,0.11756373937677053,0.8169727070386874,1.0,4/10,13.76%,DPP4;FAP;CHADL;TNFRSF1B
prerank,cellular response to pH (GO:0071467),0.5960875125889169,1.331259971505734,0.12631578947368421,0.8157261593745241,1.0,6/17,19.97%,RAB11FIP5;SLC9A1;GPR68;CHP1;GPLD1;ASIC1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.48619189837035065,1.3310396126678992,0.07306889352818371,0.8147309439949318,1.0,44/80,30.64%,SGSM2;DCTN1;RAB7B;BET1L;RAB6A;CLTC;STX5;HEATR5A;RAB6B;VPS52;SNX1;SURF4;LMAN1;MAGEL2;TBC1D17;GGA1;TBC1D10A;TBC1D23;GOSR1;ARFRP1;TMEM87A;EVI5;PHETA2;SNX6;PREPL;DENND2A;STX16;ANKFY1;VTI1A;BAIAP3;RAB29;RNF126;GOSR2;GBF1;RBSN;VAMP3;YKT6;RHOBTB3;SPAG9;TBC1D5;RAB9B;TMEM87B;PIKFYVE;TRAPPC10
prerank,negative regulation of response to stimulus (GO:0048585),0.49633815321390173,1.3306346240126306,0.08942202835332606,0.8147260597607482,1.0,6/60,4.31%,CD34;COL3A1;SRMS;MAPK7;SLIT2;ACVR1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.4904715786823992,1.3304565938906379,0.07537154989384288,0.8116625070310268,1.0,21/78,17.38%,DCTN1;SEC24D;DYNC1LI2;ACTR1B;CLTC;KLC1;SEC31A;AP1M1;SEC24A;AP2A2;SEC23A;DYNC1LI1;DYNC1I1;KIF2A;ARF1;AP1S2;KIF3A;KIF3B;DYNC1H1;CTSD;SEC24B
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.4904715786823992,1.3304565938906379,0.07537154989384288,0.8116625070310268,1.0,21/78,17.38%,DCTN1;SEC24D;DYNC1LI2;ACTR1B;CLTC;KLC1;SEC31A;AP1M1;SEC24A;AP2A2;SEC23A;DYNC1LI1;DYNC1I1;KIF2A;ARF1;AP1S2;KIF3A;KIF3B;DYNC1H1;CTSD;SEC24B
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.4672477215594364,-1.33034075498516,0.14912280701754385,0.5778772199874712,1.0,4/16,3.84%,PHLDB2;ARHGAP6;THBS1;APOD
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.4672477215594364,-1.33034075498516,0.14912280701754385,0.5778772199874712,1.0,4/16,3.84%,PHLDB2;ARHGAP6;THBS1;APOD
prerank,pentose-phosphate shunt (GO:0006098),-0.5256240101445726,-1.3297773100862922,0.1824561403508772,0.5756199152387721,1.0,6/11,22.90%,DERA;PGLS;TALDO1;RBKS;RPE;RPIA
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.48802345517737067,1.3295414850873093,0.07301587301587302,0.8143402742071557,1.0,10/73,9.36%,LBP;SYK;EPHB2;MIF;TMEM106A;PTPRJ;IL33;TIRAP;PSEN1;TLR4
prerank,atrioventricular valve development (GO:0003171),0.6216634890426966,1.3291102667334904,0.1422924901185771,0.8144978357068355,1.0,5/14,6.84%,TGFB2;SLIT3;TGFBR2;ACVR1;MDM4
prerank,negative chemotaxis (GO:0050919),0.5305302013478429,1.3290946381898567,0.13099415204678364,0.8125941484979702,1.0,10/33,13.40%,SEMA3C;ITGB3;SLIT3;SLIT2;SLIT1;NTN1;SEMA3A;ITGAV;SEMA3D;RHOA
prerank,monosaccharide transmembrane transport (GO:0015749),0.5969023211868048,1.3289918974471546,0.14136125654450263,0.8111509826237153,1.0,5/16,13.12%,SLC5A9;SLC50A1;SLC2A10;SLC23A1;SLC23A2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.5539668059175789,1.3283798093135522,0.13059250302297462,0.8122885255601282,1.0,4/24,6.47%,CCBE1;EIF2AK3;SULF2;SULF1
prerank,ribosome assembly (GO:0042255),0.5069547924568344,1.328361460782792,0.08719646799116998,0.8104322299785841,1.0,20/47,26.22%,RPSA;MRPS11;C1QBP;NPM1;EIF6;SBDS;RPS27L;RPS5;RRP7A;RPL6;NOP53;PWP2;RPF2;MPV17L2;NOP2;EIF2A;RSL24D1;BRIX1;ERAL1;DHX29
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.46708021367847796,-1.328029898926406,0.12396694214876033,0.5762931153590755,1.0,5/15,9.07%,GGACT;GGT5;PRODH;ALDH4A1;SARDH
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.47684724457539307,1.3278137041713225,0.05323590814196242,0.8113854112981225,1.0,21/95,16.45%,LBP;CD80;AXL;ADAM9;MAPK14;NR1D1;CXCL10;CARD16;TIRAP;SIRT2;TLR4;SIRPA;IRAK1;ZFP36;RHOA;TNFRSF1B;ZC3H12A;CD14;SELENOS;PDCD4;IL6
prerank,glycosaminoglycan catabolic process (GO:0006027),0.502995069083075,1.3275797528738342,0.07282608695652174,0.8106446392610787,1.0,14/55,16.75%,DCN;GPC6;GPC3;CD44;OGN;FGF2;ACAN;VCAN;HSPG2;SLC9A1;CHP1;NAGLU;SDC2;IDUA
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.43469948233888545,-1.3274741112020343,0.12886597938144329,0.5739354455062134,1.0,3/21,3.32%,OSBPL10;PLA1A;OSBPL8
prerank,pyroptosis (GO:0070269),-0.4748510752983829,-1.327451953060154,0.12167300380228137,0.570292902679539,1.0,7/15,30.71%,AIM2;CASP4;GSDMD;CASP1;ZBP1;NLRC4;TREM2
prerank,establishment of spindle orientation (GO:0051294),0.5442160064914813,1.3271650842339684,0.14320096269554752,0.8108527831905015,1.0,10/28,22.09%,GPSM2;DCTN1;LLGL1;NDEL1;ZW10;MAP4;CDK5RAP2;PAFAH1B1;NUMA1;FBXW11
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5678996035052111,1.3269731886316405,0.14432989690721648,0.8098374079617974,1.0,4/21,4.19%,IGFBP5;MMP2;FGF2;MEF2D
prerank,endoderm formation (GO:0001706),0.530809806416241,1.3269679346901115,0.10788863109048724,0.8079185822175672,1.0,9/35,11.66%,COL8A1;COL11A1;MMP2;ITGB5;ITGA5;COL12A1;COL6A1;ITGAV;SETD2
prerank,positive regulation of vacuole organization (GO:0044090),0.6513180264240306,1.3267890412027104,0.14788732394366197,0.8068524841206816,1.0,4/10,20.13%,ANXA2;PIP4K2C;LRSAM1;PIP4K2B
prerank,regulation of muscle contraction (GO:0006937),-0.4093126061621858,-1.326187993183694,0.0880503144654088,0.5697167439025359,1.0,7/26,10.32%,ATP1A2;TPM1;KCNB2;CAV1;ENO1;MYL9;KCNA1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.482420879359966,1.3260883744868197,0.06659729448491156,0.8085126610653969,1.0,38/91,26.97%,STON2;SYK;BET1L;CD177;GAS1;ATP9A;RINT1;SRC;RIT2;ABL2;ARFGAP1;INPP5F;STX4;SCFD1;ITGAV;RAB3D;RUFY1;USP7;MAP2K2;RAB33B;NSF;SYT1;RAB5B;RAB5C;VAMP2;RIMS2;RALA;RAB10;MAPK1;PACSIN3;PACSIN2;RAB12;TSC2;STXBP5L;RUFY2;RAB3C;MBTPS1;RAB8B
prerank,cell proliferation in forebrain (GO:0021846),0.6556452099166383,1.326035444539847,0.15677966101694915,0.8068551429107256,1.0,3/10,5.76%,NUMBL;AKNA;DOCK7
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6438154242580583,1.3257171107045804,0.1553398058252427,0.8065906949303385,1.0,4/11,5.80%,SMAD4;LMNA;ATP2B4;FOXO1
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.4516765535948648,-1.3255742677614786,0.12393162393162394,0.5675536669272067,1.0,4/18,7.67%,EPHA4;SP1;ABCG1;CASP3
prerank,long-chain fatty acid transport (GO:0015909),-0.39435612174438306,-1.3249633384293402,0.09615384615384616,0.5655109858120515,1.0,7/30,11.27%,PRKAG2;ACSL1;APOE;PRKAA2;ACSL3;SLC25A20;ACACB
prerank,activation of phospholipase C activity (GO:0007202),0.5450338888679517,1.3244925943035115,0.10756501182033097,0.8106271209339767,1.0,4/29,3.89%,AVPR1A;EGFR;ANG;LPAR1
prerank,epidermal cell differentiation (GO:0009913),0.5139181324195305,1.324475028891066,0.10490307867730901,0.8087839695303023,1.0,7/41,12.21%,LORICRIN;ANXA1;SCEL;ADAM9;KRT10;JAG1;ERCC3
prerank,regulation of platelet activation (GO:0010543),0.5646229021442029,1.3242020999784487,0.1325898389095415,0.808256385077851,1.0,3/21,1.22%,SYK;C1QTNF1;PRKCA
prerank,positive regulation of microtubule polymerization (GO:0031116),0.5427884109532457,1.3240507395169732,0.11592505854800937,0.8070839236415784,1.0,12/28,20.59%,DCTN1;PSRC1;CLIP1;TOGARAM1;MAPRE1;MAPT;SLAIN2;CDK5RAP2;AKAP9;CKAP5;NAV3;NUMA1
prerank,visual perception (GO:0007601),0.4809843657764863,1.32377875093515,0.06342494714587738,0.8065264064515308,1.0,20/84,20.42%,COL1A1;SLC4A10;ROM1;RABGGTA;COL11A1;ABLIM1;MYO9A;CNGB1;COL2A1;CRYBB1;RPGR;CABP1;CRYZ;OPA3;EFEMP1;TYR;SFRP5;RP2;KIFC3;ATF6
prerank,negative regulation of defense response to virus (GO:0050687),0.6572591573691497,1.3235081612962585,0.13674033149171272,0.805912506626065,1.0,5/10,20.97%,TARBP2;ITCH;C1QBP;ILRUN;TSPAN6
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5882424524130339,1.323427403469986,0.13971539456662355,0.8044526656058458,1.0,3/17,3.81%,PCSK6;PCSK5;HDAC9
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6435855451258362,1.3232468801625734,0.13012729844413012,0.803528035988169,1.0,4/11,16.46%,HPN;MST1R;SIRT2;HGF
prerank,long-term synaptic potentiation (GO:0060291),0.5726357495174687,1.3227838550922608,0.1397712833545108,0.8040112984459382,1.0,8/21,18.69%,NPTN;NFATC4;MPP2;GRIN2D;STX4;SLC8A2;GRIN2A;VAMP2
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.6267101207277415,1.3227376438141125,0.17687074829931973,0.8024153964620022,1.0,7/12,21.03%,DCTN1;BICD1;KIF3A;BBS4;NIN;CCDC120;PCM1
prerank,dendritic spine morphogenesis (GO:0060997),0.6003652529813863,1.322535912347788,0.14437086092715232,0.8015758827250427,1.0,7/15,21.08%,EPHB2;DLG4;EPHB3;CTNND2;DIP2A;EPHB1;PTEN
prerank,RNA transport (GO:0050658),0.4946923831036005,1.3222890079524041,0.07352941176470588,0.8009348913664801,1.0,24/71,19.57%,SRSF2;HNRNPA1;SRSF6;RFTN1;NXF1;TGFBR2;ZFP36L1;RTRAF;U2AF1;ATXN2;SRSF3;SIDT2;SRSF11;THOC7;ZFP36;POLDIP3;THOC2;THOC1;ZC3H11A;CKAP5;SRRM1;DDX39A;SLBP;U2AF2
prerank,phospholipid translocation (GO:0045332),0.5431104217593021,1.3218879539173372,0.13761467889908258,0.8009419687459085,1.0,8/28,12.66%,ATP8B1;PLSCR4;ATP9A;ABCA1;ATP11A;ATP9B;TMEM30A;ABCC1
prerank,atrial septum morphogenesis (GO:0060413),0.6599225967832101,1.3215715835404689,0.15362731152204837,0.8006082620055741,1.0,2/10,4.31%,TGFB2;ACVR1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.6281194457650888,1.321313278934296,0.1394700139470014,0.7982405734329351,1.0,7/12,24.31%,EFNA5;MELTF;KANK1;RCC2;CORO1C;FBLN1;DMTN
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.6281194457650888,1.321313278934296,0.1394700139470014,0.7982405734329351,1.0,7/12,24.31%,EFNA5;MELTF;KANK1;RCC2;CORO1C;FBLN1;DMTN
prerank,calcium-mediated signaling (GO:0019722),0.47144572762503606,1.3204103830124672,0.07731958762886598,0.8009212936930269,1.0,23/93,20.25%,ACKR3;EGFR;EIF2AK3;PLCE1;ANK2;TNNI3;PTPRJ;RCAN3;STIMATE;MCU;ACKR4;PPP3CC;RCAN1;CAMKK2;SLC9A1;ATP2A2;PPP3CA;CXCR4;PPP1R9B;CXCR2;BCAP31;PPP3CB;SAMD14
prerank,blood vessel morphogenesis (GO:0048514),0.49665348935869963,1.3203759964214037,0.10075839653304441,0.7992797759791683,1.0,8/54,3.25%,SYK;HAS2;CCBE1;GLMN;WT1;VEGFA;TGFBR2;TNNI3
prerank,response to molecule of bacterial origin (GO:0002237),0.490241574858174,1.3202498089007604,0.08449197860962566,0.7980442438003276,1.0,17/69,14.48%,LBP;IRAK3;FOXP1;F2R;S100A8;S100A9;TIRAP;CYP27B1;SIRT2;TLR4;SMAD6;C4B;SLPI;IRAK1;CD14;GGT7;FER
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6628006695398196,1.3201778146485204,0.13900709219858157,0.7965484770748682,1.0,4/10,7.63%,GRB10;ITGB3;ITGA5;PRKD2
prerank,axonal transport of mitochondrion (GO:0019896),0.6381181007934003,1.3201183804514163,0.1632928475033738,0.7950397357573502,1.0,4/11,11.42%,NEFL;TRAK2;SYBU;MAPT
prerank,neuron differentiation (GO:0030182),0.4642624587298422,1.320044552841546,0.022267206477732792,0.7935990267522032,1.0,16/165,5.07%,LMX1A;LRP6;LHX8;WNT2;WNT10B;UGDH;CTF1;NEUROD2;RUNX1;WNT9A;VEGFA;TGFB2;PBX1;LMX1B;IRX5;TENM3
prerank,regulation of osteoblast proliferation (GO:0033688),0.5910444149961886,1.3197412905290322,0.1382842509603073,0.7933845821702094,1.0,4/17,8.29%,MN1;TMEM119;TNN;SOX8
prerank,icosanoid metabolic process (GO:0006690),0.5142664134164685,1.3197331289394116,0.08914285714285715,0.7916470597579998,1.0,13/40,18.83%,MGLL;CYP2S1;DPEP1;DAGLA;PON3;PTGR1;GPX1;PNPLA8;ABCC1;FADS1;DAGLB;EPHX1;CYP1B1
prerank,polyol metabolic process (GO:0019751),-0.3592215242557689,-1.3180397483495694,0.060240963855421686,0.5802980701629413,1.0,14/46,11.63%,ITPKB;INPP4B;PLCG1;ISYNA1;SLC5A3;NUDT4;PLCB1;ITPK1;INPPL1;INPP5D;MINPP1;NUDT3;ITPKC;PLCD3
prerank,insulin secretion (GO:0030073),0.5736340211684674,1.3178760778706153,0.15552699228791775,0.7989411642673611,1.0,3/19,7.52%,RAB11FIP5;ANXA1;ADCYAP1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.4888304692357154,1.3175255447648633,0.08691099476439791,0.7988831272130218,1.0,9/67,2.49%,GHR;SYK;DDR2;EPHB2;SRMS;EGFR;FGFR1;EPHA3;FYN
prerank,coenzyme A metabolic process (GO:0015936),0.6044237049332258,1.3174697178554269,0.15989159891598917,0.79734393188598,1.0,8/14,21.97%,ACLY;NUDT7;SLC25A16;PANK1;DCAKD;PANK3;ACAT1;CROT
prerank,muscle tissue development (GO:0060537),-0.5055840855249393,-1.3167511466076707,0.1434108527131783,0.5802262604202663,1.0,4/13,8.16%,PGM5;ENG;PTCH1;STRA6
prerank,nucleosome organization (GO:0034728),0.5005616730363617,1.316698683211816,0.09902067464635474,0.799335340522778,1.0,25/55,22.95%,CHAF1B;SMARCD2;MCM3AP;SMARCD1;SPTY2D1;POLE3;NPM1;SMARCC2;SETD2;ANP32B;INO80;DMAP1;SMARCA4;GRWD1;SRCAP;NAP1L2;SET;CTCF;PRDM9;ZNHIT1;PAF1;NAP1L3;KAT6B;BRD2;VPS72
prerank,polyamine metabolic process (GO:0006595),0.6169362193572073,1.3166947886182119,0.1284153005464481,0.7975780497810744,1.0,6/13,22.08%,SRM;HDAC6;ODC1;SMS;SAT1;AMD1
prerank,regulation of neurotransmitter transport (GO:0051588),-0.45755343647217006,-1.3162061122477746,0.136986301369863,0.5780306126588663,1.0,3/16,7.75%,SNCAIP;MEF2C;MCTP1
prerank,response to organophosphorus (GO:0046683),0.5968100964394766,1.3146910047867308,0.14809960681520315,0.8055001738836245,1.0,2/16,2.84%,DUOX1;DGKQ
prerank,"wound healing, spreading of cells (GO:0044319)",0.5467796784361298,1.314219404841175,0.14720194647201945,0.806054216711276,1.0,7/24,14.09%,COL5A1;TMEFF2;CD44;ITGA5;TOR1A;RHOA;DDR1
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.623444741121604,1.3139969722358313,0.17183098591549295,0.8054230433477537,1.0,5/12,16.45%,ESR1;NCOR2;NCOR1;ZC3H12A;IL6
prerank,positive regulation of receptor internalization (GO:0002092),0.5598475574488286,1.3139728545078961,0.1506172839506173,0.803778796704556,1.0,8/22,23.16%,SFRP4;VEGFA;EGF;MAGI2;AHI1;ATAD1;ARRB1;PICK1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.550329434201728,1.3125912299435285,0.12395709177592372,0.8085982651016684,1.0,15/24,30.27%,MAPK7;VEGFA;NFE2L2;CREB3L1;KLF2;MUC1;CEBPB;ATF6;ATF4;SESN2;CHD6;DDIT3;RBPJ;TP53;HSF1
prerank,positive regulation of leukocyte activation (GO:0002696),0.5717502721675358,1.3123586426834246,0.16709511568123395,0.8080081641427066,1.0,3/18,9.36%,LBP;IL33;TLR4
prerank,protein mono-ADP-ribosylation (GO:0140289),0.6364963695052153,1.3118761379844655,0.15664335664335666,0.8086354886951851,1.0,4/11,10.88%,PARP3;PARP11;PARP6;PARP14
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.4823155248486313,-1.3116504003414615,0.17870722433460076,0.5863923831580835,1.0,10/14,39.42%,WDR48;ARID2;MRNIP;FANCB;TIMELESS;WRAP53;RAD51AP1;ERCC6;WAS;PARP1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5086793610098129,1.3115231854813572,0.11160220994475138,0.8086698453635202,1.0,13/45,16.74%,AREG;EGFR;PLCE1;BTC;SRC;PIK3CA;IQGAP1;EGF;AKT1;CBL;AAMP;SOS1;EFEMP1
prerank,negative regulation of immune effector process (GO:0002698),0.6207084343532393,1.3113441578291123,0.1611185086551265,0.8077499092890397,1.0,4/13,14.48%,CD55;RC3H1;CD47;FER
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.6060289765518961,1.3112935224097815,0.15494791666666666,0.806258928632319,1.0,4/15,6.50%,TRIAP1;CD44;MIF;MUC1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.6195004573554137,1.3109774852907181,0.1483957219251337,0.8060060562976865,1.0,4/12,12.36%,SRI;CAMK2D;PDE4D;CALM2
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5256020075075891,1.3107133200816055,0.12099644128113879,0.8056640941525222,1.0,6/32,13.15%,ANG;S100A9;CXCL14;CXCL10;RNASE6;CCL13
prerank,negative regulation of hemostasis (GO:1900047),0.6151907001984447,1.3106163244357927,0.1598951507208388,0.8043839662067314,1.0,1/12,0.11%,CD34
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.5981061799466768,1.3105695793732788,0.15712383488681758,0.8028754614860185,1.0,3/15,3.79%,FANCD2;EME1;TIPIN
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.48217852615312085,1.3104455696259616,0.07240293809024134,0.8017255860027438,1.0,13/79,6.77%,HTRA3;TNMD;SULF2;SKIL;FGF2;SLIT2;SMAD4;SMURF2;SKI;CREB3L1;ATP2B4;SULF1;SMAD5
prerank,water transport (GO:0006833),-0.4949086690669139,-1.3103961117238403,0.14015151515151514,0.5861179334545353,1.0,2/12,8.69%,PDPN;AQP11
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.5934713397211522,1.3097666916277801,0.15194805194805194,0.8032857980971696,1.0,13/17,31.71%,SYVN1;HERPUD1;SELENOS;AUP1;DERL1;SEL1L;SEC61B;HSP90B1;UFD1;NPLOC4;HM13;DERL2;TMEM129
prerank,regulation of catecholamine secretion (GO:0050433),0.5397216214851617,1.3093912367862928,0.13022700119474312,0.8033516735457931,1.0,7/29,10.53%,SYT2;STX1A;SYT12;SYT11;SYT13;DTNBP1;KCNA2
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.6175726851198674,1.3092152332392095,0.1602136181575434,0.8024628006426288,1.0,2/14,9.17%,CD80;PAEP
prerank,response to estradiol (GO:0032355),0.5368323812216054,1.3092121625634354,0.13309352517985612,0.800767829120315,1.0,5/31,6.36%,ESR1;EGFR;ANXA1;SOCS2;NCOA3
prerank,energy reserve metabolic process (GO:0006112),0.5709476934438299,1.3090633864098784,0.16896120150187735,0.7998016277546142,1.0,4/19,7.05%,GFPT2;UGP2;GFPT1;PID1
prerank,T cell activation involved in immune response (GO:0002286),-0.4971432726200756,-1.3087010812387183,0.18248175182481752,0.5869313025759598,1.0,6/12,31.49%,MDK;ICAM1;CD74;LCP1;SLC11A1;LILRB1
prerank,intestinal absorption (GO:0050892),-0.4883477367376836,-1.3084732473212688,0.15625,0.5839860462361903,1.0,4/13,10.21%,F11R;TJP2;ADRA2A;KCNQ1
prerank,myotube differentiation (GO:0014902),0.5803369612566655,1.3083507071601206,0.1475195822454308,0.8016785513643958,1.0,3/17,4.22%,ADAMTS5;SIX4;SKI
prerank,oogenesis (GO:0048477),-0.45854951987868303,-1.3081464311466091,0.16015625,0.5813149327975862,1.0,1/15,0.09%,PTN
prerank,import into nucleus (GO:0051170),0.4856777362780855,1.3074468596529716,0.08985200845665962,0.8044077119356686,1.0,31/73,27.08%,SYK;GEMIN6;HNRNPA1;SPRN;NUP93;NUP107;AKT1;BACH2;IPO9;TNPO2;E2F3;DDX20;SNRPG;SNRPD3;IPO5;NXT2;NUP50;SMN1;HTATIP2;RANBP6;TPR;IPO11;IPO13;TSC2;TNPO1;NUP85;NUP133;NUP188;KPNB1;FAM53C;NUP88
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.462340951279149,1.3074055755033607,0.06659836065573771,0.8029585284378365,1.0,26/113,13.48%,SYK;ESR1;PSMC4;GTF2H3;VEGFA;CDC42EP2;MPP7;RAP1B;GNL3L;ABCA1;FSCN1;PSMC6;SRC;STUB1;DHX33;TIRAP;TLR4;TPPP3;BMF;USP50;ERCC3;BAK1;ERCC4;DDB1;IL5;TERF1
prerank,ncRNA metabolic process (GO:0034660),0.5213768645999239,1.306827487179658,0.13615560640732266,0.8040360384481927,1.0,10/37,18.34%,TARBP2;TRIM71;DGCR8;MEPCE;AGO2;MAPT;DDX17;DDX4;ZCCHC8;TENT4B
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.6420102493105537,1.3065453562022207,0.1752136752136752,0.8020755611075835,1.0,9/11,27.65%,RBM4;TRIM71;AGO2;EIF6;ZFP36;AGO4;AGO3;TNRC6A;AGO1
prerank,miRNA mediated inhibition of translation (GO:0035278),0.6420102493105537,1.3065453562022207,0.1752136752136752,0.8020755611075835,1.0,9/11,27.65%,RBM4;TRIM71;AGO2;EIF6;ZFP36;AGO4;AGO3;TNRC6A;AGO1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.48348177918475654,1.3058369900743454,0.08635394456289978,0.803753526417816,1.0,27/69,25.66%,UBE2J2;SYVN1;EDEM1;RNF121;PSMC6;STUB1;FBXO2;ANKZF1;EDEM2;FBXO17;ECPAS;UBE2G2;HERPUD1;DNAJB2;TMUB2;SGTA;AMFR;SELENOS;AUP1;JKAMP;USP19;DERL1;SEL1L;RHBDD2;SEC61B;HSP90B1;UFD1
prerank,N-glycan processing (GO:0006491),-0.4451114378759639,-1.305736340759454,0.12727272727272726,0.5842251295163705,1.0,6/18,13.38%,FUT8;ST8SIA4;MAN2A1;MGAT4A;ST8SIA2;ST8SIA6
prerank,positive regulation of cell cycle (GO:0045787),0.4921826860016857,1.305600332586494,0.08964781216648879,0.8032290233540731,1.0,17/62,17.12%,LRP6;PRKCA;EGFR;TGFB2;PSRC1;SMOC2;PKD1;CDK4;MEIS2;MAPRE3;PKD2;AKT1;NUDT16;CCND1;NUPR1;USP22;TTL
prerank,protein localization to nucleus (GO:0034504),0.468622103053297,1.305220125965048,0.06878850102669405,0.8034349788641624,1.0,41/102,26.32%,SYK;COL1A1;SIX4;SPRN;LMNA;TOR1AIP2;NUP93;TAF8;NUP107;YWHAE;TOR1A;TAF3;AKT1;BCL3;IPO9;SIX1;TNPO2;BBS4;E2F3;NOP53;PML;IPO5;NXT2;RPF2;TBRG1;NUP50;PAF1;RANBP6;TPR;IPO11;DVL1;IPO13;TSC2;MDM2;CALR;TNPO1;NUP85;NUP133;NUP188;KPNB1;FAM53C
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.5994964198418552,1.3050921075769017,0.15570469798657718,0.8023823810763269,1.0,8/15,24.28%,SKI;ACVR1;DACT1;IGSF1;MAGI2;ACVR2A;FKBP1A;ACVR1B
prerank,myelination in peripheral nervous system (GO:0022011),0.5990938365249251,1.3049609799576072,0.16464237516869096,0.8013724280642185,1.0,4/13,9.62%,MYOC;SKI;SIRT2;ARHGEF10
prerank,regulation of vasculature development (GO:1901342),-0.39249158064964873,-1.3049599600583495,0.12087912087912088,0.5827509415029407,1.0,11/26,15.64%,ETS1;SP100;PLXND1;EMP2;TSPAN12;ERBB2;SFRP1;EGLN1;CTNNB1;ADGRA2;EPHA2
prerank,plasma membrane organization (GO:0007009),0.49096460208338893,1.304712162012158,0.09663409337676439,0.8008049277091077,1.0,12/61,11.20%,AHNAK2;COL5A1;STX2;ANK2;PLSCR4;BIN1;SYT11;TLCD2;OSBPL2;STX4;EHD2;FA2H
prerank,cell projection assembly (GO:0030031),0.5583963707703268,1.304106943975484,0.13358302122347065,0.8019069762066944,1.0,4/22,10.12%,GSN;SCIN;RHOJ;RHOQ
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.4857974880685739,-1.3039255830366965,0.16030534351145037,0.5821388549163412,1.0,7/14,17.51%,RAPGEF2;PKIG;PRKAR1B;SIRT1;HTT;PRKAR2B;ADRB2
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6433146911672714,1.3028103969665261,0.15706051873198848,0.8063280084759867,1.0,3/10,5.21%,FGF7;ADAM9;MTOR
prerank,regulation of dopamine secretion (GO:0014059),0.5459954964018123,1.302713456351964,0.14268292682926828,0.8051803868535161,1.0,8/25,17.19%,SYT2;SYT12;SYT11;SYT13;DTNBP1;KCNA2;GDNF;SYT1
prerank,protein targeting to peroxisome (GO:0006625),0.535353444873368,1.3026979073914247,0.14726840855106887,0.8036167646806421,1.0,14/29,23.90%,PXMP2;PEX16;GDAP1;ALDH3A2;PXMP4;PEX12;PEX1;SLC25A17;PEX3;PEX5;ATAD1;ABCD3;PEX2;FIS1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.4880060972256885,1.3026899802073533,0.0924548352816153,0.8020058257273328,1.0,26/69,21.52%,IRS1;FGFR1;PLCE1;PIK3C2B;PIK3R2;CD160;ZFP36L1;PLCB4;C1QBP;PIK3CA;INPP5F;SIRT2;AKT1;IRS2;PDGFRA;PLEKHA1;RHOA;PI4KB;PI4KA;OGT;PLCD4;GAB2;TYRO3;PTEN;NF1;PIK3CG
prerank,intracellular protein transport (GO:0006886),0.4511849991632612,1.3024242725562034,0.012,0.8016564683300992,1.0,123/304,25.64%,SYK;SGSM2;COPA;DESI1;STX2;RAB32;RABGAP1L;RAB6A;AP4B1;TMED1;STX1A;SPRN;CLTC;STX5;SEC31A;PKD1;STX11;RAB23;RAB6B;RAB19;NUP93;PREB;SCFD2;ARF4;TBCK;TRAK2;SCG5;AP3D1;STX1B;NUP107;HDAC6;SNX1;STRADA;ACD;USO1;SURF4;TBC1D2B;LMAN1;ARFGAP3;HPS4;STX4;TBC1D17;GGA1;SCFD1;ARF1;STX12;AP4E1;COPB2;NPM1;SEC23IP;AKT1;VPS33A;TBC1D10A;NAPA;STX17;RAB43;RPGR;IPO9;ARFRP1;TNPO2;SYNDIG1;GGA2;ARF6;GIPC1;COPZ2;E2F3;CHP1;AP4M1;NSF;EVI5;SGSM1;EVI5L;TBC1D13;NAPG;RAB5B;BCS1L;ARCN1;RAB1B;RAB5C;SNX6;IPO5;ADPRH;NXT2;STX3;TBC1D22B;NUP50;CLIP3;TBC1D15;RAB24;TMED2;VPS33B;VPS36;AP1S3;COX18;RUNDC1;SMURF1;CTTN;BAG3;TBC1D8B;STX16;RANBP6;NAPB;TPR;XPO7;TBC1D12;PICK1;IPO11;TECPR2;FUT10;RABL3;STAM;IPO13;TSC2;CALR;RAB18;TNPO1;STX7;NUP85;NUP133;KIF13B;RAB1A;RAB29;NUP188
prerank,regulation of cilium movement (GO:0003352),-0.5270871886325732,-1.3022743345947765,0.2,0.5832802153199868,1.0,8/10,35.74%,DNAH11;CFAP43;CFAP298;ODAD2;DRC1;CCDC65;CFAP206;CCDC40
prerank,macrophage activation (GO:0042116),0.5303059224135114,1.3020807309293871,0.1306884480746791,0.8015879559653998,1.0,4/34,3.86%,LBP;SYK;FOXP1;TMEM106A
prerank,alpha-amino acid metabolic process (GO:1901605),0.5097222313690704,1.3019116783879239,0.1174496644295302,0.8006792173472773,1.0,2/45,2.42%,NOX4;ALDH18A1
prerank,lipoprotein localization (GO:0044872),0.6329289387293192,1.3018871752959273,0.16216216216216217,0.7991662916815993,1.0,2/11,5.29%,LRP1;MIA3
prerank,reticulophagy (GO:0061709),0.6253476859200311,1.3012581851718725,0.15902964959568733,0.8004524483884914,1.0,7/12,18.71%,ATG2B;ULK2;ATG2A;ULK1;UFC1;UFL1;UFM1
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.452063740497443,-1.3008661498305634,0.14732142857142858,0.5833878276492502,1.0,13/16,45.65%,TRIB2;TNFRSF21;JAK3;DLL1;FCGR2B;AGER;LILRB1;TYROBP;PDCD1LG2;IL23A;FOXP3;IL12B;IL23R
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.4452815247721267,-1.3008056057046242,0.15966386554621848,0.5801539951835843,1.0,8/18,11.66%,PTN;IL34;TENM4;NOTCH1;PTPRZ1;TNFRSF21;MDK;SLC45A3
prerank,cartilage development (GO:0051216),0.4990082059347367,1.300618756463577,0.10927152317880795,0.8019378255325155,1.0,11/49,10.29%,WNT10B;CD44;SULF2;RUNX1;FGF2;SLC39A14;PKD1;NFIB;SULF1;SOX5;COL2A1
prerank,neurotransmitter uptake (GO:0001504),-0.4906255166887321,-1.3004797992262442,0.15471698113207547,0.5775468605727551,1.0,3/12,1.63%,ATP1A2;SLC1A3;GLUL
prerank,establishment of protein localization to extracellular region (GO:0035592),0.5131825987130338,1.3004065992627545,0.12104072398190045,0.8012887799764984,1.0,19/39,30.52%,NECAB3;STEAP3;MIA3;PREB;RCN3;ABCA1;ARFGAP3;RAB3D;MON1A;RAB10;COPG1;SEL1L;RAB12;AFM;RAB3C;RAB8B;PDIA4;COPG2;TMEM167A
prerank,regulation of macrophage differentiation (GO:0045649),0.5915087794796373,1.3000329606304237,0.1599479843953186,0.8014606799653557,1.0,3/15,6.82%,LIF;PRKCA;INHA
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5270278659360369,-1.299481418405238,0.18556701030927836,0.5766368174700759,1.0,5/10,12.24%,BMP6;NOTCH1;RGCC;NOTCH4;PPM1F
prerank,female gamete generation (GO:0007292),-0.39641615267646274,-1.299375466511644,0.13690476190476192,0.573632458405917,1.0,4/29,3.91%,PTN;MCM9;DIAPH2;TOB2
prerank,cellular response to oxygen levels (GO:0071453),0.6291656048219687,1.2990886925173206,0.1669024045261669,0.8042870812372623,1.0,5/10,23.16%,ATP6V0A2;ATP6AP1;CCDC115;TMEM199;PICK1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5011031283954789,1.2990511344689466,0.11171960569550932,0.8028475344422638,1.0,10/47,13.85%,SYK;CD177;TGFBR2;MAPK14;PID1;DHRS4;TLR4;MAPT;CDKN1A;ZC3H12A
prerank,negative regulation of proteolysis (GO:0045861),0.5203758753936111,1.2990460681977538,0.1391509433962264,0.8012561351302208,1.0,7/34,11.24%,TIMP2;GAS1;ECM1;CAMK2N1;HDAC6;CSTB;AKT1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.47523699288443894,1.2986009816265514,0.08783068783068783,0.8017102662197463,1.0,12/74,5.21%,COL1A1;PHLDB1;LOXL2;TGFB3;HPN;LDLRAD4;EPHA3;TGFB2;TGFBR2;SMAD4;WWTR1;MTOR
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.532974620754495,1.2980451374507371,0.14695340501792115,0.8028564547651893,1.0,12/28,21.77%,MAP1B;MAPRE3;GAS2L1;MAPRE1;CAMSAP1;GBA2;MAPT;FKBP4;STMN4;CLASP2;MAP1A;MAP1S
prerank,B cell activation involved in immune response (GO:0002312),-0.4647174565935158,-1.2978965978308028,0.12345679012345678,0.574152137730502,1.0,7/13,26.62%,MSH2;CD180;BATF;RNF8;GPR183;LIG4;FCGR2B
prerank,protein hydroxylation (GO:0018126),0.5924145192004211,1.2975531180801696,0.15251989389920426,0.8036421611289916,1.0,7/15,23.01%,PLOD2;PLOD3;P3H1;VPS33B;PLOD1;OGFOD1;JMJD7
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.4847693236841254,1.2973930179334827,0.09004237288135593,0.8028050716605936,1.0,29/71,27.49%,FAP;CAPN2;ZRANB1;VPS4B;NR1D1;STUB1;HDAC6;UBE2W;CLPX;OTUD7B;UBA52;RSPRY1;DDB1;CLPP;NGLY1;ZER1;SOCS6;IDE;NEDD8;RNF41;PDCD6IP;ZYG11B;RNF123;CTSK;MDM2;PRPF19;CTSB;CTSL;CASP8
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.44245176536028763,-1.2971173983079738,0.13414634146341464,0.5728795113232844,1.0,3/16,3.60%,PTN;SOX6;FOXC1
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.5162134050611104,1.2969632303502718,0.13942857142857143,0.8031947257924517,1.0,10/37,13.22%,PHLDB1;CDK2AP2;EFNA5;EPHA3;MAPRE3;GAS2L1;BICD1;MAPRE1;MAPT;MAP6
prerank,engulfment of apoptotic cell (GO:0043652),-0.46627913463364196,-1.2969553107858898,0.14785992217898833,0.5700993112153004,1.0,5/15,16.72%,RHOBTB1;THBS1;RHOH;XKR6;MEGF10
prerank,ESCRT complex disassembly (GO:1904896),0.6399479587955477,1.2959232324761774,0.15417867435158503,0.8047792457118818,1.0,2/10,5.28%,CHMP7;VPS4B
prerank,ESCRT III complex disassembly (GO:1904903),0.6399479587955477,1.2959232324761774,0.15417867435158503,0.8047792457118818,1.0,2/10,5.28%,CHMP7;VPS4B
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.6027865396894501,1.2959195008907718,0.15678524374176547,0.8032034014109809,1.0,6/14,21.97%,EHHADH;CRAT;SCP2;ACOX1;HSD17B4;CROT
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5733993989058244,1.2958852909676486,0.1464968152866242,0.8017656532082822,1.0,4/19,5.31%,MYOC;VEGFA;S100A10;PTPRJ
prerank,intracellular cholesterol transport (GO:0032367),0.5835986964803359,1.295435630833228,0.16005291005291006,0.8022565388022027,1.0,3/15,6.94%,LRP6;ABCA1;OSBPL2
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6385168716028039,1.2951959662691956,0.1673469387755102,0.8017535246925327,1.0,3/11,5.45%,SESTD1;BIN1;CAMK2D
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.4570548027650413,1.2951195533433135,0.05342741935483871,0.800479075100524,1.0,28/152,11.99%,RSPO2;SFRP4;COL1A1;DKK2;EGFR;SCEL;GPC3;PSMC4;SULF2;UBE2B;SMURF2;SKI;AXIN1;DACT1;ZRANB1;SULF1;PSMC6;DAAM2;PSMD8;GSKIP;TMEM9;KANK1;PLEKHA4;CSNK1G1;PRDM15;EGF;CSNK1G3;JUP
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.5335372763506001,1.29446471272737,0.14064362336114422,0.8019652831991437,1.0,4/26,6.47%,CCBE1;EIF2AK3;SULF2;SULF1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.6245723473019982,1.2925077680016595,0.17222222222222222,0.8096977729970641,1.0,3/11,4.31%,TGFB2;TGFBR2;ACVR1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.5376016837399209,1.2921899425322014,0.154126213592233,0.8096659333841643,1.0,6/26,4.39%,ST3GAL2;B4GALT3;B4GALT1;OGN;CHST1;ACAN
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.3727926546757913,-1.2919709082883633,0.10071942446043165,0.5790767932611421,1.0,9/33,4.27%,NR2F2;PTPRG;SP100;ADAMTS9;APOE;THBS1;DAB2IP;DUSP10;PTPRM
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5581753605220572,1.2918818219285095,0.17237008871989862,0.8095606830445012,1.0,5/19,14.20%,LBP;TIRAP;TLR4;IRAK1;CD14
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.46755221304026945,1.291729084380582,0.07804370447450572,0.8086936943379841,1.0,35/104,23.47%,ASPN;HTRA3;LDLRAD4;SKIL;PMEPA1;TGFBR2;SMAD4;SMURF2;SKI;ACVR1;IGSF1;SMAD5;STUB1;SMAD6;PEG10;SLC2A10;MAGI2;VASN;UBA52;PIN1;SNX6;HTRA4;TGFBR1;STRAP;NBL1;BMPER;UBE2D3;ACVR2A;PPM1A;BMPR1A;SMURF1;CILP;CD109;FKBP1A;SKOR2
prerank,iron ion transport (GO:0006826),0.4974448437121573,1.2911602168342935,0.125,0.8097364354177365,1.0,13/47,16.28%,SCARA5;STEAP3;CLTC;SLC39A14;ATP6V0A2;SLC11A2;MELTF;ATP6V1E1;ATP6AP1;REP15;ATP6V1D;ATP6V0A1;ATP6V1B2
prerank,artery development (GO:0060840),-0.4011786420117387,-1.290668882248355,0.1144578313253012,0.5792022780273972,1.0,9/23,9.53%,ROBO1;ENG;ROBO2;TBX1;NRP1;BMPR2;STRA6;HECTD1;PDE2A
prerank,cardiac muscle cell differentiation (GO:0055007),0.5531414066219961,1.2906000119257268,0.15423514538558786,0.8107732758932054,1.0,4/21,4.31%,AKAP13;WT1;VEGFA;ACVR1
prerank,microtubule bundle formation (GO:0001578),0.507879394711604,1.2904238139458124,0.140893470790378,0.8100530265882862,1.0,14/42,22.05%,NAV1;PSRC1;CLIP1;GAS2L1;TOGARAM1;RSPH1;TPPP3;TTLL3;CHP1;CDK5RAP2;SPAG16;NUMA1;MAP1S;DCX
prerank,mRNA metabolic process (GO:0016071),0.46799870367608987,1.290129771763473,0.08532778355879292,0.8099013596851888,1.0,32/90,21.53%,SRSF2;DIS3L2;RNASE4;U2AF1;ZFP36L2;PRPF3;CPSF6;USP39;AURKAIP1;NUDT16L1;SON;ERN1;TCERG1;NUDT16;SRSF11;ZFP36;CNOT10;SF3B4;SF3A1;DDX5;SNRPG;SNRPD3;AGO4;YTHDF2;SLBP;AGO3;U2AF2;HIPK3;PTBP1;SF3B2;AKAP8L;KIN
prerank,basement membrane organization (GO:0071711),0.5887905537526299,1.2900409432459643,0.18070652173913043,0.8087512873949034,1.0,3/14,3.12%,HPN;FLRT2;NTN4
prerank,positive regulation of B cell activation (GO:0050871),0.4905946979053739,1.2895107721420922,0.11661166116611661,0.8096351132118363,1.0,12/50,16.45%,SYK;EPHB2;MIF;CLCF1;HMCES;TIRAP;CD81;TNFSF13B;IRS2;CD27;IL4;IL6
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.6315575976050645,1.2894551611736087,0.20251396648044692,0.8083822619563888,1.0,7/10,30.21%,CSGALNACT2;B3GAT3;XYLT1;XYLT2;B3GAT2;DSEL;CSGALNACT1
prerank,regulation of intracellular pH (GO:0051453),0.5191693424627206,1.2893327820673215,0.13953488372093023,0.8073658316168021,1.0,12/34,16.89%,SLC4A10;SLC4A8;SLC4A3;SLC9A9;VPS33A;SLC4A4;SLC9A1;SLC26A6;CHP1;SLC9A6;SLC9A7;TMEM165
prerank,neuron apoptotic process (GO:0051402),-0.4194827257504111,-1.2893082869656325,0.1323529411764706,0.5792261857822427,1.0,9/19,16.68%,APP;BCL2;TRPC5;FAM162A;TNFRSF21;FAS;CDK5;GAPDH;ERBB3
prerank,regulation of interleukin-4 production (GO:0032673),0.5534207564662951,1.2892797676393928,0.149616368286445,0.8060758360044517,1.0,2/21,1.17%,SYK;IRF4
prerank,lymphocyte mediated immunity (GO:0002449),0.618271736125411,1.2891233440952634,0.16712328767123288,0.8052522618864448,1.0,3/12,15.21%,CD55;JAG1;BTN3A3
prerank,phosphatidylserine metabolic process (GO:0006658),-0.3728454339109629,-1.2877544254763233,0.10067114093959731,0.5800470364706546,1.0,6/32,13.00%,OSBPL10;PLA1A;OSBPL8;PLSCR1;PLAAT3;PLA2G15
prerank,sensory perception of light stimulus (GO:0050953),0.4675818673243863,1.287737548149651,0.08928571428571429,0.8101327041377008,1.0,20/87,20.42%,COL1A1;SLC4A10;ROM1;RABGGTA;COL11A1;ABLIM1;MYO9A;CNGB1;COL2A1;CRYBB1;RPGR;CABP1;CRYZ;OPA3;EFEMP1;TYR;SFRP5;RP2;KIFC3;ATF6
prerank,ribosomal subunit export from nucleus (GO:0000054),0.6076281040781969,1.2877191584509913,0.1632928475033738,0.8086590513237156,1.0,5/13,12.33%,SDAD1;ABCE1;NOP9;NPM1;EIF6
prerank,establishment of spindle localization (GO:0051293),0.5917359592469305,1.2873578162178443,0.16666666666666666,0.8088485141458096,1.0,7/14,26.17%,TLE6;LLGL1;DYNC1H1;MAP4;CLASP2;NLRP5;KPNB1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.3882153585522515,-1.2873128787554193,0.15527950310559005,0.5779538338128761,1.0,5/26,3.32%,SORBS1;OCLN;INSR;IGF1;OSBPL8
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.6131272710152633,1.2870157380827807,0.18410041841004185,0.8089401589279377,1.0,8/12,21.97%,EPHB2;NFIB;GLI2;MYCBP2;TSKU;EPHB1;PAFAH1B1;SPTBN4
prerank,regulation of interleukin-8 production (GO:0032677),0.473806270591191,1.286279777235745,0.10897435897435898,0.8106900743310271,1.0,14/69,16.45%,LBP;SYK;ANXA1;F2R;TLR5;PRKD2;TIRAP;TLR4;OTUD7B;BCL3;CD14;KLF4;ANXA4;IL6
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.5012911929906653,-1.2857870229095723,0.1948529411764706,0.5788404571098911,1.0,3/11,12.68%,ENPP3;CTPS2;SLC19A3
prerank,positive regulation of histone acetylation (GO:0035066),0.5370228385262075,1.2853987558478015,0.15442092154420922,0.8132657232698103,1.0,4/23,10.16%,LIF;SMAD4;MUC1;BRD7
prerank,positive regulation of organelle organization (GO:0010638),0.5209549780188274,1.285282414488807,0.15535097813578827,0.812248184595227,1.0,7/32,12.71%,ANXA1;ANXA2;SORBS3;SURF4;LMAN1;LNPK;SMCR8
prerank,nuclear membrane organization (GO:0071763),0.5668217505744464,1.2852706148010662,0.16750629722921914,0.8107707624154995,1.0,5/19,9.30%,DCTN1;TMEM43;CHMP7;TARDBP;TOR1A
prerank,L-amino acid transport (GO:0015807),-0.3773590725777579,-1.2851939712933549,0.125,0.5773767639669436,1.0,6/28,9.08%,SLC7A2;SLC1A3;SLC7A5;SLC3A2;CTNS;SLC38A5
prerank,establishment of mitotic spindle orientation (GO:0000132),0.5464813585374537,1.2850156875014018,0.17581047381546136,0.8103570146942268,1.0,4/23,5.01%,GPSM2;DCTN1;NDEL1;ZW10
prerank,regulation of axonogenesis (GO:0050770),-0.341772460152458,-1.2849828695350234,0.046511627906976744,0.5748743014819024,1.0,8/51,5.65%,PLXNA2;ROBO1;EPHA4;PLXNA4;CHN1;PLXND1;SIPA1L1;ROBO2
prerank,regulation of RNA splicing (GO:0043484),0.47308117453508436,1.2848056254275877,0.1033013844515442,0.8099194480614123,1.0,12/69,10.68%,AHNAK2;AHNAK;AFF2;MBNL1;ZPR1;CLK1;SRSF3;RBM22;MBNL2;SON;ERN1;HNRNPH1
prerank,regulation of immune effector process (GO:0002697),0.5007450276907914,1.2843009710483242,0.1446051167964405,0.8106353670721289,1.0,9/41,13.82%,CD55;IRF4;CFH;C7;C1QBP;CD81;C4B;SERPING1;CR2
prerank,cellular response to chemokine (GO:1990869),0.49266775756514525,1.2842997472579902,0.13727678571428573,0.8091304147743354,1.0,8/46,13.85%,ACKR3;CCL8;CXCL10;CCL25;STK39;CCL13;RHOA;ZC3H12A
prerank,eosinophil chemotaxis (GO:0048245),0.5951443870978568,1.2832398112047572,0.15824468085106383,0.8109762023192937,1.0,2/14,13.15%,CCL8;CCL13
prerank,eosinophil migration (GO:0072677),0.5951443870978568,1.2832398112047572,0.15824468085106383,0.8109762023192937,1.0,2/14,13.15%,CCL8;CCL13
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6125956506794505,1.2831454000884395,0.20849933598937584,0.8098720444388958,1.0,2/12,5.34%,DCN;ATP2B4
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.4759418170798718,-1.282986903560381,0.16498316498316498,0.5767574095635786,1.0,1/12,0.68%,IL1R1
prerank,canonical Wnt signaling pathway (GO:0060070),0.47293960187411777,1.2826361491555323,0.12260127931769722,0.8108179337115745,1.0,8/68,5.12%,SFRP4;LRP6;WNT2;WNT10B;WNT9A;PLPP3;AXIN1;TCF7L2
prerank,arachidonate transport (GO:1903963),0.6291088139672094,1.2822354717249165,0.1757142857142857,0.8095648491606233,1.0,2/10,11.70%,ANXA1;PNPLA8
prerank,arachidonic acid secretion (GO:0050482),0.6291088139672094,1.2822354717249165,0.1757142857142857,0.8095648491606233,1.0,2/10,11.70%,ANXA1;PNPLA8
prerank,regulation of establishment of cell polarity (GO:2000114),0.5810733188969424,1.2821708816070945,0.1595744680851064,0.8083680457661826,1.0,7/16,19.88%,GSN;RAP1B;KANK1;KIF20B;BCAS3;SHTN1;ARFGEF1
prerank,lysosome organization (GO:0007040),0.5145708871029269,1.282123117334365,0.1382488479262673,0.8071222729230475,1.0,13/36,20.44%,HOOK2;ACP2;MTOR;ABCA1;TPP1;CLVS2;HPS4;VPS33A;GAA;SNAPIN;TMEM165;CLVS1;ACP3
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.5649413030756014,1.2820351062591382,0.1554140127388535,0.8060354968448791,1.0,5/18,17.56%,FBN1;LRRC17;TLR4;IL4;GPR137B
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.5211885274645462,-1.2817902230003546,0.1864406779661017,0.5767210023939366,1.0,6/10,13.67%,EPHA4;DAB2IP;ATRAID;NELL1;RGP1;RIC1
prerank,recombinational repair (GO:0000725),0.46651924559836344,1.2814417671701137,0.09282700421940929,0.8071552260771888,1.0,25/77,18.50%,REV3L;XRCC3;SFR1;RAD51B;RFWD3;UBE2N;RHNO1;HELQ;AP5S1;SAMHD1;SMC5;RMI1;FAN1;ERCC4;SEM1;SMC6;INO80;NBN;RNF138;RECQL;SPIDR;RAD50;ERCC5;MORF4L1;BLM
prerank,amino acid transport (GO:0006865),-0.326953422444791,-1.2812560027257966,0.10679611650485436,0.5749453555965504,1.0,13/49,12.92%,SLC7A11;SLC7A2;SLC6A12;PDPN;SLC38A11;SLC7A5;SLC3A2;SLC38A5;SLC25A44;SLC6A17;SLC6A6;SLC43A1;SLC7A14
prerank,negative regulation of interferon-gamma production (GO:0032689),0.5352424103806588,1.2811566398217418,0.16058394160583941,0.8070292301335004,1.0,6/23,13.85%,AXL;C1QBP;INHA;GAS6;TLR4;ZC3H12A
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.5812026375667828,1.2810363383919086,0.17328042328042328,0.8061339297121318,1.0,5/15,16.77%,TSEN54;RTRAF;ERN1;CPSF4;TRPT1
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.4294344802013443,-1.2810200034300052,0.1346153846153846,0.5725677035167477,1.0,5/17,10.66%,PRKAG2;PRKAA2;PPARA;CAV1;ADIPOR2
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.5809091393317227,1.280671475466005,0.1919060052219321,0.8063909028316731,1.0,4/16,12.36%,PRKCA;SLC39A14;GRP;KLK6
prerank,keratan sulfate metabolic process (GO:0042339),0.5173246947726088,1.2799449918796106,0.169392523364486,0.8081984833272571,1.0,6/31,4.39%,ST3GAL2;B4GALT3;B4GALT1;OGN;CHST1;ACAN
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.5000957159877675,1.2798524291073987,0.14642451759364358,0.8072005695180375,1.0,4/38,9.03%,NOX4;DLG4;GAS6;SRCIN1
prerank,response to peptide (GO:1901652),0.5168546232072408,1.2797742576316267,0.17249417249417248,0.8061203728848426,1.0,5/33,7.92%,ANXA1;IRS1;MMP2;FYN;STAT5A
prerank,protein heterotetramerization (GO:0051290),0.6027458567275038,1.2796502312310079,0.190224570673712,0.8051875364745681,1.0,5/13,14.32%,PKD1;KRT10;PKD2;CPSF6;HSD17B8
prerank,negative regulation of ATP metabolic process (GO:1903579),0.570508290988271,1.2794280261976083,0.17120622568093385,0.804722613519991,1.0,7/17,15.07%,MLXIPL;PID1;FLCN;TIGAR;NCOR1;HDAC4;NUPR1
prerank,regulation of cellular protein localization (GO:1903827),0.48701920062204346,1.2792503739812982,0.14994363021420518,0.8040780543653284,1.0,13/45,17.49%,RAB11FIP5;GPC6;GPC3;NDEL1;TRIM46;TOR1A;EGF;MAPT;SETD2;PIN1;HSP90AA1;SPIDR;TRIM67
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.5297307045362707,1.2787513263891064,0.15587529976019185,0.8049845822769696,1.0,11/26,20.59%,DCTN1;PSRC1;CLIP1;TOGARAM1;MAPRE1;MAPT;SLAIN2;CDK5RAP2;AKAP9;NAV3;NUMA1
prerank,positive regulation of immune effector process (GO:0002699),0.5271197390435544,1.277643060238179,0.17589175891758918,0.8086289878987977,1.0,3/27,8.29%,LBP;PTPRJ;CD81
prerank,regulation of fibrinolysis (GO:0051917),0.6012598163929062,1.2769146108228895,0.1931216931216931,0.810427557039522,1.0,2/13,3.75%,FAP;KLKB1
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5488488040349082,1.276664250911656,0.17625,0.8100837924573684,1.0,4/20,8.21%,IGFBP5;LRP1;SLIT2;NDRG4
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.48013744597348335,1.2759633840374414,0.13412017167381973,0.8118353604917893,1.0,13/57,18.11%,GHR;LIF;CTF1;VEGFA;CLCF1;TNFRSF18;INPP5F;PARP14;PIBF1;FLT3;IL4;IL6;IL18
prerank,snRNA metabolic process (GO:0016073),0.5825288589584858,1.2753466226722345,0.16352201257861634,0.8132047120726146,1.0,7/17,18.86%,INTS3;MEPCE;INTS10;INTS6;ZCCHC8;INTS2;INTS12
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.36263299895265305,-1.2751819768362656,0.11888111888111888,0.5842005366336613,1.0,5/32,4.36%,PRKAG2;SORBS1;APOE;PRKAA2;PPARA
prerank,selective autophagy (GO:0061912),0.4850540078132894,1.274462068464623,0.12554585152838427,0.8159396697895419,1.0,20/56,18.99%,DYNC1LI2;HDAC6;ARL13B;UBE2N;ATG2B;DYNC1LI1;DYNC1I1;SQSTM1;UBA52;ULK2;ATG2A;ULK1;DYNC1H1;UFC1;NBR1;UFL1;PEX5;AUP1;UFM1;ATG13
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.6402091377940198,1.2743760418660188,0.1773049645390071,0.8148684733765453,1.0,3/10,13.66%,CNGB1;SAG;GNB1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.5965426508117737,1.274049920924172,0.19573901464713714,0.8149865432471766,1.0,3/13,12.39%,SEC16B;CD81;TMEM30A
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.5664060035460862,1.2739249932115684,0.18870346598202825,0.814203381421722,1.0,8/17,24.40%,GET4;EMC1;EMC10;EMC8;SGTA;EMC3;EMC2;EMC6
prerank,ribonucleoprotein complex assembly (GO:0022618),0.44874301302057384,1.2732898640246546,0.06585612968591692,0.8156471165530815,1.0,54/132,27.22%,RPSA;GEMIN6;TARBP2;MRPS11;SRSF6;ABT1;LSM4;WDR77;CPSF6;USP39;KHDC4;CELF2;EIF6;EIF3A;TGS1;XRCC5;POLR2D;RPS27L;RPS5;RRP7A;HSP90AA1;DDX20;RPL6;NOP53;SNRPG;SNRPD3;LUC7L3;PWP2;PUF60;RPF2;EIF2S2;GCFC2;STRAP;LUC7L2;SF3B1;SRPK1;NOP2;SMN1;RSL24D1;COIL;RBM5;BRIX1;CPSF7;EIF4H;RAMAC;CELF3;ERAL1;DHX29;CRNKL1;PRPF19;PRPF6;DDX1;PRKDC;CELF1
prerank,peripheral nervous system development (GO:0007422),0.5396372061900729,1.2726708673007099,0.16482164821648215,0.8170755377030388,1.0,7/23,14.36%,PMP22;SOX10;ALDH3A2;SOX8;GDNF;ASIC2;ARTN
prerank,negative regulation of immune system process (GO:0002683),0.5815062943298517,1.2725457836753828,0.1880794701986755,0.8162178761112959,1.0,1/16,0.16%,COL3A1
prerank,positive regulation of lipid transport (GO:0032370),0.6069969693783472,1.2724236717478241,0.18588873812754408,0.8153139017844686,1.0,2/12,1.73%,LRP1;TRIAP1
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.48310938650108204,-1.2722973148212757,0.16981132075471697,0.5886026538507156,1.0,3/13,4.04%,DDO;GLUL;MTHFS
prerank,regulation of trophoblast cell migration (GO:1901163),0.5925844387968597,1.2720414705889747,0.17263427109974425,0.8156964786433213,1.0,4/14,8.89%,VEGFA;SMURF2;C1QBP;AGO2
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.49748083144770644,1.2717552589670962,0.15560640732265446,0.8154862894924383,1.0,9/40,5.21%,COL1A1;LOXL2;TGFB3;TGFB2;TGFBR2;SMAD4;WWTR1;TCF7L2;MTOR
prerank,regulation of actomyosin structure organization (GO:0110020),0.5948911285474517,1.2714664896645846,0.1963109354413702,0.8154578436869147,1.0,5/13,16.22%,AKAP13;ASAP3;ALMS1;SLC9A1;ACTG1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.45254537298827346,1.2710462531623485,0.08504098360655737,0.8160442015759297,1.0,26/110,17.51%,SYK;GSN;VEGFA;CDC42EP2;MPP7;AIDA;GNL3L;PREB;FARP2;ABCA1;SRC;STX1B;HDAC6;TFIP11;TIRAP;HJURP;BMF;NAPA;BAK1;ULK1;HSP90AA1;NOP53;HRK;IAPP;SPIDR;PEX5
prerank,regulation of microtubule-based process (GO:0032886),0.505969186574846,1.270983405810398,0.14965986394557823,0.8148769591550716,1.0,10/36,15.05%,PHLDB1;CDK2AP2;EFNA5;EPHA3;ATF5;BICD1;HDAC6;MAPT;MAP6;DIAPH1
prerank,acylglycerol biosynthetic process (GO:0046463),0.5418190201034456,1.270930749062681,0.16767189384800965,0.8137002994689936,1.0,8/23,20.27%,PLCE1;GPAT4;ANG;MOGAT1;MOGAT2;GPAT3;GPAM;LPIN3
prerank,dopamine metabolic process (GO:0042417),-0.4205100157292798,-1.269630685285718,0.1542056074766355,0.5923718869165618,1.0,4/18,8.01%,SNCAIP;MOXD1;SNCA;GCH1
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.6274110759152095,1.269187094858184,0.22420907840440166,0.8203026780800621,1.0,2/10,2.23%,AREG;BTC
prerank,proteolysis (GO:0006508),0.44355845970528157,1.269073794724381,0.031093279839518557,0.8193487952459673,1.0,60/252,19.16%,CAPN5;HTRA3;PCSK6;PRSS48;DPP4;BMP1;FAP;HPN;PCSK5;DESI2;DESI1;PSMC4;MMP2;ANPEP;CAPN2;KLKB1;ADAM19;ADAMTS3;ACAN;ADAM33;PCSK4;PRCP;SPCS1;RET;LNPEP;FBXO2;TPP1;CAPN1;CLPX;PSEN1;ECE1;FBXL2;CNDP2;XPNPEP3;EEF1AKMT4-ECE2;ECE2;CAPN11;SPPL2B;NAPSA;THOP1;NPEPPS;RSPRY1;TASP1;FAM111A;CLPP;OGT;CTSD;HGF;LAP3;SENP6;SPG7;HTRA2;IDE;PGPEP1;MMP16;HTRA4;METAP2;CAPN10;NEDD8;PCSK7
prerank,peptidyl-tyrosine modification (GO:0018212),0.47950893054422195,1.2690244311142338,0.13304721030042918,0.8181721858595901,1.0,11/56,7.91%,SYK;DDR2;EPHB2;SRMS;EGFR;FGFR1;EPHA3;FYN;SRC;ABL2;ABI1
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.6062047539334978,1.268910582385785,0.18037135278514588,0.8172937772477259,1.0,3/13,7.11%,AR;ESR1;PLPP1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.5536548352848649,1.2675808798013082,0.14949748743718594,0.8219092163589743,1.0,8/21,17.76%,RAD51B;CDK4;VPS4B;DTL;NPM1;FBXO5;CCND1;RCC2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.3948296391013226,-1.2673141615522354,0.13714285714285715,0.5952958668153618,1.0,10/25,17.04%,ATP1B3;ACTN2;DMD;WNK4;SLC6A9;TRPC6;NDUFA4;COX17;ATP1B1;GLRX
prerank,ERBB signaling pathway (GO:0038127),0.47061353765439357,1.2672260708358793,0.12951167728237792,0.8221300225250088,1.0,16/64,16.74%,AREG;PRKCA;EGFR;PLCE1;BTC;SRC;STUB1;PIK3CA;IQGAP1;EGF;AKT1;CBL;AAMP;HSP90AA1;SOS1;EFEMP1
prerank,regulation of defense response to virus (GO:0050688),0.5919660731197613,1.2671690377362024,0.19078947368421054,0.8210182305222906,1.0,5/14,16.48%,ITCH;C1QBP;RNF216;ILRUN;TRAF3
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5338822641002703,1.2670624604562897,0.17698019801980197,0.8201210445078185,1.0,7/22,15.05%,AREG;FGF7;SRSF6;ZFP36L1;VDR;ZFP36;SNAI2
prerank,regulation of protein kinase activity (GO:0045859),0.4502398813532086,1.266722140874879,0.1195097037793667,0.8202741756862533,1.0,25/106,13.19%,DDR2;LRP6;TARBP2;PLCE1;CAMKK1;CAMK2N1;WWTR1;MAP2K3;DTNBP1;RTRAF;MAPRE3;RASSF2;YWHAG;ADCYAP1;GAS6;GSKIP;IQGAP1;INPP5K;CAMKK2;AKT1;XRCC5;DEPTOR;SFN;SMCR8;CDKN1A
prerank,protein glycosylation (GO:0006486),0.4510773508739083,1.2662796243034269,0.07817258883248732,0.8208982396287684,1.0,28/125,17.61%,GFPT2;PLOD2;ST3GAL2;B4GALT1;B3GALNT1;GFPT1;FUT2;MGAT1;POMGNT2;GALNT10;GALNT18;OGA;PLOD3;ALG1;LARGE1;FUT9;B3GNT8;GALNT1;MGAT5;ST3GAL4;MGAT2;MGAT4B;OGT;TUSC3;B3GALNT2;TMEM165;ST3GAL3;ST3GAL1
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5903177402028732,1.265604613142913,0.18586387434554974,0.8224185495908751,1.0,4/13,12.36%,SRI;CAMK2D;PDE4D;CALM2
prerank,ERAD pathway (GO:0036503),0.46426345797054996,1.2652113983298074,0.11192468619246862,0.8228011026426343,1.0,32/83,25.66%,UBE2J2;GET4;SYVN1;EDEM1;RNF121;RCN3;PSMC6;STUB1;FBXO2;ANKZF1;FBXO17;TOR1A;ECPAS;UBE2G2;HERPUD1;DNAJB2;TMUB2;SGTA;AMFR;SELENOS;AUP1;UGGT1;JKAMP;USP13;USP19;DERL1;SEL1L;UBXN6;RHBDD2;SEC61B;HSP90B1;UFD1
prerank,regulation of exosomal secretion (GO:1903541),0.550097520799218,1.264545404222198,0.18922305764411027,0.8245878849277045,1.0,3/19,5.90%,SMPD3;VPS4B;ATP9A
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5646775618029547,1.2641289683099555,0.183206106870229,0.8250771988203862,1.0,4/18,11.49%,LAX1;MIA3;AKT1;GPNMB
prerank,lytic vacuole organization (GO:0080171),0.5131900655900453,1.263967946613828,0.16801853997682503,0.8244511265962061,1.0,11/32,20.44%,HOOK2;ACP2;MTOR;ABCA1;TPP1;CLVS2;HPS4;GAA;SNAPIN;CLVS1;ACP3
prerank,peptidyl-proline modification (GO:0018208),0.5339577969975992,1.2638468855183083,0.17718446601941748,0.8236355797243393,1.0,14/25,25.87%,FKBP10;PPIL6;NTMT1;NKTR;PPIC;PIN1;PPIA;FKBP4;FKBP7;OGFOD1;FKBP1A;CWC27;PPIG;PPIH
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.4476427742040935,1.2628305332133782,0.07621009268795056,0.8267722915217849,1.0,38/122,17.52%,AR;NIBAN1;EGFR;IRS1;FGF2;CTC1;TGFB2;TMEM106A;SMOC2;MTOR;IL33;GLI2;PRKD2;LARP4;EPM2AIP1;HNRNPD;TLR4;DYRK2;NPM1;EGF;AKT1;BCL3;PASK;IRS2;DNA2;EIF6;RPS27L;ZCCHC4;RBM3;POLDIP3;KLF4;EIF3E;IL4;IL6;HGF;FXR2;EIF3D;YTHDF1
prerank,detection of mechanical stimulus (GO:0050982),0.5623865196139253,1.262422092617599,0.20382165605095542,0.8273558276852323,1.0,4/19,11.99%,PIEZO2;PKD1;PKD2;JUP
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.5344550204654304,1.2621590043912132,0.18282208588957055,0.8270934560342627,1.0,10/24,17.93%,SEC24D;SEC31A;SEC24A;SEC23A;PDIA3;MFSD6;IDE;SEC24B;ABCB9;BCAP31
prerank,regulation of phospholipase activity (GO:0010517),0.6150111840602608,1.261935244941062,0.20110192837465565,0.8267473844479892,1.0,2/10,1.44%,LRP1;FGFR1
prerank,positive regulation of B cell proliferation (GO:0030890),0.5202687170828671,1.2618891163490802,0.17204301075268819,0.8255629670238661,1.0,8/29,15.09%,EPHB2;MIF;CLCF1;TIRAP;CD81;TNFSF13B;IRS2;IL4
prerank,cGMP metabolic process (GO:0046068),-0.47384443162572376,-1.2617929557830887,0.18045112781954886,0.6061392052182883,1.0,4/12,12.95%,GUCY1B1;NPR1;PDE2A;GUCY1A1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.5644419943421295,1.2617836833552147,0.2054973821989529,0.8246759209192146,1.0,8/15,22.00%,TGFBR2;IRX5;PDGFRA;TWIST1;SIX1;TGFBR1;NIPBL;LHX1
prerank,regulation of keratinocyte migration (GO:0051547),0.6065728760410104,1.2616270415326996,0.1765536723163842,0.8240038400391708,1.0,8/12,28.34%,FGF7;ADAM9;MTOR;ARF6;PTEN;IQSEC1;FGF10;MAPRE2
prerank,sulfur compound catabolic process (GO:0044273),0.4990537985566435,1.2616066141844386,0.15246636771300448,0.8227264955296775,1.0,14/38,25.63%,DCN;OGN;ACAN;VCAN;NUDT7;DPEP1;GGT7;IDUA;MPST;TXN2;ACAT1;OMD;BGN;CTH
prerank,cellular response to estrogen stimulus (GO:0071391),0.5876108222746727,1.2614096467147267,0.19518716577540107,0.8222905458788946,1.0,2/14,3.46%,AR;SFR1
prerank,monocarboxylic acid transport (GO:0015718),-0.32614351389007,-1.26115113569072,0.10377358490566038,0.6047575219549353,1.0,9/51,2.26%,SLC6A13;SLC16A12;ABCC4;SLC16A2;ABCG2;SLCO2B1;SLCO1C1;SLC6A12;SLC16A6
prerank,cell-matrix adhesion (GO:0007160),0.454268120567577,1.2604217151225126,0.11203319502074689,0.8253424133250773,1.0,24/95,14.92%,CD34;COL3A1;THBS3;COL17A1;ITGA11;CD44;ITGBL1;ITGB3;TNN;ADAM9;PPFIA2;PKD1;ITGB5;ITGA2;TIMM10B;SRC;TESK2;ITGAV;L1CAM;TAOK2;ADAM15;SGCE;DDR1;PPFIA1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.4816624729960124,1.260211100768981,0.15299334811529933,0.8250096822474955,1.0,20/51,23.96%,DBN1;DCLK1;TAOK3;TRIO;DTNBP1;WASF1;SNX1;KIF20B;TAOK2;SLC9A6;ANKRD27;SRGAP2;GAS7;SHTN1;GPM6A;NBL1;MAP1S;CTTN;CNTNAP1;ALS2
prerank,regulation of osteoblast differentiation (GO:0045667),-0.30021767658653875,-1.2600571199822506,0.08928571428571429,0.6046446745536492,1.0,23/82,10.58%,BMP6;RANBP3L;SMOC1;WNT4;TMEM64;PTCH1;IGF1;MEF2C;BMP7;PRKD1;NOTCH1;ZHX3;CDK6;IL6R;ATRAID;FGFR2;NELL1;NOCT;BMPR2;NPNT;LRP3;YAP1;BMP2
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5292387267565232,1.2599884232249752,0.18545454545454546,0.8246700260589371,1.0,8/22,17.48%,VEGFA;RASSF2;GPNMB;CALM2;TAOK2;TNKS1BP1;NBN;RAD50
prerank,ribosomal small subunit biogenesis (GO:0042274),0.4950815698374612,1.2599120572429638,0.17361894024802707,0.8236969558309959,1.0,14/39,20.71%,RPSA;MRPS11;RIOK1;RRP36;NPM1;RPS27L;RPS5;SNU13;RRP7A;DDX52;PWP2;SRFBP1;RIOK2;RPS25
prerank,organelle fission (GO:0048285),0.5363835243034816,1.2597376249363845,0.19709794437726724,0.8231238226599531,1.0,3/24,5.18%,SEC16B;DNM1;GDAP1
prerank,organic acid transport (GO:0015849),-0.29414810689347165,-1.2595974279735047,0.08333333333333333,0.6027746490203972,1.0,13/94,4.37%,SLC7A11;SLC7A2;SLC6A13;ABCC4;SLC13A3;ACSL1;ABCG2;SLCO2B1;SLC26A7;SLCO1C1;SLC6A12;PDPN;SLC22A6
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.5374208630517152,1.2587931033632238,0.2004950495049505,0.8259368089905345,1.0,7/23,18.83%,GHR;F2R;IL10RA;PIBF1;IL4;IL6;CYP1B1
prerank,regulation of regulated secretory pathway (GO:1903305),0.5029247042823319,1.2583413570947772,0.17321016166281755,0.8266199151644695,1.0,10/34,19.18%,SYT2;SYT12;SYT11;SYT13;DTNBP1;RAB3D;SNAPIN;SYT1;PREPL;RIMS2
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.5142975026468712,1.2571604133078036,0.1707035755478662,0.8306038784211794,1.0,12/31,18.66%,HOXA3;TGFBR2;IRX5;HOXA4;COL2A1;PDGFRA;TWIST1;SIX1;HOXC4;HOXA9;TGFBR1;DYNC2I1
prerank,mitochondrion distribution (GO:0048311),0.6097203533567611,1.2571065246561768,0.20214190093708165,0.8294796700557792,1.0,4/12,14.53%,CLUH;TRAK2;MAPT;ATCAY
prerank,establishment of protein localization to membrane (GO:0090150),0.46911920168656734,1.2570763716174531,0.12378902045209902,0.828251243256237,1.0,35/66,32.64%,EGFR;RFTN1;NECTIN3;ZDHHC7;VPS37D;TAOK2;VPS37C;ZDHHC2;SEC63;FRMPD1;ZDHHC4;ZDHHC24;ZDHHC21;VPS37B;ZDHHC20;NACA;RAB10;ATG3;ZDHHC18;COX18;ICMT;SDCBP;SYNE3;GORASP1;MICALL1;PRKCI;ZDHHC15;PARD3;MYO1C;GOLGA7B;PIKFYVE;ARL6;ZDHHC3;CHM;RAB3GAP1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5446102718231344,1.2565861986300686,0.19901719901719903,0.8289973992339286,1.0,6/21,15.93%,EIF2AK3;CREB3L1;SYVN1;HERPUD1;SELENOS;NCK1
prerank,proteoglycan biosynthetic process (GO:0030166),0.5127892023472713,1.2555370173948661,0.19388954171562867,0.8323584799022077,1.0,10/31,12.56%,UGDH;CSGALNACT2;CHST10;EXT1;GAL3ST3;CHST12;FOXL1;B3GAT3;XYLT1;GLCE
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.4748106052227778,1.2554197260116908,0.1411111111111111,0.8315403026361374,1.0,15/54,11.99%,FGF18;PRKCA;FGFR1;ANGPT4;VEGFA;FGF2;MAPK14;MAP2K3;ATP2B4;PRCP;PRKD2;STAT5A;AKT3;AKT1;JUP
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.5436866355318286,1.255319942665389,0.18337408312958436,0.830608131978754,1.0,6/23,14.80%,CCDC88C;HOOK2;MYO10;DYNC1I1;MAP6;CCDC186
prerank,catecholamine biosynthetic process (GO:0042423),-0.489565078701029,-1.2552558200409785,0.18118466898954705,0.6108790654026146,1.0,4/11,10.09%,MOXD1;SNCA;GCH1;DDC
prerank,regulation of protein kinase B signaling (GO:0051896),0.4404674957797607,1.255225546266372,0.05527638190954774,0.8297010160593669,1.0,36/193,13.33%,AREG;MYOC;CD80;FGF18;ESR1;AXL;FGF7;EGFR;IRS1;FGFR1;BTC;FYN;FGF2;MST1R;PIK3R2;OTUD3;TCF7L2;PTPRJ;RCN3;C1QBP;SRC;RET;BANK1;FLCN;GAS6;FLT3LG;PIK3CA;PHLPP2;INPP5K;EGF;AKT1;MAGI2;IRS2;PDGFRA;FLT3;PLEKHA1
prerank,response to estrogen (GO:0043627),0.5127685041065727,1.255049258325952,0.17988165680473372,0.829117370248581,1.0,4/31,8.57%,AR;ESR1;SFR1;CYP27B1
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.62492582424993,1.2542066932777316,0.2002840909090909,0.8301828330732147,1.0,1/10,1.04%,SMPD3
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.62492582424993,1.2542066932777316,0.2002840909090909,0.8301828330732147,1.0,1/10,1.04%,SMPD3
prerank,Golgi localization (GO:0051645),0.604908771446864,1.2538667290761212,0.2094017094017094,0.8304487329083307,1.0,2/11,1.51%,ARHGAP21;STK25
prerank,carnitine shuttle (GO:0006853),-0.5092705269824062,-1.2536878319358582,0.21481481481481482,0.6118771997598641,1.0,4/11,11.27%,PRKAG2;PRKAA2;SLC25A20;ACACB
prerank,positive regulation of interleukin-8 production (GO:0032757),0.48330938234919685,1.252597435256856,0.1537598204264871,0.8348742234831544,1.0,7/49,9.36%,LBP;SYK;F2R;TLR5;PRKD2;TIRAP;TLR4
prerank,response to chemokine (GO:1990868),-0.4684376314558206,-1.2521254041737924,0.183206106870229,0.6126623273179128,1.0,5/13,5.60%,SLC12A2;FOXC1;DOCK8;CXCL12;LRCH1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.43186342882313805,1.252099468290245,0.013,0.8356211514076906,1.0,92/390,16.46%,ANGPTL1;GHR;SYK;DDR2;EPHB2;COL1A1;FGF18;AXL;ARHGEF28;NCF4;FGF7;SRMS;EGFR;TNK1;POLR2H;IRS1;FGFR1;HPN;EFNA5;DNM1;FLRT2;EIF2AK3;HNRNPA1;GRB10;MMP2;EPHA3;SULF2;ITGB3;FYN;VEGFA;FGF2;MST1R;SLC39A14;PIK3R2;MAPK14;ATP6V0A2;ANKS1B;NFATC4;PTPRJ;TRIM71;SOCS2;FOXO1;AP2A2;SULF1;SRC;RET;ACTR3;PRKD2;POLR1G;ABI1;PIK3CA;PSEN1;FOXC2;SIRT2;MAPK11;EPHB3;EFS;ITGAV;RHOQ;MUSK;HNRNPH1;AKT1;RBFOX2;ATP6V1E1;EPHA10;IRS2;SHOC2;FLRT3;NGEF;PDGFRA;POLR2D;ATP6AP1;POLR2G;FLT3;RHOA;CBL;AAMP;DDR1;FER;HSP90AA1;GTF2F1;RAPGEF1;ATP6V1D;ATP6V0A1;NCK1;ARPC1A;AHI1;ACTG1;ATP6V1B2;SDC2;SOS1;HGF
prerank,negative regulation of T cell differentiation (GO:0045581),0.6225739785750786,1.2518304977510273,0.19060773480662985,0.83547246143314,1.0,2/10,10.97%,ZC3H8;GLI3
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.45726656797404525,1.2518167877811222,0.1338174273858921,0.8341838686254633,1.0,13/75,8.01%,DCN;TNMD;ANGPT4;ISM1;SPARC;TGFB2;CD160;THBS4;ATP2B4;HOXA5;CXCL10;SULF1;SERPINF1
prerank,cell junction assembly (GO:0034329),-0.3085983411873588,-1.2516842054135768,0.09523809523809523,0.6107952682983444,1.0,25/100,13.05%,TJP1;PKP4;CDH5;ITGA6;CLDN5;SPOCK2;CDH1;SHANK3;DNM3;PLXND1;CDH6;ACTB;TLN2;RYK;CDH7;OPHN1;SDK2;LIMS1;CDK5;SDK1;BDNF;TRPV4;FBLIM1;PCDHB14;SLITRK1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.4724764405161328,1.2516631497231214,0.17032967032967034,0.8335757017606407,1.0,15/54,17.36%,HAS1;GPC6;UGDH;GPC3;EXT1;B3GAT3;XYLT1;HS2ST1;HSPG2;HS3ST6;HS3ST5;NAGLU;SDC2;IDUA;NDST2
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.4004439829506256,-1.2513993242044417,0.1507537688442211,0.6086727495998445,1.0,9/23,20.41%,SASH1;DAB2IP;DVL3;TNFRSF11A;EDN1;MAP3K5;ARHGEF5;DUSP19;MAP3K10
prerank,antibacterial humoral response (GO:0019731),0.5620364696379835,1.2512743121753598,0.20844327176781002,0.8340613037785386,1.0,4/16,12.63%,ANG;SLPI;DMBT1;RNASE6
prerank,negative regulation of lymphocyte activation (GO:0051250),0.5485128982099989,1.2510543439873782,0.18270401948842874,0.8337335898647233,1.0,4/21,11.97%,LAX1;BANK1;GPNMB;PIBF1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5407411149094765,1.2507986049414266,0.20785804816223066,0.8335566635839288,1.0,7/19,17.16%,HPN;MAPK7;TMEM106A;KLF2;EGF;KLF4;CHRNA7
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.517408943610691,1.2507621976686014,0.19098457888493475,0.8324185160276114,1.0,8/27,14.16%,AHNAK;JSRP1;ANK2;CAMK2D;YWHAE;PDE4D;CALM2;CACNB1
prerank,positive regulation of T cell differentiation (GO:0045582),0.48973067305701684,1.2506602628064352,0.18296892980437285,0.8315425071075196,1.0,6/36,10.97%,TNFSF9;ZMIZ1;GLI2;ZBTB1;BCL6;GLI3
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5441735599231408,1.2498601618514096,0.18271604938271604,0.8338082198063932,1.0,5/22,11.38%,LBP;RAB7B;NR1D1;TIRAP;WDFY1
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5072657063369727,1.2495733581209931,0.19744483159117304,0.8337166644141256,1.0,10/33,18.83%,ANXA1;MAPK7;NFE2L2;HDAC6;ANKZF1;SIRPA;PLEKHA1;OSER1;IL6;CYP1B1
prerank,cellular response to reactive oxygen species (GO:0034614),0.4689628141007546,1.2492872807116229,0.13980789754535752,0.8336805352390751,1.0,17/59,14.48%,UCP1;EGFR;ANXA1;MAPK7;NFE2L2;HDAC6;PKD2;ANKZF1;CHUK;SIRPA;CAMKK2;AKT1;MAPT;PDGFRA;PLEKHA1;OSER1;FER
prerank,protein localization to cell junction (GO:1902414),-0.3988679453213317,-1.248480996276648,0.18181818181818182,0.6134150156251452,1.0,4/22,4.34%,TJP1;CGNL1;TJP2;PCLO
prerank,protein secretion (GO:0009306),0.4712429537318887,1.2478364396998791,0.1588170865279299,0.8387672810824041,1.0,10/56,8.54%,ANXA1;NECAB3;PCSK5;STEAP3;MIA3;PREB;RCN3;ABCA1;ADCYAP1;ARFGAP3
prerank,response to alcohol (GO:0097305),0.5168238516143507,1.2478078529655054,0.1776470588235294,0.8375599194025914,1.0,7/27,18.08%,SLIT3;SLIT2;TGFBR2;GRIN3A;PMVK;GRIN2A;TGFBR1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5372622476867178,1.2477955922674635,0.2019704433497537,0.8362892757220799,1.0,3/21,7.80%,ASPN;ECM1;GAS6
prerank,regulation of biomineral tissue development (GO:0070167),0.5154975133100138,1.2476265865126683,0.20613496932515338,0.8357364294715465,1.0,10/26,16.25%,DDR2;ECM1;GAS6;CYP27B1;BMP2K;SGMS2;FBXO5;CEBPB;TWIST1;NBR1
prerank,alpha-amino acid catabolic process (GO:1901606),-0.3697737953156623,-1.2476171886363665,0.16326530612244897,0.6126282541510667,1.0,14/29,32.83%,DDO;PRODH;ALDH4A1;SARDH;BLMH;CBS;THNSL2;KYNU;HSD17B10;HOGA1;FAH;IL4I1;HGD;HAAO
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.5962363481490924,1.247568229434283,0.2245762711864407,0.8347035971648855,1.0,4/12,13.85%,ESR1;NCOR2;NCOR1;ZC3H12A
prerank,regulation of urine volume (GO:0035809),0.6210197901079536,1.2474713592115372,0.20899854862119013,0.833862129688153,1.0,2/10,10.25%,HAS2;INPP5K
prerank,mRNA transport (GO:0051028),0.4526018351607663,1.2465910246511787,0.11202466598150052,0.8364893073608799,1.0,44/101,27.86%,SRSF2;SRSF6;NXF1;DDX19B;ZFP36L1;NUP93;MCM3AP;NUP107;U2AF1;SRSF3;NUP98;CPSF4;SRSF11;THOC7;ZFP36;SMG7;POLDIP3;THOC2;THOC1;NUP37;SMG6;FYTTD1;ZC3H11A;CPSF2;SRRM1;DDX39A;SLBP;NUP50;U2AF2;TPR;AGFG1;CPSF1;WDR33;NUP85;NUP133;NUP188;ALYREF;UPF3B;NUP88;SMG5;UPF1;THOC5;CPSF3;CDC40
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.6033071907602026,1.24638996018705,0.218707015130674,0.8360696698443878,1.0,5/11,17.21%,MTOR;DDX11;SMARCA4;NOP53;IPPK
prerank,regulation of cell differentiation (GO:0045595),0.43823251906143046,1.2459579901929259,0.07870837537840565,0.8366691832985549,1.0,35/148,16.19%,LIF;AR;PHLDB1;TRPS1;SCIN;FGFR1;EPHA3;RUNX1;BIN1;ZFP36L1;HOPX;HEMGN;NR1D2;TAF8;NR1D1;ZFHX3;TRIP4;YWHAG;CDK9;PDCD2;BCL6;PLEKHB2;CEBPB;ST7;KLK6;ANP32B;DDX17;GDNF;SIX1;FADS1;KLF4;SNAI2;KLHL41;CDK5RAP2;FLOT2
prerank,glycolipid metabolic process (GO:0006664),0.47497971765777314,1.2453401324886466,0.15736607142857142,0.8379800299351653,1.0,11/47,13.71%,SMPD3;ST3GAL2;ARSA;B3GALNT1;FUT2;GBA2;ST3GAL4;PIGW;GLA;CERK;GLTP
prerank,regulation of osteoclast differentiation (GO:0045670),0.49791861950052096,1.245070325811655,0.21307779030439683,0.8378776880795513,1.0,7/33,17.56%,FBN1;MTOR;LRRC17;TLR4;CEBPB;IL4;GPR137B
prerank,cardiocyte differentiation (GO:0035051),0.6147627482870233,1.2448386908407236,0.21971830985915494,0.8376043046848698,1.0,3/10,10.93%,AKAP13;TGFB2;EEF1AKMT4-ECE2
prerank,cellular response to cytokine stimulus (GO:0071345),0.4294408923041296,1.2438258035977945,0.011,0.8406290689941331,1.0,87/416,16.55%,IL4R;GHR;LBP;SYK;COL1A2;LIF;HAS2;CD80;DUOX1;AXL;CCL8;IRF4;ANXA1;IL16;NUMBL;CTF1;GRB10;MMP2;FYN;IRAK3;VEGFA;FGF2;STX1A;NFE2L2;ZFP36L1;CLCF1;PTPRJ;SOCS2;USP10;FOXO1;NR1D1;CXCL10;CSK;FSCN1;IL10RA;MUC1;PID1;RC3H1;ABL2;GAS6;STAT5A;FLT3LG;ZFP36L2;CHUK;PIK3CA;CDK9;CCL25;STX4;TLR4;UBE2G2;MAPK11;SIRPA;INPP5K;BCL6;CD47;IRAK4;AKT1;CSF2RA;SLC26A6;IRAK1;STK39;CDC34;UBA52;ZFP36;CCL13;CDKN1A;FLT3;RHOA;IL5;TWIST1;CCND1;CBL;TNFRSF1B;ZC3H12A;FER;HSP90AA1;CNTFR;RAPGEF1;IL4;BAG4;ZEB1;STAT5B;SOS1;IL6;HGF;SOCS6;CXCR4
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.6064700359575493,1.2437571507833458,0.20502092050209206,0.8396285057859965,1.0,6/10,24.40%,EMC1;EMC10;EMC8;EMC3;EMC2;EMC6
prerank,negative regulation of coagulation (GO:0050819),0.5693297303341718,1.243626472464022,0.21437740693196405,0.838936249853196,1.0,2/14,4.88%,CD34;PROCR
prerank,secondary palate development (GO:0062009),0.5741109026835932,1.243428140340618,0.20671140939597316,0.8384746896639698,1.0,4/14,3.71%,TGFB3;TGFB2;TGFBR2;SMAD4
prerank,negative regulation of cellular component organization (GO:0051129),0.45631535528029843,1.243305962522401,0.14375655823714587,0.8377028033162268,1.0,18/74,17.51%,AR;FAP;TMEFF2;EPHA3;IRAK3;VEGFA;SYT11;AIDA;SRC;HDAC6;SCAMP5;TFIP11;DNAJB2;XRCC5;ULK1;NOP53;IAPP;PEX5
prerank,chondrocyte differentiation (GO:0002062),0.5061541021955709,1.243283309209395,0.18044237485448195,0.8365192562228362,1.0,8/32,8.71%,WNT10B;EIF2AK3;SULF2;RUNX1;SLC39A14;NFIB;SULF1;SOX5
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.6086817166784788,1.2429236615742016,0.2200825309491059,0.8368189293424487,1.0,5/11,17.83%,TIMM10B;TIMM9;AGK;TIMM22;TIMM8B
prerank,regulation of spindle assembly (GO:0090169),0.5179172604621772,1.2425258336495746,0.17904993909866018,0.8373003111003523,1.0,9/25,22.76%,GPSM2;VPS4B;CCSAP;CEP97;DYNC1H1;SENP6;NUMA1;PDCD6IP;TPR
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.4465792649345749,-1.2424719024466284,0.20901639344262296,0.6232301051690479,1.0,5/16,13.38%,ST8SIA4;ST6GALNAC3;ST6GALNAC5;ST8SIA2;ST8SIA6
prerank,long-chain fatty acid import into cell (GO:0044539),-0.517180111401627,-1.242268875706133,0.20462046204620463,0.6207214893216064,1.0,3/10,5.91%,ACSL1;SLC2A1;ACSL3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.5957331074365874,1.2418666743697684,0.21810699588477367,0.8377849981443739,1.0,4/11,12.36%,SRI;PKD2;GSTM2;CALM2
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.5957331074365874,1.2418666743697684,0.21810699588477367,0.8377849981443739,1.0,4/11,12.36%,SRI;PKD2;GSTM2;CALM2
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.5421598580781348,1.2414653283676516,0.1900121802679659,0.8382834030650678,1.0,2/21,4.40%,LRP6;AXIN1
prerank,regulation of signal transduction (GO:0009966),0.4342906482118695,1.2411858435318976,0.07021063189568706,0.8381840978384086,1.0,34/190,9.13%,IGFBP5;CD80;CD55;ESR1;MGLL;SRMS;PLCE1;FYN;CD177;GAS1;RUNX1;DGKQ;IGFBP6;CDKN2AIP;LLGL1;WWTR1;ACVR1;IGFBP4;AXIN1;GNG4;TSPEAR;MTCH1;ZDHHC7;SOCS2;DTNBP1;CSK;SULF1;SRC;YWHAG;MDFIC;ADCYAP1;FOXL1;GSKIP;RFNG
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.4431235584448364,1.2409214384311205,0.10905349794238683,0.838079200027556,1.0,25/112,13.64%,COL3A1;COL1A2;WNT2;TGFB3;CLEC3B;MAPK7;ZMIZ1;TGFB2;TGFBR2;ADAM9;SMAD4;ZFP36L1;SKI;ACVR1;ITGB5;SMAD5;SRC;ZFP36L2;PARD6A;SOX5;SMAD6;AMHR2;UBA52;RHOA;CBL
prerank,regulation of intracellular transport (GO:0032386),0.48775540205988593,1.2406101708850013,0.18303571428571427,0.8381982514382492,1.0,14/38,23.57%,GAS1;NDEL1;RBM4;ATP9A;RINT1;INPP5F;SCFD1;ANTKMT;DYNC1H1;REEP5;CAPN10;NUMA1;GRIPAP1;CRYAB
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.38198123317702226,-1.24053054886004,0.1488095238095238,0.622414155579384,1.0,6/28,3.38%,PTN;EPHA4;ADCY1;APP;APOE;SHANK3
prerank,respiratory tube development (GO:0030323),0.5174840567202185,1.240486746421685,0.1866977829638273,0.8374781247499639,1.0,5/28,6.96%,FGF7;PCSK5;VEGFA;FGF2;GLI2
prerank,positive regulation of interleukin-13 production (GO:0032736),0.6032120722016475,1.2403742066995007,0.23132183908045978,0.8367220365073543,1.0,6/10,29.53%,IRF4;IL4;IL18;RARA;PRKCZ;LGALS9
prerank,phospholipid dephosphorylation (GO:0046839),0.49199484028540874,1.2402638623855204,0.19080459770114944,0.8359198972212029,1.0,16/37,24.79%,MTMR11;PLPP3;PLPP5;PLPP1;OCRL;INPP5F;INPP5K;PLPPR3;MTMR6;MTMR1;PIP4P1;PLPP2;INPP5B;PTEN;SGPP1;MTM1
prerank,negative regulation of viral entry into host cell (GO:0046597),0.5916582983196127,1.2387639171147884,0.22783083219645292,0.8411715681367722,1.0,3/12,10.43%,GSN;MID2;TRIM11
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5515058624974742,1.2387285637805485,0.21419185282522996,0.8400497477699526,1.0,4/17,11.67%,SLC4A8;STX1A;SCAMP5;RAB3D
prerank,embryonic limb morphogenesis (GO:0030326),0.49793980019354533,1.2386903054523253,0.20833333333333334,0.8389575403103388,1.0,9/34,13.51%,LRP6;AFF3;MBNL1;TGFB2;SKI;ECE1;FBXW4;GLI3;TWIST1
prerank,cellular response to lipid (GO:0071396),0.43248324687299994,1.2381857886112222,0.06143001007049345,0.8399285908427604,1.0,41/191,17.28%,LBP;AR;CD80;UCP1;ESR1;AXL;WNT2;WNT10B;EGFR;IRS1;EPHA3;WNT9A;ADAM9;ATP1A3;ATP1A1;MAPK14;NR1D1;CXCL10;NCOA3;CARD16;RET;PID1;ABL2;FZD7;TLR4;SIRPA;URI1;IRAK1;ADCY8;ZFP36;ADAM15;RHOA;TNFRSF1B;ZC3H12A;CD14;SELENOS;FZD4;PDCD4;IL6;HTRA2;NRIP1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.4254209558222975,1.2377582269124912,0.008,0.8406510690454368,1.0,98/532,16.55%,MID1;IL4R;GHR;TNFSF9;LBP;ACKR3;SYK;COL1A2;LIF;CD80;DUOX1;CCL8;IL1RL1;IRF4;ANXA1;IRS1;IL16;NUMBL;CTF1;PSMC4;GRB10;CD44;MMP2;FYN;ANXA2;IRAK3;VEGFA;FGF2;STX1A;MIF;SMAD4;RAP1B;CLCF1;PTPRJ;CAMK2D;SOCS2;IL33;FOXO1;CXCL10;CSK;FSCN1;IL10RA;MUC1;TNFRSF11B;PSMC6;SRC;PELI3;IL17RA;ABL2;STAT5A;UBE2N;FLT3LG;CHUK;TNFRSF18;PIK3CA;PSMD8;CCL25;TNFSF13B;STX4;PLVAP;ARF1;SAMHD1;SQSTM1;BCL6;IRAK4;AKT1;CSF2RA;IRAK1;IRS2;UBA52;CD27;CCL13;TRAF3IP2;CDKN1A;FLT3;IL5;TWIST1;CCND1;CBL;TNFRSF1B;MAP3K14;FER;HSP90AA1;CNTFR;SMARCA4;RAPGEF1;EDA;IL4;BAG4;ZEB1;TRIM68;STAT5B;PDCD4;SOS1;IL6;HGF;TRAF3;SOCS6
prerank,epithelium development (GO:0060429),0.43933106132468136,1.2376057121235036,0.12037037037037036,0.8400534561022851,1.0,23/107,16.73%,CD34;DHRS9;WNT2;WT1;MEOX2;VEGFA;PKD1;SOX10;DACT1;TRIM71;RCN3;PKD2;TPP1;NDRG4;SOX8;ACADVL;DMBT1;SIX1;SNAI2;VDAC1;AHI1;ANXA4;BDH2
prerank,primary neural tube formation (GO:0014020),0.5053573807007334,1.2369941833163838,0.1824561403508772,0.8415228792789043,1.0,4/30,4.22%,LRP6;TGFB2;COBL;SKI
prerank,regulation of centrosome cycle (GO:0046605),0.528800058806177,1.2369333349420097,0.21544209215442092,0.8405683047760362,1.0,4/21,10.75%,XRCC3;ATF5;VPS4B;NPM1
prerank,regulation of biosynthetic process (GO:0009889),0.6057207635644856,1.23662338650052,0.21994535519125682,0.8406555164886007,1.0,1/11,0.59%,UCP1
prerank,cell differentiation in spinal cord (GO:0021515),-0.49735818401779897,-1.236087363788674,0.21835443037974683,0.6307989611848357,1.0,2/10,2.48%,SOX6;SOX13
prerank,camera-type eye development (GO:0043010),0.5129169798017625,1.23599120196696,0.21754807692307693,0.8421593372358004,1.0,7/25,12.57%,FBN1;WT1;VEGFA;SKI;TENM3;TSKU;ALDH1A3
prerank,cellular biogenic amine metabolic process (GO:0006576),0.5785673004089218,1.2359110424855062,0.2248995983935743,0.8412772208142282,1.0,4/12,13.67%,SRM;ODC1;TRH;SMS
prerank,cellular response to oxygen-containing compound (GO:1901701),0.42729230951979863,1.2358138304102022,0.031031031031031032,0.8404682077184987,1.0,67/291,17.28%,IGFBP5;LBP;CD80;UCP1;ESR1;AXL;WNT2;WNT10B;EGFR;IRS1;WT1;EPHA3;CAPN2;WNT9A;SLIT2;ADAM9;ZFP36L1;MAPK14;P2RX3;RAP1B;MTOR;ATP2B4;FOXO1;NR1D1;CXCL10;NCOA3;CARD16;RET;PID1;ABL2;PKD2;DPEP1;CHUK;FZD7;TIRAP;TLR4;SIRPA;HCN4;INPP5K;SSH1;CAMKK2;AKT1;MAPT;SLC26A6;IRAK1;TSHR;MTR;PDGFRA;ZFP36;RHOA;GNB1;NSMF;TNFRSF1B;RRAGD;ZC3H12A;CD14;FER;RAPGEF1;KCNC2;SELENOS;CPEB1;FZD4;PDCD4;IL6;HTRA2;AKAP9;NRIP1
prerank,aorta development (GO:0035904),-0.43650032085919116,-1.235589368462254,0.17829457364341086,0.6289707522476352,1.0,8/14,9.55%,ROBO1;ADAMTS9;ROBO2;TBX1;HECTD1;PDGFRB;PDE2A;TBX2
prerank,chromatin assembly (GO:0031497),0.49270510799318135,1.235217695468573,0.1811926605504587,0.8417415477445346,1.0,21/38,29.81%,CHAF1B;NOC2L;SPTY2D1;POLE3;NPM1;ANP32B;EZH1;GRWD1;BAHD1;NAP1L2;CTCF;PRDM9;PAF1;NAP1L3;KAT6B;BRD2;H1-0;LIN54;ATRX;TP53;SOX9
prerank,body fluid secretion (GO:0007589),0.5639107172385207,1.2348710371441092,0.2073669849931787,0.841989894193314,1.0,2/15,2.80%,GPAT4;VEGFA
prerank,phospholipid homeostasis (GO:0055091),0.6075608217760002,1.2344810683923444,0.24091520861372812,0.8424494734949903,1.0,3/11,6.10%,TLCD2;RCN3;ABCA1
prerank,regulation of macrophage cytokine production (GO:0010935),0.5889867610704073,1.2343383081465813,0.22432432432432434,0.8417993796383699,1.0,3/13,2.88%,TGFB3;IRAK3;TGFB2
prerank,negative regulation of angiogenesis (GO:0016525),0.44789028793000807,1.234290534939477,0.147119341563786,0.8407842052771887,1.0,15/84,8.01%,DCN;TNMD;ANGPT4;ISM1;SPARC;TGFB2;CD160;THBS4;CREB3L1;KLF2;ATP2B4;HOXA5;CXCL10;SULF1;SERPINF1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.46382634200188533,1.2342802980067522,0.17462039045553146,0.839583794903244,1.0,20/57,22.36%,CDC14B;FANCD2;EME1;TIPIN;TAOK3;RFWD3;RINT1;DTL;FBXO31;RPS27L;TAOK2;CDKN1A;ABRAXAS1;CCND1;NBN;NOP53;BLM;DONSON;CLSPN;SDE2
prerank,negative regulation by host of viral process (GO:0044793),0.6002380815303121,1.233859949078131,0.2148876404494382,0.840196553213744,1.0,2/10,13.85%,CCL8;ZC3H12A
prerank,tube closure (GO:0060606),0.5022249819427003,1.2338261367794505,0.18118466898954705,0.8391156772064268,1.0,4/31,4.22%,LRP6;TGFB2;COBL;SKI
prerank,nucleoside salvage (GO:0043174),0.5969130572962345,1.2337841533084595,0.22740524781341107,0.8380223456619215,1.0,2/10,5.48%,TK2;TK1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.44930472395304677,1.2337816269087407,0.1360759493670886,0.8368145485725628,1.0,19/87,13.64%,COL3A1;COL1A2;TGFB3;ZMIZ1;TGFB2;TGFBR2;ADAM9;SMAD4;SKI;ACVR1;ITGB5;SMAD5;SRC;PARD6A;SMAD6;AMHR2;UBA52;RHOA;CBL
prerank,muscle cell development (GO:0055001),-0.3588162154430181,-1.23357394696724,0.17682926829268292,0.6313478448858467,1.0,8/30,8.74%,NEBL;ENG;DMD;IGF1;DYSF;CXADR;MYOF;MYH11
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.4861250788891427,-1.2331437490866466,0.20072992700729927,0.6296465953160757,1.0,5/11,5.90%,ADAMTS9;EPN2;THBS1;PIK3CB;SEMA6A
prerank,mRNA destabilization (GO:0061157),0.48392108200141026,1.232256385681594,0.18771331058020477,0.8422744320652642,1.0,14/38,21.82%,DIS3L2;ZFP36L1;TRIM71;TARDBP;RC3H1;ZFP36L2;PUM1;POLR2D;ZFP36;ZC3H12A;YTHDF2;YTHDF1;RC3H2;YTHDF3
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.4986098006683779,1.2321783759226903,0.19910011248593926,0.8413904655963578,1.0,15/33,22.91%,IRS1;PIK3C2B;PIK3R2;CD160;ZFP36L1;C1QBP;PIK3CA;SIRT2;AKT1;PLEKHA1;TYRO3;PTEN;NF1;PIK3CG;HTR2A
prerank,regulation of histone modification (GO:0031056),0.5732249751620242,1.2319934214213455,0.22251655629139072,0.8409564769113236,1.0,6/13,14.73%,FLCN;UBE2N;CDK9;PARG;AKAP8;SETD5
prerank,response to cholesterol (GO:0070723),0.5526546994202524,1.2319419527141027,0.2266839378238342,0.8399642425459811,1.0,3/17,3.24%,LRP6;GRAMD1A;TGFBR2
prerank,epithelial cell differentiation (GO:0030855),0.4457243481477094,1.2317169426528614,0.14822546972860126,0.8396968245567265,1.0,17/88,16.73%,FSTL1;DHRS9;ANXA1;WT1;VEGFA;ZDHHC7;TPP1;FZD7;JAG1;TDRD7;ACADVL;AKT1;DMBT1;SIX1;VDAC1;ANXA4;BDH2
prerank,positive regulation of translation (GO:0045727),0.4440372020116691,1.2313551680843942,0.13692946058091288,0.8400175769511533,1.0,33/94,21.82%,NIBAN1;DAZL;MTOR;C1QBP;LARP4;AGO2;HNRNPD;MRPS27;NPM1;BCL3;PASK;EIF6;LARP1;POLR2D;RPS27L;POLR2G;ZCCHC4;RBM3;CDC123;POLDIP3;EIF3E;PKM;IL6;FXR2;EIF3D;YTHDF2;YTHDF1;RCC1L;RMND1;PCIF1;EIF5A2;MPV17L2;YTHDF3
prerank,global genome nucleotide-excision repair (GO:0070911),0.5071187978964511,1.231312007049465,0.19833729216152018,0.8389608397824818,1.0,7/26,13.05%,GTF2H3;RAD23B;RNF111;ERCC3;UBA52;ERCC4;DDB1
prerank,protein targeting (GO:0006605),0.4434380002986609,1.2310547471635158,0.1184346035015448,0.8388515604398395,1.0,60/118,32.71%,AP4B1;PEX16;EDEM1;GDAP1;ZDHHC7;SPCS1;VPS37D;TIMM10B;TRAK2;TIMM9;HPS4;AP4E1;TAOK2;VPS37C;ZDHHC2;PEX12;SEC63;PEX1;GIPC1;SEC61A1;TIMM22;AP4M1;ZDHHC4;ZDHHC24;ZDHHC21;VPS37B;ZDHHC20;TIMM8B;NACA;BCAP31;TOMM5;ATG3;AP1S3;ZDHHC18;TIMM17A;ICMT;SDCBP;FUT10;FIS1;SRPRB;KIF13B;TOMM40;MICALL1;PITRM1;PRKCI;NLGN1;SPCS3;ZDHHC15;PARD3;MYO1C;GOLGA7B;MFN2;PIKFYVE;CDC37;TOMM34;ARL6;ZDHHC3;CHM;PEX19;AP4S1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.4693345829910435,1.2306415723701511,0.1926006528835691,0.839407206481643,1.0,15/46,18.87%,ANTXR1;TMEFF2;ITGB3;NTN4;RADIL;MEGF9;SRCIN1;EPHB3;ITGAV;ATRN;RHOA;FER;SRGAP2;ILK;LAMC1
prerank,synaptic vesicle exocytosis (GO:0016079),0.48281588562865946,1.230430814599721,0.2106430155210643,0.8391397195201468,1.0,15/40,19.18%,SYT2;STX2;STX1A;STX11;STX1B;STX4;SNAP23;SNAP25;SNAP47;SNAPIN;SYT1;SNPH;STX3;VAMP2;RIMS2
prerank,Golgi inheritance (GO:0048313),0.5973196575982614,1.2303158673287358,0.23699421965317918,0.8384349211852798,1.0,2/11,3.60%,STK25;STX5
prerank,positive regulation of heart contraction (GO:0045823),-0.40607622153554473,-1.2300753677291933,0.16587677725118483,0.6351619272047667,1.0,6/19,16.91%,ATP1A2;KCNQ1;RYR2;EDN1;ADM;EDN3
prerank,placenta development (GO:0001890),0.5856155564720873,1.2300661563327018,0.21779548472775564,0.838292194589392,1.0,2/12,4.25%,ANG;ADAM19
prerank,ureteric bud morphogenesis (GO:0060675),0.5545253594100623,1.2295372067539734,0.2262210796915167,0.8393907931791749,1.0,5/16,13.67%,WT1;FGF2;PKD2;GDNF;SIX1
prerank,glucose transmembrane transport (GO:1904659),-0.39861531165990977,-1.2293165388593577,0.20614035087719298,0.6342645420954095,1.0,3/18,3.64%,SORT1;SLC2A1;SLC5A3
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.3648799060758034,-1.2291641423840924,0.16666666666666666,0.631760816153015,1.0,7/26,13.47%,ACER2;NOS3;GCH1;NOS1;SPR;SPHK1;SPTLC2
prerank,production of siRNA involved in RNA interference (GO:0030422),0.6108346623105549,1.229153304540429,0.22647058823529412,0.8398013868894656,1.0,2/10,8.89%,TARBP2;AGO2
prerank,regulation of neuroinflammatory response (GO:0150077),0.5419204029362157,1.2285391081829216,0.21830065359477124,0.841161030529944,1.0,9/19,18.11%,IL33;NR1D1;DAGLA;CD200R1;TNFRSF1B;NUPR1;IL4;IL6;IL18
prerank,negative regulation of B cell proliferation (GO:0030889),-0.47029082065314404,-1.228523684473694,0.22372881355932203,0.6305459745560326,1.0,4/11,13.56%,LYN;TNFRSF21;ATM;CD300A
prerank,positive regulation of protein secretion (GO:0050714),-0.30005955486981983,-1.2284920355673314,0.1,0.6277738109888353,1.0,10/69,3.75%,BMP6;WLS;UNC13B;FRMD4A;MYRIP;IGF1;RBP4;CD2AP;MYO18A;ACSL4
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.535352333529677,1.2284396118422591,0.20535714285714285,0.8403821893754032,1.0,5/18,11.07%,DDR2;RUNX1;FSCN1;MELTF;COLGALT1
prerank,positive regulation of chemotaxis (GO:0050921),-0.331202097414754,-1.2282283396578646,0.14634146341463414,0.6255890339116229,1.0,14/43,12.28%,PTN;F3;THBS1;PRKD1;SEMA5A;KDR;IL6R;NRP1;NTRK3;PDGFRB;CDH13;MDK;PPM1F;TGFB1
prerank,regulation of glucose metabolic process (GO:0010906),0.49180244980795046,1.2279864679318055,0.19610091743119265,0.8411091434149646,1.0,11/34,19.41%,IRS1;DGKQ;FOXK2;AKT1;IRS2;ZNF692;USP7;SELENOS;OGT;RORA;GPLD1
prerank,positive regulation of axon extension (GO:0045773),0.5238911652118685,1.2277581440430176,0.2201722017220172,0.8408657609817258,1.0,9/22,18.15%,DBN1;VEGFA;NTN1;ISLR2;DSCAM;L1CAM;MAPT;GOLGA4;SHTN1
prerank,negative regulation of axonogenesis (GO:0050771),0.5072203174359271,1.2272720116032505,0.20164126611957797,0.8417223762184431,1.0,8/27,14.62%,FGF13;PTPRS;TRIM46;GDI1;ULK2;RHOA;ULK1;DCC
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.33880216368881805,-1.2272416967110615,0.12307692307692308,0.6254290474250397,1.0,14/38,17.58%,BMP6;SASH1;PLSCR1;POLR3C;POLR3B;DDX60;PUM2;GBP5;LY86;NMI;USP15;LY96;CYBA;DHX58
prerank,RNA export from nucleus (GO:0006405),0.44590920511747567,1.2271087334301647,0.1384297520661157,0.8411992126045595,1.0,43/100,27.86%,SRSF2;HNRNPA1;SRSF6;NXF1;DDX19B;NUP93;MCM3AP;NUP107;U2AF1;SRSF3;NUP98;CPSF4;SRSF11;THOC7;SMG7;POLDIP3;THOC2;THOC1;NUP37;SMG6;FYTTD1;ZC3H11A;CPSF2;SRRM1;DDX39A;SLBP;NUP50;U2AF2;TPR;AGFG1;CPSF1;WDR33;NUP85;NUP133;NUP188;ALYREF;UPF3B;NUP88;SMG5;UPF1;THOC5;CPSF3;CDC40
prerank,response to lipopolysaccharide (GO:0032496),0.433461483931164,1.2265638668503094,0.11020408163265306,0.8424545450208663,1.0,30/138,16.45%,LBP;CD80;AXL;IRAK3;FOXP1;F2R;ADAM9;S100A8;S100A9;MAPK14;NR1D1;CXCL10;CARD16;TIRAP;CYP27B1;TLR4;SIRPA;SMAD6;SLPI;IRAK1;ZFP36;RHOA;TNFRSF1B;ZC3H12A;CD14;GGT7;FER;SELENOS;PDCD4;IL6
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.5220036856584879,1.2265454010056274,0.21559074299634592,0.8413508553885719,1.0,9/23,21.08%,MTMR11;OCRL;INPP5F;INPP5K;MTMR6;MTMR1;PIP4P1;INPP5B;PTEN
prerank,regulation of protein import into nucleus (GO:0042306),0.4885217660786859,1.2265114466134799,0.1774193548387097,0.8402873143614515,1.0,17/36,22.76%,ZPR1;PIK3R2;RAB23;MDFIC;PSEN1;RBM22;HDAC3;JUP;CABP1;ZC3H12A;DMAP1;CHP1;IPO5;UFM1;FLNA;BAG3;TPR
prerank,sensory perception of chemical stimulus (GO:0007606),0.5610210894298558,1.226334724132827,0.22117962466487937,0.8398567793671747,1.0,2/15,14.38%,GNAS;BBS4
prerank,positive regulation of response to external stimulus (GO:0032103),-0.2783440215990513,-1.2262379100352059,0.09090909090909091,0.6251261056964704,1.0,38/128,17.93%,PTN;BMP6;ETS1;SASH1;APP;THBS1;SNCA;WNT5A;GPR4;PLSCR1;POLR3C;OPTN;AGTR1;NAPEPLD;POLR3B;DDX60;PUM2;FEM1A;TLR3;CX3CL1;PDGFRB;PDE2A;GBP5;MDK;RIPK1;PPM1F;TGFB1;NFKBIA;USF1;LY86;NMI;SERPINE1;USP15;LPL;LY96;CYBA;DHX58;RARRES2
prerank,protein import into nucleus (GO:0006606),0.45742917786824605,1.2262041343220966,0.15767195767195769,0.8392674422031267,1.0,28/66,27.08%,SYK;SPRN;NUP93;KPNA2;NUP107;AKT1;IPO9;TNPO2;E2F3;IPO5;NXT2;KPNA1;NUP50;RPL23;CBLB;RANBP6;TPR;IPO11;IPO13;TSC2;TNPO1;NUP85;NUP133;NUP188;KPNA6;KPNB1;FAM53C;NUP88
prerank,intermediate filament organization (GO:0045109),0.5442410132159459,1.225012877862612,0.24015247776365947,0.843159342581279,1.0,2/17,6.58%,KRT20;NEFL
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5109715578017118,1.2245342322035422,0.21566265060240963,0.8440317515603417,1.0,9/27,14.20%,IRAK3;TLR5;TIRAP;TLR4;IRAK4;TNIP1;IRAK1;UBA52;CD14
prerank,acute-phase response (GO:0006953),0.5856767970801532,1.2237066044777638,0.23392612859097128,0.8463425978901417,1.0,4/12,18.80%,LBP;CEBPB;IL6;MBL2
prerank,regulation of DNA metabolic process (GO:0051052),0.4721582020494145,1.2233559620450225,0.18791946308724833,0.8466301102467575,1.0,20/44,28.00%,KPNA2;UBE2N;CDK9;HNRNPD;PARG;MPHOSPH8;XRCC5;NBN;THOC1;SMG6;KPNA1;KDM1B;TERF2IP;WDR18;POLH;KAT7;ALYREF;SMG5;UPF1;HDAC8
prerank,in utero embryonic development (GO:0001701),0.5055954764581636,1.2232551465151345,0.2057074910820452,0.845819485597853,1.0,7/25,8.29%,TGFB3;MBNL1;VEGFA;LMX1B;PKD1;FLCN;SOX8
prerank,regulation of telomere maintenance (GO:0032204),0.5080056623452599,1.2232363710838983,0.21785714285714286,0.8447141200147766,1.0,15/26,28.93%,HNRNPD;XRCC5;ERCC4;NBN;USP7;SMG6;PML;RAD50;TINF2;TERF2IP;ERCC1;SMG5;UPF1;HDAC8;ATRX
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.5903006808404455,1.2231240593490675,0.2503401360544218,0.844001875238696,1.0,4/11,16.92%,EGFR;MAP2K2;IL6;DDX5
prerank,microtubule anchoring at centrosome (GO:0034454),0.5996409430003443,1.2231137926816331,0.23255813953488372,0.8428669574817841,1.0,6/10,21.03%,DCTN1;KIF3A;BBS4;NIN;CCDC120;PCM1
prerank,regulation of peptidase activity (GO:0052547),0.5389008950631566,1.223084060329294,0.2266500622665006,0.841805424203582,1.0,4/19,10.65%,MAPK12;ECM1;RCN3;CSTB
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4349686047875398,1.2228767256141873,0.09897959183673469,0.8415182697004061,1.0,27/128,13.64%,COL3A1;COL1A2;AMH;TMEM100;TGFB3;ZMIZ1;TGFB2;TGFBR2;ADAM9;SMAD4;SMURF2;SKI;ACVR1;ITGB5;BMP15;FAM83G;RNF111;SMAD5;SRC;STUB1;PARD6A;BMP8A;SMAD6;AMHR2;UBA52;RHOA;CBL
prerank,cellular response to cAMP (GO:0071320),0.5005379065872471,1.2228181681660057,0.21107266435986158,0.8405706410739834,1.0,8/30,11.54%,IGFBP5;WT1;ZFP36L1;RAP1B;PKD2;HCN4;INPP5K;SLC26A6
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.4599014130401,1.2221334990436812,0.1879049676025918,0.8423679254380898,1.0,13/63,18.11%,EPHB2;CD80;ANXA1;MIF;CLCF1;TIRAP;CD81;TNFSF13B;IRS2;IL4;NCK1;IL6;IL18
prerank,regulation of cell morphogenesis (GO:0022604),0.5015021752176632,1.2218078367430145,0.21631205673758866,0.8426264659433652,1.0,7/30,10.96%,EFNA5;SPARC;CD44;ZRANB1;MYO9A;LARP4;CAMSAP1
prerank,heart contraction (GO:0060047),-0.3324297322546305,-1.221787778539704,0.13333333333333333,0.6340825350417238,1.0,3/41,1.43%,ATP1A2;TPM1;DMD
prerank,endosome organization (GO:0007032),0.4769920981763114,1.2215219698646884,0.1871476888387824,0.8426978650530061,1.0,17/41,26.85%,DNM1;HOOK2;PLEKHF1;PI4K2B;SQSTM1;TMEM9;USP50;PHETA2;VPS11;ANXA8;ANXA8L1;VPS33B;CORO1C;PI4K2A;ALS2;ARFGEF2;SNX33
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5750519282102297,1.2211776547725604,0.2269021739130435,0.8407043598114826,1.0,6/12,23.61%,CUL3;CDC23;ANAPC5;CDC27;ANAPC4;NSMCE2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5750519282102297,1.2211776547725604,0.2269021739130435,0.8407043598114826,1.0,6/12,23.61%,CUL3;CDC23;ANAPC5;CDC27;ANAPC4;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5750519282102297,1.2211776547725604,0.2269021739130435,0.8407043598114826,1.0,6/12,23.61%,CUL3;CDC23;ANAPC5;CDC27;ANAPC4;NSMCE2
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.49470798231886765,1.2205745466931353,0.21739130434782608,0.8420358119567268,1.0,4/33,2.65%,IGFBP5;TGFB3;ANG;OGN
prerank,respiratory system development (GO:0060541),0.5010669137676914,1.2202428830260066,0.2015855039637599,0.8423539523110734,1.0,6/32,6.96%,FGF7;WT1;DISP1;VEGFA;FGF2;GLI2
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.6086845605277006,1.2202023803459974,0.24,0.8413915886006812,1.0,3/10,9.24%,C1QTNF1;CD9;ADAMTS18
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.4888769870329637,1.2201054142054875,0.21096543504171633,0.8406257983962591,1.0,11/32,14.55%,ANXA1;MEOX2;VEGFA;FGF2;HDAC7;HDAC9;FOXC2;AKT3;RHOJ;RHOA;KLF4
prerank,neurotrophin signaling pathway (GO:0038179),-0.39323584794750427,-1.220098711798629,0.2146341463414634,0.6357316842433897,1.0,6/21,12.26%,RAPGEF2;SORT1;ZFYVE27;CASP3;NTRK2;BDNF
prerank,modulation by host of viral genome replication (GO:0044827),0.5600611517950704,1.2187641559512299,0.22795115332428764,0.8452982814724533,1.0,3/13,13.85%,CCL8;FBXL2;ZC3H12A
prerank,cellular response to drug (GO:0035690),-0.3836676682769948,-1.2187556758533327,0.17318435754189945,0.6363535605553463,1.0,8/25,12.24%,PPM1E;MEF2C;ACER2;AIM2;TFRC;KCNQ1;CERS1;PPM1F
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.544902154463909,1.2178437847481052,0.2360248447204969,0.8480517217484547,1.0,6/18,19.18%,SLC4A8;RAP1B;DTNBP1;SNAPIN;PREPL;RIMS2
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.3471614037336478,-1.2161621230111168,0.16129032258064516,0.6405968561127336,1.0,10/35,8.54%,PLXNA2;NRP2;PLXNA4;SEMA5A;SEMA7A;PLXND1;SEMA6A;NRP1;SEMA3B;PLXNB1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.4287857456174384,1.215954527921702,0.12841253791708795,0.8549992861774094,1.0,19/138,7.91%,ANGPTL1;SYK;LIF;DDR2;EPHB2;AXL;SRMS;EGFR;TNK1;FGFR1;EPHA3;FYN;MST1R;TRIO;PTPRF;SRC;RET;POLR1G;ABI1
prerank,actomyosin structure organization (GO:0031032),-0.30330762325065275,-1.2155994336934075,0.1276595744680851,0.6394265977227253,1.0,12/75,6.37%,TJP1;SORBS1;TPM1;ACTN2;PGM5;FRMD5;PHACTR1;EPB41;F11R;MYO18A;EPB41L5;TMOD3
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.529067160365366,1.2149929828039148,0.2350791717417783,0.8578482949300811,1.0,6/22,9.57%,ABT1;URB1;KRI1;ERI3;NOP9;EXOSC7
prerank,autophagy of nucleus (GO:0044804),0.5487366467966621,1.214743101703907,0.23513870541611626,0.857661687053174,1.0,8/16,21.17%,ATG2B;WIPI2;WDR45B;ULK2;ATG2A;ULK1;ATG13;ATG3
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.3788155580387154,-1.2145594117852156,0.1921182266009852,0.6393712563228514,1.0,7/20,14.59%,WNT4;BMP5;ACADL;SIK1;BMP2;CEACAM1;GPER1
prerank,myoblast differentiation (GO:0045445),0.5614424923789477,1.2143525851705026,0.22727272727272727,0.858173884564503,1.0,6/14,16.92%,MAPK12;MBNL1;TCF7L2;JAG1;DDX17;DDX5
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.4432420952611857,1.2141026023605244,0.15129533678756477,0.8581202329787866,1.0,42/96,27.86%,SRSF2;SRSF6;NXF1;DDX19B;NUP93;MCM3AP;NUP107;U2AF1;SRSF3;NUP98;CPSF4;SRSF11;THOC7;SMG7;POLDIP3;THOC2;THOC1;NUP37;SMG6;FYTTD1;ZC3H11A;CPSF2;SRRM1;DDX39A;SLBP;NUP50;U2AF2;TPR;AGFG1;CPSF1;WDR33;NUP85;NUP133;NUP188;ALYREF;UPF3B;NUP88;SMG5;UPF1;THOC5;CPSF3;CDC40
prerank,response to progesterone (GO:0032570),0.5329723664597812,1.2133766906555281,0.23969072164948454,0.8600902550417031,1.0,4/18,6.79%,TGFB3;TGFB2;CATSPERB;SRC
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.4708921661255903,1.2133169676467634,0.20045558086560364,0.859173353035796,1.0,14/44,16.46%,TRIAP1;CD44;VEGFA;CARD16;SRC;GAS6;CAST;DPEP1;YWHAE;GPX1;AKT1;SFN;KLF4;HGF
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.35194373914681887,-1.2132012140725006,0.15,0.6402062074694785,1.0,8/37,6.02%,ALCAM;TENM4;PTPRD;FAT4;CADM1;HMCN1;CXADR;VCAM1
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.5271981821195639,1.213185709325683,0.23544303797468355,0.8585655671230935,1.0,6/22,18.83%,GHR;F2R;IL10RA;MGAT5;IL6;CYP1B1
prerank,kidney development (GO:0001822),0.4541664296636615,1.2130766654436638,0.18763326226012794,0.8578769734310054,1.0,10/65,6.96%,HAS2;WT1;PCSK5;SULF2;VEGFA;TGFB2;C1GALT1;PKD1;SULF1;GLI2
prerank,positive regulation of mitochondrial fission (GO:0090141),0.5361687607327668,1.2129285645421928,0.23455233291298866,0.8573666655442688,1.0,3/18,8.72%,DCN;MIEF2;MCU
prerank,protein localization to chromosome (GO:0034502),0.4833113447814082,1.212716231878238,0.2091121495327103,0.8571344210418385,1.0,9/34,18.67%,ESR1;PARP3;CHMP7;ACD;TPP1;XRCC5;IFFO1;CTCF;TINF2
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.5412202967711022,1.2125996910285983,0.22407170294494239,0.8564322736519365,1.0,7/18,17.76%,RAD51B;CDK4;VPS4B;DTL;FBXO5;CCND1;RCC2
prerank,peptidyl-lysine modification (GO:0018205),0.4409664767852607,1.2125315619555936,0.1554192229038855,0.8555823189510047,1.0,17/99,9.72%,PLOD2;LOXL2;LIPT2;STX1A;HDAC9;RNF212B;NUP93;PIAS3;NUP107;HDAC6;UBA2;NUP98;PLOD3;SIRT2;KAT2B;NDUFAB1;LOXL1
prerank,regulation of protein sumoylation (GO:0033233),0.5464296202667587,1.2121176761517105,0.24120603015075376,0.8561619382698905,1.0,5/17,14.10%,ZMIZ1;GNL3L;PIAS3;UBA2;HDAC4
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.4079863260704195,-1.2109535023807154,0.21578947368421053,0.6432138305455808,1.0,5/20,8.53%,GRK3;MGRN1;SNCA;CRY1;APLP1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4511623927602895,1.2109036426528814,0.1893939393939394,0.8602268913443565,1.0,16/66,14.55%,CDK2AP2;EGFR;ANXA1;FHL1;PKD1;DACT1;CDK4;PRMT2;PKD2;BRD7;AKT1;GPNMB;CDKN1A;CCND1;INO80;KLF4
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.5837453404295736,1.2101062090425545,0.24645892351274787,0.8623920822452528,1.0,4/10,21.27%,RC3H1;ZC3H12A;IL4;RC3H2
prerank,tRNA 5'-leader removal (GO:0001682),0.566536271591549,1.209916636493633,0.2453083109919571,0.8620863756291905,1.0,5/13,15.79%,RPP25;RPP21;PRORP;RPP25L;POP4
prerank,protein localization to organelle (GO:0033365),0.4258475101945305,1.2096195010053201,0.13535353535353536,0.8621267098288921,1.0,48/133,29.07%,COL1A1;TSPAN17;SIX4;RAB6A;ANK2;STX1A;STX5;LMNA;UBE2J2;GET4;ALDH3A2;BICD1;WDR83OS;BBS9;YWHAE;TOR1A;TRAM2;TMEM30A;SIX1;SGTA;ARFRP1;TRAM1;BBS4;MTCH2;ARF6;ATP6V1D;RAB33B;RAB35;AUP1;VAMP2;TOLLIP;PAF1;CROCC;PACSIN2;DVL1;EMD;MDM2;CALR;SEC61B;DCP1A;GBF1;DDX1;MICALL1;DNAJA1;TOPORS;ZBTB7A;CNTLN;PRNP
prerank,regulation of bone mineralization (GO:0030500),-0.31346511107413033,-1.2093764714219009,0.14666666666666667,0.644569913620357,1.0,15/55,8.04%,PTN;BMP6;WNT4;ADGRV1;MEF2C;BMP7;ENPP1;OSR1;ANKH;KL;S1PR1;ATRAID;NELL1;NOTUM;BMPR2
prerank,epithelial cell-cell adhesion (GO:0090136),0.5883553865690035,1.2087673781233368,0.2521613832853026,0.8646242129869159,1.0,4/11,11.99%,SERPINB8;THBS4;ITGB5;JUP
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5626450101012801,1.2084446352874518,0.24932975871313673,0.8648661081439293,1.0,4/14,15.79%,CARD16;PELI3;GAS6;NLRP2B
prerank,amide transport (GO:0042886),-0.36632642175486063,-1.2082463063487097,0.19230769230769232,0.6448583807268384,1.0,7/26,9.08%,PLTP;ABCG2;PDPN;PLEKHA8;CERT1;AQP11;SLC38A5
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5534864292071247,1.2082257013645732,0.24396782841823056,0.8635538197565961,1.0,4/15,12.93%,ZFP36L1;ZFP36L2;AGO2;ZFP36
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5534864292071247,1.2082257013645732,0.24396782841823056,0.8635538197565961,1.0,4/15,12.93%,ZFP36L1;ZFP36L2;AGO2;ZFP36
prerank,RNA metabolic process (GO:0016070),0.42973611885687185,1.208076598238809,0.1365953109072375,0.8630178048700695,1.0,40/127,20.12%,POLR2H;ADARB1;HNRNPA1;RNASE4;RBM4;BICD1;PRPF4;ATXN2;TFIP11;AGO2;DUSP11;HNRNPD;EXOSC7;SIDT2;HNRNPH1;DHX8;CELF2;RBFOX2;DDX17;RNASE6;POLR2D;MPHOSPH10;POLR2G;ZC3H12A;RBM3;HNRNPA3;THOC1;GTF2F1;DDX20;AGO4;NUFIP1;TENT2;RBM6;RBM39;HNRNPUL1;SUPV3L1;DDX24;AGO3;NOVA1;PTBP1
prerank,regulation of myotube differentiation (GO:0010830),0.5065999275345989,1.2075921385413613,0.2249093107617896,0.8639711794504455,1.0,6/24,14.10%,TMEM119;HDAC9;MAPK14;ATP11A;HDAC3;HDAC4
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5157654443187387,1.2070987232558683,0.2236024844720497,0.8649066660104111,1.0,4/24,5.31%,MYOC;VEGFA;S100A10;PTPRJ
prerank,regulation of lymphocyte migration (GO:2000401),0.5939795788512935,1.2067202543196376,0.2630057803468208,0.8653330627240483,1.0,5/10,27.60%,MIA3;AKT1;SLC8B1;STK10;WASL
prerank,retinoid metabolic process (GO:0001523),0.44577477760366835,1.206378833230328,0.17446808510638298,0.8656190710731064,1.0,6/71,2.24%,AKR1B1;DHRS9;LRP1;GPC6;CYP2S1;GPC3
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.4629823899382597,1.206360008128508,0.23322332233223322,0.8645568788912664,1.0,9/46,12.61%,IGFBP5;ANG;OGN;FOXP1;ELN;TCF7L2;NDRG4;AKT1;XRCC5
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5286096684338402,1.2061911507188112,0.2474747474747475,0.864152474433826,1.0,9/19,20.36%,UGDH;EXT1;B3GAT3;XYLT1;HS2ST1;HS3ST5;GLCE;NDST2;XYLT2
prerank,positive regulation of T cell migration (GO:2000406),-0.4068529007599614,-1.2059875767940962,0.1875,0.6478414487506878,1.0,5/20,4.59%,ADAM10;APP;WNT5A;DOCK8;CXCL12
prerank,regulation of supramolecular fiber organization (GO:1902903),0.5209546185476267,1.2055372652506218,0.24334600760456274,0.8658451822096984,1.0,8/22,11.42%,MAP1B;AKAP13;MAPRE3;PIK3CA;CAMSAP1;GPX1;GBA2;MAPT
prerank,relaxation of muscle (GO:0090075),0.5641033945665398,1.2049538137234335,0.24867724867724866,0.8671038666269826,1.0,6/13,11.08%,GSN;ATP1A1;CAMK2D;KCNJ2;PIK3CA;GSTM2
prerank,regulation of filopodium assembly (GO:0051489),0.48169085733522854,1.2043897070578777,0.23675310033821872,0.8683465671522057,1.0,16/38,24.31%,TGFB3;ARHGAP44;GAP43;MYO10;FSCN1;PALM;RHOQ;BCAS3;ARF6;FXR2;ARAP1;GPM6A;RALA;ABITRAM;DOCK11;DMTN
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.5570524384381765,1.204312566635627,0.24360699865410498,0.8675501541514161,1.0,6/14,26.80%,TSEN54;RTRAF;CPSF4;TRPT1;CPSF1;DDX1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5127034034728623,1.204133992596743,0.23264311814859928,0.8671470154159385,1.0,5/24,7.63%,TNMD;GRB10;ITGB3;ITGA5;PRKD2
prerank,regulation of viral transcription (GO:0046782),0.47440432661021614,1.203905347119309,0.22628571428571428,0.8669623969737597,1.0,12/39,15.57%,POLR2H;TARBP2;MID2;MDFIC;CDK9;TRIM11;POLR2D;ZFP36;POLR2G;CTDP1;GTF2F1;UBP1
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.47301616047741596,1.2037891672075929,0.22947131608548932,0.8663363070571519,1.0,15/37,27.14%,ENTPD2;NUDT1;HNRNPD;EXOSC7;SIDT2;NUDT16;RNASE6;DNASE1L2;NUDT5;ENTPD6;SUPV3L1;DFFB;RNASEH2C;DNASE1L1;ADPRM
prerank,regulation of exit from mitosis (GO:0007096),0.4776222529651355,1.2036281633144124,0.2227324913892078,0.8659110938361116,1.0,14/38,25.88%,CDC14B;ZW10;SIRT2;CDC23;ANAPC5;UBA52;CDC27;PPP1R9B;CDC26;ANAPC4;ANAPC10;ANAPC15;CDC14A;ANAPC2
prerank,negative regulation of blood coagulation (GO:0030195),0.47508921639498447,1.2032790932737507,0.21934758155230596,0.8661960502650997,1.0,3/38,3.75%,CD34;C1QTNF1;KLKB1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.4725842641924879,1.2030417218001543,0.23068181818181818,0.8661029248668621,1.0,22/42,31.40%,MARS2;TARS1;SARS2;VARS1;GARS1;HARS1;EEF1E1;VARS2;EPRS1;QARS1;AIMP1;EARS2;AIMP2;NARS1;PPA1;YARS1;SARS1;PPA2;DARS1;AARS1;LARS2;WARS2
prerank,cardiac muscle tissue development (GO:0048738),-0.3188439554468409,-1.203001537411446,0.14942528735632185,0.6528582929060497,1.0,12/50,10.58%,GJB6;BMP5;ADAMTS9;BMP7;RBP4;NOTCH1;TBX18;GJA1;BMPR2;TBX2;SIK1;BMP2
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.5746182335999233,1.2028108925420107,0.2726008344923505,0.8659422064342128,1.0,4/12,18.11%,IL33;NUPR1;IL6;IL18
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.3358585616747233,-1.2027676463649126,0.1282051282051282,0.6506722718283157,1.0,15/39,14.46%,ROBO1;TSPAN14;EPN2;MAML3;CREBBP;NOS3;NOTCH1;ROBO2;JAG2;NOTCH4;MAML2;YAP1;EP300;PDCD10;TSPAN5
prerank,androgen metabolic process (GO:0008209),0.5324781375190538,1.2026099313081302,0.2613333333333333,0.8656777746624829,1.0,5/18,23.43%,DHRS9;SRD5A1;HSD17B4;HSD17B11;SRD5A3
prerank,regulation of macrophage activation (GO:0043030),0.4922523605713116,1.20245470417021,0.24790419161676647,0.8652361073830591,1.0,10/30,20.14%,LBP;MIF;IL33;TLR4;ZC3H12A;IL4;LRFN5;IL6;GPR137B;IL31RA
prerank,response to purine-containing compound (GO:0014074),0.5391098748430682,1.2023891656511654,0.26572528883183566,0.8643738807415325,1.0,2/17,2.84%,DUOX1;DGKQ
prerank,endothelial cell migration (GO:0043542),0.476919990573822,1.2023226354582273,0.21956769055745165,0.8635651119101864,1.0,5/37,2.80%,FSTL1;LOXL2;DPP4;FAP;VEGFA
prerank,mRNA export from nucleus (GO:0006406),0.4368646283895071,1.2023048188556364,0.16821465428276575,0.8625262734102689,1.0,44/102,27.86%,SRSF2;SRSF6;NXF1;DDX19B;NUP93;MCM3AP;NUP107;U2AF1;SRSF3;NUP98;CPSF4;SRSF11;THOC7;POLR2D;SMG7;POLDIP3;THOC2;THOC1;NUP37;SMG6;FYTTD1;ZC3H11A;CPSF2;SRRM1;DDX39A;SLBP;NUP50;U2AF2;TPR;AGFG1;CPSF1;PABPN1;WDR33;NUP85;NUP133;NUP188;ALYREF;UPF3B;NUP88;SMG5;UPF1;THOC5;CPSF3;CDC40
prerank,cAMP metabolic process (GO:0046058),-0.448109257190012,-1.2022778444704805,0.21132075471698114,0.6491547568440363,1.0,4/13,8.72%,ADCY5;ADCY1;ADCY4;ADCY9
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.42220015696330115,1.202119846731406,0.13008130081300814,0.8621569845723182,1.0,16/140,10.38%,ACKR3;CD55;ESR1;C1QTNF1;LPAR3;NPTN;PLCE1;F2R;DLG4;LPAR1;P2RX3;ABL2;ADCYAP1;GPR20;ACKR4;CALCA
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.43459381690520754,1.201638963301581,0.15805785123966942,0.8629862473551704,1.0,18/93,13.85%,MID1;SH3RF3;STK25;GADD45G;VEGFA;TGFB2;TAOK3;AXIN1;KLHDC10;RASSF2;SEMA3A;FZD7;TIRAP;EMC10;ANKRD6;CD27;TAOK2;ZC3H12A
prerank,positive regulation of protein kinase activity (GO:0045860),0.42193775812533135,1.2013576934187697,0.1328600405679513,0.8629990136740767,1.0,30/148,14.68%,NOX4;DDR2;CAMKK1;ITGB3;VEGFA;TGFB2;TGFBR2;DLG4;TAOK3;AXIN1;MAP2K3;ETAA1;MAPRE3;RASSF2;SRC;ADCYAP1;GAS6;STRADA;SYAP1;SRCIN1;IQGAP1;CALCA;CALM2;XRCC5;TAOK2;CDKN1A;RHOA;SLC8A2;STK3;HSP90AA1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5116242310517756,1.2011861297554567,0.24092009685230023,0.862633020472914,1.0,14/25,26.70%,STUB1;HDAC6;UBE2W;CUL3;TOR1A;CLPP;NGLY1;ZER1;AUP1;UGGT1;DERL1;ZYG11B;UFD1;UGGT2
prerank,regulation of ossification (GO:0030278),0.4766731273793892,1.201178300293301,0.2277456647398844,0.861571002550847,1.0,9/36,10.07%,DDR2;LRP6;TGFB2;ECM1;ACVR1;CYP27B1;BMP2K;SGMS2;SMAD6
prerank,RNA processing (GO:0006396),0.4210099252768992,1.2010656469217655,0.11256281407035176,0.8609959707280037,1.0,57/176,21.53%,SRSF2;WT1;MBNL1;ADARB1;TSEN54;DHX16;RBM4;ZCRB1;TENT4A;TARDBP;BICD1;LSM4;PRPF4;U2AF1;TFIP11;PRPF3;CPSF6;DUSP11;USP39;AURKAIP1;HNRNPD;SON;TCERG1;HNRNPH1;DHX8;CELF2;SRSF11;DDX17;MPHOSPH10;RBM3;THOC1;ZCCHC8;SF3B4;DDX20;BCAS2;SF3A1;SNRPG;SNRPD3;PPP1R9B;NUFIP1;TENT2;LUC7L3;SRRM1;RBM6;PDCD7;RBM39;TENT4B;HNRNPUL1;U2AF2;ZMAT5;NOVA1;PTBP1;SF3B2;SF3B1;SRPK1;AKAP8L;KIN
prerank,regulation of immunoglobulin production (GO:0002637),0.511186698227468,1.200515400689219,0.23057644110275688,0.8622110799064969,1.0,5/23,16.45%,EPHB2;CLCF1;STX4;IL4;IL6
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.4425603063494093,-1.2004865597383074,0.20078740157480315,0.6512190741890849,1.0,5/13,11.88%,GLUL;NOS3;PRODH;ALDH4A1;NOS1
prerank,positive regulation of synaptic transmission (GO:0050806),0.4412138095084286,1.2003558109935772,0.20442571127502634,0.8618195373374088,1.0,26/72,25.13%,EPHB2;NPTN;DLG4;NFATC4;DTNBP1;MPP2;GRIN2D;STX1B;STX4;SQSTM1;CACNG2;LGI1;ADCY8;ZDHHC2;SLC8A2;GRIN2A;CHRNA7;SYT1;VAMP2;RIMS2;CLSTN3;NMU;FLOT1;GRIK2;BAIAP3;PRKCZ
prerank,inflammatory response (GO:0006954),0.4148304247360247,1.2003271389721304,0.10050251256281408,0.8608429165307326,1.0,34/195,18.11%,NOX4;MGLL;CCL8;ANXA1;CD44;F2R;S100A8;S100A9;HDAC9;NFATC4;ITCH;CXCL10;TLR5;CHUK;LTB4R2;CCL25;TLR4;HSPG2;CEBPB;PXK;GPR68;ACKR1;ADCY8;CCL13;TRAF3IP2;HDAC4;CD14;TUSC2;IL4;IL6;CXCR4;ABCF1;CXCR2;IL18
prerank,protein transport (GO:0015031),0.4128788261387234,1.2002801795729188,0.05205205205205205,0.8599525689982175,1.0,110/332,23.16%,SGSM2;LRP1;COPA;NECAB3;STX2;RAB32;RABGAP1L;RAB6A;STEAP3;TMED1;STX1A;CLTC;STX5;SEC31A;STX11;ATP6V0A2;RAB23;ARRDC2;RAB6B;RAB19;MIA3;TOM1;PREB;SCFD2;RCN3;ABCA1;SCAMP3;IL10RA;ARF4;TBCK;SCG5;AP3D1;STX1B;HDAC6;SCAMP5;SNX1;ACD;USO1;TBC1D2B;ARFGAP3;STX4;TBC1D17;GGA1;SCFD1;ARF1;STX12;COPB2;NPM1;SEC23IP;VPS33A;ATP6V1E1;RAB3D;TBC1D10A;NAPA;STX17;RUFY1;KIF3A;LRP1B;RAB43;ATP6AP1;RPGR;KIF3B;CMTM6;ARFRP1;SYNDIG1;GGA2;ARF6;REP15;COPZ2;ATP6V1D;ATP6V0A1;GOLGA4;AP4M1;SPTBN1;NSF;ATP6V1B2;EVI5;SGSM1;EVI5L;BLZF1;TBC1D13;NAPG;RAB5B;ARCN1;RAB1B;RAB5C;SNX6;ADPRH;PREPL;STX3;TBC1D22B;VAMP2;TBC1D15;RAB24;MON1A;LRSAM1;TMED2;VPS33B;RAB10;COPG1;RUNDC1;CTTN;VAMP4;TBC1D8B;SEL1L;STX16;NAPB;GOLPH3L;TBC1D12;PICK1
prerank,protein O-linked glycosylation via serine (GO:0018242),0.5983505936026801,1.200157633663091,0.26264044943820225,0.8594152309586519,1.0,5/10,23.84%,GALNT16;GALNT1;MGAT5B;POGLUT2;GALNT4
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5053068593702786,1.19994646359411,0.24539877300613497,0.8591742499852726,1.0,9/24,14.73%,SRSF6;RUNX1;ZFP36L1;NCOA3;CYP27B1;VDR;ZFP36;NME2;HOXA7
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.4968901566161977,1.1992391707328471,0.2294887039239001,0.8610613074960154,1.0,13/27,28.97%,RNASE4;NYNRIN;ERN1;NUDT16;RNASE6;ZC3H12A;RPP30;RNASE1;KHNYN;NHP2;TRIR;CPSF3;PDE12
prerank,neuron cell-cell adhesion (GO:0007158),0.5552209630296483,1.1989566253202308,0.25891677675033026,0.8611020740149145,1.0,10/14,33.33%,CEL;RET;NRXN3;CNTN4;NLGN1;NLGN3;NRXN1;NLGN2;NCAM2;NRXN2
prerank,negative regulation of phosphorylation (GO:0042326),0.43986312608424705,1.198757620902429,0.16475495307612095,0.8608084484056935,1.0,32/85,23.19%,EPHB2;LRP6;NIBAN1;SLIT2;WWTR1;PLPP3;TARDBP;MYADM;INHA;PID1;PIP5KL1;TIGAR;SIRPA;INPP5K;MAPT;IRS2;CDKN1A;NCOR1;ZC3H12A;HDAC4;NUPR1;CHP1;PPIA;IBTK;FKBP8;CORO1C;FBLN1;PTEN;CDKN2C;TERF2IP;ANKLE2;ATG14
prerank,protein localization to phagophore assembly site (GO:0034497),0.5803331629018766,1.1987004412241817,0.26551226551226553,0.8599432167626092,1.0,5/11,18.99%,PACS2;WIPI2;WDR45B;STX17;ATG13
prerank,positive regulation of actin filament polymerization (GO:0030838),0.46327254271659724,1.1986172848009629,0.22322435174746336,0.8592010826268798,1.0,9/44,15.93%,GSN;SCIN;CDC42EP2;BIN1;PFN2;FCHSD1;FER;ARF6;NCK1
prerank,growth hormone receptor signaling pathway (GO:0060396),0.5670024497124089,1.1985497769959041,0.24765729585006693,0.8583912795329807,1.0,3/14,7.92%,GHR;SOCS2;STAT5A
prerank,positive regulation of signaling (GO:0023056),0.47250391485397364,1.1981426451621466,0.21914648212226068,0.859038227319976,1.0,15/37,23.22%,CD80;ANXA2;CDKN2AIP;DLG4;INPP5F;ECE1;HCRT;LGI1;NSF;SYT1;ILK;RIMS2;CLSTN3;NMU;GRIK2
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.3603135016779038,-1.1981292296588548,0.19879518072289157,0.6548481597719887,1.0,6/28,8.42%,SORT1;BCL2;DAB2IP;CASP8AP2;DELE1;GABARAP
prerank,establishment of mitotic spindle localization (GO:0040001),0.49551264013578405,1.1978449753341924,0.25766871165644173,0.8591846531171895,1.0,9/28,22.09%,GPSM2;DCTN1;NDEL1;ZW10;CDK5RAP2;PAFAH1B1;CLASP2;NUMA1;FBXW11
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3121426981538086,-1.1976776904493895,0.18085106382978725,0.6532316609470376,1.0,4/41,2.02%,TJP1;GCNT2;PODXL;BMP7
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.4185141542616438,-1.1972365796581603,0.1984126984126984,0.6516048451057888,1.0,4/16,4.70%,RANBP3L;MEF2C;IGFBP3;PLCB1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.4862776256648699,1.1972108415294285,0.2312206572769953,0.8607027947948065,1.0,7/30,15.05%,ACKR3;CD44;MIF;FBXO5;TWIST1;THOC1;SNAI2
prerank,positive regulation of cellular component organization (GO:0051130),0.4251241095798369,1.1971656431945792,0.1683884297520661,0.859817481107431,1.0,21/107,12.87%,SYK;AR;LRP1;TGFB3;DCTN1;GPC3;NEUROD2;RUNX1;VEGFA;TGFB2;CDC42EP2;MPP7;GNL3L;TIRAP;SURF4;LMAN1;GPX1;BMF;BAK1;TMEM30A;CALY
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.31836318409462866,-1.1969683014095012,0.14545454545454545,0.6495641787223411,1.0,8/41,6.96%,TPM1;ENG;CPE;MEF2C;NOTCH1;TGFBR3;FGFR2;HEYL
prerank,defense response to fungus (GO:0050832),0.5315406726830638,1.1967197666539813,0.2490170380078637,0.8605370031544343,1.0,2/17,3.65%,S100A8;S100A9
prerank,regulation of trans-synaptic signaling (GO:0099177),0.48138674755497923,1.1965695369697007,0.23742690058479532,0.8600730274923687,1.0,19/33,31.63%,CEL;SLC4A8;NRG3;PXK;BTBD9;GRID1;FABP5;GRIK5;GRIK2;BCR;GRIK4;EIF4EBP2;GRID2;NLGN1;NLGN3;IQSEC2;PSMC5;NLGN2;NGF
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.42961482935269824,1.1963489388817923,0.1762252346193952,0.8599064746345721,1.0,32/95,23.47%,ASPN;HTRA3;LDLRAD4;SKIL;PMEPA1;TGFBR2;SMAD4;SMURF2;SKI;RNF111;STUB1;FLCN;SMAD6;PEG10;SLC2A10;VASN;UBA52;PIN1;BCL9;GIPC1;DKK3;SNX6;HTRA4;TGFBR1;STRAP;PPM1A;ZEB2;SMURF1;SDCBP;CD109;FKBP1A;SKOR2
prerank,anion transmembrane transport (GO:0098656),-0.3018505846484185,-1.1959046567229652,0.09836065573770492,0.6497537434350764,1.0,14/67,9.58%,SLC7A2;SLC6A13;SLC1A3;SLC16A12;SLC13A4;SLC13A3;SLC39A8;SLC7A5;SLC6A9;SLC25A42;SLC3A2;LRRC8B;SLC38A5;SLC25A11
prerank,relaxation of cardiac muscle (GO:0055119),0.5692224922509135,1.1954199792752296,0.2554054054054054,0.8627053619074373,1.0,6/13,11.08%,GSN;ATP1A1;CAMK2D;KCNJ2;PIK3CA;GSTM2
prerank,positive regulation of double-strand break repair (GO:2000781),-0.3303318965098884,-1.195077275788012,0.13559322033898305,0.6493153483696181,1.0,18/39,19.44%,WDR48;SPIRE1;KMT5B;SHLD1;DTX3L;KMT5C;SLF2;ARID2;MGMT;MRNIP;PNKP;RIF1;SMCHD1;SETMAR;PARP9;FANCB;TIMELESS;MAD2L2
prerank,regulation of fibroblast proliferation (GO:0048145),0.4671510058537546,1.1939224363999328,0.23007856341189675,0.867621500818198,1.0,9/45,13.19%,DDR2;WNT2;MIF;SKI;CDK4;GAS6;S100A6;PDGFRA;CDKN1A
prerank,spliceosomal snRNP assembly (GO:0000387),0.4760253319725111,1.1936414831790496,0.24351747463359638,0.8677100434236923,1.0,13/38,22.69%,GEMIN6;CD2BP2;USP4;LSM4;WDR77;PRPF3;TGS1;DDX20;SNRPG;SNRPD3;STRAP;SMN1;COIL
prerank,ventricular septum morphogenesis (GO:0060412),0.49519372727490957,1.1931872829194559,0.24824355971896955,0.8685010704611098,1.0,7/27,7.31%,TGFB2;SLIT3;SLIT2;TGFBR2;SMAD4;ACVR1;ZFPM2
prerank,positive regulation of glycolytic process (GO:0045821),-0.3912583636782885,-1.1929638733605838,0.21081081081081082,0.649462971155285,1.0,4/20,3.96%,INSR;IGF1;APP;PRKAA2
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3912583636782885,-1.1929638733605838,0.21081081081081082,0.649462971155285,1.0,4/20,3.96%,INSR;IGF1;APP;PRKAA2
prerank,regulation of fat cell differentiation (GO:0045598),0.43533605827453586,1.1929638579713981,0.21019108280254778,0.8683803989657431,1.0,17/74,14.01%,MEDAG;WNT10B;WWTR1;ZFP36L1;TRIO;TAF8;FOXO1;NR1D1;ZFPM2;ZFP36L2;SIRT2;SYAP1;AKT1;CEBPB;ZFP36;ZC3H12A;WDFY2
prerank,replicative senescence (GO:0090399),-0.457187524552309,-1.1929123136073427,0.24014336917562723,0.6469609675713371,1.0,7/12,31.93%,TERT;ATM;SERPINE1;PLA2R1;CHEK1;ATR;WNT16
prerank,high-density lipoprotein particle assembly (GO:0034380),0.5960541137013466,1.1928473602811611,0.2915492957746479,0.8678051176401589,1.0,2/10,6.10%,BMP1;ABCA1
prerank,T cell differentiation in thymus (GO:0033077),0.5538274157203494,1.1927474491441905,0.26052631578947366,0.8671389488904916,1.0,3/14,10.97%,ZFP36L1;ZFP36L2;GLI3
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.5461098218648819,1.1925523549275903,0.2757697456492637,0.8668587644112346,1.0,5/14,18.36%,ENTPD2;NUDT1;NUDT16;NUDT5;ENTPD6
prerank,tRNA aminoacylation (GO:0043039),0.47499860583285064,1.1914622136428188,0.23717217787913342,0.8701943270456728,1.0,21/37,31.40%,MARS2;TARS1;SARS2;VARS1;GARS1;HARS1;EEF1E1;EPRS1;QARS1;AIMP1;QRSL1;AIMP2;NARS1;PPA1;YARS1;SARS1;PPA2;DARS1;AARS1;LARS2;WARS2
prerank,regulation of endothelial cell proliferation (GO:0001936),0.4340412338783539,1.1914439579480987,0.1756198347107438,0.869206389533052,1.0,19/88,11.44%,FGF18;TNMD;PRKCA;SPARC;ITGB3;ANG;VEGFA;FGF2;ECM1;FUT2;THBS4;SULF1;PRKD2;STAT5A;AKT3;EMC10;EGF;AKT1;NRAS
prerank,glycogen biosynthetic process (GO:0005978),0.5748355490477556,1.1911120642347586,0.2874828060522696,0.8685102551000817,1.0,4/12,13.07%,UGP2;NR1D1;PGM2L1;PPP1R3C
prerank,glucan biosynthetic process (GO:0009250),0.5748355490477556,1.1911120642347586,0.2874828060522696,0.8685102551000817,1.0,4/12,13.07%,UGP2;NR1D1;PGM2L1;PPP1R3C
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.5489635084443337,1.1909243567145273,0.2756827048114434,0.8681860773296436,1.0,5/17,12.36%,DGKQ;SIRT2;INPP5K;PPEF2;CALM2
prerank,regulation of amyloid-beta formation (GO:1902003),-0.3509568609892717,-1.1908838811856481,0.19014084507042253,0.649751820969555,1.0,9/34,11.89%,EPHA4;IGF1;SP1;APOE;GGA3;ABCG1;CASP3;SORL1;NTRK2
prerank,actin-myosin filament sliding (GO:0033275),-0.32016829201831015,-1.1902272487221963,0.14285714285714285,0.6462674740715704,1.0,3/38,1.43%,TPM1;ACTN2;DMD
prerank,muscle filament sliding (GO:0030049),-0.32016829201831015,-1.1902272487221963,0.14285714285714285,0.6462674740715704,1.0,3/38,1.43%,TPM1;ACTN2;DMD
prerank,positive regulation of developmental process (GO:0051094),0.41633668396955403,1.1898515817909732,0.12877263581488935,0.8715649711405389,1.0,26/164,8.89%,DCN;AR;PHLDB1;BMP1;FGFR1;WT1;TMEM119;TLE6;NEUROD2;VEGFA;DLG4;COBL;LMNA;SMURF2;ACVR1;KRT10;NCOA3;C1QBP;SRC;MIEF2;HMCES;SOX8;PSEN1;SOX5;MCU;AGO2
prerank,cellular protein localization (GO:0034613),0.4097167835294432,1.1897964532173042,0.0871743486973948,0.8707285945936992,1.0,100/285,23.16%,FGF7;SGSM2;EGFR;COPA;STX2;RAB32;RABGAP1L;CD177;RAB6A;ANK2;TMED1;STX1A;CLTC;STX5;SEC31A;STX11;RAB23;RAB6B;RAB19;SCFD2;JAM3;USP4;ARF4;TBCK;SCG5;AP3D1;BICD1;STX1B;HDAC6;SNX1;PACS2;ACD;USO1;TBC1D2B;ARFGAP3;STX4;TBC1D17;GGA1;SCFD1;WIPI2;ARF1;STX12;WDR45B;COPB2;NPM1;SEC23IP;VPS33A;TBC1D10A;NAPA;STX17;DUOXA1;RAB43;RPGR;HPS6;RRAGD;ARFRP1;PIGK;BBS4;SYNDIG1;GGA2;ARF6;COPZ2;AP4M1;NSF;AHI1;EVI5;SGSM1;EVI5L;TBC1D13;NAPG;RAB5B;ARCN1;RAB1B;RAB5C;SNX6;ADPRH;STX3;NIPBL;TBC1D22B;ATG13;TBC1D15;RAB24;TMED2;VPS33B;FLNA;CNTN2;COX18;RUNDC1;SMURF1;ABHD17A;CTTN;CROCC;TBC1D8B;STX16;SEPTIN9;NAPB;ARMCX3;CNTNAP1;TBC1D12;PICK1
prerank,RNA splicing (GO:0008380),0.4299486278132757,1.189771037720886,0.19773429454170957,0.8697567274161224,1.0,29/95,21.15%,SRSF2;WT1;MBNL1;DHX16;ZCRB1;TARDBP;LSM4;PRPF4;U2AF1;PRPF3;USP39;TCERG1;DHX8;SRSF11;MPHOSPH10;SF3B4;BCAS2;SNRPG;SNRPD3;PPP1R9B;LUC7L3;SRRM1;PDCD7;ZMAT5;NOVA1;PTBP1;SF3B2;SF3B1;SRPK1
prerank,peptide catabolic process (GO:0043171),0.5118111033343877,1.1897323394361827,0.24908869987849333,0.8688452556610532,1.0,8/23,17.11%,ANPEP;LNPEP;TPP1;DPEP1;ECE1;NPEPPS;GGT7;IDE
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.5507271050341481,1.1893362085882706,0.27102803738317754,0.8693955074428452,1.0,5/14,12.93%,MAPK14;DAZL;TARDBP;TIRAP;ZFP36
prerank,negative regulation of viral life cycle (GO:1903901),0.5425631053871496,1.1891830784175206,0.2643979057591623,0.8689922903972905,1.0,3/15,10.43%,GSN;MID2;TRIM11
prerank,cytoplasmic translational initiation (GO:0002183),0.5322975776722881,1.1889675337971448,0.25257731958762886,0.8687800118722976,1.0,9/17,27.39%,RBM4;EIF4A1;EIF3A;EIF3D;EIF2S2;EIF4H;EIF4G1;DHX29;EIF3M
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.5385792274994345,1.188440770599993,0.25487646293888166,0.8697985352575656,1.0,5/16,13.67%,WT1;FGF2;PKD2;GDNF;SIX1
prerank,positive regulation of cytokine production (GO:0001819),0.4111042620945987,1.1881767363261,0.0940940940940941,0.8698294345508082,1.0,34/292,9.63%,CD34;LBP;SYK;CD80;CCBE1;IRF4;ANXA1;POLR2H;GLMN;IL16;EIF2AK3;RAB7B;SULF2;RUNX1;RFTN1;FOXP1;F2R;MIF;TMEM106A;MAPK14;IL33;SULF1;CGAS;TLR5;SCAMP5;IL17RA;POLR3E;DHX33;PRKD2;TIRAP;PAEP;TLR4;MAPK11;POLR3D
prerank,regulation of actin filament-based movement (GO:1903115),0.5921264358101022,1.188081344216414,0.26822157434402333,0.8691584364814247,1.0,4/10,15.66%,ANK2;SRI;PDE4D;STC1
prerank,protein N-linked glycosylation (GO:0006487),0.44206263783613015,1.1876502441809804,0.21283422459893048,0.8698874864766677,1.0,21/66,26.70%,GFPT2;B4GALT1;GFPT1;MGAT1;LMAN1;ALG1;MGAT5;MGAT2;MGAT4B;TUSC3;TMEM165;ST3GAL1;DDOST;UGGT1;MGAT5B;SRD5A3;DPM2;KRTCAP2;PGM3;MPDU1;UGGT2
prerank,telomere capping (GO:0016233),0.542878347072292,1.1874320186035625,0.27784891165172854,0.8696589902759705,1.0,9/16,21.89%,CTC1;ACD;TFIP11;TERF1;NBN;RAD50;TINF2;DCLRE1A;TERF2IP
prerank,myelin assembly (GO:0032288),0.5883125123907149,1.187275827259361,0.2713068181818182,0.8692858006685913,1.0,2/10,1.72%,CD9;PMP22
prerank,response to thyroid hormone (GO:0097066),0.5601253603464027,1.1872537701379542,0.2736842105263158,0.8683191926307795,1.0,2/13,7.15%,HPN;GAS2L1
prerank,epidermis development (GO:0008544),0.4505474909078388,1.1869010959527029,0.23394994559303592,0.868708044221162,1.0,10/56,16.92%,COL17A1;FGF7;SCEL;EMP1;ALDH3A2;SVEP1;ATP2A2;EVPL;FLOT2;FABP5
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.46001409596797443,-1.1868907260753654,0.2773972602739726,0.6524879424597924,1.0,5/11,14.89%,EFNB2;MEF2C;TGFB1;GPER1;MYOCD
prerank,epithelial cell migration (GO:0010631),0.47261706613867943,1.1868299393538135,0.24129930394431554,0.8679031803773096,1.0,4/37,1.41%,FSTL1;LOXL2;DPP4;FAP
prerank,mitochondrial transport (GO:0006839),0.4497483382413135,1.1867826744493326,0.22114347357065803,0.8670349695941685,1.0,21/53,25.43%,SLC25A31;GDAP1;TIMM10B;TIMM9;SLC25A4;SLC25A16;BAK1;HSP90AA1;TIMM22;SPG7;BCS1L;FLVCR1;TIMM8B;BCAP31;TOMM5;ABCB10;TIMM17A;COX18;FIS1;TMEM14A;TOMM40
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5894045794355696,1.1859803395028723,0.2849002849002849,0.86935205232496,1.0,6/10,26.05%,DLGAP4;DLGAP3;DLGAP1;AKAP9;NPTX1;BEGAIN
prerank,response to steroid hormone (GO:0048545),0.48053610711485367,1.1859749473580092,0.2497096399535424,0.8683330074554988,1.0,6/31,4.13%,AR;TGFB3;TGFB2;CATSPERB;ATP1A3;ATP1A1
prerank,steroid hormone biosynthetic process (GO:0120178),0.473825573053953,1.1859151893522393,0.25717703349282295,0.8675440584450592,1.0,6/29,23.43%,AKR1B1;SRD5A1;HSD17B8;FDX1;HSD17B11;SRD5A3
prerank,negative regulation of cell junction assembly (GO:1901889),-0.3684620943551248,-1.1855113039053382,0.1935483870967742,0.6533565165682288,1.0,5/25,5.65%,PHLDB2;ARHGAP6;THBS1;APOD;ROBO2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4667741186354101,1.1852018649622278,0.24235560588901472,0.8694612633543526,1.0,15/39,20.81%,MYOC;CORO2B;EFNA5;MELTF;FZD7;JAG1;KANK1;ADAM15;RHOA;HOXA7;FZD4;RCC2;RASA1;CORO1C;FBLN1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.43466322317082295,1.1850244445235723,0.20231822971549,0.8691595250873333,1.0,12/73,7.80%,LIF;EGFR;CD44;VEGFA;MIF;AXIN1;ATP2B4;DOCK7;PFN2;HDAC6;PRKD2;GAS6
prerank,epithelial structure maintenance (GO:0010669),-0.46937583968038554,-1.184903041897755,0.2509505703422053,0.6524290755596778,1.0,2/11,5.97%,RBP4;CXADR
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.5502806466333443,1.184563366263295,0.2718832891246684,0.8700598529804854,1.0,4/14,8.21%,IGFBP5;LRP1;SLIT2;NDRG4
prerank,hepaticobiliary system development (GO:0061008),-0.38759411597169585,-1.184414447024417,0.22702702702702704,0.6511381232157255,1.0,6/20,9.13%,ARID5B;WNT4;LSR;TGFBR3;PHF2;CITED2
prerank,dendritic cell differentiation (GO:0097028),0.505075422555049,1.1841079836730153,0.26022304832713755,0.8708216305198615,1.0,5/22,15.09%,AXL;TGFBR2;GAS6;FLT3;IL4
prerank,metal ion export (GO:0070839),0.4875280197954007,1.1840420590965484,0.23672055427251731,0.8700551959891525,1.0,8/31,11.43%,KCNK5;KCNT2;ATP1A4;ATP1A3;ATP1A1;ATP2B4;SLC4A4;SLC9A1
prerank,positive regulation of protein polymerization (GO:0032273),0.44207723683352157,1.183930138628445,0.2145922746781116,0.8694970125188451,1.0,22/65,21.89%,DCTN1;CDC42EP2;BIN1;PSRC1;CLIP1;PFN2;TOGARAM1;MAPRE1;MAPT;TPPP3;FCHSD1;SLAIN2;FER;HSP90AA1;ARF6;NCK1;CDK5RAP2;AKAP9;NAV3;NUMA1;PYCARD;CTTN
prerank,homologous chromosome segregation (GO:0045143),0.5201056153915484,1.1833346288491746,0.27490542244640603,0.870866088791745,1.0,6/20,21.35%,FANCD2;RNF212B;TERB1;CENPC;PRDM9;FMN2
prerank,negative regulation of multicellular organismal process (GO:0051241),0.4111076314833611,1.1829287175426382,0.125250501002004,0.8714208109079125,1.0,35/199,11.99%,ADAMTS5;LOXL2;PARP3;WNT10B;RAB11FIP5;EGFR;HPN;NPTN;LDLRAD4;SRSF6;F2R;HDAC9;SYT11;TRPV3;PROCR;ATP2B4;DOCK7;NR1D1;NFIB;PFN2;LNPEP;FLCN;GAS6;WDR77;SPX;FOXC2;PAEP;TLR4;SMAD6;ALPK2;GPNMB;HS3ST5;SLC6A4;VASN;PGAM5
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.4720233049384695,1.1825787876950777,0.2348916761687571,0.8717306004958162,1.0,18/38,26.78%,UBE2J2;USP36;LMAN1;HPS4;NPEPPS;BAG4;HTRA2;ARIH2;VPS11;ATG13;SREBF1;UBE2D3;SAE1;CSNK2A2;LEPROT;PARL;FBXW7;RNF31
prerank,outflow tract septum morphogenesis (GO:0003148),0.49207112921496493,1.1825738519840445,0.2555012224938875,0.8707162551430182,1.0,7/24,10.07%,SEMA3C;TGFB2;TGFBR2;SMAD4;ACVR1;ZFPM2;SMAD6
prerank,establishment of protein localization to organelle (GO:0072594),0.44047375853136767,1.1825113089347206,0.20628272251308902,0.8699163955041018,1.0,27/72,27.08%,SYK;TSPAN17;SPRN;NUP93;IL10RA;NUP107;AKT1;IPO9;TNPO2;E2F3;IPO5;NXT2;NUP50;LRSAM1;RALA;RANBP6;TPR;IPO11;IPO13;TSC2;TNPO1;NUP85;NUP133;NUP188;KPNB1;FAM53C;NUP88
prerank,regulation of rRNA processing (GO:2000232),0.5352998539762188,1.1824822773514205,0.2723735408560311,0.8690062041376811,1.0,7/16,19.86%,DIMT1;USP36;RIOK1;KAT2B;NUDT16;YTHDF2;RIOK2
prerank,response to muscle stretch (GO:0035994),0.5470212954535508,1.1824758605996097,0.29178082191780824,0.86801123307448,1.0,3/15,11.43%,GSN;PIK3CA;SLC9A1
prerank,heart morphogenesis (GO:0003007),-0.3059032442597659,-1.1814475289883275,0.20588235294117646,0.6563309923536883,1.0,14/50,10.93%,CHD7;INSR;ENG;EPHB4;NOS3;NOTCH1;TBX3;TGFBR3;TBX1;HEYL;SOX17;TBX2;BMP2;RYR2
prerank,blood circulation (GO:0008015),0.45224451148605377,1.1811757372079306,0.22967032967032966,0.8722061926862843,1.0,10/49,13.08%,AVPR1A;GCLC;MEOX2;TNNI3;ELN;CXCL10;HCN4;GPX1;SERPING1;SGCZ
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5412414139265631,1.1811488485063237,0.2780678851174935,0.8712794035690162,1.0,4/14,15.59%,CREB3L1;SYVN1;HERPUD1;SELENOS
prerank,regulation of neuron migration (GO:2001222),0.49284375725741,1.1810167699881329,0.26290516206482595,0.870831187782007,1.0,9/26,18.47%,COL3A1;IGSF10;TNN;SEMA3A;KIF20B;NSMF;SRGAP2;SHTN1;NIPBL
prerank,ceramide transport (GO:0035627),-0.4413782748994496,-1.181012463665949,0.26545454545454544,0.6548374055998848,1.0,3/12,3.66%,PLTP;PLEKHA8;CERT1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.5126763525283147,1.1809918773139576,0.26163522012578616,0.8699024917817878,1.0,10/20,23.17%,SPATA2;STUB1;HSP90AA1;NUPR1;OGT;FLOT2;PDCD6IP;SDCBP;FLOT1;CYLD
prerank,cellular response to chemical stress (GO:0062197),0.42458299551748474,1.1806829497627123,0.20573183213920163,0.8701402981139125,1.0,19/96,17.41%,NOX4;NCF4;LRRC8D;STX2;NFE2L2;FOXO1;PKD2;BRF2;PIK3CA;SIRT2;STX4;GPX1;ZC3H12A;EIF2S1;SELENOS;SOD3;KEAP1;HTRA2;PPIA
prerank,negative regulation of endopeptidase activity (GO:0010951),0.45636765958090425,1.180615585040022,0.2085201793721973,0.8693781245995336,1.0,9/47,12.48%,TIMP2;SERPINB8;BIN1;SERPINE3;SERPINF1;SERPINH1;AKT1;SERPING1;RECK
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.40340710860987633,-1.179480280849707,0.2119815668202765,0.6564574490121807,1.0,3/17,1.97%,PRKG1;TPM1;MEF2C
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.5658414059571207,1.1794657038684901,0.28454172366621067,0.8729533392754492,1.0,6/11,20.96%,TIPIN;FBXO5;GMNN;BLM;SMARCAL1;DONSON
prerank,regulation of endocytosis (GO:0030100),0.4376191062961779,1.1791758670207302,0.23394994559303592,0.8731538945440886,1.0,11/61,8.54%,STON2;LRP1;GPC3;EPHA3;CD177;SYT11;SRC;RIT2;SCAMP5;ABL2;ARFGAP1
prerank,male gonad development (GO:0008584),0.4742848162242849,1.1787504795724608,0.2491186839012926,0.8738066773571834,1.0,6/34,10.06%,AR;WT1;SIX4;TGFB2;SOX8;COL9A3
prerank,muscle organ development (GO:0007517),0.44243199263514765,1.1785468844043443,0.2397336293007769,0.8735886472525238,1.0,10/54,10.34%,COL6A3;MAPK12;CTF1;FHL1;ITGA11;SRI;MEF2D;CXCL10;LARGE1;CHD2
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.38254106951810685,-1.178273881170684,0.20765027322404372,0.6571788560349607,1.0,8/23,12.83%,ACSL1;ELOVL7;ACSL4;HACD1;ACSL3;HACD2;ACSL6;ELOVL1
prerank,cell projection organization (GO:0030030),0.4837858704242625,1.1776199984395779,0.2747909199522103,0.876319219047377,1.0,4/30,10.12%,GSN;SCIN;RHOJ;RHOQ
prerank,negative regulation of catabolic process (GO:0009895),0.45266900187391007,1.1773954243297244,0.2574585635359116,0.8761529113582351,1.0,14/47,21.84%,EGFR;IRAK3;ZDHHC7;MDM4;TIGAR;SIRT2;NCOR1;PIN1;PDE3B;HDAC4;NUPR1;FLNA;FMN2;AZIN2
prerank,negative regulation of RNA metabolic process (GO:0051253),0.5192645369481559,1.1772351901495517,0.28994845360824745,0.8758168901605539,1.0,6/18,13.85%,ESR1;KAT2B;NUDT16;NCOR2;NCOR1;ZC3H12A
prerank,response to insulin (GO:0032868),0.42811826650874873,1.1769438247025072,0.2191780821917808,0.8759857286005515,1.0,31/80,21.55%,IRS1;SLC39A14;HDAC9;PIK3R2;ZFP36L1;FOXO1;MEAK7;MYO5A;INSIG2;SYAP1;EPM2AIP1;KAT2B;RHOQ;INPP5K;AKT1;IRS2;EIF6;PDE3B;FER;SELENOS;CPEB1;OGT;PKM;EPRS1;CAPN10;VAMP2;GPLD1;LPIN3;RAB10;GOT1;SLC25A33
prerank,protein import into peroxisome matrix (GO:0016558),0.5634130462971928,1.1766141384867945,0.29110512129380056,0.8763126430524325,1.0,6/12,21.47%,PEX16;PEX12;PEX1;PEX5L;PEX5;PEX2
prerank,modulation by symbiont of entry into host (GO:0052372),-0.4205201340140222,-1.1762758511064437,0.234375,0.6600677187439883,1.0,8/16,23.22%,TRIM25;CAV1;NECTIN2;TRIM62;TRIM21;EXOC2;TRIM5;TRIM6
prerank,regulation of T cell migration (GO:2000404),-0.39978081018544426,-1.176215845268118,0.20982142857142858,0.6576550990821786,1.0,5/18,5.60%,APP;DOCK8;APOD;CXCL12;LRCH1
prerank,thyroid hormone generation (GO:0006590),0.5857877946117163,1.1757980083417798,0.28864569083447333,0.8786021923526807,1.0,1/10,0.53%,DUOX1
prerank,regulation of mononuclear cell migration (GO:0071675),-0.36491369490280956,-1.1757518750101235,0.23645320197044334,0.6563920614162657,1.0,4/23,2.70%,LYN;IL34;BMP5;THBS1
prerank,histone H4-K16 acetylation (GO:0043984),0.514006028361191,1.175693242899732,0.2694235588972431,0.87806306405239,1.0,8/19,17.93%,MSL2;MSL3;ING4;MSL1;WDR5;KANSL3;OGT;KMT2A
prerank,vesicle organization (GO:0016050),0.44847746732704,1.1756905043346921,0.26096491228070173,0.8770626237702663,1.0,11/46,18.44%,CD34;DNM1;HOOK2;PLEKHF1;PI4K2B;SQSTM1;USP50;PHETA2;VPS11;ANXA8;ANXA8L1
prerank,vesicle transport along microtubule (GO:0047496),0.49522617433487903,1.175506189509208,0.2803398058252427,0.876739064235449,1.0,10/23,26.28%,NDEL1;TRAK2;DYNC1I1;KIF3A;KIF3B;DYNC1H1;PAFAH1B1;FBXW11;RAB1A;KIFAP3
prerank,skeletal muscle contraction (GO:0003009),0.5223830153610812,1.1753614589177053,0.2737642585551331,0.8763324434861663,1.0,3/19,8.98%,JSRP1;TNNI3;MYH14
prerank,interstrand cross-link repair (GO:0036297),0.4434599929755154,1.175293244429826,0.24835164835164836,0.8756064289264335,1.0,12/53,14.18%,FANCD2;XRCC3;EME1;RFWD3;FANCL;FAAP100;FANCE;EXO5;UBA52;FAN1;ERCC4;FANCG
prerank,nucleosome disassembly (GO:0006337),0.5376882784439668,1.1749150819798522,0.2728476821192053,0.8750814292092338,1.0,6/14,17.73%,SMARCD2;SMARCD1;SMARCC2;SMARCA4;GRWD1;SET
prerank,chromatin disassembly (GO:0031498),0.5376882784439668,1.1749150819798522,0.2728476821192053,0.8750814292092338,1.0,6/14,17.73%,SMARCD2;SMARCD1;SMARCC2;SMARCA4;GRWD1;SET
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.569342562899355,1.174878927823695,0.27045769764216365,0.8742069585558532,1.0,7/11,27.76%,ZMIZ1;SMARCD1;PADI2;SERTAD2;ELOF1;ARID1A;ARID1B
prerank,transport along microtubule (GO:0010970),0.5590450117132515,1.1745902796920227,0.28825136612021857,0.8743588487645886,1.0,6/13,21.98%,ARHGAP21;APBA1;DYNC1I1;CLIP3;COPG1;BAG3
prerank,tRNA 5'-end processing (GO:0099116),0.5328035765514598,1.1740218292558258,0.2905317769130999,0.8756201413490758,1.0,5/15,15.79%,RPP25;RPP21;PRORP;RPP25L;POP4
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.45505598955369275,1.1737886080838404,0.23820224719101124,0.8755129035640382,1.0,4/45,5.45%,MID1;IRF4;CD44;CAMK2D
prerank,regulation of multicellular organism growth (GO:0040014),0.5364350962007484,1.173535902122265,0.27882037533512066,0.8754944878363622,1.0,2/15,7.92%,GHR;STAT5A
prerank,TOR signaling (GO:0031929),0.4869633154542457,1.173455040632643,0.2593939393939394,0.8748147513543052,1.0,14/26,28.80%,MTOR;MEAK7;FLCN;SYAP1;AKT1;LARP1;CARD11;CCDC88A;TIPRL;MAPKAP1;PRR5;EIF4EBP2;RHEBL1;FNIP1
prerank,transepithelial transport (GO:0070633),-0.4248333184024259,-1.173276951008096,0.2245762711864407,0.6601098155739706,1.0,4/15,5.97%,SLC1A3;ABCG2;SLC12A2;CXADR
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.5134513313419222,1.1725907530474713,0.28050314465408804,0.8772672798642139,1.0,11/20,28.28%,PPIL6;NKTR;PPIC;PIN1;PPIA;FKBP4;FKBP1A;CWC27;PPIG;PPIH;FKBP1B
prerank,positive regulation of lyase activity (GO:0051349),-0.41597057500620843,-1.1725331310222433,0.265625,0.6594365786803005,1.0,4/14,12.91%,NOS3;CACNA1D;NOS1;ISCU
prerank,nucleus organization (GO:0006997),0.4503993435776287,1.1723278238617794,0.25305216426193117,0.8773109330691702,1.0,9/47,9.30%,BIN1;USP36;REEP3;CHMP7;NUP93;VPS4B;SYNE1;NUP98;TOR1A
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.38663604178143174,-1.172215984111769,0.21518987341772153,0.6576504791002704,1.0,2/18,0.55%,ATP1A2;NEDD4L
prerank,double-strand break repair via homologous recombination (GO:0000724),0.420475885998845,1.1721473814618164,0.21495327102803738,0.876990763924585,1.0,26/95,18.50%,REV3L;XRCC3;SFR1;RAD51B;RFWD3;UBE2N;HELQ;AP5S1;SAMHD1;SMC5;MCM3;RMI1;FAN1;ERCC4;SEM1;SMC6;INO80;NBN;RNF138;RECQL;SPIDR;RAD50;ERCC5;MORF4L1;NIPBL;BLM
prerank,heterotypic cell-cell adhesion (GO:0034113),0.4994917724760696,1.172133771450118,0.25938967136150237,0.8760525913734452,1.0,7/25,13.57%,ITGB3;ITGA5;DSC2;JAM3;ITGAV;JUP;CD200R1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.4836512617981793,1.171544132872513,0.2654462242562929,0.8774237043123441,1.0,10/30,18.67%,HNRNPA1;CTC1;GNL3L;SRC;ACD;ERCC4;CDKN1A;TERF1;TENT4B;TINF2
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.5258522574055988,1.171349765740235,0.2793733681462141,0.8772110439115749,1.0,4/17,8.72%,THBS4;C1QBP;TIRAP;MCU
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.5891447411015002,1.17126593475811,0.2900976290097629,0.8765468135749986,1.0,3/10,8.21%,LRP1;PTPRJ;NDRG4
prerank,defense response to Gram-positive bacterium (GO:0050830),0.45267613101787124,1.1711203891898545,0.2703619909502262,0.876137252074933,1.0,7/40,18.80%,LBP;ANG;TIRAP;DMBT1;RNASE6;IL6;MBL2
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.3784719271185709,-1.171064753715549,0.20212765957446807,0.6582528083920784,1.0,3/22,4.36%,SORBS1;APOE;PPARA
prerank,cellular response to increased oxygen levels (GO:0036295),0.5655287811342942,1.1708431790777958,0.3069306930693069,0.8762683189137466,1.0,5/11,19.99%,ATP6V0A2;FOXO1;ATP6AP1;CCDC115;TMEM199
prerank,regulation of T cell cytokine production (GO:0002724),0.5329045857739774,1.1707942841750765,0.28418230563002683,0.875447742755734,1.0,1/15,0.51%,CD55
prerank,7-methylguanosine RNA capping (GO:0009452),0.47152411243874065,1.1706336645631568,0.26480836236933797,0.8741034316715675,1.0,8/31,15.70%,POLR2H;GTF2H3;ERCC3;POLR2D;POLR2G;CCNH;GTF2F1;CMTR2
prerank,7-methylguanosine mRNA capping (GO:0006370),0.47152411243874065,1.1706336645631568,0.26480836236933797,0.8741034316715675,1.0,8/31,15.70%,POLR2H;GTF2H3;ERCC3;POLR2D;POLR2G;CCNH;GTF2F1;CMTR2
prerank,prostanoid metabolic process (GO:0006692),0.5537744919572517,1.1703140422269298,0.2882273342354533,0.8743310071947789,1.0,3/13,15.53%,CYP2S1;PTGR1;ACOX1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.46524211960322315,1.1701539000623737,0.2571428571428571,0.8740126840503831,1.0,12/38,19.03%,ANK2;BIN1;DSC2;CAMK2D;KCNJ2;YWHAE;HCN4;JUP;KCNJ3;SCN4B;AKAP9;KCNH2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.5540426333472741,1.1700245532658446,0.30173564753004006,0.873541753173783,1.0,4/13,15.37%,CD2BP2;USP4;PRPF3;DDX20
prerank,C4-dicarboxylate transport (GO:0015740),0.5453530728477167,1.168929332794266,0.2855227882037534,0.87700379049859,1.0,2/14,4.69%,LRRC8D;SLC1A6
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.5540685439242347,1.1688483004695576,0.2717241379310345,0.8763287691365081,1.0,1/12,1.22%,PRKCA
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.539315141489142,1.1685926571544496,0.27344782034346105,0.8763651040863685,1.0,6/14,19.46%,WNT9A;CHADL;SNAI2;EFEMP1;TGFBR1;RFLNA
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.5494817255245638,1.1685019246987662,0.2888283378746594,0.8757475089260206,1.0,6/13,26.58%,XRCC3;DYNC1LI1;CDK5RAP2;ANAPC15;TPR;DUSP1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.3601581914876825,-1.1679582866537168,0.19607843137254902,0.663767917626198,1.0,8/21,10.22%,CNOT2;SAMD4A;CNOT9;PAN3;CNOT7;TUT4;CNOT11;TUT7
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.41468825384417124,1.1674737889654967,0.19655521783181357,0.878763463705956,1.0,23/129,11.99%,SFRP4;COL1A1;DKK2;EGFR;SCEL;GPC3;PSMC4;UBE2B;SMURF2;AXIN1;DACT1;PSMC6;DAAM2;PSMD8;GSKIP;TMEM9;KANK1;PLEKHA4;CSNK1G1;PRDM15;EGF;CSNK1G3;JUP
prerank,positive regulation of cartilage development (GO:0061036),0.5172289405916102,1.1674614991187362,0.2974025974025974,0.8778367395532046,1.0,3/17,8.71%,LOXL2;BMP1;SOX5
prerank,inositol phosphate dephosphorylation (GO:0046855),0.5667325300565553,1.167399219369725,0.2925824175824176,0.87613495552174,1.0,5/11,27.59%,OCRL;INPP5K;INPP5B;PTEN;SYNJ2
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.5667325300565553,1.167399219369725,0.2925824175824176,0.87613495552174,1.0,5/11,27.59%,OCRL;INPP5K;INPP5B;PTEN;SYNJ2
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.4836204624835144,1.1673713770750944,0.279901356350185,0.8752723603568371,1.0,4/29,11.88%,FANCD2;RNF212B;SYCP2;TERB1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.4452939181182102,-1.1673391600183747,0.25773195876288657,0.6627125546552834,1.0,3/12,3.45%,CDH5;SNCA;DYRK1A
prerank,positive regulation of endothelial cell migration (GO:0010595),0.42696579115806726,1.1668784134360717,0.22012578616352202,0.8763064225166745,1.0,23/84,14.35%,FGF18;PRKCA;FGFR1;ANGPT4;SPARC;ITGB3;VEGFA;FGF2;FOXP1;SMOC2;PLPP3;MAPK14;MAP2K3;PRKD2;STAT5A;FOXC2;AKT3;EMC10;EGF;AKT1;ZC3H12A;AAMP;BCAS3
prerank,toll-like receptor signaling pathway (GO:0002224),0.4274655475419056,1.1668477004966336,0.22083333333333333,0.8754681032050657,1.0,36/84,30.35%,LBP;IRAK3;RFTN1;S100A8;S100A9;TLR5;SCARA3;CHUK;TIRAP;TLR4;IRAK4;TNIP1;IRAK1;UBA52;EPG5;CD14;TRAF3;UBE2D3;ITGAM;TAB2;MAP3K7;TNIP2;CTSK;HSP90B1;TICAM1;CTSB;CTSL;CASP8;BCL10;MAPKAPK3;SFTPA2;SFTPA1;MYD88;LGALS9;TRIL;TRAF6
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.5269583780269067,1.1662281026278736,0.2886866059817945,0.8768805654619728,1.0,5/16,18.14%,SRSF6;RBM17;DDX17;DDX5;PUF60
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.46722635000362456,1.1654217197460166,0.2715617715617716,0.8790144316220869,1.0,5/31,11.49%,CD80;GLMN;RC3H1;CEBPB;GPNMB
prerank,regulation of phosphate metabolic process (GO:0019220),0.5292025132622147,1.165299499540835,0.3055198973042362,0.878508854919123,1.0,6/16,15.09%,TIGAR;PSEN1;SIRT2;SMG7;SMG6;IL4
prerank,glutamate metabolic process (GO:0006536),0.508662187000376,1.1645734532122023,0.29214929214929214,0.8804779539108022,1.0,6/19,15.82%,GCLC;ALDH18A1;GLS2;GLS;ALDH5A1;GLUD1
prerank,positive regulation of cellular protein localization (GO:1903829),0.4314481335378444,1.1645731594905422,0.26264800861141013,0.879509331299239,1.0,23/69,25.20%,LIF;EIF2AK3;FYN;WWTR1;SYT11;GNL3L;MEAK7;BICD1;PARD6A;STX4;AKT1;MAPT;GPR137B;STX3;ENTR1;NUMA1;MAP1A;SESN2;CROCC;CCDC88A;TRAPPC12;RTN4;KAT7
prerank,protein K63-linked deubiquitination (GO:0070536),0.47258140738750426,1.1640690362327841,0.2671232876712329,0.8805467891259189,1.0,9/31,14.83%,ZRANB1;SPATA2;OTUD1;USP33;OTUD7B;USP50;ABRAXAS1;STAMBPL1;USP7
prerank,positive regulation of wound healing (GO:0090303),0.4660748398406521,1.163824417371849,0.24804469273743016,0.8804872945837166,1.0,9/36,12.02%,DUOX1;ANXA1;F2R;SMOC2;PLPP3;MTOR;FOXC2;KANK1;ST3GAL4
prerank,positive regulation of protein export from nucleus (GO:0046827),0.5287350714266617,1.1638030532692407,0.2885375494071146,0.8796048966806834,1.0,8/15,24.14%,TCF7L2;GAS6;YWHAE;RBM22;ANP32B;BAG3;TPR;EMD
prerank,negative regulation of cell growth (GO:0030308),0.41204822003048064,1.1637937111999772,0.20385395537525355,0.8786669994670363,1.0,25/121,14.90%,WT1;DCBLD2;FHL1;DACT3;FGF13;TGFB2;SLIT3;SLIT2;CDKN2AIP;PTPRS;PSRC1;SMAD4;GNG4;PTPRJ;TRIM46;FLCN;CYP27B1;BCL6;DNAJB2;ULK2;ADAM15;CDKN1A;ULK1;DCC;SMARCA4
prerank,regulation of mitochondrion organization (GO:0010821),0.4425885219656355,1.1635236350540172,0.26229508196721313,0.8787414940931337,1.0,20/47,26.74%,USP36;MIEF2;PID1;HDAC6;FLCN;SQSTM1;MAPT;VDAC1;IAPP;HTRA2;SREBF1;CSNK2A2;STAT2;PARL;FIS1;FBXW7;RHOT2;INF2;MUL1;PLSCR3
prerank,monoacylglycerol metabolic process (GO:0046462),0.5534857073631875,1.163221811605283,0.28194993412384717,0.8789792562198483,1.0,1/13,0.65%,MGLL
prerank,regulation of complement activation (GO:0030449),0.4566107571932369,1.1628414426235039,0.2778402699662542,0.8794868189413695,1.0,8/40,13.82%,CD55;CFH;C7;C1QBP;CD81;C4B;SERPING1;CR2
prerank,lung development (GO:0030324),0.47180977106422534,1.1627868971194688,0.2818489289740699,0.8787299815097074,1.0,6/33,6.96%,FGF7;VEGFA;FGF2;PKD1;RCN3;GLI2
prerank,gonad development (GO:0008406),0.45516516340378316,1.1620791900950664,0.2655172413793103,0.8806128659056146,1.0,8/41,10.06%,AR;WT1;SIX4;TGFB2;IRX5;NUP107;SOX8;COL9A3
prerank,negative regulation of cell migration (GO:0030336),0.4120680698691774,1.1620374022962339,0.18365287588294651,0.8798184120615126,1.0,42/137,21.45%,COL3A1;IGFBP5;HAS1;LRP1;TMEFF2;ADARB1;LDLRAD4;TNN;FGF2;SLIT2;MIF;GTPBP4;MIA3;PTPRJ;SRGAP1;SULF1;PFN2;PIP5KL1;FLCN;DPEP1;NDRG4;JAG1;MITF;KANK1;MAGI2;RECK;ADAM15;STK24;HOXA7;IL4;STC1;SRGAP3;SRGAP2;NAV3;CYP1B1;STK26;CLASP2;CORO1C;RNF41;BMPR1A;PTEN;NF1
prerank,regulation of GTPase activity (GO:0043087),-0.26680091990949384,-1.1615677137829497,0.0,0.6757106531943389,1.0,43/177,10.70%,PLXNA2;PKP4;PRKG1;EPHA4;RAPGEF2;RAPGEF3;CHN2;ITGA6;RAP1GDS1;PLXNA4;NET1;FGD4;CHN1;CDKL5;F11R;FGD5;DAB2IP;DOCK8;TGM2;RASGRP2;PLXND1;SIPA1L1;RASIP1;LRCH1;RGS6;MAP4K4;DVL3;DOCK9;CPEB2;BCAR3;PLXNB1;ERBB2;CAV2;CX3CL1;STMN3;SFRP1;AGRN;TBC1D30;USP6NL;ZC3H15;ARL2;LIMS1;RGP1
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.5318801670568358,1.1615282622899377,0.2952755905511811,0.880814704102229,1.0,3/16,4.33%,IGFBP5;IGFBP6;IGFBP4
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5642845233290475,1.1614964985756184,0.3078014184397163,0.8799722031561826,1.0,1/11,0.45%,GSN
prerank,negative regulation of kinase activity (GO:0033673),0.43313035127523664,1.1614441460464833,0.24167561761546724,0.87922420949593,1.0,19/62,18.18%,LRP6;TARBP2;CAMK2N1;WWTR1;DTNBP1;RTRAF;YWHAG;GSKIP;INPP5K;AKT1;MAPT;IRS2;DEPTOR;SFN;SMCR8;CHP1;CEP85;PPIA;QARS1
prerank,dendrite self-avoidance (GO:0070593),0.5319217058873144,1.1611731957700666,0.2956058588548602,0.8793121025731273,1.0,7/16,21.43%,NPTN;TNN;DSCAM;PALLD;IGSF9;CNTN4;CNTN2
prerank,response to tumor necrosis factor (GO:0034612),0.4171522532232977,1.161061844727913,0.21627188465499486,0.8787734694834005,1.0,18/91,15.28%,HAS2;CCL8;AFF3;ADAM9;NFE2L2;ZFP36L1;NR1D1;PID1;ZFP36L2;CHUK;CCL25;INPP5K;AKT1;ZFP36;CCL13;ZC3H12A;GGT7;BAG4
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.4293402038610399,-1.16094862924229,0.26591760299625467,0.6749556964787985,1.0,5/13,11.88%,NOS3;PPARA;PINK1;ENO1;NOS1
prerank,oligodendrocyte development (GO:0014003),0.5366383804584889,1.1607062010244524,0.2994858611825193,0.8792217285482345,1.0,8/15,27.47%,PRDM8;SOX10;PLP1;EIF2B1;CNTNAP1;B4GALT5;EIF2B2;MYRF
prerank,mitochondrial genome maintenance (GO:0000002),0.5701879016519579,1.1605526535955297,0.3116531165311653,0.8788447967130022,1.0,5/11,22.83%,SLC25A4;AKT3;SLC25A36;SLC25A33;MGME1
prerank,regulation of leukocyte activation (GO:0002694),-0.4333040420151961,-1.1603987822624875,0.2886178861788618,0.6739554580162429,1.0,6/14,15.72%,LYN;MYO18A;PLSCR1;CD200;GPER1;CD74
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.43204651665687427,1.160280461079003,0.23703703703703705,0.8790290896602325,1.0,15/62,17.82%,ACKR3;MAPK7;NFE2L2;CREB3L1;SYVN1;SRC;NOC2L;HERPUD1;URI1;AKT1;SNAI2;SELENOS;HTRA2;PPIA;PLAUR
prerank,Golgi organization (GO:0007030),0.4112935147120388,1.160262120614766,0.2043343653250774,0.8781655695945815,1.0,44/112,27.22%,SEC16B;ATP8B1;ARHGAP21;STK25;TMED1;STX5;FBXW8;ZW10;FHDC1;PI4K2B;LYSMD3;RAB30;SEC22B;SYNE1;SURF4;LMAN1;RAB2A;SEC23IP;STX17;RAB43;BCAS3;BLZF1;HACE1;DYNC2H1;ARFGEF1;TMED2;CLASP2;TJAP1;ATP8B2;VAMP4;PI4K2A;STX16;GOLPH3L;VTI1A;TRAPPC12;BAG5;RAB1A;RAB29;GOSR2;GBF1;CUL7;ARHGEF7;VCPIP1;GORASP1
prerank,cellular response to oxidative stress (GO:0034599),0.4143031759957949,1.160221183012198,0.20875763747454176,0.8773603516888099,1.0,25/118,17.41%,NOX4;UCP1;NCF4;EGFR;STX2;NFE2L2;FOXO1;PKD2;BRF2;CHUK;SIRT2;STX4;GPX1;CAMKK2;AKT1;MAPT;PDGFRA;ZC3H12A;EIF2S1;FER;SELENOS;SOD3;KEAP1;HTRA2;PPIA
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.40811012553895226,1.1601094688442695,0.18328298086606243,0.8768419099769881,1.0,24/152,14.41%,ADGRD1;GNAS;VIPR2;LPAR3;GPR12;GNAI3;LPAR1;GLP2R;CXCL10;ABCA1;S1PR2;HTR1F;ADCYAP1;ADGRG2;CRHR1;GNAZ;GPR161;CALCA;AKAP12;GPR37L1;TSHR;ADCY8;GPR37;LHCGR
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.41756626509595796,-1.1595643594968508,0.2625482625482625,0.6738481892001803,1.0,7/14,18.42%,PLCG1;THBS1;ITGA4;RGCC;ECSCR;GPER1;CD40
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.45294073506186705,-1.1591854616434725,0.2775800711743772,0.6723655688629966,1.0,5/11,11.89%,WNT4;BMP5;SIRT1;BMP2;FGFR4
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.32737978911997495,-1.1590970772815632,0.19834710743801653,0.6701200359996798,1.0,9/36,12.26%,SGMS1;BCL2;DAB2IP;TPD52L1;DAPK2;ING5;CX3CL1;FAS;BDNF
prerank,mesenchymal to epithelial transition (GO:0060231),0.5625355314520458,1.1589038990075258,0.30286493860845837,0.8806196465268312,1.0,2/10,8.23%,WT1;FZD7
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5789605335534378,1.1586047334406842,0.2892086330935252,0.8808020883113029,1.0,3/10,11.24%,MIA3;TLR4;AKT1
prerank,nucleoside catabolic process (GO:0009164),-0.45312972176698485,-1.1585579937719828,0.28859060402684567,0.6691061921412799,1.0,4/11,7.99%,DPYD;UPB1;NT5E;DERA
prerank,ovarian follicle development (GO:0001541),0.5539368369525383,1.1584222069437071,0.3140604467805519,0.8805751195799821,1.0,5/13,14.41%,ANG;VEGFA;INHA;CEBPB;LHCGR
prerank,protein-DNA complex disassembly (GO:0032986),0.5216402165698403,1.1577828960874355,0.2883116883116883,0.8822418351442355,1.0,7/16,19.77%,SMARCD2;SMARCD1;SMARCC2;SMARCA4;GRWD1;SET;RPL23
prerank,T cell homeostasis (GO:0043029),0.5816763254008893,1.1574277725204,0.30823863636363635,0.8826992456190128,1.0,2/10,11.24%,ZC3H8;AKT1
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.48210412698467775,1.1573622823875533,0.2710059171597633,0.8819989485842198,1.0,5/26,8.83%,IRAK3;ITCH;CARD16;C1QBP;SIRT2
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.29457321649610274,-1.1573190279870829,0.19642857142857142,0.6700202384874876,1.0,27/61,24.33%,PRKAG2;PPARA;PSMC1;CAV1;PSMA5;SIRT5;PSMD12;PSMF1;PSMA2;SIRT1;PSMA3;PSME2;FGFR4;PSME1;PSMB10;PSMA1;PSMB8;PSMB9;PSMB4;PSMA8;PSMD6;PDK4;NQO1;NR1H4;PSMD10;PSMD11;PSMD9
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.3909936632784891,-1.1572079004951743,0.2557077625570776,0.6679118434040633,1.0,6/17,18.42%,ATP1A2;GJA1;RYR2;ATP1B1;GJC1;GJD3
prerank,regulation of monooxygenase activity (GO:0032768),0.4939864548060512,1.1571973187068605,0.28501228501228504,0.8816980927916921,1.0,8/23,17.58%,CYGB;EGFR;VDR;AKT1;POR;GDNF;HSP90AA1;ZDHHC21
prerank,ventricular septum development (GO:0003281),0.4561134298730024,1.1569268221499907,0.2779017857142857,0.8818047176380245,1.0,8/37,7.31%,TGFB2;SLIT3;SLIT2;TGFBR2;SMAD4;ACVR1;MDM4;ZFPM2
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5565339948841265,1.1565420921265464,0.30517711171662126,0.8823506128416171,1.0,6/11,27.19%,MOSPD3;BNIP1;RTN4;ATL1;LPCAT3;VCPIP1
prerank,negative regulation of secretion by cell (GO:1903531),0.45591874200668264,1.1564169723795057,0.26719278466741825,0.8818912593371779,1.0,4/38,5.42%,LIF;ANXA1;SYT11;RHBDF1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5791726844707769,1.1563104254996772,0.32471264367816094,0.881378190712092,1.0,2/10,2.75%,IRF4;RUNX1
prerank,regulation of protein catabolic process (GO:0042176),0.4162029193620552,1.1560766467059878,0.22981366459627328,0.8813661582907876,1.0,29/99,21.84%,EGFR;GPC3;IRAK3;STX5;SMURF2;AXIN1;DACT1;ITCH;FOXO1;SEC22B;MDM4;EGLN2;WDR91;SIRT2;DTL;ODC1;HECW2;TMEM9;DDB1;ZDHHC2;PIN1;NSF;HACE1;IDE;FLNA;RNF41;FMN2;SMURF1;AZIN2
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.515463932949082,1.1560396517891505,0.305591677503251,0.8805870061184108,1.0,1/16,0.26%,ACKR3
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.49614236584161703,1.1558038658263974,0.28746928746928746,0.8805861236526448,1.0,7/22,17.21%,EIF2AK3;MTOR;DHX33;UBTF;DDX11;SMARCA4;IPPK
prerank,cellular response to lipopolysaccharide (GO:0071222),0.4135873370386509,1.1557773729129026,0.22765072765072766,0.8797539584353852,1.0,19/101,16.45%,LBP;CD80;AXL;ADAM9;MAPK14;NR1D1;CXCL10;CARD16;TLR4;SIRPA;IRAK1;ZFP36;RHOA;TNFRSF1B;ZC3H12A;CD14;SELENOS;PDCD4;IL6
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.3041976352558161,-1.1556138100758713,0.19480519480519481,0.6695820389807883,1.0,7/51,4.64%,PTN;IL34;VEGFC;THBS1;HMGB1;CXCL12;IL6R
prerank,response to reactive oxygen species (GO:0000302),0.4341405650849754,1.1553387770224925,0.26659528907922914,0.8805412530115021,1.0,14/54,14.48%,UCP1;EGFR;STK25;FYN;ADAM9;PKD2;CHUK;GPX1;CAMKK2;AKT1;MAPT;PDGFRA;STK24;FER
prerank,maturation of LSU-rRNA (GO:0000470),0.48460255455439816,1.1553105842489833,0.27327690447400244,0.8797170449074746,1.0,10/26,21.73%,DDX18;URB1;ZNHIT6;RPL10A;EIF6;SNU13;RSL1D1;RPF2;MAK16;NOP2
prerank,positive regulation of viral process (GO:0048524),0.4332322557995054,1.1551829126792705,0.25674217907227614,0.8792745887707167,1.0,15/60,17.41%,AXL;POLR2H;TARBP2;ADARB1;KPNA2;MDFIC;CDK9;LARP1;POLR2D;DDB1;POLR2G;CTDP1;GTF2F1;HACD3;PPIA
prerank,calcineurin-mediated signaling (GO:0097720),0.5703517190797368,1.155014175863747,0.29705882352941176,0.8780582319138975,1.0,5/10,19.43%,NFATC4;NFATC1;PPP3CC;PPP3CA;PPP3CB
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5703517190797368,1.155014175863747,0.29705882352941176,0.8780582319138975,1.0,5/10,19.43%,NFATC4;NFATC1;PPP3CC;PPP3CA;PPP3CB
prerank,response to organic cyclic compound (GO:0014070),0.44000216767944184,1.154927419546858,0.25274725274725274,0.8774300191761426,1.0,10/52,18.83%,IGFBP5;ESR1;ANXA1;SOCS2;CYP27B1;GGT7;STAT5B;IL18;GLDC;CYP1B1
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.42385834003434436,1.1546757115037058,0.2531779661016949,0.8774997796550991,1.0,19/78,15.97%,AR;EPHB2;EGFR;LRP1;EPHA3;TMBIM1;CLTC;ATP2B4;ZDHHC7;PID1;STX4;RHOQ;SQSTM1;AKT1;ZDHHC2;PPFIA1;ARF6;SPTBN1;PLS1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4685243001631246,1.154606719087002,0.28762135922330095,0.876856149659346,1.0,8/34,8.83%,WNT10B;WWTR1;TRIO;FOXO1;ZFPM2;FLCN;ZFP36L2;SIRT2
prerank,regulation of peptide hormone secretion (GO:0090276),-0.28651179476938116,-1.1545920578787066,0.125,0.6698815131871684,1.0,11/67,5.35%,ITPR1;RAPGEF4;CHD7;RAPGEF3;SLC2A1;CACNA1E;KCNB1;CACNA1D;HADH;ITPR3;KCNS3
prerank,proton transmembrane transport (GO:1902600),0.45938875359749853,1.154581572998246,0.26719278466741825,0.8760479591079764,1.0,7/36,11.43%,UCP1;ATP1A4;ATP1A3;ATP1A1;SLC25A27;ATP5PO;SLC9A1
prerank,cellular response to sterol (GO:0036315),0.5453074809858279,1.1543742937614154,0.3103448275862069,0.8759328757454643,1.0,3/13,8.25%,LRP6;GRAMD1A;INSIG2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.491849160246598,1.154348510789639,0.29594272076372313,0.8751141373424702,1.0,7/24,12.36%,JSRP1;SRI;CAMK2D;PKD2;GSTM2;PDE4D;CALM2
prerank,carboxylic acid transport (GO:0046942),-0.2994457662713566,-1.154129871598757,0.17857142857142858,0.668652296860506,1.0,16/55,13.48%,SLC6A13;SLC16A12;SLC13A3;SLC16A2;SLC6A12;SLC16A6;SLC7A5;SLC16A11;SLC6A9;SLC3A2;SLC16A4;SLC38A5;SLC6A17;SLC6A6;SLC6A7;SLC16A13
prerank,ceramide biosynthetic process (GO:0046513),-0.3109648545729243,-1.1537743460070236,0.17073170731707318,0.6671982334721178,1.0,13/40,14.71%,SGMS1;ST8SIA4;ST6GALNAC3;SAMD8;SPTSSA;ST6GALNAC5;DEGS2;ST8SIA2;CERS1;ST8SIA6;SPTLC2;CERS5;SPTSSB
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.3315662459668881,-1.1536204969970547,0.21794871794871795,0.6651990149982544,1.0,5/29,5.23%,SORBS1;APOE;SCARB1;PPARA;NR1H3
prerank,cardiac myofibril assembly (GO:0055003),-0.4133072794259467,-1.1533443597517936,0.24888888888888888,0.663633342905016,1.0,1/15,0.08%,NEBL
prerank,positive regulation of developmental growth (GO:0048639),0.43589502257398105,1.152983869159569,0.2814569536423841,0.8793633138368564,1.0,7/49,11.42%,GHR;DBN1;SYT2;NTN1;ISLR2;L1CAM;MAPT
prerank,response to acidic pH (GO:0010447),0.5503027326823187,1.152836804265674,0.2971887550200803,0.8789755119845859,1.0,3/13,15.39%,RAB11FIP5;SLC9A1;CHP1
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4057416008910115,1.15276896075654,0.2216599190283401,0.8783384202277085,1.0,32/136,17.01%,SFRP4;ESR1;IRAK3;BHLHE40;GLIS2;PKD1;TCF7L2;ITCH;PRMT2;RNF2;PKD2;TBX6;GAS6;CHUK;TAF3;IRAK1;COMMD6;NWD1;ZC3H12A;HDAC4;KLF4;USP7;NUPR1;CHP1;NLRP2B;RBCK1;ANXA4;TRAF3;DAP;KEAP1;TAX1BP1;UFL1
prerank,generation of neurons (GO:0048699),0.4053094099364921,1.152593818111174,0.1774193548387097,0.8780860106366131,1.0,32/190,14.94%,LMX1A;LHX8;WNT2;NAV1;WNT10B;MAP1B;FGFR1;CTF1;SIX4;NEUROD2;RUNX1;WNT9A;FGF13;TGFB2;BHLHE40;LMX1B;IRX5;DOCK7;POMGNT2;LRP12;SEMA3A;FZD7;NRBP2;FUT9;MAPT;PIN1;SIX1;MDGA1;ARTN;THOC2;TAFA1;POU3F2
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.44311420842860083,1.1524791739405669,0.2786343612334802,0.8776128404430386,1.0,18/47,24.61%,MYOC;EFNA5;S100A10;MYADM;C1QBP;MELTF;KANK1;TRIOBP;LIMS2;RAC3;RCC2;ILK;CORO1C;FLNA;FBLN1;DMTN;RAC1;CALR
prerank,ephrin receptor signaling pathway (GO:0048013),0.4237924366952941,1.1522497067793587,0.24479166666666666,0.8775837751222039,1.0,31/82,24.76%,EPHB2;ARHGEF28;EFNA5;DNM1;MMP2;EPHA3;FYN;ANKS1B;AP2A2;SRC;ACTR3;PSEN1;EPHB3;EPHA10;NGEF;RHOA;ARPC1A;ACTG1;SDC2;ARPC2;EPHB1;RASA1;TIAM1;YES1;VAV2;SDCBP;NCK2;AP2M1;ITSN1;RAC1;EPHA5
prerank,non-motile cilium assembly (GO:1905515),0.47347783816989875,1.1517961516306687,0.2966002344665885,0.8783916918821355,1.0,11/30,21.03%,DCTN1;ARL13B;TOGARAM1;PIBF1;VANGL2;BBS4;TTC8;RPGRIP1;CEP89;IFT57;PCM1
prerank,regulation of response to stress (GO:0080134),0.5733673187244938,1.15137616027694,0.3154929577464789,0.8790861228963294,1.0,2/10,12.85%,CORO2B;ADCY8
prerank,protein homooligomerization (GO:0051260),0.4130370810494524,1.1511088886061307,0.22982635342185903,0.8792015274077158,1.0,20/114,15.19%,SCARA5;SLC1A5;DISP1;MIF;P2RX3;TK1;KCNJ2;MPP2;OSBPL2;PKD2;ZBTB1;SAMHD1;VSTM5;TMEM120A;ALDH1A3;ADCY8;GLS;NACC2;KCNC2;CRYZ
prerank,regulation of mitochondrial fission (GO:0090140),0.4835612943068159,1.1509806681036596,0.29782082324455206,0.8787748859127549,1.0,10/24,26.70%,DCN;MIEF2;MCU;MAPT;DDHD1;RALA;STAT2;FIS1;INF2;MUL1
prerank,protein localization to cell surface (GO:0034394),0.48068988446356836,1.1505703659553297,0.29274292742927427,0.8795009079943112,1.0,9/26,14.95%,FGF7;CD177;ANK2;JAM3;USP4;GGA1;PIGK;GGA2;ARF6
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.5532954673157098,1.1504431428397472,0.3157894736842105,0.8790918919404759,1.0,6/11,26.58%,SLIT2;MIF;PADI2;NBL1;CCN3;DUSP1
prerank,spindle assembly (GO:0051225),0.42609507830684606,1.1503961095142938,0.26652452025586354,0.8783820892442137,1.0,22/67,21.30%,KIFC2;MAPRE3;STARD9;TOGARAM1;KIF2A;ARHGEF10;SMC1A;HDAC3;HAUS3;MAPRE1;PIBF1;NCOR1;RHOA;KIF3B;ABRAXAS1;INO80;NEK7;STAG2;CLASP2;FLNA;NUMA1;TUBGCP5
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.4924588107208572,1.150329200464475,0.29476248477466505,0.8777438244505666,1.0,8/22,22.56%,EDEM3;SYVN1;EDEM1;EDEM2;UBA52;AMFR;UGGT1;SEL1L
prerank,regulation of gastrulation (GO:0010470),-0.42188772202581953,-1.1500309137524702,0.298932384341637,0.6701098135306794,1.0,3/14,2.26%,PHLDB2;TENM4;OSR1
prerank,glycosphingolipid metabolic process (GO:0006687),0.4395583733642377,1.1499164784458515,0.27497194163860833,0.8783179127980922,1.0,8/42,13.71%,SMPD3;ARSA;B3GALNT1;LARGE1;GBA2;GLA;CERK;GLTP
prerank,response to nutrient levels (GO:0031667),0.5320546212059309,1.149449214724578,0.3216601815823606,0.879266444999902,1.0,3/17,6.23%,UCP1;MTOR;MEAK7
prerank,positive regulation of neutrophil migration (GO:1902624),0.5067353283940619,1.1491522242767145,0.3192307692307692,0.8795074583097712,1.0,4/18,8.72%,THBS4;C1QBP;TIRAP;MCU
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.476294930436645,1.1490106458672578,0.3047735618115055,0.8791478118620856,1.0,9/27,20.13%,IRS1;GRB10;TNS2;PID1;INPP5K;KANK1;NCK1;PIP4K2C;PIP4K2B
prerank,acetyl-CoA metabolic process (GO:0006084),0.5186438765087292,1.148972392766194,0.3125,0.8783935193034185,1.0,6/15,20.79%,ACLY;MVK;NUDT7;PMVK;DIP2A;ACAT1
prerank,negative regulation of cytokine production (GO:0001818),0.4030452936688232,1.148914965313418,0.201010101010101,0.8777283243889389,1.0,33/163,18.21%,CD34;AXL;ANXA1;NPTN;IRAK3;HDAC7;HDAC9;SYT11;ITCH;C1QBP;INHA;GAS6;TLR4;SIRPA;OTUD7B;GPNMB;BCL3;SLC2A10;PIBF1;ZFP36;PIN1;CD200R1;ZC3H12A;KLF4;RNF216;SELENOS;ILRUN;ANXA4;PDCD4;IL6;TAX1BP1;ATP2B1;NAV3
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.39493091488847065,1.148637887944653,0.119,0.8778705362468647,1.0,50/348,11.69%,CD34;SFRP4;AR;GSN;EPHB2;SEC16B;FGF18;AMH;FGF7;C1QTNF1;WT1;HPN;TMEM119;PKP3;EIF2AK3;ANXA2;MAPK7;ANK2;VEGFA;FGF2;DGKQ;CAMK2N1;RBMS3;NFE2L2;ZPR1;MAPK14;ADAM19;KLF2;MTOR;ITCH;IL33;DTNBP1;HOXA5;PID1;GAS6;VDR;PSEN1;INPP5F;AGO2;ECE1;TLR4;MAPK11;MITF;MUSK;MPHOSPH8;EGF;AKT1;KRAS;SLC2A10;MAGI2
prerank,anterograde axonal transport (GO:0008089),0.459034043723039,1.1485789159656719,0.2743972445464983,0.877205250648507,1.0,12/37,21.58%,DTNBP1;DLG2;NEFL;TRAK2;AP3D1;KIF3A;KIF3B;BLOC1S2;RAB27B;SNAPIN;AP3B2;MAP1A
prerank,regulation of microtubule polymerization (GO:0031113),0.4477911185405037,1.148394869600709,0.27878103837471785,0.8770203925028462,1.0,16/40,20.59%,DCTN1;PSRC1;CLIP1;MAPRE3;TOGARAM1;MAPRE1;CAMSAP1;GBA2;MAPT;SLAIN2;TUBB4A;CDK5RAP2;AKAP9;NAV3;CLIP3;NUMA1
prerank,endomembrane system organization (GO:0010256),0.39963922953700326,1.1483040829956848,0.17759838546922302,0.8764603802966286,1.0,64/178,27.22%,SEC16B;ATP8B1;ARHGAP21;DNM1;EIF2AK3;TMED1;HOOK2;SEC31A;FBXW8;TOR1AIP2;REEP3;ZW10;NUP93;TLCD2;MIA3;PLEKHF1;PI4K2B;LYSMD3;RAB30;SYNE1;OSBPL2;AP3D1;SURF4;LMAN1;TOR1A;SQSTM1;RAB2A;SEC23IP;USP50;STX17;LNPK;RAB43;BCAS3;SEC61A1;SPTBN1;PHETA2;BLZF1;HACE1;REEP5;DYNC2H1;VPS11;ANXA8;ANXA8L1;ARFGEF1;TMED2;VPS33B;CLASP2;TJAP1;ATP8B2;PI4K2A;GOLPH3L;BNIP1;TRAPPC12;ALS2;BAG5;ATL1;RAB1A;RAB29;GBF1;ARFGEF2;SNX33;CUL7;ARHGEF7;GORASP1
prerank,regulation of humoral immune response (GO:0002920),0.44588608410732095,1.1482777729513356,0.2985571587125416,0.8756560300387605,1.0,8/44,13.82%,CD55;CFH;C7;C1QBP;CD81;C4B;SERPING1;CR2
prerank,regulation of postsynapse organization (GO:0099175),-0.34581917432731496,-1.14795336021259,0.2694610778443114,0.6730038843810645,1.0,7/28,5.44%,EPHA4;PDLIM5;CDKL5;SHANK3;WNT5A;SIPA1L1;ABHD17C
prerank,mitochondrion transport along microtubule (GO:0047497),0.5430242294232719,1.147940175122535,0.31693989071038253,0.8760824334046211,1.0,6/13,25.37%,NEFL;SYBU;MAPT;UXT;MAP1S;RHOT2
prerank,purine nucleotide biosynthetic process (GO:0006164),0.555722448666515,1.1476009406032557,0.32421340629274964,0.876455614550472,1.0,5/12,16.95%,AMPD2;GART;PRPSAP1;PRPS1L1;PRPS1
prerank,neural tube closure (GO:0001843),0.457910039310212,1.1473972746290464,0.285876993166287,0.8763987705072543,1.0,4/34,4.22%,LRP6;TGFB2;COBL;SKI
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.46957221479604233,1.1472681440471908,0.2872340425531915,0.8760048920825544,1.0,10/30,16.92%,AR;FOXP1;PRMT2;HDAC6;NCOR2;NCOR1;SMARCA4;RNF14;TRIM68;DDX5
prerank,DNA geometric change (GO:0032392),0.48420953272465994,1.1469833373689333,0.3065512978986403,0.8762135365907353,1.0,10/24,19.01%,ANXA1;ASCC3;DNA2;DDX11;NBN;HMGB3;RECQL;RAD50;BLM;SUPV3L1
prerank,fatty acid beta-oxidation (GO:0006635),0.44150606891629746,1.1468655753853103,0.2891832229580574,0.8758235954338606,1.0,18/51,21.97%,EHHADH;ETFA;AUH;CRAT;SCP2;ACADVL;SLC25A17;ACOX1;ETFDH;ETFB;BDH2;MCAT;ABCD3;CPT2;ACAT1;HSD17B4;PEX2;CROT
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.4760097220329641,1.146861391422378,0.28319623971797886,0.8749538423257357,1.0,7/26,17.56%,FBN1;LRRC17;INHA;TLR4;HOXA7;IL4;GPR137B
prerank,positive chemotaxis (GO:0050918),0.5131178784368228,1.1468362389421696,0.3210659898477157,0.8741624308892324,1.0,4/17,11.49%,FGF7;VEGFA;PTPRJ;GPNMB
prerank,positive regulation of DNA metabolic process (GO:0051054),0.4310454417829344,1.1467744361208467,0.286480686695279,0.8735168016337145,1.0,16/61,17.48%,PARP3;EGFR;WT1;FGF2;SMOC2;STPG4;EYA2;PRKD2;UBE2N;TIGAR;ABRAXAS1;NBN;USP7;HGF;PML;RAD50
prerank,leukocyte cell-cell adhesion (GO:0007159),0.4819028323460215,1.1463987573087089,0.29036144578313255,0.8740747507058954,1.0,2/24,2.55%,SYK;CD177
prerank,autophagosome assembly (GO:0000045),0.43132869447382005,1.1462999914580896,0.2830601092896175,0.8735626578462307,1.0,22/52,25.47%,RAB23;RAB19;PACS2;ATG2B;WIPI2;STX12;WDR45B;STX17;ULK2;RAB43;ATG2A;ATP2A2;ULK1;ATG16L2;RAB1B;ATG13;ATG16L1;ATG3;SMURF1;ATG14;EMC6;RAB1A
prerank,peptidyl-methionine modification (GO:0018206),0.5460636487452779,1.1462029850072775,0.32142857142857145,0.8730672424079824,1.0,6/12,22.93%,NAA15;METAP2;NAA20;METAP1;METAP1D;NAA30
prerank,negative regulation of complement activation (GO:0045916),0.5710789113016703,1.145777858337353,0.32471264367816094,0.8737763549872503,1.0,3/10,13.82%,CD55;SERPING1;CR2
prerank,negative regulation of metabolic process (GO:0009892),0.4338804717771404,1.1456167092218787,0.2677595628415301,0.8735276500115688,1.0,9/54,9.36%,ADAMTS5;WNT10B;ZDHHC7;DOCK7;NR1D1;LNPEP;FLCN;FOXC2;TLR4
prerank,regulation of axon regeneration (GO:0048679),-0.4257499164256062,-1.1455368247693518,0.26804123711340205,0.677162241578697,1.0,2/12,0.50%,PTN;EPHA4
prerank,positive regulation of signal transduction (GO:0009967),0.39852910001519415,1.145462396939891,0.1646586345381526,0.8732306979143926,1.0,44/238,12.36%,RSPO2;MN1;CD80;CCBE1;AXL;PRKCA;IRS1;NPTN;GRB10;SULF2;ITGB3;ZMIZ1;TGFB2;CDKN2AIP;SLC39A14;DLG4;TEDC1;SMOC2;SKI;ADAMTS3;ITGA5;DACT1;ZRANB1;KLF2;SULF1;SRC;STX1B;UCHL5;PRKD2;PKD2;ESM1;GAS6;JAG1;CYP27B1;KAT2B;BMP2K;ITGAV;KANK1;ERN1;ENHO;MGAT5;TUBD1;BAK1;KLK6
prerank,regulation of exocytosis (GO:0017157),0.4425263106463228,1.144970212949539,0.30180180180180183,0.8741936623720211,1.0,19/46,27.09%,ANXA1;STX4;RAB3D;ATP6AP1;RAB27B;NSF;SYT1;VAMP2;RAB2B;RIMS2;RALA;RAB10;CLASP2;RAB12;STXBP5L;RAB3C;CFTR;RAB8B;IL1RAPL1
prerank,negative regulation of translation (GO:0017148),0.41485961742507815,1.144820783353741,0.2512926577042399,0.8738489621583451,1.0,21/87,19.70%,IGFBP5;EIF2AK3;RBM4;PAIP2B;TRIM71;SAMD4B;MRPL13;AGO2;PUM1;UNK;IGF2BP1;LARP1;CNOT10;EIF3E;CPEB1;FXR2;YTHDF2;YTHDF1;EPRS1;PAIP2;PCIF1
prerank,inositol lipid-mediated signaling (GO:0048017),0.4428233716365443,1.1448177097891814,0.2906458797327394,0.8729907625211559,1.0,15/50,17.46%,IRS1;FGFR1;PLCE1;PIK3C2B;PIK3R2;PLCB4;PIK3CA;INPP5F;IRS2;PDGFRA;RHOA;PI4KB;PI4KA;OGT;PLCD4
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.49849694234127484,1.1443155752480187,0.3198031980319803,0.8740510941993024,1.0,7/20,19.51%,TARBP2;TRIM71;AGO2;PUM1;AGO4;SNIP1;AGO3
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.4864856227197543,1.144314615281051,0.3007246376811594,0.8731837366478097,1.0,8/23,21.00%,SCNN1B;SLC12A8;SLC12A4;SLC9A1;SLC12A5;SLC9A7;KCNH2;SLC12A6
prerank,histone ubiquitination (GO:0016574),0.49246335908131267,1.1443047870455636,0.3164251207729469,0.8723481522218045,1.0,9/21,25.83%,UBE2B;UBE2N;ATXN7L3;PHC1;UBE2A;USP22;PAF1;UBR2;RNF20
prerank,development of primary male sexual characteristics (GO:0046546),0.45760455658838617,1.1441169103096673,0.289044289044289,0.8721764324782965,1.0,6/34,10.06%,AR;WT1;SIX4;TGFB2;SOX8;COL9A3
prerank,mRNA stabilization (GO:0048255),0.44783260766794614,1.1440691378521344,0.27720504009163804,0.871482787212397,1.0,9/40,13.00%,TENT5B;MAPK14;DAZL;TARDBP;TIRAP;IGF2BP1;LARP1;ZFP36;GDNF
prerank,cellular response to retinoic acid (GO:0071300),0.441631718535003,1.1439646146220683,0.28205128205128205,0.8709943905055254,1.0,7/42,8.23%,WNT2;WNT10B;EPHA3;WNT9A;RET;ABL2;FZD7
prerank,regulation of cytoplasmic transport (GO:1903649),0.5612036560879479,1.1438936600164038,0.33519553072625696,0.8703641093317076,1.0,5/11,20.94%,ATP9A;SRC;USP7;MAP2K2;MAPK1
prerank,positive regulation of integrin activation (GO:0033625),0.5541832821197146,1.1433168892862122,0.3070539419087137,0.8716829273613975,1.0,2/11,6.79%,RAP1B;SRC
prerank,striated muscle contraction (GO:0006941),-0.29913531113940417,-1.1432079235144437,0.20253164556962025,0.680910059196222,1.0,5/53,2.77%,ATP1A2;TPM1;DMD;RCSD1;DTNA
prerank,calcium ion transport (GO:0006816),-0.2513086112640165,-1.1428316404500902,0.0967741935483871,0.6795046878152339,1.0,25/113,13.95%,ITPR1;TRPM3;SLC24A3;TRPM6;CALCRL;NALCN;CACNA1E;ATP2C1;SLC8A3;RAMP1;CACNB2;CACNA1D;TRPC5;CAV1;SLC3A2;TRPC6;TRPC4;ORAI2;RYR2;CACNG8;ATP2A3;TRPV4;SLC24A5;TRPC7;TRPC3
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.4385820117666375,1.142757811008405,0.30491803278688523,0.8730174318496838,1.0,9/47,15.05%,CD34;FYN;ATP2B4;WDTC1;SIRPA;ACADVL;GLA;ZC3H12A;SNAI2
prerank,amino acid transmembrane transport (GO:0003333),-0.3159382958673166,-1.1426575294573535,0.24175824175824176,0.6775870895520174,1.0,7/45,6.69%,SLC7A11;SLC6A13;SLC16A2;SLC38A11;SLC7A5;SLC22A4;SLC3A2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.39343473247554306,-1.14259370750222,0.27848101265822783,0.6754247221509656,1.0,2/16,1.43%,ATP1A2;DMD
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.31407239732366166,-1.1421740492114136,0.20168067226890757,0.6741875905272493,1.0,16/43,11.97%,BMP6;WNT4;IGF1;MEF2C;BMP7;PRKD1;ZHX3;IL6R;ATRAID;NELL1;BMPR2;NPNT;LRP3;YAP1;BMP2;RUNX2
prerank,negative regulation of interleukin-12 production (GO:0032695),0.5271955145253738,1.1420004567319826,0.3373493975903614,0.874910352573785,1.0,3/14,11.97%,IRAK3;C1QBP;PIBF1
prerank,carboxylic acid metabolic process (GO:0019752),0.45835245338098024,1.141952845747336,0.2942528735632184,0.8741950471206371,1.0,11/33,18.39%,CYP2S1;LIPT2;MIF;PON3;SLC23A1;SLC23A2;SLC2A3;GLUD1;ST3GAL1;GSTO2;GNE
prerank,nuclear pore complex assembly (GO:0051292),0.5546151139581409,1.1418766796835311,0.3328785811732606,0.8735983335327007,1.0,4/10,8.78%,NUP93;AHCTF1;NUP107;NUP98
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5184428019619864,1.141543600258229,0.29673202614379085,0.8739095424636575,1.0,3/15,11.43%,PRKCA;CAMK2D;SLC9A1
prerank,positive regulation of MAPK cascade (GO:0043410),0.3954374701604098,1.1415008793010173,0.18518518518518517,0.8731992604934197,1.0,42/245,13.69%,MID1;ACKR3;LIF;FGF18;CCL8;PRKCA;EGFR;FGFR1;STK25;CD44;VEGFA;FGF2;TGFB2;PDE8A;MST1R;F2R;MIF;TMEM106A;LPAR1;TAOK3;KLHDC10;PTPRJ;RET;RIT2;ADCYAP1;DHX33;PRKD2;GAS6;NDRG4;TIRAP;CCL25;IQGAP1;EGF;GPNMB;GPR37L1;IRAK1;PDGFRA;ATP6AP1;TAOK2;CCL13;FLT3;GPR37
prerank,protein deubiquitination (GO:0016579),0.39796005572627974,1.1413244101173965,0.16516516516516516,0.8730170727406382,1.0,76/242,24.50%,AR;ESR1;UCHL1;DESI2;PSMC4;JOSD2;SMAD4;SMURF2;USP36;COPS5;OTUD3;FOXK2;ZRANB1;SPATA2;RAD23B;IL33;USP32;USP10;USP4;USP29;PSMC6;MDM4;OTUD1;UCHL5;ADRM1;PSMD8;ATXN7L3;SENP8;KAT2B;POLB;USP26;USP33;OTUD7B;ACTR5;TNIP1;USP48;USP50;UBA52;USP5;RHOA;ABRAXAS1;NFRKB;ZC3H12A;INO80;RCE1;STAMBPL1;USP7;RNF128;OGT;USP22;CCP110;TRAF3;KEAP1;WDR20;TGFBR1;NEDD8;SKP2;SUDS3;KDM1B;USP35;TRRAP;PTEN;FOXO4;CLSPN;USP13;USP19;CYLD;MAP3K7;TNIP2;RNF123;TFPT;ASXL1;STAM;PSMD4;PSMD3;MDM2
prerank,mitotic recombination (GO:0006312),0.5178571037307603,1.1412440217016235,0.2925877763328999,0.8724430049122246,1.0,8/15,26.75%,XRCC3;SMC5;SMC6;RAD50;TEP1;ERCC1;NSMCE2;RAD51D
prerank,anterior/posterior pattern specification (GO:0009952),0.435378363401418,1.1412302053807233,0.2740174672489083,0.8716435569873804,1.0,7/53,7.33%,HOXA3;WT1;PCSK5;BHLHE40;SKI;HOXA5;HOXA4
prerank,inner ear morphogenesis (GO:0042472),0.48766916911797537,1.141011686297439,0.30807453416149067,0.8715971082582492,1.0,5/22,13.67%,EPHB2;HPN;MYO3B;TTC39C;SIX1
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.3509835835543399,-1.1407271427032961,0.21341463414634146,0.6757630491511049,1.0,6/26,4.55%,NEDD4L;ATP1B3;ACTN2;DLG1;WWP2;CACNA1D
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.45213051202473875,-1.1404241631560759,0.2613240418118467,0.6741795664047578,1.0,4/10,30.71%,APPL2;CD300A;C3;TREM2
prerank,BMP signaling pathway (GO:0030509),0.4269630753050567,1.140236372812375,0.2673056443024494,0.8736864463574162,1.0,12/62,11.07%,AMH;TMEM100;TGFB3;TGFB2;SMAD4;ACVR1;BMP15;FAM83G;SMAD5;BMP8A;SMAD6;AMHR2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.570433857641067,1.1397769762688326,0.32167832167832167,0.8745843387973469,1.0,2/10,7.92%,GHR;STAT5A
prerank,N-terminal protein amino acid modification (GO:0031365),0.539201984654835,1.1395746615392124,0.32825484764542934,0.8745046798494736,1.0,6/14,21.61%,NTMT1;NAA15;NAA50;METAP2;METAP1;METAP1D
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4137508853467007,1.1389691534181512,0.26348547717842324,0.8758508138260241,1.0,13/85,5.88%,FGF18;FGF7;EGFR;HPN;SIX4;SRSF6;VEGFA;FGF2;TGFB2;FUT2;ZFP36L1;TCF7L2;NR1D1
prerank,response to lipid (GO:0033993),0.40720610340376845,1.1386957130456195,0.26337448559670784,0.8760038030525445,1.0,17/105,11.93%,LBP;ESR1;ANXA1;IRAK3;FOXP1;F2R;S100A8;S100A9;VPS4B;SOCS2;FOXO1;TIRAP;CYP27B1;TLR4;SMAD6;SLPI;IRAK1
prerank,organelle assembly (GO:0070925),0.3922069666729803,1.1386859668782214,0.111,0.8751778687264857,1.0,126/384,25.47%,CD34;GSN;NME8;CDC14B;RAB32;ABLIM1;PKD1;RAB23;RAB19;CHMP7;FHDC1;VPS4B;CENPT;FARP2;MVB12A;MAPRE3;UBAP2L;VPS37D;ARF4;STARD9;ACTR3;RC3H1;BICD1;HDAC6;LSM4;BBS9;ATXN2;ATAT1;ARL13B;PACS2;ATG2B;TMEM138;CPLANE1;HPS4;OCRL;EHD2;CNGB1;WIPI2;HDAC3;NUDCD3;STX12;HAUS3;WDR45B;DZIP1;NPM1;MAPRE1;TTC39C;AVIL;MAPT;TEKT5;PIBF1;ULK2;KIF3A;RAB43;DYNC2I2;ATG2A;ATP2A2;VPS37C;NCOR1;RPGR;KIF3B;ATXN2L;EIF2S1;IFT46;INO80;ULK1;TTLL3;BBS4;TTC8;TMOD2;DYNC1H1;ATP6V1D;KLHL41;AHI1;CENPC;DYNC2H1;ATG16L2;YTHDF2;YTHDF1;RAB1B;CEP164;VPS37B;AUP1;CEP89;CCDC28B;DYNC2I1;CEP83;ATG13;RP2;BBS5;CENPE;IFT52;NEK7;BBIP1;EXOC4;CC2D2A;SPAG16;FLNA;PCM1;ATG16L1;ATG3;VPS36;TUBGCP5;YTHDF3;EIF2A;PDCD6IP;DNAH5;FBF1;TMEM231;OGFOD1;ATG14;PDE6D;IST1;TCTN2;EDC3;RAB11FIP3;STAM;EMC6;DYNLL1;TCTN1;G3BP1;CDC14A;STX7;CEP126;NEK1;RAB1A
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5278649323350528,1.1386695179748405,0.3240371845949535,0.8743734612721996,1.0,7/13,27.76%,ZMIZ1;SMARCD1;PADI2;SERTAD2;ELOF1;ARID1A;ARID1B
prerank,protein modification by small protein removal (GO:0070646),0.39685649242827165,1.1386074547536027,0.17034068136272545,0.8737411458857817,1.0,80/252,24.50%,AR;ESR1;UCHL1;DESI2;DESI1;PSMC4;JOSD2;SMAD4;SMURF2;USP36;COPS5;OTUD3;FOXK2;ZRANB1;RAD23B;IL33;USP32;USP10;USP4;USP29;PSMC6;MDM4;OTUD1;UCHL5;ADRM1;PSMD8;SENP8;TOR1A;KAT2B;POLB;USP26;USP33;OTUD7B;ACTR5;TNIP1;USP48;USP50;UBA52;USP5;RHOA;ABRAXAS1;NFRKB;ZC3H12A;INO80;RCE1;STAMBPL1;USP7;RNF128;OGT;USP22;CCP110;TRAF3;SENP6;KEAP1;WDR20;TGFBR1;COPS4;NEDD8;SKP2;SUDS3;KDM1B;USP35;TRRAP;PTEN;FOXO4;CLSPN;USP13;USP19;CYLD;MAP3K7;TNIP2;RNF123;TFPT;ASXL1;STAM;PSMD4;SENP5;PSMD3;GPS1;MDM2
prerank,negative regulation of ossification (GO:0030279),-0.36083518644532603,-1.1384970139649901,0.26285714285714284,0.6771111448640657,1.0,7/23,14.02%,MEF2C;ENPP1;NOTCH1;SFRP1;MDK;SRGN;BCOR
prerank,positive regulation of response to stimulus (GO:0048584),0.4469639919135904,1.1379710119557171,0.3082191780821918,0.8753294269863005,1.0,9/40,18.68%,CD80;TGFB2;CDKN2AIP;CGAS;YPEL3;EEF1E1;FXR2;ILK;SELENON
prerank,positive regulation of lipid catabolic process (GO:0050996),0.5037021078547239,1.1377863414699498,0.31450577663671375,0.8751909643492117,1.0,5/19,18.98%,IRS1;IRS2;TWIST1;DAGLB;ANGPTL3
prerank,actin nucleation (GO:0045010),0.4890946322953555,1.1377555278305438,0.297029702970297,0.874460517837177,1.0,6/21,17.19%,SCIN;ACTR3;MAGEL2;ARPC5L;ARPC1A;ARPC2
prerank,membrane organization (GO:0061024),0.3957143976698019,1.1373171099465522,0.1843687374749499,0.8752347487320715,1.0,67/227,24.34%,STON2;AREG;TRIP10;EGFR;TIMM50;SYT2;DNM1;MOSPD3;BTC;ANK2;BIN1;CLTC;TMEM43;STX11;TOR1AIP2;REEP3;CHMP7;NUP93;TLCD2;VPS4B;MTCH1;AP2A2;MYADM;OSBPL2;AP3D1;SLC18A3;ACTR3;USO1;OCRL;TOR1A;SNAP23;EGF;NAPA;UBA52;SGCZ;CBL;GLTP;CHP1;FZD4;SPTBN1;ARPC1A;ACTG1;IGF2R;HACE1;NAPG;ARPC2;SYT1;VAMP2;VPS33B;CORO1C;ARRB1;CNTN2;COX18;AZIN2;CTTN;PDCD6IP;VAMP4;CCDC88A;TMEM33;PACSIN2;LDLR;PICK1;AP2M1;AGFG1;STAM;EMD;ITSN1
prerank,microtubule polymerization (GO:0046785),0.46359437015208504,1.1371025526327574,0.3225419664268585,0.8751929416423652,1.0,12/28,22.81%,FGF13;NDEL1;MAPT;TPPP3;SLAIN2;PIN1;MAP7D3;AKAP9;CKAP5;CLASP2;TUBGCP5;TUBG2
prerank,endochondral bone morphogenesis (GO:0060350),-0.4372532367655673,-1.1369484949345277,0.29850746268656714,0.678984375957917,1.0,7/11,16.55%,MEF2C;FOXC1;COL13A1;INPPL1;BMPR2;TRPV4;FGFR3
prerank,erythrocyte differentiation (GO:0030218),-0.2954520561913352,-1.136526624969531,0.20833333333333334,0.6777562068062541,1.0,11/44,13.67%,LYN;KMT2E;KIT;TGFBR3;HSPA9;CASP3;RPS14;INHBA;PTPN2;TAL1;HIPK2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.44745607864987086,1.1364629551203602,0.3052995391705069,0.8766920560849877,1.0,5/37,4.19%,IGFBP5;TGFB3;MMP2;FGF2;MEF2D
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.45614451147415247,1.136227978939547,0.30514285714285716,0.876711959629383,1.0,12/32,21.70%,CDC14B;TAOK3;RINT1;DTL;TAOK2;CDKN1A;ABRAXAS1;NBN;NOP53;BLM;DONSON;CLSPN
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.3701928459865737,-1.1361702491269619,0.265,0.6763968309660853,1.0,7/21,12.95%,ADCY5;ADCY1;GUCY1B1;ADCY4;ADCY9;NPR1;GUCY1A1
prerank,protein palmitoylation (GO:0018345),0.46733696493188537,1.136073169984891,0.2980997624703088,0.8764376013480102,1.0,13/30,23.66%,ZDHHC16;ZDHHC7;HHAT;SELENOK;ZDHHC2;ZDHHC4;ZDHHC24;ZDHHC21;ZDHHC20;CLIP3;ZDHHC18;ZDHHC8;ZDHHC5
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.32883321021674555,-1.1358791075193468,0.21739130434782608,0.6748959920351681,1.0,7/32,7.56%,INSR;IGF1;APP;PRKAA2;PPARA;PINK1;ENO1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.5283676251707493,1.1357088648568614,0.30482758620689654,0.8769601317370094,1.0,4/14,13.51%,IRS1;AKT1;IRS2;TWIST1
prerank,aorta morphogenesis (GO:0035909),-0.376182200901137,-1.1351796538482914,0.29385964912280704,0.6745334952670874,1.0,6/17,9.55%,MYLK;ADAMTS9;ENG;TBX1;PDGFRB;TBX2
prerank,cellular response to organic substance (GO:0071310),0.4050043222961255,1.1349978358843031,0.24514811031664965,0.8788045060397228,1.0,27/116,18.83%,GHR;IGFBP5;UCP1;CLEC3B;MAPK7;SLIT3;SLIT2;TGFBR2;ACVR1;SOCS2;NCOA3;PID1;HDAC6;CDK9;INPP5K;URI1;AMHR2;FLT3;RHOA;KLF4;STAT5B;CXCR4;HTRA2;PTPN5;TGFBR1;IL18;CYP1B1
prerank,mRNA processing (GO:0006397),0.3926530928894353,1.1346914939878878,0.169,0.879096919215019,1.0,112/287,29.09%,GEMIN6;SRSF2;POLR2H;CD2BP2;HNRNPA1;GTF2H3;SRSF6;DHX16;RBM4;ZCRB1;DDX42;LSM4;PRPF4;U2AF1;SRSF3;TFIP11;PRPF3;GPATCH1;CPSF6;USP39;AURKAIP1;HNRNPD;RBM22;DNAJC8;SNRPB2;SON;ERN1;TCERG1;HNRNPH1;DHX8;CPSF4;RBM17;PRPF40A;SRSF11;THOC7;ERCC3;POLR2D;POLR2G;SNU13;CCNH;HNRNPA3;POLDIP3;AQR;THOC2;THOC1;GTF2F1;ZCCHC8;SF3B4;ZC3H11A;CMTR2;BCAS2;SF3A1;PHF5A;CPSF2;SNRPA;DDX5;SNRPG;SNRPD3;PNN;SNIP1;SRRM1;RBM6;PDCD7;DDX39A;PUF60;PRCC;GCFC2;HNRNPUL1;LSM7;U2AF2;ZMAT5;NOVA1;PTBP1;ELAVL2;SF3B2;SF3B1;AKAP8L;KIN;GPKOW;PRPF38A;RNMT;RBM5;CSTF2T;SNRPA1;CPSF7;CPSF1;RALY;POLR2C;RAMAC;PABPN1;WDR33;CWC27;ALYREF;RBMX;UPF3B;PPIH;USP49;CRNKL1;PRPF19;PRPF6;CELF1;LSM5;THOC5;CPSF3;CDC40;WDR83;RBM15;HNRNPC;SNRPC;WBP11;SRSF5;TBRG4
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.4802889229634899,1.1345925037648035,0.3313032886723508,0.8786078236507555,1.0,5/24,12.60%,SEMA3C;VEGFA;SEMA3A;DSCAM;SEMA3D
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.427061738159652,1.1344829847815443,0.2941810344827586,0.8781692510408909,1.0,20/54,28.21%,SYK;SPATA2;CARD16;PELI3;GAS6;CHUK;SPPL2B;NLRP2B;RBCK1;MADD;TAX1BP1;CLIP3;PYCARD;CPNE1;CYLD;UBE2K;RNF31;OTULIN;CASP8;LAPTM5
prerank,dicarboxylic acid transport (GO:0006835),-0.3252515777138805,-1.1344790878368343,0.22077922077922077,0.6740237750312794,1.0,6/28,7.43%,SLC1A3;SLC13A3;SLC26A7;PDPN;SLC22A6;GJA1
prerank,dendritic spine organization (GO:0097061),0.4664537817740303,1.1344107905575422,0.32521315468940315,0.8775810549246629,1.0,11/26,23.16%,EPHB2;FYN;DLG4;EPHB3;ARF1;CTNND2;DIP2A;CHRNA7;EPHB1;PTEN;PICK1
prerank,regulation of cytoskeleton organization (GO:0051493),0.4108785302603259,1.1338946330899626,0.2752577319587629,0.8786120634923066,1.0,22/108,15.05%,PHLDB1;CDK2AP2;CORO2B;LRP1;ARHGAP44;EFNA5;EPHA3;CAPN2;S100A8;S100A9;SORBS3;MTOR;FSCN1;BICD1;IQGAP1;RHOQ;MAPT;TAOK2;MAP6;RHOA;RND3;DIAPH1
prerank,negative regulation of protein phosphorylation (GO:0001933),0.40210491198346404,1.1335026269922432,0.22828282828282828,0.879221337282068,1.0,38/150,16.22%,EPHB2;LRP6;NIBAN1;TARBP2;LDLRAD4;DGKQ;SLIT2;PMEPA1;CAMK2N1;WWTR1;PLPP3;DTNBP1;RTRAF;RASSF2;TARDBP;MYADM;YWHAG;MLXIPL;PID1;PIP5KL1;SIRT2;GSKIP;SIRPA;SMAD6;INPP5K;AKT1;PPEF2;PDE4D;CALM2;DEPTOR;SFN;SMCR8;TWIST1;ZC3H12A;CHP1;NLRP2B;NCK1;CEP85
prerank,connective tissue development (GO:0061448),0.44462391169324467,1.1332751214125052,0.3222094361334868,0.8792143933034495,1.0,8/35,10.29%,CD44;SULF2;SLC39A13;PKD1;SULF1;SOX8;SOX5;COL2A1
prerank,positive regulation of cell communication (GO:0010647),0.4658138999770621,1.1328180694289558,0.3233890214797136,0.8800621187559943,1.0,11/28,23.22%,CD80;CDKN2AIP;DLG4;HCRT;LGI1;SYT1;ILK;RIMS2;CLSTN3;NMU;GRIK2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.49440505785660516,1.132660445866934,0.34615384615384615,0.8797837218333684,1.0,10/20,17.93%,CAMK2D;PACS2;PSEN1;HERPUD1;SELENOK;BAK1;THADA;ATP2A2;PML;BCAP31
prerank,synaptic membrane adhesion (GO:0099560),0.5123469200970139,1.1326560182511916,0.321285140562249,0.878963195506027,1.0,3/14,6.77%,GPC6;PTPRS;PTPRF
prerank,positive regulation of lipid localization (GO:1905954),0.5438989238344086,1.132444382873398,0.33060109289617484,0.8789110368099992,1.0,2/11,13.85%,LRP1;ZC3H12A
prerank,positive regulation of secretion (GO:0051047),0.5485439992074786,1.1319946427976626,0.32716927453769556,0.8798003304916986,1.0,3/11,19.41%,SCIN;TRH;GPLD1
prerank,glycoprotein biosynthetic process (GO:0009101),0.4158280711286828,1.1317137899788736,0.27713382507903056,0.8800004223748387,1.0,17/79,12.02%,ST3GAL2;B3GALNT1;CSGALNACT2;FUT2;CHST10;TMEM106A;MGAT1;GAL3ST3;CHST12;FOXL1;XYLT1;ALG1;LARGE1;FUT9;B3GNT8;TNIP1;ST3GAL4
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5448107532624882,1.1316532828965027,0.3324022346368715,0.8793503650563467,1.0,5/12,19.99%,TMEM9;VPS33A;CCDC115;TMEM165;TMEM199
prerank,triglyceride biosynthetic process (GO:0019432),0.5053054732518198,1.1312721091388243,0.32188295165394404,0.8799472398159308,1.0,6/18,20.27%,GPAT4;MOGAT1;MOGAT2;GPAT3;GPAM;LPIN3
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.34721565332145593,-1.1311656533258612,0.2974683544303797,0.6803712918874316,1.0,10/29,12.83%,ACSL1;ELOVL7;ACSL4;HACD1;ACSL3;CBR4;HACD2;ACSL6;SCD;ELOVL1
prerank,positive regulation of exosomal secretion (GO:1903543),0.5182102251785214,1.1311141723707416,0.3346774193548387,0.8797188498029878,1.0,6/15,26.11%,SMPD3;VPS4B;PDCD6IP;SDCBP;STAM;SDC4
prerank,vasodilation (GO:0042311),0.533680398061377,1.1309388307470745,0.35013623978201636,0.8795268922838994,1.0,2/13,5.00%,KCNMA1;KLF2
prerank,positive regulation of cellular metabolic process (GO:0031325),0.4052864431736469,1.1308838257504048,0.2589928057553957,0.8788769875454523,1.0,28/98,21.79%,SFRP4;HPN;ANXA2;VEGFA;LIPT2;TGFBR2;MAPK14;ACLY;PID1;DHRS4;INPP5F;ECE1;EGF;AKT1;MAGI2;CDKN1A;ZC3H12A;KLF4;IL4;GHITM;NSF;AHI1;RAB1B;ATAD1;PRELID1;RNF41;ARRB1;CSF1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.4194002743340154,1.1307201305431493,0.26652452025586354,0.8785774817682138,1.0,20/66,22.76%,LIF;EIF2AK3;ZPR1;PIK3R2;WWTR1;MEPCE;PSEN1;RBM22;HDAC3;AKT1;JUP;CCT7;ZC3H12A;DMAP1;IPO5;FLNA;BAG3;LARP7;SESN2;TPR
prerank,axonal fasciculation (GO:0007413),0.5280895998423536,1.1304769034826676,0.3427835051546392,0.8786393438661989,1.0,3/12,9.69%,EPHB2;EPHA3;EPHB3
prerank,cell-substrate junction assembly (GO:0007044),-0.3349664228858023,-1.1304626138110798,0.2463768115942029,0.6799064468703371,1.0,7/33,6.00%,PTPRK;SORBS1;ACTN2;ITGA6;THSD1;ITGB4;PIP5K1A
prerank,cellular response to misfolded protein (GO:0071218),0.49516239483715824,1.12971652886943,0.3181242078580482,0.8805677485020444,1.0,10/20,26.70%,STUB1;UBE2W;CUL3;TOR1A;AUP1;UGGT1;DERL1;UFD1;RNF126;UGGT2
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.35183376551043144,-1.129641802137801,0.26666666666666666,0.679862610219991,1.0,4/23,6.77%,TPM1;ADAMTS9;TGFBR3;FGFR2
prerank,histone H3 deacetylation (GO:0070932),0.5168283399697372,1.1292673256274957,0.32266666666666666,0.8814075587632569,1.0,5/15,16.32%,HDAC9;SIRT2;HDAC3;HDAC4;PER1
prerank,translesion synthesis (GO:0019985),0.4350683567883544,1.1291702809950837,0.3082872928176796,0.8809241515785613,1.0,17/42,28.52%,REV3L;POLDIP2;USP10;ZBTB1;DTL;POLI;UBA52;PCLAF;RFC4;POLD1;FAAP20;REV1;POLH;UFD1;POLE2;NPLOC4;RFC3
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.4865210009091208,1.1284711944041461,0.32230392156862747,0.8818416747826655,1.0,9/22,22.97%,ZDHHC7;ZDHHC2;ZDHHC4;ZDHHC24;ZDHHC21;ZDHHC20;CLIP3;ZDHHC18;ZDHHC8
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.4865210009091208,1.1284711944041461,0.32230392156862747,0.8818416747826655,1.0,9/22,22.97%,ZDHHC7;ZDHHC2;ZDHHC4;ZDHHC24;ZDHHC21;ZDHHC20;CLIP3;ZDHHC18;ZDHHC8
prerank,xenobiotic transport (GO:0042908),-0.3873232613568528,-1.1281814055358617,0.2702702702702703,0.681265528667783,1.0,7/17,18.18%,ABCG2;SLC7A5;SLC22A4;GJA1;ABCA3;SLC22A2;SLC22A18
prerank,purine ribonucleotide metabolic process (GO:0009150),0.41805904129119237,1.1280033724039311,0.27983104540654696,0.882666135809537,1.0,16/68,22.54%,GNAI3;GPAT4;AMPD2;RAB23;ACLY;ACOT6;BPNT2;RHOQ;ACOT9;ACOT1;SULT4A1;ABHD14B;ACAT1;TPST2;CROT;ADSS2
prerank,base conversion or substitution editing (GO:0016553),0.5469081235998723,1.127644695755427,0.33379888268156427,0.8831571381509625,1.0,2/11,11.81%,ADARB1;NUDT16
prerank,positive regulation of viral transcription (GO:0050434),0.46726941807133743,1.127507932888013,0.34349355216881594,0.8828196024273663,1.0,7/25,14.84%,POLR2H;MDFIC;CDK9;POLR2D;POLR2G;CTDP1;GTF2F1
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.46892471202654956,1.1274660522838917,0.33755760368663595,0.8813012254476507,1.0,7/29,21.97%,GPAT4;ACLY;ACOT6;ACOT9;ACOT1;ACAT1;CROT
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.46892471202654956,1.1274660522838917,0.33755760368663595,0.8813012254476507,1.0,7/29,21.97%,GPAT4;ACLY;ACOT6;ACOT9;ACOT1;ACAT1;CROT
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3345103914597016,-1.1273275819692588,0.2534246575342466,0.6812740922993517,1.0,6/27,9.08%,SLC7A2;SLC1A3;SLC7A5;SLC6A9;SLC3A2;SLC38A5
prerank,glycogen metabolic process (GO:0005977),-0.33939804229641735,-1.1267047186738892,0.2754491017964072,0.6804701022820498,1.0,6/27,5.34%,PRKAG2;PHKB;PYGM;GBE1;AGL;GYS1
prerank,regulation of neuron death (GO:1901214),0.4124728603663556,1.1266384649495629,0.29035639412997905,0.8835879817809515,1.0,21/82,20.21%,CD34;SNCB;FYN;KIR3DL2;EGLN2;AKT1;MAPT;GPNMB;CD200R1;NSMF;TNFRSF1B;EIF2S1;DCC;CHP1;HTRA2;CHRNA7;FAIM2;SARM1;EPHB1;RRAS2;ITGAM
prerank,glycerol metabolic process (GO:0006071),0.5514912081107783,1.1261948773214874,0.3393854748603352,0.8843952493275323,1.0,6/10,28.79%,GK5;COQ3;ANGPTL3;GOT1;COQ2;PGP
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.489007596497644,1.1261669032919386,0.3092909535452323,0.8836635396100676,1.0,2/22,8.46%,CD55;ZBTB1
prerank,response to copper ion (GO:0046688),0.4958822327951161,1.126021632900297,0.32170542635658916,0.8833592170697777,1.0,1/20,0.84%,LOXL2
prerank,negative regulation of signal transduction (GO:0009968),0.38984922592449694,1.1258371400656566,0.194,0.8832278893970846,1.0,38/249,11.64%,SFRP4;DCN;IGFBP5;TNMD;SRMS;EGFR;LRP1;IRS1;GPC3;GRB10;SULF2;DACT3;IRAK3;FGF2;TNS2;TMBIM1;GLIS2;ACVR1;DACT1;CREB3L1;PTPRJ;NFATC1;BEND6;CARD16;SULF1;PID1;NTN1;NDRG4;SIAH1;PALM;INPP5K;CD47;TSKU;KANK1;GLI3;EGF;AKT1;SLC2A10
prerank,GPI anchor biosynthetic process (GO:0006506),0.4589874016090951,1.125361639502959,0.30906921241050117,0.884141277135357,1.0,9/30,14.88%,PIGT;GPAA1;PIGZ;PIGC;MPPE1;PIGW;PIGS;PIGK;PIGM
prerank,cellular response to growth factor stimulus (GO:0071363),0.40035025514844536,1.1252927494804912,0.2383838383838384,0.8835610878208502,1.0,41/151,16.96%,HAS2;HAS1;WNT2;TMEM100;EGFR;ANXA1;CLEC3B;CD44;GAS1;MAPK7;VEGFA;PDE8A;TGFBR2;SMAD4;ZPR1;ZFP36L1;MAPK14;ACVR1;MAP2K3;PRKD2;ZFP36L2;SOX5;SIRT2;SYAP1;IQGAP1;INPP5K;ERN1;URI1;AMHR2;AKT1;MAPT;MAGI2;KIDINS220;ZFP36;KLF4;RAPGEF1;SNAI2;STAT5B;HGF;RAB35;HTRA2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.4534139812739479,1.1252674533952065,0.32171893147502906,0.8828389949675506,1.0,8/33,21.82%,MN1;PKD1;ATP2B4;CDKN1A;INO80;PTEN;PAF1;EZH2
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.3825913795913667,-1.1249818600258525,0.2985781990521327,0.6828957026653298,1.0,15/16,47.64%,CEACAM1;CYRIB;PTPRC;AGER;LILRB1;FADD;IL12A;IL12RB1;IL23A;KLRD1;IL12B;IL23R;RIPK3;KLRC1;XCL1
prerank,protein depolymerization (GO:0051261),0.4679141930663257,1.124784103370827,0.3325301204819277,0.8837972079720177,1.0,8/27,20.20%,GSN;VPS4B;KIF2A;TWF1;MICAL2;CKAP5;MICAL1;STMN4
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.41339235602587926,1.124533061566729,0.2828389830508475,0.8838458373118289,1.0,19/70,18.87%,ANTXR1;TMEFF2;ITGB3;NTN4;RADIL;DACT2;MEGF9;ARL13B;SRCIN1;EPHB3;ITGAV;ATRN;UNK;RHOA;FER;YTHDF2;SRGAP2;ILK;LAMC1
prerank,T cell mediated immunity (GO:0002456),0.5249967584868249,1.1243176031824396,0.3510928961748634,0.8838122537642172,1.0,3/13,15.21%,CD55;JAG1;BTN3A3
prerank,endothelial cell differentiation (GO:0045446),0.5405297857920948,1.1240473598826617,0.34346103038309117,0.883938317040351,1.0,2/12,8.47%,FSTL1;JAG1
prerank,regulation of necroptotic process (GO:0060544),0.4764436305571793,1.124022229284713,0.3373934226552984,0.8832066126870682,1.0,10/23,23.17%,SPATA2;STUB1;SLC25A4;HSP90AA1;OGT;FLOT2;PDCD6IP;SDCBP;FLOT1;CYLD
prerank,cellular response to nitrogen compound (GO:1901699),0.49154594213933833,1.123997200780769,0.3147208121827411,0.8824771645335685,1.0,10/20,30.27%,ATP2B4;EPG5;DDX11;SPIDR;BLM;NSMCE3;RIOK3;ATRX;PDE12;HSF1
prerank,regulation of microtubule depolymerization (GO:0031114),0.46861462469892007,1.1239321017811845,0.3304878048780488,0.8819109056865161,1.0,7/25,21.77%,MAP1B;FGF13;CAMSAP1;NAV3;CLASP2;MAP1A;MAP1S
prerank,striated muscle tissue development (GO:0014706),-0.33551648719343696,-1.1234410567649757,0.23255813953488372,0.6846215457269244,1.0,8/29,9.55%,BMP5;PGM5;MEF2C;BMP7;RBP4;CAV1;BMPR2;TBX2
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.4746388401700672,1.1232649664330803,0.32971014492753625,0.8834736982947266,1.0,5/22,13.05%,GTF2H3;RAD23B;ERCC3;UBA52;DDB1
prerank,positive regulation of histone deacetylation (GO:0031065),0.5403297645152432,1.122886170913485,0.3356258596973865,0.8841011612837824,1.0,6/12,21.20%,VEGFA;PRKD2;AKAP8;NIPBL;CTBP1;AKAP8L
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.5307542907762827,1.1224655151998093,0.3543956043956044,0.8849300998482778,1.0,3/13,10.81%,B3GALNT1;GAL3ST3;B3GNT8
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.4314620390232406,1.1222777763826328,0.3169642857142857,0.8847703540179693,1.0,9/46,11.99%,ADAMTS5;WNT10B;DOCK7;NR1D1;LNPEP;FLCN;FOXC2;TLR4;PGAM5
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.42626149716593054,1.1221164144834082,0.2960954446854664,0.8845231966369317,1.0,18/46,24.14%,ZPR1;PIK3R2;TCF7L2;GAS6;YWHAE;PSEN1;CPSF6;RBM22;HDAC3;JUP;ANP32B;ZC3H12A;DMAP1;IPO5;FLNA;BAG3;TPR;EMD
prerank,macromolecule catabolic process (GO:0009057),0.465527028605874,1.121981724377168,0.3154034229828851,0.8841781395507835,1.0,10/26,24.04%,MTOR;MVB12A;TPP1;CLPX;SIAH1;IDE;LRSAM1;SMURF1;USE1;TRIM24
prerank,modification-dependent protein catabolic process (GO:0019941),0.3949854069713793,1.121739076933881,0.23671013039117353,0.8842428545416234,1.0,74/193,26.14%,UBE2B;SPSB1;SPSB4;UBA6;SMURF2;SYVN1;ITCH;RBBP6;RNF111;SPSB2;RC3H1;STUB1;WDR91;MYLIP;ADRM1;SIAH1;CUL3;DTL;FBXW4;UBE2G2;USP33;SQSTM1;HERPUD1;CDC23;ANAPC5;RNF7;UBE2A;CDC34;UBA52;NDFIP1;DDB1;CDC27;CBL;UBR4;AMFR;RNF128;TRPC4AP;RNF14;KEAP1;HACE1;CDC26;NTAN1;UBE2G1;FBXO11;ANAPC4;ARIH2;UBE2R2;NEDD8;RNF19A;TOLLIP;KCTD21;UBE3C;ARIH1;KCTD6;KCTD10;ANAPC10;ARRB1;RC3H2;SMURF1;ANAPC15;RNF6;RNF114;RNF13;UBQLN4;PSMD3;MDM2;RNF166;FBXO22;UFD1;RNF20;ANAPC2;UBE2K;RNF167;RNF126
prerank,leukotriene biosynthetic process (GO:0019370),-0.42152837406365873,-1.1208188406682353,0.2581967213114754,0.6895318865329663,1.0,9/14,33.48%,GGT5;GGTA1;MGST3;GGT1;PLA2G4A;MGST2;ALOX5;PLA2G5;ALOX5AP
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.4702905173745329,1.1207845795410836,0.34782608695652173,0.8869233434463736,1.0,7/25,13.03%,ANK2;FGF13;DSC2;CAMK2D;HCN4;JUP;ATP2A2
prerank,regulation of dendritic spine development (GO:0060998),0.494326268674633,1.1207336439116433,0.32124352331606215,0.8863006146045752,1.0,7/19,14.95%,PTPRS;PPFIA2;GRIN3A;PSEN1;TANC2;LLPH;ARF6
prerank,neuron projection organization (GO:0106027),0.5104505568068219,1.1206924490513301,0.3526315789473684,0.8856175594585556,1.0,8/15,23.16%,DCTN1;ATP1A3;PSEN1;ARF1;PLS1;CHRNA7;MAP1A;PICK1
prerank,organic hydroxy compound transport (GO:0015850),-0.32156646779235143,-1.1204904182250561,0.2900763358778626,0.6881471659738642,1.0,9/36,12.25%,ABCC4;SLCO2B1;SLCO1C1;RBP4;SLC5A3;STRA6;NCOA1;CEACAM1;OSBP
prerank,neuron remodeling (GO:0016322),-0.4534125050047991,-1.1204285467835406,0.3356401384083045,0.6860387388080595,1.0,7/10,23.82%,APP;EPHA8;ANKS1A;CX3CL1;C1QA;SCARF1;C3
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.49363249485825567,1.120286666951951,0.3354673495518566,0.8862076199936443,1.0,5/19,15.09%,THBS4;C1QBP;TIRAP;MCU;IL4
prerank,mRNA catabolic process (GO:0006402),0.4376882879842493,1.1199460176183773,0.31483578708946774,0.8866338721328504,1.0,19/44,28.97%,DIS3L2;RC3H1;ZFP36L2;NUDT16L1;ERN1;NUDT16;ZFP36;CNOT10;DDX5;AGO4;YTHDF2;SUPV3L1;AGO3;THRAP3;EXOSC10;UPF1;LSM5;AGO1;PDE12
prerank,cellular response to acid chemical (GO:0071229),0.4657759340661537,1.1199441302361515,0.3285198555956679,0.8858262328385265,1.0,10/27,23.18%,CAPN2;VEGFA;KLF2;MTOR;NSMF;RRAGD;CPEB1;IPO5;SESN2;SLC38A9
prerank,neural crest cell differentiation (GO:0014033),0.49521400993729736,1.1195022110079964,0.3410553410553411,0.8866638992387431,1.0,4/18,15.05%,LRP6;SOX8;NOLC1;SNAI2
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.4082331092540636,1.1194312940407778,0.2848167539267016,0.8861024606463571,1.0,30/88,21.31%,AP1G2;AP4B1;CLTC;LLGL1;ACBD3;AP1M1;DTNBP1;SCAMP3;MYO5A;CLVS2;STX4;SCFD1;ARF1;SNAP23;AP4E1;AP1S2;PUM1;NAPA;AP4M1;CORO7;GOPC;SORCS1;VAMP2;RP2;EXOC4;CLVS1;SH3D19;RAB10;ARRB1;AP1S3
prerank,"base-excision repair, gap-filling (GO:0006287)",0.44300800658122297,1.119159062819936,0.3170441001191895,0.8862667758131048,1.0,3/35,10.07%,MPG;POLB;PARG
prerank,negative regulation of wound healing (GO:0061045),0.4611652626025099,1.1189805017021328,0.3277310924369748,0.8860563647412243,1.0,2/28,2.82%,CD34;FGF2
prerank,inositol phosphate-mediated signaling (GO:0048016),0.49213183937994237,1.1189071077573445,0.34580645161290324,0.8855394628806381,1.0,6/19,19.43%,PLCE1;NFATC4;NFATC1;PPP3CC;PPP3CA;PPP3CB
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.40310530124883953,1.1188235317435662,0.2876288659793814,0.8850473577779406,1.0,23/93,17.17%,LIF;EGFR;CD44;VEGFA;MIF;AXIN1;ATP2B4;DOCK7;RASSF2;PFN2;MLXIPL;HDAC6;PRKD2;GAS6;INPP5K;AKT1;PDE4D;TNKS1BP1;HSP90AA1;NLRP2B;NCK1;IL6;AKAP9
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5505498618912066,1.1184282880966465,0.37393767705382436,0.8856331089101792,1.0,2/10,8.71%,LOXL2;SOX5
prerank,regulation of protein localization to nucleus (GO:1900180),0.4323160641071796,1.118335161572002,0.3262092238470191,0.8851497502578981,1.0,8/43,15.63%,LIF;EIF2AK3;WWTR1;FLCN;OTUD7B;AKT1;PIN1;ILRUN
prerank,axon development (GO:0061564),0.41069298896566553,1.118285698942158,0.2927835051546392,0.8845033743438145,1.0,30/78,26.99%,EPHB2;MAP1B;GAP43;LLGL1;ZPR1;DOCK7;S100A6;EPHB3;L1CAM;PLP1;MAPT;MTR;TAOK2;RTN4RL1;DCC;SHTN1;CNTN4;RAB10;SLITRK4;MAP1A;MAP1S;SPTBN4;NTNG2;RTN4;MARK2;ATL1;PAX2;NRCAM;SLITRK5;PAK3
prerank,regulation of ERBB signaling pathway (GO:1901184),0.509667735156411,1.1181941334950776,0.35117493472584854,0.8840500877127171,1.0,5/15,14.48%,EGFR;RHBDF1;MVB12A;EGF;FER
prerank,cell part morphogenesis (GO:0032990),0.5267927680610828,1.1181200556958777,0.35685752330226367,0.883521980356412,1.0,7/13,24.79%,WASF1;PID1;MYH14;SUPV3L1;PACSIN2;FIS1;MTM1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.42115363667184447,1.118030861135767,0.28540540540540543,0.8830370093765363,1.0,13/56,13.57%,EGFR;ANXA1;RAD51B;CDK4;VPS4B;CUL3;DTL;CDC23;AKT1;FBXO5;ANAPC5;CDC27;CCND1
prerank,negative regulation of cartilage development (GO:0061037),0.5219067908133547,1.1176970382458273,0.33986928104575165,0.8834335156966041,1.0,5/13,18.08%,WNT9A;CHADL;SNAI2;EFEMP1;TGFBR1
prerank,retinol metabolic process (GO:0042572),0.5136596813172725,1.1173332978885355,0.33877551020408164,0.8839898283713182,1.0,1/14,0.75%,DHRS9
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.5326046271591411,1.117189420004365,0.35492957746478876,0.8837011813504012,1.0,5/12,18.81%,FOXP1;TIRAP;TLR4;KLF4;MBP
prerank,NAD biosynthetic process (GO:0009435),-0.369010229753897,-1.1171091364845784,0.3088235294117647,0.6926931296179365,1.0,7/20,17.09%,NAMPT;PTGS2;PTGIS;PARP10;NUDT12;NMNAT3;PARP9
prerank,positive regulation of T cell activation (GO:0050870),0.41807269183784845,1.1170788615145213,0.31939978563772775,0.883291347679,1.0,11/62,16.45%,CD80;ANXA1;ZMIZ1;CD81;ZBTB1;SIRPA;CD47;IL4;NCK1;FLOT2;IL6
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.49898733533049794,1.1168848204830526,0.3550446998722861,0.8831595648631927,1.0,1/18,0.19%,TNFSF9
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.5200248770144863,1.1168378218590282,0.3550065019505852,0.8825280826001931,1.0,2/13,6.96%,ZC3H8;GLI2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.5335353811152171,1.1166254969978548,0.34642356241234223,0.8824548563198332,1.0,3/11,10.44%,CD44;SRC;KANK1
prerank,hemopoiesis (GO:0030097),0.4064768760971139,1.1164331972983437,0.30218068535825543,0.8823407567260668,1.0,11/87,8.47%,CD34;MFAP5;WNT10B;RUNX1;TGFB2;TGFBR2;FLCN;FLT3LG;ZFP36L2;TIRAP;JAG1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4232832987914157,1.1155811421102506,0.31798245614035087,0.8845202032631292,1.0,20/52,24.63%,EPHB2;GPSM2;EGFR;LRP1;EPHA3;ATP2B4;STX4;SQSTM1;AKT1;ARF6;SPTBN1;PLS1;STX3;CLIP3;NUMA1;STAC3;EPB41L2;ZDHHC8;ZDHHC5;CNPY4
prerank,regulation of secretion by cell (GO:1903530),0.42450619254127675,1.115027638832793,0.3267543859649123,0.8856985832290178,1.0,20/54,26.97%,ANXA1;DISP1;LLGL1;RHBDF1;SCG5;STX4;RAB3D;HCRT;P3H1;NSF;SYT1;VAMP2;RIMS2;RALA;RAB10;RAB12;STXBP5L;RAB3C;VAMP3;RAB8B
prerank,protein O-linked glycosylation (GO:0006493),0.4065232384650846,1.1148458141734172,0.28955532574974147,0.8855479499151471,1.0,28/96,23.84%,PLOD2;ST3GAL2;GALNT16;C1GALT1;POFUT2;POMGNT2;GALNT10;MUC1;GALNT18;OGA;PLOD3;LARGE1;B3GNT8;GALNT1;ST3GAL4;OGT;B3GALNT2;ST3GAL3;ST3GAL1;GALNTL6;PLOD1;MGAT5B;CRPPA;TMTC3;GXYLT1;POGLUT2;DPM2;GALNT4
prerank,negative regulation of locomotion (GO:0040013),-0.42744979880805134,-1.114663636678933,0.31851851851851853,0.6969368441213057,1.0,4/12,16.44%,FRMD5;CCDC125;PTPN2;SPINT2
prerank,actin filament depolymerization (GO:0030042),0.5383341174245969,1.114487760573318,0.358356940509915,0.8860043719337285,1.0,3/11,11.32%,GSN;TWF1;MICAL2
prerank,regulation of phospholipase C activity (GO:1900274),0.5164142417067673,1.1140195400312705,0.35656836461126007,0.8868655869462361,1.0,5/15,7.51%,ESR1;FGFR1;FGF2;BICD1;ABL2
prerank,diterpenoid metabolic process (GO:0016101),0.42484870217316534,1.1139656336642123,0.3114754098360656,0.8862778279612717,1.0,5/55,5.71%,AKR1B1;LRP1;GPC6;GPC3;ALDH3A2
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.34457988142551965,-1.1139453532975372,0.25625,0.6966345690240099,1.0,10/25,24.24%,TMTC2;SNCA;CAV1;CNNM2;KCNA1;JPH2;MT3;ANK3;CIB2;GRIN1
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.40654715610863407,1.113916014070439,0.3176593521421108,0.8856607738315736,1.0,29/82,27.05%,DCTN1;ODF2;ATF5;YWHAG;SSNA1;YWHAE;ALMS1;HAUS3;NPM1;MAPRE1;SFI1;HSP90AA1;DYNC1H1;TUBB4A;TUBA4A;CDK5RAP2;CCP110;AKAP9;CEP164;CKAP5;PAFAH1B1;PCM1;DCTN2;NEDD1;DYNLL1;CEP78;ACTR1A;CSNK1E;CETN2
prerank,response to metal ion (GO:0010038),0.40858935749225833,1.1137666536030992,0.3097534833869239,0.8853800471334274,1.0,11/67,12.36%,LOXL2;KCNMA1;SNCB;ADAM9;CRIP1;SEC31A;SLC11A2;MTF1;PPP5C;MAPT;CALM2
prerank,response to axon injury (GO:0048678),0.48566690277223445,1.113728427057875,0.3464052287581699,0.8847242171023966,1.0,9/18,29.58%,GAP43;FLRT3;MTR;RTN4RL1;SARM1;MORN4;P2RX4;DHFR;MAPK8IP3
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.4682622481432649,1.1134639116711211,0.3374083129584352,0.8848278756943228,1.0,8/25,18.86%,ARHGAP44;SLIT2;PFN2;KANK1;CEP97;CCP110;EVI5L;ODF2L
prerank,positive regulation of neurogenesis (GO:0050769),-0.27617475067819586,-1.1133848724011466,0.18181818181818182,0.6959506608970646,1.0,21/68,14.59%,PLXNA2;ROBO1;CUX1;PLXNA4;PTPRD;CDKL5;SHANK3;TGM2;PLXND1;ROBO2;NUMB;PLXNB1;CX3CL1;NTRK2;SS18L1;SMARCD3;SLITRK1;CUX2;TRIM32;CTNNB1;GPER1
prerank,lysosome localization (GO:0032418),0.4397798932876403,1.1133540451619057,0.3337250293772033,0.8843853609586702,1.0,13/37,22.62%,NDEL1;HDAC6;FLCN;VPS33A;MAP6;HPS6;BLOC1S2;SNAPIN;PIP4P1;KXD1;VPS33B;PIK3CG;BORCS6
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3895633848985963,1.1132961043245024,0.2891809908998989,0.8838098464419468,1.0,25/142,17.93%,ACKR3;CD55;ESR1;C1QTNF1;LPAR3;NPTN;PLCE1;F2R;DLG4;LPAR1;ATP2B4;ABL2;ADCYAP1;YWHAE;ACKR4;CALCA;SLC35G1;PDGFRA;ADCY8;SLC8A2;CXCR4;IAPP;ATP2B1;CXCR2;BCAP31
prerank,glutathione metabolic process (GO:0006749),0.43380404439628806,1.112707230252974,0.3468208092485549,0.8850747936052478,1.0,8/38,14.28%,GCLC;DPEP1;HAGH;CNDP2;GPX1;GSTM2;NAT8;GGT7
prerank,regulation of hippo signaling (GO:0035330),-0.3790742615138496,-1.1125093097256722,0.31877729257641924,0.6960066821754624,1.0,9/17,18.57%,MOB3B;VGLL4;WTIP;WWC1;MARK3;AJUBA;SOX11;WWC2;NF2
prerank,regulation of protein phosphorylation (GO:0001932),0.38756359391468237,1.1123709644187751,0.19119119119119118,0.8855120766536948,1.0,78/256,23.19%,EPHB2;LRP6;FGF18;NIBAN1;FGF7;EGFR;EFNA5;TMEM119;NPTN;EIF2AK3;PLCE1;CCDC88C;ITGB3;FYN;VEGFA;FGF2;PDE8A;SLIT2;WWTR1;PLPP3;AXIN1;TARDBP;MYADM;PID1;PIP5KL1;FLCN;GAS6;SIRPA;HDAC3;INPP5K;TWF1;MUSK;NPM1;CAMKK2;AKT1;CEBPB;KRAS;GPNMB;PIN1;CCND1;ZC3H12A;AKAP8;WDFY2;FER;HSP90AA1;CHP1;NOP53;PPIL4;HGF;FXR2;PML;CHRNA7;PPP2R5B;PPIA;PLAUR;ILK;IBTK;CLIP3;THPO;BMPER;FKBP8;ACVR2A;CORO1C;FBLN1;PTEN;AKAP8L;ARRB1;NSD1;MOB1B;TERF2IP;SPTBN4;ATF4;SESN2;STAT2;FLOT1;FGF9;CCDC88A;ATG14
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.4053871932501847,1.112234530782431,0.2994818652849741,0.8852108419606245,1.0,31/84,25.79%,MBNL1;HNRNPA1;SRSF6;RBM4;C1QBP;SRSF3;NSRP1;NUP98;MBNL2;SON;CELF2;RBFOX2;DDX17;RBM3;SF3B4;SAP18;FXR2;DDX5;RBM39;PUF60;U2AF2;NOVA1;PTBP1;SRPK1;THRAP3;LARP7;RBM5;DAZAP1;RBM24;CELF3;RBMX
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.4648450997012842,1.1111617415052648,0.351961950059453,0.8882429527492082,1.0,5/26,12.02%,ST3GAL2;GK5;LARGE1;TNIP1;ST3GAL4
prerank,membrane depolarization (GO:0051899),-0.313659677396091,-1.1111073423760374,0.2866666666666667,0.6974670739418447,1.0,13/32,26.85%,CACNA1E;YWHAH;SCN3A;CAV1;CACNG4;ABL1;CACNB3;SCN3B;SCN7A;CHRNA4;CACNA1B;CACNB4;SCN5A
prerank,negative regulation of bone remodeling (GO:0046851),0.5476335549050022,1.1110659800627838,0.37083333333333335,0.8878169518441246,1.0,4/11,17.56%,TMEM119;CALCA;IL6;GPR137B
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.30194299748247616,-1.1108388308876018,0.2871287128712871,0.6959982549745835,1.0,11/39,11.59%,CDH5;PLCG1;THBS1;SEMA5A;KDR;ITGA4;NDNF;RGCC;TEK;ECSCR;ICAM1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5339406700611753,1.1108054910117648,0.37359550561797755,0.8879549193258187,1.0,3/12,13.51%,IRS1;IRS2;TWIST1
prerank,negative regulation of protein secretion (GO:0050709),0.44005561718488434,1.110489921960268,0.3507377979568672,0.8882916529067807,1.0,6/38,9.80%,RAB11FIP5;IRS1;F2R;MIDN;RHBDF1;BMP8A
prerank,negative regulation of B cell activation (GO:0050869),0.4797551702178932,1.1104273623315188,0.3382899628252788,0.8877261817824993,1.0,4/21,7.14%,PARP3;INHA;BANK1;RC3H1
prerank,error-free translesion synthesis (GO:0070987),0.47127828367158286,1.1102091330689414,0.34375,0.8877225767561234,1.0,12/22,33.69%,POLDIP2;UBA52;RFC4;POLD1;REV1;POLH;UFD1;NPLOC4;RFC3;SPRTN;RPA3;RCHY1
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.4859944902303537,1.110193983350798,0.36272040302267,0.8862161004209076,1.0,8/19,24.83%,POLR2H;ACD;POLR2D;POLR2G;TERF1;TINF2;TERF2IP;POLR2C
prerank,regulation of DNA recombination at telomere (GO:0072695),0.4859944902303537,1.110193983350798,0.36272040302267,0.8862161004209076,1.0,8/19,24.83%,POLR2H;ACD;POLR2D;POLR2G;TERF1;TINF2;TERF2IP;POLR2C
prerank,regulation of nuclear division (GO:0051783),0.47345135681422407,1.1100254287560156,0.3405336721728081,0.8860344869653397,1.0,5/20,13.81%,CCDC8;FBXO5;KIF20B;PIN1;CUL9
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.4960692169763672,1.1094523790268167,0.36089238845144356,0.8873242447120322,1.0,5/17,17.41%,MAPK7;NFE2L2;AKT1;HTRA2;PPIA
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.47843061526983394,1.1091741453316297,0.3502475247524752,0.8875366983068853,1.0,3/21,3.02%,EPHB2;TGFB2;SLIT2
prerank,negative regulation of developmental process (GO:0051093),0.41029933513059796,1.1091024213103113,0.3315450643776824,0.8870043221840801,1.0,15/69,12.50%,LOXL2;PARP3;NEUROD2;PTPRS;MIF;HOPX;GRIN3A;NFIB;RC3H1;GAS6;WDR77;KANK1;ALPK2;MAPT;ANP32B
prerank,positive regulation of macrophage migration (GO:1905523),-0.36563821532308644,-1.1088452109273008,0.2445414847161572,0.6989751123238017,1.0,6/19,13.76%,IL34;THBS1;CX3CL1;MDK;MAPK3;PTK2
prerank,cellular response to hexose stimulus (GO:0071331),-0.33674073850341896,-1.1088178929903645,0.30857142857142855,0.696824075040872,1.0,5/23,4.65%,UNC13B;IGF1R;PRKAA2;KCNB1;TRA2B
prerank,acute inflammatory response (GO:0002526),0.4763429036579302,1.1086642803975186,0.3399014778325123,0.8877707075095884,1.0,1/23,0.26%,LBP
prerank,T cell proliferation (GO:0042098),-0.42231151414806,-1.1085700779236338,0.3110236220472441,0.6952886999066159,1.0,3/13,4.57%,CTPS1;DOCK8;CADM1
prerank,carbohydrate derivative transport (GO:1901264),0.4925760295975957,1.1077784659295724,0.35586734693877553,0.8900926311297943,1.0,1/18,0.26%,LBP
prerank,regulation of catabolic process (GO:0009894),0.5011785840851398,1.1076325807805891,0.3628205128205128,0.8898542085535227,1.0,5/18,13.39%,FAP;ZDHHC7;ODC1;TMEM9;ZDHHC2
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.4560778194107872,1.1075617882046553,0.3556638246041413,0.889349678595576,1.0,9/28,20.13%,IRS1;GRB10;TNS2;PID1;INPP5K;KANK1;NCK1;PIP4K2C;PIP4K2B
prerank,positive regulation of ERAD pathway (GO:1904294),0.5199563037191713,1.107261801133021,0.35983827493261455,0.8896567770754557,1.0,6/13,21.90%,NFE2L2;TMEM259;HERPUD1;SGTA;BCAP31;USP13
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.46523855559158195,1.1069130518143473,0.3341404358353511,0.890146361130054,1.0,5/26,14.64%,LBP;TLR5;TIRAP;WDFY1;SLC15A4
prerank,protein localization to kinetochore (GO:0034501),0.5057276741864395,1.1066513712139558,0.35471204188481675,0.8903023843339333,1.0,3/14,5.67%,CHAMP1;ZW10;CENPT
prerank,lipoprotein catabolic process (GO:0042159),-0.4218651345444283,-1.1066305397198413,0.31899641577060933,0.6982433589358634,1.0,3/11,7.48%,APOE;ABHD17C;NOTUM
prerank,epiboly involved in wound healing (GO:0090505),0.49896387841863865,1.106163628244971,0.3153034300791557,0.8912092466985806,1.0,5/16,14.09%,TMEFF2;CD44;TOR1A;RHOA;DDR1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.3795304168594317,-1.1060113523889876,0.30042918454935624,0.6977175518850832,1.0,9/16,23.23%,SHLD1;HELB;KLHL15;RIF1;SMCHD1;FANCB;MAD2L2;RMI2;PARPBP
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.42675978497186123,1.1056249230044959,0.3348115299334812,0.8923274981422439,1.0,12/48,17.26%,IRAK3;SLIT3;SLIT2;CARD16;PELI3;GAS6;SAMHD1;PARP14;NLRP2B;PADI2;IL6;YTHDF2
prerank,negative regulation of viral release from host cell (GO:1902187),0.5151238030570311,1.1051662495409669,0.36813922356091033,0.8932504430036078,1.0,5/13,22.98%,MID2;TRIM11;PML;TRIM35;TRIM8
prerank,modulation by symbiont of host process (GO:0044003),-0.43822328263871985,-1.1050380139950446,0.32989690721649484,0.6982460079968146,1.0,4/10,18.67%,B2M;ENO1;PGK1;MRC1
prerank,multivesicular body assembly (GO:0036258),0.44968904565754547,1.1048658354229293,0.3488095238095238,0.8935432715488755,1.0,10/30,24.05%,CHMP7;VPS4B;MVB12A;VPS37D;VPS37C;VPS37B;VPS36;PDCD6IP;IST1;STAM
prerank,negative regulation of protein localization to membrane (GO:1905476),0.4743306625601026,1.1047924724655722,0.3635250917992656,0.8930736022175741,1.0,7/24,14.92%,TMBIM1;CLTC;PID1;RHOQ;GDI1;INPP5K;PPFIA1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.4893667861214055,1.1038058575755036,0.3368010403120936,0.8957014348879567,1.0,4/15,15.79%,DHX33;TLR4;USP50;NLRP2B
prerank,regulation of DNA replication (GO:0006275),0.4180641256512199,1.1037111074014456,0.33665559246954596,0.8952753061206599,1.0,11/49,15.15%,EGFR;CTC1;GTPBP4;RBBP6;GLI2;EGF;FBXO5;DNA2;TERF1;EHMT2;GMNN
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.50274550383606,1.1032503727601504,0.3753280839895013,0.8960975427668587,1.0,6/15,23.95%,TENT4A;AGO2;ZFP36;POLR2G;TENT4B;TNRC6A
prerank,histone H3-K36 demethylation (GO:0070544),-0.4617831716017231,-1.103165870271538,0.33214285714285713,0.701277222330131,1.0,2/10,2.53%,KDM7A;KDM4A
prerank,regulation of striated muscle contraction (GO:0006942),-0.31893180389604403,-1.1031281829757034,0.30434782608695654,0.6992190021157594,1.0,3/27,3.39%,ATP1A2;DMD;SLC8A3
prerank,protein modification process (GO:0036211),0.398453260669436,1.1031168682410903,0.3210912906610703,0.895743207920572,1.0,29/76,27.04%,PLOD2;LOXL2;RABGGTA;GGCX;PHKA2;ABL2;FBXO2;FBXL2;CSNK1G3;CDC34;UBA52;FBXO11;ST3GAL1;ADPRH;STK38;LOX;NEDD8;UBE2D3;FBXW2;YES1;ATG3;ICMT;MMP15;RABGGTB;FBXO22;UBA7;PIGH;DUSP12;PRKDC
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.426291093411431,1.103001699128877,0.33854748603351953,0.8953794143874936,1.0,9/40,16.15%,SFRP4;ANXA2;VEGFA;BICD1;EGF;MAGI2;CBL;IL4;AHI1
prerank,defense response to bacterium (GO:0042742),0.39544229877999326,1.1030011999235732,0.32065775950668035,0.8946070409992999,1.0,11/105,12.63%,LBP;SYK;ANG;S100A8;S100A9;TIRAP;TLR4;CEBPB;SLPI;DMBT1;RNASE6
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3813176493850044,1.102717348922112,0.21021021021021022,0.8948573003670521,1.0,66/348,14.68%,GHR;LIF;DDR2;CD80;FGF18;NIBAN1;FGF7;EGFR;TGFB3;EFNA5;TMEM119;ANGPT4;NPTN;CAMKK1;CD44;ITGB3;VEGFA;FGF2;DGKQ;TGFB2;PDE8A;MIF;SMAD4;THBS4;ACVR1;AXIN1;ITGA5;BMP15;MAP2K3;PTPRJ;ATP2B4;DOCK7;S1PR2;MAPRE3;RASSF2;SRC;INHA;PFN2;BANK1;HDAC6;ADCYAP1;FLCN;PRKD2;GAS6;CD81;CDK9;IQGAP1;BMP8A;HDAC3;MUSK;EGF;CAMKK2;AKT1;KRAS;GPNMB;CALM2;XRCC5;TAOK2;CDKN1A;PIN1;IL5;CCND1;WDFY2;TNKS1BP1;NBN;HSP90AA1
prerank,inositol phosphate metabolic process (GO:0043647),-0.30258825147199964,-1.1019502211962031,0.24444444444444444,0.7002515233699245,1.0,13/46,11.63%,ITPKB;INPP4B;PLCG1;ISYNA1;NUDT4;PLCB1;ITPK1;INPPL1;INPP5D;MINPP1;NUDT3;ITPKC;PLCD3
prerank,positive regulation of growth (GO:0045927),0.4122915918509733,1.1016113309226658,0.3208154506437768,0.8980160353528952,1.0,9/64,4.38%,EGFR;HPN;TGFB2;RFTN1;CDKN2AIP;S100A8;S100A9;ZPR1;DDX49
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.47017002232626887,1.1015107474924979,0.35695876288659795,0.8975804457161717,1.0,10/22,28.05%,VPS4B;MVB12A;VPS37D;VPS37C;VPS37B;UBAP1;VPS36;STAM;RNF126;PTPN23
prerank,regulation of cell-cell adhesion (GO:0022407),0.4328901547327067,1.1012333954709632,0.34832756632064593,0.8977949095707322,1.0,12/39,16.19%,DPP4;EFNA5;GTPBP4;TENM3;SRC;JAG1;EPHB3;CD47;FUT9;ZDHHC2;MDGA1;FLOT2
prerank,protein O-linked mannosylation (GO:0035269),-0.36340568591055616,-1.100794346160686,0.2935323383084577,0.701032205405202,1.0,3/18,3.00%,TMTC1;TMTC4;TMTC2
prerank,neural tube development (GO:0021915),0.5002563292407072,1.1006972375854394,0.36209150326797385,0.8988389312467336,1.0,5/15,7.94%,PKD1;DACT1;TRIM71;PKD2;ARL13B
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.4400491236820485,1.1005911401168385,0.34584755403868034,0.8984120994979897,1.0,15/39,24.12%,TTC7A;PIK3C2B;PIK3R2;SOCS2;PI4K2B;PIK3CA;PI4KB;PI4KA;SOCS6;PIP4K2C;PIP4K2B;IP6K1;PIK3CG;PI4K2A;TTC7B
prerank,regulation of metal ion transport (GO:0010959),0.49548767306775143,1.100397199970435,0.3641092327698309,0.8983494077647899,1.0,3/16,3.44%,IL16;ANK2;SRI
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.457996721660201,1.100189934812933,0.3763313609467456,0.898316803934161,1.0,14/27,26.23%,MRGBP;ATAT1;MSL3;KAT2B;NAT8;NAA50;MORF4L1;TAF6L;TRRAP;SGF29;KAT6B;KAT7;KAT5;BRD8
prerank,bicarbonate transport (GO:0015701),0.459285987689867,1.0998491081938981,0.33663366336633666,0.8987585384046505,1.0,5/25,11.54%,SLC4A10;SLC4A8;SLC4A3;SLC4A4;SLC26A6
prerank,neural crest cell migration (GO:0001755),0.43894747982468263,1.0997641704367327,0.36257309941520466,0.8982775359814809,1.0,7/36,13.00%,SEMA3C;RADIL;SOX10;SEMA3A;SOX8;SEMA3D;GDNF
prerank,lymphocyte migration (GO:0072676),0.4409866061440544,1.099756007630145,0.34349355216881594,0.8975398547204106,1.0,4/32,13.15%,CCL8;RET;CCL25;CCL13
prerank,triglyceride catabolic process (GO:0019433),0.4826284693174523,1.0996661246752142,0.3471698113207547,0.8970814646562244,1.0,4/19,18.79%,FABP12;FABP5;LIPC;LIPH
prerank,myelination (GO:0042552),0.4270466796825573,1.0992449841783474,0.3624161073825503,0.8978237564309717,1.0,11/46,16.55%,MYOC;PMP22;SKI;SOX10;MAL2;SIRT2;ARHGEF10;PLP1;KLK6;MARVELD1;CXCR4
prerank,negative regulation of transferase activity (GO:0051348),0.45632242523471356,1.098702963418384,0.3508982035928144,0.8989558451186821,1.0,8/28,13.48%,SRC;INPP5K;FBXO5;MAPT;IRS2;ERCC4;ZFP36;TERF1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.4074128883238405,1.0981176715190868,0.3489861259338314,0.9002151432153096,1.0,18/67,15.93%,AXL;NCF4;ITGB3;FYN;VEGFA;PIK3R2;MAPK14;SULF1;SRC;PRKD2;ABI1;PIK3CA;MAPK11;ITGAV;RHOA;AAMP;HSP90AA1;NCK1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.38468928420845294,-1.0979048453540572,0.3105022831050228,0.7065454145190924,1.0,3/17,4.55%,ATP1A2;CACNB2;CACNA1D
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.4151034791732345,1.0977057592024269,0.3492239467849224,0.9009139946116363,1.0,14/50,17.82%,TRIAP1;CD44;VEGFA;CARD16;SRC;GAS6;DPEP1;YWHAE;GPX1;AKT1;SFN;KLF4;HGF;PLAUR
prerank,regulation of protein localization to Cajal body (GO:1904869),0.5269366740324574,1.0975508518150072,0.37057220708446864,0.8999028487637895,1.0,5/11,27.59%,MEPCE;CCT7;LARP7;CCT4;CCT6A
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.5269366740324574,1.0975508518150072,0.37057220708446864,0.8999028487637895,1.0,5/11,27.59%,MEPCE;CCT7;LARP7;CCT4;CCT6A
prerank,regulation of axon extension (GO:0030516),0.4342934336008605,1.0968913721373472,0.3565714285714286,0.9013905389905122,1.0,8/37,11.42%,DBN1;PTPRS;NTN1;TRIM46;ISLR2;SEMA3A;L1CAM;MAPT
prerank,fat cell differentiation (GO:0045444),0.41372604066701624,1.0967003836613936,0.3451995685005394,0.9013119975361177,1.0,12/57,14.55%,UCP1;ATF5;METRNL;TCF7L2;FOXO1;PID1;BBS9;SOX8;SMAD6;TMEM120A;BBS4;KLF4
prerank,autophagosome organization (GO:1905037),0.41576530891139823,1.0960655136156494,0.3458980044345898,0.9027399637359947,1.0,20/50,25.47%,RAB23;RAB19;PACS2;ATG2B;WIPI2;STX12;WDR45B;ULK2;RAB43;ATG2A;ATP2A2;ULK1;ATG16L2;RAB1B;ATG13;ATG16L1;ATG3;ATG14;EMC6;RAB1A
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.37998388411064343,1.0957346507463088,0.279839518555667,0.9031179483967514,1.0,91/241,29.08%,GEMIN6;SRSF2;POLR2H;CD2BP2;HNRNPA1;SRSF6;DHX16;RBM4;ZCRB1;DDX42;LSM4;PRPF4;U2AF1;SRSF3;TFIP11;PRPF3;GPATCH1;USP39;HNRNPD;RBM22;DNAJC8;SNRPB2;HNRNPH1;DHX8;CPSF4;RBM17;PRPF40A;SRSF11;POLR2D;POLR2G;SNU13;HNRNPA3;AQR;GTF2F1;ZCCHC8;SF3B4;BCAS2;SF3A1;PHF5A;CPSF2;SNRPA;DDX5;SNRPG;SNRPD3;PNN;SNIP1;SRRM1;RBM6;PDCD7;DDX39A;PUF60;PRCC;GCFC2;HNRNPUL1;LSM7;U2AF2;ZMAT5;NOVA1;PTBP1;ELAVL2;SF3B2;SF3B1;GPKOW;PRPF38A;RBM5;CSTF2T;SNRPA1;CPSF7;CPSF1;RALY;POLR2C;PABPN1;WDR33;CWC27;ALYREF;RBMX;UPF3B;PPIH;USP49;CRNKL1;PRPF19;PRPF6;LSM5;CPSF3;CDC40;WDR83;RBM15;HNRNPC;SNRPC;WBP11;SRSF5
prerank,negative regulation of protein transport (GO:0051224),-0.3366112443534946,-1.09568556122695,0.3125,0.7103518719065333,1.0,8/25,12.24%,APOE;WWP2;SNX3;HMGCR;NDFIP2;RHBDF2;PKDCC;PPM1F
prerank,chromatin organization (GO:0006325),0.3870463207524975,1.0956677191745567,0.2815338042381433,0.9025760613641066,1.0,50/132,28.93%,ESR1;LOXL2;SMARCD2;MCM3AP;SMARCD1;PHF1;ZBTB1;SATB2;SETD7;KAT2B;KDM5C;HDAC3;NPM1;SMARCC2;SETD2;KDM5B;DR1;DDX11;INO80;EZH1;HDAC4;GATAD1;SETD5;SMARCA4;BAZ2B;NUDT5;PADI2;CHD1;SUPV3L1;TAF6L;EZH2;BAZ2A;SETDB1;KDM4C;BAZ1A;SETDB2;HP1BP3;INO80C;TCF7L1;SAFB;ARID1A;JARID2;HDAC8;SUV39H1;CHRAC1;KDM4B;TADA2A;PBRM1;ZBTB7A;ATRX
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.5273672952596724,1.0954009580432613,0.38493150684931504,0.9026955893778766,1.0,5/11,19.03%,ATP1A1;KCNJ2;YWHAE;KCNJ3;KCNH2
prerank,regulation of translation (GO:0006417),0.3830757867877737,1.0949357224930667,0.2937625754527163,0.9035150753518073,1.0,59/173,27.50%,IGFBP5;NIBAN1;PKP3;EIF2AK3;EIF3B;CTIF;RBM4;PAIP2B;MTOR;TRIM71;SAMD4B;ATXN2;LARP4;MRPL13;HNRNPD;EIF1;NPM1;BCL3;PASK;IGF2BP1;EIF6;LTN1;LARP1;RPS27L;ZCCHC4;NOLC1;CNOT10;RBM3;POLDIP3;GSPT1;EIF3E;IL6;FXR2;EIF3D;YTHDF1;EPRS1;PAIP2;PCIF1;MTIF2;NEMF;METAP1;YTHDF3;EIF2A;OGFOD1;EIF4G3;TRAP1;EIF4H;CALR;LARP6;CYFIP1;GRM5;UPF3B;EIF4G1;EIF2B2;EIF4E2;DDX1;PRKDC;UPF1;TSC1
prerank,DNA packaging (GO:0006323),0.49483902180100314,1.0949150923589857,0.36628643852978454,0.9028184017236347,1.0,2/16,7.30%,CHAF1B;NOC2L
prerank,glucose homeostasis (GO:0042593),0.39653798520379807,1.0946226597659885,0.33472803347280333,0.9030734488920261,1.0,12/83,10.25%,MTNR1B;IRS1;LRRC8D;CRTC2;PIK3R2;FOXK2;TCF7L2;FOXO1;NR1D1;MLXIPL;MCU;INPP5K
prerank,regulation of axon guidance (GO:1902667),0.5428928872559763,1.0944435496134128,0.38959212376933894,0.9029522622841024,1.0,5/10,17.52%,VEGFA;ZSWIM4;MYCBP2;ZSWIM8;YTHDF1
prerank,secondary alcohol metabolic process (GO:1902652),0.4215088270499638,1.0942468461242252,0.35570469798657717,0.9028648201062065,1.0,12/42,20.79%,ABCA1;IDH1;LCAT;TSKU;GBA2;IL4;PIP4P1;FDX1;ANGPTL3;IDH3G;IDH3B;SOAT1
prerank,positive regulation of GTPase activity (GO:0043547),-0.23458762394482963,-1.0942417067265657,0.0,0.7120849538943207,1.0,46/188,11.96%,ARHGAP29;PKP4;TBC1D4;RAPGEF2;RAPGEF3;TBC1D1;ITGA6;RAP1GDS1;NET1;CDKL5;F11R;RALGAPA1;ARHGAP24;DOCK8;TGM2;RASGRP2;SIPA1L1;ARHGEF26;RGS6;PIP5K1A;MAP4K4;DVL3;DOCK9;RANGAP1;NTRK3;TBC1D25;GRTP1;CCDC125;BCAR3;PLXNB1;TBC1D16;ERBB2;CAV2;CX3CL1;SFRP1;AGRN;TBC1D30;USP6NL;MTSS2;ZC3H15;LIMS1;RALGAPA2;RGP1;TBC1D8;TBC1D10B;SCRIB
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.45039650201084974,1.0941551769049325,0.3563892145369285,0.9024432224257375,1.0,7/27,16.45%,HAS2;CD44;SIRPA;CD47;IRAK1;RHOA;IL6
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.5555910290634096,1.0939310861045484,0.3665223665223665,0.9024617069972538,1.0,3/10,18.95%,DIS3L2;UBA52;NEDD8
prerank,digestive tract development (GO:0048565),0.44438289427870126,1.0937953098884678,0.3605200945626478,0.9021749793750861,1.0,7/32,10.97%,PCSK5;TGFB2;COBL;PKD1;GLI2;EPHB3;GLI3
prerank,regulation of cell growth (GO:0001558),0.3821489307716998,1.093777650084288,0.2832832832832833,0.9014712959639459,1.0,37/204,13.19%,EGFR;WT1;HPN;DCBLD2;FHL1;PLCE1;DACT3;TGFB2;SGK3;SGK2;SLIT3;SLIT2;CDKN2AIP;PSRC1;S100A8;S100A9;SMAD4;DDX49;GNG4;MTOR;ITCH;PTPRJ;CAMK2D;SOCS2;EGLN2;MELTF;FLCN;CYP27B1;NRG3;BCL6;URI1;AKT1;DNAJB2;LGI1;TAOK2;ADAM15;CDKN1A
prerank,nucleocytoplasmic transport (GO:0006913),0.4312545107736202,1.0936266801216807,0.3649717514124294,0.901279561978595,1.0,12/40,22.27%,GEMIN6;HNRNPA1;NUP98;NPM1;BACH2;DDX20;SNRPG;SNRPD3;NXT2;NEMF;SMN1;HTATIP2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.45852996320842015,1.0933133413616385,0.3659730722154223,0.9016408149348769,1.0,6/25,14.95%,ITGB3;DLG4;ATXN2;PSEN1;ITGAV;ARF6
prerank,positive regulation of epithelial cell migration (GO:0010634),0.39601971907657496,1.0930326718783372,0.32407407407407407,0.9018664618371051,1.0,23/92,14.95%,FGF7;PRKCA;ANGPT4;SPARC;ITGB3;VEGFA;FGF2;TGFB2;FOXP1;ADAM9;SMOC2;MTOR;SRC;HDAC6;PRKD2;FOXC2;EMC10;EGF;AKT1;ZC3H12A;AAMP;BCAS3;ARF6
prerank,protein oxidation (GO:0018158),0.5283671757931867,1.0928103187824598,0.3997326203208556,0.9018820859314018,1.0,2/11,9.72%,LOXL2;LOXL1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.46975124317059447,1.0924556908004004,0.370138017565872,0.9023028213555919,1.0,8/21,23.06%,EFNA5;EPHA3;SLK;SLC9A1;RHOA;ACTG1;CORO1C;LDB1
prerank,positive regulation of proteolysis (GO:0045862),0.4125088064125386,1.0924162766429206,0.34030837004405284,0.9016844916414156,1.0,17/55,23.63%,CCBE1;MAPK12;ADAM9;RCN3;STUB1;AURKAIP1;TNIP1;TBC1D10A;BAK1;TNFRSF1B;ZC3H12A;OGT;GPLD1;SH3D19;FBXW11;PACSIN3;IST1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.39354328817975265,1.0921516240427342,0.34375,0.901834778691088,1.0,10/88,8.27%,SYK;SMPD3;PRKCA;VEGFA;CDC42EP2;MPP7;GNL3L;VPS4B;PFN2;TIRAP
prerank,regulation of actin filament-based process (GO:0032970),0.4055220138114849,1.0919268924211236,0.3536977491961415,0.901873053369894,1.0,13/70,16.32%,CORO2B;LRP1;ARHGAP44;EFNA5;EPHA3;MTOR;FSCN1;IQGAP1;RHOQ;TAOK2;RHOA;RND3;RAC3
prerank,cellular response to tumor necrosis factor (GO:0071356),0.3786154953592346,1.0918238509498461,0.2902902902902903,0.9014937209881124,1.0,27/175,15.28%,TNFSF9;HAS2;CCL8;PSMC4;NFE2L2;ZFP36L1;NR1D1;TNFRSF11B;PSMC6;PID1;ZFP36L2;CHUK;TNFRSF18;PSMD8;CCL25;TNFSF13B;PLVAP;INPP5K;AKT1;CD27;ZFP36;CCL13;TNFRSF1B;ZC3H12A;MAP3K14;EDA;BAG4
prerank,blood vessel endothelial cell migration (GO:0043534),-0.36049178960531786,-1.0917078227897652,0.31797235023041476,0.7166482219654104,1.0,8/22,8.46%,ROBO1;CDH5;EFNB2;EPHB4;KDR;ID1;NRP1;EMP2
prerank,anterior/posterior axis specification (GO:0009948),-0.4000514077780323,-1.0916972829199547,0.34334763948497854,0.7145007372635851,1.0,2/15,3.57%,WLS;TBX3
prerank,ameboidal-type cell migration (GO:0001667),0.4139432747427023,1.091582778132641,0.35365853658536583,0.9015863866543553,1.0,11/51,13.00%,SEMA3C;GPC3;RADIL;SOX10;SEMA3A;SOX8;PDXDC1;AKT1;PDLIM1;SEMA3D;GDNF
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.38402746143656136,-1.0915220873150955,0.3252032520325203,0.7128999494508804,1.0,8/16,13.99%,IGF1;MEF2C;NOTCH1;TGFBR3;FGFR2;TBX2;AKAP6;EDN1
prerank,negative regulation of protein modification process (GO:0031400),0.4011903614512049,1.0913181153568525,0.35507246376811596,0.9017233296632967,1.0,28/79,23.19%,EPHB2;LRP6;NIBAN1;SLIT2;WWTR1;PLPP3;ATP2B4;TARDBP;MYADM;PID1;PIP5KL1;SIRPA;INPP5K;MAPT;P3H1;ZC3H12A;CDYL;CHP1;PPIA;IBTK;TINF2;FKBP8;CORO1C;FBLN1;PTEN;TERF2IP;YWHAB;ATG14
prerank,error-prone translesion synthesis (GO:0042276),0.4675226129484057,1.0911885836283832,0.36114570361145704,0.9014039914407618,1.0,8/21,28.52%,REV3L;POLI;UBA52;RFC4;REV1;POLH;POLE2;RFC3
prerank,RNA 3'-end processing (GO:0031123),0.409617532109786,1.0908796433498782,0.3501070663811563,0.9017319999171665,1.0,29/69,27.86%,SRSF2;SRSF6;TENT4A;U2AF1;SRSF3;CPSF4;SRSF11;THOC7;POLDIP3;THOC2;THOC1;ZC3H11A;CPSF2;TENT2;SRRM1;DDX39A;TENT4B;SUPV3L1;U2AF2;CSTF2T;CPSF7;CPSF1;PABPN1;WDR33;ALYREF;UPF3B;THOC5;CPSF3;CDC40
prerank,positive regulation of chemokine production (GO:0032722),0.4185895849789766,1.0902675958518302,0.3650615901455767,0.9030933499499209,1.0,10/44,18.81%,SYK;IL33;IL17RA;ADCYAP1;TIRAP;TLR4;TWIST1;IL6;IL18;MBP
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.40132324131445235,1.0899824834838423,0.335423197492163,0.903274483691568,1.0,13/72,16.91%,SYK;AXL;RUNX1;IRAK3;SPATA2;ABCE1;GAS6;CHUK;SPPL2B;IRAK1;RBCK1;MADD;TAX1BP1
prerank,regulation of cytokine production (GO:0001817),0.3840748376777671,1.0896498366155567,0.31466395112016293,0.9036789681468641,1.0,27/126,19.29%,ANXA1;GLMN;NPTN;FOXP1;MIF;HDAC9;MAPK14;SYT11;IL33;SCAMP5;SIRPA;BCL6;CD47;GPNMB;LRRC19;IGF2BP1;ACKR1;TNFRSF1B;MOG;SNAI2;BTN3A3;PER1;IL6;TRAF3;ATP2B1;VTCN1;LURAP1
prerank,mononuclear cell differentiation (GO:1903131),0.4618030862546557,1.0895577837780892,0.3781818181818182,0.9032178580877477,1.0,5/24,15.09%,AXL;VEGFA;GAS6;FLT3;IL4
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.524860588304929,1.0894972337040343,0.3741496598639456,0.9011767755000029,1.0,7/11,30.36%,SLC25A16;PANK1;DCAKD;PANK3;ACAT1;ACOT7;PANK2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.524860588304929,1.0894972337040343,0.3741496598639456,0.9011767755000029,1.0,7/11,30.36%,SLC25A16;PANK1;DCAKD;PANK3;ACAT1;ACOT7;PANK2
prerank,coenzyme A biosynthetic process (GO:0015937),0.524860588304929,1.0894972337040343,0.3741496598639456,0.9011767755000029,1.0,7/11,30.36%,SLC25A16;PANK1;DCAKD;PANK3;ACAT1;ACOT7;PANK2
prerank,positive regulation of protein binding (GO:0032092),-0.2767212985648681,-1.0893460370248986,0.26506024096385544,0.7166745693863578,1.0,18/56,14.08%,RAPGEF2;VTN;CLDN5;APP;APOE;EPB41;CAV1;B2M;DTX3L;MARK3;NMD3;HIP1R;BMP2;TERT;BDNF;ABL1;HIPK2;TRIM21
prerank,cellular glucose homeostasis (GO:0001678),0.43169459836666674,1.0885464760997126,0.35714285714285715,0.9037164683098233,1.0,9/41,12.85%,LRRC8D;SLC39A14;PIK3R2;FOXK2;FOXO1;NR1D1;GAS6;ERN1;ADCY8
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.42274686894450797,1.0881429126460374,0.36101499423298733,0.904392365512437,1.0,5/43,4.19%,IGFBP5;MMP2;FGF2;FOXP1;MEF2D
prerank,cellular potassium ion homeostasis (GO:0030007),0.5157721896715269,1.0879487792569575,0.38618925831202044,0.9042976832414463,1.0,5/13,5.78%,KCNMA1;ATP1A4;ATP1A3;ATP1A1;KCNJ2
prerank,cochlea morphogenesis (GO:0090103),0.5369853264049227,1.0878109676456948,0.3771186440677966,0.9040441155577489,1.0,2/10,7.70%,HPN;MYO3B
prerank,UV protection (GO:0009650),0.5288295181679249,1.0876658650759108,0.3813682678311499,0.9038069358284522,1.0,3/10,18.17%,SCARA3;GPX1;ERCC5
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.4072072908356437,-1.0875382802722915,0.367816091954023,0.7193620650138148,1.0,4/13,6.45%,BMP7;SOX13;NAPEPLD;PTGS2
prerank,electron transport chain (GO:0022900),0.4920488026042521,1.0863898353683084,0.4021304926764314,0.9075101215405599,1.0,6/15,17.54%,ETFA;ENOX2;POR;ETFDH;ETFB;CYB561
prerank,regulation of B cell apoptotic process (GO:0002902),0.5187137009967869,1.0863014575516332,0.3947730398899587,0.9070544352354276,1.0,4/12,12.13%,FOXP1;NOC2L;BCL6;IRS2
prerank,peptidyl-threonine modification (GO:0018210),0.3999499969759566,1.0860667368064831,0.36067297581493163,0.9071300187619917,1.0,23/66,24.84%,PRKCA;DYRK4;TGFBR2;GALNT16;ACVR1;CAMK2D;PRKD2;DYRK2;GALNT1;AKT1;STK39;HIPK4;ULK1;TGFBR1;GALNTL6;CIT;HIPK3;OXSR1;MAPK1;CSNK2A2;GALNT4;ACVR1B;MARK2
prerank,histone H2A ubiquitination (GO:0033522),0.4849078888488345,1.0859095278591997,0.3753180661577608,0.9069213324657792,1.0,8/17,22.74%,UBE2B;RNF2;RYBP;UBE2A;DDB1;RING1;KDM2B;UBR2
prerank,spliceosomal complex assembly (GO:0000245),0.4137983828682947,1.0859024179972836,0.36172566371681414,0.9062016261287202,1.0,24/46,31.93%,SRSF6;USP39;KHDC4;CELF2;SF3A1;SNRPG;LUC7L3;PUF60;GCFC2;LUC7L2;SF3B1;SRPK1;SMN1;RBM5;CELF3;CRNKL1;PRPF19;PRPF6;DDX1;CELF1;SRSF5;CELF4;SF1;SF3A2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3774566276532997,1.0858004659200542,0.2655310621242485,0.9058208130222948,1.0,42/248,11.99%,SFRP4;LRP6;COL1A1;DKK2;EGFR;TLE6;SCEL;CCDC88C;GPC3;PSMC4;UBE2B;DACT3;CDK14;AMER3;IGFBP6;RBMS3;SMURF2;WWTR1;KREMEN1;IGFBP4;AXIN1;DACT1;TCF7L2;PSMC6;DAAM2;FZD7;PSEN1;PSMD8;CUL3;GSKIP;TMEM9;TLE2;KANK1;PLEKHA4;CSNK1G1;PRDM15;GLI3;EGF;CSNK1G3;ANKRD6;TPBG;JUP
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5333510103548921,1.0856720731391534,0.3953823953823954,0.9054930249877582,1.0,4/10,15.59%,GRB10;PID1;INPP5K;SELENOS
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.46449772907471293,1.0856141250882767,0.3548780487804878,0.9049563345261302,1.0,8/23,21.55%,TIMM10B;TIMM9;AGK;BMF;HSP90AA1;TIMM22;TIMM8B;COX18
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.43462447037505236,1.085441717882901,0.3830034924330617,0.9048081399592554,1.0,10/33,21.05%,SCIN;RAB7B;MAPK14;HOXA5;MAPK11;STAT5B;PITHD1;THPO;ACVR2A;ABCB10
prerank,hydrogen peroxide metabolic process (GO:0042743),0.4814704182234755,1.0848388988514226,0.3796068796068796,0.9060684195006933,1.0,4/19,17.14%,DUOX1;GPX1;ACOX1;PXDN
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.3750714683163242,1.0848093413233393,0.2972972972972973,0.9054217782294353,1.0,100/264,29.08%,GEMIN6;SRSF2;POLR2H;CD2BP2;HNRNPA1;SRSF6;DHX16;RBM4;ZCRB1;DDX42;LSM4;PRPF4;U2AF1;SRSF3;TFIP11;WDR77;PRPF3;GPATCH1;USP39;HNRNPD;RBM22;DNAJC8;SNRPB2;HNRNPH1;DHX8;CPSF4;RBM17;PRPF40A;SRSF11;TGS1;DDX17;POLR2D;POLR2G;SNU13;HNRNPA3;AQR;GTF2F1;ZCCHC8;SF3B4;DDX20;BCAS2;SF3A1;PHF5A;CPSF2;SNRPA;DDX5;SNRPG;SNRPD3;PNN;SNIP1;SRRM1;RBM6;PDCD7;DDX39A;PUF60;PRCC;GCFC2;STRAP;HNRNPUL1;LSM7;U2AF2;ZMAT5;NOVA1;PTBP1;ELAVL2;SF3B2;SF3B1;SRPK1;SMN1;GPKOW;PRPF38A;COIL;RBM5;CSTF2T;SNRPA1;CPSF7;CPSF1;RALY;POLR2C;PABPN1;WDR33;CWC27;ALYREF;RBMX;UPF3B;PPIH;USP49;CRNKL1;PRPF19;PRPF6;DDX1;LSM5;CPSF3;CDC40;WDR83;RBM15;HNRNPC;SNRPC;WBP11;SRSF5
prerank,gene expression (GO:0010467),0.3762730019917146,1.0844933703907056,0.262,0.9057796413904798,1.0,80/348,20.05%,NOX4;RPSA;TSPAN17;SRSF2;POLR2H;ADARB1;MRPS11;SRSF6;NXF1;RRBP1;DDX19B;COPS5;RBM4;MRPS18B;NUP93;IGHMBP2;MCM3AP;BICD1;NUP107;STUB1;PRPF4;U2AF1;SRSF3;TFIP11;PPP5C;MRPL13;NUP98;MRPS17;AGO2;DUSP11;HNRNPD;HNRNPH1;DHX8;CPSF4;GSPT2;RPL10A;TNIP1;MRPL10;CELF2;MRPL55;BCL3;SRSF11;THOC7;DDX17;POLR2D;MPHOSPH10;POLR2G;RPS5;SMG7;MRPL36;RBM3;POLDIP3;DNAJB11;THOC2;MRPL3;GSPT1;THOC1;TASP1;NUP37;SMG6;FYTTD1;ZC3H11A;DDX20;RPL6;MRPL51;HARS1;CPSF2;NUFIP1;ABCF1;SRRM1;RBM6;DDX39A;RBM39;SLBP;NUP50;HNRNPUL1;U2AF2;RPL23;RPL17;NOVA1
prerank,protein K11-linked ubiquitination (GO:0070979),0.4566855688980079,1.0843360255739678,0.3838973162193699,0.9055569900055727,1.0,10/27,20.99%,UBE2B;UBE2W;CDC23;ANAPC5;UBE2A;CDC27;CDC26;ANAPC4;UBE2D3;ANAPC10
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.3143443757474905,-1.0842311734748495,0.3113207547169811,0.7263263096480688,1.0,11/38,12.21%,SP100;BMP5;BCL2L1;NOS3;THBS1;SFRP1;FAS;ICAM1;RIPK1;TNFSF10;CFLAR
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.4764713939175988,1.084224411017464,0.3875776397515528,0.9052020720502785,1.0,1/18,0.65%,LAX1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.44609355140163665,1.0839636260940224,0.3696682464454976,0.9053596714495995,1.0,12/28,22.76%,ZPR1;PIK3R2;PSEN1;RBM22;HDAC3;JUP;ZC3H12A;DMAP1;IPO5;FLNA;BAG3;TPR
prerank,cellular response to BMP stimulus (GO:0071773),0.40385692823317554,1.0838523917967515,0.3619957537154989,0.9050078543441787,1.0,12/66,11.07%,AMH;TMEM100;TGFB3;TGFB2;SMAD4;ACVR1;BMP15;FAM83G;SMAD5;BMP8A;SMAD6;AMHR2
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.42184451064457656,1.083358750949742,0.36495535714285715,0.905981242055778,1.0,13/43,21.70%,CDC14B;INTS3;TAOK3;RINT1;DTL;TAOK2;CDKN1A;ABRAXAS1;NBN;NOP53;BLM;DONSON;CLSPN
prerank,dorsal/ventral pattern formation (GO:0009953),0.4718539796394514,1.083301915912744,0.3790931989924433,0.9054170292709576,1.0,4/20,6.96%,LMX1B;ACVR1;AIDA;GLI2
prerank,peroxisome organization (GO:0007031),0.4572474532587666,1.0831662872276582,0.3852760736196319,0.9051493638777394,1.0,8/25,23.90%,SEC16B;PEX16;PEX12;PEX1;PEX3;ABCD3;PEX2;FIS1
prerank,regulation of cellular metabolic process (GO:0031323),0.4189460469068499,1.0830236087185299,0.3691275167785235,0.9048939159551315,1.0,16/45,24.73%,ACLY;COQ7;ARF4;PID1;STUB1;ARF1;SSH1;EIF6;MBOAT7;NCOR2;CYP1B1;MKLN1;RNF41;FLOT1;PARL;RSPO1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.46296436116762396,1.082738225907862,0.3837638376383764,0.9051122291513135,1.0,8/24,20.20%,FGF13;KIF2A;MAPT;TPPP3;PIN1;MAP7D3;CKAP5;STMN4
prerank,positive regulation of stress fiber assembly (GO:0051496),0.4241670787077204,1.08272659819603,0.3712707182320442,0.9044250445785866,1.0,9/44,10.32%,MYOC;TGFB3;S100A10;LPAR1;SORBS3;PFN2;ARHGEF10L;ARHGEF10;CD47
prerank,positive regulation of phosphorylation (GO:0042327),0.37912795252358,1.0826039772679898,0.2852852852852853,0.9041519904594059,1.0,60/240,19.45%,DDR2;AR;EPHB2;FGF18;AXL;NIBAN1;FGF7;EGFR;GLMN;FGFR1;EFNA5;TMEM119;NPTN;EPHA3;ITGB3;ANG;VEGFA;FGF2;PDE8A;MST1R;MIF;AXIN1;RET;MLXIPL;FLCN;GAS6;FZD7;PSEN1;EPHB3;HDAC3;DSCAM;MUSK;EGF;CAMKK2;AKT1;SLC4A4;KRAS;GPNMB;EPHA10;PDGFRA;FLT3;PIN1;CCND1;WDFY2;DDR1;NBN;HSP90AA1;KCTD20;HGF;FXR2;CHRNA7;PPIA;RAD50;PLAUR;ILK;EPHB1;CLIP3;DSTYK;ROR1;THPO
prerank,nucleic acid metabolic process (GO:0090304),0.40072731688030633,1.0818931335134734,0.3497854077253219,0.9058417987929622,1.0,18/69,20.12%,POLR2H;HNRNPA1;KPNA2;ATXN2;DUSP11;DNASE2;HNRNPD;HNRNPH1;RBFOX2;DNA2;POLR2D;POLR2G;HNRNPA3;DNASE1L2;GTF2F1;RAD50;DDX24;PTBP1
prerank,mRNA 3'-end processing (GO:0031124),0.40024012846334334,1.0815914425806217,0.3535031847133758,0.9061329780616676,1.0,33/78,27.86%,SRSF2;SRSF6;SCAF8;U2AF1;SRSF3;CPSF6;CPSF4;SRSF11;THOC7;POLR2D;POLDIP3;THOC2;THOC1;ZC3H11A;CPSF2;PAPOLB;TENT2;SRRM1;DDX39A;SLBP;TENT4B;U2AF2;PAF1;CSTF2T;CPSF7;CPSF1;PABPN1;WDR33;ALYREF;UPF3B;THOC5;CPSF3;CDC40
prerank,response to growth factor (GO:0070848),0.4264528975346597,1.0814434053918593,0.3818589025755879,0.9058865723393842,1.0,16/41,25.39%,MAPK7;TGFBR2;ACVR1;HDAC6;URI1;AMHR2;AKT1;KLF4;STAT5B;HTRA2;TGFBR1;ACVR2A;BMPR1A;EMD;ACVR1B;LRP2
prerank,microtubule anchoring (GO:0034453),0.5134513316354933,1.0811629571387718,0.3878954607977992,0.9061014707348585,1.0,4/12,21.03%,SAXO1;BICD1;CLASP2;PCM1
prerank,positive regulation of cation channel activity (GO:2001259),0.42223748848973824,1.0810344883298768,0.387458006718925,0.9057805516333856,1.0,7/40,14.23%,EPHB2;ANK2;PKD2;GSTM2;CALM2;ANTKMT;CASQ1
prerank,inhibitory synapse assembly (GO:1904862),0.5221919032437242,1.081004939815847,0.4111888111888112,0.9051512900563782,1.0,2/11,2.82%,LGI2;FGF13
prerank,regulation of protein transport (GO:0051223),0.44782509059787273,1.0809136351009514,0.37902264600715135,0.9047194267937146,1.0,8/27,15.39%,DISP1;LLGL1;NDEL1;RHBDF1;SCFD1;NDFIP1;P3H1;CHP1
prerank,inorganic anion transport (GO:0015698),-0.2680619520090528,-1.0807139522035958,0.323943661971831,0.7336368329162267,1.0,14/53,18.56%,SLC13A4;SLC26A7;ENPP1;ANO1;ENPP3;CLIC5;SLC5A5;SLC25A11;FXYD1;CLCN2;PACC1;ANO8;CLCN1;RACGAP1
prerank,neutrophil activation involved in immune response (GO:0002283),0.37397747404762155,1.0804954243087121,0.246,0.905403345340915,1.0,106/428,22.38%,SYK;TIMP2;GSN;CD55;ARSA;B4GALT1;CD44;ANPEP;ANXA2;CD177;RAB6A;ACTR1B;TMBIM1;TCN1;S100A8;S100A9;MIF;SPTAN1;MAPK14;AP1M1;RAP1B;ACLY;TMEM63A;PTPRJ;TOM1;PLEKHO2;AP2A2;PRCP;RAB37;IDH1;DOK3;ATP11A;COPB1;CAPN1;SURF4;ARHGAP9;DYNC1LI1;PSEN1;IQGAP1;ABCA13;SNAP23;ITGAV;SIRPA;LPCAT1;CD47;CSTB;NRAS;RAB3D;SLPI;JUP;GLA;TMEM30A;XRCC5;NIT2;RHOA;CMTM6;TNFRSF1B;SNAP25;NME2;UBR4;CD14;SLC2A3;SLC15A4;HSP90AA1;DYNC1H1;DIAPH1;ATP6V1D;GAA;ATP6V0A1;PKM;IGF2R;PADI2;CTSD;CAP1;FABP5;RAB5B;CANT1;ILF2;PPIA;SLC44A2;RAB5C;CXCR2;PLAUR;COTL1;TMEM179B;VAMP2;PRG2;PYGB;RAB24;ALDOA;APAF1;DDOST;TOLLIP;ITGAM;RAB10;QSOX1;ACP3;MAPK1;PYCARD;COMMD9;ERP44;CAB39;CPNE1;ANXA3;STK11IP;SDCBP
prerank,protein dephosphorylation (GO:0006470),-0.23889898663515075,-1.0801532374566774,0.1875,0.7329289629236668,1.0,35/135,15.29%,PTPRK;PTPN14;EYA1;PTPRG;PTPRB;PPM1E;PPM1H;CTTNBP2NL;PTPRD;PPM1D;DUSP10;PTPN9;PTPRM;PTPRN2;PTPRZ1;SSU72;RPRD1B;PTPRO;PTPN1;UBLCP1;PPP2R2C;PPP1R15B;PPM1L;PPP2R5A;PTPRT;PTPN4;PTPN2;PPM1F;PTPN21;DUSP7;UBASH3B;PPP1CB;CTDNEP1;PPP4R1;TAB1
prerank,receptor-mediated endocytosis (GO:0006898),0.38094212163049607,1.0798569494807047,0.3353596757852077,0.9068860234122845,1.0,16/132,8.68%,ACKR3;SYK;LRP6;LRP1;CD9;DNM1;SPARC;AP1G2;CLTC;COLEC11;WASF1;AP2A2;PDLIM7;SNX1;CD81;INPP5F
prerank,ubiquinone metabolic process (GO:0006743),0.48834420324190325,1.0781714494948398,0.39572192513368987,0.911860172520566,1.0,4/15,10.71%,COQ10B;COQ7;AIFM2;COQ3
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.3894624277475568,1.078096179764926,0.36325678496868474,0.9113916974775026,1.0,17/87,14.55%,CDK2AP2;FHL1;PSMC4;ZFP36L1;DACT1;CDK4;PRMT2;PSMC6;PKD2;ZFP36L2;PSMD8;AVEN;BRD7;FBXO5;GPNMB;CDKN1A;KLF4
prerank,response to ionizing radiation (GO:0010212),0.3951736391026594,1.0777537258798315,0.3880597014925373,0.9117964243815432,1.0,17/70,18.60%,ANXA1;FANCD2;INTS3;MAPK14;RFWD3;COP1;IKBIP;INIP;RHNO1;RAD1;CDKN1A;ABRAXAS1;INO80;TNKS1BP1;SPIDR;BLM;SMPD1
prerank,cell-cell junction maintenance (GO:0045217),0.5268029076895601,1.07755799191549,0.41168289290681503,0.9117297254186968,1.0,4/11,8.34%,CD177;F2R;MYADM;PARD6A
prerank,Wnt signaling pathway (GO:0016055),0.39094745120058094,1.077453799877799,0.365702479338843,0.9113740710587585,1.0,10/92,5.12%,SFRP4;LRP6;WNT2;WNT10B;CCDC88C;WNT9A;PLPP3;AXIN1;ZRANB1;TCF7L2
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.48833214692450017,1.0773962112807827,0.38223938223938225,0.9108571454541209,1.0,5/15,19.03%,ATP1A1;KCNJ2;YWHAE;KCNJ3;KCNH2
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3865362226510627,1.0770848451054444,0.3414882772680938,0.9111913726506549,1.0,43/107,26.95%,NIBAN1;EIF2AK3;PIK3R2;THBS4;RASGRF1;CREB3L1;SYVN1;TMEM259;RCN3;SCAMP5;ERN1;HERPUD1;SELENOK;CEBPB;BBC3;BAK1;QRICH1;ATP2A2;EIF2S1;PDIA3;UFC1;SELENOS;NCK1;UFL1;BCAP31;UFM1;ATF6;ERP44;TMTC3;ATF4;USP19;JUN;DERL1;SEL1L;FLOT1;TMEM33;ATG10;UBXN6;HSP90B1;DDIT3;TMCO1;CFTR;MBTPS1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.4891972987301824,1.0770597757561673,0.3715415019762846,0.9105555830065599,1.0,9/15,32.30%,ACTR3;MAGEL2;ARPC5L;ARPC1A;ARPC2;ARPC4;ARPC5;WHAMM;TRIM27
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.32801411542170716,-1.0768986906091587,0.305,0.7397638970087084,1.0,6/22,14.01%,SLC16A2;NES;PTPRZ1;APPL2;MDK;TOX
prerank,negative regulation by host of viral transcription (GO:0043922),0.5232224801363947,1.0767770954305782,0.38873626373626374,0.9107427435720727,1.0,4/12,22.47%,TARDBP;INPP5K;TFAP4;JUN
prerank,negative regulation of immune response (GO:0050777),0.37850683491781645,1.0762377966949959,0.35317860746720486,0.9117956611351148,1.0,26/154,16.64%,COL3A1;SYK;VIPR2;FYN;IRAK3;MAPK14;ITCH;GLP2R;C1QBP;SRC;RC3H1;ADCYAP1;DPEP1;CRHR1;SIRT2;GPR20;CALCA;GPR45;TSHR;ADCY8;GNB1;LHCGR;FER;ILRUN;IL6;IAPP
prerank,positive regulation of biosynthetic process (GO:0009891),0.4247302155862809,1.0758694825939052,0.34966592427616927,0.9122723087813732,1.0,8/40,11.24%,TGFB3;RUNX1;F2R;CREB3L1;MTOR;MLXIPL;TLR4;AKT1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5147604402620789,1.0758313056760482,0.38605898123324395,0.9116723593048256,1.0,4/13,15.05%,CD44;MIF;TWIST1;SNAI2
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.4246305485497363,1.0757574322211754,0.37813211845102507,0.9111888686132367,1.0,12/38,18.18%,OTUD3;PTPRJ;BANK1;FLCN;PHLPP2;INPP5K;AKT1;MAGI2;PLEKHA1;NOP53;PPP2R5B;SFRP5
prerank,inorganic ion transmembrane transport (GO:0098660),0.5170639264669845,1.0757469854131463,0.4127659574468085,0.9105022430592827,1.0,6/12,28.37%,P2RX3;PKD2;ASIC2;ABCC8;KCNJ11;CACNA1H
prerank,glutamine family amino acid metabolic process (GO:0009064),0.4335291950853698,1.0754888829499392,0.3900709219858156,0.9106301257398034,1.0,11/33,20.76%,GCLC;ALDH18A1;ART4;NIT2;GLS2;GLS;ALDH5A1;GLUD1;PYCR1;DDAH2;GOT1
prerank,regulation of ion transport (GO:0043269),0.39466223443233545,1.0754452587969516,0.3704092339979014,0.9100587253133359,1.0,19/76,18.69%,SYT2;ITGB3;ATP1A1;SYT12;SYT11;SYT13;DTNBP1;KCNJ2;TOR1A;CLDN10;KCNA2;PXK;GDNF;KCNJ3;STC1;PER1;SYT1;SNX6;VAMP2
prerank,cytosolic transport (GO:0016482),0.38514208567988006,1.0753749250982685,0.35640495867768596,0.9095711305261146,1.0,51/108,31.51%,DCTN1;BET1L;RAB6A;CLTC;STX5;HOOK2;HEATR5A;RAB6B;VPS52;SNX1;WDR91;MAGEL2;TBC1D17;GGA1;TBC1D10A;TBC1D23;GOSR1;ARFRP1;TMEM87A;AP4M1;EVI5;ANKRD27;CORO7;PHETA2;SNX6;PREPL;DENND2A;STX16;ANKFY1;VTI1A;BAIAP3;SNX16;RAB29;RNF126;GOSR2;GBF1;RBSN;VAMP3;YKT6;PTPN23;STX8;LAPTM5;RHOBTB3;SPAG9;TBC1D5;RAB9B;TMEM87B;PIKFYVE;SNX5;AP2A1;RAB14
prerank,negative regulation of JNK cascade (GO:0046329),0.4401717821750642,1.0753153799718813,0.38941176470588235,0.9090559267718983,1.0,9/31,16.37%,TAOK3;DACT1;AIDA;ITCH;SIRPA;HDAC3;NCOR1;PER1;PDCD4
prerank,negative regulation of telomere maintenance (GO:0032205),0.4920506589013143,1.0752541778047802,0.40397350993377484,0.9085361714718996,1.0,7/15,23.30%,ERCC4;TERF1;NBN;SMG6;RAD50;TERF2IP;ERCC1
prerank,ganglion development (GO:0061548),-0.4144898785543918,-1.0746903715742973,0.34812286689419797,0.7438034228250364,1.0,3/11,14.38%,NRP2;NRP1;CTNNB1
prerank,nucleosome assembly (GO:0006334),0.44322937689185976,1.0746288592508255,0.37689614935822635,0.9099340263857637,1.0,16/31,32.85%,CHAF1B;SPTY2D1;NPM1;ANP32B;UBN1;GRWD1;NAP1L2;NAP1L3;KAT6B;BRD2;ATRX;HIRA;SOX9;RSF1;IPO4;NASP
prerank,myeloid cell development (GO:0061515),0.4753627441056333,1.0744179694511349,0.39331619537275064,0.9099140697950195,1.0,3/18,6.79%,ANXA2;FOXP1;SRC
prerank,neural crest cell development (GO:0014032),0.41564262339145835,1.0739812491127652,0.3924914675767918,0.9105853351018333,1.0,9/44,15.05%,SEMA3C;RADIL;SOX10;SEMA3A;SOX8;SEMA3D;GDNF;NOLC1;SNAI2
prerank,translational elongation (GO:0006414),0.3856882861277979,1.0739798918305135,0.3764102564102564,0.9098727228431347,1.0,24/101,17.04%,MRPS11;MRPL38;EEF2K;MRPS18B;GTPBP2;CHCHD1;MRPL13;MRPS17;AURKAIP1;MRPS27;MRPL30;DAP3;MRPL10;GFM1;MRPL55;MRPS10;LTN1;MRPL36;MRPL3;MRPL21;MRPS34;MRPL51;EEF1B2;EEF1G
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.4132581081550351,1.0739340189939741,0.385038503850385,0.909317725797214,1.0,23/52,28.82%,MBNL1;HNRNPA1;SRSF6;RBM4;NSRP1;MBNL2;CELF2;RBFOX2;DDX17;SAP18;FXR2;DDX5;PUF60;NOVA1;PTBP1;THRAP3;RBM5;RBM24;CELF3;RBMX;CELF1;RBM15;ZBTB7A
prerank,embryonic digestive tract development (GO:0048566),0.4733474310360729,1.0737276718029451,0.38107416879795397,0.9092784835227402,1.0,5/18,12.80%,PCSK5;TGFB2;GLI2;GLI3;PDGFRA
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.3477868793610231,-1.0733275877600215,0.3275862068965517,0.7453546951489413,1.0,4/23,2.10%,PRKAG2;CEMIP;BMP7;APP
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.43215289469207924,1.0733008883445978,0.40675990675990675,0.9099763411897073,1.0,11/36,18.18%,TAOK3;DACT1;AIDA;ITCH;FOXO1;SIRPA;HDAC3;NCOR1;PER1;PPIA;QARS1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5043217007240224,1.0729863533823698,0.39017735334242837,0.9103220098830076,1.0,4/13,10.32%,CHST1;NAGK;OGA;LARGE1
prerank,regulation of response to cytokine stimulus (GO:0060759),0.46902740307724966,1.072927698363488,0.40960809102402024,0.9098254752317451,1.0,4/19,14.55%,MAPK7;RUNX1;IRAK1;KLF4
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.4061357546272798,1.0726996467515433,0.3751363140676118,0.9091424581247473,1.0,23/51,31.19%,LMNA;REEP3;CHMP7;NUP93;AHCTF1;NUP107;NUP98;SIRT2;NUP37;PPP2R2A;CC2D1B;ANKLE2;IST1;EMD;NUP85;NUP133;NUP188;KPNB1;SUMO1;CHMP4C;CHMP4A;CHMP4B;SEC13
prerank,mitotic nuclear membrane organization (GO:0101024),0.4061357546272798,1.0726996467515433,0.3751363140676118,0.9091424581247473,1.0,23/51,31.19%,LMNA;REEP3;CHMP7;NUP93;AHCTF1;NUP107;NUP98;SIRT2;NUP37;PPP2R2A;CC2D1B;ANKLE2;IST1;EMD;NUP85;NUP133;NUP188;KPNB1;SUMO1;CHMP4C;CHMP4A;CHMP4B;SEC13
prerank,cell-cell junction assembly (GO:0007043),-0.27051540325403994,-1.0725647970165046,0.3064516129032258,0.7452576094812283,1.0,12/63,7.92%,TJP1;PKP4;CDH5;GJB6;CLDN5;PATJ;GJB2;CDH6;ACTB;TLN2;GJA1;CDH7
prerank,protein methylation (GO:0006479),0.4124519050541411,1.0725469323740564,0.38111490329920367,0.908919807917039,1.0,14/40,26.53%,RAB6A;PRMT2;NTMT1;EHMT2;GSPT1;SNRPD3;EEF2KMT;N6AMT1;NSD1;CARM1;ICMT;EZH2;CAMKMT;EEF1AKMT3
prerank,cilium organization (GO:0044782),0.37540678163658275,1.071929987542928,0.3350050150451354,0.9102564653000116,1.0,72/209,27.02%,GSN;NME8;CDC14B;ODF2;ABLIM1;PKD1;RAB23;FHDC1;ARF4;ACTR3;HDAC6;BBS9;PKD2;ATAT1;ARL13B;TMEM138;CPLANE1;OCRL;EHD2;CNGB1;NUDCD3;DZIP1;TTC39C;AVIL;TEKT5;PIBF1;KIF3A;DYNC2I2;RPGR;KIF3B;IFT46;TTLL3;BBS4;TTC8;ATP6V1D;CCP110;AHI1;FAM161B;DYNC2H1;CEP164;CEP89;CCDC28B;DYNC2I1;CEP83;RP2;BBS5;IFT52;BBIP1;EXOC4;CC2D2A;SPAG16;FLNA;PCM1;DNAH5;FBF1;TMEM231;PDE6D;TCTN2;RAB11FIP3;CFAP126;DYNLL1;TCTN1;CEP78;CDC14A;CEP126;NEK1;RAB1A;CFAP70;KIFAP3;GBF1;RAB8B;IFT81
prerank,female gonad development (GO:0008585),0.47139524693045914,1.0718844902765299,0.41811414392059554,0.9096944556068838,1.0,7/19,14.41%,ANG;VEGFA;INHA;NUP107;COL9A3;CEBPB;LHCGR
prerank,positive regulation of cholesterol transport (GO:0032376),-0.3279650019757985,-1.0718471637560938,0.34210526315789475,0.7450441097945136,1.0,10/27,16.65%,PLTP;PTCH1;APOE;NR1H3;CAV1;SIRT1;ABCA3;NFKBIA;EEPD1;ABCA5
prerank,regulation of acute inflammatory response (GO:0002673),0.4769837307985554,1.0717193631769093,0.4002607561929596,0.909558243364144,1.0,6/18,33.06%,KLKB1;IL4;IL6;OSMR;PTGES;IL6ST
prerank,response to X-ray (GO:0010165),0.4962712363337669,1.0716022368294484,0.4092178770949721,0.9092489261780907,1.0,5/14,18.50%,ANXA1;IKBIP;XRCC5;NIPBL;BLM
prerank,response to prostaglandin E (GO:0034695),-0.43398541488093195,-1.0714309375445927,0.3737024221453287,0.7439953733218743,1.0,5/10,24.95%,TGFBR3;SFRP1;GNG2;CCL19;ADCY6
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.37799074906853464,-1.07135102562187,0.34519572953736655,0.742085476393537,1.0,6/14,17.93%,IL34;THBS1;MDK;MAPK3;PTK2;RARRES2
prerank,negative regulation of vascular permeability (GO:0043116),0.5083015094967019,1.071274981049744,0.3903448275862069,0.9096676076843447,1.0,3/12,5.31%,VEGFA;SLIT2;PTPRJ
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.4310776472777752,1.07114262850946,0.38838268792710706,0.9094062937778101,1.0,5/35,11.53%,GHR;F2R;IL10RA;EGF;BCL3
prerank,regulation of protein export from nucleus (GO:0046825),-0.3277315093875305,-1.070824761420274,0.3333333333333333,0.7413529423077158,1.0,3/23,1.29%,PTPN14;SP100;RAPGEF3
prerank,regulation of Ras protein signal transduction (GO:0046578),0.39185162832759995,1.0703164558781322,0.3653250773993808,0.91142798835897,1.0,21/85,16.64%,EPHB2;ARHGEF28;ARHGAP44;AKAP13;PLCE1;TGFB2;RASGRF1;RASGEF1A;FLCN;MYO9B;ARFGAP1;SQSTM1;KANK1;IRS2;SHOC2;DENND1A;ARF6;RAPGEF1;OGT;MADD;EPS8L2
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.4780587777142801,1.0703128266825361,0.3994910941475827,0.9107296164963521,1.0,3/18,9.80%,IRS1;MIDN;BMP8A
prerank,negative regulation of intracellular protein transport (GO:0090317),0.4589241650917886,1.0701146926692244,0.4070904645476773,0.9106844577058875,1.0,9/22,18.71%,RAB23;MDFIC;LMAN1;GDI1;INPP5K;CABP1;BAG4;CHP1;UFM1
prerank,aminoglycan catabolic process (GO:0006026),0.4414914576595496,1.0700118307024542,0.3872901678657074,0.9103312606657469,1.0,7/28,18.16%,GPC6;GPC3;HSPG2;NAGLU;SDC2;IDUA;OVGP1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.3919456719530371,1.069861345070363,0.3583509513742072,0.9101299113750481,1.0,28/72,28.97%,RNASE4;GTF2H3;EDC4;PNRC2;DNA2;ERCC3;UBA52;FAN1;ERCC4;RNASE6;DDB1;ZC3H12A;DNASE1L2;RFC4;RAD50;ERCC5;POLD1;OGG1;ERCC1;EDC3;RNASE1;DNASE1L1;DCP1A;DCP1B;DDX1;MEI4;RFC3;PDE12
prerank,establishment of melanosome localization (GO:0032401),-0.35148052439088917,-1.0694967871914147,0.31981981981981983,0.7428314807186638,1.0,8/19,18.55%,SHROOM2;BLOC1S5;RAB11A;BBS7;MREG;RAB27A;BLOC1S6;MLPH
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.4445051849954604,-1.0694075959212104,0.3864406779661017,0.7408888021049052,1.0,5/10,16.20%,ATP5F1C;ATP5F1D;ATP5MG;ATP5PD;ATP5MC2
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3984688673320395,1.0693727312413588,0.38389121338912136,0.9110390533676651,1.0,19/70,21.86%,SYK;FYN;WIPF1;PIK3R2;MYO10;SRC;ACTR3;ABI1;PIK3CA;MYH2;HSP90AA1;NCK1;ARPC1A;ACTG1;ARPC2;PLD2;MAPK1;YES1;VAV2
prerank,regulation of lamellipodium assembly (GO:0010591),0.436020962481753,1.069367132171274,0.3783783783783784,0.91036247451262,1.0,10/34,17.19%,PLCE1;SLIT2;AKIRIN1;FSCN1;ACTR3;PIK3CA;TWF1;AVIL;FER;ARPC2
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.4312600329135858,1.069343325676623,0.3811764705882353,0.9097410135072059,1.0,6/31,12.60%,DBN1;ARHGAP44;PPFIA2;SRCIN1;TANC2;NGEF
prerank,positive regulation of gene expression (GO:0010628),0.36740998634149524,1.069332732755987,0.276,0.9090664834910872,1.0,68/442,14.18%,CD34;SFRP4;AR;GSN;EPHB2;SEC16B;FGF18;AMH;NIBAN1;FGF7;C1QTNF1;EGFR;POLR2H;GLMN;WT1;HPN;TMEM119;PKP3;EIF2AK3;ANK2;VEGFA;FGF2;DGKQ;CAMK2N1;RBMS3;MIF;NFE2L2;ZPR1;MAPK14;ADAM19;MTOR;IL33;DTNBP1;HOXA5;TENT4A;PID1;SCAMP5;GAS6;POLR1G;LARP4;VDR;PSEN1;AGO2;HNRNPD;RBM22;TLR4;MAPK11;KAT2B;MITF;MUSK;ERN1;NPM1;DDX21;EGF;AKT1;KRAS;BCL3;SLC2A10;PASK;NAT8;EIF6;RPS27L;NWD1;ZCCHC4;TWIST1;ZC3H12A;RBM3;POLDIP3
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.38528388815975817,-1.0692676438495474,0.32916666666666666,0.739124834602347,1.0,9/14,25.44%,TFB1M;MTERF2;FASTKD1;TEFM;PNPT1;POLRMT;TWNK;FASTKD5;TFB2M
prerank,regulation of Golgi organization (GO:1903358),0.47851490325214097,1.0688881913880228,0.37516339869281046,0.9097756831772058,1.0,9/17,27.40%,STX5;MYO5A;MAP2K2;RAB33B;AKAP9;ARMH3;MAPK1;RBSN;PDE4DIP
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.38757864013421994,1.0682598733882556,0.38095238095238093,0.9110944289673955,1.0,19/84,19.70%,IGFBP5;EIF2AK3;BIN1;RBM4;PAIP2B;TRIM71;SAMD4B;MRPL13;ORMDL2;IGF2BP1;LARP1;PIN1;CNOT10;RTN3;FXR2;CHRNA7;EPRS1;PAIP2;PCIF1
prerank,stabilization of membrane potential (GO:0030322),0.48464739046593014,1.0681239858762974,0.40568475452196384,0.9108044856940354,1.0,3/16,9.47%,KCNK5;KCNK13;KCNK9
prerank,negative regulation of macrophage activation (GO:0043031),0.4838998837744167,1.0679751188234874,0.4170984455958549,0.9106114937822959,1.0,7/16,23.09%,SYT11;NR1D1;ZC3H12A;IL4;LRFN5;IL31RA;LDLR
prerank,positive regulation of kinase activity (GO:0033674),0.380355727534434,1.06790551492406,0.3712820512820513,0.9101489436285641,1.0,26/107,14.36%,DDR2;EPHB2;AXL;EGFR;FGFR1;CAMKK1;EPHA3;MST1R;MAP2K3;MAPRE3;RASSF2;RET;ADCYAP1;GAS6;TIGAR;IQGAP1;EPHB3;MUSK;MAPT;EPHA10;XRCC5;PDGFRA;CDKN1A;FLT3;DDR1;NBN
prerank,telomere maintenance (GO:0000723),0.4035162379157652,1.0677726956523066,0.391304347826087,0.9098880337836266,1.0,19/50,23.98%,PARP3;XRCC3;CTC1;ACD;SMC5;DNA2;XRCC5;ERCC4;TERF1;SMC6;NBN;RAD50;BLM;POLD1;TINF2;TEP1;TERF2IP;NSMCE2;LTO1
prerank,regulation of autophagosome assembly (GO:2000785),0.43021307113622204,1.0676385044879715,0.4045077105575326,0.9096387206201477,1.0,16/33,30.94%,SEC22B;SCFD1;SMCR8;NUPR1;PIP4K2C;RAB1B;ADPRH;LRSAM1;PIP4K2B;TBC1D12;MTM1;TMEM39A;PIKFYVE;CHMP4A;CHMP4B;IFT20
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.4092255517407193,1.0670879068327561,0.38100436681222705,0.9107829437633611,1.0,14/46,25.43%,TIMM50;GDAP1;TIMM10B;TIMM9;AKT1;GRPEL2;TIMM22;TIMM8B;BCAP31;RALA;TOMM5;TIMM17A;FIS1;TOMM40
prerank,actin cytoskeleton reorganization (GO:0031532),0.39729355901063906,1.0669906253643469,0.395021645021645,0.9103805549208425,1.0,9/63,9.87%,ANTXR1;GSN;FGF7;ANXA1;DTNBP1;FARP2;S1PR2;MCU;EFS
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.40812744646584853,1.0667267767577375,0.38327904451682954,0.9105424875032468,1.0,11/55,13.85%,UCP1;TGFBR2;MAPK14;COQ7;ARF4;PID1;DHRS4;SIRT2;EIF6;CDKN1A;ZC3H12A
prerank,regulation of macroautophagy (GO:0016241),0.37837616929375734,1.0666096322533571,0.363265306122449,0.9102160521861876,1.0,24/105,16.28%,DCN;UCHL1;GNAI3;USP36;ATP6V0A2;MTOR;PRKAB2;HDAC6;CAPN1;GPSM1;PIK3CA;NRBP2;ERN1;AKT1;ATP6V1E1;SESN3;LARP1;SMCR8;RRAGD;ULK1;IL4;ATP6V1D;ATP6V0A1;ATP6V1B2
prerank,cellular response to superoxide (GO:0071451),-0.4382702993797439,-1.0664546233297978,0.4212328767123288,0.7448383514892455,1.0,5/10,18.66%,NOS3;PRDX1;SOD1;PRDX2;MT3
prerank,positive regulation of cell aging (GO:0090343),0.5216380492660241,1.0664109281096288,0.4072524407252441,0.9101644738811338,1.0,4/11,16.33%,LMNA;CGAS;YPEL3;EEF1E1
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3978721081806371,1.0663925104714593,0.3880753138075314,0.9095357052004193,1.0,19/71,21.86%,SYK;FYN;WIPF1;PIK3R2;MYO10;SRC;ACTR3;ABI1;PIK3CA;MYH2;HSP90AA1;NCK1;ARPC1A;ACTG1;ARPC2;PLD2;MAPK1;YES1;VAV2
prerank,regulation of viral life cycle (GO:1903900),0.4612210671113682,1.066153732322143,0.4093198992443325,0.9096317168141096,1.0,6/21,20.60%,AXL;KPNA2;HS3ST5;TRIM68;PPIA;TYRO3
prerank,metal ion transport (GO:0030001),-0.2470475117697929,-1.0660171154066833,0.358974358974359,0.7438634916932759,1.0,20/86,12.66%,ITPR1;CALCRL;SLC41A1;CACNA1E;ATP2C1;SLC8A3;RAMP1;SLC39A8;CACNA1D;TRPC5;CAV1;SLC3A2;SLC30A1;TRPC4;RYR2;CACNG8;NDFIP2;ATP2A3;TRPV4;NIPA2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.5260262948236424,1.0659660243597726,0.39528432732316227,0.9095384198775146,1.0,1/10,1.23%,DPP4
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.5237627793918143,1.065523068496877,0.40198863636363635,0.9103006620290038,1.0,6/10,28.45%,C1QBP;SEC14L1;TSPAN6;UFD1;RIOK3;NPLOC4
prerank,regulation of protein localization to cell periphery (GO:1904375),0.477674166730921,1.06547194597752,0.40633245382585753,0.9097611080912036,1.0,4/18,15.96%,AR;ZDHHC7;ZDHHC2;SPTBN1
prerank,regulation of B cell activation (GO:0050864),0.4430948788732477,1.0652387446136617,0.4045346062052506,0.9098085477116061,1.0,5/25,16.45%,ZFP36L1;BANK1;ZFP36L2;IL4;IL6
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.45907938498747836,1.065160816687092,0.4191852825229961,0.9093552388393055,1.0,7/22,22.99%,TIMP2;ADAM9;TNFRSF1B;GPLD1;PTPN3;SH3D19;PACSIN3
prerank,regulation of cardiac conduction (GO:1903779),-0.2809949087273518,-1.0648556610716806,0.2875,0.7447373458004132,1.0,12/54,11.88%,ATP1A2;ITPR1;ATP1B3;AHCYL1;SLC8A3;ABCC9;ITPR3;NPR1;FXYD1;RYR2;ATP2A3;NOS1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.5198772404762408,1.0648432103363972,0.42075736325385693,0.9097325039948789,1.0,2/10,3.59%,NPTN;DLG4
prerank,protein processing (GO:0016485),0.38549299028437445,1.0646790528379044,0.3726899383983573,0.9095767898502283,1.0,25/102,19.16%,PCSK6;PCSK5;KLKB1;PRSS12;ADAM19;ADAMTS3;TMEM208;PCSK4;SPCS1;PSEN1;ECE1;SEC11C;XPNPEP3;EEF1AKMT4-ECE2;ECE2;KLK1;KLK6;RCE1;FAM111A;OGT;SPG7;HTRA2;MMP16;METAP2;PCSK7
prerank,negative regulation of myotube differentiation (GO:0010832),0.49956206074541887,1.0646721317115222,0.41120218579234974,0.9089033308462546,1.0,3/12,14.10%,TMEM119;HDAC3;HDAC4
prerank,regulation of cellular response to heat (GO:1900034),0.38918199972116635,1.0646372814652747,0.3953732912723449,0.9083341172775853,1.0,26/77,25.64%,CD34;NUP93;MTOR;CAMK2D;DNAJC2;NUP107;YWHAE;NUP98;MAPT;HSP90AA1;HSBP1;NUP37;BAG4;CHORDC1;FKBP4;NUP50;DNAJB1;MAPK1;BAG3;TPR;CRYAB;BAG5;HSPH1;NUP85;NUP133;NUP188
prerank,response to organonitrogen compound (GO:0010243),0.417402391758207,1.0642833190298928,0.39578713968957874,0.9087846867934465,1.0,5/38,6.23%,IRAK3;SYVN1;MTOR;RCN3;MEAK7
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.391979022801457,-1.0641908121570618,0.348,0.7443982774278831,1.0,2/14,3.53%,ADAM10;WNT5A
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.3158642750683619,-1.0638535637843058,0.2847222222222222,0.7431868932920417,1.0,5/31,3.83%,RANBP3L;TMEM64;PTCH1;NOTCH1;CDK6
prerank,positive regulation of phospholipase activity (GO:0010518),0.4607979194210919,1.063692358724352,0.41309823677581864,0.9099803307000114,1.0,5/22,7.51%,ESR1;FGFR1;FGF2;ARF4;ABL2
prerank,mRNA splice site selection (GO:0006376),0.4380168675236665,1.0636488037318297,0.4133489461358314,0.9094314568844108,1.0,15/30,31.93%,SRSF6;KHDC4;CELF2;SF3A1;PSIP1;LUC7L3;PUF60;LUC7L2;CELF3;CELF1;SNRPC;SRSF5;CELF4;SF1;SF3A2
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.48285602060148436,1.0635754611488621,0.3991989319092123,0.9089988204590643,1.0,6/16,23.59%,AMPD2;PAICS;GART;ATIC;ADSS2;LHPP
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5241239622032304,1.0635133920620967,0.4013793103448276,0.9085293782084769,1.0,7/10,28.09%,SIRT2;NCK1;DNAJB1;BAG3;JUN;VHL;IMPACT
prerank,positive regulation of glucose metabolic process (GO:0010907),0.4904514640651699,1.0635002301194787,0.41420911528150134,0.9078859628210878,1.0,5/14,19.41%,IRS1;AKT1;IRS2;DDB1;GPLD1
prerank,positive regulation of nuclear division (GO:0051785),-0.3306901077776351,-1.0633582395460235,0.3259668508287293,0.7424182553629624,1.0,6/25,9.50%,INSR;TGFA;IGF1;RGCC;IGF2;PDGFRB
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.4945682415212461,1.0631224674283788,0.4208389715832206,0.9084543743062926,1.0,7/14,24.20%,CPSF6;ERN1;CPSF4;CPSF2;CSTF2T;CPSF7;CPSF1
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.3834861836492907,1.0630320088424987,0.3874614594039055,0.9080677525827059,1.0,21/113,11.44%,AREG;FGF7;PRKCA;EGFR;HPN;ITGB3;ANG;SRSF6;VEGFA;FGF2;ECM1;THBS4;TCF7L2;PRKD2;STAT5A;FZD7;AKT3;EMC10;EGF;AKT1;NRAS
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.27745920938739566,-1.0628219466331408,0.390625,0.7417827456604882,1.0,13/62,8.76%,LYN;H3-3A;MEF2C;CREBBP;KMT2E;THBS1;CDK6;PURB;HSPA9;MYL9;MEIS1;CTR9;PRKCQ
prerank,transferrin transport (GO:0033572),0.4246077620608185,1.062444016940373,0.3851508120649652,0.9093535567226192,1.0,9/33,16.28%,STEAP3;CLTC;ATP6V0A2;ATP6V1E1;ATP6AP1;REP15;ATP6V1D;ATP6V0A1;ATP6V1B2
prerank,embryonic axis specification (GO:0000578),-0.36036129591149824,-1.0619647744889942,0.38306451612903225,0.7421107771951879,1.0,3/15,3.57%,PTCH1;CXXC4;TBX3
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.26388884316278105,-1.061928840050178,0.29411764705882354,0.7401190414007102,1.0,19/70,14.11%,SORT1;BCL2L1;SMAD3;BCL2;DAB2IP;IL6R;CASP8AP2;TNFSF12;DELE1;CASP3;GABARAP;TLR3;INHBA;FAS;RIPK1;TGFB1;CASP9;BCL2L2;DEDD2
prerank,neuromuscular process (GO:0050905),0.4789723229813898,1.0618861927579366,0.4015645371577575,0.9104354602405136,1.0,3/16,8.00%,DCTN1;MYCBP2;TPP1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.46721261425808563,1.0613642994438628,0.38875,0.9114374962064725,1.0,8/19,25.36%,USP36;HDAC6;CAMKK2;VDAC1;HTRA2;SREBF1;CSNK2A2;FBXW7
prerank,postsynaptic membrane organization (GO:0001941),0.47059726612847447,1.061333810405584,0.4142857142857143,0.910849596010029,1.0,4/17,14.06%,CEL;DLG4;MUSK;DNAJA3
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.3984889400550464,-1.061046556527056,0.3595505617977528,0.7406861467630192,1.0,2/12,2.02%,GCNT2;BMP7
prerank,nervous system development (GO:0007399),0.36553625123242894,1.0606614130608374,0.295,0.9123426301882125,1.0,98/429,19.58%,GSN;EPHB2;NAV2;AXL;WNT2;NAV1;DCLK1;SCIN;EFNA5;NUMBL;MBNL1;PMP22;DCTN1;NEUROD2;VEGFA;FGF13;FGF2;MST1R;GLIS2;APBA1;DLG4;LPAR1;DPF2;WWTR1;PKD1;ACAN;SOX10;DACT1;VCAN;NAB1;MARCKS;TRIM71;ALDH3A2;JRKL;DPF1;FARP1;TRAK2;MTF1;ADAM22;PKD2;TBX6;SCRG1;TPP1;MYLIP;SOX8;SH3GL1;JAG1;DAGLA;SIAH1;GDA;PCDHA1;DSCAM;LSAMP;L1CAM;IRF2BPL;GBA2;AVIL;RBFOX2;IGF2BP1;KLK6;FLRT3;LGI1;MTR;MOBP;GDNF;GJB1;ASIC2;HDAC4;ARTN;MOG;NDUFV2;CNTFR;SH3GL3;TMOD2;POU3F2;NR2C2;ALDH5A1;DAGLB;CDK5RAP2;NAGLU;AHI1;CXCR4;SPG7;PRPS1;BTD;TGFBR1;NAV3;GMFB;EPHB1;CNTN4;GPM6A;SMPD1;MBP;SCD5;COX7B;SNTG2;APAF1;NBL1
prerank,protein targeting to lysosome (GO:0006622),-0.3449510928959293,-1.0603559157556322,0.3645320197044335,0.740562411792733,1.0,5/20,11.13%,SCARB2;GGA3;RAB7A;SORL1;GCC2
prerank,multivesicular body organization (GO:0036257),0.42968907896736624,1.059907728380763,0.4211150652431791,0.9140873042391574,1.0,10/31,24.05%,CHMP7;VPS4B;MVB12A;VPS37D;VPS37C;VPS37B;VPS36;PDCD6IP;IST1;STAM
prerank,mitochondrion morphogenesis (GO:0070584),0.5155192142182203,1.0594903113705785,0.41304347826086957,0.9147336684331355,1.0,6/11,24.79%,WASF1;PID1;MYH14;SUPV3L1;FIS1;MTM1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.38702345563759066,1.0594813003938504,0.40756302521008403,0.9140700287393636,1.0,16/87,14.65%,CORO2B;LRP1;ARHGAP44;EFNA5;EPHA3;MTOR;FSCN1;ABL2;PIK3CA;IQGAP1;RHOQ;TWF1;PDGFRA;TAOK2;RHOA;RND3
prerank,copper ion transport (GO:0006825),0.5103651756105978,1.0593898653193508,0.39077340569877883,0.913662880133273,1.0,2/11,6.64%,STEAP3;SLC11A2
prerank,heme catabolic process (GO:0042167),-0.3851062857661395,-1.059240209342502,0.39759036144578314,0.7394875172623355,1.0,2/14,1.58%,ABCG2;SLCO2B1
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.3851062857661395,-1.059240209342502,0.39759036144578314,0.7394875172623355,1.0,2/14,1.58%,ABCG2;SLCO2B1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.4889289472270676,1.058968268660749,0.4196547144754316,0.9143393863935205,1.0,6/15,22.76%,HECW2;CDC23;CDC27;CENPE;RIOK2;TPR
prerank,P-body assembly (GO:0033962),0.4972347355192977,1.058816133302451,0.43621399176954734,0.9141456037913996,1.0,4/12,14.86%,RC3H1;LSM4;ATXN2;DYNC1H1
prerank,serine family amino acid metabolic process (GO:0009069),0.47115198752228693,1.058622142483972,0.42428198433420367,0.9141133443126496,1.0,1/16,0.81%,GCLC
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5176687264683804,1.0585318206203216,0.42213114754098363,0.913696494522675,1.0,6/11,29.74%,CREB3L1;CEBPB;ATF6;ATF4;DDIT3;TP53
prerank,chromatin assembly or disassembly (GO:0006333),0.5185712654685116,1.0583139778698576,0.41889985895627646,0.9137219087303349,1.0,2/11,7.30%,CHAF1B;NOC2L
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.3266020106029435,-1.0580608503710267,0.366120218579235,0.7406941591790093,1.0,11/25,28.23%,IGF1;NIBAN2;TGFB1;SOX11;MAD2L2;HEY1;HEY2;TRIM6;RB1;PARK7;SIN3A
prerank,potassium ion homeostasis (GO:0055075),0.4559804743069131,1.0575142062118845,0.39501779359430605,0.9155755766912387,1.0,7/23,7.45%,KCNMA1;SLC12A8;ATP1A4;ATP1A3;ATP1A1;KCNJ2;SLC12A4
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.40754440505345246,-1.0572876862153322,0.3890909090909091,0.7407827180550444,1.0,9/11,46.71%,PRKCQ;MALT1;NFKBID;IL12RB1;CARD9;IL23A;IL12B;IL23R;CLEC6A
prerank,regulation of cellular localization (GO:0060341),0.40790809256227234,1.0571458837282108,0.42105263157894735,0.9160745675827551,1.0,13/46,17.49%,GSN;EFNA5;CAMK2D;NR1D1;TRIM46;PARD6A;GOSR1;FER;HSP90AA1;DYNC1H1;REEP5;TTL;TRIM67
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4073293032513665,1.0571141298727196,0.4048140043763676,0.9154787770727113,1.0,6/53,14.41%,LPAR3;ANXA1;MTNR1B;HTR1F;TSHR;LHCGR
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.4105641368100807,-1.057093974132657,0.3686274509803922,0.7391470304715906,1.0,5/13,10.42%,SORBS1;IGF2;ECHDC3;SORL1;SIRT1
prerank,cellular response to amino acid stimulus (GO:0071230),0.4250847888194699,1.057079331236182,0.40945790080738176,0.9149171332495949,1.0,13/33,23.18%,FYN;CAPN2;MTOR;SESN3;NSMF;RRAGD;CPEB1;IPO5;CASTOR2;KLHL22;SESN2;UBR2;SLC38A9
prerank,regulation of macrophage migration (GO:1905521),0.5206945141690358,1.0570238944701662,0.40431654676258993,0.9144264070462615,1.0,3/10,21.79%,CD81;CD200R1;CSF1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5266631511481961,1.0569288484324122,0.4246771879483501,0.9140461478637499,1.0,5/10,18.83%,JAM3;MUC1;PDE3B;SNAI2;CYP1B1
prerank,mesoderm formation (GO:0001707),0.47219051735594914,1.0568908725374142,0.41762452107279696,0.9134781631716644,1.0,2/17,4.49%,ITGB3;ITGA2
prerank,RNA interference (GO:0016246),0.4730881039574958,1.05634337508299,0.40632911392405063,0.9145510331002656,1.0,6/17,27.65%,TARBP2;AGO2;AGO4;AGO3;CELF1;AGO1
prerank,cellular response to interferon-gamma (GO:0071346),0.38091558113772184,1.0563105253485774,0.3903966597077244,0.9139921607631194,1.0,11/88,13.15%,MID1;CCL8;IRF4;CD44;CAMK2D;CCL25;TLR4;SIRPA;CD47;SLC26A6;CCL13
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4211831383892666,1.0559347189457875,0.41628440366972475,0.9144944049569415,1.0,10/38,21.01%,ESR1;USP10;NR1D1;OTUD7B;TNIP1;ZC3H12A;PER1;RORA;PPM1A;PYCARD
prerank,negative regulation of axon extension (GO:0030517),0.43216199326720284,1.0558813138511394,0.4221165279429251,0.9139781208884259,1.0,5/30,12.60%,SEMA3C;PTPRS;TRIM46;SEMA3A;SEMA3D
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.3372550808402528,-1.0551798386818347,0.3502824858757062,0.7422265077161525,1.0,4/23,3.96%,INSR;IGF1;APP;PRKAA2
prerank,response to interleukin-6 (GO:0070741),-0.42503887263418016,-1.0547389963372318,0.3898305084745763,0.7414607903828342,1.0,3/10,10.46%,ST3GAL6;PTGIS;PTPRT
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4802811595102802,1.0545054727385907,0.4184491978609626,0.917713286908324,1.0,4/15,10.32%,CHST1;NAGK;OGA;LARGE1
prerank,negative regulation of protein metabolic process (GO:0051248),0.404667158130428,1.054475115662172,0.4004400440044004,0.9171343372060464,1.0,19/48,27.73%,EGFR;ITGB3;IRAK3;MDM4;SIRT2;ITGAV;PIN1;FLOT2;IAPP;PFDN6;FLNA;FMN2;AZIN2;LDLR;CRYAB;VBP1;PFDN2;PRKCG;NFKB1
prerank,regulation of B cell proliferation (GO:0030888),0.40534760380217805,1.054447608389498,0.41564245810055866,0.9165418895601031,1.0,9/44,15.09%,EPHB2;MIF;CLCF1;RC3H1;TIRAP;CD81;TNFSF13B;IRS2;IL4
prerank,manganese ion transport (GO:0006828),-0.3900122773137279,-1.0543602815916957,0.364,0.7405622378218398,1.0,8/14,13.95%,ATP2C1;SLC30A10;SLC39A8;TRPC5;TRPC6;TRPC4;TRPC7;TRPC3
prerank,chromatin remodeling (GO:0006338),0.3764588704122339,1.0538050394050524,0.3845360824742268,0.9179899121201105,1.0,48/100,32.22%,ESR1;SMARCD2;SMARCD1;POLE3;ZBTB1;SATB2;KAT2B;KDM5C;NPM1;SMARCC2;ACTR5;KDM5B;DR1;INO80;EZH1;HDAC4;GATAD1;CHD8;SMARCA4;BAHD1;SRCAP;BAZ2B;NUDT5;CHD3;TAF6L;BAZ2A;KDM4C;BAZ1A;MBD2;INO80C;ARID1A;JARID2;ARID1B;CHRAC1;KDM4B;TADA2A;PBRM1;ZBTB7A;ATRX;HNRNPC;SOX9;MBD3;HCFC2;HCFC1;RSF1;TADA2B;RUVBL1;KDM4D
prerank,nuclear envelope organization (GO:0006998),0.4564704209033422,1.0536759524907853,0.40425531914893614,0.917728789623487,1.0,4/20,9.30%,TMEM43;REEP3;NUP93;TOR1A
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.41257785679170367,1.0536585516493566,0.4147727272727273,0.9171028415419087,1.0,16/44,27.30%,ZFP36L1;RC3H1;ZFP36L2;AGO2;ZC3HAV1;PUM1;ZFP36;POLR2G;ZC3H12A;YTHDF2;YTHDF1;YTHDF3;TNRC6A;RBM24;CELF1;UPF1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.4343442850214534,1.053313653327493,0.41854934601664684,0.9174975057451671,1.0,10/29,19.83%,MRPS11;ABT1;KRI1;NOP9;RRP36;WDR46;DCAF13;PWP2;TBL3;NOL10
prerank,negative regulation of cell population proliferation (GO:0008285),0.3645582999410208,1.0532748301632826,0.335,0.9169527348626106,1.0,42/351,10.16%,NOX4;SFRP4;MN1;IGFBP5;AR;TGFB3;SCIN;GLMN;FAP;WT1;HPN;DIS3L2;RPS6KA2;ADARB1;TNN;ANG;OGN;WNT9A;TGFB2;TNS2;CAMK2N1;F2R;IGFBP6;LMNA;ATF5;SKI;GTPBP4;PTPRJ;ZBTB7C;MDM4;PLPP1;FLCN;PKD2;ABI1;NDRG4;CYP27B1;VDR;SIRT2;KAT2B;ING4;SMAD6;BRD7
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.34021391093923886,-1.0530998643315903,0.37438423645320196,0.742016410885717,1.0,10/22,31.49%,WNT5A;SLC7A5;LACC1;SPHK2;NOD2;BTK;TRIM6;CCR2;TNFRSF14;LILRB1
prerank,protein prenylation (GO:0018342),0.5133548381432143,1.0528880357922816,0.4206128133704735,0.917519127701145,1.0,6/10,33.37%,RABGGTA;RCE1;RABGGTB;CHML;CHM;FNTB
prerank,immunoglobulin mediated immune response (GO:0016064),0.5308333200247425,1.0526856073392654,0.430835734870317,0.9174720813758037,1.0,2/10,12.41%,CD81;CD27
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.48283927745270416,1.052404916267145,0.42618741976893454,0.9176826663750929,1.0,4/16,18.54%,EME1;RMI1;ERCC4;TOP2B
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.38502733631768804,-1.0523904677060245,0.35968379446640314,0.7418707433480861,1.0,4/13,16.70%,BMP5;APOE;BMP2;SOD1
prerank,positive regulation of catabolic process (GO:0009896),0.39063385095399417,1.0522361585485034,0.4319654427645788,0.9175279143920698,1.0,18/65,21.72%,GPC3;STX5;SMURF2;AXIN1;DACT1;ITCH;FOXO1;SEC22B;EGLN2;DTL;HECW2;DDB1;NSF;HACE1;IDE;ANGPTL3;RNF41;SMURF1
prerank,positive regulation of protein metabolic process (GO:0051247),0.3733323649360668,1.0521346265650842,0.3946830265848671,0.9171382903037129,1.0,25/110,18.11%,CD80;GPC3;MAPK7;STX5;SMURF2;AXIN1;DACT1;KLF2;ITCH;FOXO1;SEC22B;EGLN2;PSEN1;DTL;PAEP;HECW2;AKT1;DDB1;KLF4;NSF;HACE1;IDE;CHRNA7;RAB1B;IL18
prerank,cGMP biosynthetic process (GO:0006182),-0.4196292510033205,-1.0512099494626792,0.4205298013245033,0.7429953462187892,1.0,4/10,21.52%,GUCY1B1;NPR1;GUCY1A1;GUCY2C
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.40175755670642155,-1.0508992055951076,0.3905109489051095,0.7418097210309106,1.0,3/11,5.82%,NEDD4L;ACTN2;CAV1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.4590344177196551,1.050895288876444,0.4178168130489335,0.9204055531222688,1.0,5/20,18.11%,LBP;TLR4;IRAK1;CD14;IL18
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.4961655321788551,1.0506195189728804,0.4258064516129032,0.9206112378253519,1.0,5/14,20.12%,SRSF6;C1QBP;SAP18;U2AF2;PTBP1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.42997513636315676,1.0505711566365243,0.4201388888888889,0.9201142945208977,1.0,14/30,26.78%,UBE2J2;USP36;HPS4;NPEPPS;HTRA2;ARIH2;VPS11;ATG13;UBE2D3;SAE1;CSNK2A2;LEPROT;FBXW7;RNF31
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.4293541485502724,1.0504664982568908,0.41705069124423966,0.9197828764877992,1.0,17/31,31.91%,DIS3L2;LSM4;EDC4;EXOSC7;POLR2G;EXOSC1;LSM7;EDC3;DCP1A;DCP1B;LSM5;HBS1L;LSM1;EXOSC3;PATL1;CNOT8;LSM6
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.45530877602549746,1.0501279014573655,0.42197253433208487,0.9201802161283891,1.0,4/20,6.77%,VEGFA;SMAD4;NFE2L2;SMAD5
prerank,cellular response to UV-A (GO:0071492),0.5063278328191464,1.0501250750841071,0.4320652173913043,0.9195201192025146,1.0,1/11,2.43%,MMP2
prerank,regulation of organelle assembly (GO:1902115),0.3865833831968233,1.0499223728829148,0.4153522607781283,0.9194825874280056,1.0,26/72,24.81%,GSN;CEP295NL;ATXN2;TBC1D2B;ALMS1;TBC1D17;NPM1;TBC1D10A;ATXN2L;DYNC2LI1;EVI5;SENP6;TBC1D13;RAB1B;ADPRH;VPS11;TBC1D22B;TBC1D15;TBC1D19;ATG3;PDCD6IP;TBC1D12;CYLD;TRAPPC12;STAM;CDKL1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.39180149263432923,1.0493436388111486,0.41412012644889357,0.9206286206639068,1.0,19/73,21.86%,SYK;FYN;WIPF1;PIK3R2;MYO10;SRC;ACTR3;ABI1;PIK3CA;MYH2;HSP90AA1;NCK1;ARPC1A;ACTG1;ARPC2;PLD2;MAPK1;YES1;VAV2
prerank,cilium assembly (GO:0060271),0.36463241325311696,1.0493357498689424,0.366,0.91997813325447,1.0,101/296,27.05%,GSN;NME8;DCTN1;CDC14B;ODF2;ABLIM1;PKD1;RAB23;FHDC1;ARF4;YWHAG;ACTR3;HDAC6;BBS9;SSNA1;ATAT1;ARL13B;TMEM138;TOGARAM1;YWHAE;CPLANE1;OCRL;RSPH1;EHD2;ALMS1;CNGB1;NUDCD3;HAUS3;DZIP1;MAPRE1;TTC39C;AVIL;TEKT5;PIBF1;VANGL2;KIF3A;DYNC2I2;SFI1;RPGR;KIF3B;CEP97;IFT46;TTLL3;BBS4;DNAAF3;HSP90AA1;TTC8;DYNC1H1;TUBB4A;TUBA4A;ATP6V1D;DYNC2LI1;CDK5RAP2;CCP110;AHI1;AKAP9;DYNC2H1;CEP164;RPGRIP1;CKAP5;CEP89;CCDC28B;DYNC2I1;CEP83;PAFAH1B1;RP2;BBS5;IFT52;BBIP1;EXOC4;CC2D2A;SPAG16;FLNA;IFT57;PCM1;DYNLRB1;DNAH5;DCX;FBF1;TMEM231;DCTN2;PDE6D;TCTN2;NEDD1;RAB11FIP3;DYNLL1;TCTN1;CEP78;TNPO1;CDC14A;CEP126;NEK1;RAB1A;ACTR1A;CFAP70;KIFAP3;CSNK1E;GBF1;RAB8B;IFT81;CETN2
prerank,regulation of viral entry into host cell (GO:0046596),0.42519179827904874,1.0491604838973723,0.42427884615384615,0.9198392155865931,1.0,5/30,11.57%,GSN;MID2;LGALS1;TRIM11;HS3ST5
prerank,positive regulation of mRNA processing (GO:0050685),0.4448832137452871,1.0490241939613554,0.4164588528678304,0.9195754109996894,1.0,12/21,34.73%,NUP98;RBM3;SF3B4;THRAP3;PAF1;DAZAP1;CELF3;RBMX;CELF4;CIRBP;NCBP2;NCL
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.4926280219121691,1.0485094121676153,0.4316644113667118,0.9205301924791814,1.0,5/13,17.16%,EPHB2;SQSTM1;ADCY8;ZDHHC2;CHRNA7
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.35991716247144295,-1.048376190365622,0.33014354066985646,0.7466118860430416,1.0,7/17,20.19%,NEDD4L;GPD1L;KCNQ1;RYR2;SNTA1;KCNE4;SCN3B
prerank,phospholipid metabolic process (GO:0006644),0.39101005960472074,1.04829474559906,0.4139387539598733,0.9205513683424217,1.0,16/71,20.13%,SMPD3;PLPP3;PLPP1;LCAT;AGPAT3;LPCAT1;PLPPR3;AGPAT5;FADS1;PLA2G4E;PIP4P1;GPAM;PLPP2;SMPD1;ANGPTL3;PIP4K2B
prerank,positive regulation of lamellipodium organization (GO:1902745),0.42494000320844927,1.0480818009363693,0.41435185185185186,0.9205527684498274,1.0,7/32,11.37%,PLCE1;AKIRIN1;FSCN1;SRC;ACTR3;PIK3CA;AVIL
prerank,fatty acid oxidation (GO:0019395),0.39864995184856444,1.047930378945035,0.4152173913043478,0.9203667251546482,1.0,15/57,21.97%,EHHADH;ALDH3A2;AUH;SCP2;ACADVL;SLC25A17;ACOX1;BDH2;MCAT;ABCD3;CPT2;ACAT1;HSD17B4;PEX2;CROT
prerank,regulation of actin filament depolymerization (GO:0030834),-0.4077809503564265,-1.0479224436826797,0.3769230769230769,0.7458242779025576,1.0,2/12,3.22%,PLEKHH2;SEMA5A
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.3577705835127981,-1.0478833332115915,0.3601694915254237,0.7439072512286716,1.0,5/16,17.34%,PDK1;SCARB2;SIRT1;PDK3;ADIPOR1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.4912876561389342,1.0478761880651526,0.4279891304347826,0.9198725314390637,1.0,2/13,7.80%,AXL;GAS6
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.36805775211180464,1.0477689526416787,0.39213709677419356,0.9195324486761867,1.0,30/161,16.47%,SFRP4;LRP6;DKK2;TLE6;CCDC88C;PSMC4;TNN;DACT3;IGFBP6;RBMS3;WWTR1;KREMEN1;IGFBP4;AXIN1;DACT1;TCF7L2;PSMC6;PSMD8;CUL3;TLE2;GLI3;ANKRD6;TPBG;STK3;AMFR;CHD8;SNAI2;FZD4;LMBR1L;DKK3
prerank,peptidyl-serine modification (GO:0018209),0.3701363625125688,1.0475546832836722,0.4108761329305136,0.9195219260926228,1.0,29/166,14.05%,PRKCA;MAPK12;EIF2AK3;RPS6KA2;DYRK4;DGKQ;SGK3;SGK2;TGFBR2;GALNT16;MAPK14;PKD1;MTOR;CAMK2D;NTMT1;MAST4;PRKD2;GAS6;CHUK;AKT3;DYRK2;CSNK1G1;GALNT1;CSNK1G3;AKT1;STK39;ULK2;HIPK4;ULK1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.3732302103281377,1.0474816659776012,0.42137718396711205,0.9190863292509917,1.0,17/110,14.41%,ADGRD1;GNAS;LPAR3;GPR12;LPAR1;CXCL10;ABCA1;S1PR2;ADCYAP1;ADGRG2;CRHR1;GPR161;CALCA;TSHR;ADCY8;GNB1;LHCGR
prerank,positive regulation of transport (GO:0051050),0.37804588478181933,1.047407678751182,0.4132917964693666,0.9186527665781253,1.0,21/85,21.01%,LRP1;ANXA1;SCIN;GPC3;ANXA2;SGK2;GAS6;SIRPA;INPP5K;CD47;BAK1;CALY;DYNC1H1;CHP1;KMT2A;SMPD1;CAPN10;CLIP3;GPLD1;NUMA1;PYCARD
prerank,neutrophil degranulation (GO:0043312),0.36238871466340355,1.0466020150068296,0.363,0.9204944561963522,1.0,105/425,22.38%,TIMP2;GSN;CD55;ARSA;B4GALT1;CD44;ANPEP;ANXA2;CD177;RAB6A;ACTR1B;TMBIM1;TCN1;S100A8;S100A9;MIF;SPTAN1;MAPK14;AP1M1;RAP1B;ACLY;TMEM63A;PTPRJ;TOM1;PLEKHO2;AP2A2;PRCP;RAB37;IDH1;DOK3;ATP11A;COPB1;CAPN1;SURF4;ARHGAP9;DYNC1LI1;PSEN1;IQGAP1;ABCA13;SNAP23;ITGAV;SIRPA;LPCAT1;CD47;CSTB;NRAS;RAB3D;SLPI;JUP;GLA;TMEM30A;XRCC5;NIT2;RHOA;CMTM6;TNFRSF1B;SNAP25;NME2;UBR4;CD14;SLC2A3;SLC15A4;HSP90AA1;DYNC1H1;DIAPH1;ATP6V1D;GAA;ATP6V0A1;PKM;IGF2R;PADI2;CTSD;CAP1;FABP5;RAB5B;CANT1;ILF2;PPIA;SLC44A2;RAB5C;CXCR2;PLAUR;COTL1;TMEM179B;VAMP2;PRG2;PYGB;RAB24;ALDOA;APAF1;DDOST;TOLLIP;ITGAM;RAB10;QSOX1;ACP3;MAPK1;PYCARD;COMMD9;ERP44;CAB39;CPNE1;ANXA3;STK11IP;SDCBP
prerank,fatty acid catabolic process (GO:0009062),0.38947373041786415,1.0465692678872136,0.4115138592750533,0.9199392116893766,1.0,19/67,21.97%,EHHADH;CEL;NUDT7;ALDH3A2;AUH;SCP2;ACADVL;SLC25A17;ACOX1;BDH2;NUDT19;MCAT;ABCD3;LPIN3;CPT2;ACAT1;HSD17B4;PEX2;CROT
prerank,somite development (GO:0061053),0.49953654975587825,1.0460862702198146,0.416551724137931,0.9208006799208265,1.0,1/11,1.69%,MEOX2
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3852731185320628,1.046064369298474,0.4288747346072187,0.9201991089522236,1.0,13/72,13.64%,DCN;MYOC;FGFR1;FGF2;TGFB2;F2R;SRC;PIK3CA;EGF;IRS2;PDGFRA;FLT3;CBL
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.40784673999259496,-1.0457941743112604,0.38910505836575876,0.7473853514092113,1.0,1/11,0.53%,LYN
prerank,negative regulation of organelle assembly (GO:1902116),0.41761404512722744,1.0455245005947573,0.4092485549132948,0.9212214534989536,1.0,12/35,19.70%,SMAD4;SEC22B;SCFD1;KAT2B;SMCR8;CEP97;NUPR1;CDK5RAP2;CCP110;EVI5L;ODF2L;MDM1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.4711852818928785,1.0454214307208916,0.4339622641509434,0.920884700408779,1.0,6/15,20.26%,TRIAP1;GPX1;AKT1;GHITM;HGF;PRELID1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.4431301493801424,1.0451919065171784,0.4283965728274174,0.9209102980317311,1.0,3/22,8.07%,AHNAK;SRI;CRHR1
prerank,negative regulation of platelet activation (GO:0010544),0.4692198864193239,1.0451610015922517,0.43041237113402064,0.9203592438322926,1.0,4/16,12.80%,C1QTNF1;CD9;ADAMTS18;PDGFRA
prerank,diacylglycerol metabolic process (GO:0046339),0.44728968239862227,1.0450056528532659,0.43672456575682383,0.9202121824094466,1.0,6/23,13.24%,PLCE1;ANG;DGKQ;MOGAT1;DAGLA;MOGAT2
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.3944061211026981,1.044982726015893,0.42513661202185793,0.919613625025426,1.0,21/56,29.02%,LBP;S100A8;S100A9;TLR5;TLR4;IRAK4;IRAK1;UBA52;CD14;TRAF3;TAB2;MAP3K7;CTSK;HSP90B1;CTSB;CTSL;BCL10;MAPKAPK3;SFTPA2;SFTPA1;MYD88
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.42467534220470826,1.0444014139234477,0.4381625441696113,0.9206946813325393,1.0,11/29,24.60%,ESR1;RUNX1;AXIN1;UFL1;GPAM;VPS11;UFM1;KCTD6;CARM1;LATS1;UFSP2
prerank,neuron projection development (GO:0031175),0.36502495863745765,1.0442551996344427,0.4038267875125881,0.9204801760053389,1.0,47/168,18.59%,DBN1;MYOC;EPHB2;DCLK1;DLG4;ZPR1;TAOK3;RASGRF1;TRIO;UNC5A;DTNBP1;DOCK7;LRP12;ADCYAP1;TOR1A;EPHB3;TSKU;L1CAM;PLP1;CAMSAP1;MAPT;KIF20B;TBC1D23;FLRT3;LGI1;GDNF;TAOK2;ULK1;CTNND2;ATCAY;BLOC1S2;MAP4;MANF;SLC9A6;IL6;ANKRD27;SNAPIN;DIP2A;RAB35;PPP1R9B;SRGAP2;GAS7;SHTN1;STX3;EPHB1;CNTN4;GPM6A
prerank,neutrophil mediated immunity (GO:0002446),0.3612323900760891,1.0437780087454287,0.374,0.9212773525405538,1.0,107/432,22.38%,TIMP2;GSN;CD55;ARSA;B4GALT1;CD44;ANPEP;ANXA2;CD177;RAB6A;ACTR1B;TMBIM1;TCN1;S100A8;S100A9;MIF;SPTAN1;MAPK14;AP1M1;RAP1B;ACLY;TMEM63A;PTPRJ;TOM1;PLEKHO2;AP2A2;PRCP;RAB37;IDH1;DOK3;ATP11A;COPB1;CAPN1;SURF4;ARHGAP9;DYNC1LI1;PSEN1;IQGAP1;ABCA13;SNAP23;ITGAV;SIRPA;LPCAT1;CD47;IRAK4;CSTB;NRAS;RAB3D;SLPI;JUP;GLA;TMEM30A;XRCC5;NIT2;RHOA;CMTM6;TNFRSF1B;SNAP25;NME2;UBR4;CD14;SLC2A3;SLC15A4;HSP90AA1;DYNC1H1;DIAPH1;ATP6V1D;GAA;ATP6V0A1;PKM;IGF2R;PADI2;CTSD;IL6;CAP1;FABP5;RAB5B;CANT1;ILF2;PPIA;SLC44A2;RAB5C;CXCR2;PLAUR;COTL1;TMEM179B;VAMP2;PRG2;PYGB;RAB24;ALDOA;APAF1;DDOST;TOLLIP;ITGAM;RAB10;QSOX1;ACP3;MAPK1;PYCARD;COMMD9;ERP44;CAB39;CPNE1;ANXA3;STK11IP;SDCBP
prerank,positive regulation of cell differentiation (GO:0045597),0.36243595807492823,1.043731715188325,0.39779559118236474,0.920769412221846,1.0,25/237,6.15%,CD34;MEDAG;DDR2;CDON;AR;COL1A1;LOXL2;TMEM100;TGFB3;FGFR1;MAPK12;TMEM119;NEUROD2;TGFB2;TGFBR2;SMAD4;WWTR1;ZFP36L1;MAPK14;ACVR1;RBM4;MTOR;HOXA5;AKIRIN1;BEND6
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.41672928579884855,1.0429295665090272,0.4323394495412844,0.9226043416727093,1.0,4/39,5.31%,AREG;EGFR;BTC;PTPRJ
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.40086043009158345,1.0427065971223117,0.4250559284116331,0.9226042523049948,1.0,20/51,30.07%,HNRNPA1;CTC1;GNL3L;SRC;ACD;CCT7;XRCC5;TERF1;SMG6;TENT4B;TINF2;NEK7;MAPK1;CCT4;EXOSC10;SMG5;CCT6A;STN1;HNRNPC;NAT10
prerank,negative regulation of cell death (GO:0060548),0.3783230029600149,1.0424505843857979,0.42224510813594235,0.9227435753525908,1.0,16/88,17.49%,CD34;FYN;KIR3DL2;CCN5;SRSF6;FGF2;PDE8A;VPS4B;TIGAR;AKT1;GPNMB;CD200R1;TNFRSF1B;NCK1;HTRA2;SRGAP2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4024998106275204,1.0424122512890737,0.432967032967033,0.9222013837815651,1.0,11/48,15.05%,JSRP1;ANK2;F2R;SRI;CAMK2D;CXCL10;GSTM2;PDE4D;CALM2;CASQ1;DIAPH1
prerank,skeletal muscle tissue development (GO:0007519),0.4170763524813403,1.0421584479505526,0.42105263157894735,0.9223290211642695,1.0,8/32,21.40%,SIX4;SVIL;SKI;MYH14;SIX1;KLHL41;SELENON;MYORG
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.2857461076520187,-1.0420781996760797,0.38181818181818183,0.7553795986294058,1.0,19/42,26.60%,WDR48;SHLD1;ARID2;HELB;MRNIP;KLHL15;RIF1;SMCHD1;PPP4C;FANCB;TIMELESS;MAD2L2;RPA2;RMI2;RAD51;PARPBP;CHEK1;WRAP53;SIRT6
prerank,negative regulation of MAPK cascade (GO:0043409),0.37816452502928777,1.041926165024692,0.42408376963350786,0.922405952540212,1.0,24/87,21.45%,EPHB2;UCHL1;IRAK3;CAMK2N1;SMAD4;PIK3R2;PTPRJ;FOXO1;FLCN;TLR4;SIRPA;INPP5K;PRDM15;TNIP1;PPEF2;PIN1;PPIA;QARS1;SMPD1;STK38;SYNJ2BP;FBLN1;PTEN;NF1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.4533812896177555,1.0417476974378959,0.4441687344913151,0.9223064118849235,1.0,6/22,18.81%,CD44;MAPK7;MYADM;KLF4;FLOT2;MBP
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4457870944326244,1.0417111266705683,0.4355444305381727,0.9217619283171693,1.0,2/19,4.65%,DBN1;FBXW8
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.3649756994456829,1.041447424153002,0.4225352112676056,0.9219426939232678,1.0,58/184,26.41%,DCTN1;CDC14B;PSMC4;ODF2;ZFP36L1;PKD1;ZW10;PSMC6;YWHAG;SSNA1;ZFP36L2;YWHAE;PSMD8;SIRT2;CUL3;ALMS1;HECW2;HAUS3;CDC23;MAPRE1;FBXO5;ANAPC5;ERCC3;UBA52;SFI1;DDB1;CDC27;INO80;HSP90AA1;DYNC1H1;TUBB4A;TUBA4A;CDK5RAP2;CCP110;PPP1R9B;TFAP4;AKAP9;CDC26;CEP164;CKAP5;ANAPC4;PAFAH1B1;CENPE;RIOK2;ANAPC10;PCM1;DCTN2;ANAPC15;NEDD1;PSMD4;PSMD3;DYNLL1;CEP78;CDC14A;ANAPC2;ACTR1A;PSMB3;CSNK1E
prerank,positive regulation of cell growth (GO:0030307),0.3755944346045295,1.0407601994578588,0.44387229660144184,0.9233495862568619,1.0,28/96,23.14%,DBN1;EGFR;HPN;SYT2;TGFB2;CDKN2AIP;S100A8;S100A9;DDX49;NTN1;ISLR2;L1CAM;AKT1;MAPT;LGI1;INO80;GOLGA4;SYT1;TGFBR1;SHTN1;SUPV3L1;RIMS2;N6AMT1;SLC25A33;SMURF1;KLHL22;SDCBP;RNF157
prerank,positive regulation of protein transport (GO:0051222),-0.26100221467225243,-1.0402704790961832,0.3888888888888889,0.7583267167346974,1.0,11/67,6.15%,BMP6;UNC13B;FRMD4A;IGF1;CD2AP;ATP2C1;MYO18A;CEP290;PRR5L;ACSL3;ABCG1
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.4278387474408746,-1.0400110270749034,0.37293729372937295,0.7570559282624718,1.0,2/10,3.53%,ADAM10;WNT5A
prerank,regulation of centrosome duplication (GO:0010824),0.4290891257666305,1.0399089548841491,0.43233532934131735,0.9253027539799424,1.0,5/29,10.75%,CEP295NL;XRCC3;VPS4B;ALMS1;NPM1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.47164427299899214,1.0398679790768863,0.4287581699346405,0.9248073093149836,1.0,3/17,10.87%,CD160;PTPRJ;UBASH3A
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.4584227733580707,1.0396182275059478,0.43333333333333335,0.9249220442242957,1.0,7/18,19.88%,LLGL1;RAP1B;KANK1;KIF20B;BCAS3;SHTN1;ARFGEF1
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.46901386473068807,1.0391015429152528,0.44627054361567636,0.9259133658414763,1.0,5/17,11.01%,AR;ATP1A3;ATP1A1;SRC;URI1
prerank,protein localization to lysosome (GO:0061462),-0.3070782184907097,-1.0385670848134618,0.34868421052631576,0.7588221589714419,1.0,7/28,11.13%,SCARB2;GGA3;RAB7A;MFSD1;LAMTOR5;SORL1;GCC2
prerank,activation of protein kinase B activity (GO:0032148),-0.30386645603368023,-1.0384692621446447,0.38414634146341464,0.7570695925663646,1.0,8/29,8.92%,INSR;IGF1;OSBPL8;WNT5A;PINK1;FGF1;NTRK3;ADRA2A
prerank,positive regulation of organelle assembly (GO:1902117),0.39963331517846934,1.0383724629589246,0.43032329988851725,0.9274823258015834,1.0,19/44,27.46%,GPSM2;SAXO1;FSCN1;IL5;BBS4;DYNC1H1;CCP110;PIP4K2C;ENTR1;LRSAM1;PIP4K2B;NUMA1;PDCD6IP;SDCBP;CROCC;CCDC88A;G3BP1;SDC4;FUZ
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.4613095709058239,1.0382731498648576,0.4320203303684879,0.9271365534183964,1.0,6/20,14.92%,TMBIM1;CLTC;CSK;PID1;RHOQ;PPFIA1
prerank,negative regulation of potassium ion transport (GO:0043267),-0.371404415323109,-1.038171074429544,0.4024896265560166,0.7558361396542891,1.0,3/13,5.82%,NEDD4L;ACTN2;CAV1
prerank,maturation of SSU-rRNA (GO:0030490),0.42041067175221275,1.0379646136339116,0.4289044289044289,0.9274347325626756,1.0,18/34,31.91%,MRPS11;RIOK1;RRP36;WDR46;SNU13;DCAF13;DDX52;PWP2;SRFBP1;NOL10;RIOK2;TSR3;RIOK3;TSR1;NAT10;RPS28;NOL11;LSM6
prerank,response to interferon-alpha (GO:0035455),0.46775585134716635,1.0376728501355703,0.42802056555269924,0.9276501413455466,1.0,2/16,7.80%,AXL;GAS6
prerank,glycoprotein catabolic process (GO:0006516),0.467742156549379,1.0372591460180698,0.4244791666666667,0.9282629845074927,1.0,5/17,8.85%,EDEM1;FBXO2;OGA;EDEM2;FBXO17
prerank,cellular response to organonitrogen compound (GO:0071417),0.3747492248380648,1.0371607793199586,0.42769857433808556,0.9279100992741827,1.0,25/99,19.52%,IGFBP5;WT1;CAPN2;SLIT2;ZFP36L1;P2RX3;RAP1B;MTOR;PKD2;HCN4;INPP5K;SSH1;SLC26A6;JUP;TSHR;LARP1;NSMF;RRAGD;RAPGEF1;DIAPH1;CPEB1;AKAP9;IPO5;HCN1;GABRG2
prerank,regulation of cell aging (GO:0090342),0.515342678187963,1.0371092011936502,0.4474393530997305,0.9274186995881568,1.0,4/11,16.97%,MIF;LMNA;RSL1D1;NEK4
prerank,regulation of protein localization to centrosome (GO:1904779),0.5090067632401271,1.037108529117399,0.42020497803806733,0.9267658118723506,1.0,2/10,8.34%,BICD1;PARD6A
prerank,negative regulation of cell motility (GO:2000146),0.3714442161785995,1.037087929590829,0.4346938775510204,0.9261863291188733,1.0,32/108,21.45%,IGFBP5;TMEFF2;ADARB1;LDLRAD4;SLIT2;MIF;GTPBP4;MIA3;PTPRJ;SRGAP1;SULF1;PIP5KL1;FLCN;DPEP1;JAG1;MITF;KANK1;MAGI2;RECK;ADAM15;PIN1;STK24;STC1;SRGAP3;SRGAP2;NAV3;CYP1B1;STK26;RNF41;FBLN1;PTEN;NF1
prerank,membrane fusion (GO:0061025),0.4173798236913321,1.036994060350891,0.42857142857142855,0.9258099315869514,1.0,11/33,20.34%,DNM1;STX11;USO1;SNAP23;NAPA;CHP1;NSF;HACE1;NAPG;VAMP2;VPS33B
prerank,regulation of kinase activity (GO:0043549),0.3748162142396589,1.0366692268705293,0.4336099585062241,0.926150386492698,1.0,19/89,14.36%,DDR2;EPHB2;AXL;EGFR;FGFR1;PLCE1;EPHA3;MST1R;RET;EPHB3;MUSK;CAMKK2;MAPT;EPHA10;IRS2;PDGFRA;FLT3;DDR1;NBN
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.4197522449642242,-1.036611108210771,0.41638225255972694,0.7581869685925838,1.0,3/10,4.51%,NEDD4L;OSR1;PRKCE
prerank,positive regulation of macroautophagy (GO:0016239),0.3996725813325029,1.0366107925579724,0.44835164835164837,0.925676962484897,1.0,17/48,24.36%,DCN;GNAI3;GPSM1;SLC25A4;SESN3;LARP1;SMCR8;IL4;VDAC1;PIP4K2C;LRSAM1;PIP4K2B;VPS13D;BAG3;SESN2;MAP3K7;TSC2
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.45917949863791796,1.0361380343938902,0.4375,0.9264070815133636,1.0,4/18,11.49%,EIF2AK3;MAF1;DHX33;UBTF
prerank,protein localization to chromatin (GO:0071168),0.4551468849593775,1.0360884472242111,0.43994778067885115,0.925901433415565,1.0,2/18,5.01%,ESR1;CHMP7
prerank,regulation of histone deacetylation (GO:0031063),0.4856478237347151,1.0359810016732436,0.4543010752688172,0.925585797852867,1.0,5/13,21.20%,CAMK2D;AKAP8;NIPBL;CTBP1;AKAP8L
prerank,neuron projection morphogenesis (GO:0048812),0.36847688521568284,1.0358389117555844,0.4071065989847716,0.9253951306982691,1.0,50/137,26.20%,DBN1;EPHB2;DCLK1;MAP1B;TNN;LLGL1;DLG4;TAOK3;TRIO;DTNBP1;DOCK7;FARP1;S100A6;IQGAP1;EPHB3;KIF20B;FLRT3;TAOK2;MAP6;CTNND2;DCC;SLC9A6;SDC2;ANKRD27;DIP2A;SRGAP2;GAS7;SHTN1;EPHB1;CNTN4;GPM6A;NBL1;RAB10;SLITRK4;PTEN;ABITRAM;MAP1A;MAP1S;CTTN;SPTBN4;CPNE1;CNTNAP1;NTNG2;ALS2;DVL1;LRP2;ATL1;PAX2;NRCAM;SLITRK5
prerank,Rap protein signal transduction (GO:0032486),-0.41365888529666917,-1.0347123617243161,0.40875912408759124,0.7613549432136696,1.0,2/10,1.29%,RAPGEF2;RAPGEF3
prerank,B cell receptor signaling pathway (GO:0050853),0.4195465302608055,1.03451601430316,0.44380069524913096,0.9288542562296913,1.0,2/32,3.07%,SYK;RFTN1
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.49170971447282485,1.0344554491785,0.44591029023746703,0.9283918001491521,1.0,4/12,11.69%,WT1;JAG1;IQGAP1;MAGI2
prerank,regulation of cation channel activity (GO:2001257),0.3745705806367144,1.0344437577608019,0.4452479338842975,0.927775848199468,1.0,20/89,19.61%,AHNAK;JSRP1;ANK2;FGF13;CNIH3;DLG4;CAMK2D;DLG2;NEFL;CAPN1;GRIA2;CACNG2;PDE4D;CALM2;CACNB1;GRIN2A;FGF14;SELENON;VAMP2;GRIA3
prerank,negative regulation of cellular process (GO:0048523),0.3551303750981271,1.0341871051024345,0.382,0.9279336461117884,1.0,99/521,17.49%,NOX4;CD34;SFRP4;AR;EPHB2;CD9;TGFB3;SCIN;GLMN;WT1;DIS3L2;EIF2AK3;DCBLD2;FHL1;RPS6KA2;ADARB1;TMEM98;CCN5;DACT3;SRSF6;WNT9A;FGF2;TGFB2;PDE8A;TNS2;SLIT3;SLIT2;CAMK2N1;F2R;IGFBP6;CDKN2AIP;PSRC1;MIF;SMAD4;LMNA;ATF5;SKI;SYT11;GNG4;HOPX;DACT2;GTPBP4;VPS4B;MIA3;PTPRJ;ZBTB7C;INHA;MDM4;TGFBI;PLPP1;ADAM22;FLCN;PKD2;ABI1;CYP27B1;VDR;SIRT2;PLXNA3;KAT2B;ING4;SIRPA;SMAD6;BRD7;BCL6;DSCAM;NPM1;FBXO5;GPNMB;MAGI2;DNAJB2;ANP32B;ADAM15;SPOCD1;CDKN1A;P3H1;TMEM127;TNFRSF1B;NACC2;PDE3B;ORC6;DDX4;DNAJA3;KLF4;SMARCA4;NUPR1;GMNN;NLRP2B;NCK1;NUDT6;EEF1E1;PDCD4;IL6;PML;HTRA2;PPP1R9B;TFAP4;CD164;NME1;SRGAP2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.42252226417852734,1.033800226599166,0.4515752625437573,0.9284567163965138,1.0,12/34,24.61%,MYOC;S100A10;MYADM;C1QBP;TRIOBP;LIMS2;RAC3;ILK;FLNA;DMTN;RAC1;CALR
prerank,regulation of secretion (GO:0051046),0.48712385922249557,1.0337218435275486,0.44594594594594594,0.9280635907068159,1.0,3/13,10.98%,SCIN;POFUT2;EGF
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.36041507320823696,1.0334834799302515,0.44421906693711966,0.928130797098552,1.0,51/166,21.82%,NIBAN1;EGFR;IRS1;FGF2;CTC1;SMOC2;KLF2;MTOR;NR1D1;GLI2;MLXIPL;PRKD2;PKD2;LARP4;EPM2AIP1;HNRNPD;TLR4;DYRK2;NPM1;EGF;AKT1;BCL3;ELOVL5;PASK;IRS2;DNA2;EIF6;DUOXA1;RPS27L;DDB1;ZCCHC4;RBM3;POLDIP3;KLF4;HSP90AA1;EIF3E;GIPC1;CHP1;IL6;HGF;FXR2;EIF3D;YTHDF1;SREBF1;GPLD1;PCIF1;DDAH2;OPN3;ABCB10;ZEB2;YTHDF3
prerank,negative regulation of neuron death (GO:1901215),0.3730891270983239,1.0334249282390893,0.41985522233712513,0.927674162167776,1.0,22/93,22.04%,CD34;TGFB3;SIX4;KIR3DL2;F2R;CLCF1;NFATC4;NRBP2;AKT1;GPNMB;GDNF;CD200R1;SIX1;TNFRSF1B;HTRA2;SNX6;SET;RASA1;TYRO3;KDM2B;CSF1;ATF4
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.4604199727251848,1.0333513583199814,0.4381720430107527,0.9272776692881639,1.0,8/15,25.47%,REEP3;LNPK;RTN3;RAB10;TMEM33;RTN4;RAB18;ATL1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.43967741064183485,1.032611195274398,0.4573170731707317,0.9288967693159245,1.0,6/24,11.37%,PLCE1;AKIRIN1;FSCN1;ACTR3;PIK3CA;AVIL
prerank,negative regulation of growth (GO:0045926),0.36742678402917045,1.0319003666224467,0.46998982706002035,0.9303994977058127,1.0,19/121,13.19%,WT1;DCBLD2;FHL1;DACT3;TGFB2;SLIT3;SLIT2;CDKN2AIP;PSRC1;SMAD4;GNG4;PTPRJ;FLCN;CYP27B1;ING4;BCL6;DNAJB2;ADAM15;CDKN1A
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.4744626243647926,1.0317998850683405,0.43275632490013316,0.9294194895755334,1.0,5/15,21.19%,DTNBP1;AP3D1;BLOC1S2;SNAPIN;AP3B2
prerank,anterograde synaptic vesicle transport (GO:0048490),0.4744626243647926,1.0317998850683405,0.43275632490013316,0.9294194895755334,1.0,5/15,21.19%,DTNBP1;AP3D1;BLOC1S2;SNAPIN;AP3B2
prerank,negative regulation of biosynthetic process (GO:0009890),-0.36276243987079526,-1.0317467013365649,0.41379310344827586,0.7673572450869283,1.0,8/16,28.00%,SLC30A10;PPARA;CEACAM1;GPER1;CIITA;SLC18A2;PARK7;ASXL3
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.4337636869797438,1.0316060998340546,0.4305210918114144,0.9293816542629476,1.0,13/25,29.44%,SCAF8;EAF2;SETD5;THOC1;EAF1;TCEA2;LDB1;ELL;KAT7;ALYREF;THOC5;HTATSF1;WDR43
prerank,retrograde axonal transport (GO:0008090),0.4673516498911328,1.0314538836011378,0.438058748403576,0.9291802372387388,1.0,7/16,22.09%,DST;DLG2;NEFL;DYNC1H1;PAFAH1B1;MAP1A;FBXW11
prerank,cholesterol transport (GO:0030301),0.39575931097946915,1.0313514428780508,0.45393258426966293,0.9288633562687683,1.0,7/45,10.43%,CEL;ABCA1;ABCG4;OSBPL2;LCAT;TSKU;STX12
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.5016745485982788,1.0304784155169904,0.4726775956284153,0.930839999531355,1.0,3/11,15.59%,AXL;GAS6;SELENOS
prerank,regulation of cell cycle (GO:0051726),0.3584034057465879,1.0299152203902329,0.424,0.9319598029956243,1.0,63/271,18.42%,LRP6;FAP;MAPK12;CDC14B;GADD45G;RPS6KA2;ADARB1;CKS1B;TGFB2;CAMK2N1;TRNP1;BIN1;MIF;PKD1;CDK4;JUND;TCF7L2;RASSF1;TTC28;TARDBP;INHA;MLXIPL;GAS2L1;PKD2;CDK9;MYBL2;SIRT2;DTL;IQGAP1;BEX2;KAT2B;ING4;SON;ERN1;FBXO5;PUM1;MAGI2;KIF20B;LIN9;PCLAF;CDKN1A;FBXL3;CCND1;CDC123;PLAGL1;NBN;NUPR1;UHRF2;GMNN;NLRP2B;NOP53;NUDT6;PDCD4;MADD;E4F1;PML;HTRA2;PPP1R9B;TFAP4;CDC26;TGFBR1;TBRG1;PRCC
prerank,gene silencing by miRNA (GO:0035195),0.4156080000248125,1.0297850509044228,0.4486735870818916,0.9317175399815616,1.0,10/32,19.51%,TARBP2;RBM4;TRIM71;AGO2;PUM1;EIF6;ZFP36;AGO4;SNIP1;AGO3
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.407611290839392,1.029739025074591,0.44692737430167595,0.9312105411946199,1.0,15/40,25.36%,GLMN;DESI1;AXIN1;RAD23B;SGTA;PML;UFL1;RPL23;PTEN;SMURF1;CSNK2A2;UBE3A;LATS1;UBQLN4;FBXW7
prerank,positive regulation of intracellular protein transport (GO:0090316),0.36260644009519216,1.029506195796355,0.43434343434343436,0.9313030897521806,1.0,52/144,25.52%,SEC16B;FYN;ZPR1;PIK3R2;UBE2J2;USP36;TCF7L2;MIEF2;YWHAG;GAS6;YWHAE;CD81;HPS4;PSEN1;B3GAT3;RBM22;HDAC3;PPP3CC;KIF20B;BBC3;JUP;NPEPPS;TMEM30A;ANP32B;SFN;ZDHHC2;ZC3H12A;BCAS3;DMAP1;CHP1;HTRA2;IPO5;ARIH2;VPS11;VAMP2;ATG13;UBE2D3;ITGAM;FLNA;SAE1;PCM1;ICE1;CSNK2A2;BAG3;YWHAB;TPR;LEPROT;FIS1;EMD;MTCL1;FBXW7;RAB29
prerank,regulation of NMDA receptor activity (GO:2000310),0.41449005149289986,1.02941575754185,0.4322429906542056,0.9309706426838973,1.0,6/32,9.58%,EPHB2;DLG4;DLG2;NEFL;CAPN1;GRIA2
prerank,organelle disassembly (GO:1903008),0.4134864234341918,1.0293327425252614,0.4571092831962397,0.9305837406940154,1.0,10/33,20.92%,STX5;KLC1;ATG2B;ULK2;ATG2A;ULK1;UFC1;UFL1;UFM1;MTIF2
prerank,mitochondrial fission (GO:0000266),0.4730304913398172,1.0292515578437404,0.4453024453024453,0.9301987104241186,1.0,4/16,16.37%,DNM1;GDAP1;SLC25A46;MTFR1L
prerank,response to sterol (GO:0036314),0.4979411294511492,1.029140780498488,0.4379172229639519,0.9298877734428249,1.0,4/11,19.40%,TGFBR2;PMVK;TGFBR1;RORA
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.41766266523766105,1.0290598636530393,0.4543297746144721,0.9295224643648404,1.0,8/33,17.82%,AREG;BTC;DOK1;EGF;AKT1;CBL;ARAP1;PLAUR
prerank,cellular zinc ion homeostasis (GO:0006882),0.4280508875408844,1.0288989307863992,0.4392857142857143,0.9293960745680735,1.0,5/26,16.80%,SLC39A14;SLC39A13;SLC39A7;SLC30A9;SLC30A5
prerank,negative regulation of cell differentiation (GO:0045596),0.3603523055395554,1.0288953701972894,0.44455645161290325,0.9287753335087129,1.0,40/181,19.40%,COL5A2;COL5A1;WNT10B;EGFR;HPN;LDLRAD4;ITGB3;TNN;WNT9A;HDAC7;WWTR1;SKI;TRIO;HOPX;MEIS2;FOXO1;ABCA1;ZFPM2;ZFP36L2;CHADL;SOX8;JAG1;SIRT2;ITGAV;SMAD6;TSKU;VASN;ANP32B;TWIST1;HOXA9;SNAI2;NBR1;PDCD4;IL6;EFEMP1;YTHDF2;TGFBR1;CNTN4;SDHAF2;RORA
prerank,peptidyl-serine phosphorylation (GO:0018105),0.36478107850191854,1.0277967717738377,0.44646464646464645,0.9313706510031455,1.0,27/153,14.05%,PRKCA;MAPK12;EIF2AK3;RPS6KA2;DYRK4;DGKQ;SGK3;SGK2;TGFBR2;MAPK14;PKD1;MTOR;CAMK2D;MAST4;PRKD2;GAS6;CHUK;AKT3;ERN1;DYRK2;CSNK1G1;CSNK1G3;AKT1;STK39;ULK2;HIPK4;ULK1
prerank,regulation of cellular component movement (GO:0051270),0.39073692603934357,1.0276442108626815,0.4419642857142857,0.9311639443295819,1.0,16/49,18.08%,EGFR;CD9;BTC;VEGFA;ZSWIM4;HDAC6;ABL2;MYCBP2;INPP5F;EGF;RHOA;DIAPH1;ZSWIM8;ARAP1;YTHDF1;TGFBR1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3894935254287042,1.027555934734575,0.44432194046306506,0.9307936847218509,1.0,15/52,18.98%,EPHB2;EGFR;LRP1;EPHA3;ATP2B4;STX4;SQSTM1;AKT1;ZDHHC2;ARF6;SPTBN1;PLS1;CNST;STX3;CLIP3
prerank,cellular response to cadmium ion (GO:0071276),0.4293673097729644,1.0273006676529368,0.4437577255871446,0.9309676833260334,1.0,8/24,30.27%,EGFR;CHUK;AKT1;MAPK1;JUN;SUMO1;FOS;HSF1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.44909954195917867,1.027147492977313,0.46633416458852867,0.9307789697278376,1.0,6/22,14.23%,ANK2;PKD2;GSTM2;SLC9A1;CALM2;CASQ1
prerank,tRNA processing (GO:0008033),0.3856836884423951,1.0270222380478011,0.45112781954887216,0.9304914839387969,1.0,20/61,24.58%,ANKRD16;TSEN54;TRMT6;RPP21;RTRAF;TRMT61A;FTSJ1;CPSF4;TRMT10B;TRMT1;DTWD1;TRPT1;QTRT1;TYW5;PTCD1;TRUB1;METTL1;RPP30;CPSF1;WDR4
prerank,hexose transmembrane transport (GO:0008645),0.44053973962293913,1.0269091183804502,0.4618272841051314,0.9301771600556049,1.0,5/21,18.29%,SLC5A9;SLC50A1;SLC2A10;SLC2A3;SLC45A1
prerank,negative regulation of autophagosome assembly (GO:1902902),0.47839850719724936,1.0268875617061537,0.4656084656084656,0.9296044128044554,1.0,8/13,30.73%,SEC22B;SCFD1;SMCR8;NUPR1;MTM1;TMEM39A;CHMP4A;CHMP4B
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.35191525066876145,1.026856758071215,0.375,0.9290510196233607,1.0,160/834,16.74%,LMX1A;DCN;LIF;AR;LRP6;ESR1;WNT2;NFIX;IRF4;EGFR;TGFB3;WT1;MEOX2;TRIAP1;HSF2;ELF4;MAPK7;ZMIZ1;RUNX1;VEGFA;FGF2;TGFB2;PBX1;GLIS2;SMAD4;NFE2L2;CRTC2;PIK3R2;ATF5;DPF2;WWTR1;LMX1B;AKNA;MEF2D;SKI;PKD1;ACVR1;COPS5;FOXK2;KLF2;JUND;TCF7L2;NR1D2;MAFF;MEIS2;NFATC1;IL33;SMARCD2;HOXA5;FOXO1;NR1D1;RTRAF;CXCL10;AKIRIN1;NFIB;NCOA3;RNF111;MUC1;SSBP3;NFIA;ZFHX3;ARF4;DPF1;SMAD5;MEPCE;GLI2;MLXIPL;PID1;ACTR3;MTF1;SMARCD1;ZFPM2;ADCYAP1;FLCN;PRKD2;PKD2;CHUK;CD81;SOX8;JAG1;VDR;SATB2;CDK9;MYBL2;FOXC2;SIRT2;AGO2;MED24;TLR4;BEX1;KAT2B;ONECUT1;ATAD2B;RHOQ;SQSTM1;RNF10;HDAC3;MITF;HELZ2;TCERG1;MZF1;NPM1;PRDM15;GLI3;SLC30A9;TNIP1;IRF2BPL;CSRNP3;MICAL2;CEBPB;SLC9A1;TOX2;DCAF6;JUP;ZNF462;KANSL3;AKIRIN2;UBA52;CCNC;DDX17;MED13;ATF1;GDNF;DR1;PEG3;PIN1;TWIST1;SIX1;RFX5;ZC3H12A;NME2;INO80;HDAC4;PLAGL1;PTOV1;BCAS3;PPP3CA;KLF4;HOXC4;MLXIP;EAF2;HOXA7;BCL9;GTF2F1;CHD8;SMARCA4;POU3F2;IL4;NR2C2;E2F3;UBP1;OGT;NCK1;AHI1;STAT5B;PER1;IL6;HGF;E4F1;BCLAF3
prerank,midbody abscission (GO:0061952),0.46222768183220286,1.0268527004402142,0.4425806451612903,0.928426134580634,1.0,2/17,5.28%,CHMP7;VPS4B
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.4993293460781638,1.0267059585972074,0.457182320441989,0.9282313162274347,1.0,5/10,31.58%,CRHR1;GNB5;GPR35;DRD2;CALM1
prerank,polarized epithelial cell differentiation (GO:0030859),0.48106580942256805,1.026519206868731,0.44778067885117495,0.9281439938768917,1.0,4/13,20.34%,ZDHHC7;MYO9A;RHOA;RAB10
prerank,protein stabilization (GO:0050821),0.36137070496676577,1.0264404086593257,0.45271629778672035,0.9277551623798269,1.0,58/168,27.71%,WNT10B;SAXO1;UBE2B;ANK2;PLPP3;USP36;OTUD3;GTPBP4;SYVN1;RASSF2;MDM4;PFN2;HPS4;USP33;STX12;CCT7;CDKN1A;PIN1;P3H1;CCNH;IFT46;STK3;HSP90AA1;USP7;BAG4;CHP1;NOP53;FLOT2;NAPG;NAA15;TBRG1;RPL23;FLNA;PTEN;USP13;BAG3;USP19;SEL1L;FLOT1;TNIP2;CRYAB;RABL3;PER3;BAG5;DVL1;CCT4;TRIM44;CALR;RTN4;CRTAP;VHL;FBXW7;AFM;STXBP4;MUL1;TSC1;CCT6A;ATF7IP
prerank,negative regulation of insulin secretion (GO:0046676),0.4648818027431336,1.0261928589288898,0.4508301404853129,0.9278163503839534,1.0,3/17,9.80%,IRS1;MIDN;BMP8A
prerank,negative regulation of TOR signaling (GO:0032007),-0.2803721570987263,-1.0258237906235799,0.3953488372093023,0.781820037764639,1.0,9/36,16.28%,RNF152;UBR1;EPM2A;PRKAA2;SIRT1;SPAAR;ATM;SESN1;TNFAIP8L1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.41862341155992333,1.0254147184380595,0.4384057971014493,0.9295057483825837,1.0,7/26,14.68%,TMEM106A;KLF2;PKD2;TLR4;AKT1;KLF4;HSP90AA1
prerank,positive regulation of protein sumoylation (GO:0033235),0.5193830992666592,1.0252982060155882,0.4508990318118949,0.9292263634270639,1.0,5/10,26.70%,PIAS3;UBA2;HDAC4;SAE1;MUL1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.456856457711784,1.0249560598097365,0.4789272030651341,0.9295991097614903,1.0,7/18,23.97%,MAPK7;NFE2L2;AKT1;HTRA2;PPIA;TRAP1;BAG5
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.41228259301131,1.0246597210054686,0.43202764976958524,0.9299060872244097,1.0,9/34,17.37%,RAB7B;IRAK3;PTPRS;NR1D1;TLR4;CD14;NLRP2B;GRAMD4;SARM1
prerank,regulation of cell motility (GO:2000145),0.3647137789715949,1.0245855386013825,0.44693877551020406,0.9295103965388671,1.0,22/121,13.51%,FGF18;DUOX1;FGF7;EGFR;BTC;FGF2;SGK3;LMNA;MEAK7;NTN1;ABL2;SLK;INPP5F;PLXNA3;SRCIN1;KIF2A;EGF;AKT1;CCDC25;RHOA;PIN1;TWIST1
prerank,positive regulation of nervous system process (GO:0031646),-0.3340751374316267,-1.0240883958540685,0.413953488372093,0.7844312391245124,1.0,2/18,0.94%,UNC13B;TENM4
prerank,regulation of actin filament polymerization (GO:0030833),0.3780001475019094,1.0239101867645881,0.45864661654135336,0.9308295233033097,1.0,21/69,21.89%,DBN1;SLIT2;CDC42EP2;BIN1;MYADM;PFN2;KANK1;TWF1;SSH1;GBA2;FCHSD1;FER;ARF6;NCK1;COTL1;ARFGEF1;RASA1;PYCARD;ABITRAM;SSH3;CTTN
prerank,axon guidance (GO:0007411),0.3575827538289399,1.0239078072244392,0.449,0.9302067745546695,1.0,42/201,13.22%,SEMA3C;EPHB2;PRKCA;EFNA5;NPTN;GRB10;EPHA3;FYN;MAPK7;GAP43;VEGFA;SLIT3;SLIT2;NTN4;SLIT1;SPTAN1;DOK1;UNC5A;SPTA1;NFIB;PDLIM7;SRC;RET;GLI2;NTN1;SEMA3A;PIK3CA;SIAH1;PLXNA3;EPHB3;DOK4;USP33;DSCAM;UNC5D;L1CAM;EPHA10;IRS2;PALLD;SEMA3D;LGI1;GDNF;IGSF9
prerank,regulation of cell population proliferation (GO:0042127),0.3512225065721546,1.0237340126774608,0.397,0.930099640335651,1.0,113/691,14.10%,NOX4;SFRP4;LIF;AR;AREG;HAS2;FGF18;AVPR1A;WNT2;FGF7;DPP4;EGFR;TGFB3;SCIN;GLMN;IRS1;FGFR1;WT1;DIS3L2;CTF1;RPS6KA2;ADARB1;BTC;SIX4;RUNX1;WNT9A;VEGFA;FGF2;TGFB2;TNS2;SGK3;SGK2;MST1R;CAMK2N1;TGFBR2;TRNP1;F2R;IGFBP6;TIPIN;LMNA;ATF5;ELN;WWTR1;ZFP36L1;SKI;CDK4;GTPBP4;JUND;TCF7L2;CLCF1;MEIS2;PTPRJ;TRIM71;GLP2R;CXCL10;S1PR2;MEAK7;ZBTB7C;INHA;MDM4;MLXIPL;PLPP1;MELTF;PKD2;TBX6;ESM1;ABI1;STAT5A;DNAJA2;FLT3LG;CAPN1;CD81;WDR77;JAG1;CYP27B1;VDR;SIRT2;CUL3;STX4;KAT2B;ING4;ITGAV;SMAD6;BRD7;BCL6;CD47;NPM1;EGF;AKT1;FBXO5;RBFOX2;KRAS;GPNMB;MAGI2;KIF20B;JUP;UBE2A;TSHR;IRS2;DNAJB2;XRCC5;PDGFRA;GDNF;CDKN1A;FLT3;RHOA;P3H1;TMEM127;SIX1;NACC2;CDC123;DNAJA3;HDAC4
prerank,double-strand break repair (GO:0006302),0.3604788116439996,1.023611619538579,0.4579533941236069,0.9298619101270904,1.0,38/158,18.50%,PARP3;REV3L;XRCC3;EME1;SFR1;RAD51B;RFWD3;KPNA2;TENT4A;CYREN;UBE2N;PPP5C;HELQ;AP5S1;POLB;SAMHD1;SMC5;RMI1;ACTR5;DNA2;FAN1;XRCC5;ERCC4;ABRAXAS1;SEM1;BRIP1;SMC6;INO80;TNKS1BP1;NBN;IFFO1;RNF138;RECQL;SPIDR;RAD50;ERCC5;MORF4L1;BLM
prerank,regulation of centriole replication (GO:0046599),0.46065942745284527,1.0233838448040025,0.4774436090225564,0.9299048463399604,1.0,6/17,19.70%,CEP295NL;ALMS1;KAT2B;NPM1;CDK5RAP2;MDM1
prerank,signal transduction by p53 class mediator (GO:0072331),0.4155254279983469,1.0228636639021502,0.4578884934756821,0.9308137790810187,1.0,10/30,25.18%,TRIAP1;USP10;MDM4;BCL3;FHIT;NBN;DDX5;PYCARD;SESN2;E2F7
prerank,metanephric mesenchyme development (GO:0072075),0.5067957607970361,1.022785572315085,0.44692737430167595,0.9304206570684406,1.0,4/10,13.67%,WT1;SIX4;PKD2;SIX1
prerank,cellular response to alkaloid (GO:0071312),-0.3504369484262268,-1.021925728614386,0.4025974025974026,0.7884019293444023,1.0,8/17,22.50%,TGM2;CASP3;CASP7;RYR2;CASP6;HTR1B;CASQ2;RAD51
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.48573302060426454,1.0218163076678428,0.4733893557422969,0.9320285502594632,1.0,4/12,15.39%,ATP2B4;DYRK2;RCAN1;CHP1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.48573302060426454,1.0218163076678428,0.4733893557422969,0.9320285502594632,1.0,4/12,15.39%,ATP2B4;DYRK2;RCAN1;CHP1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.3281360991130046,-1.0214965144812265,0.38571428571428573,0.7875839856105075,1.0,4/20,4.51%,NEDD4L;ACTN2;OSR1;PRKCE
prerank,phospholipid transport (GO:0015914),0.39204103472139085,1.0211695977430457,0.4692982456140351,0.9333281650579431,1.0,11/52,12.66%,ATP8B1;TRIAP1;ATP9A;ABCA1;OSBPL2;PRELID3A;ATP11A;SCP2;ATP9B;TMEM30A;ABCC1
prerank,cellular response to inorganic substance (GO:0071241),0.44430967337134497,1.0211318052573708,0.44389027431421446,0.9328180158461299,1.0,8/21,22.51%,FOXO1;DPEP1;MTR;DDX11;KCNC2;SPIDR;BLM;NSMCE3
prerank,calcium ion import (GO:0070509),-0.3103744236928009,-1.0211112145195067,0.4588235294117647,0.7866880078714983,1.0,6/28,12.32%,CACNA1E;CACNB2;CACNA1D;MICU2;TRPC4;TRPV4
prerank,negative regulation of establishment of protein localization (GO:1904950),0.5110837754429228,1.0208905436031281,0.45285714285714285,0.9328966607606313,1.0,4/10,13.48%,CORO2B;MAPT;NDFIP1;TERF1
prerank,positive regulation of inflammatory response (GO:0050729),0.37176362847578925,1.0207749602988199,0.4579831932773109,0.9326082063928871,1.0,16/86,18.91%,LBP;IL16;S100A8;S100A9;IL33;IL17RA;CD81;TLR4;CD47;TNIP1;ABCC1;NUPR1;PDCD4;IL6;IL18;IFI35
prerank,serine family amino acid catabolic process (GO:0009071),-0.3979087921150506,-1.0205894860376263,0.431438127090301,0.7860896323082688,1.0,8/10,36.82%,DLD;CBS;GCSH;THNSL2;SHMT2;SHMT1;AMT;DAO
prerank,membrane repolarization during action potential (GO:0086011),0.4793329903470613,1.0203971260852853,0.4737550471063257,0.9330301407909664,1.0,3/13,8.24%,ATP1A1;KCNJ2;YWHAE
prerank,arachidonic acid metabolic process (GO:0019369),0.4076698240253054,1.0201842882649241,0.45774647887323944,0.9329937088143277,1.0,8/35,18.83%,MGLL;CYP2S1;DAGLA;GPX1;PNPLA8;DAGLB;EPHX1;CYP1B1
prerank,regulation of mast cell degranulation (GO:0043304),0.4778127564586239,1.0200531749586403,0.4707482993197279,0.9327794120319117,1.0,1/14,0.27%,SYK
prerank,cellular response to insulin stimulus (GO:0032869),0.3617520072881183,1.0192290374133217,0.45621181262729127,0.9345986410281597,1.0,39/124,21.55%,IRS1;GRB10;SLC39A14;HDAC9;PIK3R2;ZFP36L1;ATP6V0A2;ZDHHC7;FOXO1;MYO5A;INSIG2;FOXC2;SYAP1;KAT2B;RHOQ;INPP5K;AKT1;ATP6V1E1;IRS2;ATP6AP1;PDE3B;FER;ATP6V1D;ATP6V0A1;SELENOS;CPEB1;PKM;ATP6V1B2;SOS1;IDE;EPRS1;CAPN10;VAMP2;GPLD1;LPIN3;RAB10;GOT1;FOXO4;SLC25A33
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3846085452094235,1.0187610797304845,0.46120218579234973,0.9353539358492413,1.0,10/56,10.07%,TGFB3;LDLRAD4;TGFB2;PMEPA1;SMAD4;ACVR1;BMP15;INHA;BMP8A;SMAD6
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.36995582577605063,1.0183722163722055,0.46041666666666664,0.9358630222151586,1.0,14/88,13.65%,IGFBP5;EIF2AK3;CAMK2N1;RBM4;PAIP2B;TRIM71;SAMD4B;HDAC6;MRPL13;CSTB;AKT1;IGF2BP1;LARP1;CNOT10
prerank,cardiac atrium morphogenesis (GO:0003209),-0.35594475250029833,-1.0183333745338363,0.4327731092436975,0.7904712463736489,1.0,4/16,10.58%,ENG;NOTCH1;BMPR2;BMP2
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.37998935690513086,1.0182397677647488,0.4518201284796574,0.9356564779801038,1.0,17/59,21.95%,PRKCA;DYRK4;TGFBR2;ACVR1;CAMK2D;PRKD2;DYRK2;AKT1;STK39;HIPK4;ULK1;TGFBR1;CIT;HIPK3;OXSR1;MAPK1;CSNK2A2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.42219431289906073,1.018220887419099,0.4540023894862604,0.935085180397624,1.0,10/26,19.75%,FGFR1;MAPK7;RET;EYA2;AKT1;GDNF;PPP2R1B;SNAI2;HTRA2;MCL1
prerank,triglyceride metabolic process (GO:0006641),0.3897083738292116,1.0181560650391583,0.45543478260869563,0.9346360254393657,1.0,12/48,22.56%,GPAT4;FABP12;MOGAT1;GK5;MOGAT2;GPAT3;FABP5;GPAM;LIPC;LIPH;LPIN3;SEL1L
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.413184590726707,1.018104884050302,0.450887573964497,0.9341628218086071,1.0,7/29,18.17%,GTF2H3;RAD23B;ERCC3;UBA52;DDB1;CCNH;ERCC5
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.48687130746349766,1.018076837072804,0.46544428772919605,0.933619594174917,1.0,3/12,11.24%,MIA3;FUT9;AKT1
prerank,positive regulation of cilium assembly (GO:0045724),0.4571888472801384,1.0178315682373547,0.47435897435897434,0.9337002612322328,1.0,9/18,29.33%,SAXO1;BBS4;CCP110;ENTR1;CROCC;SEPTIN9;CCDC88A;FUZ;KCTD17
prerank,oligosaccharide biosynthetic process (GO:0009312),0.448469773638276,1.017740691231706,0.4578005115089514,0.9333347938921464,1.0,5/20,12.02%,ST3GAL2;B4GALT1;FUT2;FUT9;ST3GAL4
prerank,protein lipidation (GO:0006497),0.3805053942892906,1.017687381232438,0.4445640473627557,0.9328514266769409,1.0,21/59,23.69%,ZDHHC16;ZDHHC7;PIGZ;WIPI2;HHAT;PIGC;WDR45B;SELENOK;MPPE1;PIGW;ZDHHC2;PIGM;ZDHHC21;ZDHHC20;GPLD1;ZDHHC18;ZDHHC8;ATG10;PIGL;ZDHHC5;DPM2
prerank,spermatid development (GO:0007286),0.4108665804366794,1.0175192926584133,0.45433526011560693,0.9327165157444787,1.0,5/32,14.54%,TOPAZ1;DPY19L2;RSPH1;BBS4;CDYL
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.34081871459351326,-1.0172898752580621,0.42035398230088494,0.7913791247040167,1.0,7/17,23.87%,APOE;ABCG1;FGF1;SOD1;MBTPS2;ERLIN2;ABCA2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.36268562655768294,1.017282650091911,0.4669421487603306,0.9327878780428546,1.0,33/101,23.63%,NIBAN1;DACT1;MTOR;STUB1;LARP4;AURKAIP1;HNRNPD;NPM1;AKT1;BCL3;TBC1D10A;PASK;BAK1;EIF6;RPS27L;ZCCHC4;RBM3;POLDIP3;KLF4;HSP90AA1;EIF3E;OGT;IL6;FXR2;EIF3D;YTHDF1;VPS11;PCIF1;CSF1;YTHDF3;FBXW11;ATG10;IST1
prerank,regulation of activated T cell proliferation (GO:0046006),0.408894086230776,1.0172293658436466,0.4788235294117647,0.9323264988628813,1.0,2/30,7.14%,TNFSF9;RC3H1
prerank,positive regulation of rRNA processing (GO:2000234),0.4992764027598414,1.0171633012993635,0.4769874476987448,0.9319096066309385,1.0,2/10,4.91%,DIMT1;RIOK1
prerank,cellular response to gamma radiation (GO:0071480),-0.34753983413628825,-1.01694570812232,0.451063829787234,0.7903401390040928,1.0,8/17,20.15%,MAP3K20;YAP1;ATM;TMEM109;RPL26;WRN;HRAS;TSPYL5
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.4120031005045034,-1.016833378219287,0.4392523364485981,0.7885640062983044,1.0,5/10,31.49%,CEACAM1;ARRB2;PTPRC;FCGR2B;LILRB1
prerank,nuclear export (GO:0051168),0.3739628231474651,1.0163406564582678,0.4708333333333333,0.9337183858993701,1.0,27/80,25.84%,SRSF2;DESI1;HNRNPA1;SRSF6;NXF1;PKD1;U2AF1;SRSF3;STRADA;SRSF11;THOC7;POLDIP3;THOC2;THOC1;ZC3H11A;CHP1;SRRM1;DDX39A;U2AF2;NEMF;SMURF1;TPR;XPO7;CALR;NUP188;ALYREF;UPF3B
prerank,regulation of microtubule nucleation (GO:0010968),0.49859681114506216,1.016180764781795,0.45492957746478874,0.9335878577216883,1.0,4/10,28.20%,DCTN1;CKAP5;ARHGEF7;RANGRF
prerank,negative regulation of protein catabolic process (GO:0042177),0.39738171329863475,1.0161639224572991,0.4513172966781214,0.9330209251234611,1.0,5/40,8.83%,TIMP2;EGFR;IRAK3;MDM4;SIRT2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.41296299942294945,1.0159259953070423,0.43705463182897863,0.9331214026215414,1.0,11/30,23.97%,UCHL5;RYBP;SGTA;FHIT;USP7;GIPC1;OGT;NOP53;MAP1A;SDCBP;BAG5
prerank,positive regulation of tissue remodeling (GO:0034105),0.5047989529494347,1.0157467300914869,0.4638728323699422,0.9330494051360045,1.0,2/10,18.11%,TMBIM1;IL18
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.32073273881283465,-1.0156852592477892,0.4431818181818182,0.7876558236328032,1.0,4/23,3.20%,TFDP2;BCL2;PPP1R13B;YWHAH
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.32073273881283465,-1.0156852592477892,0.4431818181818182,0.7876558236328032,1.0,4/23,3.20%,TFDP2;BCL2;PPP1R13B;YWHAH
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.38076742364029503,-1.0156171860278373,0.45,0.7858768997406932,1.0,3/13,5.29%,ENTPD1;ENPP1;ENPP3
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.4821174078145249,1.0155213154011642,0.46537396121883656,0.9331445896612972,1.0,4/13,23.22%,SLC4A10;SLC8A2;SHISA6;GRIK2
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.30657422075740215,-1.0154932457206516,0.37333333333333335,0.7842389997317022,1.0,4/28,4.20%,ITPR1;BCL2;DAB2IP;CASP4
prerank,cellular lipid catabolic process (GO:0044242),0.42678827064836794,1.0153587276970117,0.451338199513382,0.9330078082413371,1.0,7/27,20.27%,CEL;SIRT2;ACOX1;CYP1B1;ANGPTL3;NUDT19;LPIN3
prerank,positive regulation of mitochondrion organization (GO:0010822),0.38163009143014454,1.014831037650672,0.45483870967741935,0.9339237460361348,1.0,14/57,21.01%,DCN;MIEF2;MCU;CAMKK2;BMF;BBC3;BAK1;MLLT11;HRK;HTRA2;PLAUR;DDHD1;RALA;PYCARD
prerank,DNA replication (GO:0006260),0.35943306941319736,1.0145152780718165,0.4815195071868583,0.9342529050660451,1.0,34/105,25.29%,REV3L;TIPIN;IGHMBP2;NT5M;RHNO1;POLE3;POLG2;POLB;ING4;MCM3;RMI1;DNA2;RAD1;PCLAF;DBF4;BRIP1;ORC6;NBN;FAM111A;GRWD1;RFC4;RAD50;SET;TBRG1;BLM;POLD1;DONSON;KIN;CLSPN;REV1;BAZ1A;ORC2;KAT7;KAT5
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.4587601692052007,1.014506135525898,0.4600262123197903,0.9336605923713808,1.0,3/16,11.43%,PRKCA;CAMK2D;SLC9A1
prerank,negative regulation of nervous system development (GO:0051961),-0.3527644894284094,-1.014273589101472,0.41630901287553645,0.78548162225474,1.0,5/17,10.39%,NOTCH1;ROBO2;B2M;APPL2;SORL1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3530624734356328,1.014081292313164,0.45,0.9343251240964268,1.0,103/314,26.18%,UCHL1;PSMC4;UBE2B;SPSB1;SPSB4;NFE2L2;SMURF2;UBE2J2;SYVN1;EDEM1;ITCH;TRIM71;RAD23B;RNF121;RMND5B;COP1;PSMC6;SPSB2;STUB1;UBE2W;FBXO2;ANKZF1;SIAH1;PSMD8;SIRT2;FBXO17;CUL3;ECPAS;FBXL2;FBXW4;UBE2G2;HECW2;FBXL20;HERPUD1;CDC23;FBXO5;FBXO31;ANAPC5;UBE2A;CDC34;DNAJB2;UBA52;LTN1;TMUB2;DDB1;CDC27;FBXL3;SGTA;AMFR;RNF216;SELENOS;ZSWIM8;RBCK1;RNF187;KCTD2;HACE1;PML;CDC26;DMAC2;FBXL5;UBE2G1;AUP1;ANAPC4;PCNP;SKP2;UBE2D3;FBXL19;CUL5;KCTD10;ANAPC10;NEMF;ARRB1;JKAMP;SMURF1;KLHL22;FBXW11;UBXN11;SPSB3;USP19;DERL1;SEL1L;ANAPC15;UBR2;IFI27;FBXO38;ECRG4;DCAF12;PSMD4;RHBDD2;FBXL12;PSMD3;MDM2;SEC61B;AGAP3;HSP90B1;KAT5;FBXW7;UFD1;ANAPC2;UBE2K;DDIT3;RNF126;PSMB3
prerank,positive regulation of programmed cell death (GO:0043068),0.3541555375148924,1.0139901534453906,0.454,0.9339601398991362,1.0,70/272,22.47%,SFRP4;SYK;WNT10B;KCNMA1;TGFB3;SCIN;AKAP13;GADD45G;RPS6KA2;SLIT2;BIN1;TRIO;MTCH1;ADAMTSL4;HOXA5;FOXO1;PRMT2;RASSF2;C1QBP;AIFM2;ARHGEF3;HDAC6;PIP5KL1;FLCN;PSEN1;SIAH1;PDCD2;RYBP;ING4;TIAM2;SQSTM1;BCL6;CSRNP3;BMF;ERCC3;BAK1;UBA52;NGEF;QRICH1;DIABLO;CALHM2;STK3;MTCH2;MLLT11;DDX20;NLRP2B;HRK;EEF1E1;CTSD;SOS1;IL6;SAP18;IAPP;HTRA2;TFAP4;SMPD1;CYP1B1;CLIP3;GPLD1;APAF1;SUDS3;TRIM35;ATF6;TIAM1;PYCARD;NF1;VAV2;ATF4;HTATIP2;JUN
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.4515328050542153,1.0137297605536075,0.455026455026455,0.9340856297509508,1.0,9/16,31.61%,NUP98;RBM3;SF3B4;THRAP3;DAZAP1;CELF3;RBMX;CELF4;CIRBP
prerank,negative regulation of response to external stimulus (GO:0032102),0.3610112451465105,1.013684001279576,0.4727646454265159,0.9336094138633243,1.0,20/105,15.63%,MAPK7;IRAK3;FGF2;PTPRS;METRNL;MVK;ITCH;NR1D1;CARD16;C1QBP;INPP5F;SIRT2;SIRPA;FNDC4;RTN4RL1;KLF4;IL4;LRFN5;SELENOS;ILRUN
prerank,DNA duplex unwinding (GO:0032508),0.3867727974061689,1.0136331072476545,0.45755237045203967,0.9331497954778395,1.0,13/50,19.01%,ANXA1;GTF2H3;RAD23B;ASCC3;ERCC3;UBA52;DDB1;DDX11;NBN;RECQL;RAD50;BLM;SUPV3L1
prerank,positive regulation of protein catabolic process (GO:0045732),0.3672930998872717,1.0132852766314877,0.4753410283315845,0.933601162787286,1.0,23/84,21.72%,GPC3;ADAM9;STX5;SMURF2;AXIN1;DACT1;ITCH;FOXO1;SEC22B;EGLN2;DTL;HECW2;DDB1;TNFRSF1B;HSP90AA1;NSF;HACE1;IDE;VPS11;GPLD1;SH3D19;RNF41;SMURF1
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.45902181969948574,1.0132278512053305,0.46526867627785057,0.9331453437724604,1.0,4/16,12.35%,PRCP;SPX;GPR37L1;KLK1
prerank,zinc ion homeostasis (GO:0055069),0.41793306666427515,1.013198490561471,0.47423887587822017,0.9326161643232042,1.0,5/28,16.80%,SLC39A14;SLC39A13;SLC39A7;SLC30A9;SLC30A5
prerank,positive regulation of dendritic spine development (GO:0060999),0.4355079494174878,1.013100850213636,0.44823232323232326,0.9323068621537794,1.0,3/20,14.16%,DBN1;PSEN1;LLPH
prerank,protein deacetylation (GO:0006476),0.39184535692559636,1.0128058867515946,0.46145251396648046,0.9325519307724487,1.0,14/41,22.56%,HDAC7;HDAC9;SIN3B;HDAC6;MSL3;SIRT2;RCOR3;HDAC3;HDAC4;MORF4L1;SUDS3;MIER1;FLNA;BAZ2A
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.516394435579442,1.0126471495049465,0.4779516358463727,0.9323945212520275,1.0,4/10,16.42%,ETFA;ACADVL;ETFDH;ETFB
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.30867256919236263,-1.0121899517770696,0.42424242424242425,0.7890946437132266,1.0,11/26,16.10%,CNOT2;STRN3;PIAS2;CNOT9;HEYL;CRY1;SFRP1;SIRT1;KANK2;DAB2;VPS18
prerank,positive regulation of immunoglobulin production (GO:0002639),0.405242210283325,1.0121159744922954,0.47591069330199764,0.933352063869929,1.0,4/31,9.23%,EPHB2;CLCF1;HMCES;STX4
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.4402722506022636,1.0115691356437324,0.4560099132589839,0.9343051757027967,1.0,5/21,6.52%,TGFB3;SMAD4;WWTR1;NUP93;SH2B1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.47212136852770936,1.0115385239558663,0.45479082321187586,0.9337836650261743,1.0,3/13,17.19%,STX1A;SCAMP5;SYT1
prerank,ketone body metabolic process (GO:1902224),-0.3964099908074158,-1.0115012447935865,0.4562043795620438,0.789127872223788,1.0,3/10,9.69%,ACSS3;HMGCS2;AACS
prerank,organonitrogen compound catabolic process (GO:1901565),0.3836912765530287,1.0113038719286764,0.47186147186147187,0.933834665346606,1.0,20/57,27.10%,ANPEP;MTOR;NAGK;LNPEP;TPP1;CLPX;SIAH1;PDXDC1;PNPLA8;NPEPPS;IDE;MPST;LIPC;LRSAM1;TXN2;USE1;TRIM24;CTH;PLA2G7;PPT1
prerank,regulation of interferon-alpha production (GO:0032647),0.42191662262195573,1.0111477598330534,0.4614427860696517,0.9336921539670398,1.0,4/23,11.66%,PTPRS;CHUK;TLR4;SETD2
prerank,base-excision repair (GO:0006284),0.38219539764576493,1.0107437851679972,0.4553672316384181,0.9342438748417706,1.0,8/48,20.78%,MPG;POLB;PARG;DNA2;RFC4;ERCC5;POLD1;OGG1
prerank,mitochondrial translational elongation (GO:0070125),0.366988138543223,1.0106976242788062,0.48805815160955346,0.9337744384067032,1.0,19/88,15.77%,MRPS11;MRPL38;MRPS18B;CHCHD1;MRPL13;MRPS17;AURKAIP1;MRPS27;MRPL30;DAP3;MRPL10;GFM1;MRPL55;MRPS10;MRPL36;MRPL3;MRPL21;MRPS34;MRPL51
prerank,keratan sulfate catabolic process (GO:0042340),0.48565458771199443,1.0104843973348747,0.4772117962466488,0.9337936614666248,1.0,2/11,4.39%,OGN;ACAN
prerank,protein maturation (GO:0051604),0.3680810357482988,1.0102796505054559,0.48290155440414506,0.933791983898225,1.0,27/95,22.36%,PCSK6;TSPAN17;PCSK5;LIPT2;ADAM19;ADAMTS3;PCSK4;STUB1;PSEN1;ECE1;XPNPEP3;NDUFAB1;EEF1AKMT4-ECE2;ECE2;DNAJB11;TASP1;OGT;CIAO2B;NAA15;MMP16;NAA50;METAP2;PCSK7;BACE1;CCS;CPZ;SDE2
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.39743982427583047,-1.0102307908476056,0.4318181818181818,0.7907497676149261,1.0,2/11,6.23%,ABCG1;AGTR1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3810007719370683,1.0099834659129605,0.48327939590075514,0.9340216869610779,1.0,27/59,29.81%,CDK4;TCF7L2;MED24;MITF;CEBPB;CCNC;MED13;CDKN1A;TWIST1;CCND1;MED15;IL6;AGO4;MED23;MED6;AGO3;PTEN;JUN;MED7;RELA;TNRC6A;MED26;AGO1;NFKB1;BAX;TP53;SOX9
prerank,cellular response to organic cyclic compound (GO:0071407),0.35826814497018195,1.0098325791966527,0.4889112903225806,0.9338334909972184,1.0,34/141,19.52%,IGFBP5;AR;ESR1;EGFR;WT1;ZFP36L1;ATP1A3;ATP1A1;P2RX3;RAP1B;NCOA3;PKD2;HCN4;INPP5K;SSH1;URI1;SLC26A6;JUP;LARP1;ADCY8;EPG5;GNB1;ZC3H12A;RAPGEF1;DIAPH1;SPIDR;AKAP9;NRIP1;IL18;BLM;CYP1B1;HCN1;RORA;GABRG2
prerank,response to hydroxyurea (GO:0072710),0.48420183822558194,1.0097754887660908,0.475,0.9333967841318,1.0,6/11,28.93%,DDX11;SPIDR;BLM;NSMCE3;KAT7;ATRX
prerank,mitochondrial protein processing (GO:0034982),-0.4027922267260706,-1.0096605454342067,0.43462897526501765,0.7903647734746485,1.0,4/11,18.52%,IMMP2L;ATP23;YME1L1;STOML2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.3720657272781185,1.009433528941732,0.48214285714285715,0.9338017001052674,1.0,15/75,11.44%,PRKCA;FGFR1;ITGB3;ANG;VEGFA;FGF2;ECM1;THBS4;PRKD2;STAT5A;AKT3;EMC10;EGF;AKT1;NRAS
prerank,negative regulation of signaling receptor activity (GO:2000272),0.4186816617643726,1.0094094690235302,0.46107784431137727,0.933265325251544,1.0,2/25,4.03%,EPHB2;CNRIP1
prerank,negative regulation of cellular component movement (GO:0051271),-0.35949444435521705,-1.0093736107900348,0.40408163265306124,0.7891558640461623,1.0,5/15,11.01%,SP100;FRMD5;TGFBR3;CCDC125;ACTN1
prerank,mitotic metaphase plate congression (GO:0007080),0.3782645671720408,1.0090217051014334,0.46974697469746973,0.9337901559044666,1.0,13/51,23.03%,CHAMP1;PSRC1;CHMP7;ZW10;VPS4B;CUL3;CDC23;PIBF1;CENPC;CENPE;PDCD6IP;DCTN2;RMDN1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.4624602164791397,1.0080317370613838,0.4718498659517426,0.9359962925000725,1.0,5/15,18.36%,ENTPD2;NME2;CMPK2;AK8;ENTPD6
prerank,translational termination (GO:0006415),0.36507751218958495,1.0079753079483817,0.4963805584281282,0.935555193876268,1.0,21/95,15.77%,MRPS11;MRPL38;MRPS18B;ABCE1;CHCHD1;MRPL13;MRPS17;AURKAIP1;MRPS27;GSPT2;MRPL30;DAP3;MRPL10;MRPL55;MRPS10;MRPL36;MRPL3;GSPT1;MRPL21;MRPS34;MRPL51
prerank,positive regulation of cellular process (GO:0048522),0.3462517878492893,1.007862350424102,0.455,0.9352687485929762,1.0,95/565,15.09%,LBP;LIF;AR;AREG;HAS2;LRP6;FGF18;AVPR1A;WNT2;FGF7;PRKCA;DPP4;EGFR;LRP1;TGFB3;IRS1;FGFR1;HPN;CTF1;BTC;VEGFA;FGF2;TGFB2;MST1R;TGFBR2;F2R;CDKN2AIP;S100A8;S100A9;TIPIN;LMNA;WWTR1;ZFP36L1;DDX49;P2RX3;CDK4;ACLY;CLCF1;MEIS2;PTPRJ;GLP2R;POFUT2;S1PR2;ZFHX3;C1QBP;MLXIPL;FLCN;PRKD2;TBX6;ESM1;GAS6;DNAJA2;FLT3LG;CAPN1;FZD7;TNFRSF18;CD81;WDR77;SIRT2;CUL3;STX4;TLR4;ITGAV;SIRPA;RNF10;CD47;SMC5;NPM1;EGF;AKT1;FBXO5;MAPT;KRAS;KIF20B;UBE2A;TSHR;IRS2;LGI1;PDGFRA;ZFP36;GDNF;FLT3;CCND1;TNFRSF1B;ZC3H12A;SMC6;CDC123;INO80;HDAC4;FER;PPP3CA;DYNC1H1;POU3F2;NUPR1;IL4
prerank,response to cadmium ion (GO:0046686),0.41550895587926673,1.0078104854958025,0.4690157958687728,0.9348029234163739,1.0,8/26,30.27%,EGFR;CHUK;AKT1;MAPK1;JUN;SUMO1;FOS;HSF1
prerank,negative regulation of cyclase activity (GO:0031280),0.4659823922231351,1.0070833753575437,0.47282608695652173,0.9363438280034447,1.0,3/14,8.84%,GNAI3;PALM;LTB4R2
prerank,negative regulation of phosphatase activity (GO:0010923),0.4196530983297213,1.0069416475318438,0.4839901477832512,0.9361308677313028,1.0,13/25,30.19%,TGFB2;PPP1R1B;URI1;CHP1;SH2D4A;FKBP1A;TIPRL;PPP1R26;CRY2;FKBP1B;GPATCH2;PTPA;BOD1
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.42171490469330486,1.006827488197351,0.4897959183673469,0.935864236442787,1.0,7/27,16.92%,EGFR;AGO2;PUM1;ZFP36;MAP2K2;IL6;DDX5
prerank,negative regulation of interleukin-17 production (GO:0032700),0.4928150502599175,1.0063286236243811,0.47,0.9367043854829128,1.0,5/10,36.82%,TLR4;DDIT3;PRNP;NCKAP1L;VSIR
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4104057286066769,1.006291282091972,0.47437425506555425,0.9362165837760279,1.0,6/33,10.87%,CD160;PTPRJ;RC3H1;PRKD2;CD81;UBASH3A
prerank,inositol phosphate catabolic process (GO:0071545),0.47623195620982806,1.0059130361222623,0.48728246318607765,0.9366572432791677,1.0,5/12,27.59%,OCRL;INPP5K;INPP5B;PTEN;SYNJ2
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.3054383863654856,-1.0059100633916171,0.4585635359116022,0.7967239586101159,1.0,6/26,13.69%,EPHA4;LYN;AIM2;TTBK1;PSME2;PSME1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.39014609255107074,1.0056796421266125,0.4868131868131868,0.9366981611539725,1.0,9/51,10.32%,MYOC;TGFB3;S100A10;LPAR1;SORBS3;PFN2;ARHGEF10L;ARHGEF10;CD47
prerank,positive regulation of cell junction assembly (GO:1901890),0.3795109233656552,1.0056314094088028,0.4840834248079034,0.93623756673977,1.0,5/56,5.31%,MYOC;EPHB2;VEGFA;S100A10;PTPRJ
prerank,regulation of pH (GO:0006885),0.4924421755870002,1.005631060188061,0.48951048951048953,0.935636346981069,1.0,4/11,16.13%,ATP1A4;SLC9A1;ATP6AP1;SLC9A7
prerank,regulation of glycogen metabolic process (GO:0070873),0.47774878220601535,1.0055790296608293,0.47360912981455067,0.9351732810670892,1.0,5/12,24.33%,INPP5K;AKT1;PPP1R3C;PPP1R3D;PPP1R3E
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3778231785422811,1.0051855045831988,0.4796137339055794,0.93569869071991,1.0,17/64,20.91%,MGLL;DAGLA;SCP2;SLC27A3;GPX1;GSTM2;PNPLA8;ELOVL5;FADS1;ACOT1;DAGLB;ACAD9;ACOX1;EPHX1;CYP1B1;CPT2;HSD17B4
prerank,response to UV (GO:0009411),0.36245646343904525,1.0047708718078536,0.49793388429752067,0.9363169737250587,1.0,31/95,24.09%,EGFR;TRIAP1;UBE2B;NOC2L;SCARA3;RHNO1;ZBTB1;DTL;NPM1;GPX1;AKT1;BCL3;BMF;UBE2A;ERCC3;BAK1;ERCC4;PCLAF;CCND1;EIF2S1;INO80;UVSSA;ERCC5;POLD1;SMPD1;ATF4;SDE2;NSMCE3;REV1;RELA;POLH
prerank,positive regulation of potassium ion transport (GO:0043268),0.39229915630261053,1.0047441987334216,0.4601571268237935,0.9357851813320204,1.0,6/38,13.66%,KCNMA1;FHL1;ANK2;KCNJ2;KCNJ3;GNB1
prerank,B cell activation (GO:0042113),0.37338290586937783,1.004385210346414,0.47720042417815484,0.9362456562338074,1.0,10/68,15.09%,EPHB2;LAX1;HDAC9;CLCF1;PTPRJ;BANK1;FLT3;CR2;HDAC4;IL4
prerank,positive regulation of mitochondrial translation (GO:0070131),0.4611808849094424,1.004361994341491,0.47354497354497355,0.935710234152476,1.0,5/14,21.70%,C1QBP;MRPS27;RCC1L;RMND1;MPV17L2
prerank,negative regulation of gene expression (GO:0010629),0.3480548996389447,1.00430281104579,0.4774774774774775,0.9352731610071197,1.0,50/302,13.85%,CD34;IGFBP5;ESR1;DIS3L2;NPTN;EIF2AK3;RUNX1;VEGFA;FGF2;DGKQ;TGFB2;FOXP1;RBMS3;MIF;HDAC9;SYT11;RBM4;CREB3L1;PAIP2B;ATP2B4;TRIM71;SAMD4B;CREBZF;TARDBP;MYADM;FLCN;PHF1;ZFP36L2;VDR;PSEN1;MRPL13;AGO2;NUDT16L1;KAT2B;ERN1;MPHOSPH8;PARP14;MAPT;GPNMB;SLC2A10;NUDT16;IGF2BP1;NCOR2;NDFIP1;LARP1;SMCR8;ZFP36;NCOR1;CNOT10;ZC3H12A
prerank,endocardial cushion morphogenesis (GO:0003203),0.4430062127903209,1.004301100757678,0.47416020671834624,0.9346775028722214,1.0,4/18,6.84%,TGFB2;TGFBR2;ACVR1;MDM4
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.40794595941221795,1.0042810780439722,0.4766899766899767,0.934132307811543,1.0,8/31,21.47%,TIMM50;PEX16;GRPEL2;PEX12;PEX1;PEX5;TIMM17A;PEX2
prerank,lipid biosynthetic process (GO:0008610),0.3643530233616949,1.0040671391541485,0.48898216159496327,0.9341577628268667,1.0,19/77,19.88%,GPAT4;ACLY;MVK;SCP2;SRD5A1;GGPS1;NDUFAB1;AGPAT3;LPCAT1;AGPAT5;FADS1;HSD17B8;GPAM;LIPC;LIPH;SCD5;SREBF1;MCAT;ABCD3
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.3627824609084784,1.0039999725437536,0.48393782383419687,0.93377181568904,1.0,35/94,27.05%,DCTN1;ODF2;YWHAG;SSNA1;YWHAE;ALMS1;HAUS3;MAPRE1;SFI1;CEP97;HSP90AA1;DYNC1H1;TUBB4A;TUBA4A;CDK5RAP2;CCP110;AHI1;AKAP9;CEP164;CKAP5;CEP89;CEP83;PAFAH1B1;CC2D2A;PCM1;FBF1;DCTN2;TCTN2;NEDD1;DYNLL1;TCTN1;CEP78;ACTR1A;CSNK1E;CETN2
prerank,platelet aggregation (GO:0070527),0.398035469145102,1.0039741268394673,0.4727061556329849,0.9332431251066413,1.0,10/33,21.59%,GNAS;ITGB3;PDGFRA;ACTG1;PPIA;ILK;FLNA;TYRO3;PIK3CG;METAP1
prerank,protein localization to condensed chromosome (GO:1903083),0.4708833529692067,1.003897744688997,0.47657295850066933,0.9328452410728048,1.0,2/12,5.01%,CHAMP1;ZW10
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3859819749518725,1.0037999490710268,0.4820224719101124,0.9325197010107382,1.0,10/47,14.01%,MEDAG;ZFP36L1;METRNL;SYAP1;AKT1;CEBPB;ZFP36;SIX1;ZC3H12A;WDFY2
prerank,receptor catabolic process (GO:0032801),0.4167704848668451,1.0029571419981835,0.46740467404674046,0.9343458208254746,1.0,4/24,8.25%,CLTC;AP2A2;MVB12A;MYLIP
prerank,negative regulation of autophagy (GO:0010507),0.37858054126989577,1.0024771539809902,0.4928806133625411,0.9350922030629139,1.0,23/54,28.00%,USP36;FOXK2;MTOR;IL10RA;PIK3CA;SIRT2;NRBP2;AKT1;BMF;SMCR8;NUPR1;HGF;DAP;MCL1;QSOX1;TAB2;KLHL22;EIF4G3;LEPR;EIF4G1;CTSA;TSC1;ZKSCAN3
prerank,tRNA wobble base modification (GO:0002097),-0.3633415689310167,-1.0024665594513864,0.45867768595041325,0.8040351718999211,1.0,2/14,3.39%,ELP3;TRMT9B
prerank,T cell migration (GO:0072678),-0.3791006692981487,-1.0020789520091467,0.40304182509505704,0.8031159389632293,1.0,4/13,10.51%,SLC12A2;S1PR1;PIK3CD;CXCL16
prerank,regulation of glycolytic process (GO:0006110),-0.24434269844218015,-1.0017987797312164,0.45,0.8018399746766897,1.0,11/68,7.96%,PRKAG2;INSR;IGF1;APP;PRKAA2;CBFA2T3;PPARA;NUP35;NDC1;RAE1;PGAM1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.3482869964484088,1.0014503989929124,0.495,0.9373402296378711,1.0,114/341,26.18%,UCHL1;PSMC4;UBE2B;SPSB1;SPSB4;NFE2L2;UBA6;SMURF2;ZRANB1;SYVN1;ITCH;VPS4B;TRIM71;RAD23B;RMND5B;RBBP6;MVB12A;COP1;RNF111;VPS37D;PSMC6;SPSB2;RC3H1;STUB1;UBE2W;WDR91;MYLIP;ADRM1;SIAH1;PSMD8;SIRT2;CUL3;DTL;FBXW4;UBE2G2;HECW2;USP33;SQSTM1;OTUD7B;HERPUD1;CDC23;ANAPC5;RNF7;UBE2A;CDC34;NDFIP1;DDB1;VPS37C;CDC27;CBL;UBR4;AMFR;RNF128;TRPC4AP;RNF216;RNF14;ZSWIM8;RBCK1;RNF187;KEAP1;KCTD2;HACE1;PML;CDC26;NTAN1;UBE2G1;FBXO11;VPS37B;ANAPC4;ARIH2;UBE2R2;UBAP1;PCNP;NEDD8;SKP2;RNF19A;TOLLIP;KCTD21;UBE3C;ARIH1;UBE2D3;FBXL19;KCTD6;KCTD10;ANAPC10;ARRB1;RC3H2;SMURF1;KLHL22;FBXW11;UBXN11;SPSB3;ANAPC15;RNF6;RNF114;IFI27;RNF13;PSMD4;UBQLN4;PSMD3;MDM2;AGAP3;RNF166;FBXO22;KAT5;FBXW7;UFD1;RNF20;ANAPC2;UBE2K;RNF167;DDIT3;RNF126;PSMB3
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3590126311686829,1.0013408136526722,0.4937888198757764,0.9370453968323061,1.0,28/100,21.52%,DCN;MYOC;EGFR;FGFR1;FGF2;TGFB2;F2R;SRC;PIK3CA;FBXL2;EGF;PIK3IP1;IRS2;PDGFRA;FLT3;TWIST1;CBL;NOP53;HGF;PPP2R5B;PIP4K2C;IL18;DIPK2A;ROR1;PIP4K2B;MAPK1;PTEN;PIK3CG
prerank,regulation of lipid storage (GO:0010883),0.4248946529487003,1.0010979205483457,0.48034398034398035,0.9371299681037659,1.0,5/22,16.45%,ITGB3;ALKBH7;ITGAV;ZC3H12A;IL6
prerank,protein catabolic process (GO:0030163),0.3757257785977406,1.0009386691027897,0.47811816192560175,0.936977534932738,1.0,22/59,24.16%,MTOR;NR1D1;FBXO2;TPP1;OGA;CLPX;SIAH1;FBXO17;UBE2G2;DDB1;HSP90AA1;NGLY1;CTSD;SOCS6;HTRA2;IDE;UBE2G1;LRSAM1;RNF41;USE1;TRIM24;RAB12
prerank,positive regulation of T cell cytokine production (GO:0002726),0.42872485878199357,1.0008762981018753,0.4802547770700637,0.9365521736320062,1.0,7/20,25.13%,CD55;CD81;IL4;IL6;IL18;MAP3K7;PRKCZ
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.34220020084920183,1.000864284135318,0.487,0.9359893375915157,1.0,222/1082,18.11%,LMX1A;DCN;LIF;AR;LRP6;CD80;COL1A1;ESR1;WNT2;FGF7;NFIX;IRF4;EGFR;TGFB3;CREB5;WT1;ZC3H8;MEOX2;TRIAP1;EIF2AK3;HSF2;ELF4;SIX4;MAPK7;ZMIZ1;RUNX1;VEGFA;FGF2;PBX1;F2R;GLIS2;SFR1;PSRC1;SMAD4;NFE2L2;CRTC2;ZPR1;PIK3R2;ATF5;DPF2;WWTR1;LMX1B;AKNA;MEF2D;SKI;PKD1;ACVR1;AXIN1;CXXC1;COPS5;SOX10;FOXK2;MAP2K3;KLF2;JUND;TCF7L2;NR1D2;MAFF;MTOR;MEIS2;NFATC1;IL33;SCAF8;SMARCD2;HOXA5;FOXO1;NR1D1;RTRAF;CXCL10;AKIRIN1;NFIB;PRMT2;MAPRE3;EBF3;NCOA3;RNF111;SSBP3;NFIA;ZFHX3;ARF4;DPF1;SMAD5;RET;TRIP4;GLI2;MLXIPL;MDFIC;PID1;ACTR3;DNAJC2;MTF1;SMARCD1;ZFPM2;ADCYAP1;FLCN;DHX33;PRKD2;PKD2;CHUK;FZD7;CD81;SOX8;JAG1;VDR;SATB2;CDK9;PSEN1;MYBL2;FOXC2;SIRT2;AGO2;HNRNPD;ATXN7L3;MED24;TLR4;RYBP;BEX1;KAT2B;ONECUT1;ATAD2B;RHOQ;SQSTM1;BRD7;RNF10;HDAC3;INPP5K;MITF;HELZ2;TCERG1;MZF1;NPM1;PRDM15;SMARCC2;GLI3;EGF;SLC30A9;TNIP1;IRF2BPL;CAMKK2;CSRNP3;AKT1;CEBPB;SLC9A1;TOX2;UBTF;BCL3;DCAF6;JUP;ZNF462;KANSL3;AKIRIN2;UBA52;CCNC;DDX17;QRICH1;MED13;ATF1;GDNF;DR1;PEG3;PIN1;TWIST1;RAI1;SIX1;RFX5;ZC3H12A;NME2;INO80;HDAC4;PLAGL1;PTOV1;BCAS3;PPP3CA;KLF4;MLLT11;HOXC4;MLXIP;EAF2;HOXA7;BCL9;THOC1;GTF2F1;TASP1;CHD8;SMARCA4;POU3F2;IL4;NR2C2;E2F3;MAP2K2;UBP1;RNF14;OGT;USP22;FZD4;NCK1;CDK5RAP2;AHI1;HIVEP3;STAT5B;RNF187;PER1;PADI2;IL6;HGF;PHF5A;E4F1;BCLAF3;PML;NEK4;PITHD1;TFAP4;NUFIP1;NRIP1;ILF2;HIVEP1;ABHD14B;ILK;NAA15;KMT2A;TGFBR1;IL18
prerank,nuclear pore organization (GO:0006999),0.46025427991379325,1.0005962635411074,0.4966974900924703,0.9361741148067584,1.0,4/14,8.78%,NUP93;AHCTF1;NUP107;NUP98
prerank,inorganic cation transmembrane transport (GO:0098662),0.3481331906885502,1.0002395044533305,0.511,0.9365709554516547,1.0,38/268,11.94%,SCARA5;KCNK5;SCNN1B;UCP1;HPN;KCNV1;SLC4A8;SLC39A14;SLC39A13;ATP1A4;ATP1A3;ATP1A1;PKD1;P2RX3;TRPV3;ATP2B4;KCNJ2;SLC9A9;KCND1;SLC11A2;SLC6A8;ABCB8;PKD2;GAS6;SLC25A27;ATP5PO;KCNK13;KCNK9;ITGAV;HCN4;SLC39A7;KCNA2;KCNA6;SLC4A4;SLC9A1;SLC6A11;KCNAB3;SLC6A4
prerank,negative regulation of DNA binding (GO:0043392),-0.3001462680908701,-1.0000056947614193,0.4228187919463087,0.8047298045324975,1.0,2/28,0.78%,LEF1;SP100
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.39262507318186296,0.9998227468189735,0.4977324263038549,0.9371456335049603,1.0,4/43,5.31%,AREG;EGFR;BTC;PTPRJ
prerank,histone mRNA catabolic process (GO:0071044),-0.3595886182781531,-0.9993214271618506,0.4426229508196721,0.8046488336641899,1.0,6/15,16.80%,SSB;TUT1;TUT4;TUT7;ATM;MTPAP
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.49385423598046635,0.9988910540151031,0.5084269662921348,0.939238202632302,1.0,5/10,13.86%,UBE2B;PDE11A;PDE4D;CDC34;PDE3B
prerank,alcohol catabolic process (GO:0046164),0.4907511318232418,0.9987362616080703,0.5064748201438849,0.9390955520813089,1.0,1/10,1.40%,CEL
prerank,myeloid cell differentiation (GO:0030099),-0.2653303318602992,-0.9984219879859118,0.4942528735632184,0.805260449176561,1.0,21/47,26.29%,LYN;KMT2E;KIT;HSPA9;CASP3;PRDX3;RPS14;INHBA;PTPN2;TAL1;HIPK2;SNRK;ACIN1;UBA5;JAK3;SPI1;RASGRP4;KAT8;ALAS2;CEBPA;HCLS1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.41837644163761445,0.998311621548646,0.4920828258221681,0.9397301520795253,1.0,2/25,3.98%,CD55;CD160
prerank,regulation of acrosome reaction (GO:0060046),-0.3928952987882025,-0.9980108576510451,0.4358108108108108,0.8044575696482824,1.0,1/10,4.70%,PLCB1
prerank,positive regulation of protein import (GO:1904591),0.4069004808456699,0.997990496571623,0.4982373678025852,0.9400486566503092,1.0,12/30,22.76%,ZPR1;PIK3R2;PSEN1;RBM22;HDAC3;JUP;ZC3H12A;DMAP1;IPO5;FLNA;BAG3;TPR
prerank,release of cytochrome c from mitochondria (GO:0001836),0.4409716743122155,0.9977491831526534,0.4640102827763496,0.940111740863411,1.0,4/17,12.70%,TIMM50;BBC3;BAK1;SFN
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.29003988657928864,-0.9974655821242828,0.42657342657342656,0.8040569478334817,1.0,10/29,14.59%,THBS1;CAV1;TNFSF12;SFRP1;WWOX;INHBA;RIPK1;TNFSF10;DEDD2;GPER1
prerank,carbohydrate biosynthetic process (GO:0016051),0.4333280113154485,0.9974369339931483,0.489281210592686,0.9404099983771478,1.0,5/21,12.02%,ST3GAL2;B4GALT1;FUT2;FUT9;ST3GAL4
prerank,regulation of establishment of protein localization (GO:0070201),0.4718197889072971,0.9973410534473671,0.48663101604278075,0.940074199488426,1.0,4/13,16.82%,CORO2B;SCFD1;CTSD;SPIDR
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.4703445875144396,0.9973041814883833,0.4844804318488529,0.939587692959852,1.0,6/12,26.71%,STX4;ADCY8;GPLD1;PPP3CB;BAIAP3;CFTR
prerank,regulation of endopeptidase activity (GO:0052548),0.37285152566537905,0.9972497126066936,0.4941050375133976,0.9391366535421292,1.0,7/59,11.56%,TIMP2;SERPINB8;SERPINE3;SERPINF1;SERPINH1;AKT1;SERPING1
prerank,positive regulation of ATPase activity (GO:0032781),-0.266716354741665,-0.9971546114297085,0.4594594594594595,0.80301249808387,1.0,12/41,18.67%,TPM1;ATP1B3;PLSCR1;SSBP1;MSH3;RYR2;PFN1;MSH2;ATP1B1;SETMAR;DYNLL2;TNNT3
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.34617121034214104,0.9968184991081697,0.5155155155155156,0.9397268775807018,1.0,39/234,16.45%,DDR2;AR;LRP6;ESR1;WNT2;RAB7B;NEUROD2;IRAK3;VEGFA;S100A8;S100A9;CRTC2;MID2;PLPP3;COPS5;CARD16;DHX33;PRKD2;UBE2N;CHUK;TIRAP;TLR4;BEX1;NPM1;AKT1;IRAK1;JUP;UBA52;ADCY8;HDAC4;STK3;FER;SMARCA4;EDA;FZD4;RBCK1;FLOT2;TRIM68;IL6
prerank,methylguanosine-cap decapping (GO:0110156),0.4845140310771293,0.9967843114873136,0.5021037868162693,0.9392299039170138,1.0,7/10,29.56%,EDC4;PNRC2;EDC3;DCP1A;DCP1B;LSM1;PATL1
prerank,histone modification (GO:0016570),0.3544978862525538,0.9967139048279804,0.5,0.9388440242400277,1.0,33/109,22.56%,UBE2B;HDAC9;USP36;MRGBP;PRMT2;NTMT1;SIN3B;HDAC6;EYA2;UBE2N;MSL3;SIRT2;ATXN7L3;RCOR3;PHC1;UBE2A;HDAC4;EHMT2;USP22;PADI2;UFL1;NAA50;MORF4L1;SUDS3;MIER1;TAF6L;TRRAP;NSD1;CARM1;SGF29;EZH2;KAT6B;BAZ2A
prerank,defense response to tumor cell (GO:0002357),0.4870126186599739,0.996706050370667,0.4909090909090909,0.9382756461343944,1.0,3/10,14.55%,RBMS3;DLEC1;KLF4
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.47007363961921855,0.9965256047187284,0.4883720930232558,0.938184658416775,1.0,3/13,8.84%,GNAI3;PALM;LTB4R2
prerank,MAPK cascade (GO:0000165),0.3461129839581186,0.996425195931958,0.501,0.9378823998505311,1.0,59/295,16.46%,AREG;FGF18;FGF7;EGFR;IRS1;FGFR1;MAPK12;BTC;PSMC4;FYN;FGF13;FGF2;DLG4;PIK3R2;TAOK3;ZFP36L1;SPTAN1;RASGRF1;SPTA1;DLG2;NEFL;PSMC6;RASGEF1A;RET;RIT2;FLT3LG;ZFP36L2;CHUK;YWHAE;RGL1;PPP5C;PIK3CA;PSMD8;CUL3;MAPK11;PLVAP;ITGAV;RGL2;EGF;CAMKK2;CSF2RA;NRAS;KRAS;IRS2;UBA52;SHOC2;PDGFRA;ZFP36;GDNF;TAOK2;FLT3;IL5;ARTN;RCE1;MAP2K2;SPTBN1;PPP1CC;SOS1;HGF
prerank,myeloid leukocyte differentiation (GO:0002573),0.37201751002934696,0.9961841257133015,0.5063694267515924,0.9379750206033434,1.0,8/65,7.46%,RUNX1;VEGFA;FOXP1;TGFBR2;MAPK14;CDK4;FARP2;OSTM1
prerank,regulation of apoptotic process (GO:0042981),0.3413845352194831,0.996153085699857,0.512,0.937471278271242,1.0,155/676,20.69%,SFRP4;COMP;TNFSF9;FSTL1;AXL;GCLC;WNT10B;ARHGAP10;KCNMA1;EGFR;ANXA1;TGFB3;SCIN;AKAP13;WT1;HPN;RABGGTA;ANGPT4;TRIAP1;GADD45G;RPS6KA2;SIX4;CD44;GAS1;VEGFA;STEAP3;SLIT2;BIN1;MIF;ATF5;USP36;TRIO;COPS5;ITCH;MTCH1;CBX4;SOCS2;DDX42;ADAMTSL4;HOXA5;FOXO1;CXCL10;PRMT2;RASSF2;TARDBP;ARF4;C1QBP;SRC;EGLN2;AIFM2;ARHGEF3;HS1BP3;PIP5KL1;FLCN;GAS6;DPEP1;SLK;SOX8;PSEN1;SIAH1;PDCD2;RYBP;BEX2;AVEN;LGALS1;ING4;TIAM2;SMAD6;SQSTM1;HDAC3;SON;BCL6;NPM1;ALPK2;CSRNP3;AKT1;BCL3;BMF;IRAK1;ERCC3;NAT8;BAK1;UBA52;CD27;ANP32B;NGEF;QRICH1;GDNF;DIABLO;GLS2;FLT3;CBL;NSMF;WDR73;NME2;CALHM2;DNAJA3;STK3;MTCH2;MLLT11;HSP90AA1;NUPR1;IL4;BAG4;RSL1D1;DDX20;VDAC1;NLRP2B;NOP53;HRK;AHI1;ANXA4;EEF1E1;MADD;CTSD;SOS1;IL6;HGF;SAP18;IAPP;TAX1BP1;HTRA2;TFAP4;FAIM2;NME1;PPIA;FBXO11;TMBIM4;PLAUR;NAA15;ERCC5;VTCN1;SMPD1;UFM1;CYP1B1;CLIP3;SUPV3L1;DSTYK;PRDM9;SKP2;GPLD1;APAF1;SUDS3;MCL1;TRIM35;HIPK3;IL31RA;RASA1;PRELID1;ATF6;STK26;DDAH2;FLNA;TIAM1;IFT57
prerank,mitochondrial transcription (GO:0006390),-0.3919634494590571,-0.996136222707505,0.4527027027027027,0.8038947063776952,1.0,6/10,25.44%,TFB1M;MTERF2;TEFM;POLRMT;TWNK;TFB2M
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.38149651224452447,0.996034465511705,0.5032894736842105,0.937213812677889,1.0,17/49,23.90%,EIF2AK3;S100A8;S100A9;SRC;NOC2L;SIAH1;HERPUD1;URI1;BMF;BBC3;NUPR1;PLAUR;BCAP31;MCL1;PYCARD;CYLD;FIS1
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.37333458065904734,0.9959367095477294,0.5134553283100107,0.9368910427030548,1.0,12/67,17.83%,FBLN2;MYOC;VIT;S100A10;MYADM;C1QBP;CCL25;JUP;TRIOBP;LIMS2;RAC3;ILK
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.46220337940646594,0.9957745407834222,0.5020080321285141,0.9367769713677799,1.0,4/15,15.09%,ADAM9;MAPK14;EHD2;IL4
prerank,regulation of cell development (GO:0060284),0.39983178845154144,0.9957480048144481,0.47735191637630664,0.9362661337579761,1.0,5/36,11.24%,BHLHE40;HDAC9;DOCK7;FOXO1;AKT1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.4552248273613929,0.9955051868867207,0.5065104166666666,0.936401266485092,1.0,3/17,6.39%,CD55;PRKCA;CARD16
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.3906184519702079,0.9954525813527685,0.47565118912797283,0.9359585823119133,1.0,9/39,11.24%,MAPK7;VEGFA;AKNA;GTPBP4;MIA3;MYADM;FXYD5;JAG1;AKT1
prerank,regulation of cell size (GO:0008361),0.42658433753208075,0.9953183705196491,0.49817739975698666,0.9357696575071015,1.0,8/23,25.84%,RAP1GAP2;MTOR;DEPTOR;RHOA;PTEN;VAV2;RAC1;RARG
prerank,endodermal cell fate commitment (GO:0001711),-0.39540368930942277,-0.9948287919117631,0.44554455445544555,0.8054812323436531,1.0,2/10,8.51%,SOX17;CTR9
prerank,DNA metabolic process (GO:0006259),0.34224086641730284,0.9947993346964296,0.5225225225225225,0.9366754968189005,1.0,59/270,19.29%,MPG;PARP3;INTS3;XRCC3;UBE2B;GTF2H3;CTC1;RAD51B;NUDT1;TCF7L2;KPNA2;IGHMBP2;UBE2N;ACD;INIP;POLE3;ZBTB1;FANCL;DNASE2;POLB;SAMHD1;PARG;SMC1A;MCM3;NPM1;DDX21;POLI;UBE2A;CDC34;DNA2;ERCC3;UBA52;FAN1;XRCC5;ERCC4;RAD1;DDB1;TERF1;DBF4;ORC6;INO80;FANCG;NBN;DNASE1L2;USP7;UHRF2;GMNN;HMGB3;NOP53;RFC4;RECQL;RAD50;ERCC5;BLM;POLD1;TOP2B;TINF2;SUPV3L1;NOC3L
prerank,calcium ion import across plasma membrane (GO:0098703),0.47157679031214456,0.9945648560291637,0.49387755102040815,0.9367574023941662,1.0,6/14,27.00%,TRPV3;ATP2B4;SLC8A2;CACNA2D1;TRPV2;SLC24A2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.3678706322915989,-0.9942884528471978,0.4558303886925795,0.8050902213059938,1.0,10/13,42.85%,OAS2;STAT1;CRLF1;IL27;OASL;IL27RA;CANX;STAT3;EBI3;TYK2
prerank,regulation of isotype switching (GO:0045191),0.46019890440938893,0.9942029090960888,0.4780821917808219,0.9371584489921634,1.0,4/14,15.09%,PARP3;HMCES;SLC15A4;IL4
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.48060771883675174,0.9941594445118866,0.5,0.9366949179785539,1.0,3/12,9.97%,ITGB3;ABCA1;ITGAV
prerank,protein K48-linked ubiquitination (GO:0070936),0.380864703643684,0.9941514903373625,0.4923913043478261,0.9361317202605911,1.0,21/54,23.28%,UBE2B;SYVN1;ITCH;CUL3;UBE2G2;UBE2A;CDC34;AMFR;RNF216;RNF187;HACE1;UBE2G1;ARIH2;UBE2R2;SKP2;UBE2D3;UBE2Q2;UBE3A;RNF6;IFI27;FBXO38
prerank,regulation of phagocytosis (GO:0050764),0.3757449342394587,0.9941463728855334,0.4918918918918919,0.9355619806067212,1.0,6/53,10.32%,SYK;SYT11;GAS6;ITGAV;SIRPA;CD47
prerank,protein K48-linked deubiquitination (GO:0071108),0.42034806191189594,0.9937047101138743,0.4821002386634845,0.9362245294583138,1.0,5/23,12.55%,OTUD3;USP33;OTUD7B;USP50;USP5
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.3384676580971112,-0.9932749550641573,0.4636363636363636,0.8058299056484146,1.0,3/17,3.19%,CDH5;CLDN5;F11R
prerank,cellular iron ion homeostasis (GO:0006879),0.37134491544840853,0.9932220707434661,0.49411764705882355,0.9370013811009704,1.0,5/55,6.64%,SCARA5;SLC39A14;SMAD4;ATP6V0A2;SLC11A2
prerank,positive regulation of hormone secretion (GO:0046887),-0.3416390622701639,-0.9928701930950707,0.47767857142857145,0.8049709420950188,1.0,6/17,16.91%,C1QTNF3;SPP1;EDN1;HFE;SOX11;EDN3
prerank,post-translational protein modification (GO:0043687),0.3432258543373686,0.9927576658140452,0.525,0.9376652268856266,1.0,91/332,25.47%,IGFBP5;FSTL1;FBN1;WSB1;RABGGTA;GPC3;PSMC4;PRSS23;SPSB1;SPSB4;IGFBP4;COPS5;BMP15;FBXW8;CALU;VCAN;MIA3;SOCS2;WDTC1;CCDC8;COP1;TULP4;GAN;PSMC6;SPSB2;MELTF;GAS6;FBXO2;PSMD8;FBXO17;CUL3;DTL;SENP8;FBXW4;ASB12;LGALS1;FBXL20;RAB2A;WDR5;FBXO31;DCAF6;RNF7;DDB1;FBXL3;CUL9;DCAF13;ASB8;MXRA8;DCAF10;KLHL41;SDC2;IL6;SOCS6;KEAP1;FBXL5;CHRDL1;RAB1B;FBXO11;COPS4;LAMC1;NEDD8;SKP2;FBXL19;KCTD6;QSOX1;CUL5;FBXW9;FBXW2;PRKCSH;ICMT;CSF1;KLHL22;KLHL9;FBXW11;SUMF2;SPSB3;DCAF5;PSMD4;KLHL11;FBXL12;PSMD3;GPS1;RABGGTB;DNAJC3;FBXO22;HSP90B1;VHL;FBXW7;FBXO30;SERPINC1;RAB1A
prerank,homotypic cell-cell adhesion (GO:0034109),0.38455311772822387,0.9924107547995683,0.5022883295194508,0.9380441041289862,1.0,12/39,21.59%,GNAS;ITGB3;PLPP3;DSC2;PDGFRA;ACTG1;PPIA;ILK;FLNA;TYRO3;PIK3CG;METAP1
prerank,phagosome-lysosome fusion (GO:0090385),0.49054166473896144,0.9920604646565797,0.504950495049505,0.9384357477443502,1.0,1/10,2.18%,RAB7B
prerank,response to ATP (GO:0033198),0.44130270538024224,0.9916469368156293,0.4770408163265306,0.9389928534215772,1.0,3/18,10.62%,DGKQ;P2RX3;SSH1
prerank,intraciliary retrograde transport (GO:0035721),0.48429105889985385,0.991435363669714,0.49731182795698925,0.9389898452737611,1.0,4/12,18.66%,DYNC2I2;DYNC2LI1;DYNC2H1;DYNC2I1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3535862976658778,0.9914181479577457,0.5169230769230769,0.9384649943304287,1.0,33/102,21.55%,IRS1;SLC39A14;HDAC9;PIK3R2;ZFP36L1;FOXO1;SRC;MYO5A;CRHR1;INSIG2;SYAP1;KAT2B;RHOQ;INPP5K;AKT1;TSHR;IRS2;ADCY8;PDE3B;LHCGR;FER;SELENOS;CPEB1;PKM;EPRS1;CAPN10;VAMP2;PRKAR2A;GPLD1;LPIN3;RAB10;GOT1;SLC25A33
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.30861542247652224,-0.9913776869678861,0.47641509433962265,0.807032105141999,1.0,5/23,5.04%,ENG;SMAD3;LTBP4;ITGA3;TGFBR3
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3423760371990214,0.9911377682977139,0.5435435435435435,0.9386669647971825,1.0,72/336,17.01%,PARP3;MAPK12;INTS3;ZDHHC16;XRCC3;UBE2B;GTF2H3;FOXP1;CDKN2AIP;TAOK3;UBA6;CRIP1;RAD51B;MAPK14;NUDT1;RFWD3;USP10;FOXO1;RBBP6;ETAA1;CGAS;ALKBH7;IGHMBP2;PHF1;HMCES;INIP;POLE3;ZBTB1;TIGAR;SETD7;PSEN1;FANCL;DTL;POLB;SAMHD1;SMC1A;BCL6;SMC5;DYRK2;NPM1;POLI;FBXO31;BCL3;UBE2A;ERCC3;BAK1;FAN1;XRCC5;ERCC4;RAD1;SFN;DDB1;PCLAF;TAOK2;CDKN1A;DDX11;CCND1;TNFRSF1B;ZC3H12A;SMC6;INO80;FANCG;NBN;FAM111A;NOP53;RFC4;RECQL;SPIDR;PML;HTRA2;NEK4;UFL1
prerank,protein modification by small protein conjugation (GO:0032446),0.343827235526848,0.991076923801472,0.542,0.9382551190132287,1.0,131/361,27.33%,TSPAN17;MIB2;UBE2B;NEUROD2;SPSB1;SPSB4;STX1A;NFE2L2;UBA6;SMURF2;UBE2J2;RNF212B;FBXW8;SYVN1;NUP93;ITCH;RFWD3;PIAS3;MSL2;RNF111;GAN;SPSB2;NUP107;STUB1;UBA2;MYCBP2;UBE2W;FBXO2;UBE2N;MYLIP;NUP98;CUL3;FBXL2;UBE2G2;ASB12;HECW2;TRIM11;CDC23;RNF7;UBE2A;CDC34;UBA52;USP5;BSPRY;DDB1;CDC27;FBXL3;CBL;PEX12;CUL9;AMFR;USP7;NUP37;TRPC4AP;UHRF2;UFC1;SELENOS;KLHL41;RNF14;UVSSA;ZSWIM8;TRIM68;RNF187;RNF138;KEAP1;HACE1;UFL1;FBXL5;UBE2G1;PEX5;FBXO11;ARIH2;UBE2R2;VPS11;PCNP;UFM1;NUP50;NEDD8;BRAP;TRIM35;ARIH1;UBE2D3;CUL5;KCTD10;RNF41;SAE1;ATG3;ARRB1;PEX2;PAF1;SMURF1;DTX2;KLHL9;FBXW11;UBE2Q2;SDE2;FBXO24;DERL1;LZTR1;UBR2;TPR;RNF6;UBE2Z;RNF157;ATG10;NSMCE2;RTF1;TRIM24;TRIM44;MDM2;MKRN2;BCL11A;NUP85;NUP133;VHL;FBXW7;UBA7;NUP188;RNF20;UBE2K;UBE2F;DCUN1D1;MUL1;CUL7;OTULIN;PRKDC;NUP88;URM1;VCPIP1;EIPR1;DTX3
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.4950599147439125,0.9910711846574558,0.516546762589928,0.937112469743305,1.0,4/10,15.07%,TIGAR;NCOR1;HDAC4;NUPR1
prerank,negative regulation of glycolytic process (GO:0045820),0.4950599147439125,0.9910711846574558,0.516546762589928,0.937112469743305,1.0,4/10,15.07%,TIGAR;NCOR1;HDAC4;NUPR1
prerank,cardiac cell development (GO:0055006),0.4816863944074563,0.9907089355696901,0.5312934631432545,0.9375590303662078,1.0,3/11,11.10%,VEGFA;JAG1;ALPK2
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.350017421995377,-0.9906942877736334,0.44696969696969696,0.8070074746140246,1.0,6/15,20.86%,OSBPL8;PPARA;PNPLA2;LPL;ABHD5;FITM2
prerank,lymphocyte chemotaxis (GO:0048247),0.3958472394952581,0.9903778348623166,0.4982698961937716,0.9378554672453977,1.0,6/34,13.15%,CCL8;CXCL10;GAS6;CCL25;HSD3B7;CCL13
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.36035198541595503,0.990249126617146,0.5144927536231884,0.9376295501751787,1.0,22/101,14.25%,FGF18;EGFR;FGFR1;VEGFA;FGF2;MST1R;PSRC1;PKD1;ATP2B4;ETAA1;MAPRE3;SRC;PKD2;SYAP1;EGF;AKT1;IRAK1;CALM2;FLT3;RHOA;CCND1;SLC8A2
prerank,anterograde trans-synaptic signaling (GO:0098916),0.34956414167535593,0.9900617948404007,0.5346038114343029,0.9375550931920478,1.0,48/224,21.00%,LRP6;LPAR3;SNCB;MTNR1B;APBA3;CEL;PMP22;RPS6KA2;CAMKK1;APBA1;DLG4;SLC1A6;GABRR3;DLG2;SLC18A3;RIT2;HTR1F;SLC12A4;GRIA2;PLP1;CAMKK2;HCRT;SLC12A5;SNAP25;ASIC2;CACNB1;DLGAP1;GABRG3;GIPC1;GAD2;GRIN2A;CHRNA7;CHRFAM7A;AKAP9;SYT1;GRM1;CHRNA5;SYNJ2BP;MBP;HTR2C;PAFAH1B1;PRKAR2A;GABRG2;EXOC4;GRIA3;NOVA1;MAPK1;SLC12A6
prerank,retina homeostasis (GO:0001895),-0.29909160196249923,-0.9899902594043684,0.47126436781609193,0.8069883755988148,1.0,7/23,16.70%,POTEF;ACTB;B2M;WHRN;PRDX1;HSPB1;SOD1
prerank,nuclear membrane reassembly (GO:0031468),0.37250547049726523,0.9899668125496408,0.49023861171366595,0.9372352827223454,1.0,23/54,31.19%,LMNA;REEP3;CHMP7;NUP93;AHCTF1;NUP107;NUP98;SIRT2;NUP37;PPP2R2A;CC2D1B;ANKLE2;IST1;EMD;NUP85;NUP133;NUP188;KPNB1;SUMO1;CHMP4C;CHMP4A;CHMP4B;SEC13
prerank,regulation of phosphorylation (GO:0042325),0.3533216165297652,0.9897285241287855,0.5106815869786369,0.9372858955800207,1.0,44/120,25.64%,AR;EGFR;GLMN;CCDC88C;ANG;MIF;NUP93;INHA;NUP107;FLCN;FZD7;PSEN1;NUP98;SIRT2;DSCAM;EGF;EIF6;CDKN1A;PIN1;FER;NUP37;IL4;OGT;NOP53;KCTD20;PML;ILK;NUP50;CORO1C;CDKN2C;SDCBP;SESN2;STAT2;TPR;ANKLE2;CCDC88A;LDB2;LDB1;ATG14;DYNLL1;NUP85;NUP133;GRM5;NUP188
prerank,morphogenesis of an epithelium (GO:0002009),0.4162732275639718,0.9895549430840218,0.49144254278728605,0.9371700349515585,1.0,7/25,22.00%,LRP6;SOX10;SOX8;AHI1;ACTG1;KDM2B;LHX1
prerank,embryonic organ development (GO:0048568),0.369026950446051,0.9891746953478605,0.5112781954887218,0.9376498106334693,1.0,14/61,13.00%,PCSK5;TGFB2;PBX1;TGFBR2;COBL;GLI2;FLT3LG;NDRG4;COL2A1;GLI3;TBC1D23;ERCC3;ALDH1A3;GDNF
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.4587154667928873,0.9889994655680422,0.5013157894736842,0.9375523363625766,1.0,4/13,17.93%,EDEM1;EDEM2;UBE2G2;BCAP31
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.46154546215858683,0.9888623266085411,0.491869918699187,0.9373579380686874,1.0,4/13,12.89%,ABT1;KRI1;NOP9;RCL1
prerank,regulation of myoblast fusion (GO:1901739),0.4858492300938474,0.9884539412675016,0.5095628415300546,0.9378902661692045,1.0,4/11,22.85%,MAPK14;EHD2;IL4;FLOT1
prerank,mitotic spindle organization (GO:0007052),0.34560706421726034,0.9884510972537837,0.5150602409638554,0.9373260391382411,1.0,37/153,20.57%,GPSM2;DYNC1LI2;CLIP1;NDEL1;ZW10;CENPT;KIFC2;AHCTF1;NUP107;TOGARAM1;DYNC1LI1;ZWINT;NUP98;DYNC1I1;KIF2A;ARHGEF10;SMC1A;MAPRE1;PIBF1;SBDS;RHOA;KIF3B;ABRAXAS1;DYNC1H1;NUP37;MAP4;CENPC;PPP1CC;CKAP5;RCC2;PAFAH1B1;CENPE;EML1;STAG2;WDR62;CLASP2;FLNA
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3828749692608397,0.9881738952816308,0.5016648168701443,0.9375195977674269,1.0,12/45,19.86%,EGFR;DIMT1;ZPR1;RIOK1;RBM22;ERN1;MAP2K2;IL6;DDX5;SUPV3L1;U2AF2;RIOK2
prerank,tricarboxylic acid metabolic process (GO:0072350),0.4700342456702239,0.9881506103343045,0.5069252077562327,0.9370073632602282,1.0,6/12,20.20%,ACLY;IDH1;ACO2;GLUD1;IDH3G;IDH3B
prerank,ncRNA catabolic process (GO:0034661),0.41174131713181433,0.9879172679062166,0.4912485414235706,0.9370590240796769,1.0,6/28,18.34%,DIS3L2;NUDT16L1;EXOSC7;NUDT16;ZCCHC8;TENT4B
prerank,cellular response to UV (GO:0034644),0.36331111940650107,0.9878190590221699,0.5262605042016807,0.9367452247092014,1.0,23/76,23.30%,TRIAP1;MMP2;CRIP1;CARD16;NOC2L;RHNO1;ZBTB1;NPM1;ACTR5;BMF;BAK1;ERCC4;DDB1;CDKN1A;EIF2S1;INO80;POLD1;SMPD1;OPN3;ATF4;SDE2;NSMCE3;ERCC1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.4701251078670172,0.9877627359121983,0.4897400820793434,0.9363369580989633,1.0,8/12,32.05%,RFWD3;FBXO31;RPS27L;CCND1;SDE2;PRKDC;TP53;WAC
prerank,protein targeting to mitochondrion (GO:0006626),0.37809318026941807,0.9877543335300574,0.5171650055370985,0.9357822612752652,1.0,17/52,28.02%,TIMM50;GDAP1;TIMM10B;TIMM9;AGK;GRPEL2;HSP90AA1;IMMP1L;TIMM22;TIMM8B;BCAP31;TOMM5;TIMM17A;FIS1;TOMM40;NDUFA13;PITRM1
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.48068588467619894,0.9877152861183506,0.5087719298245614,0.9353170547092058,1.0,6/11,27.71%,MPHOSPH8;SETDB1;TPR;SETDB2;TASOR;ATF7IP
prerank,rRNA pseudouridine synthesis (GO:0031118),0.49081674286037963,0.9876138578365677,0.500697350069735,0.9350169163893314,1.0,4/10,26.77%,RPUSD1;GAR1;TSR3;NHP2
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.4663066333137118,0.9876044231023202,0.5100133511348465,0.9344646283129169,1.0,5/14,15.09%,SYT11;NR1D1;CD200R1;TNFRSF1B;IL4
prerank,microvillus assembly (GO:0030033),-0.35291426426271855,-0.9874734796798225,0.46963562753036436,0.8117633514923962,1.0,3/14,6.36%,RAPGEF2;TNIK;MAP4K4
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.4272101337468926,0.9874287829534477,0.5154894671623296,0.9343810931376828,1.0,3/20,12.60%,SEMA3C;SEMA3A;SEMA3D
prerank,maintenance of protein localization in organelle (GO:0072595),0.4314010359055761,0.9874225844274085,0.4896373056994819,0.9338334076066209,1.0,6/19,16.96%,TAF8;TAF3;AKT1;BCL3;BBS4;PML
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.340547197886461,0.9874022584476386,0.531062124248497,0.933319444324299,1.0,28/214,13.43%,ACKR3;SYK;EPHB2;CCL8;PRKCA;EGFR;CD44;FGF2;PDE8A;CAMK2N1;F2R;MIF;SMAD4;ADCYAP1;FLCN;PRKD2;GAS6;NDRG4;TIRAP;CCL25;TLR4;SIRPA;TNIP1;GPNMB;PDGFRA;ATP6AP1;CCL13;PIN1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.39441591678406895,0.9870639399763058,0.49942857142857144,0.9336550201263963,1.0,5/36,5.34%,DCN;ANGPT4;FGF2;SLIT2;ATP2B4
prerank,regulation of cell adhesion (GO:0030155),0.3512291516486915,0.9869047687532916,0.5292307692307693,0.9335344465625154,1.0,24/129,10.35%,EPHB2;PRKCA;EFNA5;VEGFA;FUT2;DACT2;MIA3;PTPRJ;ZFHX3;MYADM;C1QBP;SRC;RET;TGFBI;ADAM22;ABL2;FLCN;PRKD2;TNFRSF18;PLXNA3;STX4;EPHB3;ITGAV;DSCAM
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.40042646695275697,-0.9868470151605548,0.445859872611465,0.8116307104218909,1.0,3/10,7.65%,DPYD;UPB1;NT5E
prerank,motor neuron axon guidance (GO:0008045),0.4484331583225825,0.9866572817172943,0.4876783398184176,0.9336609015648556,1.0,4/15,8.20%,SLIT2;SLIT1;NTN1;SEMA3A
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.30350584201891256,-0.9864730823359423,0.4025157232704403,0.8107272113260491,1.0,8/27,13.76%,FLT1;PRKD1;KIT;EPHA8;PDGFRB;TEK;TGFB1;PTK2
prerank,positive regulation of filopodium assembly (GO:0051491),0.423568532295267,0.9862281563035998,0.5024330900243309,0.9342736019157072,1.0,8/24,20.24%,TGFB3;FSCN1;PALM;RHOQ;BCAS3;ARAP1;GPM6A;RALA
prerank,pre-miRNA processing (GO:0031054),0.45987927200210016,0.9861955521959386,0.5019505851755527,0.9338103636117342,1.0,4/14,19.51%,TARBP2;AGO2;AGO4;AGO3
prerank,regulation of T cell differentiation (GO:0045580),0.39450238785855263,0.9860500397581702,0.5046948356807511,0.9336352903996791,1.0,4/33,8.46%,ZMIZ1;RUNX1;TNFRSF18;ZBTB1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.32161594530512183,-0.9860241409580263,0.467005076142132,0.809994233826795,1.0,7/22,18.25%,PPM1E;PPM1D;DUSP10;PPM1F;DUSP7;DUSP6;PPP2CA
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3366400981906574,0.9860198152613902,0.585,0.9331406707947786,1.0,295/1668,16.50%,LMX1A;EBF2;DCN;PRRX1;LIF;AR;LRP6;LHX8;HOXA3;ESR1;PAX9;WNT2;EBF1;TRPS1;LOXL2;NFIX;FOXP2;SP9;IRF4;EGFR;TGFB3;CREB5;PAX1;WT1;ZFHX4;MEOX2;TRIAP1;TLE6;TBX15;SCRT2;ZNF367;HSF2;TADA1;CCNL2;HOXA2;ELF4;SIX4;HIVEP2;SKIL;NEUROD2;MAPK7;ZMIZ1;GTF2H3;RUNX1;VEGFA;FGF2;DGKQ;KLF3;TSHZ2;PBX1;KLF12;FOXP1;BHLHE40;GLIS2;TLX3;ZNF25;SMAD4;NFE2L2;TEF;CRTC2;HDAC9;PIK3R2;ATF5;DPF2;SMURF2;WWTR1;LMX1B;AKNA;MEF2D;SKI;MAPK14;PKD1;ACVR1;COPS5;SOX10;DACT1;CDK4;IRX5;HOPX;CREB3L1;FOXK2;ZBTB12;MED13L;RFX1;TCF25;KLF2;JUND;TCF7L2;NR1D2;NFATC4;MAFF;MRGBP;MEIS2;ATP2B4;CAMK2D;CBX4;RBAK;NFATC1;IL33;SMARCD2;HOXA5;FOXO1;NR1D1;RTRAF;PIAS3;CXCL10;AKIRIN1;NFIB;CREBZF;EBF3;ZBTB7C;NCOA3;RNF111;MUC1;SSBP3;NFIA;ZFHX3;ARF4;DPF1;SMAD5;C1QBP;MDM4;GLI2;MLXIPL;PID1;ACTR3;MYT1;MTF1;SIN3B;NOC2L;SMARCD1;ZFPM2;HOXA4;RNF2;ADCYAP1;FLCN;PRKD2;PKD2;TBX6;BRD9;MAMSTR;STAT5A;FOXL1;ETV3;CHUK;CD81;SOX8;ZNF260;WDR77;ZBTB1;NR6A1;JAG1;KDM3B;VDR;SATB2;CDK9;PSEN1;SOX5;MYBL2;FOXC2;SIRT2;AGO2;ATXN7L3;MED24;TLR4;RCOR3;BEX1;ELP4;KAT2B;ONECUT1;ATAD2B;SMAD6;RHOQ;ZMYM5;SQSTM1;BRD7;RNF10;HDAC3;BCL6;MITF;HELZ2;CHD2;OTUD7B;MYPOP;ZNF3;TCERG1;MZF1;NPM1;ZHX2;TAF3;PRDM15;SMARCC2;GLI3;SLC30A9;URI1;ATF7;TNIP1;IRF2BPL;CSRNP3;CEBPB;SLC9A1;TOX2;DCAF6;CRYM;JUP;ZNF462;KANSL3;AKIRIN2;UBA52;BACH2;LIN9;NCOR2;CCNC;DDX17;KDM5B;ZFP36;MED13;ATF1;GDNF;ZNF112;ZNF691;DR1;CDKN1A;NCOR1;PEG3;PROX2;PIN1;IKZF5;TWIST1;CCND1;RAI1;SIX1;RFX5;NACC2;ZC3H12A;BRIP1;NME2;CCNH;INO80;DNAJA3;EZH1;HDAC4;PLAGL1;PTOV1;EHMT2;ZNF569;BCAS3;PPP3CA;CTDP1;KLF4;HOXC4;MLXIP;PLAGL2;DMAP1;EAF2;HOXA7;ZNF692;HSBP1;BCL9;GTF2F1;CHD8;SMARCA4;HOXA9;NFE2L3;POU3F2;SNAI2;IL4;NR2C2;E2F3;DDX20;ZEB1;CCNQ;YEATS2;HMGB3;SRCAP;ZBTB5;UBP1;RNF14;BAZ2B;OGT;MED15;ZBTB25;NOP53;NCK1;PPIL4;PSIP1;AHI1;HIVEP3;STAT5B;ZFP28;ANXA4;PER1;IL6;HGF;SAP18
prerank,axonogenesis (GO:0007409),0.344417932691217,0.9859285106948668,0.547,0.9328269923350591,1.0,66/237,21.97%,SEMA3C;EPHB2;PRKCA;MAP1B;EFNA5;NPTN;GRB10;EPHA3;FYN;MAPK7;SLIT3;SLIT2;NTN4;LLGL1;SLIT1;SPTAN1;DOK1;UNC5A;SPTA1;DOCK7;PDLIM7;SRC;RET;GLI2;S100A6;SEMA3A;PIK3CA;SIAH1;EPHB3;DOK4;USP33;DSCAM;UNC5D;L1CAM;EPHA10;IRS2;PALLD;ULK2;SEMA3D;LGI1;GDNF;TAOK2;IGSF9;ULK1;ARTN;DCC;HSP90AA1;SPTBN1;SLC9A6;SOS1;CXCR4;NRXN3;SHTN1;EPHB1;CNTN4;PPP3CB;GFRA2;GAB2;RAB10;SLITRK4;MAPK1;PTEN;CNTN2;MAP1A;MAP1S;SPTBN4
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.3630438278009492,-0.9856223793998622,0.4566929133858268,0.8090934670524762,1.0,6/14,20.84%,DMD;WNK4;ATP1B1;GLRX;ACTN4;ANK3
prerank,regulation of response to external stimulus (GO:0032101),0.34959096253409927,0.9855042916423038,0.5386178861788617,0.9334089906692935,1.0,21/121,17.01%,EPHB2;CD55;MGLL;ANXA1;FOXP1;F2R;AKNA;SPATA2;NR1D2;TIRAP;CNGB1;SAMHD1;BCL6;SAG;LRRC19;PDGFRA;STK24;DAGLB;TRAF3;CXCR4;UFL1
prerank,purine nucleotide metabolic process (GO:0006163),0.41513057032859585,0.9853527237873028,0.5121951219512195,0.9332510114329776,1.0,7/24,16.95%,GDA;GPX1;FHIT;GART;PRPSAP1;PRPS1L1;PRPS1
prerank,negative regulation of mRNA processing (GO:0050686),0.4611046724895643,0.9852405144556488,0.49104859335038364,0.9329841579325684,1.0,5/15,20.12%,SRSF6;C1QBP;SAP18;U2AF2;PTBP1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3448779854861235,0.9851284563604334,0.5391566265060241,0.9327258307683265,1.0,27/186,11.69%,SFRP4;LRP6;DKK2;LRP1;TLE6;CCDC88C;PSMC4;GRB10;DACT3;IGFBP6;RBMS3;WWTR1;KREMEN1;IGFBP4;AXIN1;DACT1;TCF7L2;NFATC1;PSMC6;PSMD8;CUL3;TSKU;TLE2;GLI3;ALPK2;ANKRD6;TPBG
prerank,negative regulation of receptor binding (GO:1900121),0.49318203774049263,0.9850171207989109,0.5067064083457526,0.9324320897150122,1.0,3/10,13.12%,PTPRF;ATP2A2;ADAM15
prerank,microvillus organization (GO:0032528),-0.36410207224346425,-0.9848830615887693,0.45348837209302323,0.8092619343396107,1.0,3/13,6.36%,RAPGEF2;TNIK;MAP4K4
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.34812272697910995,0.9847247449411016,0.5304259634888439,0.9326619707655143,1.0,27/138,15.36%,AR;ESR1;POLR2H;GTF2H3;HDAC7;HDAC9;WWTR1;NR1D2;TAF8;NR1D1;NR6A1;VDR;CDK9;KAT2B;HDAC3;TAF3;ERCC3;NCOR2;POLR2D;DR1;POLR2G;NCOR1;GTF2A2;CCNH;GTF2F1;NR2C2;E2F3
prerank,negative regulation of developmental growth (GO:0048640),0.39918241241676944,0.9846439591724913,0.5046403712296984,0.9323189006273066,1.0,8/30,14.62%,FGF13;PTPRS;TRIM46;SLC6A4;ULK2;CDKN1A;ULK1;DCC
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.4237685465565852,0.984541920133858,0.5055350553505535,0.9320282735274766,1.0,4/22,13.85%,GADD45G;VEGFA;EMC10;ZC3H12A
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.4096973031155374,-0.9844377640785292,0.4645390070921986,0.8085987664814578,1.0,1/10,0.20%,MLLT3
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.47495817424232645,0.9844195192508742,0.5102040816326531,0.9317876577857884,1.0,5/11,18.83%,STK25;GSKIP;DIABLO;STK24;CYP1B1
prerank,cellular protein metabolic process (GO:0044267),0.3394402957039871,0.9842671598218519,0.561,0.9316232388229212,1.0,85/396,21.17%,PLOD2;IGFBP5;FSTL1;RPSA;FBN1;LOXL2;RABGGTA;PCSK5;GPC3;PRSS23;MMP2;MRPS11;RRBP1;IGFBP6;IGFBP4;TMEM208;COPS5;BMP15;CALU;GGCX;MRPS18B;MSRB1;VCAN;MIA3;PHKA2;SPCS1;IGHMBP2;MELTF;ABL2;GAS6;FBXO2;PSEN1;MRPL13;MRPS17;AGO2;SEC11C;FBXL2;UBE2G2;LGALS1;GSPT2;RPL10A;TNIP1;MRPL10;CSNK1G3;CSF2RA;MRPL55;DMBT1;NAPSA;CDC34;UBA52;RPS5;ZDHHC2;MRPL36;MRPL3;GSPT1;MXRA8;RPL6;MRPL51;HARS1;SDC2;IL6;SPG7;HTRA2;IDE;UBE2G1;CHRDL1;ABCF1;FBXO11;ST3GAL1;ADPRH;FDX1;STK38;LOX;LAMC1;NEDD8;RPL23;RPL17;UBE2D3;QSOX1;FBXW2;RPS25;D2HGDH;PRKCSH;YES1;ATG3
prerank,positive regulation of reproductive process (GO:2000243),0.39291369281588945,0.9842506625387965,0.49941656942823803,0.9311001328765911,1.0,5/31,8.89%,VEGFA;SMURF2;C1QBP;SIRT2;AGO2
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3635002319443484,0.9840622157799258,0.5331928345626976,0.9310459662646936,1.0,21/80,20.24%,TGFB3;SAXO1;PLCE1;CDC42EP2;NDEL1;AKIRIN1;FSCN1;ACTR3;PIK3CA;PALM;RHOQ;AVIL;BCAS3;BBS4;CCP110;EPS8L2;ARPC2;ARAP1;GPM6A;ENTR1;RALA
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.46584372875134283,0.9840148451883824,0.5092838196286472,0.9306205881737526,1.0,4/13,6.52%,TGFB3;SMAD4;NUP93;SH2B1
prerank,regulation of dephosphorylation (GO:0035303),0.45019579333066456,0.9835691444425488,0.5058977719528178,0.9312011189125425,1.0,5/15,15.47%,SRC;INPP5K;SMG7;SMG6;MTMR1
prerank,lipid transport (GO:0006869),0.35188545887635836,0.9834986561650441,0.5275510204081633,0.9308431054213269,1.0,12/97,9.94%,LBP;SLCO2A1;ATP8B1;TRIAP1;SLC51A;ABCA1;ABCG4;OSBPL2;PRELID3A;SCP2;SLC27A3;ABCA13
prerank,regulation of defense response to virus by host (GO:0050691),0.4030526565102429,0.9831834874927856,0.506508875739645,0.9311470320822343,1.0,7/30,15.42%,TARBP2;CGAS;TRAF3IP2;ZC3H12A;HSP90AA1;IL4;RNF216
prerank,neuron development (GO:0048666),0.34531615660531234,0.9829115849946369,0.5510616784630941,0.9313308149046281,1.0,38/141,18.59%,MYOC;UGDH;RUNX1;TGFB2;PBX1;RASGRF1;UNC5A;TENM3;DTNBP1;DOCK7;LRP12;GLI2;ADCYAP1;TOR1A;L1CAM;PLP1;CAMSAP1;GBA2;MAPT;TBC1D23;UNK;FLRT3;LGI1;GDNF;ULK1;THOC2;ATCAY;BLOC1S2;POU3F2;MAP4;MANF;IL6;SNAPIN;RAB35;PPP1R9B;STX3;CNTN4;GPM6A
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.31355887849541986,-0.9828088397788574,0.5164835164835165,0.8110657047063172,1.0,6/23,11.60%,CBFA2T3;PPARA;CRY1;C1QTNF3;SIK1;EP300
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.473362159682,0.9825774883935863,0.4881450488145049,0.9316654657448242,1.0,6/11,26.70%,TOR1A;AUP1;UGGT1;DERL1;UFD1;UGGT2
prerank,insulin receptor signaling pathway (GO:0008286),0.3616754378083424,0.9823165007157575,0.5147368421052632,0.9318010963364995,1.0,19/69,17.11%,IRS1;GRB10;SLC39A14;PIK3R2;ATP6V0A2;FOXO1;PIK3CA;FOXC2;RHOQ;AKT1;ATP6V1E1;IRS2;ATP6AP1;FER;ATP6V1D;ATP6V0A1;ATP6V1B2;SOS1;IDE
prerank,purine-containing compound biosynthetic process (GO:0072522),0.4102658866314898,0.9820299275990524,0.5036407766990292,0.9320091164058893,1.0,6/25,16.95%,AMPD2;PAICS;GART;PRPSAP1;PRPS1L1;PRPS1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.4143622234491369,0.9815552333565075,0.5172004744958482,0.9326704997320032,1.0,6/26,17.12%,PRKCA;SMOC2;MEIS2;CUL3;USP22;TTL
prerank,cellular protein catabolic process (GO:0044257),0.37081147331518655,0.9811889681365681,0.5151515151515151,0.9330818137828284,1.0,21/59,27.49%,FAP;CAPN2;CLTC;AP2A2;MYLIP;CLPX;UBE2G2;RSPRY1;CLPP;HTRA2;IDE;UBE2G1;AFG1L;RNF123;AP2M1;RAB12;CTSK;MDM2;CTSB;CTSL;CASP8
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.3552596239527941,0.9811317880898651,0.5140771637122002,0.9326751402617963,1.0,19/80,17.93%,SYK;TRIAP1;CD44;VEGFA;F2R;CARD16;SRC;GAS6;DPEP1;YWHAE;GPX1;AKT1;SFN;KLF4;GRAMD4;CTSD;HGF;HTRA2;BCAP31
prerank,postreplication repair (GO:0006301),0.3754733395030907,0.9809788169892231,0.5191441441441441,0.9325283565272662,1.0,15/45,25.08%,UBE2B;USP10;UBE2N;ZBTB1;DTL;POLI;UBE2A;UBA52;PCLAF;RFC4;POLD1;FAAP20;REV1;POLH;WDR33
prerank,ureteric bud development (GO:0001657),0.438639762663235,0.9809784093247534,0.5082174462705437,0.9319749332655912,1.0,4/17,7.64%,WT1;GPC3;SLIT2;PKD2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.3670163512816129,-0.9808442570034469,0.4346153846153846,0.8144382723034209,1.0,4/12,15.26%,PTPN14;TGFB1;KHDRBS1;NUP214
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.4861118240567599,0.9804638792794225,0.5034770514603616,0.9327616019136429,1.0,3/10,11.97%,INPP5F;PARP14;PIBF1
prerank,positive regulation of peptidase activity (GO:0010952),0.42713659401488613,0.980450433250889,0.51010101010101,0.9322375983805972,1.0,2/20,6.00%,MAPK12;RCN3
prerank,calcium ion import into cytosol (GO:1902656),0.455604552619833,0.9803360942419571,0.5046480743691899,0.9320041989512899,1.0,6/15,27.00%,TRPV3;ATP2B4;SLC8A2;CACNA2D1;TRPV2;SLC24A2
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3586844305278041,0.9802100272388984,0.5289778714436248,0.9317739635845005,1.0,17/72,18.76%,POLR2H;GTF2H3;COPS5;ERCC3;UBA52;ERCC4;POLR2D;DDB1;POLR2G;CCNH;AQR;USP7;UVSSA;RFC4;ERCC5;POLD1;COPS4
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.4498199584026229,0.9801790104084152,0.5053191489361702,0.9313068695056506,1.0,2/14,8.96%,AVPR1A;ECE1
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.43194608181113037,0.9801351324003351,0.5088161209068011,0.9308662781446281,1.0,5/20,14.92%,TMBIM1;CLTC;PID1;RHOQ;PPFIA1
prerank,negative regulation of DNA replication (GO:0008156),0.4587954510648517,0.980044077906958,0.5,0.9305558726150848,1.0,3/13,15.15%,GTPBP4;TERF1;GMNN
prerank,nuclear body organization (GO:0030575),0.46414291844733685,0.9794891850982014,0.5235531628532974,0.9315244168592567,1.0,4/12,16.96%,AFF2;ZPR1;USP50;PML
prerank,defense response to Gram-negative bacterium (GO:0050829),0.38545940773212983,0.9793941890590299,0.5067567567567568,0.9312272279166168,1.0,5/42,16.45%,LBP;TLR4;DMBT1;RNASE6;IL6
prerank,negative regulation of defense response (GO:0031348),0.3583943578921994,0.9791467701612231,0.5274841437632135,0.9313037317497507,1.0,15/77,15.63%,MAPK7;IRAK3;METRNL;MVK;ITCH;NR1D1;C1QBP;SIRT2;SIRPA;FNDC4;KLF4;IL4;LRFN5;SELENOS;ILRUN
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.29340404191638125,-0.9790919161947604,0.4620253164556962,0.817475212900099,1.0,9/29,13.76%,FLT1;PRKD1;KIT;DGKZ;EPHA8;PDGFRB;TEK;TGFB1;PTK2
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.3485934464601582,-0.9790804992697204,0.4959677419354839,0.8156172072864807,1.0,4/17,8.92%,RAPGEF2;ADRA1B;ADCY9;ADRA2A
prerank,response to exogenous dsRNA (GO:0043330),0.4378995382648186,0.9789192262793611,0.5058670143415906,0.9313565734911772,1.0,3/18,6.63%,IRAK3;RFTN1;CGAS
prerank,fluid transport (GO:0042044),-0.37310491752013386,-0.9788603096156041,0.44357976653696496,0.8143416084751485,1.0,2/12,8.69%,PDPN;AQP11
prerank,isotype switching (GO:0045190),-0.38412458989194204,-0.9788157825591305,0.4618055555555556,0.8125886747844755,1.0,4/10,22.85%,MSH2;BATF;RNF8;LIG4
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.47139565062776834,0.9783293412812603,0.5007012622720898,0.932380383557199,1.0,1/11,2.75%,RUNX1
prerank,cellular response to glucose starvation (GO:0042149),-0.25988839118881757,-0.9780635904143161,0.49166666666666664,0.8126254832673728,1.0,5/41,4.48%,PRKAG2;SIK2;PRKAA2;NUAK1;NIM1K
prerank,positive regulation of cell population proliferation (GO:0008284),0.33754164237170153,0.978019904198522,0.577,0.9326449929406206,1.0,66/423,14.10%,LIF;DDR2;AR;AREG;HAS2;FGF18;AVPR1A;WNT2;FGF7;DPP4;EGFR;TGFB3;IRS1;FGFR1;TMEM119;CTF1;BTC;VEGFA;FGF2;TGFB2;MST1R;FOXP1;TGFBR2;F2R;MIF;TIPIN;WWTR1;CDK4;TCF7L2;CLCF1;MEIS2;GLP2R;S1PR2;MLXIPL;PID1;ZFPM2;TBX6;ESM1;GAS6;S100A6;DNAJA2;FLT3LG;CAPN1;CD81;SOX8;WDR77;CUL3;STX4;ITGAV;CD47;NPM1;EGF;AKT1;FBXO5;KRAS;KIF20B;UBE2A;TSHR;IRS2;PDGFRA;GDNF;CDKN1A;FLT3;NME2;CDC123;HDAC4
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.37032916894888324,-0.9780091212678396,0.45,0.810889754848276,1.0,3/12,4.59%,APP;DOCK8;CXCL12
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.3618523661280412,-0.9778908305298912,0.5205992509363296,0.8093393231217427,1.0,2/14,1.15%,ATP1B3;ACTN2
prerank,regulation of tube diameter (GO:0035296),0.4527142527633022,0.9777453120589461,0.5020352781546812,0.9322859822948929,1.0,1/13,0.81%,GCLC
prerank,vascular process in circulatory system (GO:0003018),0.4527142527633022,0.9777453120589461,0.5020352781546812,0.9322859822948929,1.0,1/13,0.81%,GCLC
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3515660096994012,0.977682168148441,0.5416238437821171,0.9318926980405398,1.0,31/100,25.21%,GLMN;DESI1;RAD23B;COP1;STUB1;UCHL5;SIRT2;RYBP;HERPUD1;DNAJB2;USP5;FHIT;USP7;GIPC1;RNF14;OGT;NOP53;ZER1;KEAP1;UFL1;ARIH2;RNF19A;ARIH1;MAP1A;SDCBP;ZYG11B;BAG5;DVL1;UBQLN4;MDM2;FBXO22
prerank,cell-cell junction organization (GO:0045216),0.36232653474524895,0.9774001331315323,0.527027027027027,0.9320905166678058,1.0,13/79,8.34%,CADM3;TGFB3;PKP3;ANG;CD177;TGFB2;F2R;NECTIN3;CSK;FSCN1;MYADM;FLCN;PARD6A
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.3552560009431791,0.977289846779614,0.5428870292887029,0.9318254882599962,1.0,23/86,21.89%,DCTN1;CDC42EP2;BIN1;PSRC1;CLIP1;PFN2;TOGARAM1;PSEN1;MAPRE1;GPX1;COLGALT1;MAPT;FCHSD1;SLAIN2;FER;ARF6;NCK1;CDK5RAP2;AKAP9;NAV3;NUMA1;PYCARD;CTTN
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.3463923242425785,0.9770955082467688,0.5425101214574899,0.9317742044410475,1.0,36/125,25.25%,GPSM2;DYNC1LI2;CLIP1;NDEL1;ZW10;CENPT;AHCTF1;NUP107;DYNC1LI1;ZWINT;NUP98;DYNC1I1;KIF2A;MAPRE1;SETD2;SBDS;KIF3B;DYNC1H1;NUP37;MAP4;CENPC;PPP1CC;CKAP5;RCC2;PAFAH1B1;CENPE;EML1;WDR62;CLASP2;DCTN2;TUBG2;RMDN1;DYNLL1;NUP85;NUP133;CEP126
prerank,regulation of vasoconstriction (GO:0019229),0.40353994555214107,0.9769822106496759,0.5165094339622641,0.9315336929149391,1.0,5/27,17.59%,AVPR1A;F2R;ECE1;ZDHHC21;ATP2B1
prerank,positive regulation of apoptotic process (GO:0043065),0.34078058164294817,0.9766115722407085,0.585,0.9319844452686572,1.0,75/293,22.04%,SFRP4;WNT10B;KCNMA1;TGFB3;SCIN;FAP;AKAP13;GADD45G;RPS6KA2;TGFB2;SLIT2;BIN1;TRIO;MTCH1;ADAMTSL4;HOXA5;FOXO1;PRMT2;RASSF2;C1QBP;AIFM2;ARHGEF3;PIP5KL1;FLCN;PSEN1;SIAH1;SIRT2;PDCD2;RYBP;ING4;TIAM2;SQSTM1;BCL6;CSRNP3;BMF;ERCC3;BAK1;UBA52;NGEF;QRICH1;DIABLO;ZC3H12A;CALHM2;STK3;MTCH2;MLLT11;NUPR1;DDX20;NLRP2B;HRK;EEF1E1;CTSD;SOS1;IL6;SAP18;IAPP;HTRA2;PTRH2;TFAP4;TGFBR1;SMPD1;CYP1B1;CLIP3;GPLD1;APAF1;SUDS3;TRIM35;ATF6;BACE1;TIAM1;PYCARD;NF1;BTG1;VAV2;ATF4
prerank,activation of protein kinase activity (GO:0032147),0.3485246177679691,0.9764705311819921,0.5497435897435897,0.9318314858035384,1.0,20/106,15.09%,GHR;ITGB3;ANG;VEGFA;TGFB2;TGFBR2;TAOK3;AXIN1;MTOR;GAS6;STRADA;TIRAP;CALCA;AKT1;IRAK1;PIBF1;ADCY8;TAOK2;STK3;IL4
prerank,cholesterol metabolic process (GO:0008203),0.3606870025033457,0.9762210559326601,0.5263724434876211,0.9319601395850484,1.0,15/68,20.79%,CEL;ACLY;MVK;ABCA1;INSIG2;LCAT;GGPS1;TSKU;GBA2;IL4;PMVK;PIP4P1;FDX1;ANGPTL3;SOAT1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.4332922972428424,0.9752637463311368,0.522077922077922,0.9339411317286384,1.0,10/18,31.30%,DLG4;STX1B;CHRNA7;RIMS2;PTEN;PRKCZ;NLGN1;NLGN3;NRXN1;NLGN2
prerank,regulation of membrane depolarization (GO:0003254),0.426779185088501,0.975248937564004,0.5221799746514575,0.9334326355621178,1.0,3/18,10.18%,FHL1;CAMK2D;HCN4
prerank,autonomic nervous system development (GO:0048483),0.4278335163110183,0.9751409383605011,0.5144736842105263,0.9331743321823712,1.0,4/17,13.00%,SOX10;SEMA3A;SOX8;GDNF
prerank,regulation of gene expression (GO:0010468),0.3336621253996452,0.9749884643027568,0.624,0.932993786458701,1.0,156/903,17.06%,CD34;SFRP4;AHNAK2;AR;GSN;EPHB2;SEC16B;FGF18;AMH;AHNAK;ESR1;AFF3;FGF7;C1QTNF1;BNC2;C1D;GLMN;WT1;HPN;AFF2;TMEM119;MBNL1;PKP3;EIF2AK3;SCRT2;PRDM8;RUNX1;ANK2;VEGFA;FGF2;DGKQ;TGFB2;MLF2;FOXP1;CAMK2N1;BHLHE40;RBMS3;MIF;NFE2L2;ZPR1;ATF5;WWTR1;LMX1B;CRIP1;ZFP36L1;USP36;MAPK14;ADAM19;CXXC1;CDK4;CREB3L1;FOXK2;NAB1;NR1D2;MTOR;COQ7;CLK1;ATP2B4;TRIM71;SPIN4;RBAK;IL33;DTNBP1;HOXA5;IGSF1;NFIA;ZFHX3;TARDBP;MYADM;TRIP4;MLXIPL;PID1;RC3H1;STX1B;MYT1;NUP107;HDAC6;FLCN;GAS6;PHF1;MSL3;SPTY2D1;FZD7;LARP4;VDR;PSEN1;MYBL2;AGO2;HNRNPD;TLR4;RYBP;TDRD7;MAPK11;ONECUT1;SIRPA;MBNL2;SON;BCL6;MITF;TSKU;TRIM11;MUSK;HNRNPH1;MZF1;CPSF4;PARP14;EGF;GPX1;ATF7;ALPK2;ACTR5;AKT1;PUM1;CEBPB;MAPT;KRAS;SLC2A10;ZNF462;LRRC19;IGF2BP1;NAT8;NDFIP1;LARP1;SMCR8;GDNF;NWD1;PEG3;PIN1;TWIST1;SIX1;ZC3H12A;FADS1;HDAC4;SLC8A2;MOG;KLF4;SNAI2;IL4;BTN3A3;NR2C2;RPL6;MAP2K2;RNF14;FLOT2;TRIM68;ACTG1;RNF187;PER1;IL6;TRAF3;DIP2A;EFEMP1;CHD3;PML;PTRH2;AGO4
prerank,mitotic spindle assembly (GO:0090307),0.37584357921592176,0.9749598453089262,0.5016835016835017,0.9325157682567694,1.0,12/42,20.57%,KIFC2;TOGARAM1;KIF2A;ARHGEF10;SMC1A;PIBF1;RHOA;KIF3B;ABRAXAS1;STAG2;CLASP2;FLNA
prerank,positive regulation of cell death (GO:0010942),-0.24480375245140473,-0.9748741481481403,0.5955056179775281,0.8154307541770964,1.0,7/59,5.55%,SLC6A13;EFNB2;ACER2;SNCA;WNT5A;PRODH;AXIN2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.4195795322338026,0.9738957694784962,0.5360303413400759,0.9347272748983311,1.0,4/22,11.43%,PRKCA;SMAD4;CAMK2D;SLC9A1
prerank,positive regulation of interferon-beta production (GO:0032728),-0.27856414246058414,-0.9732252869931582,0.5384615384615384,0.8179427664588143,1.0,7/33,10.08%,TRIM56;POLR3C;MAVS;POLR3B;TLR3;OAS2;RNF135
prerank,bile acid metabolic process (GO:0008206),0.40827669622736684,0.9730783249510061,0.5362663495838288,0.9363022930028368,1.0,6/27,11.25%,OSBPL3;OSBPL2;SCP2;HSD3B7;OSBPL6;GBA2
prerank,central nervous system development (GO:0007417),0.34038788571934186,0.9726002894148699,0.593,0.9369964832691966,1.0,55/250,19.38%,GSN;DCLK1;SCIN;AFF2;VIT;UGP2;PBX1;TGFBR2;GLIS2;ZPR1;PKD1;ACAN;SOX10;VCAN;MEIS2;MARCKS;ALDH3A2;JRKL;NFIB;GRIN2D;ZFHX3;MTF1;ADAM22;PKD2;TBX6;TPP1;NDRG4;SOX8;SH3GL1;EEF1AKMT4-ECE2;HSPG2;GBA2;TBC1D23;KLK6;SLC23A1;MDGA1;ASIC2;MOG;SH3GL3;CHD8;UFC1;ALDH5A1;CDK5RAP2;AHI1;GRIN2A;CXCR4;BTD;QARS1;NIPBL;CNTN4;UFM1;MBP;EML1;COX7B;SNTG2
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.36080989972048116,-0.9724579232460825,0.4759825327510917,0.8181483125997601,1.0,6/14,12.35%,VEGFC;FOXC1;KDR;NRP1;PIK3CD;FLT4
prerank,aortic valve morphogenesis (GO:0003180),0.3942077947999888,0.9723499126874534,0.517490952955368,0.9370680611546459,1.0,8/30,15.05%,SLIT3;SLIT2;ELN;NFATC1;JAG1;SMAD6;TWIST1;SNAI2
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.43608627727904115,0.9723026982282325,0.5241199478487614,0.9366458108675205,1.0,8/16,30.73%,CHMP7;TMEM50A;VPS36;LEPROT;STAM;CHMP4C;CHMP4A;CHMP4B
prerank,regulation of neuroblast proliferation (GO:1902692),-0.3401946283150936,-0.9722384474205987,0.46296296296296297,0.8168720231190725,1.0,5/15,17.38%,PTN;CX3CL1;SMARCD3;CTNNB1;DISC1
prerank,monocyte chemotaxis (GO:0002548),0.39142910675177234,0.9719391659359644,0.5287221570926143,0.9370186883457653,1.0,6/32,16.45%,CCL8;ANXA1;CCL25;CALCA;CCL13;IL6
prerank,negative regulation of cell activation (GO:0050866),0.45092013588872776,0.971819765646082,0.5020352781546812,0.9367766544367778,1.0,3/14,12.80%,C1QTNF1;NR1D1;PDGFRA
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.37345562898489787,0.9715070947983684,0.5157437567861021,0.9370124869701024,1.0,13/49,19.68%,SCIN;RAB7B;RUNX1;DPY30;KAT2B;WDR5;EIF6;PITHD1;AGO4;KMT2A;THPO;AGO3;KMT2C
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.4484362851287068,0.9712960093319617,0.522020725388601,0.9370164691906113,1.0,2/15,9.33%,SMPD3;ORMDL2
prerank,cellular response to arsenic-containing substance (GO:0071243),0.4472171937696489,0.9712911135930988,0.5267379679144385,0.936481739673125,1.0,3/15,18.07%,HNRNPA1;ZC3H12A;GSTO2
prerank,regulation of execution phase of apoptosis (GO:1900117),0.4721566270219736,0.9709668037161345,0.5176630434782609,0.9367840655428209,1.0,3/11,13.85%,FAP;SIRT2;ZC3H12A
prerank,entry into host (GO:0044409),0.4579864136666929,0.970796364782811,0.5277777777777778,0.9366881315891079,1.0,5/13,17.41%,SRC;ITGAV;CBL;CXCR4;PPIA
prerank,cell cycle G1/S phase transition (GO:0044843),0.3631946810586943,0.9702663759682033,0.5080042689434365,0.937505722223664,1.0,14/61,15.36%,ACVR1;CDK4;TRIM71;USP29;BCAT1;CUL3;USP26;CDC34;CDKN1A;CCND1;DBF4;CCNH;GSPT1;E2F3
prerank,negative regulation of response to wounding (GO:1903035),0.42511964936423363,0.9697947220950127,0.528178243774574,0.9381823530708068,1.0,4/19,13.32%,FGF2;PTPRS;INPP5F;RTN4RL1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.39846688512627565,0.9696502883824504,0.5305651672433679,0.9380169384369723,1.0,8/29,19.51%,TARBP2;TRIM71;DGCR8;AGO2;PUM1;AGO4;SNIP1;AGO3
prerank,quinone biosynthetic process (GO:1901663),0.44246336284796256,0.9694094683435643,0.5287817938420348,0.9381082891168452,1.0,6/14,25.80%,COQ10B;COQ7;COQ3;COQ5;COQ10A;COQ2
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.3837947661978332,0.9689189890502716,0.5360824742268041,0.9388369312653166,1.0,14/37,23.97%,UCHL5;RYBP;SGTA;FHIT;USP7;GIPC1;OGT;NOP53;PML;RPL23;MAP1A;CSNK2A2;SDCBP;BAG5
prerank,positive regulation of ion transport (GO:0043270),-0.26475830530456046,-0.9686657318305351,0.53125,0.8245364494950707,1.0,9/48,8.92%,MYLK;ACTN2;AHCYL1;DLG1;CACNB2;CACNA1D;TRPC6;GPD1L;ADRA2A
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.29909172485012103,-0.9686360282316493,0.5185185185185185,0.8227652415996305,1.0,4/23,8.22%,CADM1;AP1G1;NECTIN2;PIK3R6
prerank,regulation of focal adhesion assembly (GO:0051893),0.37009780669380776,0.968083807173608,0.5342163355408388,0.9404552152375113,1.0,16/54,21.08%,MYOC;EFNA5;EPHA3;VEGFA;S100A10;PTPRJ;SRC;SLK;SLC9A1;RHOA;BCAS3;ACTG1;RCC2;CLASP2;CORO1C;PTEN
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.35769807339052395,-0.9677664934371166,0.49333333333333335,0.8233790643562785,1.0,5/15,22.04%,PRKCH;AGTR1;MAPK9;LPL;MSR1
prerank,negative regulation of anoikis (GO:2000811),0.43740766726659797,0.9674696669970804,0.5171052631578947,0.9415143356627188,1.0,6/14,19.75%,ITGA5;SRC;PIK3CA;SNAI2;PTRH2;MCL1
prerank,sulfate transport (GO:0008272),-0.33736959869822114,-0.9672302132483598,0.4979757085020243,0.8228631816624224,1.0,2/14,1.64%,SLC13A4;SLC26A7
prerank,apoptotic nuclear changes (GO:0030262),-0.294679815177304,-0.9670947923617331,0.5138121546961326,0.8213248569256912,1.0,9/24,23.30%,CECR2;HMGB1;CASP3;DEDD2;GPER1;BLCAP;ACIN1;TOP2A;FOXL2
prerank,sodium-independent organic anion transport (GO:0043252),0.47946114975349213,0.9664771754523759,0.5242718446601942,0.9435066913233152,1.0,1/10,0.44%,SLCO2A1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.41544953923189193,0.9664243414140218,0.5180572851805728,0.9431110512416374,1.0,7/20,23.06%,ZFP36L1;MEIS2;HOXA5;ZFP36;HOXA9;PAF1;LDB1
prerank,regulation of JNK cascade (GO:0046328),0.3496598939487422,0.9663189362973337,0.5749741468459152,0.9428187039420178,1.0,19/101,13.21%,SH3RF3;EGFR;GADD45G;TAOK3;AXIN1;COPS5;DACT1;AIDA;ITCH;RASSF2;SEMA3A;FZD7;TIRAP;SIRPA;HDAC3;ANKRD6;CD27;TAOK2;NCOR1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.41858261057194934,0.9663170426345781,0.5241116751269036,0.9422778997447545,1.0,2/20,2.88%,HAS2;TGFB2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.442241538069716,0.96631480547636,0.523447401774398,0.9417382820441695,1.0,4/17,15.05%,CD44;MIF;TWIST1;SNAI2
prerank,cell cycle checkpoint signaling (GO:0000075),0.46502988765071646,0.9661375656571944,0.556497175141243,0.9416721815300126,1.0,3/12,18.42%,ZW10;ZWINT;PRCC
prerank,regulation of angiogenesis (GO:0045765),0.33741066386214696,0.9658626167097251,0.5885311871227364,0.9418163978595212,1.0,28/192,11.99%,CD34;DCN;FGF18;TNMD;PRKCA;ANGPT4;ISM1;SPARC;RUNX1;VEGFA;FGF2;TGFB2;ECM1;CD160;SMOC2;THBS4;ATP2B4;HOXA5;CXCL10;SULF1;PRKD2;SERPINF1;AGO2;RHOJ;EMC10;HSPG2;GPNMB;JUP
prerank,negative regulation of cell cycle (GO:0045786),-0.23156612374413876,-0.9658376151069727,0.62,0.8229423968245115,1.0,14/73,12.28%,PTPRK;NR2F2;BMP7;SMAD3;PPP1R13B;FOXC1;CDK6;TAF6;BRINP3;INHBA;BMP2;CDKN1C;SCRIB;TGFB1
prerank,aortic valve development (GO:0003176),0.382426727050527,0.9653317229768832,0.5334114888628371,0.9425711942258844,1.0,9/34,15.05%,SLIT3;SLIT2;ELN;NFATC1;JAG1;SMAD6;TWIST1;TNFRSF1B;SNAI2
prerank,positive regulation of vasculature development (GO:1904018),0.34776938369992394,0.9651464725808364,0.5837669094693028,0.942508647694066,1.0,9/94,3.98%,CD34;FGF18;PRKCA;ANGPT4;RUNX1;VEGFA;FGF2;ECM1;SMOC2
prerank,sodium ion homeostasis (GO:0055078),0.42961194196310276,0.9644442125686692,0.5388349514563107,0.9436864063363406,1.0,4/21,4.13%,SCNN1B;ATP1A4;ATP1A3;ATP1A1
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.3094476667173852,-0.9643822563625623,0.5123152709359606,0.8247613310508778,1.0,5/22,14.59%,APOD;ADRA2A;PPP2R5A;CEACAM1;GPER1
prerank,protein deneddylation (GO:0000338),0.4712105099317837,0.9642226523663134,0.5216763005780347,0.9437206162851985,1.0,7/10,31.33%,COPS5;TOR1A;COPS4;GPS1;COPS6;COPS3;COPS7B
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.45169438701611275,0.9639459016404635,0.5348525469168901,0.9438855992917166,1.0,1/13,0.54%,TNMD
prerank,central nervous system neuron development (GO:0021954),0.4454378803250504,0.963913372361307,0.5447154471544715,0.9434430791279445,1.0,4/15,14.68%,LHX8;GBA2;MAPT;HSP90AA1
prerank,hemidesmosome assembly (GO:0031581),0.4769660791021863,0.9638221718884931,0.5332428765264586,0.9431138615943542,1.0,2/11,5.06%,COL17A1;DST
prerank,regulation of cell-substrate adhesion (GO:0010810),0.37223386783097545,0.9635867713923371,0.5349344978165939,0.9431857122170703,1.0,5/42,8.23%,FBLN2;CORO2B;VIT;MYADM;FZD7
prerank,replication fork processing (GO:0031297),0.3826744291911641,0.963453435966892,0.5387243735763098,0.9429880903491263,1.0,11/38,20.11%,EME1;RFWD3;ETAA1;CDK9;SAMHD1;DNA2;DDX11;THOC1;FAM111A;BLM;SMARCAL1
prerank,regulation of transport (GO:0051049),-0.26911480782738295,-0.963233180764043,0.5,0.8258334813908912,1.0,9/36,12.02%,EPB41;SNCA;ICA1;ACTB;WWC1;PINK1;NRP1;RAB11A;CDK5
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.32838131167107687,0.9630622345992041,0.735,0.9434490119303507,1.0,293/1646,17.09%,LMX1A;EBF2;PRRX1;AR;LRP6;CD80;COL1A1;LHX8;HOXA3;ESR1;PAX9;EBF1;ATP8B1;GCLC;TRPS1;LOXL2;FGF7;NFIX;FOXP2;SP9;BNC2;IRF4;EGFR;TGFB3;CREB5;PAX1;WT1;ZFHX4;ZC3H8;MEOX2;TBX15;SCRT2;ZNF367;HSF2;PRDM8;TADA1;CCNL2;HOXA2;ELF4;SIX4;HIVEP2;NEUROD2;ZMIZ1;RUNX1;VEGFA;FGF2;DGKQ;KLF3;TSHZ2;PBX1;CDK14;KLF12;MLF2;FOXP1;BHLHE40;F2R;GLIS2;TLX3;SFR1;PSRC1;ZNF25;SMAD4;NFE2L2;TEF;HDAC9;ATF5;DPF2;SMURF2;WWTR1;LMX1B;MEF2D;MAPK14;ACVR1;TSC22D4;AXIN1;CXXC1;SOX10;IRX5;HOPX;CREB3L1;FOXK2;ZBTB12;MED13L;RFX1;MAP2K3;KLF2;JUND;NAB1;TCF7L2;NR1D2;NFATC4;MAFF;MRGBP;MEIS2;ATP2B4;SPIN4;CAMK2D;CBX4;RBAK;NFATC1;SMARCD2;HOXA5;FOXO1;NR1D1;PIAS3;NFIB;PRMT2;CREBZF;MAPRE3;EBF3;ZBTB7C;IGSF1;RNF111;NFIA;ZFHX3;DPF1;SMAD5;RET;MDM4;TRIP4;GLI2;MLXIPL;MDFIC;DNAJC2;MYT1;MTF1;NUP107;HDAC6;SMARCD1;ZFPM2;HOXA4;TBX6;GAS6;BRD9;MAMSTR;PHF1;STAT5A;FOXL1;BRF2;MSL3;SPTY2D1;ETV3;CHUK;FZD7;SOX8;ZNF260;WDR77;ZBTB1;NR6A1;KDM3B;VDR;SATB2;PSEN1;SOX5;MYBL2;MAGEL2;FOXC2;SIRT2;HNRNPD;ATXN7L3;MED24;RYBP;RCOR3;ELP4;CIPC;ONECUT1;KDM5C;ING4;SMAD6;BRD7;RNF10;PHC3;HDAC3;INPP5K;BCL6;MITF;CHD2;TLE2;CALCA;MYPOP;ZNF3;MPHOSPH8;MZF1;PHC1;NPM1;ZHX2;PRDM15;SMARCC2;GLI3;EGF;SAMD1;URI1;ATF7;ACTR5;IRF2BPL;CAMKK2;CSRNP3;AKT1;FBXO5;RBFOX2;CEBPB;TOX2;BCL3;BACH2;LIN9;NCOR2;CCNC;XRCC5;DDX17;QRICH1;KDM5B;MED13;ATF1;ZNF112;ZNF691;CDKN1A;NCOR1;PEG3;CBFA2T2;PROX2;IKZF5;TWIST1;RAI1;SIX1;RFX5;NACC2;BRIP1;NME2;FADS1;CCNH;HDAC4;PLAGL1;ZNF569;KLF4;MLLT11;HOXC4;MLXIP;PLAGL2;DMAP1;HOXA7;SETD5;ZNF692;THOC1;TASP1;CHD8;SMARCA4;HOXA9;NFE2L3;POU3F2;SNAI2;IL4;GMNN;NR2C2;E2F3;ZEB1;RPL6;CCNQ;YEATS2;BAHD1;HMGB3;SRCAP;ZBTB5;MAP2K2;UBP1;RNF14;BAZ2B;OGT;USP22;FZD4;ZBTB25;PSIP1;CDK5RAP2;HIVEP3;STAT5B;RNF187;ZFP28;ANXA4;PER1;PDCD4;IL6;DKK3;PHF5A;SAP18;CHD1;DAP;E4F1;EFEMP1;CHD3;DDX5;PML;NEK4;PITHD1;TFAP4
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.3809149084696961,-0.9630029381451481,0.4981684981684982,0.8246618853481529,1.0,4/12,10.42%,SORBS1;IGF2;SORL1;SIRT1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.3489137474080106,-0.962937878417789,0.5278969957081545,0.8230153228738735,1.0,8/15,27.15%,TNK2;PIK3CB;HIP1R;DAB2;NEU3;SCYL2;AAK1;SMAP1
prerank,cellular response to light stimulus (GO:0071482),0.3581691603281481,0.9629279545767807,0.5576719576719577,0.943241995007568,1.0,19/66,22.51%,TRIAP1;NOC2L;RHNO1;ZBTB1;CNGB1;NPM1;BMF;SAG;BAK1;ERCC4;GNB1;EIF2S1;INO80;POLD1;SMPD1;OPN3;ATF4;SDE2;NSMCE3
prerank,positive regulation of phospholipid transport (GO:2001140),0.47212993655934543,0.9622544238371172,0.532033426183844,0.9443742804071602,1.0,4/10,23.94%,TRIAP1;TMEM30A;PRELID1;ABCB4
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.3396043418871485,0.9617724575605124,0.597979797979798,0.9450550881357541,1.0,30/145,17.76%,DCTN1;FHL1;PSMC4;ODF2;RAD51B;CDK4;VPS4B;PSMC6;YWHAG;SSNA1;YWHAE;PSMD8;DTL;ALMS1;AVEN;HAUS3;MAPRE1;FBXO5;SFI1;CCND1;HSP90AA1;DYNC1H1;TUBB4A;TUBA4A;CDK5RAP2;CCP110;AKAP9;CEP164;CKAP5;RCC2
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3545434302139425,0.9617363917591738,0.5689119170984456,0.944604471263998,1.0,18/75,16.13%,SLC39A14;SLC12A8;ATP1A4;ATP1A3;ATP1A1;TRPV3;ATP2B4;KCNJ2;SLC9A9;SLC12A4;KCNK9;HCN4;SLC9A1;SLC12A5;KCNJ3;SLC8A2;SLC9A6;SLC9A7
prerank,calcium import into the mitochondrion (GO:0036444),0.4837928742682318,0.9616582333155476,0.5461200585651538,0.9442483051357728,1.0,2/10,11.82%,MCU;MCUB
prerank,protein polyubiquitination (GO:0000209),0.3345520129684454,0.9616328871572237,0.621,0.9437714454177024,1.0,103/297,26.78%,WSB1;MIB2;PSMC4;UBE2B;SPSB1;HECTD2;SMURF2;UBE2J2;FBXW8;SYVN1;ITCH;TRIM71;RBBP6;PSMC6;PELI3;RC3H1;STUB1;LNPEP;UBE2W;ANKRD39;FBXO2;UBE2N;MYLIP;SIAH1;MAGEL2;PSMD8;FBXO17;CUL3;DTL;FBXW4;UBE2G2;HECW2;FBXL20;CDC23;FBXO31;ANAPC5;UBE2A;THOP1;CDC34;NPEPPS;UNKL;UBA52;TRAF3IP2;CDC27;FBXO28;FBXL3;AMFR;RNF216;RNF14;RBCK1;TRIM68;RNF187;TRAF3;HACE1;CDC26;FBXL5;UBE2G1;FBXO11;ANAPC4;ARIH2;UBE2R2;SKP2;RNF19A;LRSAM1;UBE3C;TPP2;ARIH1;UBE2D3;FBXL19;FBXW9;RNF41;FBXW2;ANAPC10;RC3H2;SMURF1;FBXW11;UBE2Q2;UBE3A;UBR2;RNF6;RNF114;TRIM36;IFI27;TRAF5;FBXO38;PSMD4;FBXL12;PSMD3;MDM2;RNF166;FBXO22;FBXW7;FBXO30;ZNRF2;RNF20;ANAPC2;UBE2K;RNF167;RNF126;PSMB3;MUL1;PRPF19;RNF31
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.45883494078299075,0.9614689752892057,0.5260869565217391,0.9436632233091725,1.0,4/12,23.03%,CHAMP1;CENPC;CENPE;RMDN1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.35876366773343554,0.9613611892910221,0.548936170212766,0.9433997599455802,1.0,13/65,17.82%,AREG;EGFR;BTC;DOK1;PTPRJ;RHBDF1;MVB12A;EGF;AKT1;CBL;FER;ARAP1;PLAUR
prerank,cellular response to calcium ion (GO:0071277),0.35610013998686785,0.9613611813467313,0.5618336886993603,0.9428609822414422,1.0,10/67,9.15%,SYT2;NEUROD2;CPNE8;SYT12;SYT11;SYT13;CAMK2D;PKD2;DPEP1;IQGAP1
prerank,mesenchyme development (GO:0060485),-0.3387907554508451,-0.961309360558313,0.4863636363636364,0.8253752675646971,1.0,4/15,10.58%,BMP7;FGFR2;BMPR2;BMP2
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.3893492157769928,0.9612494598468694,0.5323910482921084,0.9426021572247729,1.0,12/32,26.07%,GPAT4;CHKB;SLC44A1;LCAT;LPCAT1;CEPT1;SLC44A2;LPIN3;CSNK2A2;PCTP;SLC27A1;LPCAT3
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.2644931941076632,-0.9611456367300419,0.5684931506849316,0.8240111610787673,1.0,15/39,20.84%,NEDD4L;DMD;OSR1;WNK4;YWHAH;PRKCE;GPD1L;FXYD1;GLRX;FGF11;UTRN;SLMAP;HECW1;SCN3B;ANK3
prerank,macrophage differentiation (GO:0030225),0.44848173907564104,0.9611214697501409,0.532,0.9423824022652498,1.0,4/13,27.49%,VEGFA;IL31RA;CSF1;CASP8
prerank,vitamin D metabolic process (GO:0042359),0.4496361212766854,0.961035116657211,0.5418326693227091,0.9420460863015236,1.0,5/13,27.20%,CYP27B1;VDR;GC;LRP2;CYP2R1
prerank,brain morphogenesis (GO:0048854),0.45729684328531184,0.9605697583224061,0.5393858477970628,0.9426773114054952,1.0,7/12,27.97%,SLC6A4;BBS4;PAFAH1B1;PTEN;FBXW11;PAX2;SPEF2
prerank,acidic amino acid transport (GO:0015800),-0.32703151258469176,-0.9605072679980418,0.5215311004784688,0.8239183402296415,1.0,4/17,7.43%,SLC6A13;SLC1A3;SLC6A1;GJA1
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.3596949164227424,-0.9600554473063426,0.5158730158730159,0.8233650163177506,1.0,4/13,15.51%,RNF152;SPAAR;ATM;SESN1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.44526667330794517,0.9591604596394641,0.5271523178807948,0.9457630436647293,1.0,2/15,1.27%,SRMS;EGFR
prerank,glycerolipid catabolic process (GO:0046503),0.41874212261255045,0.9588287859716598,0.5489949748743719,0.9460349663715721,1.0,1/19,0.65%,MGLL
prerank,regulation of cell division (GO:0051302),0.35486837498041185,0.9588124334099651,0.5641569459172853,0.9455327377250856,1.0,16/72,16.10%,CDK2AP2;TLE6;FSD1;AHCTF1;NCOA3;FLCN;SIRT2;PRDM15;SETD2;PRPF40A;CALM2;SFN;PIN1;ORC6;BBS4;CCP110
prerank,cortical actin cytoskeleton organization (GO:0030866),0.4134955750792914,0.9587630039847717,0.5328185328185329,0.9451271343354458,1.0,6/20,14.95%,LLGL1;FMNL1;RHOQ;FMNL3;FHOD3;ARF6
prerank,metanephros development (GO:0001656),0.40135296556763167,0.9585694644578978,0.5432692307692307,0.9450944042621354,1.0,6/26,13.67%,WT1;SIX4;PKD1;PKD2;GDNF;SIX1
prerank,protein complex oligomerization (GO:0051259),0.34919451749229313,0.9584466906210802,0.5711318795430945,0.9448527274338616,1.0,27/85,26.57%,UGDH;LRRC8D;ZNHIT6;MPP2;PKD2;ZBTB1;MCU;CPSF6;SLC9A1;VSTM5;MAT2A;TMEM120A;ADCY8;NACC2;ZC3H12A;KCNC2;BLM;CARD11;PYCARD;PDCD6IP;KCNC1;ALS2;CPSF7;ATL1;HGSNAT;RBMX;GLRA3
prerank,apoptotic cell clearance (GO:0043277),0.385931590357709,0.9580733104216291,0.5463182897862233,0.9452616180105328,1.0,5/30,9.97%,LRP1;ANXA1;ITGB3;GAS6;ITGAV
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.4240745229167585,0.9580237637617105,0.5611979166666666,0.9448543347451002,1.0,2/17,5.76%,IGFBP5;DOCK7
prerank,regulation of proteolysis (GO:0030162),0.36372112158343817,0.9579767967206222,0.5427302996670367,0.9444343019478705,1.0,16/48,23.74%,CAMK2N1;ITCH;STUB1;HDAC6;AURKAIP1;CSTB;AKT1;TBC1D10A;BAK1;OGT;TRAF3;PLAUR;NEDD8;FBXW11;IST1;PARL
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.4207129556908788,0.9578860849460389,0.5242346938775511,0.9441154242287303,1.0,6/19,21.46%,PAPSS2;BPNT2;SULT4A1;SLC26A1;ABHD14B;TPST2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.37867779218216024,0.9577744731418311,0.5629965947786606,0.9438540917897688,1.0,12/40,20.96%,EME1;TIPIN;RFWD3;ETAA1;CDK9;DDX11;THOC1;FAM111A;BLM;POLD1;SMARCAL1;DONSON
prerank,negative regulation of cell development (GO:0010721),0.4023618552155279,0.9577729921860412,0.5471236230110159,0.9433237822958382,1.0,1/25,0.36%,FBN1
prerank,regulation of lamellipodium organization (GO:1902743),0.4407798351992854,0.9576490787619886,0.5459317585301837,0.943086809943843,1.0,5/14,24.58%,CD44;TWF1;FER;DMTN;RAC1
prerank,regulation of chromatin organization (GO:1902275),-0.3489677641372325,-0.9574808346077245,0.5095785440613027,0.8280704797204562,1.0,3/14,7.99%,MLLT3;SSRP1;IGF2
prerank,chemical synaptic transmission (GO:0007268),0.33410681464129693,0.9574642381592801,0.6526526526526526,0.9430241116037584,1.0,67/284,23.22%,LRP6;LPAR3;SNCB;MTNR1B;APBA3;CEL;PMP22;RPS6KA2;CAMKK1;STX1A;APBA1;DLG4;SLC1A6;GABRR3;DLG2;GRIN2D;SLC18A3;RIT2;HTR1F;SLC12A4;ERC2;GRIA2;PLP1;CAMKK2;HCRT;NAPA;FCHSD1;SLC12A5;SNAP25;ASIC2;NSG1;CACNB1;DLGAP1;GABRG3;GIPC1;GAD2;GRID1;GRIN2A;SNAPIN;CHRNA7;CHRFAM7A;AKAP9;SYT1;GRM1;SNPH;CHRNA5;VAMP2;SYNJ2BP;MBP;HTR2C;PAFAH1B1;PRKAR2A;GABRG2;EXOC4;GRIA3;NOVA1;STAC3;MAPK1;SLC12A6;PTEN;SHISA6;SDCBP;NAPB;HTR2A;GRIK5;NPTX1;GRIK2
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.3959635831335785,0.9572434836462522,0.509478672985782,0.9430421290450202,1.0,12/27,28.13%,CCDC88C;CHUK;MAPK11;UBA52;TAOK2;MAPK1;FBXW11;MAP3K7;TNIP2;KAT7;NFKB1;CUL1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.2986186424886333,-0.9570496647857571,0.5567010309278351,0.8274306840694949,1.0,9/22,20.91%,PSMA5;PSMA2;PSMA3;PSMB10;PSMA1;PSMB8;PSMB9;PSMB4;PSMA8
prerank,positive regulation of cellular respiration (GO:1901857),-0.38497810492872037,-0.9565554256273489,0.5114503816793893,0.8269205980029465,1.0,4/11,12.91%,IFNAR1;IL10RB;PINK1;ISCU
prerank,V(D)J recombination (GO:0033151),-0.3790953542483946,-0.9558504029477387,0.5181159420289855,0.8269490888437568,1.0,1/11,2.75%,HMGB1
prerank,regulation of developmental growth (GO:0048638),0.3927301480561377,0.9554876265014646,0.5349397590361445,0.9468603604051041,1.0,7/29,18.47%,GHR;SIX4;STAT5A;MUSK;SIX1;STAT5B;NIPBL
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.44219111160089364,0.9551325097126122,0.5266757865937073,0.9472126558733778,1.0,3/14,16.67%,PKD1;PKD2;KEAP1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.4058524636018651,0.9551294124325609,0.540272614622057,0.9466833420673199,1.0,3/23,8.41%,INTS3;ZW10;ZWINT
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.32714838641661725,0.9547324136672765,0.681,0.9471420769070394,1.0,99/476,18.50%,AR;LRP6;CD80;COL1A1;ESR1;FGF7;IRF4;EGFR;TGFB3;CREB5;WT1;ELF4;SIX4;ZMIZ1;RUNX1;FGF2;F2R;GLIS2;SFR1;PSRC1;SMAD4;ATF5;ACVR1;AXIN1;CXXC1;SOX10;FOXK2;MAP2K3;KLF2;NR1D2;NFATC1;FOXO1;NR1D1;NFIB;PRMT2;MAPRE3;EBF3;RNF111;ZFHX3;SMAD5;RET;TRIP4;GLI2;MLXIPL;MDFIC;DNAJC2;CHUK;FZD7;SOX8;PSEN1;FOXC2;HNRNPD;ATXN7L3;MED24;RYBP;BRD7;RNF10;INPP5K;MITF;NPM1;SMARCC2;GLI3;EGF;CAMKK2;AKT1;CEBPB;BCL3;QRICH1;MED13;RAI1;SIX1;NME2;HDAC4;KLF4;MLLT11;TASP1;CHD8;SMARCA4;IL4;MAP2K2;RNF14;USP22;FZD4;CDK5RAP2;HIVEP3;RNF187;IL6;PHF5A;PML;NEK4;PITHD1;TFAP4;ILF2;ILK;NAA15;KMT2A;TGFBR1;CTCF;BLM
prerank,regulation of response to biotic stimulus (GO:0002831),0.40148645444249825,0.9545439336069643,0.5455635491606715,0.9470893411596197,1.0,4/28,10.01%,CD55;FOXP1;TIRAP;SAMHD1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3279267467100214,0.9542943945080189,0.685,0.947158590408313,1.0,105/497,18.54%,IGFBP5;PAX9;ATP8B1;GCLC;LOXL2;FOXP2;WT1;ZC3H8;EIF2AK3;SIX4;FOXP1;BHLHE40;GLIS2;SMAD4;HDAC9;ATF5;DPF2;SMURF2;TSC22D4;RBM4;CREB3L1;FOXK2;PAIP2B;GTPBP4;NAB1;TCF7L2;NR1D2;TRIM71;CBX4;RBAK;SAMD4B;FOXO1;NR1D1;PRMT2;CREBZF;DPF1;MLXIPL;MDFIC;HDAC6;ZFPM2;GAS6;SOX8;VDR;MRPL13;MAGEL2;SIRT2;RCOR3;CIPC;KDM5C;ING4;BRD7;PHC3;HDAC3;INPP5K;BCL6;TLE2;CALCA;MPHOSPH8;PHC1;ZHX2;SMARCC2;GLI3;SAMD1;RBFOX2;BCL3;PASK;IGF2BP1;NCOR2;XRCC5;LARP1;CDKN1A;NCOR1;CBFA2T2;TERF1;TWIST1;CNOT10;NACC2;HDAC4;KLF4;DMAP1;HOXA7;CHD8;SMARCA4;IL4;GMNN;ZEB1;YEATS2;BAHD1;SELENOS;PER1;PDCD4;DKK3;SAP18;DAP;FXR2;PML;TFAP4;SNX6;SET;EPRS1;QARS1;CTCF;NIPBL;PAIP2;GCFC2
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.4050212662623646,0.9540245536724502,0.5454545454545454,0.9473020780916453,1.0,12/25,31.78%,PRPF4;PRPF3;MPHOSPH10;SF3B4;BCAS2;SRRM1;SF3B1;PRPF6;WDR83;LSM1;PRPF8;GEMIN2
prerank,regulation of sodium ion transport (GO:0002028),-0.2791097146083297,-0.954020710615307,0.5211267605633803,0.8299160361376003,1.0,10/34,12.19%,WNK4;AHCYL1;YWHAH;DLG1;GPD1L;SIK1;NKAIN4;NKAIN3;NOS1;NKAIN1
prerank,nucleotide-excision repair (GO:0006289),0.3412763839016302,0.9538247731755264,0.580082135523614,0.9472771943014116,1.0,23/101,18.76%,POLR2H;GTF2H3;COPS5;RAD23B;RNF111;POLB;SLC30A9;ERCC3;UBA52;FAN1;ERCC4;POLR2D;DDB1;POLR2G;BRIP1;CCNH;AQR;USP7;UVSSA;RFC4;ERCC5;POLD1;COPS4
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.34772631836312734,0.9536080014523318,0.5778947368421052,0.9472938215358433,1.0,20/77,20.26%,AR;TRIAP1;ACVR1;TCF7L2;SRC;PELI3;NOC2L;ITGAV;HERPUD1;GPX1;URI1;AKT1;IL4;GHITM;HGF;PLAUR;TGFBR1;QARS1;MCL1;PRELID1
prerank,apoptotic DNA fragmentation (GO:0006309),-0.33134801834421435,-0.9535216770741668,0.5441860465116279,0.8293000396240962,1.0,3/16,7.67%,CECR2;HMGB1;CASP3
prerank,DNA repair (GO:0006281),0.3292818351421113,0.953445296334162,0.6489468405215647,0.9471527739541078,1.0,47/284,14.36%,MPG;PARP3;FANCD2;INTS3;XRCC3;UBE2B;GTF2H3;EME1;RAD51B;NUDT1;RFWD3;RAD23B;KPNA2;TENT4A;IGHMBP2;UBE2N;INIP;RHNO1;ZBTB1;PPP5C;FANCL;FAAP100;POLB;FANCE;SMC1A;ASCC3;NPM1;EXO5;SLC30A9;POLI;ACTR5;SETD2;UBE2A;DNA2;ERCC3;UBA52;FAN1;XRCC5;ERCC4;RAD1;DDB1;ABRAXAS1;BRIP1;INO80;FANCG;TNKS1BP1;NBN
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.3719001059156466,0.9534027677611061,0.5660592255125285,0.9467332790540747,1.0,11/39,23.30%,GTF2H3;ERCC3;UBA52;FAN1;ERCC4;DDB1;RFC4;ERCC5;POLD1;OGG1;ERCC1
prerank,sterol metabolic process (GO:0016125),-0.23646761266908203,-0.9533910413825747,0.5733333333333334,0.8278750675390883,1.0,15/60,19.39%,PRKAG2;CYP7B1;APOE;CYP26B1;HMGCR;ABCG1;LDLRAP1;FDXR;CYP39A1;CLN8;ABCA5;DHCR7;LBR;EBP;SC5D
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.42477992177170165,0.9532085728534383,0.5516795865633075,0.9466586385271136,1.0,5/17,23.77%,ANK2;SCN4B;AKAP9;KCNH2;CACNA2D1
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4507751329216432,0.953164606675205,0.547683923705722,0.946237712893368,1.0,6/13,24.20%,CPSF6;CPSF4;CPSF2;CSTF2T;CPSF7;CPSF1
prerank,neuromuscular junction development (GO:0007528),-0.2895759820798828,-0.9528412161275641,0.5129533678756477,0.8275024603147628,1.0,5/24,5.69%,UNC13B;PDZRN3;UNC13C;CACNB2;PPFIBP2
prerank,mesonephric tubule development (GO:0072164),0.4421043916255597,0.9527419722914319,0.5504587155963303,0.9467109994356727,1.0,4/15,7.64%,WT1;SLIT2;PKD1;PKD2
prerank,pulmonary valve morphogenesis (GO:0003184),0.42688984787668255,0.9526320371018024,0.5480153649167734,0.9464716663881861,1.0,5/17,10.07%,TGFB2;SLIT2;NFATC1;JAG1;SMAD6
prerank,melanosome organization (GO:0032438),0.4030789331891241,0.9524867691762318,0.55819774718398,0.9463402520283911,1.0,7/26,16.57%,RAB32;AP1M1;DTNBP1;AP3D1;HPS4;BLOC1S2;SNAPIN
prerank,sterol homeostasis (GO:0055092),-0.23305452480351602,-0.9524799501507722,0.56,0.8267089645432397,1.0,12/65,11.89%,CYP7B1;GRAMD1B;APOE;SCARB1;TTC39B;NR1H3;CAV1;ABCG1;LDLRAP1;EPHX2;SIRT1;FGFR4
prerank,mitochondrial translational termination (GO:0070126),0.34619700773591755,0.9512051704760583,0.5665280665280665,0.9489563445812066,1.0,18/88,15.77%,MRPS11;MRPL38;MRPS18B;CHCHD1;MRPL13;MRPS17;AURKAIP1;MRPS27;MRPL30;DAP3;MRPL10;MRPL55;MRPS10;MRPL36;MRPL3;MRPL21;MRPS34;MRPL51
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.4178477708099767,0.9508677810887686,0.5443196004993758,0.9492510932173381,1.0,7/20,13.03%,ANK2;TNNI3;CAMK2D;GSTM2;SLC9A1;CALM2;ATP2A2
prerank,digestive tract morphogenesis (GO:0048546),-0.34430306685236234,-0.9508149329706502,0.5307692307692308,0.8295758952916623,1.0,6/14,15.76%,RBPMS2;FGFR2;SOX17;STRA6;BBS7;SOX11
prerank,positive regulation of synapse assembly (GO:0051965),0.3902521706144314,0.9507648150007275,0.5567765567765568,0.9489793942942644,1.0,13/27,31.30%,EPHB2;EPHB3;VSTM5;SYNDIG1;EPHB1;CLSTN3;IL1RAPL1;GRID2;NLGN1;NLGN3;LRRC4B;NRXN1;NLGN2
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.385731681480761,-0.9504908656721348,0.5202702702702703,0.8285367734807956,1.0,3/10,12.00%,PCGF5;IGF2;ZFP57
prerank,negative regulation of lyase activity (GO:0051350),0.43007405878941685,0.9504847157082285,0.5327102803738317,0.9491050908945319,1.0,3/16,8.84%,GNAI3;PALM;LTB4R2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.4498213621048642,0.950352242396152,0.5497311827956989,0.9488901628310481,1.0,2/13,6.14%,NFATC4;NFIB
prerank,determination of bilateral symmetry (GO:0009855),-0.29948316924976104,-0.9499446900794443,0.5369458128078818,0.8282684453681054,1.0,13/24,29.80%,NOTCH1;TBX1;CITED2;BBS7;GALNT11;DNAH11;STIL;ZIC3;CFAP53;DLL1;ODAD2;ODAD3;FOXJ1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.4305136383323277,0.9498488147976946,0.5314207650273224,0.949567934366465,1.0,2/15,6.96%,LRP6;GLI2
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.3898275519838729,0.9496886192363644,0.5507246376811594,0.949439097167046,1.0,8/29,10.62%,SLIT2;SMAD4;MYADM;PFN2;PIK3CA;KANK1;TWF1;SSH1
prerank,lung epithelium development (GO:0060428),0.47719034103781643,0.9491963271547622,0.5497159090909091,0.9500963215517727,1.0,2/10,6.00%,PKD1;RCN3
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.38175319839680955,0.9491889250201434,0.5593023255813954,0.9495821669793526,1.0,8/34,10.51%,ANXA1;GAS1;VEGFA;MAPK14;MAP2K3;PRKD2;PIK3CA;ERN1
prerank,regulation of cellular component organization (GO:0051128),0.3349420355817432,0.9489610114497992,0.6125760649087221,0.9496497977536948,1.0,26/135,14.96%,STON2;PLCE1;CD177;IRAK3;SGK3;SGK2;ATF5;RAP1B;MTOR;ITCH;CAMK2D;SOCS2;EGLN2;RIT2;MELTF;ABL2;ARFGAP1;HJURP;NRG3;URI1;SLC2A10;RUFY1;TAOK2;HSP90AA1;SETD5;RAPGEF1
prerank,cellular response to leucine starvation (GO:1990253),0.47436339519873905,0.9489482309440695,0.5657142857142857,0.9491548362153068,1.0,5/10,28.09%,MTOR;SESN3;RRAGD;SESN2;IMPACT
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3624579637644174,0.9488571029192954,0.5546786922209695,0.9488364853460933,1.0,8/46,13.43%,EPHB2;CAMK2N1;SMAD4;FLCN;TLR4;SIRPA;TNIP1;PIN1
prerank,sphingolipid metabolic process (GO:0006665),0.33995583221595593,0.9486472652135814,0.5720164609053497,0.9488072607756074,1.0,20/108,13.71%,CERS6;SMPD3;ARSA;B3GALNT1;PLPP3;ALDH3A2;TECR;PLPP1;PRKD2;ORMDL2;AGK;PDXDC1;SGMS2;FA2H;GBA2;ELOVL5;GLA;CERK;PRKD3;GLTP
prerank,phagolysosome assembly (GO:0001845),0.4473539265465223,0.9485135049366589,0.5589459084604715,0.9485849414282033,1.0,1/12,2.18%,RAB7B
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.3460020787280598,0.9484181984919241,0.5782241014799154,0.9482976303566079,1.0,29/80,27.39%,NIBAN1;SMPD3;MTOR;LARP4;HNRNPD;NPM1;BCL3;PASK;EIF6;RPS27L;ZCCHC4;RBM3;POLDIP3;EIF3E;IL6;FXR2;EIF3D;CHRNA7;YTHDF1;PCIF1;NSMAF;YTHDF3;LRRTM3;RELA;LARP6;UPF3B;SLC2A13;PRKDC;IFNGR1
prerank,pore complex assembly (GO:0046931),0.41468532087441745,0.9483396021986459,0.5393401015228426,0.9479589073314385,1.0,4/19,8.78%,NUP93;AHCTF1;NUP107;NUP98
prerank,regulation of endothelial cell migration (GO:0010594),0.3473440293152274,0.9482973224433022,0.6141078838174274,0.947530619854003,1.0,20/85,14.35%,DCN;PRKCA;ANGPT4;SPARC;ITGB3;VEGFA;FGF2;SLIT2;FOXP1;SMOC2;PRCP;PRKD2;FOXC2;RHOJ;EMC10;EGF;AKT1;ZC3H12A;AAMP;BCAS3
prerank,organophosphate biosynthetic process (GO:0090407),0.3825570124840126,0.9482280170541446,0.5629213483146067,0.9471706286422076,1.0,11/37,23.26%,FGF2;GK5;AGPAT3;LPCAT1;AGPAT5;FADS1;NFS1;IPPK;GPAM;IP6K1;MOCS1
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.2756818609719764,-0.9477411567740244,0.5524475524475524,0.8322899495822931,1.0,8/32,13.56%,CDH5;ITGA1;PPP1R16B;PPP1R15B;PDGFRB;PPP2R5A;TGFB1;CD300A
prerank,response to retinoic acid (GO:0032526),0.3548069378820199,0.9474592684323316,0.5809935205183585,0.9485147785459299,1.0,7/59,8.23%,WNT2;WNT10B;EPHA3;WNT9A;RET;ABL2;FZD7
prerank,negative regulation of interferon-beta production (GO:0032688),0.4678416595181315,0.9474312667621171,0.5553977272727273,0.9480686139599701,1.0,2/10,9.99%,PTPRS;SIRPA
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.4120434574380437,0.9472093299059843,0.5396618985695709,0.948124848461816,1.0,4/18,14.10%,TMEM119;FZD7;HDAC3;HDAC4
prerank,regulation of ion transmembrane transport (GO:0034765),-0.265622331756712,-0.9470509030930103,0.5594405594405595,0.8322237584211981,1.0,6/33,12.14%,NEDD4L;AHCYL1;WWP2;KCNQ1;KCNJ12;AKAP6
prerank,vacuolar acidification (GO:0007035),0.41227833403804154,0.9470164868534485,0.5648854961832062,0.9480805878089748,1.0,8/21,27.10%,ATP6V0A2;TMEM9;DMXL2;CCDC115;ATP6V0A1;TMEM199;DMXL1;PPT1
prerank,regulation of DNA binding (GO:0051101),-0.24521654699027098,-0.9469868167445545,0.5670103092783505,0.8306228200067491,1.0,5/44,3.60%,LEF1;SP100;IGF1;HMGB1;FOXC1
prerank,cellular transition metal ion homeostasis (GO:0046916),0.3412233538797862,0.9468609062739354,0.5851393188854489,0.9479429767701771,1.0,16/91,17.74%,SCARA5;SLC39A14;SLC39A13;SMAD4;ATP6V0A2;COX19;SLC11A2;ARF1;SLC39A7;SLC30A9;NDFIP1;ATP6AP1;CCDC115;SLC30A5;FBXL5;FLVCR1
prerank,dendrite morphogenesis (GO:0048813),0.37192120930278855,0.9468087699584108,0.5417142857142857,0.947532448888697,1.0,13/35,21.10%,EPHB2;DLG4;FARP1;EPHB3;TAOK2;MAP6;CTNND2;SDC2;DIP2A;CHRNA7;EPHB1;PTEN;ABITRAM
prerank,epithelial tube morphogenesis (GO:0060562),0.38396632399220454,0.9466557959351372,0.5584112149532711,0.947371164173662,1.0,6/32,7.64%,SLIT2;PKD1;ACVR1;GLI2;PRKD2;PKD2
prerank,regulation of cell cycle process (GO:0010564),0.34004763383882286,0.9464672951902359,0.6065573770491803,0.947314019942134,1.0,27/104,22.45%,TIPIN;ATF5;CCDC8;FSD1;AHCTF1;FLCN;FBXO5;SETD2;KIF20B;NUDT16;PRPF40A;CALM2;PIN1;DBF4;CUL9;BBS4;DYNC1H1;CCP110;CEP85;E4F1;TTL;YTHDF2;ENTR1;NUMA1;CSNK2A2;KLHL9;USP19
prerank,positive regulation of MAP kinase activity (GO:0043406),0.35428451899828645,0.9464669661059137,0.5991379310344828,0.9467936504459923,1.0,7/66,3.95%,FGF18;EGFR;FGFR1;VEGFA;FGF2;MST1R;TAOK3
prerank,heterochromatin organization (GO:0070828),0.4376692619764132,0.9462431695268215,0.5511288180610889,0.946830564760523,1.0,8/14,26.04%,LOXL2;POLE3;SETD7;EZH1;BAHD1;SETDB1;SETDB2;HP1BP3
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.3517941555719887,0.9459940974239103,0.5821052631578948,0.9469059586305544,1.0,10/70,9.97%,NCF4;PSMC4;ITGB5;SEC22B;PSMC6;LNPEP;CHUK;PSMD8;SNAP23;ITGAV
prerank,snRNA processing (GO:0016180),0.43913145919972657,0.9458883471116238,0.5425257731958762,0.946624084107587,1.0,5/16,18.86%,INTS3;INTS10;INTS6;INTS2;INTS12
prerank,regulation of gene silencing by RNA (GO:0060966),0.3637238302096311,0.9458303599930654,0.5808903365906624,0.945732247183693,1.0,20/50,27.65%,POLR2H;NUP93;TRIM71;NUP107;NUP98;AGO2;PUM1;POLR2D;POLR2G;NUP37;NUP50;TPR;TNRC6A;POLR2C;NUP85;NUP133;NUP188;EIF4G1;NUP88;AGO1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.3637238302096311,0.9458303599930654,0.5808903365906624,0.945732247183693,1.0,20/50,27.65%,POLR2H;NUP93;TRIM71;NUP107;NUP98;AGO2;PUM1;POLR2D;POLR2G;NUP37;NUP50;TPR;TNRC6A;POLR2C;NUP85;NUP133;NUP188;EIF4G1;NUP88;AGO1
prerank,proteasomal protein catabolic process (GO:0010498),0.33334750697056215,0.9456629952890061,0.6355421686746988,0.9456046910728235,1.0,62/201,26.18%,UCHL1;PSMC4;UBE2B;SPSB1;SPSB4;NFE2L2;SMURF2;SYVN1;ITCH;TRIM71;RAD23B;NR1D1;RMND5B;RCN3;COP1;PSMC6;SPSB2;STUB1;UBE2W;SIAH1;PSMD8;SIRT2;CUL3;HECW2;UBE2A;CDC34;DDB1;RNF216;ZSWIM8;RBCK1;RNF187;SOCS6;KCTD2;HACE1;PML;UBE2G1;PCNP;SKP2;UBE2D3;FBXL19;KCTD10;RNF41;ARRB1;SMURF1;KLHL22;FBXW11;UBXN11;SPSB3;DERL1;SEL1L;IFI27;UBXN6;PSMD4;PSMD3;MDM2;AGAP3;KAT5;FBXW7;UBE2K;DDIT3;RNF126;PSMB3
prerank,negative regulation of receptor internalization (GO:0002091),0.4484512665018917,0.9454331890831491,0.5304964539007092,0.9456410698993145,1.0,2/12,7.68%,DLG4;ATXN2
prerank,cellular response to interleukin-1 (GO:0071347),0.33365737214274294,0.945430373620753,0.6129685916919959,0.9451281711076678,1.0,22/143,13.85%,HAS2;CCL8;PSMC4;IRAK3;USP10;NR1D1;PSMC6;PELI3;RC3H1;UBE2N;CHUK;PSMD8;CCL25;MAPK11;SIRPA;SQSTM1;CD47;IRAK4;IRAK1;UBA52;CCL13;ZC3H12A
prerank,regulation of neuron projection development (GO:0010975),0.33178497430763176,0.9448752230752206,0.6295546558704453,0.9459124972765136,1.0,34/163,13.45%,DBN1;ARHGAP44;NPTN;EPHA3;PTPRS;S100A9;LPAR1;PPFIA2;NDEL1;TENM3;RET;RIT2;STX1B;ABL2;FRMD7;SEMA3A;NDRG4;MYLIP;RTN4IP1;PSEN1;SRCIN1;EPHB3;TSKU;KANK1;TWF1;FUT9;AKT1;AVIL;MAGI2;TANC2;KIDINS220;RTN4RL1;CBFA2T2;P3H1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.3757768578349511,-0.9444703709217201,0.5051903114186851,0.8350807433805043,1.0,4/11,10.95%,WTIP;PUM2;XPO5;AJUBA
prerank,negative regulation of protein binding (GO:0032091),0.352106727431324,0.9444407619598255,0.5972369819341127,0.9464599966088462,1.0,15/71,14.84%,DACT1;GNL3L;CARD16;PTPRF;TFIP11;USP33;AKT1;SLPI;DNAJB2;ATP2A2;ADAM15;CDKN1A;PIN1;DDX11;GTF2F1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.32976578680258417,-0.9443761694754557,0.5141700404858299,0.8335505628606119,1.0,7/16,18.52%,ATP5F1C;ATP5F1D;ATP5F1E;ATP5MG;ATP5PD;ATP5MC2;STOML2
prerank,cholesterol homeostasis (GO:0042632),-0.23420834893940648,-0.9441213738956269,0.5789473684210527,0.8324364888006986,1.0,12/64,11.89%,CYP7B1;GRAMD1B;APOE;SCARB1;TTC39B;NR1H3;CAV1;ABCG1;LDLRAP1;EPHX2;SIRT1;FGFR4
prerank,positive regulation of type 2 immune response (GO:0002830),0.43541726251350016,0.943877210262591,0.5298013245033113,0.9473156663905601,1.0,6/14,25.13%,CD81;IL4;IL6;IL18;RARA;PRKCZ
prerank,positive regulation of cyclase activity (GO:0031281),-0.34164752052816516,-0.9431413612239878,0.5357142857142857,0.8331713991908376,1.0,5/14,12.81%,NOS3;CACNA1D;MAPK8;NOS1;MAPK3
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.4238958504102037,0.942966215758229,0.5712484237074401,0.9489333892750298,1.0,5/18,16.78%,SLC25A31;ALKBH7;SLC25A4;BAK1;SPG7
prerank,mitotic nuclear division (GO:0140014),0.3458276125912256,0.9417464096645388,0.6078224101479915,0.9513438200772851,1.0,15/71,14.53%,NDEL1;CHMP7;ZW10;KIFC2;TOGARAM1;ZWINT;KIF2A;ARHGEF10;SMC1A;PIBF1;RHOA;KIF3B;ABRAXAS1;INO80;CTDP1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.34373055544583114,0.9417188432151816,0.5966386554621849,0.9508996408893527,1.0,15/74,15.09%,AR;SCRT2;MAPK7;TMBIM1;ACVR1;TCF7L2;SRC;PELI3;EYA2;ITGAV;GPX1;AKT1;GDNF;SNAI2;IL4
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.45088456790563536,0.9416806405186777,0.5289256198347108,0.9504718836292934,1.0,2/12,10.81%,B3GALNT1;B3GNT8
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.37193880769316334,0.9415829473480143,0.5661680092059839,0.9501815684010511,1.0,11/37,22.52%,MAPK14;IL17RA;TLR4;SIRPA;ZC3H12A;PER1;PDCD4;IL6;PYCARD;CUEDC2;CHID1
prerank,Golgi to endosome transport (GO:0006895),-0.32949306178080406,-0.9415528786295942,0.5140562248995983,0.8354988692940427,1.0,4/16,13.58%,SORT1;VPS13A;DOP1B;EPS15
prerank,lipid droplet formation (GO:0140042),-0.3719743938690635,-0.9413733799804215,0.5147058823529411,0.8341722241289533,1.0,4/10,21.00%,ZFYVE1;PLA2G4C;FITM2;CDS2
prerank,striated muscle cell development (GO:0055002),-0.3327212646069143,-0.9413008054497022,0.5142857142857142,0.8326145889268384,1.0,2/14,6.37%,PGM5;TMOD3
prerank,protein acylation (GO:0043543),0.3731446049702197,0.9411370969630345,0.5520361990950227,0.9507336611531408,1.0,13/38,23.66%,ZDHHC16;ZDHHC7;FOXO1;KAT2B;HHAT;ING4;SELENOK;ZDHHC2;ZDHHC21;ZDHHC20;ZDHHC18;ZDHHC8;ZDHHC5
prerank,positive regulation of leukocyte migration (GO:0002687),0.39550847146316803,0.9406767604827536,0.5678271308523409,0.9513291680919098,1.0,7/27,16.45%,VEGFA;MIA3;JAM3;TNFRSF18;PLVAP;IL4;IL6
prerank,cellular macromolecule catabolic process (GO:0044265),0.3604488950076774,0.9404157070872873,0.5600436681222707,0.9514358592909401,1.0,18/49,25.15%,FBXO2;OGA;FBXO17;HNRNPD;UBE2G2;EXOSC7;SIDT2;RNASE6;DNASE1L2;NGLY1;HTRA2;IDE;UBE2G1;SUPV3L1;RAB12;DFFB;RNASEH2C;DNASE1L1
prerank,response to nitric oxide (GO:0071731),0.4440026161875301,0.9401617039984136,0.5624161073825503,0.9515175358512468,1.0,4/13,14.97%,FOXO1;DPEP1;MTR;KCNC2
prerank,positive regulation of exocytosis (GO:0045921),0.37139560968508667,0.9401161772058662,0.5534665099882491,0.9511067249239977,1.0,12/35,26.71%,SMPD3;VPS4B;RAB3D;ATP6AP1;RAB27B;RAB2B;CLASP2;PDCD6IP;SDCBP;STAM;SDC4;CFTR
prerank,cellular response to ATP (GO:0071318),0.4358807095697515,0.9400763879872159,0.5521796565389696,0.9506915991979052,1.0,2/14,10.62%,P2RX3;SSH1
prerank,protein ubiquitination (GO:0016567),0.32449378476643503,0.9399426669418288,0.726,0.95050646129553,1.0,167/471,28.26%,SH3RF3;WSB1;TSPAN17;MIB2;PSMC4;UBE2B;NEUROD2;SPSB1;HECTD2;SPSB4;NFE2L2;UBA6;SMURF2;UBE2J2;FBXW8;SYVN1;ITCH;TRIM71;RFWD3;RBBP6;MSL2;RNF111;GAN;PSMC6;PELI3;SPSB2;RC3H1;STUB1;LNPEP;MYCBP2;UBE2W;FBXO2;UBE2N;MYLIP;FANCL;SIAH1;PSMD8;FBXO17;CUL3;DTL;FBXL2;FBXW4;UBE2G2;ASB12;HECW2;FBXL20;RNF10;TRIM11;CDC23;PHC1;FBXO31;RNF141;RNF7;UBE2A;THOP1;CDC34;NPEPPS;UNKL;UBA52;USP5;BSPRY;DDB1;CDC27;FBXO28;FBXL3;CBL;PEX12;CUL9;AMFR;USP7;TRPC4AP;UHRF2;SELENOS;KLHL41;RNF14;USP22;UVSSA;ZSWIM8;RBCK1;TRIM68;RNF187;RNF138;KEAP1;HACE1;FBXL5;UBE2G1;PEX5;FBXO11;ARIH2;UBE2R2;VPS11;PCNP;NEDD8;BRAP;SKP2;RNF19A;LRSAM1;TRIM35;UBE3C;TPP2;ARIH1;UBE2D3;FBXL19;CUL5;KCTD10;FBXW9;RNF41;FBXW2;ATG3;ARRB1;RC3H2;PEX2;PAF1;SMURF1;KLHL22;DTX2;KLHL9;FBXW11;UBE2Q2;SDE2;FBXO24;DERL1;LZTR1;UBE3A;UBR2;RNF6;UBE2Z;RNF114;TRIM36;RNF157;RTF1;RNF13;TRIM24;PSMD4;FBXL12;PSMD3;TRIM44;MDM2;MKRN2;RNF166;FBXO22;VHL;FBXW7;FBXO30;ZNRF2;RNF20;UBE2K;RNF167;RNF126;PSMB3;KLHL12;MUL1;PRPF19;RNF31;CUL7;OTULIN;PRKDC;VCPIP1;EIPR1;DTX3;BCL10;UBE3B;FBXO41;CUL1;TOPORS;PSMB2;PSMD5
prerank,negative regulation of protein kinase activity (GO:0006469),0.3400636976166679,0.9398965276878581,0.6024716786817713,0.9500931714849512,1.0,21/88,18.18%,LRP6;TARBP2;ADARB1;CAMK2N1;WWTR1;DTNBP1;RTRAF;YWHAG;GSKIP;SRCIN1;INPP5K;NPM1;AKT1;DEPTOR;SFN;SMCR8;CDKN1A;CHP1;CEP85;PPIA;QARS1
prerank,contractile actin filament bundle assembly (GO:0030038),0.4344569394035209,0.9398189639139689,0.5684210526315789,0.949237843076349,1.0,6/15,13.40%,ITGB5;FHDC1;SRC;CUL3;PDLIM1;RHOA
prerank,stress fiber assembly (GO:0043149),0.4344569394035209,0.9398189639139689,0.5684210526315789,0.949237843076349,1.0,6/15,13.40%,ITGB5;FHDC1;SRC;CUL3;PDLIM1;RHOA
prerank,regulation of lipid kinase activity (GO:0043550),0.46453774352327704,0.9396038259459367,0.5628491620111732,0.9492539089801522,1.0,2/11,8.14%,PIK3R2;WDR91
prerank,cation transport (GO:0006812),0.33157621034818635,0.9395845013360516,0.6268806419257773,0.9487831233821358,1.0,24/167,14.25%,KCNK5;SCNN1B;SLC5A9;PIEZO2;KCNMA1;KCNV1;FGF13;SLC7A6;ATP1A4;SLC47A1;KCNJ2;SLC11A2;KCNK9;CNGB1;HCN4;KCNA2;KCNA6;SLC4A4;KCNAB3;NDFIP1;SLC23A1;CATSPER3;KCNJ3;SLC8A2
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.38173423696048997,0.9395022134438303,0.5474189675870348,0.9484393676307012,1.0,6/27,18.81%,F2R;LPAR1;GPR20;CALCA;GRM1;HTR2C
prerank,T-helper cell differentiation (GO:0042093),0.43958100713536624,0.9393735534243421,0.5317997293640054,0.9482298112008838,1.0,4/14,16.45%,TMEM98;FOXP1;IL4;IL6
prerank,positive regulation of lymphocyte activation (GO:0051251),0.39552980495273055,0.939332990237058,0.5815347721822542,0.9478082665262733,1.0,11/28,29.22%,SIRPA;CD47;IL6;PYCARD;TNIP2;TICAM1;CCDC88B;FGF10;PRKDC;XRCC6;SH3KBP1
prerank,regulation of cell cycle phase transition (GO:1901987),0.3406447045936744,0.938648547513539,0.5952626158599382,0.9489208286338084,1.0,16/91,17.75%,MN1;PSMC4;ATP2B4;PSMC6;PSMD8;CDC23;FBXO5;ANAPC5;ERCC3;DDB1;CDKN1A;CDC27;DBF4;TFAP4;CDC26;ANAPC4
prerank,activation of adenylate cyclase activity (GO:0007190),-0.257084443080721,-0.9384464309209378,0.5933333333333334,0.8380712823229717,1.0,6/35,8.72%,ADCY5;ADCY1;CAP2;ADCY4;EDNRA;ADCY9
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.35980468636941,0.9384158385604796,0.5835140997830802,0.9489375400684235,1.0,7/53,7.32%,GLMN;DESI1;PKD1;RHBDF1;RAD23B;PSMC6;UCHL5
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.3264229887329938,-0.9383821403802193,0.5466101694915254,0.8364858369542832,1.0,7/17,18.52%,ATP5F1C;ATP5F1D;ATP5F1E;ATP5MG;ATP5PD;ATP5MC2;STOML2
prerank,regulation of inflammatory response (GO:0050727),0.32536890488884596,0.9377752626932795,0.6492985971943888,0.9498795254008852,1.0,39/190,19.40%,MGLL;ANXA1;IL16;MAPK7;FOXP1;S100A8;S100A9;AKNA;METRNL;SPATA2;NR1D2;MVK;IL33;NR1D1;IL17RA;DAGLA;TLR4;SIRPA;FNDC4;BCL6;CD47;TNIP1;LRRC19;ABCC1;CD200R1;TNFRSF1B;KLF4;IL4;DAGLB;LRFN5;SELENOS;PDCD4;IL6;UFL1;SNX6;IL18;VAMP2;IFI35;RORA
prerank,regulation of oxidoreductase activity (GO:0051341),0.44478157788680983,0.9376763242704945,0.5590969455511288,0.9495956682531194,1.0,2/13,7.51%,HDAC6;ABL2
prerank,positive regulation of histone modification (GO:0031058),0.3783157104810757,0.937418521107961,0.5834319526627219,0.9497101935312972,1.0,10/33,21.48%,UBE2N;CDK9;BRD7;AKAP8;NIPBL;GLYR1;CTBP1;AKAP8L;ARRB1;PAF1
prerank,neuron projection fasciculation (GO:0106030),0.4576624399100315,0.9372723439958736,0.5619047619047619,0.9495542810024236,1.0,2/10,9.69%,EPHB2;EPHB3
prerank,hexose biosynthetic process (GO:0019319),0.3631863055493642,0.9367993169600974,0.5795454545454546,0.9501413676748925,1.0,3/42,3.76%,AKR1B1;SLC39A14;CRTC2
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.3195005689433337,-0.936015722162073,0.5323383084577115,0.8407007415620603,1.0,6/18,14.36%,DAB2IP;FTH1;SFRP1;PARP10;CD300A;TRIM32
prerank,DNA double-strand break processing (GO:0000729),0.4100498239553475,0.9356262764547462,0.5719745222929936,0.9524706424697358,1.0,6/18,18.50%,UBE2N;DNA2;NBN;RNF138;RAD50;BLM
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.31177780061713756,-0.935534590553847,0.5454545454545454,0.8402395878989132,1.0,8/21,22.90%,HK2;DERA;PGLS;TALDO1;RBKS;RPE;GPI;RPIA
prerank,regulation of sprouting angiogenesis (GO:1903670),0.36860548634991197,0.9353201142521719,0.5679723502304147,0.9526310558930066,1.0,6/33,5.00%,FGF18;VEGFA;FGF2;ITGA5;CREB3L1;KLF2
prerank,cellular response to hydroxyurea (GO:0072711),0.4604445391111128,0.9350264971662078,0.5671852899575672,0.9527839637829034,1.0,5/10,28.93%,DDX11;SPIDR;BLM;NSMCE3;ATRX
prerank,histone lysine methylation (GO:0034968),0.37309605227864656,0.9346893130476349,0.574095682613769,0.9530769959070244,1.0,15/33,28.16%,CXXC1;DPY30;WDR5;EHMT2;KMT2A;PRDM9;SETD1B;N6AMT1;EZH2;SETDB1;SETDB2;WDR5B;MEN1;PRDM5;SUV39H1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.44593462672969364,0.9346841941616837,0.5532786885245902,0.9525807496906703,1.0,3/12,11.97%,WDTC1;ACADVL;PIBF1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.32049578928887595,-0.9346840849074595,0.5652173913043478,0.8407876812203334,1.0,7/19,9.55%,MEF2C;RBP4;VGLL4;NOTCH1;TGFBR3;FGFR2;TBX2
prerank,cellular protein modification process (GO:0006464),0.3182772862687926,0.9345727767204856,0.819,0.9523098862216983,1.0,270/982,25.69%,PLOD2;COL3A1;IGFBP5;FSTL1;SYK;FBN1;LORICRIN;LOXL2;PARP3;WSB1;DCLK1;ST3GAL2;PRKCA;ANXA1;TIMM50;TNK1;CEL;FGFR1;STK25;RABGGTA;EIF2AK3;CDC14B;GPC3;PSMC4;PRSS23;B3GALNT1;CDKL2;FYN;IRAK3;SPSB1;TGFB2;SGK3;SGK2;CDK14;LMTK3;SPSB4;PIGT;TGFBR2;PTPRS;FUT2;TAOK3;GPAA1;ACVR1;IGFBP4;ART4;COPS5;CDK4;BMP15;FBXW8;CALU;KRT10;GGCX;VCAN;MGAT1;MTOR;MIA3;PTPRJ;CAMK2D;SOCS2;PHKA2;WDTC1;CCDC8;CSK;COP1;TULP4;ILKAP;GAN;ARF4;PSMC6;PTPRF;RET;TBCK;SPSB2;MELTF;PARP6;ABL2;PRKD2;GAS6;STRADA;FBXO2;OGA;TNNI3K;CHUK;PPP5C;TESK2;CDK9;PSMD8;SIRT2;FBXO17;CUL3;DUSP11;CTDSP2;DTL;PPM1G;SENP8;AKT3;CDK20;FBXL2;FBXW4;ASB12;LOXL1;NRBP2;WIPI2;LGALS1;BMP2K;FBXL20;ALG1;LARGE1;RAB2A;ERN1;WDR45B;DYRK2;SSH1;WDR5;FUT9;B3GNT8;PARP14;ZC3HAV1;AMHR2;PPP3CC;CSNK1G3;MAP3K6;CAMKK2;AKT1;FBXO31;HS3ST5;DCAF6;RNF7;IRAK1;PPEF2;ST3GAL4;STK39;PASK;PXK;CDC34;UBA52;PIGS;DDB1;TAOK2;P3H1;FBXL3;CUL9;DCAF13;ASB8;ULK1;PIGK;RCE1;STK24;STK3;FER;PPP3CA;CTDP1;TRIOBP;PPP2R1B;MTMR6;MXRA8;DCAF10;EVPL;NGLY1;KLHL41;SDC2;PPP1CC;IL6;B3GALNT2;SOCS6;KEAP1;NEK4;UFL1;PTPN5;PPP2R5B;FBXL5;ST3GAL3;CHRDL1;RAB1B;FBXO11;ST3GAL1;ILK;PDP2;ADPRH;TGFBR1;GMFB;METAP2;STK38;LOX;COPS4;LAMC1;PPP2R2A;SDHAF2;NEDD8;NEK7;SKP2;PPP3CB;PTPN3;DDOST;HIPK3;UBE2D3;FBXL19;CTBP1;KCTD6;QSOX1;OXSR1;STK26;CUL5;ACVR2A;PPM1A;FBXW9;FBXW2;PRKCSH;MAPK1;BMPR1A;PTEN;YES1;PPP6C;SRPK1;ATG3;METAP1;METAP1D;ICMT;CSF1;KLHL22;KLHL9;FBXW11;SUMF2;CDKL4;BRD2;SPSB3;OGFOD1;CSNK1G2;JMJD7;PTPN18;PICK1;CDC25B;DCAF5;ATG10;CTDSP1;FUT10;LHPP;FAM20B;VRK2;UST;PSMD4;KLHL11;LATS1;BCR;WNK2;ACVR1B;FBXL12;PSMD3;STK10;GPS1;MMP15;MTM1;CDKL1;MARK2;RABGGTB;DNAJC3;RARA;NRBP1;PRKCZ;FBXO22;HSP90B1;VHL;FBXW7;FBXO30;SERPINC1;NEK1;RAB1A;UBA7;CTH;PARP16
prerank,regulation of pseudopodium assembly (GO:0031272),0.4584674705420053,0.9345098275371085,0.5854700854700855,0.9514300345678819,1.0,1/10,3.30%,CDC42EP2
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.4584674705420053,0.9345098275371085,0.5854700854700855,0.9514300345678819,1.0,1/10,3.30%,CDC42EP2
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.34068798741459116,-0.9343650527889666,0.5426008968609866,0.8398775473543884,1.0,7/15,23.01%,RPS7;DTX3L;RPL5;ABL1;MAD2L2;BAG2;MAD2L1
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.3721383001928311,-0.9338209394447645,0.5226480836236934,0.8394798244307501,1.0,2/10,8.76%,RAPGEF2;CTNS
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.32830541859010537,0.933602569974065,0.6198179979777553,0.9530328544308888,1.0,19/151,13.15%,ACKR3;CCL8;PRKCA;EGFR;CD44;FGF2;PDE8A;F2R;MIF;ADCYAP1;PRKD2;GAS6;NDRG4;TIRAP;CCL25;GPNMB;PDGFRA;ATP6AP1;CCL13
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.4183498285523115,0.933161823846861,0.5657216494845361,0.9535225623273067,1.0,7/18,26.70%,SYVN1;EDEM2;UBA52;AMFR;UGGT1;SEL1L;UGGT2
prerank,regulation of cell death (GO:0010941),0.33398800789183886,0.9329816561011878,0.6217616580310881,0.9534287085070872,1.0,28/94,28.09%,SNCB;LRP1;CCN5;SRSF6;FGF2;PDE8A;VPS4B;TNFRSF1B;ZC3H12A;DCC;CHP1;NCK1;CHRNA7;SARM1;SRGAP2;EPHB1;RRAS2;DUS2;CRYAB;CCN3;NOA1;RAB29;PARP16;EIF4G1;ADNP2;CELF1;TSC1;IMPACT
prerank,cellular response to decreased oxygen levels (GO:0036294),0.34598244394687355,0.9329293444607201,0.5982721382289417,0.9530295211517893,1.0,15/65,15.93%,ANGPT4;VEGFA;LMNA;ZFP36L1;MTOR;CARD16;MDM4;EGLN2;STUB1;TIGAR;SIRT2;NPEPPS;TWIST1;CPEB1;NOP53
prerank,response to amino acid (GO:0043200),0.3827880759432734,0.9329147567626909,0.5737704918032787,0.9525474118207611,1.0,9/31,23.18%,CAPN2;MTOR;MEAK7;NSMF;RRAGD;CPEB1;IPO5;SESN2;SLC38A9
prerank,translation (GO:0006412),0.32654774574451567,0.9328988373833257,0.669,0.9520673814769925,1.0,78/208,31.40%,RPSA;MRPS11;RRBP1;EEF2K;COPS5;MRPS18B;MARS2;ABCE1;IGHMBP2;GTPBP2;FTSJ1;MRPL13;MRPS17;AGO2;TARS1;GSPT2;RPL10A;TNIP1;MRPL10;SARS2;MRPL55;UBA52;RPS5;MRPL36;VARS1;MRPL3;GSPT1;RPL6;MRPS34;GARS1;MRPL51;HARS1;EEF1B2;EEF1E1;EEF1G;ABCF1;EPRS1;QARS1;AIMP1;RPL22L1;RPL23;RPL17;N6AMT1;RWDD1;RPS25;QRSL1;RSL24D1;NOA1;AIMP2;RPL22;NARS1;ASMT;APEH;PPA1;EIF4G1;EIF4EBP2;MRPL34;YARS1;EEF1D;RPL34;TMA7;RPS29;HBS1L;SARS1;RPS26;PPA2;DARS1;IGF2BP3;RPS15;RPLP2;RPS20;RPL31;AARS1;LARS2;RPS28;MRPL23;RPS6;WARS2
prerank,bile acid biosynthetic process (GO:0006699),0.3965899488016503,0.9322745780343462,0.5640718562874252,0.9529850884953037,1.0,5/24,10.09%,OSBPL3;OSBPL2;SCP2;HSD3B7;OSBPL6
prerank,long-term memory (GO:0007616),0.4094150692958881,0.9317834643392777,0.56,0.9535913114016816,1.0,11/19,36.70%,RASGRF1;NFATC4;LDLR;NPAS4;PRNP;CAMK4;CALB1;SHANK1;CPEB3;EIF2AK4;PJA2
prerank,negative regulation of phagocytosis (GO:0050765),-0.32440368206493986,-0.9317339787597734,0.5482456140350878,0.8427051008444727,1.0,4/17,4.47%,HMGB1;PLSCR1;DYSF;SNX3
prerank,protein phosphorylation (GO:0006468),0.32207015672718237,0.9309813111326993,0.758,0.9549428324007466,1.0,80/478,14.48%,SYK;DDR2;EPHB2;SRMS;DCLK1;PRKCA;EGFR;TNK1;FGFR1;STK25;MAPK12;EIF2AK3;RPS6KA2;EPHA3;CDKL2;FYN;DYRK4;GTF2H3;IRAK3;DGKQ;TGFB2;SGK3;SGK2;CDK14;LMTK3;TGFBR2;TAOK3;MAPK14;PKD1;ACVR1;EEF2K;CDK4;MTOR;CAMK2D;CSK;MAST4;SRC;RET;TBCK;ABL2;PRKD2;GAS6;STRADA;ABI1;SLK;TNNI3K;CHUK;TESK2;CDK9;AKT3;TLR4;CDK20;EPHB3;NRBP2;BMP2K;MUSK;ERN1;DYRK2;CSNK1G1;AMHR2;CSNK1G3;MAP3K6;CAMKK2;AKT1;STK16;IRAK1;STK39;PASK;PXK;ULK2;PDGFRA;TAOK2;FLT3;HIPK4;CCNH;ULK1;DDR1;STK24;STK3;FER
prerank,regulation of MAPK cascade (GO:0043408),0.3267343466412687,0.930946473790043,0.6683569979716024,0.9545113850433667,1.0,28/157,16.64%,SYK;LIF;MYOC;EGFR;FGFR1;FGF2;F2R;PIK3R2;TMEM106A;LPAR1;TAOK3;PTPRJ;RET;RIT2;DHX33;IQGAP1;PRDM15;EGF;GPR37L1;PPEF2;TAOK2;FLT3;GPR37;STK3;MAP2K2;NBR1;IL6;IAPP
prerank,protein autophosphorylation (GO:0046777),0.3273986761683396,0.9307037627339364,0.657258064516129,0.9545825311274635,1.0,31/157,14.48%,DDR2;SRMS;EGFR;TNK1;FGFR1;STK25;EIF2AK3;TAOK3;EEF2K;MTOR;CAMK2D;SRC;PRKD2;SLK;EPHB3;MUSK;ERN1;CAMKK2;AKT1;STK16;IRAK1;STK39;PASK;ULK2;PDGFRA;TAOK2;FLT3;ULK1;DDR1;STK24;FER
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.31804290697366694,0.9305630962449346,0.76,0.954416422591131,1.0,78/509,14.35%,DCN;LIF;AREG;MYOC;CD80;FGF18;ESR1;AXL;FGF7;EGFR;IRS1;FGFR1;AKAP13;MIB2;BTC;FYN;NEUROD2;VEGFA;FGF2;TGFB2;MST1R;ECM1;F2R;S100A8;S100A9;MIF;PIK3R2;TMEM106A;LPAR1;MID2;P2RX3;TCF7L2;PTPRJ;CARD16;CGAS;C1QBP;SRC;RET;RIT2;FLCN;DHX33;PRKD2;TFG;GAS6;UBE2N;FLT3LG;CHUK;TIRAP;PPP5C;PIK3CA;SIAH1;IQGAP1;TLR4;LGALS1;ITGAV;HDAC3;IRAK4;DDX21;EGF;PUM1;BMF;GPR37L1;IRAK1;BBC3;IRS2;LRRC19;CD27;NDFIP1;SMCR8;PDGFRA;TRAF3IP2;FLT3;RHOA;CBL;GPR37;RRAGD;CD14;MAP3K14
prerank,potassium ion transmembrane transport (GO:0071805),0.3301963820122112,0.9298748764396711,0.6413373860182371,0.9554979964444618,1.0,26/135,16.13%,KCNK5;KCNT2;HPN;KCNV1;SLC12A8;ATP1A4;ATP1A3;ATP1A1;KCNJ2;SLC9A9;KCND1;SLC12A4;ABCB8;PKD2;KCNK13;KCNK9;HCN4;KCNA2;KCNA6;SLC9A1;KCNAB3;SLC12A5;KCNJ3;KCNC2;SLC9A6;SLC9A7
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.33266024086231144,0.9298232186113791,0.6435137895812053,0.9550977618185706,1.0,40/119,25.38%,TTC7A;FGF2;PIK3C2B;PIK3R2;SOCS2;PIGZ;PI4K2B;FIG4;PIK3CA;OCRL;INPP5F;ARF1;PIGC;INPP5K;PLEKHA4;MPPE1;PIGW;RUFY1;MBOAT7;INPP4A;PLEKHA1;PI4KB;PIGM;MTMR6;PI4KA;MTMR1;SOCS6;PIP4K2C;CDIPT;PIP4K2B;IP6K1;PITPNM1;PTEN;PIK3CG;PI4K2A;PIGL;DPM2;TTC7B;MTM1;SLC27A1
prerank,peptide hormone secretion (GO:0030072),0.3871296612418574,0.9290453972401445,0.583232077764277,0.9563773092011746,1.0,5/26,19.18%,ANXA1;ADCYAP1;CRHR1;IL6;RIMS2
prerank,response to amyloid-beta (GO:1904645),0.3591832529945084,0.9290307608057519,0.5885650224215246,0.9558993500566781,1.0,11/44,17.68%,LRP1;MMP2;FYN;ATP1A3;PSEN1;TLR4;ABCC1;CACNB1;GRIN2A;CHRNA7;SNX6
prerank,peptidyl-lysine dimethylation (GO:0018027),0.4152915100171803,0.9284875438128076,0.5786082474226805,0.956609291077051,1.0,6/18,19.93%,SETD7;SETD2;EHMT2;KMT2A;PRDM9;SETD1B
prerank,neuron migration (GO:0001764),0.35724826809694354,0.9282358177449844,0.5919037199124726,0.9566557742323856,1.0,8/48,8.20%,NAV1;MAP1B;FGFR1;VEGFA;FGF13;POMGNT2;LRP12;SEMA3A
prerank,negative regulation of cellular senescence (GO:2000773),-0.33744786450391334,-0.9280079609394145,0.5576208178438662,0.8503940351809492,1.0,8/13,23.56%,SLC30A10;CDK6;MAP3K3;SIRT1;TERT;RBL1;TERF2;HMGA2
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.36884318054323756,-0.9278802559762709,0.47924528301886793,0.8489591134185598,1.0,4/10,29.27%,CAV1;KCNE4;ANK3;KCNAB1
prerank,regulation of endocytic recycling (GO:2001135),0.4504986675405004,0.9277715584873826,0.573187414500684,0.9571975473753682,1.0,4/11,15.10%,ATP9A;INPP5F;EHD2;PLA2G4E
prerank,prostaglandin metabolic process (GO:0006693),0.38993311680346643,0.9275943275020438,0.5813953488372093,0.9570860498842607,1.0,6/26,15.53%,CYP2S1;MIF;PTGR1;PNPLA8;DAGLB;ACOX1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.4118039829877683,0.9270429532545525,0.5643203883495146,0.957810893859125,1.0,7/20,12.88%,KCNMA1;ATP1A4;ATP1A3;ATP1A1;KCNJ2;SLC9A1;ATP6AP1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.3792644561926446,0.9265180761073345,0.5836341756919374,0.9585463242193976,1.0,4/29,13.00%,PKP3;TENT5B;LARP1;GDNF
prerank,vesicle transport along actin filament (GO:0030050),-0.3051035696221876,-0.9264717939146807,0.5336322869955157,0.8506106751203081,1.0,7/19,19.86%,MYO1B;FNBP1L;MYO1D;MYO5B;MYO19;ACTN4;MYO5C
prerank,regulation of myelination (GO:0031641),0.3911936881276852,0.9264046626705098,0.5825242718446602,0.9583171655755751,1.0,6/25,13.76%,EIF2AK3;TMEM98;ZPR1;SIRT2;RNF10;TNFRSF1B
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.32242705132058974,0.9261712025758507,0.708124373119358,0.9583729072777782,1.0,92/259,28.06%,GSN;NME8;PMP22;CDC14B;EMP3;EMP1;ABLIM1;PKD1;RAB23;RAP1B;FHDC1;S1PR2;FSCN1;ARF4;ACTR3;NTN1;HDAC6;BBS9;ATAT1;ARL13B;TMEM138;FXYD5;CPLANE1;OCRL;EHD2;CNGB1;INPP5K;NUDCD3;DZIP1;TTC39C;AVIL;TEKT5;VSTM5;PIBF1;KIF3A;DYNC2I2;RPGR;KIF3B;IFT46;TTLL3;BBS4;TTC8;ARF6;ATP6V1D;AHI1;PPP1R9B;DYNC2H1;SRGAP2;CEP164;CEP89;SHTN1;CCDC28B;DYNC2I1;CEP83;RP2;BBS5;IFT52;BBIP1;EXOC4;CC2D2A;STK26;SPAG16;FLNA;PCM1;DNAH5;FBF1;TMEM231;SDCBP;CCDC88A;PDE6D;TCTN2;RAB11FIP3;DMTN;DYNLL1;TCTN1;RAC1;CDC14A;CEP126;CYFIP1;NEK1;RAB1A;CFAP70;GBF1;RAB8B;ARHGEF7;IFT81;SPATA13;RAP1A;FUZ;RAP2B;PTPN23;PTPDC1
prerank,positive regulation of cell cycle process (GO:0090068),0.3349121046634618,0.9261416057562798,0.628099173553719,0.9579399819216342,1.0,18/91,14.97%,GPSM2;CDC14B;BTC;XRCC3;SVIL;DYNC1LI1;RHNO1;SIRT2;CUL3;EGF;KIF20B;NUDT16;RHOA;DDX11;DBF4;INO80;DYNC1H1;GIPC1
prerank,nitric oxide metabolic process (GO:0046209),-0.32991011080565913,-0.9259093466112697,0.5573122529644269,0.8501461233127499,1.0,4/14,12.28%,NOS3;GCH1;NOS1;SPR
prerank,intracellular protein transmembrane transport (GO:0065002),0.3621238561267206,0.9259014612777612,0.5812154696132596,0.9579927737644712,1.0,12/42,25.43%,TIMM50;PEX16;GRPEL2;PEX12;SEC63;PEX1;SEC61A1;PEX5;TIMM17A;PEX2;SEC61B;TOMM40
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.3534740088361437,-0.9257965905854362,0.5524193548387096,0.84868327630671,1.0,3/12,8.83%,DPYD;CTPS1;CTPS2
prerank,cranial nerve development (GO:0021545),-0.3590111179898439,-0.9256811868441618,0.5773584905660377,0.8472681711466461,1.0,2/11,6.58%,CHD7;SALL1
prerank,regulation of protein polymerization (GO:0032271),0.3691872429117989,0.925594335588628,0.6002331002331003,0.9581855522510073,1.0,13/35,21.89%,DBN1;MAPRE3;PFN2;CAMSAP1;GBA2;MAPT;TPPP3;FCHSD1;HSP90AA1;COTL1;RASA1;ABITRAM;CTTN
prerank,regulation of DNA damage checkpoint (GO:2000001),0.4573499241500997,0.9252631740795483,0.5816618911174785,0.9584285562103725,1.0,3/10,14.78%,RFWD3;ETAA1;THOC1
prerank,zinc ion transport (GO:0006829),0.3968436398717627,0.9251219217459579,0.5753424657534246,0.9582475053837738,1.0,6/21,20.02%,SLC39A14;SLC39A13;SLC39A7;SLC30A9;SLC30A5;SLC39A3
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.3455917194184893,0.9245792051793831,0.6285714285714286,0.9589878147484614,1.0,12/60,16.46%,HNRNPA1;FGF2;SMOC2;PRKD2;ACD;POLG2;CCT7;XRCC5;KLF4;HSP90AA1;RFC4;HGF
prerank,peptidyl-lysine acetylation (GO:0018394),-0.36387903394858884,-0.9244863081489503,0.5420875420875421,0.8484371619175577,1.0,3/10,11.60%,CREBBP;SIRT1;EP300
prerank,fatty acid transport (GO:0015908),-0.31615258372327865,-0.9241909843959413,0.555045871559633,0.8474744880681363,1.0,2/17,2.52%,ACSL1;APOE
prerank,regulation of programmed cell death (GO:0043067),0.3239505548008194,0.9239184666622583,0.6629778672032193,0.9600243014771113,1.0,35/161,20.69%,TNFSF9;RABGGTA;TRIAP1;GAS1;STEAP3;USP36;DDX42;CXCL10;TARDBP;AIFM2;HS1BP3;SLK;TIGAR;BEX2;LGALS1;BCL6;ALPK2;AKT1;BCL3;ANP32B;GLS2;FLT3;NME2;DNAJA3;HSP90AA1;RSL1D1;NOP53;MADD;NME1;FBXO11;SKP2;APAF1;PRELID1;STK26;IFT57
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.3530302902585647,-0.9238868354185418,0.5340136054421769,0.8465134044915688,1.0,4/11,10.87%,WNT5A;FGFR2;TBX1;STAT1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.32785901759675784,-0.9237940730693981,0.5513307984790875,0.8450473447013926,1.0,6/14,14.68%,STARD13;THBS1;NOTCH1;PDCD10;TBXA2R;HDAC5
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.331027716044214,0.9236512525156508,0.6697154471544715,0.9601543892749165,1.0,33/124,24.58%,SFRP4;CCDC88C;PSMC4;CLTC;SMURF2;TCF7L2;NFATC1;AP2A2;PSMC6;FZD7;PARD6A;PSMD8;AGO2;VANGL2;RHOA;GNB1;PPP3CA;FZD4;AGO4;DAAM1;SFRP5;PPP3CB;AGO3;TIAM1;GNAO1;SMURF1;MAP3K7;AP2M1;TNRC6A;PSMD4;DVL1;PSMD3;RAC1
prerank,O-glycan processing (GO:0016266),0.355363542904681,0.9235076541214533,0.6343612334801763,0.9599645973682409,1.0,9/54,17.61%,ST3GAL2;C1GALT1;GALNT10;MUC1;B3GNT8;GALNT1;ST3GAL4;ST3GAL3;ST3GAL1
prerank,Golgi to lysosome transport (GO:0090160),-0.36394537202977273,-0.9227557024166181,0.5451263537906137,0.845777084592385,1.0,5/11,23.30%,SORT1;AP1G1;CLN3;EHD3;CCDC91
prerank,response to calcium ion (GO:0051592),0.33121144306463074,0.9227190728992527,0.6409989594172737,0.961230269873274,1.0,13/102,9.15%,KCNMA1;SYT2;NEUROD2;CPNE8;ADAM9;SEC31A;SYT12;SYT11;SYT13;CAMK2D;PKD2;DPEP1;IQGAP1
prerank,plasma membrane invagination (GO:0099024),0.37554882518467053,0.9220172329189897,0.5825358851674641,0.9623300330589759,1.0,1/29,0.45%,GSN
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.28287010844584437,-0.9212558626060954,0.5722543352601156,0.847762890614686,1.0,3/25,3.26%,CDH5;ENG;NOTCH1
prerank,second-messenger-mediated signaling (GO:0019932),0.3342524535513044,0.921219686031712,0.6220145379023884,0.96367972004132,1.0,8/82,11.22%,ACKR3;EIF2AK3;PLCE1;RCAN3;MCU;ACKR4;RCAN1;CAMKK2
prerank,glycolipid biosynthetic process (GO:0009247),0.35984579032434366,0.9210144308986395,0.5824800910125142,0.9636364796932779,1.0,8/38,14.88%,ST3GAL2;PIGZ;PIGC;LARGE1;MPPE1;ST3GAL4;PIGW;PIGM
prerank,protein mannosylation (GO:0035268),-0.28109247397536963,-0.9209525264518492,0.5698924731182796,0.8467723288959815,1.0,3/22,3.00%,TMTC1;TMTC4;TMTC2
prerank,regulation of viral release from host cell (GO:1902186),0.3980830932020092,0.920912014624973,0.5925925925925926,0.9633665233779563,1.0,7/21,22.98%,MID2;TRIM11;DDB1;PML;VPS37B;TRIM35;TRIM8
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.3858475771422175,0.9207133498824556,0.5931198102016607,0.9633163311043773,1.0,2/26,2.23%,AREG;BTC
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3986713668423521,0.9206516724090312,0.5841708542713567,0.9629460941055153,1.0,4/21,13.51%,MED24;MITF;MED13;TWIST1
prerank,organic substance transport (GO:0071702),0.32704100086870125,0.9204930693597169,0.6744659206510681,0.9628077610293985,1.0,20/121,13.54%,SLCO2A1;DISP1;SLC50A1;TCN1;ARRDC2;MIA3;TOM1;SLC47A1;RCN3;ABCA1;SCAMP3;ABCG4;SCAMP5;ABCA13;SLC6A4;RUFY1;KIF3A;LRP1B;SLC23A1;CMTM6
prerank,determination of left/right symmetry (GO:0007368),-0.25860359299669256,-0.9203279343995071,0.5947712418300654,0.8465874473265699,1.0,20/36,36.01%,NOTCH1;TBX1;CITED2;BBS7;GALNT11;ENKUR;DNAH11;STIL;ZIC3;CFAP53;DLL1;ODAD2;ODAD3;FOXJ1;MEGF8;ODAD4;SHH;OFD1;CCDC40;LEFTY1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.45674949197867765,0.9202498973678858,0.592797783933518,0.96284528870116,1.0,2/10,13.40%,MYO9A;RHOA
prerank,cobalamin metabolic process (GO:0009235),0.4123293954115937,0.9200162889538515,0.589058524173028,0.9628511239604012,1.0,6/17,24.66%,TCN1;ABCC1;MTR;MMADHC;MMAB;MTRR
prerank,regulation of phosphatase activity (GO:0010921),0.3872675443827079,0.9198860718399251,0.5842696629213483,0.9626497862299661,1.0,10/24,28.77%,PPP6R2;URI1;CHP1;SH2D4A;TIPRL;HSP90B1;PPP1R26;TSC1;GPATCH2;PTPA
prerank,positive regulation of phosphatase activity (GO:0010922),-0.31078460924558515,-0.9197906632027582,0.5271739130434783,0.8462619759227198,1.0,6/21,13.56%,ITGA1;MEF2C;PPP1R15B;PDGFRB;BMP2;CD300A
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3268404150383365,0.9197726865836852,0.6507128309572301,0.9624002104448237,1.0,19/117,16.64%,SYK;VIPR2;FYN;MAPK14;GLP2R;SRC;ADCYAP1;DPEP1;CRHR1;CD81;GPR20;CALCA;GPR45;TSHR;ADCY8;GNB1;LHCGR;IL6;IAPP
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.41875241751388187,0.9192772595528402,0.5873015873015873,0.9630113166764266,1.0,6/15,29.24%,CUL3;NPM1;PAF1;EZH2;STXBP4;GLI1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.38609080263286577,0.9191688674797565,0.5886699507389163,0.9627536617346085,1.0,4/23,15.79%,CARD16;GAS6;ZC3H12A;NLRP2B
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.38075288201722274,0.9190443554332139,0.5727810650887574,0.9625324297088299,1.0,12/27,30.28%,BHLHE40;RBM4;FBXL3;PPP1CC;PER1;PML;PER3;FBXL12;CRY2;CRTC1;TP53;FBXL8
prerank,mitotic sister chromatid segregation (GO:0000070),0.32740739564577265,0.9188816446724256,0.6253838280450358,0.9623898041905816,1.0,24/98,22.81%,DIS3L2;PSRC1;CHMP7;ZW10;VPS4B;TENT4A;ZWINT;CUL3;SMC1A;CDC23;PIBF1;NCAPG;INO80;SMC2;SET;NAA50;NIPBL;CENPE;AKAP8L;KLHL22;CSNK2A2;PDCD6IP;DCTN2;TUBG2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.35408258558269434,0.9187670718804286,0.6097285067873304,0.9621415269344198,1.0,5/43,6.14%,WT1;FGF2;TGFB2;NFATC4;NFIB
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.4377216618296388,0.9187506942147523,0.5947802197802198,0.9616794761509224,1.0,2/13,3.71%,TGFBR2;SMAD4
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.31922978035854765,-0.9185949165488059,0.5918367346938775,0.8474301748803733,1.0,5/16,10.42%,BMP7;SOX13;NAPEPLD;PTGS2;SIRT1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3680300680741739,0.9185520641013933,0.6104046242774567,0.9616315243841472,1.0,20/37,32.96%,KIF3A;DYNC2I2;KIF3B;IFT46;DYNC2LI1;DYNC2H1;DYNC2I1;IFT52;IFT57;PCM1;DYNLRB1;DYNLL1;TNPO1;KIFAP3;IFT81;IFT20;KIF3C;IFT172;TRAF3IP1;KIF17
prerank,regulation of synapse assembly (GO:0051963),0.34851445211194115,0.9183966553917502,0.6094808126410836,0.9614718932839563,1.0,11/46,19.74%,EPHB2;GPC6;SLIT1;EPHB3;MUSK;MDGA1;SYNDIG1;SETD5;LRFN5;EPHB1;CLSTN3
prerank,negative regulation of cilium assembly (GO:1902018),0.4362390466969162,0.9176014131782906,0.5963938973647711,0.9627194847681374,1.0,5/12,18.86%,CEP97;MAP4;CCP110;EVI5L;ODF2L
prerank,fatty acid metabolic process (GO:0006631),0.3291265804099463,0.917472981335437,0.6619289340101523,0.9624990797022056,1.0,27/115,21.97%,CEL;ACLY;ACOT6;CPT1C;ALKBH7;CRAT;PON3;SLC27A3;NDUFAB1;GPX1;FA2H;PNPLA8;HSD17B8;ACOT1;ACAD9;ACOX1;GPAM;LIPC;LIPH;ANGPTL3;NUDT19;MCAT;ABCD3;LPIN3;CPT2;PEX2;CROT
prerank,glucose import (GO:0046323),-0.34133680865434196,-0.9173574954608983,0.5330578512396694,0.8488457367364014,1.0,2/13,1.80%,SORT1;SLC2A1
prerank,positive regulation of locomotion (GO:0040017),0.3786969709185747,0.9173139838508334,0.5793269230769231,0.9623580070770921,1.0,5/27,13.51%,DUOX1;NTN1;STX4;CCDC25;TWIST1
prerank,purine-containing compound salvage (GO:0043101),0.4338114918849139,0.9170818685353103,0.6063977746870653,0.9623767240479587,1.0,1/12,2.31%,AMPD2
prerank,organelle organization (GO:0006996),0.3171910579932129,0.9170672667149404,0.759,0.9619000285961654,1.0,115/388,25.86%,SEC16B;ATP8B1;ARHGAP21;ARHGAP10;EIF2AK3;PLCE1;RAB32;ODF2;DIAPH3;PEX16;TMED1;BIN1;SEC31A;FBXW8;TOR1AIP2;CLUH;ZRANB1;CHMP7;ZW10;DST;VPS4B;MIA3;CENPT;PLEKHF1;PI4K2B;LYSMD3;RAB30;MAST4;SYNE1;MIEF2;PKD2;SURF4;LMAN1;LARP4;STX4;TOR1A;POLG2;RAB2A;SEC23IP;CAMSAP1;MICAL2;PRPF40A;STX17;LNPK;PALLD;KIF3A;RAB43;FMNL3;CCL13;HPS6;PEX12;WDR73;DNAJA3;FANCG;BCAS3;PTCD2;PEX1;DIAPH1;GEM;SEC61A1;FAM161B;ANK1;PEX3;BLZF1;HACE1;REEP5;DYNC2H1;YTHDF2;BCS1L;PPIA;YTHDF1;AUP1;VPS11;RANBP10;SLC25A36;MICAL1;SH3D19;ABCD3;ARFGEF1;TMED2;PLD2;VPS13D;CLASP2;NUMA1;PEX2;TJAP1;SLC25A33;ATP8B2;GABPA;YTHDF3;PDCD6IP;ZMYM3;AFG1L;PI4K2A;GOLPH3L;PACSIN3;CNTNAP1;PACSIN2;BNIP1;TRAPPC12;SYNE3;ESRRA;BAG5;CFAP126;DMTN;CEP78;RAB18;STX7;RHOT2;ATL1;RAB1A;RAB29;ATP5F1B;STRIP1;MAST2
prerank,regulated exocytosis (GO:0045055),0.31930711981765514,0.9168196176887572,0.6934673366834171,0.961950353730645,1.0,35/173,20.57%,RAB11FIP5;CD9;TGFB3;SCIN;SYT2;CLEC3B;SPARC;ITGB3;VEGFA;TGFB2;ECM1;STX1A;SYT12;SYT11;SYT13;GTPBP2;GAS6;EGF;SERPING1;SNAP25;RAB27B;TUBA4A;LGALS3BP;MANF;HGF;SNAPIN;SYT1;VAMP2;RIMS2;ALDOA;PPP3CB;APOOL;RAB10;QSOX1;FLNA
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.35857975247568724,-0.916742227184126,0.5222672064777328,0.8486264805699942,1.0,3/11,7.16%,NOVA2;PCBP3;IGF2BP2
prerank,negative regulation of heart contraction (GO:0045822),-0.3623586104364268,-0.9159101798061163,0.5352112676056338,0.848932742632201,1.0,1/11,0.02%,ATP1A2
prerank,cellular response to glucose stimulus (GO:0071333),0.37500534521007656,0.9154830660524369,0.5899532710280374,0.9643915179268507,1.0,6/30,12.85%,RAB11FIP5;SLC39A14;MLXIPL;GAS6;ERN1;ADCY8
prerank,positive regulation of protein acetylation (GO:1901985),-0.3449879912534637,-0.9152758169938277,0.5537848605577689,0.8487186963910514,1.0,2/12,3.96%,RAPGEF3;PRKAA2
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.40891412705025254,0.9152563476352403,0.5883838383838383,0.9643969988980537,1.0,5/18,16.45%,SMAD4;SRC;CBL;FER;IL6
prerank,regulation of cellular response to stress (GO:0080135),0.32713804104550637,0.9149612428954734,0.6608606557377049,0.9645349104383188,1.0,39/115,26.02%,CORO2B;NUP93;MTOR;CAMK2D;AIFM2;DNAJC2;NUP107;YWHAE;NUP98;NPM1;CEBPB;MAPT;ADCY8;HSP90AA1;HSBP1;AMFR;NUP37;NUPR1;BAG4;RSL1D1;CHORDC1;MANF;NEK4;FKBP4;NUP50;MCL1;DNAJB1;MAPK1;BAG3;ATF4;USP19;TPR;CRYAB;BAG5;HSPH1;NUP85;NUP133;NUP188;EIF4G1
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.33734019966865453,0.9149396789518272,0.6424759871931697,0.9640835931518892,1.0,21/75,25.10%,MGLL;PLCE1;DGKQ;SLC39A14;GNG4;ZDHHC7;ADCYAP1;CNGB1;USP33;SAG;KLK6;FRMPD1;PPP1R9B;METAP2;METAP1;YWHAB;RNF157;MRAP2;GNG7;CAMKMT;RGS2
prerank,tRNA methylation (GO:0030488),0.3667071038010303,0.9148952875780567,0.6025492468134415,0.9636766764475306,1.0,7/34,15.07%,PRORP;TYW3;TRMT61A;FTSJ1;DALRD3;THADA;TRMT1
prerank,dendritic cell migration (GO:0036336),-0.31576044585715807,-0.914858642724078,0.5414847161572053,0.8479806692500691,1.0,2/16,2.75%,EPS8;HMGB1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.33490634086566984,0.9145915306805025,0.6405919661733616,0.963871273041881,1.0,21/76,21.25%,IRAK3;ITCH;PRMT2;CHUK;IRAK1;COMMD6;NWD1;ZC3H12A;KLF4;USP7;CHP1;NLRP2B;RBCK1;ANXA4;TRAF3;DAP;TAX1BP1;UFL1;CYP1B1;PYCARD;ARRB1
prerank,RNA modification (GO:0009451),0.34966160344461916,0.9142652176639201,0.6285714285714286,0.9640565876888787,1.0,17/54,27.12%,ADARB1;ANKRD16;TRMT6;MEPCE;TRMT61A;FTSJ1;TRMT1;DTWD1;QTRT1;TYW5;TRUB1;METTL1;NOP2;TSR3;WDR4;FTSJ3;URM1
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.3224218317950662,0.9141532590881319,0.6991951710261569,0.9638056031030091,1.0,24/163,15.98%,SYK;LAX1;PRAM1;PSMC4;FYN;RFTN1;PIK3R2;PTPRJ;CSK;PSMC6;RC3H1;PRKD2;UBE2N;CHUK;PIK3CA;PSMD8;FYB2;PDE4D;PLEKHA1;ZC3H12A;MOG;BTN3A3;NCK1;RBCK1
prerank,phosphatidylinositol metabolic process (GO:0046488),0.32806550867863304,0.9138389910117718,0.6608247422680412,0.9640114197250311,1.0,30/109,21.52%,MTMR11;FGF2;PIK3C2B;PIK3R2;PI4K2B;FIG4;PIK3CA;OCRL;INPP5F;ARF1;INPP5K;PLEKHA4;PIGW;RUFY1;MBOAT7;INPP4A;PLEKHA1;PI4KB;PLA2G4E;MTMR6;PI4KA;MTMR1;PIP4P1;PIP4K2C;CDIPT;INPP5B;PIP4K2B;PITPNM1;PTEN;PIK3CG
prerank,pulmonary valve development (GO:0003177),0.40635669921938544,0.9137860464230682,0.6069142125480154,0.9636312817192036,1.0,6/18,13.76%,TGFB2;SLIT2;NFATC1;JAG1;SMAD6;TNFRSF1B
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.360946278958533,0.9135847173125685,0.6022598870056497,0.9635847791228123,1.0,6/42,11.99%,MYOC;VEGFA;S100A10;PTPRJ;CCL25;JUP
prerank,positive regulation of viral genome replication (GO:0045070),0.3760822665687492,0.9133749750541567,0.6218787158145065,0.9635071309781941,1.0,10/29,25.87%,TARBP2;ADARB1;LARP1;DDB1;HACD3;PPIA;TOP2B;SRPK1;TMEM39A;PPIH
prerank,regulation of sequestering of calcium ion (GO:0051282),0.4411451295809442,0.9126244114155404,0.6091794158553546,0.9647053298486357,1.0,3/12,15.05%,ANK2;CASQ1;DIAPH1
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.4324510743521502,0.9124119823305438,0.5991735537190083,0.9646819659220384,1.0,7/12,27.60%,SLIT2;MIA3;AKT1;NBL1;CCN3;DUSP1;WASL
prerank,sprouting angiogenesis (GO:0002040),0.35042442148704744,0.9123652690909136,0.6147816349384099,0.9642798588293863,1.0,9/51,12.48%,CCBE1;LOXL2;VEGFA;FGF2;SLIT2;MIA3;ESM1;AKT1;RECK
prerank,sister chromatid segregation (GO:0000819),0.369318732537378,0.9122079497781663,0.5974178403755869,0.9641282055020223,1.0,9/31,24.18%,CHAMP1;ZW10;ZWINT;SMC1A;INO80;TOP2B;KLHL22;TUBG2;LATS1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.26850339378036203,-0.9121407641818996,0.5865921787709497,0.852872380936533,1.0,10/27,20.19%,NEDD4L;YWHAH;DLG1;GPD1L;FXYD1;NOS1;UTRN;SNTA1;SLMAP;SCN3B
prerank,negative regulation of transport (GO:0051051),0.35036417459685815,0.9120249410603628,0.6341730558598029,0.9640359242408288,1.0,10/51,12.62%,EPHA3;ITGB3;SYT11;SCAMP5;ITGAV;SIRPA;YRDC;EGF;PXK;NDFIP1
prerank,organelle fusion (GO:0048284),0.3909566861580207,0.9116172143097256,0.6029411764705882,0.9644162130374294,1.0,9/22,30.56%,GDAP1;MIEF2;STX4;SPG7;VPS11;FIS1;CHCHD3;BAX;MFN2
prerank,regulation of protein kinase A signaling (GO:0010738),-0.2956025747194996,-0.9112966168455533,0.5918367346938775,0.8532419124817746,1.0,7/20,17.51%,ADGRV1;AKAP7;PRKAR1B;AKAP6;PRKAR2B;TCIM;ADRB2
prerank,nitric oxide biosynthetic process (GO:0006809),-0.33514738309871883,-0.9105196954024998,0.5791505791505791,0.8532920256062524,1.0,4/13,12.28%,NOS3;GCH1;NOS1;SPR
prerank,organic anion transport (GO:0015711),0.33392238091108956,0.9102707409883597,0.6382754994742377,0.9668599883955861,1.0,11/76,13.11%,SLCO2A1;SLC4A10;LRRC8D;SLC4A8;SLC4A3;SLC35B1;SLC25A4;SLC4A4;SLC26A6;SLC2A10;SLC23A1
prerank,regulation of small molecule metabolic process (GO:0062012),-0.26631777487168584,-0.9101938656092406,0.6066666666666667,0.8524413139295987,1.0,7/28,10.42%,PDK1;APOE;TTC39B;PPARA;ACADL;EPHX2;SIRT1
prerank,regulation of mRNA catabolic process (GO:0061013),0.32785098672495466,0.9099379719118167,0.6913705583756345,0.9670856079177779,1.0,24/121,17.73%,PRKCA;PKP3;PSMC4;ZFP36L1;SAMD4B;PSMC6;RC3H1;CARHSP1;ZFP36L2;PSMD8;HNRNPD;EXOSC7;ZC3HAV1;AKT1;PUM1;IGF2BP1;UBA52;ZFP36;EXOSC1;ZC3H12A;FXR2;YTHDF2;YTHDF1;SET
prerank,histone deubiquitination (GO:0016578),0.39902105941091637,0.9098966186575227,0.5913272010512484,0.9666774959928669,1.0,5/18,21.03%,USP36;ATXN7L3;USP7;USP22;TRRAP
prerank,metal ion homeostasis (GO:0055065),0.3593594748867031,0.9092171800669969,0.623155505107832,0.9676432628831597,1.0,10/40,21.00%,SCNN1B;SLC12A8;SLC12A4;CYP27B1;COX11;SLC12A5;CNNM4;SELENON;KCNH2;SLC12A6
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.3406165545957053,0.9090623361616174,0.6425531914893617,0.9674654099814924,1.0,9/67,9.97%,NCF4;PSMC4;ITGB5;SEC22B;PSMC6;CHUK;PSMD8;SNAP23;ITGAV
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.42610705457721854,0.9088873899439172,0.5922330097087378,0.9673607425645044,1.0,3/13,9.34%,FGFR1;FGF2;AKT3
prerank,rRNA modification (GO:0000154),0.39284772203827373,0.9085183467824265,0.6075471698113207,0.9676654851364607,1.0,11/21,35.84%,DIMT1;GAR1;ZCCHC4;TSR3;FTSJ3;NHP2;NAT10;FBL;NSUN3;BUD23;THUMPD1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.41526221637451993,0.9085180056962762,0.6020671834625323,0.967168713828118,1.0,5/15,24.94%,NYNRIN;NUDT16;ZC3H12A;RPP30;KHNYN
prerank,sphingoid metabolic process (GO:0046519),0.43653213649996203,0.9083727646193297,0.6131687242798354,0.9669859789836286,1.0,4/12,24.55%,PLPP3;PLPP1;PLPP2;SGPP1
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.3013595797633221,-0.9082851832684266,0.6106194690265486,0.8552741516134295,1.0,6/18,13.67%,VGLL4;DAB2IP;ATRAID;NELL1;RGP1;RIC1
prerank,negative regulation of protein polymerization (GO:0032272),0.3748477559815356,0.9082836155055327,0.6011976047904192,0.9666881656916642,1.0,11/27,21.81%,SLIT2;MYADM;PFN2;KANK1;TWF1;SSH1;MAPRE1;TUBB4A;CLIP3;ARFGEF1;SSH3
prerank,reverse cholesterol transport (GO:0043691),-0.33742135767028447,-0.9080236359789394,0.5526315789473685,0.8542448052973733,1.0,3/13,6.15%,APOE;SCARB1;ABCG1
prerank,ATP transport (GO:0015867),0.4576293501340011,0.9074624833995589,0.6127167630057804,0.9679571749756277,1.0,3/10,15.22%,SLC25A4;CD47;SLC25A17
prerank,B cell differentiation (GO:0030183),0.35096049605637986,0.9074160636903917,0.6355653128430296,0.9675584767745428,1.0,8/46,15.09%,HDAC9;SYVN1;CLCF1;PTPRJ;FLT3;CR2;HDAC4;IL4
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.32217609895341437,0.9073268517111982,0.6744659206510681,0.9672443868913685,1.0,19/116,16.64%,SYK;VIPR2;FYN;MAPK14;GLP2R;SRC;ADCYAP1;DPEP1;CRHR1;GPR20;CALCA;GPR45;TSHR;ADCY8;GNB1;LHCGR;SELENOS;IL6;IAPP
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.2933792634213417,-0.9069403450840587,0.5904255319148937,0.8536172759719887,1.0,3/21,2.54%,EYA1;BCL2L1;BCL2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.2933792634213417,-0.9069403450840587,0.5904255319148937,0.8536172759719887,1.0,3/21,2.54%,EYA1;BCL2L1;BCL2
prerank,regulation of protein secretion (GO:0050708),0.326015676691479,0.9065423628976694,0.6771894093686355,0.9684519008310774,1.0,12/119,5.42%,PRKCA;DPP4;MTNR1B;TGFB3;DISP1;CACNA2D2;ANG;TGFB2;STX1A;ADAM9;LLGL1;RHBDF1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.44422915614916186,0.9064061648762359,0.6096491228070176,0.9677566147764053,1.0,1/10,9.69%,CNGB1
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.44422915614916186,0.9064061648762359,0.6096491228070176,0.9677566147764053,1.0,1/10,9.69%,CNGB1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.4492116029298495,0.9061400175782393,0.5818181818181818,0.9678363516372953,1.0,2/10,11.91%,MLXIPL;ELOVL5
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.24754210361061035,-0.9060593772355003,0.6636363636363637,0.8541418955686965,1.0,13/41,19.80%,PRKAG2;SCARB2;NUP35;NDC1;RAE1;PGAM1;NUP153;EP300;NUP214;POM121;NUP155;HIF1A;NUP205
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.43457607726703124,0.9058086143474329,0.5941255006675568,0.9680263287116044,1.0,4/12,27.59%,GNL3L;CCT7;CCT4;CCT6A
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.33914907861439486,0.9054388944229408,0.634698275862069,0.9683169397042096,1.0,10/61,12.43%,COL3A1;AKAP13;F2R;LPAR1;RASGRF1;RASGEF1A;ARHGEF3;GPR20;IRS2;SHOC2
prerank,photoperiodism (GO:0009648),0.37343616060982665,0.9053212607546932,0.5887191539365453,0.9680765623479035,1.0,12/28,30.28%,BHLHE40;RBM4;FBXL3;PPP1CC;PER1;PML;PER3;FBXL12;CRY2;CRTC1;TP53;FBXL8
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.41392116577882954,0.9052173258818914,0.603112840466926,0.9677878046801571,1.0,1/15,1.10%,SRM
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.38608642044936947,0.9049937432234624,0.6158612143742255,0.9677711115814492,1.0,3/22,10.26%,RUNX1;TNFRSF18;BCL6
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.3276367375918786,-0.9049398592258974,0.6163793103448276,0.8551172905668617,1.0,2/14,2.58%,AUTS2;KMT2E
prerank,thymus development (GO:0048538),0.43125316501064653,0.904822572404347,0.6118421052631579,0.9676538131339815,1.0,6/13,27.13%,ZBTB1;EPHB3;SIX1;TGFBR1;FGF10;HES1
prerank,protein destabilization (GO:0031648),0.3712828526228624,0.9045824555681931,0.6014150943396226,0.9677248954637541,1.0,4/32,8.87%,GSN;CCDC88C;NR1D1;CUL3
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.3549061939747019,0.9041805231987411,0.622554660529344,0.9681187569651426,1.0,10/40,19.75%,RFWD3;ETAA1;UBE2N;CDK9;PARG;FBXO5;MAPT;FXR2;NEK4;MCL1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.34139647266130246,0.9041548694965506,0.6434689507494646,0.9676807532440749,1.0,25/60,29.81%,CDK4;TCF7L2;MED24;CEBPB;CCNC;MED13;CDKN1A;CCND1;MED15;IL6;AGO4;MED23;MED6;AGO3;PTEN;MED7;RELA;TNRC6A;MED26;AGO1;ATF7IP;NFKB1;BAX;TP53;SOX9
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.2027634069125642,-0.9039463328907551,0.6896551724137931,0.8558464116578961,1.0,32/87,20.76%,RPL13;SEC61A2;RPS7;RPL37;RPS27;RPS13;RPL19;RPL36;RPL30;RPL36A;RPL18A;RPS14;SRP14;RPS18;RPS21;RPL5;RPL7A;RPS24;RPS11;RPL29;RPL39;SRP72;RPL26;RPS23;RPL35;RPL37A;RPL14;RPL24;SRP68;RPL18;ZFAND2B;RPL9
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3259579497956967,0.9039121988341466,0.6790890269151139,0.9677254958781587,1.0,20/98,15.97%,EPHB2;EGFR;LRP1;EPHA3;FYN;ATP2B4;MIEF2;YWHAG;YWHAE;CD81;STX4;SQSTM1;PPP3CC;AKT1;BBC3;SFN;ARF6;CHP1;SPTBN1;PLS1
prerank,monocyte differentiation (GO:0030224),0.45255308474561695,0.9036105967686487,0.6277777777777778,0.9678759977375991,1.0,1/10,2.80%,VEGFA
prerank,negative regulation of apoptotic process (GO:0043066),0.3098055548724736,0.9034994931354856,0.812,0.9676463348466867,1.0,94/444,21.40%,COMP;FSTL1;AXL;GCLC;ARHGAP10;PRKCA;EGFR;ANXA1;TGFB3;WT1;HPN;ANGPT4;TRIAP1;SIX4;CD44;VEGFA;F2R;MIF;ATF5;COPS5;ITGA5;CLCF1;NFATC4;ITCH;CBX4;SOCS2;FOXO1;CARD16;ARF4;SRC;GAS6;DPEP1;YWHAE;SOX8;PIK3CA;PSEN1;AVEN;NRBP2;SMAD6;SQSTM1;HDAC3;SON;NPM1;GPX1;AKT1;BCL3;IRAK1;NAT8;UBA52;CD27;SFN;GDNF;CBL;SIX1;WDR73;ZC3H12A;NME2;KLF4;SNAI2;NUPR1;IL4;BAG4;VDAC1;AHI1;ANXA4;IL6;HGF;TAX1BP1;PTRH2;FAIM2;SNX6;SET;TMBIM4;PLAUR;NAA15;ERCC5;QARS1;VTCN1;UFM1;SUPV3L1;DSTYK;PRDM9;MCL1;HIPK3;IL31RA;RASA1;PRELID1;DDAH2;FLNA;TYRO3;MAPK1;OPN3;FMN2;KDM2B
prerank,positive regulation of chromatin organization (GO:1905269),0.4397861594189589,0.903479630937409,0.6042553191489362,0.9671981026043786,1.0,6/12,21.89%,UBE2N;ACD;TERF1;TINF2;MIER1;TERF2IP
prerank,protein localization to plasma membrane (GO:0072659),0.321143052663764,0.9034650013829284,0.6992864424057085,0.966739959236723,1.0,21/129,12.24%,LRP6;TTC7A;TSPAN17;PKP3;PRAM1;ANK2;FGF13;S100A10;NECTIN3;PLEKHF1;MYADM;MYO5A;GAS6;PACS2;CD81;EHD2;INPP5K;FYB2;RAB3D;JUP;PIGW
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.41947997732297626,0.9033719157089192,0.6026666666666667,0.9664618826980735,1.0,3/13,13.20%,AGO2;ZFP36;POLR2G
prerank,sympathetic nervous system development (GO:0048485),-0.3201431550520154,-0.9033685658386608,0.6175298804780877,0.8555363785745634,1.0,4/15,15.76%,NRP2;NRP1;CTNNB1;SOX11
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.3404641401593155,0.9031371437269673,0.6429341963322546,0.9664735731819876,1.0,16/59,21.85%,OSBPL3;ACLY;OSBPL2;SCP2;HSD3B7;NDUFAB1;OSBPL6;GAMT;ALDH1A3;HSD17B8;LIPC;LIPH;MCAT;ABCD3;HSD17B4;SRR
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.4379675641758479,0.9030650279242558,0.6198910081743869,0.9661190203616613,1.0,6/12,29.43%,DGKQ;SREBF1;LPCAT3;KPNB1;MBTPS1;SREBF2
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.35711661066363143,0.9029640606275036,0.6292134831460674,0.9658638517667738,1.0,10/41,18.81%,FGF2;F2R;TRPV3;ATP2B4;GRIN2D;PKD2;SLC8A2;GRIN2A;IBTK;HTR2C
prerank,cellular response to leucine (GO:0071233),0.4462593240346867,0.9029582193609159,0.611032531824611,0.9648906762304214,1.0,6/10,22.74%,MTOR;SESN3;RRAGD;KLHL22;SESN2;UBR2
prerank,response to leucine (GO:0043201),0.4462593240346867,0.9029582193609159,0.611032531824611,0.9648906762304214,1.0,6/10,22.74%,MTOR;SESN3;RRAGD;KLHL22;SESN2;UBR2
prerank,protein-containing complex assembly (GO:0065003),0.31475340570921756,0.9026154498722887,0.7464929859719439,0.9651633535829095,1.0,52/259,18.87%,AREG;SEC16B;SEC24D;CNIH3;WIPF1;LLGL1;DLG4;STX5;SEC31A;GPAA1;AXIN1;ZW10;TCF7L2;PREB;ZNHIT6;SEC24A;FARP2;WASF1;SEC22B;MDM4;TFG;SEC23A;USO1;LMAN1;MCU;CUL3;SCFD1;MITF;TLE2;SEC23IP;SLC9A1;NAPA;ADCY8;CNIH1;TRAPPC2L;ZC3H12A;CDC123;BCL9;SMARCA4;NSF;SPG7;PML;NAPG;TFAP4;SEC24B;RAB1B;KMT2A;EPRS1;PYGO2;BLM;VAMP2;LAMC1
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.4442185641441642,0.9016097768221689,0.6027972027972028,0.9668473140959337,1.0,1/10,0.48%,LRP6
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.44436078853950267,0.9013587938140024,0.6213991769547325,0.9668705620068903,1.0,2/11,9.23%,CD177;STX4
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.3862816366843331,0.9011895173432871,0.615,0.9662454149052178,1.0,5/21,18.17%,GTF2H3;ERCC3;ERCC4;DDB1;ERCC5
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.3862816366843331,0.9011895173432871,0.615,0.9662454149052178,1.0,5/21,18.17%,GTF2H3;ERCC3;ERCC4;DDB1;ERCC5
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.35936018679694726,0.9010422627493926,0.6435868331441543,0.9660824780910413,1.0,9/37,17.93%,S100A8;S100A9;SIAH1;BMF;BBC3;NACC2;NUPR1;NCK1;BCAP31
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.31674633779010736,0.9010240534151178,0.7079556898288016,0.965635752896133,1.0,49/166,25.33%,AR;ESR1;POLR2H;GTF2H3;HDAC7;HDAC9;WWTR1;NR1D2;TAF8;NR1D1;POLR1G;BRF2;NR6A1;VDR;CDK9;KAT2B;HDAC3;TAF3;UBTF;ERCC3;NCOR2;POLR2D;POLR2G;NCOR1;GTF2A2;CCNH;GTF2F1;BRF1;NR2C2;E2F3;POLR3H;MED23;RORA;NR2C2AP;RRN3;GTF2E2;POLR1C;TBP;MED7;POLR1B;NR3C1;ESRRA;TAF13;NCOA6;POLR2C;MED26;RARA;NRBP1;GTF2E1
prerank,negative regulation of DNA recombination (GO:0045910),0.3465229848692161,0.9007263706569868,0.619625137816979,0.9658026839633395,1.0,14/43,26.82%,PARP3;POLR2H;CGAS;ACD;POLR2D;POLR2G;TERF1;BLM;TINF2;TERF2IP;UBQLN4;POLR2C;H1-0;MSH6
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3288171024750693,0.900667181073416,0.6639004149377593,0.9654354286033702,1.0,12/85,11.79%,COL1A1;PIEZO2;COL11A1;SLC26A5;MYO1A;PDZD7;TSPEAR;MYO3B;TIMM9;MYH14;COL2A1;CRYM
prerank,defense response to protozoan (GO:0042832),0.4320171376951927,0.9005443678619096,0.6299319727891156,0.9652061430780731,1.0,1/12,1.17%,IRF4
prerank,positive regulation of cellular catabolic process (GO:0031331),0.31809875904796225,0.9002532479140783,0.7119675456389453,0.9653583553402597,1.0,29/132,20.42%,DCN;IRS1;ADAM9;MID2;DACT1;ITCH;FOXO1;PLEKHF1;MLXIPL;RC3H1;FLCN;PSEN1;ZC3HAV1;SLC4A4;IRS2;TWIST1;TNFRSF1B;ZC3H12A;ULK1;HSP90AA1;DAGLB;ZSWIM8;TRIM68;UFL1;VPS11;SUPV3L1;GPLD1;SH3D19;ATF6
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.3379946458677833,0.9001800203727425,0.6458557588805167,0.9650305244299527,1.0,9/54,13.66%,KCNMA1;FHL1;BIN1;KCNJ2;YWHAE;KCNAB3;STK39;KCNJ3;GNB1
prerank,positive regulation of RNA splicing (GO:0033120),0.36030359119811717,0.9001720368113626,0.6210153482880756,0.9645578090768653,1.0,11/29,25.79%,ZPR1;NUP98;RBM22;ERN1;RBM3;SF3B4;U2AF2;THRAP3;DAZAP1;CELF3;RBMX
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.3076658251621072,-0.8999226018505746,0.6075949367088608,0.8619782154496899,1.0,6/16,22.50%,SSBP1;PURA;WRN;MCMDC2;TWNK;RAD51
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.3320291502652597,-0.8995672249137017,0.5758754863813229,0.8611797633821501,1.0,2/12,1.56%,UNC13B;UNC13C
prerank,cellular response to topologically incorrect protein (GO:0035967),0.3633490808606915,0.8993289323098456,0.6260257913247362,0.9658194484893283,1.0,7/31,15.78%,STUB1;HDAC6;UBE2W;HSPA13;ERN1;BAK1;HSPA14
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3400379696630874,0.8992347209391398,0.639697950377562,0.9655338867206072,1.0,21/52,27.49%,UBE2J2;USP36;YWHAG;YWHAE;HPS4;PPP3CC;BBC3;NPEPPS;SFN;HTRA2;ARIH2;VPS11;ATG13;UBE2D3;SAE1;CSNK2A2;YWHAB;LEPROT;FBXW7;RNF31;CASP8
prerank,cholesterol efflux (GO:0033344),0.3947887392985478,0.8992004716012636,0.6070087609511889,0.9651163097486155,1.0,4/20,10.43%,ABCA1;ABCG4;TSKU;STX12
prerank,histone deacetylation (GO:0016575),0.34893773422921753,0.8989390506151678,0.6164229471316085,0.9651778365086936,1.0,12/43,20.14%,HDAC9;SIN3B;HDAC6;MSL3;SIRT2;RCOR3;HDAC3;HDAC4;PER1;MORF4L1;SUDS3;MIER1
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.32252298325768364,0.8988584197393962,0.727547931382442,0.9648525473346353,1.0,24/140,10.15%,TRIP10;ARHGAP21;ARHGAP10;ARHGAP44;AKAP13;PLCE1;SLIT2;PIK3R2;RASGRF1;TRIO;SRGAP1;SRC;ARHGEF3;FLCN;MYO9B;MYO9A;ARHGAP9;OCRL;RHOJ;TAGAP;ITGAV;TIAM2;RHOQ;SQSTM1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.3079739464421244,-0.8988349960319513,0.586046511627907,0.8612769276121306,1.0,3/16,7.47%,CADM1;AP1G1;NECTIN2
prerank,mitochondrial membrane organization (GO:0007006),0.36901381782420745,0.8983657422100975,0.6089965397923875,0.9654089220018329,1.0,10/32,22.11%,TIMM50;SLC25A31;SLC25A4;BAK1;GHITM;SPG7;RCC1L;MICOS10;APOOL;IMMT
prerank,icosanoid secretion (GO:0032309),0.42851985414749116,0.8983375883956121,0.6088154269972452,0.9649859119497795,1.0,2/12,11.70%,ANXA1;PNPLA8
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.2755273717124588,-0.8980534995032046,0.5859872611464968,0.8613715361306763,1.0,7/26,12.41%,APOE;SCARB1;PIK3CB;NPR3;GCH1;TERT;S100A1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.44598852378719106,0.8977241165601341,0.6260623229461756,0.9657671317392742,1.0,4/10,16.40%,MIA3;AKT1;CD200R1;PADI2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.394310176923868,0.8975077054552415,0.5959849435382685,0.9657429999248406,1.0,4/18,12.85%,VEGFA;CRTC2;PRKD2;ADCY8
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.4079408470990836,0.8974787639586348,0.6251673360107095,0.9653185123321039,1.0,6/15,20.01%,VEGFA;FGF2;ITGA5;KLF4;PKM;BMPER
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.42444455028084727,0.8972082287641775,0.6239782016348774,0.9653797221718495,1.0,2/12,5.76%,IGFBP5;DOCK7
prerank,positive regulation of endocytosis (GO:0045807),0.3425545187450575,0.8966677039802251,0.6439732142857143,0.9660051184019114,1.0,11/45,18.98%,AXL;LRP1;GPC3;BICD1;TOR1A;ABCA13;CALY;CBL;IL4;SMPD1;CLIP3
prerank,potassium ion import across plasma membrane (GO:1990573),0.3546010764652678,0.8965090204050123,0.6554054054054054,0.9658424747043979,1.0,10/41,13.62%,SLC12A8;ATP1A4;ATP1A3;ATP1A1;KCNJ2;SLC12A4;KCNK9;HCN4;SLC12A5;KCNJ3
prerank,iron ion homeostasis (GO:0055072),0.33295918271752883,0.8963475529787648,0.6518046709129511,0.965684363289448,1.0,12/58,19.99%,SCARA5;SMAD4;ATP6V0A2;SLC11A2;NDFIP1;ATP6AP1;CCDC115;BDH2;FBXL5;FLVCR1;NEDD8;TMEM199
prerank,positive regulation of establishment of protein localization (GO:1904951),0.40236711165291483,0.896302402756269,0.6254728877679697,0.965299787512471,1.0,3/18,15.39%,CORO2B;CCT7;CHP1
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.3857238640793428,0.8959834404796647,0.6105006105006106,0.9654821114333461,1.0,6/23,15.05%,FYN;ANK2;CAMK2D;CACNB1;CASQ1;DIAPH1
prerank,glycoprotein metabolic process (GO:0009100),0.3416912197879924,0.8959722427410258,0.658669574700109,0.9650214240875504,1.0,10/53,15.61%,PCSK6;ST3GAL2;FBXO2;OGA;FBXO17;LARGE1;TNIP1;ST3GAL4;MGAT4B;NGLY1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.3339333793909633,0.8956425360898091,0.663471778487753,0.9652075813230249,1.0,17/64,23.06%,MYOC;EFNA5;EPHA3;SLK;JAG1;CCL25;SLC9A1;JUP;ADAM15;RHOA;HOXA7;ACTG1;RASA1;CORO1C;NF1;CSF1;LDB1
prerank,regulation of cholesterol transport (GO:0032374),0.3912140595015928,0.8954119483516746,0.6096324461343473,0.9651983780843202,1.0,3/20,10.09%,LRP1;ABCA13;OSBPL6
prerank,regulation of calcium-mediated signaling (GO:0050848),0.37461247192713765,0.895273531196423,0.6103739445114595,0.9650202459506089,1.0,6/25,17.75%,NEUROD2;P2RX3;RIT2;MAPT;SLC8A2;TMBIM4
prerank,ncRNA transcription (GO:0098781),0.42434905297159564,0.8948502274909993,0.6047430830039525,0.9654402953845301,1.0,6/13,30.07%,ANG;POLR1G;BRF1;SPIN1;SNAPC3;SIRT7
prerank,histone H3-K4 methylation (GO:0051568),0.370356049075414,0.8946220733564282,0.6353790613718412,0.9654213183801235,1.0,8/26,19.93%,CXXC1;DPY30;WDR5;OGT;KMT2A;PRDM9;KMT2C;SETD1B
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.37211224642747703,0.8945485265223423,0.6166056166056166,0.9650790055415726,1.0,9/24,15.59%,IRS1;EPM2AIP1;INPP5K;DYRK2;AKT1;PASK;IRS2;PPP1R3C;SELENOS
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.3084759524428082,0.8945409570255861,0.783,0.9646157752303935,1.0,59/306,18.53%,RPSA;ST3GAL2;POLR2H;MRPS11;RRBP1;EXT1;TIPIN;EEF2K;COPS5;MRPS18B;IGHMBP2;INHA;NT5M;GTPBP2;RHNO1;POLE3;PPP5C;MRPL13;MRPS17;AGO2;ING4;LARGE1;MCM3;RMI1;FUT9;GSPT2;RPL10A;TNIP1;MRPL10;MRPL55;BCL3;ST3GAL4;DNA2;RAD1;POLR2D;PCLAF;POLR2G;RPS5;DBF4;BRIP1;MRPL36;ORC6;NBN;MRPL3;GSPT1;FAM111A;RPL6;GRWD1;MRPL51;HARS1;EEF1B2;RFC4;EEF1G;ABCF1;RAD50;SET;TBRG1;BLM;POLD1
prerank,positive regulation of positive chemotaxis (GO:0050927),0.41297183616878025,0.8941916868956957,0.6010498687664042,0.9648898495197926,1.0,2/15,2.80%,IL16;VEGFA
prerank,histone exchange (GO:0043486),0.35694486664153213,0.8938968617549354,0.6407657657657657,0.9650343092869029,1.0,9/37,22.95%,CENPT;SPTY2D1;HJURP;NPM1;DMAP1;SRCAP;CENPC;ZNHIT1;VPS72
prerank,Ras protein signal transduction (GO:0007265),0.31588273752314716,0.8938005668571379,0.7112676056338029,0.9647517192626938,1.0,29/137,16.83%,COL1A2;GPSM2;PLCE1;FGF2;CDC42EP2;MAPK14;RAP1B;RASSF1;FARP2;WASF1;RIT2;NTN1;ARHGEF3;MYO9B;MAPK11;RGL2;GDI1;NRAS;KRAS;USP50;SHOC2;CDKN1A;RHOA;GNB1;RAPGEF1;HACD3;SOS1;EPS8L2;HACE1
prerank,regulation of chemotaxis (GO:0050920),-0.26552050114587344,-0.8935845383592461,0.6744186046511628,0.8698929807526169,1.0,8/30,12.28%,EFNB2;ZSWIM6;THBS1;USP14;PDGFRB;PTPN2;PPM1F;TGFB1
prerank,"phototransduction, visible light (GO:0007603)",0.42023387329198825,0.8934558621694725,0.6192411924119241,0.9649944608103401,1.0,3/14,13.66%,CNGB1;SAG;GNB1
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.2769079441212282,-0.893354730212428,0.671875,0.868804931199783,1.0,9/21,21.10%,NUDT4;NT5E;HPRT1;PDE2A;NUDT3;NT5C2;NT5C1A;FITM2;AMPD3
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.4254493741572832,0.8929969676829985,0.6364883401920439,0.9654620092702206,1.0,2/12,7.14%,RUNX1;RC3H1
prerank,regulation of insulin secretion (GO:0050796),0.31803967248884163,0.8929889734116526,0.6847492323439099,0.9649980409901436,1.0,18/101,16.45%,PRKCA;DPP4;MTNR1B;IRS1;EFNA5;CACNA2D2;STX1A;MIDN;TCF7L2;NR1D1;MCU;BMP8A;IRS2;TRH;SNAP25;KCNC2;GLUD1;IL6
prerank,male meiosis I (GO:0007141),0.41221760769237586,0.8928615226205646,0.6217616580310881,0.964804611256706,1.0,3/16,18.72%,SLC25A31;DDX4;FOXJ2
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.4249496141896422,0.8927045802465009,0.6195652173913043,0.9646349512812307,1.0,4/12,14.90%,FOXP1;NCOR2;NCOR1;SMARCA4
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3093254361355161,0.892598885871641,0.7379518072289156,0.9643760033315797,1.0,57/208,23.77%,ESR1;AKAP13;MIB2;ECM1;F2R;TMEM106A;LPAR1;MID2;USP10;NR1D1;CARD16;TFG;UBE2N;CHUK;TIRAP;PPP5C;LGALS1;SQSTM1;OTUD7B;IRAK4;DDX21;TNIP1;IRAK1;NDFIP1;TRAF3IP2;RHOA;ZC3H12A;MAP3K14;RBCK1;SLC20A1;TRIM68;PER1;TRAF3;UFL1;CANT1;SLC44A2;UNC5CL;CARD11;LURAP1;RORA;ROR1;MIER1;PPM1A;FLNA;GOLT1B;TSPAN6;PYCARD;TAB2;TERF2IP;TRAF4;CPNE1;TRIM8;TRAF5;MAP3K7;FKBP1A;TNIP2;RELA
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.40040715661734483,0.8923783394374798,0.615979381443299,0.9643437253970687,1.0,4/17,5.29%,VEGFA;FGF2;SLIT2;MIA3
prerank,regulation of interferon-gamma production (GO:0032649),0.33098264290390284,0.8923227832140653,0.6517571884984026,0.9639862008837307,1.0,10/71,14.20%,AXL;C1QBP;INHA;GAS6;TLR4;SIRPA;CD47;PDE4D;ZC3H12A;CD14
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.43217252832136244,0.8922620904993493,0.6043656207366985,0.9636487195525163,1.0,3/12,11.99%,BIN1;DSC2;JUP
prerank,negative regulation of programmed cell death (GO:0043069),0.3072769683054446,0.892031733174146,0.81,0.9636557286260024,1.0,71/355,20.57%,COMP;FSTL1;AXL;GCLC;ARHGAP10;EGFR;ANXA1;WT1;HPN;ANGPT4;TRIAP1;SIX4;CD44;VEGFA;MIF;ATF5;COPS5;ITCH;CBX4;SOCS2;FOXO1;ARF4;SRC;AIFM2;GAS6;DPEP1;SOX8;TIGAR;PSEN1;AVEN;SMAD6;SQSTM1;HDAC3;SON;NPM1;AKT1;BCL3;IRAK1;NAT8;UBA52;CD27;GDNF;CBL;WDR73;NME2;NUPR1;IL4;BAG4;VDAC1;AHI1;ANXA4;IL6;HGF;TAX1BP1;FAIM2;TMBIM4;PLAUR;NAA15;ERCC5;VTCN1;UFM1;SUPV3L1;DSTYK;PRDM9;MCL1;HIPK3;IL31RA;RASA1;PRELID1;DDAH2;FLNA
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.3933758375659273,0.8917715177294372,0.6416978776529338,0.9637423706562471,1.0,7/21,14.23%,ANK2;SRI;CAMK2D;GSTM2;PDE4D;CALM2;CASQ1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.3938014751746598,0.8917203827605462,0.6261319534282018,0.9633724227299395,1.0,2/18,8.08%,ZFP36L1;ZFP36L2
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.3062170873612039,-0.8915703276514574,0.6419213973799127,0.8713226457900747,1.0,6/16,17.72%,DCPS;CWC15;SNRNP200;SRSF1;SRSF12;WBP4
prerank,nuclear transport (GO:0051169),0.406008831721315,0.8915498209532701,0.6198675496688741,0.963245837361118,1.0,4/16,18.05%,NUP98;NPM1;PSIP1;NXT2
prerank,glycerolipid metabolic process (GO:0046486),-0.3507546608506617,-0.891156665716753,0.5774647887323944,0.8705848750441183,1.0,7/11,24.04%,DGKB;DGKZ;PIP5K1A;PLA2G15;PNPLA3;GAL3ST1;DGKG
prerank,negative regulation of protein processing (GO:0010955),0.42632904663121257,0.8910099202974986,0.6146540027137042,0.9638757941222497,1.0,1/12,2.58%,GAS1
prerank,mammary gland epithelium development (GO:0061180),0.4018109359280935,0.8907906508620181,0.618925831202046,0.9638228224376798,1.0,1/14,0.75%,WNT2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.3301427545864478,-0.8905702126094837,0.5854545454545454,0.8702564953577148,1.0,7/13,19.03%,ELOVL7;HACD1;HACD4;HACD2;ELOVL1;ELOVL4;TECRL
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.3060636409516305,-0.8905474936559395,0.5551181102362205,0.8686795168551379,1.0,3/16,7.65%,DPYD;UPB1;NT5E
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.41314315547177044,0.8905277542599462,0.6149584487534626,0.9638861969542705,1.0,5/14,21.89%,ACD;TPP1;XRCC5;TINF2;TERF2IP
prerank,amyloid-beta metabolic process (GO:0050435),-0.31769535901032986,-0.890217571187314,0.6061946902654868,0.8678496630363076,1.0,3/16,3.45%,BACE2;MGAT3;DYRK1A
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.2665486556765958,-0.8900097723163337,0.6449704142011834,0.8666810148686213,1.0,9/27,16.94%,PRKCH;PPARA;NR1H3;ABCG1;AGTR1;NFKBIA;MAPK9;ABCA5;LPL
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.2922819692291722,-0.8897964505281017,0.6355555555555555,0.8654931576883858,1.0,1/20,0.17%,NR2F2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.3067093566745201,0.8897926166261082,0.84,0.9648951878549032,1.0,87/417,18.54%,PAX9;ATP8B1;GCLC;LOXL2;FOXP2;WT1;ZC3H8;SIX4;FOXP1;BHLHE40;GLIS2;SMAD4;HDAC9;ATF5;DPF2;SMURF2;TSC22D4;CREB3L1;FOXK2;NAB1;TCF7L2;NR1D2;CBX4;RBAK;FOXO1;NR1D1;PRMT2;CREBZF;DPF1;MLXIPL;MDFIC;HDAC6;ZFPM2;GAS6;SOX8;VDR;MAGEL2;SIRT2;RCOR3;CIPC;KDM5C;ING4;BRD7;PHC3;HDAC3;INPP5K;BCL6;TLE2;CALCA;MPHOSPH8;PHC1;ZHX2;SMARCC2;GLI3;SAMD1;RBFOX2;BCL3;NCOR2;XRCC5;NCOR1;CBFA2T2;TWIST1;NACC2;HDAC4;KLF4;DMAP1;HOXA7;CHD8;SMARCA4;IL4;GMNN;ZEB1;YEATS2;BAHD1;PER1;PDCD4;DKK3;SAP18;DAP;PML;TFAP4;SNX6;SET;QARS1;CTCF;NIPBL;GCFC2
prerank,regulation of Notch signaling pathway (GO:0008593),0.32408523064196093,0.8892576542402094,0.6628151260504201,0.9655101830154753,1.0,14/76,11.26%,EGFR;ZMIZ1;TGFB2;LLGL1;TSPEAR;BEND6;SRC;JAG1;RFNG;KAT2B;BMP2K;EGF;AKT1;ENHO
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.3348955375298766,-0.8889640748558694,0.5851851851851851,0.8658544312633217,1.0,4/13,7.36%,IGF1;RAMP1;PLCB1;ALG10B
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.3065862999937214,-0.8889471485230721,0.6693227091633466,0.8642684296143511,1.0,15/15,69.38%,QDPR;KYNU;FAH;IL4I1;HGD;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD;TAT;KYAT1;GSTZ1;KMO
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.33350974685407975,0.8888885682100008,0.6815286624203821,0.9657938871598625,1.0,14/62,15.54%,POLR2H;GTF2H3;CDK9;ADRM1;ELP4;SETD2;ERCC3;POLR2D;POLR2G;CCNH;CTDP1;EAF2;GTF2F1;EAF1
prerank,phagosome maturation (GO:0090382),0.3553561505464527,0.8888654568311879,0.6289017341040463,0.965370413202968,1.0,7/35,16.28%,RAB32;ATP6V0A2;ATP6V1E1;RAB43;ATP6V1D;ATP6V0A1;ATP6V1B2
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.337959366525834,-0.8888638683389696,0.6145038167938931,0.8628527144397087,1.0,4/12,16.75%,HUS1;TOPBP1;SETMAR;ORC1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3268980110607731,0.8887492354521467,0.6784188034188035,0.9651278127036408,1.0,22/72,23.57%,FGF13;SLIT2;SMAD4;MYADM;PFN2;CHADL;PIK3CA;KANK1;TWF1;SSH1;MAPRE1;CAMSAP1;TUBB4A;IAPP;PFDN6;NAV3;CLIP3;ARFGEF1;CLASP2;SSH3;LDLR;CRYAB
prerank,defense response to symbiont (GO:0140546),-0.21030737461639135,-0.888639051522452,0.8823529411764706,0.8617341536181177,1.0,16/92,13.30%,BCL2L1;SERINC3;BCL2;TRIM56;PLSCR1;ABCC9;IFITM3;MAVS;CNOT7;IFIT1;IFIT2;TLR3;OAS2;STAT1;IFIT3;RNASEL
prerank,carbohydrate derivative catabolic process (GO:1901136),0.39267175778515034,0.8884762004896963,0.6224226804123711,0.9652333039474857,1.0,5/18,15.61%,FBXO2;OGA;FBXO17;SAMHD1;NGLY1
prerank,regulation of calcium ion import (GO:0090279),0.38247284260635994,0.88808852523951,0.6370370370370371,0.9655776338347353,1.0,4/21,15.66%,FYN;PKD2;EGF;STC1
prerank,positive regulation of angiogenesis (GO:0045766),0.3154305783898804,0.8876939656103365,0.7131147540983607,0.965898744212404,1.0,10/108,4.55%,CD34;FGF18;PRKCA;ANGPT4;RUNX1;VEGFA;FGF2;ECM1;SMOC2;ITGA5
prerank,tetrapyrrole metabolic process (GO:0033013),0.39592845273726246,0.8874797419593439,0.6342710997442456,0.9658636218753632,1.0,6/18,24.66%,TCN1;ABCC1;MTR;MMADHC;MMAB;MTRR
prerank,regulation of cytoplasmic translation (GO:2000765),0.4105048023059711,0.8874556928016968,0.6287581699346405,0.9654508844197979,1.0,5/14,28.80%,UNK;CPEB1;PKM;RBM24;CNBP
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.347188821590356,0.8872145341024433,0.6632064590542099,0.9654698035492064,1.0,8/37,18.53%,GTF2H3;ERCC3;UBA52;ERCC4;DDB1;RFC4;ERCC5;POLD1
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.35549005235714287,0.887175520367388,0.6584507042253521,0.9650866849940077,1.0,3/34,9.23%,EPHB2;CLCF1;STX4
prerank,protein monoubiquitination (GO:0006513),0.3512677708086578,0.8867327422836881,0.6231721034870641,0.9655156702163631,1.0,14/36,26.27%,UBE2B;UBE2W;FANCL;CUL3;DTL;ATXN7L3;PEX12;UBE2R2;UBE2D3;PAF1;KLHL22;RNF20;RNF126;KLHL12
prerank,rRNA transcription (GO:0009303),0.39724858109619166,0.8866268516805398,0.6177606177606177,0.9652678884866448,1.0,6/17,23.60%,ANG;POLR1G;GTF3C2;BRF1;SPIN1;GTF3C5
prerank,regulation of gluconeogenesis (GO:0006111),0.3625095050140982,0.8865609812004348,0.6349765258215962,0.9649144099280897,1.0,6/27,15.80%,DGKQ;DDB1;ZNF692;USP7;SELENOS;OGT
prerank,outer dynein arm assembly (GO:0036158),0.4096494468358214,0.8861665356077424,0.616600790513834,0.9652051488767192,1.0,4/14,22.37%,DNAH8;DNAAF5;DNAH5;DNAL1
prerank,apical protein localization (GO:0045176),0.4461524964931547,0.8860620288209092,0.6329113924050633,0.9649545600358153,1.0,5/10,20.93%,ATP8B1;JAM3;VANGL2;GOPC;SHROOM3
prerank,DNA recombination (GO:0006310),0.3487487512105366,0.8854875194033021,0.6468571428571429,0.9656600671201533,1.0,9/37,19.01%,XRCC3;RAD51B;IGHMBP2;RHNO1;HMGB3;RECQL;RAD50;BLM;SUPV3L1
prerank,apoptotic mitochondrial changes (GO:0008637),0.35576574714398135,0.8851872098418649,0.6437869822485207,0.9657869132515939,1.0,6/32,12.70%,TIMM50;AIFM2;BBC3;NDUFS1;BAK1;SFN
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3048223317679273,0.88496919264272,0.885,0.9657439776651935,1.0,159/572,26.13%,AR;ESR1;TRPS1;LOXL2;NFIX;FOXP2;WT1;TLE6;SCRT2;SKIL;RUNX1;VEGFA;KLF12;FOXP1;BHLHE40;GLIS2;ZNF25;SMAD4;HDAC9;DPF2;SMURF2;SKI;SOX10;DACT1;TCF25;KLF2;TCF7L2;NR1D2;NFATC4;MEIS2;CBX4;IL33;NR1D1;NFIB;ZFHX3;C1QBP;MDM4;GLI2;SIN3B;NOC2L;ZFPM2;RNF2;FLCN;TBX6;SOX8;ZBTB1;NR6A1;VDR;PSEN1;FOXC2;SIRT2;ZMYM5;HDAC3;BCL6;MITF;OTUD7B;MYPOP;ZNF3;TCERG1;MZF1;ZHX2;TAF3;GLI3;URI1;IRF2BPL;CEBPB;CRYM;UBA52;NCOR2;ZFP36;DR1;NCOR1;PEG3;IKZF5;TWIST1;CCND1;NACC2;DNAJA3;EZH1;HDAC4;EHMT2;KLF4;DMAP1;HOXA7;ZNF692;HSBP1;CHD8;SMARCA4;SNAI2;IL4;NR2C2;DDX20;ZEB1;YEATS2;ZBTB5;NOP53;PER1;E4F1;CHD3;DDX5;NRIP1;HIVEP1;CTCF;NIPBL;UXT;SUDS3;RPL23;DNAJB1;UBE2D3;MIER1;CTBP1;KDM1B;PPM1A;PHF21A;NSD1;HSF4;KDM2B;PEX2;PAF1;ZEB2;EZH2;BAG3;ATF4;SDCBP;LARP7;JUN;TPR;VPS72;GATAD2A;LDB2;LDB1;IFI27;ZNF431;SKOR2;NR3C1;RTF1;RELA;PER3;LCOR;HEXIM1;ORC2;MDM2;CALR;PHF12;RARA;MBD2;BCL11A;MAFK;E2F7;VHL;KAT5;PHF6;RARG;MYT1L;KLF10;KMT5A;H1-0;DDIT3;CRY2
prerank,negative regulation of neuron projection development (GO:0010977),0.33200263914824196,0.8844137797972346,0.6535947712418301,0.9663628059721957,1.0,20/56,25.52%,PTPRS;LPAR1;STX1B;SEMA3A;MYLIP;GDI1;TSKU;KANK1;NGEF;RTN4RL1;CBFA2T2;RHOA;DCC;FKBP4;PTEN;CRMP1;BAG5;RTN4;BCL11A;RAB29
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.43437495793124037,0.8842363348262025,0.6185714285714285,0.9662656590062259,1.0,3/10,12.13%,IRS1;AKT1;IRS2
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.3393366258882633,-0.8836564201084699,0.611764705882353,0.8714091438822019,1.0,4/12,8.84%,PROM1;NKD1;CEP290;SDK2
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.3284035641788501,-0.883514452946601,0.6221374045801527,0.870119631894923,1.0,4/13,12.28%,NOS3;GCH1;QDPR;SPR
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.41729941622371536,0.8830523863055018,0.629878869448183,0.9680685525829562,1.0,2/13,3.24%,VEGFA;TGFBR2
prerank,positive regulation of transferase activity (GO:0051347),0.31291450320922903,0.8829369986642817,0.7381193124368048,0.9678254641038577,1.0,32/142,19.40%,DDR2;EPHB2;AXL;EGFR;FGFR1;EPHA3;MST1R;AXIN1;RET;UBE2N;ACD;EPM2AIP1;HNRNPD;EPHB3;POLG2;MUSK;EPHA10;XRCC5;PDGFRA;FLT3;PIN1;DDR1;NBN;KLF4;HSP90AA1;RFC4;CHRNA7;RAD50;EPHB1;DSTYK;NEK7;ROR1
prerank,telomere organization (GO:0032200),0.34237863606746827,0.8829149810289887,0.6674132138857782,0.9674006031301955,1.0,12/43,18.67%,PARP3;CTC1;ACD;DNA2;XRCC5;ERCC4;TERF1;NBN;RAD50;BLM;POLD1;TINF2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.30162954975610656,-0.882734387705872,0.6142857142857143,0.8701526205272985,1.0,3/17,7.47%,CADM1;AP1G1;NECTIN2
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.36398722892674257,0.8819977986964046,0.6440281030444965,0.9688166253285683,1.0,7/26,12.78%,SRI;PKD2;CRHR1;YWHAE;GSTM2;CALM2;THADA
prerank,innate immune response (GO:0045087),0.3052053546885526,0.8819818071061524,0.7811244979919679,0.9683784714058132,1.0,41/217,23.17%,LBP;SYK;SRMS;TNK1;FYN;ANG;MID2;MSRB1;COLEC11;CXCL10;SRC;CHUK;CYP27B1;MASP2;TLR4;TRIM11;IRAK4;SETD2;SLPI;DMBT1;IRAK1;RNASE6;ADAM15;CR2;FER;IL4;TRIM68;RNF187;PML;AKAP1;SMPD1;MBL2;SKP2;TRIM35;YES1;SRPK1;PIK3CG;POLR3A;TRIM8;IFI27;CYLD
prerank,organophosphate ester transport (GO:0015748),0.371847295072341,0.8819340247269846,0.6324062877871826,0.9680016394513041,1.0,9/24,23.09%,TRIAP1;OSBPL2;PRELID3A;SCP2;EPG5;PRELID1;PITPNM1;PCTP;LDLR
prerank,negative regulation of RNA splicing (GO:0033119),0.3971880057410332,0.8818873821561144,0.6428571428571429,0.9676256455409005,1.0,8/19,28.55%,SRSF6;C1QBP;SAP18;U2AF2;PTBP1;PTBP2;RBMX;RPS26
prerank,transcription by RNA polymerase II (GO:0006366),0.30572389276032763,0.8818760826088269,0.8168168168168168,0.9671929528708352,1.0,82/305,25.08%,PRRX1;AR;ESR1;NFIX;POLR2H;PAX1;ZC3H8;INTS3;GTF2H3;ABT1;HDAC7;HDAC9;WWTR1;NR1D2;TAF8;SCAF8;NR1D1;INTS10;ZBTB1;NR6A1;VDR;CDK9;ADRM1;SOX5;ELP4;KAT2B;INTS6;HDAC3;CPSF4;TAF3;DDX21;SETD2;ERCC3;NCOR2;POLR2D;POLR2G;NCOR1;GTF2A2;CCNH;CTDP1;EAF2;GTF2F1;NFE2L3;BTF3;NR2C2;E2F3;EAF1;CPSF2;INTS2;DDX5;SNRPG;SNRPD3;SLBP;MED23;INTS12;RORA;NR2C2AP;GTF2E2;MBD1;ICE1;PAF1;TFCP2;LHX1;ATF4;RNMT;TBP;MED7;ELL;CSTF2T;NR3C1;RTF1;ESRRA;TAF13;TRIM24;CPSF7;CPSF1;POLR2C;PABPN1;MED26;RARA;NRBP1;WDR33
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3898211024381356,0.8818296733371447,0.6556543837357052,0.9668196020661779,1.0,10/19,29.64%,PARD3B;DLG2;FSCN1;SYNJ2BP;MTCL1;MARK2;CRB1;PRKCI;LRRC7;PARD3
prerank,regulation of adenylate cyclase activity (GO:0045761),0.3771075525598432,0.8815130498916782,0.6381909547738693,0.9669903154600292,1.0,7/22,21.45%,GNAI3;CRHR1;PALM;LTB4R2;CAP1;STIM1;NF1
prerank,regulation of cellular respiration (GO:0043457),-0.3145882994697584,-0.8814943178684588,0.6183574879227053,0.871291406551406,1.0,4/17,7.51%,IFNAR1;CBFA2T3;IL10RB;PRDM16
prerank,transcription preinitiation complex assembly (GO:0070897),0.41358877055504795,0.8813955162097922,0.623448275862069,0.9667511654812853,1.0,5/12,23.04%,DR1;GTF2A2;TAF7L;TBP;BDP1
prerank,Golgi ribbon formation (GO:0090161),-0.32673930142297813,-0.8809185512141587,0.6138211382113821,0.8709337428001191,1.0,5/13,13.59%,STX6;MYO18A;OPTN;GCC2;GOLGA2
prerank,negative regulation of viral transcription (GO:0032897),0.4165015686642307,0.8805963026595687,0.6377410468319559,0.9678391188918009,1.0,6/13,24.09%,MID2;TRIM11;ZFP36;UBP1;LARP7;HEXIM1
prerank,positive regulation of isotype switching (GO:0045830),-0.31377340709246093,-0.8805606418496938,0.5932203389830508,0.8700928482880782,1.0,9/15,21.36%,KMT5B;SHLD1;KMT5C;TFRC;TGFB1;RIF1;CD40;MAD2L2;TNFSF13
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3092619120134077,0.8803636800816088,0.7736418511066399,0.9678241991535431,1.0,45/198,21.52%,GFPT2;EPHB2;PFKP;PLCE1;GFPT1;PLPP3;PLCB4;ACP2;MTOR;PLPP1;GK5;TIGAR;PIK3CA;OCRL;LCAT;AGK;INPP5K;AKT1;PGM2L1;CERK;INPP4A;PLPPR3;PPP3CA;PLA2G4E;PI4KA;G6PC3;SLC20A1;NUDT5;PIP4P1;IPPK;PLCD4;PLPP2;ANGPTL3;ALDOA;PANK3;PPP3CB;TOLLIP;INPP5B;PIP4K2B;ACYP1;IP6K1;ACP3;PPM1A;PTEN;PIK3CG
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.2698054391959813,-0.8801761491605318,0.6927374301675978,0.8693013197410225,1.0,4/23,9.76%,CECR2;HMGB1;CASP3;REXO4
prerank,rRNA methylation (GO:0031167),0.37350863091771347,0.8801698009128726,0.62625,0.9677707347707443,1.0,4/22,14.33%,DIMT1;FDXACB1;ZCCHC4;MRM3
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.3079340253246014,0.8801574304848474,0.7583081570996979,0.9673276877870203,1.0,49/172,22.80%,GPAT4;FGF2;DGKQ;PIK3C2B;PIK3R2;PI4K2B;FAR1;FIG4;CHKB;PIK3CA;OCRL;INPP5F;SLC44A1;LCAT;AGK;ARF1;AGPAT3;INPP5K;LPCAT1;PLEKHA4;RUFY1;MBOAT7;INPP4A;PLEKHA1;AGPAT5;PI4KB;CEPT1;GPAT3;MTMR6;PI4KA;MTMR1;PIP4K2C;SLC44A2;GPAM;LIPH;CDIPT;DDHD1;PLD2;PIP4K2B;LPIN3;PITPNM1;TAMM41;PTEN;PIK3CG;CSNK2A2;CPNE1;PCTP;PI4K2A;PTDSS1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3507779009129509,0.8800476073691252,0.6616279069767442,0.9670678130810885,1.0,7/33,14.55%,ANGPT4;MEOX2;FGF2;ATP2B4;JUP;RHOA;KLF4
prerank,positive regulation of nervous system development (GO:0051962),0.34139478186075944,0.8798881984718219,0.6655251141552512,0.9669157168162439,1.0,4/42,9.69%,EPHB2;NUMBL;SERPINF1;EPHB3
prerank,substantia nigra development (GO:0021762),0.3508860153747694,0.8797137167084204,0.6528735632183909,0.9667736233742958,1.0,14/37,25.24%,YWHAE;SIRT2;PLP1;CALM2;RAD1;RHOA;GLUD1;PADI2;NDRG2;MBP;SUDS3;FGF9;DYNLL1;MAPKAP1
prerank,mesenchymal cell development (GO:0014031),-0.2982894201440063,-0.8794736322564705,0.6390041493775933,0.8693250166688805,1.0,6/18,17.02%,NOTCH1;FOXC1;HEYL;TAPT1;SOX11;CDH2
prerank,signal transduction in response to DNA damage (GO:0042770),0.3327800660874131,0.8791422978393717,0.6622950819672131,0.967432884953796,1.0,19/49,30.44%,TRIAP1;MAPK14;USP10;MDM4;RHNO1;BCL3;RAD1;BRIP1;NBN;DONSON;CLSPN;SESN2;TIPRL;E2F7;PRPF19;RAD17;ATRX;TP53;RAD9A
prerank,cellular response to osmotic stress (GO:0071470),0.373098564544886,0.8787619495630941,0.6318407960199005,0.9677215710281932,1.0,4/21,12.09%,LRRC8D;ZFP36L1;PKD2;STK39
prerank,sensory perception of smell (GO:0007608),0.42465245742457447,0.8787534670678365,0.6276445698166432,0.9672732697074113,1.0,4/11,36.62%,BBS4;SLC24A4;DRD2;ADCY3
prerank,RNA methylation (GO:0001510),0.329676453052474,0.8787365214892904,0.6736035049288062,0.9668324271736674,1.0,9/60,13.51%,DIMT1;TRMT6;TYW3;MEPCE;TRMT61A;FTSJ1;TGS1;THADA;ZCCHC4
prerank,cellular response to copper ion (GO:0071280),-0.30835567201355,-0.878691918648784,0.6126482213438735,0.869419861032493,1.0,1/16,3.24%,SNCA
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.25322609741904767,-0.8786773547531513,0.7007299270072993,0.8678622384477765,1.0,11/35,15.78%,VTN;TNK2;PIK3CB;B2M;LDLRAP1;HIP1R;SGIP1;HNRNPK;HIP1;HFE;SERPINE1
prerank,fatty acid elongation (GO:0030497),-0.32195561204478285,-0.8786157498062309,0.6113207547169811,0.8664042571196069,1.0,6/13,16.96%,ELOVL7;HACD1;HACD4;HACD2;ELOVL1;ELOVL4
prerank,glucan catabolic process (GO:0009251),-0.30279199633142573,-0.8785929267101225,0.6273764258555133,0.8648557590251524,1.0,3/15,5.24%,PHKB;PYGM;AGL
prerank,substrate-dependent cell migration (GO:0006929),0.4061696626399778,0.8779851566456914,0.6300268096514745,0.967869156503879,1.0,3/14,7.16%,ITGA11;ITGA2;NTN1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.3539385305685777,0.8777361100742973,0.667447306791569,0.9679151370505393,1.0,11/32,21.08%,MYOC;SRC;JAG1;ADAM15;BCAS3;HOXA7;RCC2;RASA1;CLASP2;CORO1C;PTEN
prerank,negative regulation of hydrolase activity (GO:0051346),0.336883409343231,0.8776614901112585,0.6685022026431718,0.967606057682351,1.0,12/49,19.96%,MAPK7;ECM1;SLC39A14;GPSM1;CSTB;URI1;BCAS3;CHP1;SH2D4A;RCC2;ARFGEF1;TMED2
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.2820274417320115,-0.8776250694283912,0.6666666666666666,0.8653116396565016,1.0,4/21,8.48%,RAP1GDS1;SLC8A3;TGM2;MICU2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.41926353698353935,0.8774816734046637,0.6128133704735376,0.9674898925523555,1.0,5/12,23.59%,PAICS;GART;ATIC;ADSS2;LHPP
prerank,neutral amino acid transport (GO:0015804),0.3623963239297592,0.8772907865556072,0.6481927710843374,0.9673920635791303,1.0,2/28,5.44%,SLC1A5;SLC43A2
prerank,prostanoid biosynthetic process (GO:0046457),-0.3094448043551688,-0.8769650224931532,0.6291666666666667,0.8652240097768992,1.0,6/15,15.72%,PTGDS;PTGS2;PTGIS;PTGES3;EDN1;CD74
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.35009869909809155,0.8768426689634262,0.6524317912218268,0.9678421974995023,1.0,3/33,2.88%,WT1;FGF2;TGFB2
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3595196375691355,0.8768171645904453,0.6257521058965102,0.9674315092365343,1.0,4/28,9.52%,PARP3;CYREN;TFIP11;NUDT16L1
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.31094892424201614,0.8766471079116612,0.7426841574167508,0.9672979198087571,1.0,32/124,18.59%,MYOC;ODF2;RASGRF1;UNC5A;DTNBP1;DOCK7;LRP12;ADCYAP1;PKD2;TOR1A;L1CAM;PLP1;CAMSAP1;MAPT;TBC1D23;FLRT3;LGI1;GDNF;PLEKHA1;ULK1;ATCAY;BLOC1S2;MAP4;MANF;FAM161B;IL6;SNAPIN;RAB35;PPP1R9B;STX3;CNTN4;GPM6A
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3250683947329659,0.8765295209904448,0.6935312831389183,0.9670478603829279,1.0,13/63,18.08%,AR;FGFR1;ACVR1;TCF7L2;SRC;PELI3;STX4;ITGAV;DEPTOR;IL4;MADD;PML;TGFBR1
prerank,positive regulation of innate immune response (GO:0045089),0.35170402203973206,0.8761651928850945,0.6603325415676959,0.9672809925504653,1.0,4/30,14.64%,LBP;POLR3D;AKIRIN2;SLC15A4
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.2748198828621883,-0.8759304393668285,0.6810810810810811,0.8659966939281972,1.0,8/21,20.52%,EPHA7;AIM2;DELE1;TTBK1;BEX3;MT3;PSMB9;BIRC2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.23778152492988042,-0.8755536203224331,0.7288135593220338,0.865306200362511,1.0,13/41,19.80%,PRKAG2;LACC1;NUP35;NDC1;RAE1;PGAM1;NUP153;EP300;NUP214;POM121;NUP155;HIF1A;NUP205
prerank,mitochondrion localization (GO:0051646),0.3917855364335744,0.8753668817628724,0.6359039190897599,0.9683581946088549,1.0,6/19,26.70%,TLE6;TRAK2;ATCAY;MTM1;MARK2;MUL1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.35815772860483563,0.8753254183613399,0.6455542021924482,0.9679761870632768,1.0,6/25,14.68%,KLF2;PKD2;TLR4;AKT1;KLF4;HSP90AA1
prerank,cellular response to metal ion (GO:0071248),0.30965187591538545,0.875262717425842,0.736734693877551,0.9676466816611894,1.0,15/123,9.15%,EGFR;SYT2;NEUROD2;CPNE8;DLG4;SYT12;SYT11;SYT13;CAMK2D;DLG2;PKD2;DPEP1;CHUK;TIGAR;IQGAP1
prerank,mitotic cell cycle phase transition (GO:0044772),0.3076067234270237,0.8751362864042914,0.7793380140421263,0.9674314846305961,1.0,56/203,24.74%,DCTN1;ODF2;CDK14;ACVR1;CDK4;CHMP7;TRIM71;USP29;YWHAG;BCAT1;SSNA1;YWHAE;CUL3;PPP1R12B;ALMS1;USP26;HAUS3;CDC23;MAPRE1;CDC34;SFI1;CDKN1A;CDC27;FBXL3;CCND1;DBF4;CCNH;CTDP1;HSP90AA1;GSPT1;DYNC1H1;TUBB4A;TUBA4A;E2F3;CDK5RAP2;CCP110;AKAP9;CEP164;CKAP5;PAFAH1B1;PPP2R2A;SKP2;CUL5;CLASP2;PCM1;PPP6C;CDKN2C;FBXW11;DCTN2;CDC25B;NEDD1;LATS1;ACVR1B;FBXL12;DYNLL1;CEP78
prerank,primary alcohol metabolic process (GO:0034308),0.368195213845963,0.8750010905218717,0.6414634146341464,0.9672327705856988,1.0,2/25,5.71%,DHRS9;ALDH3A2
prerank,regulation of cell migration (GO:0030334),0.3014543481192368,0.8748482055939488,0.845,0.9670770111923744,1.0,51/382,11.69%,IGFBP5;SEMA3C;HAS2;MYOC;EPHB2;COL1A1;FGF18;FGF7;PRKCA;EGFR;ANXA1;IGSF10;TMEFF2;ADARB1;LDLRAD4;VEGFA;FGF2;SGK3;SLIT2;F2R;ADAM9;MIF;LMNA;ACVR1;GTPBP4;MIA3;PTPRJ;SRGAP1;MEAK7;SULF1;MYADM;SRC;RET;PIP5KL1;FLCN;DPEP1;SLK;SEMA3A;JAG1;PLXNA3;SRCIN1;STX4;KIF2A;MITF;KANK1;MAPRE1;EGF;AKT1;MGAT5;GPNMB;MAGI2
prerank,acyl-CoA biosynthetic process (GO:0071616),0.39133426548773464,0.8739989983075436,0.6304062909567497,0.968225091085989,1.0,5/16,20.79%,ACLY;HSD17B8;DIP2A;SCD5;ACAT1
prerank,gland development (GO:0048732),0.3285943153635252,0.8739904735312628,0.685501066098081,0.96777922932162,1.0,8/59,9.69%,ANXA1;TGFB3;WT1;COBL;GLI2;PKD2;ZBTB1;EPHB3
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.30627061294166574,0.8738929901965868,0.7849246231155779,0.9674990361563925,1.0,32/182,17.06%,CD34;ESR1;RUNX1;VEGFA;FGF2;DGKQ;TGFB2;FOXP1;DLG4;RBMS3;MIF;CREB3L1;ATP2B4;TARDBP;MYADM;FLCN;ATXN2;VDR;PSEN1;AGO2;PARP14;MAPT;SLC2A10;NDFIP1;SMCR8;ZC3H12A;KLF4;MAP2K2;FLOT2;DIP2A;PTRH2;AGO4
prerank,regulation of MAP kinase activity (GO:0043405),0.3167508544278163,0.8736555747081381,0.718717683557394,0.9674826298589891,1.0,9/92,5.31%,FGF18;EGFR;FGFR1;UCHL1;IRAK3;VEGFA;FGF2;MST1R;PTPRJ
prerank,positive regulation of autophagy (GO:0010508),0.3175886140903947,0.8734921842564176,0.7072402938090241,0.9673391797971038,1.0,15/81,17.01%,DCN;GNAI3;MID2;FOXO1;PLEKHF1;FLCN;GPSM1;CAMKK2;SESN3;LARP1;ZC3H12A;ULK1;IL4;TRIM68;UFL1
prerank,cellular component assembly (GO:0022607),0.3029761217864934,0.8731880766725802,0.8076152304609219,0.9674563532402274,1.0,47/253,18.87%,HAS2;GSN;HAS1;SCIN;STK25;WIPF1;LLGL1;DLG4;CHAF1B;GPAA1;ZW10;TLCD2;WASF1;FSCN1;MDM4;NOC2L;GAS6;MYO9A;ACD;TOGARAM1;SYCP2;RSPH1;RHOJ;RHOQ;MITF;RHOA;RTN3;TTLL3;SPAG17;LIMS2;SPTBN1;PLS1;ACTG1;RAC3;SPG7;PML;NAPG;TFAP4;YTHDF2;YTHDF1;ILK;KMT2A;EPRS1;TINF2;VAMP2;MICAL1;LAMC1
prerank,regulation of autophagosome maturation (GO:1901096),-0.31895386569501777,-0.8730685721826729,0.6138996138996139,0.8691896088396923,1.0,5/13,19.96%,UVRAG;TBC1D25;ADRB2;CLN3;IRGM
prerank,synapse assembly (GO:0007416),-0.21908057101822925,-0.8727385602888472,0.7575757575757576,0.8682691247717087,1.0,16/67,13.05%,SPOCK2;CDH1;SHANK3;WNT5A;DNM3;PLXND1;RYK;PLXNB1;SDK2;LRRC4;GABRB3;CDK5;SDK1;BDNF;PCDHB14;SLITRK1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.4362645997058744,0.8726158048900463,0.6685714285714286,0.968085800434968,1.0,2/11,15.09%,TMEM106A;IL4
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3258855124156016,0.8725260954952523,0.7142857142857143,0.9677885329836475,1.0,23/67,24.81%,ATP8B1;GAP43;MYO10;FSCN1;TBC1D2B;TBC1D17;TWF1;TBC1D10A;FER;ARF6;DYNC2LI1;EVI5;FXR2;TBC1D13;TBC1D22B;TBC1D15;TBC1D19;ABITRAM;ATG3;CYLD;DMTN;RAC1;CDKL1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.2612519379300687,-0.8719775414147416,0.6845637583892618,0.8682798131407219,1.0,8/30,12.21%,BMP5;BCL2L1;NOS3;FAS;ICAM1;RIPK1;TNFSF10;CFLAR
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.4393426374988287,0.8719182991615144,0.6305555555555555,0.9685185829829791,1.0,4/10,21.89%,ACD;TFIP11;DCLRE1A;TERF2IP
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3759078400727799,0.871763194407286,0.6625155666251556,0.9683624904551512,1.0,9/21,24.31%,RASSF2;MLXIPL;INPP5K;PDE4D;NLRP2B;NCK1;PTEN;NCK2;DMTN
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.28441543078648224,-0.8712576159749588,0.673469387755102,0.8682925166019347,1.0,7/20,16.68%,BCL2L1;BCL2;CASP3;FAS;CASP9;BCL2L2;ERBB3
prerank,mitotic cytokinetic process (GO:1902410),0.3804938472236647,0.8710858727156672,0.6569987389659521,0.9691854381720767,1.0,3/20,13.40%,CHMP7;VPS4B;RHOA
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.38892205736094454,0.8710064217631961,0.6520051746442432,0.9688840537071131,1.0,3/16,13.21%,WDTC1;ACADVL;NCOR1
prerank,regulation of autophagy (GO:0010506),0.30246131588808634,0.8702045339070416,0.8008008008008008,0.9699480350641599,1.0,70/216,26.72%,DCN;UCHL1;PIK3R2;MID2;USP36;ATP6V0A2;FOXK2;MTOR;USP10;FOXO1;PLEKHF1;PRKAB2;IL10RA;HDAC6;ABL2;FLCN;CAPN1;SIRT2;FBXL2;USP33;ERN1;AKT1;MAPT;BMF;ATP6V1E1;DRAM1;SMCR8;RRAGD;ZC3H12A;ULK1;CISD2;NUPR1;ATP6V1D;VDAC1;ATP6V0A1;TRIM68;ATP6V1B2;HGF;DAP;KEAP1;HTRA2;UFL1;PIP4K2C;GPR137B;SNX6;ATG13;SREBF1;EXOC4;MCL1;PIP4K2B;ATF6;TAB2;USP13;KLHL22;CSNK2A2;EIF4G3;TRIM8;SLC38A9;ATP6V0B;LEPR;DCAF12;RAB39B;KAT5;TICAM1;FBXW7;EIF4G1;DDIT3;CAPNS1;CTSA;TPCN1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.37762875850024286,0.8701855786448255,0.6423267326732673,0.9695209824005921,1.0,3/22,10.87%,CD160;PTPRJ;UBASH3A
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.33543525426691007,0.8701566800199195,0.6685022026431718,0.9691160269593198,1.0,18/48,27.54%,MYOC;S100A10;FBXW8;MYADM;C1QBP;TRIOBP;LIMS2;RAC3;ILK;FLNA;DMTN;RAC1;CALR;CUL7;ARHGEF7;PRKDC;IL1RAPL1;CAPRIN2
prerank,regulation of neutrophil migration (GO:1902622),0.43586406975916747,0.8700362010744978,0.6605890603085554,0.9688955139046045,1.0,2/10,11.74%,JAM3;MPP1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3543422729387996,0.8699601500868535,0.6760895170789164,0.9685862221558172,1.0,13/31,29.64%,PARD3B;DLG2;MYO9A;RHOA;ANK1;SYNJ2BP;PDCD6IP;MTCL1;MARK2;CRB1;PRKCI;LRRC7;PARD3
prerank,positive regulation of neuron projection development (GO:0010976),0.3167088487344387,0.8698152630566998,0.7229800629590766,0.9683846042436179,1.0,17/85,13.45%,DBN1;NPTN;EPHA3;S100A9;COBL;TENM3;RET;RIT2;ABL2;NDRG4;TWF1;FUT9;AVIL;MAGI2;KIDINS220;CBFA2T2;P3H1
prerank,mesoderm development (GO:0007498),0.3803290585239614,0.8697560218019231,0.6481958762886598,0.9680459066538963,1.0,3/18,8.79%,VEGFA;TBX6;FOXC2
prerank,granulocyte differentiation (GO:0030851),-0.2896162147265654,-0.8692762607798988,0.6486486486486487,0.8711115084183672,1.0,5/18,13.44%,LEF1;CBFA2T3;CDK2;EP300;TAL1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.34889265417472654,0.8692018731650396,0.6647662485746865,0.9686587629524094,1.0,7/34,13.27%,IRS1;FGF2;PIK3R2;WDR91;PIK3IP1;PDGFRA;FLT3
prerank,artery morphogenesis (GO:0048844),0.36015042925596147,0.8690385640007098,0.6729634002361276,0.9685259677468268,1.0,5/30,8.47%,LRP1;VEGFA;TGFB2;PKD2;JAG1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.35804886966868077,0.868963808158256,0.6646778042959427,0.9682102238479469,1.0,10/29,21.89%,ACD;GAR1;TERF1;TNKS1BP1;HSP90AA1;PPIA;RAD50;TINF2;PPP6C;TERF2IP
prerank,positive regulation of transporter activity (GO:0032411),0.4157837894563091,0.8689209449434147,0.6537949400798935,0.9678382274358643,1.0,3/13,17.93%,SGK2;STK39;KMT2A
prerank,bile acid and bile salt transport (GO:0015721),0.3668387519538354,0.8687401210383299,0.6633785450061652,0.9677018731405517,1.0,2/24,3.20%,ATP8B1;SLC51A
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.2921274181968927,-0.8686399459453534,0.6261261261261262,0.8709267363398201,1.0,2/18,1.56%,UNC13B;UNC13C
prerank,sodium ion export across plasma membrane (GO:0036376),0.4129088903854402,0.8683439043397775,0.6601307189542484,0.9679877752634962,1.0,5/13,11.43%,ATP1A4;ATP1A3;ATP1A1;SLC4A4;SLC9A1
prerank,negative regulation of cell adhesion (GO:0007162),0.3196877446464852,0.8679756739638326,0.7030752916224814,0.9682302501027475,1.0,18/72,17.10%,EPHB2;CORO2B;DACT2;GTPBP4;MIA3;JAM3;MUC1;TGFBI;ADAM22;FZD7;JAG1;PLXNA3;DSCAM;RHOA;PDE3B;SNAI2;FZD4;CD164
prerank,histone H3-K9 demethylation (GO:0033169),-0.34080142906527944,-0.8678805342792725,0.6145454545454545,0.8709652664319513,1.0,2/11,2.53%,KDM7A;KDM4A
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.43012013606268695,0.8677669628756856,0.6657142857142857,0.9681567730607097,1.0,5/10,20.59%,NCOA3;CYP27B1;VDR;NME2;NUMA1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.39928310320043237,0.867462277104054,0.637466307277628,0.9682746360386861,1.0,6/15,26.85%,ADAM9;TNFRSF1B;GPLD1;SH3D19;PACSIN3;SNX33
prerank,regulation of microglial cell activation (GO:1903978),0.40295324424919826,0.867359108938242,0.6412614980289093,0.9680228641731919,1.0,4/15,23.09%,SYT11;NR1D1;IL6;LDLR
prerank,heme biosynthetic process (GO:0006783),-0.28250066159105586,-0.8670427028394104,0.664804469273743,0.8711932776696153,1.0,3/22,6.51%,ABCG2;PGRMC1;FECH
prerank,regulation of ATP metabolic process (GO:1903578),-0.2246814251328908,-0.8670084293332825,0.8202247191011236,0.8697271274023411,1.0,16/54,19.80%,PRKAG2;NUP35;NDC1;PINK1;RAE1;PGAM1;UQCC2;NUP153;EP300;NUP214;AK4;POM121;NUP155;SPHK2;HIF1A;NUP205
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.2974075161238157,0.8667259056803689,0.94,0.9687868110088389,1.0,223/807,26.13%,AR;ESR1;PAX9;ATP8B1;GCLC;TRPS1;LOXL2;NFIX;FOXP2;WT1;ZC3H8;TLE6;SCRT2;SIX4;SKIL;RUNX1;VEGFA;KLF12;FOXP1;BHLHE40;GLIS2;ZNF25;SMAD4;HDAC9;ATF5;DPF2;SMURF2;SKI;TSC22D4;SOX10;DACT1;CREB3L1;FOXK2;TCF25;KLF2;NAB1;TCF7L2;NR1D2;MEIS2;CBX4;RBAK;IL33;MAF1;FOXO1;NR1D1;PRMT2;CREBZF;MUC1;ZFHX3;DPF1;C1QBP;MDM4;GLI2;MLXIPL;MDFIC;SIN3B;HDAC6;NOC2L;ZFPM2;RNF2;FLCN;TBX6;GAS6;SOX8;ZBTB1;NR6A1;VDR;PSEN1;MAGEL2;FOXC2;SIRT2;RCOR3;CIPC;KDM5C;ING4;ZMYM5;BRD7;PHC3;HDAC3;INPP5K;BCL6;MITF;OTUD7B;TLE2;CALCA;MYPOP;ZNF3;MPHOSPH8;TCERG1;MZF1;PHC1;ZHX2;TAF3;SMARCC2;GLI3;SAMD1;URI1;IRF2BPL;RBFOX2;CEBPB;BCL3;CRYM;UBA52;NCOR2;XRCC5;ZFP36;DR1;NCOR1;PEG3;CBFA2T2;IKZF5;TWIST1;CCND1;NACC2;DNAJA3;EZH1;HDAC4;EHMT2;KLF4;DMAP1;HOXA7;ZNF692;HSBP1;CHD8;SMARCA4;SNAI2;IL4;GMNN;NR2C2;DDX20;ZEB1;YEATS2;BAHD1;ZBTB5;NOP53;PER1;PDCD4;DKK3;SAP18;DAP;E4F1;CHD3;DDX5;PML;TFAP4;NRIP1;HIVEP1;SNX6;SET;QARS1;CTCF;NIPBL;GCFC2;UXT;BTAF1;RING1;SUDS3;PCGF6;RPL23;DNAJB1;UBE2D3;MIER1;CTBP1;KDM1B;PPM1A;FLNA;MBD1;PHF21A;NSD1;HSF4;KDM2B;PEX2;PAF1;ZEB2;EZH2;LHX1;ATF4;FBXW11;KAT6B;SDCBP;LARP7;JUN;TPR;VPS72;GATAD2A;LDB2;LDB1;IFI27;ZNF431;SKOR2;CRYAB;NR3C1;RTF1;RELA;PER3;LCOR;HEXIM1;SCMH1;ORC2;MDM2;SETDB2;CALR;L3MBTL3;PHF12;RARA;MBD2;BCL11A;SCML2;MAFK;E2F7;KAT7;VHL;KAT5;PHF6;PAX2;DPF3;RARG;MYT1L;KLF10;KMT5A;H1-0;DDIT3;CRY2
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.3018243587598837,-0.8664624296528559,0.6582914572864321,0.8693897038003308,1.0,7/18,19.70%,MSRA;ASPG;ASS1;ADI1;NAT8L;ASNS;FOLH1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.33478308726694456,0.8663872928199579,0.6674233825198638,0.9689811596271285,1.0,12/40,21.01%,TRIAP1;GPX1;AKT1;BMF;BBC3;MLLT11;HRK;GHITM;HGF;PLAUR;PRELID1;PYCARD
prerank,sensory perception of sound (GO:0007605),0.3153382154911186,0.8663666747960346,0.7307692307692307,0.9685664277456665,1.0,12/88,11.79%,COL1A1;HPN;COL11A1;SLC26A5;MYO1A;PDZD7;TSPEAR;MYO3B;TIMM9;MYH14;COL2A1;CRYM
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.3657077968550203,0.866115447268344,0.6501182033096927,0.9685968756280623,1.0,6/27,16.92%,CD44;MIF;TWIST1;SNAI2;EEF1E1;DDX5
prerank,potassium ion transport (GO:0006813),0.3081632477100208,0.8661129235127113,0.7354443309499489,0.9681484114966341,1.0,22/120,16.13%,KCNK5;KCNMA1;HPN;KCNV1;ATP1A4;KCNJ2;SLC9A9;KCND1;ABCB8;PKD2;KCNK13;KCNK9;HCN4;KCNA2;KCNA6;SLC9A1;KCNAB3;KCNJ3;KCNC2;CHP1;SLC9A6;SLC9A7
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.41781043941030493,0.8660311291926566,0.6586021505376344,0.9678580935868103,1.0,4/11,27.59%,CCT7;TERF1;CCT4;CCT6A
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.2680070594035729,-0.8659040871034185,0.6568047337278107,0.8690473969037954,1.0,6/24,11.15%,H3-3A;PPM1D;EED;SUZ12;EPC1;BMI1
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.27203486826393747,-0.8656857760442609,0.6632653061224489,0.8679552432657914,1.0,3/24,4.59%,LYN;HMGB1;CXCL12
prerank,mesenchymal cell differentiation (GO:0048762),0.3290679371756312,0.8655695284513297,0.6885428253615128,0.9682749593828696,1.0,5/51,4.05%,LRP6;LOXL2;FGFR1;TGFB2;AKNA
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.30366389565839863,0.8655015572213045,0.7937625754527163,0.9679437483924273,1.0,60/190,24.50%,ESR1;UBE2B;SLIT2;HDAC7;PIK3R2;MAPK14;OTUD3;MAP2K3;PTPRJ;ATP2B4;PDE11A;USP10;NR1D1;MYADM;SRC;PDE10A;BANK1;NOC2L;FLCN;PHLPP2;INPP5K;OTUD7B;HERPUD1;PRDM15;URI1;TNIP1;AKT1;MAGI2;PPEF2;PDE4D;PIK3IP1;CDC34;DEPTOR;PLEKHA1;TWIST1;TMEM127;ZC3H12A;PDE3B;NOP53;PER1;PPP2R5B;PLAUR;SFRP5;IFI35;RORA;CIT;MCL1;PPM1A;TSPAN6;PYCARD;PTEN;NF1;CPNE1;UBR2;RNF157;CYLD;RELA;CCN3;TSC2;MDM2
prerank,hyaluronan catabolic process (GO:0030214),0.3799455806595068,0.8652321061573065,0.6420382165605095,0.9679903958611008,1.0,4/18,15.39%,CD44;FGF2;SLC9A1;CHP1
prerank,regulation of protein acetylation (GO:1901983),-0.3284256497697545,-0.8651444331770576,0.6589147286821705,0.8675520267615248,1.0,3/12,17.31%,RAPGEF3;SIRT1;TAOK1
prerank,negative regulation of inflammatory response (GO:0050728),0.3022908595880248,0.8649204956943003,0.796576032225579,0.9681168539996159,1.0,30/182,16.64%,SYK;VIPR2;FYN;MAPK7;MAPK14;METRNL;MVK;GLP2R;NR1D1;SRC;ADCYAP1;DPEP1;CRHR1;GPR20;SIRPA;FNDC4;CALCA;GPR45;TSHR;ADCY8;CD200R1;GNB1;TNFRSF1B;LHCGR;KLF4;IL4;LRFN5;SELENOS;IL6;IAPP
prerank,positive regulation of TOR signaling (GO:0032008),0.33567634749412945,0.8647973579756242,0.6602491506228766,0.9678997521788754,1.0,10/40,23.18%,FLCN;GAS6;PIK3CA;HDAC3;SMCR8;RRAGD;PIP4P1;GPR137B;KLHL22;SLC38A9
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.30510514541490263,-0.8645764000663971,0.634453781512605,0.8672268935201797,1.0,1/16,0.42%,PDS5B
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.2769735400519928,-0.8641074681592034,0.6456310679611651,0.866669320224132,1.0,4/21,6.30%,SLC30A10;PPARA;SIRT5;PINK1
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.37244770024075746,0.86383394458732,0.6863979848866498,0.9692437977128501,1.0,9/24,19.31%,UBE2B;PDE11A;CGAS;PDE4D;CDC34;PDE3B;PEX5L;TCP11;PRKAR2A
prerank,positive regulation of neuron differentiation (GO:0045666),-0.23094019297234558,-0.8637378686909409,0.7,0.8659207396394211,1.0,10/40,16.63%,TCF4;MEF2C;HEYL;BRINP3;VWC2;BMP2;MMD2;TRIM32;SOX11;HOXD3
prerank,neuropeptide signaling pathway (GO:0007218),-0.22195984168583915,-0.8636018723401534,0.7567567567567568,0.8646651166643627,1.0,3/58,1.62%,RAPGEF2;SORT1;CPE
prerank,protein localization to cell periphery (GO:1990778),0.30407783631677604,0.8624423939712967,0.7742914979757085,0.9713634976456368,1.0,25/133,16.26%,LRP6;TTC7A;TSPAN17;PKP3;PRAM1;ANK2;FGF13;S100A10;PLEKHF1;MYADM;MYO5A;GAS6;PACS2;CD81;EHD2;INPP5K;FYB2;RAB3D;JUP;PIGW;ZDHHC2;AP4M1;SPTBN1;FLOT2;ANK1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.3492580023775103,0.8622502237809551,0.6879350348027842,0.9712681514505062,1.0,6/30,13.94%,POLR2H;GTF2H3;POLR1G;UBTF;ERCC3;CCNH
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3734202454347033,0.8620565736437237,0.6583541147132169,0.9711879176373466,1.0,5/20,18.08%,ZMIZ1;ITCH;DNAJB2;HSP90AA1;TGFBR1
prerank,hexose metabolic process (GO:0019318),0.3399527515163503,0.862042216730998,0.6812080536912751,0.9707614823170524,1.0,9/39,23.38%,CHST1;GALK1;IRS2;GAA;ALDOA;GALM;SLC37A4;SLC35A2;KCNJ11
prerank,glial cell development (GO:0021782),0.362218696429212,0.8620104721387668,0.6570048309178744,0.9703763798529496,1.0,3/25,4.49%,PRDM8;S100A9;SOX10
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.38631223873517095,0.8618825799004493,0.6679586563307494,0.9701707513417743,1.0,8/17,34.05%,ALG1;DHDDS;SRD5A3;MVD;MPDU1;NUS1;ALG8;DOLPP1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.33101626840302434,0.861602345132385,0.6802197802197802,0.9702465825212246,1.0,7/45,9.80%,TGFB3;TGFB2;SMAD4;ACVR1;BMP15;INHA;BMP8A
prerank,positive regulation of calcium ion import (GO:0090280),-0.32141379916452134,-0.8614443686454807,0.6309963099630996,0.8676884813057569,1.0,6/12,35.48%,CXCL12;PDGFRB;SPHK2;CCL2;ATP2A1;RAMP3
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.36985163580760094,0.8614344170445827,0.6658354114713217,0.970120688086155,1.0,3/21,8.29%,RUNX1;FOXP1;CD81
prerank,positive regulation of TORC1 signaling (GO:1904263),0.3810180410859985,0.8614087161111601,0.6236979166666666,0.9697139071092553,1.0,5/16,21.94%,FLCN;RRAGD;PIP4P1;GPR137B;KLHL22
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3589849554555074,0.8611344426036824,0.6915544675642595,0.9697530914901542,1.0,11/26,28.36%,EFNA5;NR1D1;STX4;ADCY8;GPLD1;PPP3CB;EPHA5;BAIAP3;STXBP4;CFTR;LRP5
prerank,positive regulation of neuron migration (GO:2001224),-0.3463805453611135,-0.86097902989229,0.6290909090909091,0.8671460084006787,1.0,4/11,11.30%,RAPGEF2;DAB2IP;SEMA6A;MDK
prerank,negative regulation of ATPase activity (GO:0032780),0.3950097883981868,0.8609068117815596,0.6517739816031537,0.969725568769201,1.0,3/16,12.78%,TNNI3;PXK;THADA
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.36245664196510685,0.8607802545972972,0.6634264884568651,0.9695022335899228,1.0,11/24,29.07%,TGFB2;NUPR1;MCL1;ITGAM;BACE1;NF1;ATF4;FBXW7;DDIT3;BAX;PRNP
prerank,melanosome localization (GO:0032400),-0.2767388416489571,-0.8607289505594391,0.649746192893401,0.8660984351574633,1.0,8/21,18.55%,SHROOM2;BLOC1S5;RAB11A;BBS7;MREG;RAB27A;BLOC1S6;MLPH
prerank,linoleic acid metabolic process (GO:0043651),0.3855207635851772,0.8606446576601626,0.665389527458493,0.9692972315439748,1.0,4/17,13.90%,GSTM2;PNPLA8;ELOVL5;FADS1
prerank,histone H3 acetylation (GO:0043966),0.33352657476527403,0.8600998373104739,0.6944127708095781,0.9698487740591071,1.0,14/40,23.28%,TADA1;POLE3;KAT2B;ING4;WDR5;DR1;KAT14;YEATS2;PER1;TAF6L;SGF29;KAT6B;LDB1;MAP3K7
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.35547611520115374,0.8600682582271371,0.6646706586826348,0.9694568385487177,1.0,8/27,23.89%,NDEL1;FRMD7;PSEN1;AKT1;NCS1;PTEN;CCDC88A;NTNG2
prerank,maturation of 5.8S rRNA (GO:0000460),0.38759763143103426,0.8600407282722113,0.6479591836734694,0.969065720793165,1.0,7/17,27.04%,C1D;URB1;EIF6;MAK16;EXOSC10;FTSJ3;PRKDC
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.3471072719236986,0.8599456875315932,0.6651053864168618,0.9687993425447344,1.0,10/33,21.89%,CTC1;ACD;GAR1;TERF1;TNKS1BP1;HSP90AA1;RAD50;TINF2;PPP6C;TERF2IP
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.4123005088814174,0.8591993899484518,0.6551264980026631,0.9697036028675173,1.0,5/12,20.34%,ZDHHC7;VANGL2;AHI1;ACTG1;RAB10
prerank,modulation by host of symbiont process (GO:0051851),0.34962918177067687,0.8588364554758704,0.6848837209302325,0.9699057466644163,1.0,8/31,17.09%,HPN;TARDBP;INPP5K;LRRC19;CTDP1;SMARCA4;CHD1;TFAP4
prerank,autophagy of mitochondrion (GO:0000422),0.34052328443798224,0.8587998796735058,0.6738148984198645,0.9695083731414306,1.0,14/38,24.84%,ATG2B;WIPI2;SQSTM1;WDR45B;ULK2;ATG2A;ULK1;CISD2;ATG13;ATG3;ATG14;FIS1;CTSK;MARK2
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.40942639924992047,0.8587890768936234,0.6774193548387096,0.9690779631068059,1.0,5/12,20.91%,SCP2;ELOVL5;FADS1;ACOX1;HSD17B4
prerank,dicarboxylic acid metabolic process (GO:0043648),0.3298570956136633,0.8584329796235831,0.7050438596491229,0.9692742499367907,1.0,13/52,25.94%,GCLC;ALDH18A1;ACLY;IDH1;NIT2;ALDH5A1;MDH2;MTHFD2L;GOT1;D2HGDH;MTHFD2;MTRR;ME3
prerank,axon extension (GO:0048675),0.3633489499180036,0.8584259861097199,0.6842751842751843,0.9688393873261433,1.0,9/23,16.12%,MAP1B;SLIT3;SLIT2;SLIT1;SEMA3A;ULK2;ULK1;HSP90AA1;SLC9A6
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.33500257405385836,0.8583722637964979,0.6891428571428572,0.9684887779490298,1.0,8/39,14.80%,MYO1A;PPFIA2;NDEL1;TRAK2;MYO5A;DYNC1I1;TANC2;CCDC186
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.4120542804861947,0.8583075149071879,0.6653005464480874,0.9681569683324648,1.0,5/13,28.68%,VDAC2;BMF;BLOC1S2;RHOT2;BAX
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.383749338778617,0.8581391709268681,0.6633291614518148,0.968031292631432,1.0,7/18,28.68%,TMEM259;ERN1;BAK1;NCK1;USP13;DDIT3;BAX
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.3554220149857713,0.8578869582763522,0.6584463625154131,0.9680614945514864,1.0,11/25,31.04%,CHMP7;VPS4B;MVB12A;TMEM50A;LYST;LEPROT;UBXN6;CHMP4C;CHMP4A;CHMP4B;LAPTM4B
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.355256827514541,0.8578790010243275,0.6810747663551402,0.9676309012891217,1.0,15/29,31.91%,LSM4;EDC4;EXOSC7;EXOSC1;LSM7;EDC3;DCP1A;DCP1B;LSM5;HBS1L;LSM1;EXOSC3;PATL1;CNOT8;LSM6
prerank,activin receptor signaling pathway (GO:0032924),0.39451748423881705,0.8574583592353979,0.6640625,0.9679643986175148,1.0,7/15,31.59%,ACVR1;AMHR2;TGFBR1;ACVR2A;ACVR1B;ACVR1C;INHBB
prerank,cellular response to interleukin-12 (GO:0071349),0.33137421767664976,0.8570697666435497,0.6917211328976035,0.9682670176620735,1.0,11/48,23.57%,ANXA2;MIF;RAP1B;ARF1;SIRPA;CD47;PDCD4;PPIA;RALA;SNRPA1;MTAP
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3207627440806615,0.8568763314472335,0.7357293868921776,0.9681631502953383,1.0,14/64,15.54%,POLR2H;GTF2H3;CDK9;ADRM1;ELP4;SETD2;ERCC3;POLR2D;POLR2G;CCNH;CTDP1;EAF2;GTF2F1;EAF1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.4023467796897821,0.8567712169304418,0.6589986468200271,0.9679138591248808,1.0,5/13,26.07%,EIF2AK3;NUPR1;MANF;USP19;LPCAT3
prerank,mitochondrial translation (GO:0032543),0.30861711687233895,0.8564621391808602,0.7394438722966015,0.9680216960706534,1.0,20/104,16.03%,MRPS11;MRPL38;MRPS18B;CHCHD1;MRPL13;MRPS17;AURKAIP1;MRPS27;MRPL30;DAP3;MRPL10;GFM1;MRPL55;MRPS10;MRPL36;MRPL3;MRPL21;MRPS34;MRPL51;HARS1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.40153454112029124,0.8560056955401942,0.6811989100817438,0.968410332297372,1.0,6/14,27.68%,PRKD2;CD81;CARD11;RELA;RAB29;BCL10
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.36838169223434875,0.855822681264226,0.6578947368421053,0.9683115242813448,1.0,6/21,23.77%,ANK2;SCN4B;AKAP9;KCNH2;FLNA;CACNA2D1
prerank,rRNA 3'-end processing (GO:0031125),0.432874675656407,0.8554502652270326,0.6567967698519516,0.9685476921045858,1.0,2/10,9.57%,ERI3;EXOSC7
prerank,regulation of protein metabolic process (GO:0051246),0.3324026536238044,0.855338083479411,0.6938775510204082,0.9682987986794184,1.0,15/44,24.50%,MAPK7;KLF2;ODC1;TMEM9;SSH1;ZDHHC2;KLF4;TRAF3;CHRNA7;PLAUR;NEDD8;LDLR;FKBP1A;PARL;MDM2
prerank,histone methylation (GO:0016571),0.35272708085614746,0.8549340546172391,0.6605392156862745,0.9685723774722755,1.0,11/26,31.77%,PRMT2;NTMT1;EHMT2;N6AMT1;NSD1;CARM1;EZH2;SUV39H1;PRMT8;SIRT7;PRMT7
prerank,cellular calcium ion homeostasis (GO:0006874),0.3008584076504682,0.8546409456085858,0.7710233029381965,0.9686424545741865,1.0,28/133,19.42%,CCL8;NPTN;ANK2;TNNI3;ATP2B4;CAMK2D;PACS2;YWHAE;PSEN1;MCU;CALCA;HERPUD1;ATP13A1;SELENOK;SLC35G1;MCUB;BAK1;ADCY8;ATP2A2;CCL13;SLC8A2;STC1;TMEM165;PML;CHRNA7;ATP2B1;HTR2C;STIM1
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.4254507402622537,0.8545598108943678,0.6684636118598383,0.968352693443378,1.0,1/10,2.80%,VEGFA
prerank,protein import into mitochondrial matrix (GO:0030150),0.37545261484076375,0.8537106045677468,0.6606217616580311,0.9695535146917114,1.0,2/18,11.78%,TIMM50;GRPEL2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.31260466477916404,0.85341072994449,0.7287958115183246,0.9696386906479257,1.0,16/83,15.36%,CDK14;ACVR1;CDK4;TRIM71;USP29;BCAT1;CUL3;USP26;FBXO5;CDC34;CDKN1A;CCND1;DBF4;CCNH;GSPT1;E2F3
prerank,ubiquinone biosynthetic process (GO:0006744),0.3852831502049248,0.8530757283687418,0.665359477124183,0.9698149480322874,1.0,6/15,25.80%,COQ10B;COQ7;COQ3;COQ5;COQ10A;COQ2
prerank,neurotransmitter transport (GO:0006836),0.3130781603281402,0.8530218972049732,0.7129237288135594,0.9694630954854884,1.0,17/73,18.69%,SLC1A7;STX1A;APBA1;PPFIA2;SLC1A6;SLC18A3;SLC6A4;GLS2;GLS;SNAP25;PPFIA1;GAD2;SNAPIN;SYT1;SLC38A1;SNPH;VAMP2
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.3182548939624992,0.8529075993923552,0.7281449893390192,0.9692084463416962,1.0,22/69,26.82%,POLR2H;ZC3H8;INTS3;TAF8;INTS10;CDK9;INTS6;POLR2D;POLR2G;GTF2A2;GTF2F1;INTS2;INTS12;GTF2E2;ICE1;TBP;ELL;TAF13;POLR2C;GTF2E1;INTS1;SNAPC3
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.29023240586432664,-0.852598083443631,0.6833976833976834,0.88144146168719,1.0,3/16,5.24%,PHKB;PYGM;AGL
prerank,genitalia development (GO:0048806),0.4072784825467658,0.8524729838466621,0.6526458616010855,0.9695377207558644,1.0,2/12,4.25%,WT1;PKD1
prerank,membrane lipid biosynthetic process (GO:0046467),0.31949862700339027,0.8522837453954312,0.7229437229437229,0.9694309107886513,1.0,11/58,12.45%,CERS6;ST3GAL2;PLPP3;ALDH3A2;PLPP1;PRKD2;SGMS2;FA2H;ELOVL5;ST3GAL4;PRKD3
prerank,membrane protein proteolysis (GO:0033619),0.338945241438216,0.8522770835129346,0.6857142857142857,0.9689956177528908,1.0,17/37,30.59%,ADAM9;ADAM19;RET;PSEN1;SPPL2B;NAPSA;CLPP;BACE1;PARL;RELA;RBMX;MBTPS1;NFKB1;HM13;ADAM17;TRAF6;PSENEN
prerank,cellular response to ketone (GO:1901655),0.341940504059144,0.8520565802572933,0.707852193995381,0.9689733789446159,1.0,6/35,13.66%,AR;SRC;LARP1;ADCY8;ADAM15;GNB1
prerank,negative regulation of catalytic activity (GO:0043086),0.3648970703333635,0.8519889261280044,0.6919254658385093,0.9686455976171691,1.0,3/24,7.28%,APBA3;TMBIM1;HDAC6
prerank,regulation of DNA recombination (GO:0000018),0.3409720233757545,0.8519464111270757,0.6950517836593786,0.9682731493689867,1.0,12/32,26.82%,KPNA2;SETD2;THOC1;IL4;SPIDR;RAD50;BLM;KPNA1;TERF2IP;ALYREF;H1-0;MSH6
prerank,negative regulation of ion transport (GO:0043271),-0.2561312789339985,-0.8517654491436056,0.6978021978021978,0.8816058369549368,1.0,9/24,21.09%,ACTN2;WNK4;SNCA;ADRA2A;NOS1;GPM6B;HTR1B;CASQ2;PLN
prerank,regulation of calcium ion transport (GO:0051924),0.3216548509027846,0.8516670087179752,0.6987951807228916,0.9683451711913716,1.0,14/54,23.77%,IL16;ANK2;F2R;SRI;PKD2;INPP5K;EGF;CASQ1;STC1;ATP2B1;STIM1;SLC8B1;PACSIN3;CACNA2D1
prerank,RNA biosynthetic process (GO:0032774),-0.24928142274324716,-0.8515514375727379,0.7222222222222222,0.8804591222044309,1.0,9/31,19.19%,PRIM2;TAF6;POLR2A;HELB;TERT;TAF7;TAF5;GTF2B;TAF10
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.3909314193134864,0.8514217002458838,0.6724832214765101,0.9683677525790263,1.0,3/15,7.63%,FGF2;SMOC2;PRKD2
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.3344220585536918,-0.85139514498897,0.6438848920863309,0.8792351266891107,1.0,4/11,12.28%,NOS3;GCH1;QDPR;SPR
prerank,protein deacylation (GO:0035601),0.3644860087560631,0.8513193594021876,0.6670776818742293,0.9681222127345963,1.0,5/23,14.10%,HDAC7;HDAC6;SIRT2;HDAC3;HDAC4
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.35829824686525946,0.8512491204585171,0.6798516687268232,0.9678022371443283,1.0,10/23,31.33%,COPS5;RAD23B;UBA52;DDB1;COPS4;GPS1;CETN2;COPS6;COPS3;COPS7B
prerank,alanine transport (GO:0032328),-0.3574656709003033,-0.8511390987615095,0.6654929577464789,0.8782409572547922,1.0,2/10,11.53%,SLC6A17;SLC6A6
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.34459193651254855,-0.850661731899998,0.6326530612244898,0.8776907275736389,1.0,3/10,12.81%,LYN;FAS;MAPK3
prerank,protein localization to centrosome (GO:0071539),0.3850362577617556,0.8505323580623035,0.681045751633987,0.9686312669305798,1.0,7/17,23.69%,NUDCD3;PIBF1;BBS4;CEP83;PCM1;DCTN2;NEDD1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3192258123506326,0.850226682873472,0.7465091299677766,0.9687211643993084,1.0,16/70,22.07%,GPAT4;PLAAT1;CHKB;SLC44A1;LCAT;LPCAT1;PNPLA8;MBOAT7;CEPT1;PLA2G4E;SLC44A2;LIPC;GPLD1;LPIN3;CSNK2A2;PCTP
prerank,proteasome assembly (GO:0043248),0.4083847041344525,0.8500059317449994,0.6629526462395543,0.9686765087851875,1.0,2/11,8.69%,PSMG2;ADRM1
prerank,positive regulation of sodium ion transport (GO:0010765),-0.32758624409397485,-0.8496978167159486,0.6629213483146067,0.8781677850413497,1.0,5/12,20.84%,AHCYL1;GPD1L;NOS1;SCN3B;ANK3
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.415396156124929,0.8493860163678595,0.6742857142857143,0.9693403162105232,1.0,2/11,8.14%,RFTN1;SCARA3
prerank,regulation of interleukin-1 beta production (GO:0032651),0.31523759656858474,0.8493784496905346,0.7117903930131004,0.9689101100679878,1.0,10/66,16.45%,FOXP1;F2R;TMEM106A;CARD16;TLR4;SIRPA;USP50;ZC3H12A;NLRP2B;IL6
prerank,negative regulation of histone methylation (GO:0031061),0.418012227322969,0.8491289800297003,0.6824512534818942,0.9689053165252961,1.0,2/10,10.73%,PHF1;WDR5
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.27793065040314935,-0.8487925555132428,0.7005347593582888,0.8783085521645599,1.0,2/23,2.02%,UACA;BMP7
prerank,protein polyglutamylation (GO:0018095),-0.3317285169525999,-0.848789921053464,0.6494464944649446,0.8768040525307332,1.0,6/11,30.25%,TTLL5;CFAP20;TTLL1;CEP41;TTLL6;TTLL2
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.39492209678682566,0.8481004851736265,0.6749311294765841,0.9702516423747787,1.0,6/13,28.35%,STX4;STX3;MAP1A;SNX33;RANGRF;TM9SF4
prerank,snRNA transcription (GO:0009301),0.31583347701363634,0.8476471369114369,0.7366737739872068,0.9706305801775336,1.0,22/70,26.82%,POLR2H;ZC3H8;INTS3;TAF8;INTS10;CDK9;INTS6;POLR2D;POLR2G;GTF2A2;GTF2F1;INTS2;INTS12;GTF2E2;ICE1;TBP;ELL;TAF13;POLR2C;GTF2E1;INTS1;SNAPC3
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.33027912611949517,0.8476099910287161,0.7208008898776418,0.9702457139202495,1.0,5/41,13.66%,KCNMA1;ANK2;KCNJ2;KCNJ3;GNB1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.41826376069487076,0.8471663620654784,0.6632947976878613,0.9706079409763342,1.0,2/10,7.80%,AXL;GAS6
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.3379463559637311,-0.84709604223189,0.6530612244897959,0.8787259523333402,1.0,4/10,22.95%,SIRT1;RIF1;DNMT1;BRCA1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.2918114749965739,-0.8470607832243449,0.6759259259259259,0.8772944474605339,1.0,4/16,14.38%,AUTS2;CTR9;BCOR;CTNNB1
prerank,sulfation (GO:0051923),0.41027356834523376,0.8468736548548889,0.6909871244635193,0.9707045291573586,1.0,3/11,24.02%,HS3ST5;SULT4A1;UST
prerank,cellular component maintenance (GO:0043954),-0.3184684710210681,-0.8468595281732475,0.6423357664233577,0.8761415505071203,1.0,3/12,4.07%,INSR;IGF1R;ITGA3
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.32795086941361745,-0.8465202956964848,0.6521739130434783,0.8753614602210156,1.0,3/12,7.14%,MAVS;CAV1;IFIT1
prerank,response to unfolded protein (GO:0006986),0.3216657103645799,0.8463738852828583,0.7070484581497798,0.9711493099376945,1.0,20/48,30.92%,HSPA13;SERPINH1;ERN1;HERPUD1;DNAJB2;BAK1;HSP90AA1;HSPA14;DNAJB1;ERP44;BAG3;DERL1;TM7SF3;HSPH1;DDIT3;DNAJA1;BAX;HSPA8;HSF1;DNAJB5
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.3249202449362723,-0.8462365190929894,0.6366906474820144,0.8744496045158526,1.0,5/13,9.55%,MEF2C;NOTCH1;TGFBR3;FGFR2;TBX2
prerank,inner mitochondrial membrane organization (GO:0007007),0.3310235205887877,0.846084325641844,0.706858407079646,0.9712256838630375,1.0,21/47,29.56%,TIMM10B;TIMM9;ATP5PO;AGK;ATP5ME;TIMM22;GHITM;SPG7;TIMM8B;MICOS10;UQCC3;APOOL;IMMT;ATP5MC3;DNAJC11;ATP5F1B;NDUFA13;CHCHD3;LETM1;ATP5F1A;CHCHD6
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.32437669340561376,0.8459982261799739,0.7111834961997828,0.9709376861618728,1.0,17/48,27.76%,POLR2H;ZMIZ1;SMARCD1;POLR1G;KAT2B;ATAD2B;DDX21;PADI2;SF3B1;POLR1C;TBP;POLR1B;SERTAD2;H1-0;ELOF1;ARID1A;ARID1B
prerank,regulation of intracellular protein transport (GO:0033157),-0.23862354160483437,-0.8455489914332707,0.759493670886076,0.8743985930842058,1.0,8/32,14.16%,PTPN14;CEP290;PRR5L;PTPN1;GCC2;TGFB1;PDCD10;RIPOR1
prerank,zinc ion transmembrane transport (GO:0071577),0.3546429692498812,0.8455410583631021,0.687041564792176,0.9713389408091689,1.0,5/22,20.02%,SLC39A14;SLC39A13;SLC39A7;SLC30A5;SLC39A3
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.33437951164396457,-0.8454980836188662,0.6148148148148148,0.8729885952582858,1.0,11/11,66.59%,PKD1L3;LPO;RTP3;TAS1R2;GNAT3;GNAT2;PIGR;TAS1R3;RTP4;RTP2;PKD2L1
prerank,positive regulation of axonogenesis (GO:0050772),0.3232076680445546,0.8454247375099564,0.6923937360178971,0.9710970357694365,1.0,10/43,13.40%,DBN1;SLIT2;NTN1;ISLR2;PLXNA3;TIAM2;L1CAM;MAPT;MAP6;RHOA
prerank,positive regulation of DNA binding (GO:0043388),-0.24832261080037205,-0.8452336030085803,0.7841726618705036,0.872054413678181,1.0,4/31,3.60%,IGF1;NIBAN2;HMGB1;FOXC1
prerank,regulation of organelle organization (GO:0033043),0.31000480051396845,0.8451703082000673,0.761854583772392,0.9710855403203409,1.0,28/80,27.40%,CAPN2;STX5;S100A8;S100A9;SYT11;PREB;MIEF2;MYO5A;SURF4;LMAN1;SQSTM1;MAPT;DIAPH1;RAB33B;AKAP9;ARMH3;VPS11;MAPK1;ZEB2;TMEM33;PARL;FIS1;MTM1;MARK2;RHOT2;MUL1;RBSN;PDE4DIP
prerank,regulation of smooth muscle contraction (GO:0006940),0.3682245005124486,0.8444133232910416,0.6937738246505718,0.9719869036548596,1.0,6/20,22.43%,PLCE1;F2R;ZDHHC21;ATP2B1;CTTN;NMU
prerank,negative regulation of JUN kinase activity (GO:0043508),0.41434728510610047,0.8440917694083108,0.6875,0.9721186428623484,1.0,3/10,19.90%,AIDA;PDCD4;HIPK3
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.3370426639674074,0.844046494394787,0.7084309133489461,0.9717557194243512,1.0,7/33,15.09%,MAPK7;NFE2L2;TCF7L2;GAS6;CAST;NUPR1;IL4
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.37569330724338224,0.8438621707848507,0.6992084432717678,0.9716440260120203,1.0,5/18,18.35%,DACT1;CD81;HSP90AA1;RNF128;VPS11
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.32872797061520564,0.84285510360782,0.6948571428571428,0.9729350828334706,1.0,9/39,18.61%,TCF7L2;GRP;ADCYAP1;MCU;IRS2;TRH;GLUD1;AIMP1;CAPN10
prerank,prostaglandin biosynthetic process (GO:0001516),-0.2815899114345898,-0.8426318489379581,0.6681818181818182,0.8757172469862464,1.0,9/18,23.47%,PTGDS;PTGS2;PTGIS;PTGES3;EDN1;CD74;TBXAS1;CBR1;PTGS1
prerank,negative regulation of leukocyte migration (GO:0002686),0.42566723189053784,0.8426246008463848,0.6882183908045977,0.9728854050033054,1.0,3/10,14.73%,SLIT2;CD200R1;HOXA7
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.32758383702003613,0.8425740803833207,0.7014590347923682,0.9725289457407903,1.0,17/45,25.55%,PKP3;TRIM71;RC3H1;ATXN2;LARP4;TDRD7;PUM1;LARP1;NOLC1;RBM3;PER1;PCIF1;METAP1;EIF2A;ATG14;CYFIP1;GRM5
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.39656995031848474,0.8424370330577011,0.6961178045515395,0.9723283497555066,1.0,9/13,34.69%,KPNA2;IPO5;KPNA1;CBLB;KPNA6;KPNB1;NUP54;RANBP2;KPNA3
prerank,carboxylic acid catabolic process (GO:0046395),0.4045768311672726,0.8423178673189892,0.666214382632293,0.9721046585899576,1.0,2/12,9.01%,NAGK;PON3
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.3862336995412833,0.8422965656470442,0.6731770833333334,0.9717033814770104,1.0,7/15,32.09%,IL17RA;TLR4;IL6;TICAM1;MYD88;IL17D;APPL1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.41818750746386985,0.8420527515965366,0.6805755395683454,0.9716842098325357,1.0,3/10,15.97%,PDZD7;TSKU;PLS1
prerank,nitrogen compound transport (GO:0071705),0.29483066046358486,0.8414039564533758,0.8113590263691683,0.9723891620777758,1.0,28/141,17.74%,SLC1A5;LRRC8D;SLC7A6;TCN1;ARRDC2;MIA3;TOM1;SLC43A2;RCN3;SCAMP3;SLC6A8;SCAMP5;SLC44A1;SLC16A10;SLC6A4;RUFY1;SLC7A3;TMEM30A;KIF3A;ABCC1;LRP1B;SLC23A1;CMTM6;SLC15A4;SEC14L1;SLC38A1;SLC44A2;FLVCR1
prerank,cell cycle G2/M phase transition (GO:0044839),0.30033555204548085,0.841078010164188,0.7876016260162602,0.9724994611768728,1.0,44/129,28.57%,DCTN1;ODF2;CDK14;YWHAG;SSNA1;YWHAE;PPP1R12B;ALMS1;HAUS3;MAPRE1;SFI1;CDKN1A;FBXL3;AKAP8;CCNH;HSP90AA1;DYNC1H1;TUBB4A;TUBA4A;CDK5RAP2;CCP110;AKAP9;CEP164;CKAP5;PAFAH1B1;PPP2R2A;SKP2;PCM1;AKAP8L;FBXW11;DCTN2;CDC25B;NEDD1;LATS1;FBXL12;DYNLL1;CEP78;ACTR1A;CSNK1E;CETN2;WEE1;CUL1;CEP152;FOXM1
prerank,lamellipodium assembly (GO:0030032),-0.2558918287364323,-0.8409804947581139,0.7151515151515152,0.8775208778407143,1.0,6/26,12.50%,PARVB;KIT;S1PR1;PTPRO;CDH13;ARHGEF4
prerank,glycogen catabolic process (GO:0005980),-0.293042813522433,-0.8409719338584333,0.7028112449799196,0.8760553561000193,1.0,3/15,5.24%,PHKB;PYGM;AGL
prerank,positive regulation of cellular senescence (GO:2000774),0.4182019034750731,0.8406187235672702,0.6930555555555555,0.9728178013679925,1.0,3/10,16.33%,CGAS;YPEL3;EEF1E1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.36666188732817,0.8401666784639421,0.7044585987261146,0.9731564400570825,1.0,5/19,22.76%,VPS4B;CCSAP;CEP97;PDCD6IP;TPR
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.3257086994637164,0.8395502387615486,0.7171717171717171,0.9738029815628985,1.0,11/42,24.09%,USP10;ZBTB1;DTL;POLI;UBA52;PCLAF;RFC4;POLD1;FAAP20;REV1;POLH
prerank,excitatory postsynaptic potential (GO:0060079),0.37025312495059,0.839542707858386,0.6721938775510204,0.9733768242457981,1.0,9/19,32.64%,MPP2;GRIN2D;AKT1;GRIN2A;NPAS4;GRID2;DRD2;GSK3A;RAB3GAP1
prerank,erythrocyte development (GO:0048821),0.41310626994374455,0.839457097618154,0.6676176890156919,0.9730800842341472,1.0,5/10,36.21%,ABCB10;DMTN;ZBTB7A;NCKAP1L;MED1
prerank,negative regulation of type I interferon production (GO:0032480),0.3291619233282844,0.8390873856859047,0.7294250281848929,0.9732767779411821,1.0,16/40,32.51%,PTPRS;ITCH;SIRPA;PIN1;RNF216;ILRUN;TAX1BP1;PYCARD;CYLD;UBA7;UFD1;HAVCR2;NPLOC4;CACTIN;TRAF3IP1;TBK1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.3232440441921118,0.8388031848823643,0.7194982896237172,0.9733421923299569,1.0,7/45,10.26%,GAS1;ZFP36L1;ZW10;ZFP36L2;ZWINT;AURKAIP1;BCL6
prerank,lymphocyte differentiation (GO:0030098),0.3098091073850097,0.83874792010419,0.7497360084477297,0.9730017504447889,1.0,10/68,16.06%,AXL;PBX1;HDAC9;CLCF1;PTPRJ;FLT3;CR2;HDAC4;IL4;LMBR1L
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.3952276598272391,0.8385083087168725,0.6895604395604396,0.9729903855024035,1.0,5/13,12.13%,IRS1;EPM2AIP1;DYRK2;AKT1;IRS2
prerank,negative regulation of cellular catabolic process (GO:0031330),0.3104045396886111,0.8384150002708021,0.7329059829059829,0.9727141248289393,1.0,17/63,23.65%,TIMP2;FOXK2;MTOR;IL10RA;SIRT2;AKT1;BMF;NUPR1;HGF;DAP;GPLD1;PTPN3;MCL1;TAB2;KLHL22;EIF4G3;LEPR
prerank,lipid phosphorylation (GO:0046834),-0.34696603540480925,-0.8383464039565022,0.6813559322033899,0.8798661426504227,1.0,3/10,4.71%,DGKB;DGKE;DGKZ
prerank,ERK1 and ERK2 cascade (GO:0070371),0.36220832839002826,0.8377223033377487,0.6855345911949685,0.9734540741251178,1.0,5/21,15.56%,ZFP36L1;ZFP36L2;ITGAV;EGF;MAP2K2
prerank,Golgi to plasma membrane transport (GO:0006893),0.32077805744724996,0.837681920195467,0.7245575221238938,0.973086287790357,1.0,15/47,22.86%,LLGL1;GGA1;ARFRP1;GGA2;GOLGA4;SPTBN1;NSF;BLZF1;GOPC;PREPL;VAMP2;EXOC4;RAB10;VAMP4;GOLPH3L
prerank,cellular response to lectin (GO:1990858),0.301334158729474,0.8375674567059317,0.7881873727087576,0.9724240205675091,1.0,10/104,11.45%,SYK;PSMC4;FYN;MUC1;PSMC6;SRC;CHUK;PSMD8;NRAS;KRAS
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.301334158729474,0.8375674567059317,0.7881873727087576,0.9724240205675091,1.0,10/104,11.45%,SYK;PSMC4;FYN;MUC1;PSMC6;SRC;CHUK;PSMD8;NRAS;KRAS
prerank,regulation of protein localization (GO:0032880),0.3170273563536099,0.8373352300380246,0.7236842105263158,0.9723833353655299,1.0,18/58,26.41%,RABGAP1L;ITGB3;ZDHHC7;TRIM46;ADCYAP1;ATCAY;HSP90AA1;RSL1D1;TRIM68;CTSD;UFL1;TRIM67;TMEM231;TPR;FKBP1A;DVL1;FBXW7;CSNK1E
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.34274402066608506,0.8364604690064513,0.7088305489260143,0.9734281868436265,1.0,12/30,22.86%,GGA1;ARFRP1;GGA2;GOLGA4;SPTBN1;NSF;BLZF1;PREPL;VAMP2;RAB10;VAMP4;GOLPH3L
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.3141757993995328,0.8362147426868387,0.7320261437908496,0.973406665437701,1.0,12/57,17.17%,CNIH3;DLG4;DLGAP4;DLG2;NEFL;CAPN1;GRIA2;DLGAP3;CACNG2;DLGAP1;GRIN2A;AKAP9
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.3362150450305771,0.836103669086748,0.7151095732410612,0.9731603433549305,1.0,6/36,14.68%,CYGB;EGFR;ATP2B4;AKT1;GLA;HSP90AA1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3006100618141958,0.8354034931536857,0.7932790224032586,0.9738944005164134,1.0,10/105,11.45%,SYK;PSMC4;FYN;MUC1;PSMC6;SRC;CHUK;PSMD8;NRAS;KRAS
prerank,regulation of amyloid-beta clearance (GO:1900221),0.3762429053929175,0.8350257200453021,0.6858974358974359,0.9741181725270396,1.0,1/16,1.29%,LRP1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.3581287999618635,0.8349139407540701,0.6894031668696712,0.9738753368959832,1.0,7/22,16.75%,WASF1;AKT1;MAPT;MAGI2;KIDINS220;RAPGEF1;RAB35
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.3734568333028463,0.8349063607200996,0.6965428937259923,0.9734508399959313,1.0,2/17,5.01%,CHAMP1;ZW10
prerank,intracellular sterol transport (GO:0032366),0.3885982989851913,0.8346606806661065,0.6842837273991655,0.9734376099490799,1.0,2/13,6.94%,ABCA1;OSBPL2
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.3607688450938006,0.8344388318619291,0.7065491183879093,0.9733779869402631,1.0,4/21,20.56%,FGF13;CAMSAP1;NAV3;CLASP2
prerank,regulation of JUN kinase activity (GO:0043506),-0.23889455505128945,-0.8343257752278698,0.7358490566037735,0.8862684024193719,1.0,10/33,20.41%,SASH1;DAB2IP;DUSP10;DVL3;TNFRSF11A;EDN1;MAP3K5;ARHGEF5;DUSP19;MAP3K10
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.380625834748198,0.8341043411731285,0.6988110964332893,0.9734922490299094,1.0,4/16,11.97%,INPP5F;PARP14;BCL3;PIBF1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.3966784130362857,0.8339793802872029,0.6939058171745153,0.9732723329327536,1.0,5/12,12.13%,IRS1;EPM2AIP1;DYRK2;AKT1;IRS2
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.40459053160046554,0.833772125429677,0.6847222222222222,0.9732033350207879,1.0,1/11,2.49%,FYN
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.32587657141420345,0.8334446041328613,0.7277840269966255,0.9733006384221333,1.0,18/42,29.93%,SMARCD2;SPTY2D1;SMARCC2;ACTR5;INO80;DMAP1;CHD8;SMARCA4;SRCAP;CHD3;ZNHIT1;VPS72;MBD2;ARID1A;ARID1B;PBRM1;HNRNPC;MBD3
prerank,lipid catabolic process (GO:0016042),0.36563331095844376,0.8327528336764194,0.6979695431472082,0.9740395836048474,1.0,4/18,18.79%,CEL;SIRT2;LIPC;LIPH
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.3347973740241095,0.8324208877561431,0.6995359628770301,0.9741619471243693,1.0,13/36,22.86%,NECTIN3;GGA1;ARFRP1;GGA2;GOLGA4;SPTBN1;NSF;BLZF1;PREPL;VAMP2;RAB10;VAMP4;GOLPH3L
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.4159622023686943,0.8323357043750651,0.6989720998531571,0.9738734807047642,1.0,5/10,36.61%,TSKU;LAPTM4B;CDH3;HSP90AB1;FN1
prerank,programmed necrotic cell death (GO:0097300),0.36723555413215075,0.8321163295152132,0.7055900621118012,0.9738147402838571,1.0,4/18,14.20%,ALKBH7;TLR4;PGAM5;CD14
prerank,neuromuscular synaptic transmission (GO:0007274),-0.27446357795258003,-0.83154202529434,0.6941747572815534,0.8901988288813613,1.0,3/18,6.67%,DTNA;TBC1D24;FCHSD2
prerank,cellular respiration (GO:0045333),0.3214434712224197,0.8304774240555632,0.7136363636363636,0.9761978837276746,1.0,14/41,27.29%,COQ10B;ETFA;NDUFS1;SURF1;MDH2;MTFR1L;ETFDH;ETFB;UQCRH;UQCR10;SDHC;COQ10A;ME3;COX15
prerank,myotube cell development (GO:0014904),0.414547393232108,0.8304672361489565,0.6836581709145427,0.9757832543390291,1.0,4/10,21.40%,SKI;SIX1;SELENON;MYORG
prerank,negative regulation of mitochondrion organization (GO:0010823),0.3296692442088215,0.8303174291378802,0.7146171693735499,0.9755934095306332,1.0,8/33,16.64%,TRIAP1;FLCN;GPX1;AKT1;MAPT;GHITM;HGF;IAPP
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.28975957150960024,-0.8302557685753013,0.6872427983539094,0.8911584329157475,1.0,5/16,12.49%,PDGFD;NRP1;PTPN1;PDGFRB;ABL1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.2530435316504665,-0.8299818681187945,0.7730061349693251,0.8901508466051433,1.0,4/26,6.67%,DNAJC6;FNBP1L;GPR107;FCHSD2
prerank,piRNA metabolic process (GO:0034587),-0.27034995297481285,-0.8298164489487279,0.7540106951871658,0.8889767228803348,1.0,17/19,50.18%,TDRKH;EXD1;MYBL1;PIWIL2;TDRD9;TDRD12;PIWIL4;FKBP6;MAEL;MOV10L1;HENMT1;ASZ1;GPAT2;BTBD18;TDRD1;PIWIL1;PLD6
prerank,acylglycerol metabolic process (GO:0006639),0.33175995166315314,0.8297885250268099,0.713631156930126,0.9760266425766583,1.0,3/37,7.69%,MGLL;DGKQ;GK5
prerank,regulation of DNA biosynthetic process (GO:2000278),0.3439545089155168,0.8294914234024326,0.7040194884287454,0.9760903956575114,1.0,6/27,16.46%,FGF2;SMOC2;PRKD2;CDKN1A;SMG6;HGF
prerank,striated muscle cell differentiation (GO:0051146),0.373112271165578,0.8294633398619428,0.676510067114094,0.975699823824135,1.0,2/16,4.22%,AKAP13;SKI
prerank,chemical homeostasis (GO:0048878),0.3136283030599751,0.8294433430662231,0.7454739084132055,0.9753018440884523,1.0,17/61,25.36%,SLC4A10;SLC4A8;NR1D2;SLC4A3;TLCD2;SLC4A4;PNPLA8;IRS2;THADA;ACOX1;TENT4B;ANGPTL3;EIF5A2;SLC4A2;ABCB4;WNK2;FBXW7
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.3137067196107897,0.8293885327792826,0.765524625267666,0.974957613260092,1.0,6/55,9.57%,FHL1;PSMC4;ATF5;PSMC6;PSMD8;AVEN
prerank,homeostasis of number of cells (GO:0048872),0.3971109916453407,0.8292073937677005,0.6833333333333333,0.9748134031676917,1.0,3/12,12.15%,F2R;UBAP2L;LRRC19
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2871093276395786,0.8291991686282991,0.92,0.9744012870916419,1.0,107/366,26.40%,ESR1;BNC2;WT1;PKP3;SCRT2;PRDM8;MLF2;BHLHE40;ATF5;WWTR1;LMX1B;CXXC1;FOXK2;NAB1;NR1D2;SPIN4;RBAK;RBBP6;IGSF1;NFIA;ZFHX3;TRIP4;MLXIPL;MYT1;NUP107;ATXN2;PHF1;MSL3;SPTY2D1;FZD7;MYBL2;HNRNPD;RYBP;ONECUT1;MITF;MZF1;ATF7;ACTR5;FBXO5;CEBPB;NOLC1;SIX1;FADS1;RBM3;EHMT2;SNAI2;GMNN;NR2C2;RPL6;RNF14;EFEMP1;CHD3;PML;GON4L;TGFBR1;MED23;GCFC2;RORA;PCIF1;ZSCAN26;JMJD1C;TAF6L;ASCC1;ELAVL2;OGG1;TRRAP;FOXO4;NSD1;BTG1;METAP1;CARM1;EZH2;SPIN1;TERF2IP;USP13;EIF2A;ATF4;KAT6B;BAZ2A;NFXL1;RNF6;CCDC88A;LDB1;NCOA2;ZNF431;SKOR2;SAP30L;TGFBRAP1;NR3C1;RABL3;ESRRA;RELA;DVL1;ACVR1B;SERTAD3;CALR;PHF12;KAT7;VHL;CYFIP1;GRM5;APBB2;RNF20;HP1BP3;DDIT3;TCF7L1;ZNF2
prerank,zymogen activation (GO:0031638),0.32726270449832306,0.8290993802275529,0.7185017026106697,0.9741447805693225,1.0,6/39,16.43%,KLKB1;PRSS12;TBC1D10A;BAK1;KLK1;GRIN2A
prerank,cellular response to peptide (GO:1901653),0.31294218625456216,0.8287286994005698,0.7364425162689805,0.9743080346187712,1.0,12/56,17.68%,LRP1;FYN;ZFP36L1;ATP1A3;SRC;PSEN1;TLR4;ABCC1;DDX11;CACNB1;GRIN2A;SNX6
prerank,positive regulation of cell migration (GO:0030335),0.28728679245760846,0.8285312675566472,0.8816449348044132,0.9741974509844104,1.0,38/253,15.09%,SEMA3C;DDR2;HAS2;MYOC;EPHB2;COL1A1;PRKCA;EGFR;VEGFA;TGFB2;F2R;ADAM9;SMURF2;ACVR1;MTOR;MIA3;MYADM;C1QBP;SRC;RET;HDAC6;SEMA3A;TNFRSF18;AGO2;STX4;MAPRE1;EGF;FBXO5;MGAT5;GPNMB;KIF20B;SEMA3D;PDGFRA;NSMF;FER;PPP3CA;SNAI2;IL4
prerank,chromosome organization (GO:0051276),0.2981255045458678,0.8283135278634164,0.791967044284243,0.9741294826628888,1.0,32/99,28.82%,COPS5;TCF7L2;RFWD3;RAD23B;CENPT;PHF1;POLE3;SETD7;HDAC3;UBA52;DDB1;EZH1;GATAD1;SMARCA4;GEM;BAHD1;PADI2;TOP2B;COPS4;EZH2;LDB1;LATS1;GPS1;NUP133;TCF7L1;SAFB;MSH6;CETN2;COPS6;HDAC8;SUV39H1;ZBTB7A
prerank,negative regulation of endocytosis (GO:0045806),0.34810687509659544,0.8281689735112395,0.7105911330049262,0.973953825212713,1.0,8/24,26.85%,EPHA3;SYT11;SCAMP5;ARF6;LRSAM1;PACSIN3;RAC1;SNX33
prerank,central nervous system myelination (GO:0022010),0.39886326867840977,0.8280181014574165,0.6867977528089888,0.9737736030146135,1.0,6/11,27.47%,SOX10;PLP1;PTEN;CNTNAP1;B4GALT5;MYRF
prerank,endothelial cell development (GO:0001885),0.3515065832631292,0.8273422092948617,0.7153024911032029,0.97444576542854,1.0,7/25,15.66%,TNMD;RAP1B;COL15A1;MYADM;PDE4D;RAPGEF1;STC1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.3308382406389641,0.8271935048410964,0.7198622273249139,0.9742607693517338,1.0,10/32,23.60%,POLR2H;GTF2H3;POLR1G;UBTF;ERCC3;CCNH;RRN3;POLR1C;TBP;POLR1B
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.34482527579178746,0.8269994530049435,0.7179176755447942,0.9741539275593619,1.0,6/26,15.39%,ATP2B4;STIMATE;DYRK2;RCAN1;SLC9A1;CHP1
prerank,regulation of mRNA stability (GO:0043488),0.29424698510134406,0.8268025027277244,0.8292929292929293,0.9740360433678925,1.0,51/145,31.87%,PRKCA;PSMC4;TENT5B;ZFP36L1;SAMD4B;PSMC6;RC3H1;CARHSP1;ZFP36L2;PSMD8;HNRNPD;EXOSC7;NPM1;AKT1;PUM1;IGF2BP1;UBA52;LARP1;ZFP36;GDNF;EXOSC1;FXR2;YTHDF2;YTHDF1;SET;RC3H2;THRAP3;YTHDF3;YWHAB;PSMD4;PSMD3;TNPO1;RBM24;DCP1A;EIF4G1;PSMB3;CELF1;PSMB2;PSMD5;PDE12;TBRG4;IGF2BP3;EXOSC3;PSMD14;HSPA8;SERBP1;PSMC5;PSMC3;CIRBP;FXR1;PSME4
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.3486299660855799,0.8267804713442837,0.7250900360144058,0.9736498167688675,1.0,2/26,1.29%,EGFR;ANXA1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.3031723552172844,0.8265774081924651,0.7667731629392971,0.9735686348701282,1.0,21/68,25.08%,POLR2H;GTF2H3;SCAF8;POLR1G;CPSF4;UBTF;ERCC3;CCNH;CPSF2;SNRPG;SNRPD3;SLBP;POLR1C;SMN1;TBP;CSTF2T;POLR1B;CPSF7;CPSF1;PABPN1;WDR33
prerank,regulation of receptor recycling (GO:0001919),0.37720412212026355,0.8265585227947353,0.6967654986522911,0.9731731158270215,1.0,4/16,16.14%,ANXA2;INPP5F;ECE1;NSF
prerank,defense response to virus (GO:0051607),-0.18890243485530928,-0.8260551149913083,0.9032258064516129,0.894629795914186,1.0,15/100,10.87%,BCL2L1;SERINC3;BCL2;TRIM56;PLSCR1;ABCC9;IFITM3;MAVS;CNOT7;IFIT1;IFIT2;TLR3;OAS2;RNF135;STAT1
prerank,protein-containing complex disassembly (GO:0032984),0.31515246082991705,0.8260238693206321,0.745928338762215,0.973615999039361,1.0,7/54,13.18%,LRP6;AXIN1;LIX1L;WIPI2;VPS33A;STX17;EPG5
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.3705626267849829,0.8257344394360112,0.696969696969697,0.9736614467611099,1.0,6/16,22.52%,SIRPA;ZC3H12A;PDCD4;PYCARD;CUEDC2;CHID1
prerank,sodium ion transmembrane transport (GO:0035725),0.3062203965716405,0.8256305830692883,0.7977296181630547,0.9734193473364949,1.0,18/84,16.35%,SCNN1B;SLC4A8;ATP1A4;ATP1A3;ATP1A1;SLC9A9;SLC6A8;PKD2;HCN4;SLC4A4;SLC9A1;SLC6A11;SLC6A4;ASIC2;SLC8A2;SLC9A6;SLC9A7;SCN4B
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.3485791243246704,0.8256027782972459,0.7184822521419829,0.9730335569704986,1.0,8/24,23.28%,ITCH;UBE2N;IRAK1;UBA52;AAMP;TAB2;CYLD;MAP3K7
prerank,regulation of defense response (GO:0031347),0.30111361645001034,0.8249992544761283,0.7780104712041885,0.9735828563462079,1.0,13/76,17.01%,MGLL;ANXA1;FOXP1;AKNA;SPATA2;NR1D2;TIRAP;SAMHD1;BCL6;LRRC19;DAGLB;TRAF3;UFL1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.29221230014084276,0.8249868727030591,0.8004073319755601,0.9731721614332123,1.0,16/114,17.83%,TNFSF9;PSMC4;TNFRSF11B;PSMC6;CHUK;TNFRSF18;PSMD8;TNFSF13B;PLVAP;CD27;TNFRSF1B;MAP3K14;EDA;BAG4;TRAF3;ILK
prerank,protein kinase A signaling (GO:0010737),-0.3103823148687936,-0.824232443782775,0.6714285714285714,0.8965840571415621,1.0,7/12,41.73%,MYOM1;PRKACB;LCP1;TTN;TCP11X2;RAB13;GAL
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.28600142336071704,0.8240129428317629,0.908,0.9744040933224152,1.0,94/327,26.40%,ESR1;BNC2;WT1;SCRT2;PRDM8;ZMIZ1;MLF2;BHLHE40;ATF5;WWTR1;LMX1B;CXXC1;FOXK2;NAB1;NR1D2;SPIN4;RBAK;IGSF1;NFIA;ZFHX3;TRIP4;MLXIPL;MYT1;NUP107;PHF1;MSL3;SPTY2D1;FZD7;MYBL2;HNRNPD;RYBP;ONECUT1;MITF;MZF1;ATF7;ACTR5;CEBPB;SIX1;FADS1;SNAI2;NR2C2;RPL6;RNF14;EFEMP1;CHD3;PML;GON4L;TGFBR1;MED23;GCFC2;RORA;ZSCAN26;JMJD1C;TAF6L;ASCC1;ELAVL2;OGG1;TRRAP;FOXO4;NSD1;BTG1;CARM1;EZH2;SPIN1;TERF2IP;USP13;ATF4;KAT6B;BAZ2A;NFXL1;RNF6;LDB1;NCOA2;ZNF431;SKOR2;SAP30L;TGFBRAP1;NR3C1;ESRRA;RELA;DVL1;ACVR1B;SERTAD3;CALR;RALY;PHF12;KAT7;VHL;APBB2;RNF20;HP1BP3;DDIT3;TCF7L1;ZNF2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3381582000990404,0.82395784355551,0.7124105011933174,0.9740611745549254,1.0,2/29,2.30%,HPN;LDLRAD4
prerank,mitochondrion organization (GO:0007005),0.2935808724593486,0.823757890207649,0.858148893360161,0.9739490647090513,1.0,45/165,25.65%,TIMM50;DNM1;RAB32;CLUH;GDAP1;WASF1;TIMM10B;MIEF2;TRAK2;AIFM2;PID1;TIMM9;SLC25A4;MYH14;TMEM70;AKT3;POLG2;NDUFS1;DNAJA3;FANCG;ATCAY;PTCD2;TIMM22;MTFR1L;SPG7;BCS1L;TIMM8B;BCAP31;SLC25A36;SUPV3L1;VPS13D;TOMM5;TIMM17A;SLC25A33;GABPA;AFG1L;MGME1;ESRRA;FIS1;RAB5IF;MTM1;RHOT2;TOMM40;RAB29;ATP5F1B
prerank,steroid metabolic process (GO:0008202),0.2982432007786097,0.8236006598079627,0.7651991614255765,0.9737757249403559,1.0,7/72,11.25%,DHRS9;DHRS4;CYP27B1;VDR;SCP2;SRD5A1;GBA2
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2871685533777418,0.8235653795159172,0.8263959390862944,0.9734118217585152,1.0,43/158,23.77%,AKAP13;MIB2;ECM1;F2R;TMEM106A;LPAR1;MID2;CARD16;TFG;UBE2N;CHUK;TIRAP;PPP5C;LGALS1;IRAK4;DDX21;IRAK1;NDFIP1;TRAF3IP2;RHOA;MAP3K14;RBCK1;SLC20A1;TRIM68;CANT1;SLC44A2;UNC5CL;CARD11;LURAP1;ROR1;MIER1;PPM1A;FLNA;GOLT1B;TSPAN6;TAB2;TERF2IP;TRIM8;TRAF5;MAP3K7;FKBP1A;TNIP2;RELA
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.2620892912915434,-0.8234457094930075,0.7864583333333334,0.8965429353386377,1.0,7/21,17.38%,NES;CX3CL1;MDK;SMARCD3;TOX;CTNNB1;DISC1
prerank,cellular response to purine-containing compound (GO:0071415),-0.3316628441706838,-0.8233853802615267,0.6859205776173285,0.8951687618694523,1.0,4/10,20.68%,RYR2;P2RY1;P2RY6;CASQ2
prerank,blood vessel diameter maintenance (GO:0097746),0.33090695780299934,0.8232238360167953,0.7241379310344828,0.9735541777782312,1.0,3/34,8.96%,GCLC;KLF2;ECE1
prerank,sodium ion transport (GO:0006814),0.3041792008660259,0.8231752606823364,0.7780061664953751,0.9732017490404837,1.0,15/85,14.25%,SCNN1B;SLC5A9;SLC4A8;FGF13;ATP1A4;SLC6A8;PKD2;HCN4;SLC4A4;SLC6A11;SLC6A4;SLC23A1;CATSPER3;ASIC2;SLC8A2
prerank,regulation of cytokinesis (GO:0032465),0.30187821844232415,0.8229467898803917,0.7709205020920502,0.9731497811801754,1.0,22/78,25.18%,CDC14B;SVIL;FSD1;AHCTF1;FLCN;CUL3;SETD2;KIF20B;PRPF40A;CALM2;RHOA;PIN1;BBS4;GIPC1;CCP110;ENTR1;CIT;KLHL9;CDC25B;RAB11FIP3;CDC14A;E2F7
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.3859794078204183,0.8228242704128441,0.6847682119205298,0.9729469984317728,1.0,5/15,23.92%,EDEM1;SPCS1;SEC61A1;RAB10;SRPRB
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.40278887078201386,0.822706987847006,0.7226074895977809,0.972720181040554,1.0,2/11,8.89%,NECAB3;AGO2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.41044611028287337,0.8225095209623681,0.6959553695955369,0.9726336757692822,1.0,3/10,8.24%,SESTD1;BIN1;YWHAE
prerank,response to zinc ion (GO:0010043),0.3481651354984445,0.8224468787043216,0.7156862745098039,0.9723100056204971,1.0,7/25,32.02%,CRIP1;SLC30A5;D2HGDH;PAM;P2RX4;GLRA2;SLC30A4
prerank,cell chemotaxis (GO:0060326),0.3075003762729087,0.8224305103465303,0.7580645161290323,0.971906017200436,1.0,11/60,18.49%,ACKR3;VEGFA;LPAR1;CCL25;ACKR4;ABCC1;PDGFRA;HGF;CXCR4;CXCR2;EPHB1
prerank,regulation of transferase activity (GO:0051338),-0.28246750651660624,-0.8222568568103822,0.7449392712550608,0.8958590394167668,1.0,6/17,20.79%,EMP2;FEM1A;ATM;SPTSSB;PARP4;HMBOX1
prerank,small GTPase mediated signal transduction (GO:0007264),0.2930445900263611,0.8213157059826401,0.8032955715756952,0.9733329231891118,1.0,35/103,24.78%,PLCE1;CCDC88C;FGF2;MAPK14;RASSF1;RIT2;NTN1;RGL1;MAPK11;TIAM2;RGL2;NRAS;KRAS;USP50;SHOC2;RRAD;CDKN1A;GNB1;CHP1;HACD3;SOS1;SHTN1;BRAP;RRAS2;PLD2;RALA;TIAM1;NF1;JUN;SETDB1;CCDC88A;BCR;G3BP1;RAC1;RAB18
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3859238217987857,0.8210953464835705,0.7208053691275168,0.9732721560938974,1.0,3/14,13.40%,FSCN1;MYO9A;RHOA
prerank,sodium ion import across plasma membrane (GO:0098719),0.36558538188946293,0.8209352330066305,0.7325581395348837,0.9730932406236714,1.0,5/17,16.13%,SLC9A9;HCN4;SLC9A1;SLC9A6;SLC9A7
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.2519511121106643,-0.820656604393528,0.7708333333333334,0.8973389950963825,1.0,8/29,15.73%,LEF1;CREBBP;TCF7;AXIN2;EP300;TERT;CTNNB1;TLE4
prerank,positive regulation of JNK cascade (GO:0046330),0.30477490655753176,0.8205271342160657,0.7885228480340064,0.973324406140208,1.0,11/70,13.08%,SH3RF3;GADD45G;TAOK3;AXIN1;RASSF2;SEMA3A;FZD7;TIRAP;ANKRD6;CD27;TAOK2
prerank,carnitine metabolic process (GO:0009437),0.3936784415606763,0.820270617112959,0.709592641261498,0.9733039349255336,1.0,5/12,22.85%,CPT1C;CRAT;CPT2;CROT;ALDH9A1
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.2731816372761087,-0.8197188644881521,0.7239819004524887,0.897527110717556,1.0,4/20,8.92%,RAPGEF2;ADRA1B;ADCY9;ADRA2A
prerank,termination of RNA polymerase II transcription (GO:0006369),0.3269597401511419,0.8194890064992693,0.7238542890716804,0.9741432352351834,1.0,11/33,25.08%,SCAF8;CPSF4;CPSF2;SNRPG;SNRPD3;SLBP;CSTF2T;CPSF7;CPSF1;PABPN1;WDR33
prerank,peptide biosynthetic process (GO:0043043),0.28877246483206936,0.8194528975957525,0.8442211055276382,0.9737768972528119,1.0,23/153,16.03%,RPSA;PCSK5;MRPS11;RRBP1;COPS5;MRPS18B;IGHMBP2;MRPL13;MRPS17;AGO2;GSPT2;RPL10A;TNIP1;MRPL10;MRPL55;RPS5;MRPL36;GGT7;MRPL3;GSPT1;RPL6;MRPL51;HARS1
prerank,histone monoubiquitination (GO:0010390),0.34710930213743885,0.8190826508109305,0.7228195937873357,0.9739469109489041,1.0,7/24,21.48%,RNF2;ATXN7L3;RYBP;DDB1;RING1;KDM2B;PAF1
prerank,peptide metabolic process (GO:0006518),0.3031622507525617,0.8190683932825908,0.7985153764581124,0.9735488630687745,1.0,13/75,12.28%,PCSK5;ANPEP;SPCS1;LNPEP;TPP1;DPEP1;PSEN1;SEC11C;GPX1;GSTM2;THOP1;NAT8;NPEPPS
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.28515333397306486,-0.8189572633842183,0.75,0.8974207177684044,1.0,2/16,3.40%,ETS1;NFAT5
prerank,filopodium assembly (GO:0046847),-0.2906312225250992,-0.8188533386485656,0.7167381974248928,0.8961429497756713,1.0,3/16,3.99%,FGD4;FGD5;DNM3
prerank,mitochondrion disassembly (GO:0061726),0.3310797942186605,0.8187127829204055,0.7248554913294798,0.97370404506705,1.0,14/34,28.76%,ATG2B;WIPI2;SQSTM1;WDR45B;ULK2;ATG2A;ULK1;CISD2;ATG3;FIS1;CTSK;MARK2;RB1CC1;WIPI1
prerank,carbohydrate homeostasis (GO:0033500),0.3013485209003105,0.8187077614314486,0.7724358974358975,0.9732895614161701,1.0,8/67,12.85%,MTNR1B;IRS1;CRTC2;TCF7L2;MLXIPL;MCU;INPP5K;ADCY8
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3092005590625049,0.8184479681045188,0.7518878101402373,0.973283937756167,1.0,11/57,17.93%,SYK;FYN;F2R;TBC1D10A;USP50;BAK1;GRAMD4;CTSD;GRIN2A;HTRA2;BCAP31
prerank,eye photoreceptor cell development (GO:0042462),0.3777550019779722,0.8184334377565081,0.7029177718832891,0.9728877131716203,1.0,3/15,17.66%,VEGFA;BBS4;RPGRIP1
prerank,synaptic vesicle cycle (GO:0099504),0.33639435875554946,0.8183136817524255,0.7328519855595668,0.9726588010792198,1.0,6/30,20.10%,STX1A;SNAP25;SYNDIG1;SNAPIN;VAMP2;PLD2
prerank,regulation of protein autophosphorylation (GO:0031952),0.3213163729601405,0.8183124954176894,0.7246871444823664,0.9722383259587152,1.0,10/36,17.48%,VEGFA;RASSF2;GPNMB;CALM2;TAOK2;TNKS1BP1;NBN;CHP1;PPP2R5B;RAD50
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.2868383760332289,0.8182076264231058,0.8424242424242424,0.9719833541124178,1.0,22/159,14.03%,CDH26;CADM3;GPC6;NPTN;CD177;TGFB2;TGFBR2;PTPRS;NECTIN3;PKD1;ACVR1;TENM3;PTPRF;DSCAM;CDH22;CLDN10;UNC5D;L1CAM;PALLD;FLRT3;IGSF9;CLDN12
prerank,secondary alcohol biosynthetic process (GO:1902653),0.33051427820008356,0.817954900714684,0.7289940828402367,0.971983362150556,1.0,4/30,9.23%,ACLY;MVK;INSIG2;GGPS1
prerank,regulation of telomere capping (GO:1904353),0.34907582481973476,0.8179250883859831,0.7087980173482032,0.9716037126893121,1.0,7/23,20.94%,HNRNPD;NBN;USP7;SMG6;RAD50;NEK7;MAPK1
prerank,negative regulation of synaptic transmission (GO:0050805),0.3446783436479636,0.8178742206999249,0.7149938042131351,0.9712710925713497,1.0,8/23,31.43%,SYT11;ARF1;ATAD1;PTEN;PICK1;SLC24A2;DRD2;CBLN1
prerank,negative regulation of reproductive process (GO:2000242),0.3672307330135632,0.817555806728853,0.7135416666666666,0.9713534147086524,1.0,3/17,9.17%,SULF1;WDR77;PAEP
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.37874638665747973,0.8174442110481801,0.7281045751633987,0.9711115682586314,1.0,5/14,24.31%,CD177;SLC2A10;LIMS2;FLNA;DMTN
prerank,regulation of stress fiber assembly (GO:0051492),0.30340985275515076,0.8171917032007427,0.7856388595564942,0.971094726223397,1.0,14/74,11.43%,MYOC;TGFB3;TMEFF2;S100A10;LPAR1;SORBS3;ASAP3;PFN2;ARHGEF10L;ALMS1;ARHGEF10;INPP5K;CD47;SLC9A1
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.2006759861941614,-0.8171230956709024,0.9523809523809523,0.8978286185548882,1.0,12/68,12.68%,PCCA;SLC2A1;ENPP1;PDXK;MTHFS;TCN2;RFK;CUBN;ALDH1L1;MMAA;MCCC2;SLC19A3
prerank,mRNA methylation (GO:0080009),0.3744268796714296,0.8170554631434574,0.7225201072386059,0.9709015004179234,1.0,2/15,8.12%,TRMT6;TRMT61A
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.368878080533239,0.8168544990416029,0.7131578947368421,0.9708028999453209,1.0,2/16,2.82%,VEGFA;FGF2
prerank,regulation of aerobic respiration (GO:1903715),-0.2890830754267567,-0.8163068370851483,0.7297297297297297,0.8978759713451252,1.0,4/15,15.42%,CBFA2T3;PINK1;UQCC2;AK4
prerank,protein autoubiquitination (GO:0051865),0.30610974203063324,0.8162940854293416,0.7702265372168284,0.9712767641628195,1.0,20/61,24.50%,SH3RF3;UBE2B;ITCH;TRIM71;STUB1;CUL3;RNF10;RNF141;UBE2A;AMFR;UHRF2;TRIM68;RNF187;LRSAM1;UBE2D3;RNF41;UBE3A;RNF157;RNF13;MDM2
prerank,negative regulation of protein depolymerization (GO:1901880),0.34495853016924594,0.8159603383219569,0.7151664611590629,0.9714003962140081,1.0,5/24,20.56%,FGF13;PIK3CA;CAMSAP1;NAV3;CLASP2
prerank,sensory organ development (GO:0007423),0.3099236868621327,0.8158601877818941,0.7453142227122381,0.9711499320689492,1.0,7/51,9.24%,SIX4;ZDHHC16;TGFB2;PBX1;MEIS2;ECE1;ADAMTS18
prerank,regulation of AMPA receptor activity (GO:2000311),-0.2555204124879167,-0.8155165229920109,0.7525773195876289,0.8977098158640867,1.0,8/25,17.51%,MEF2C;SHANK3;CACNG4;CACNG8;GSG1L;SHISA9;MINK1;ADRB2
prerank,regulation of innate immune response (GO:0045088),-0.2055447749630002,-0.8154785797816788,0.8863636363636364,0.8963091614291328,1.0,17/57,17.58%,XIAP;PLSCR1;POLR3C;ERAP1;USP18;PTPN1;POLR3B;APPL2;GBP5;RNF135;RNASEL;TRIM21;N4BP1;NMI;LRP8;PARP9;DHX58
prerank,protein localization to membrane (GO:0072657),0.2835918332569275,0.8153544109746894,0.8694779116465864,0.9715375386601841,1.0,33/187,16.26%,LRP6;TTC7A;TSPAN17;PKP3;PRAM1;RAB32;ANK2;FGF13;S100A10;RFTN1;DLG4;PLEKHF1;DLG2;MYADM;AP3D1;MYO5A;GAS6;PACS2;CD81;EHD2;INPP5K;FYB2;RAB3D;MAGI2;JUP;PIGW;ZDHHC2;HPS6;FRMPD1;AP4M1;SPTBN1;FLOT2;ANK1
prerank,cardiac muscle contraction (GO:0060048),0.32347635491782445,0.8153158574135242,0.7384259259259259,0.9711862744067459,1.0,4/34,8.60%,GSN;TNNI3;CAMK2D;PIK3CA
prerank,embryonic heart tube morphogenesis (GO:0003143),0.3165097706755211,0.815279334965982,0.7388888888888889,0.9708231699780554,1.0,9/43,16.15%,TGFBR2;ACVR1;PKD2;TBX6;NDRG4;MICAL2;VANGL2;BBS4;AHI1
prerank,cellular amide metabolic process (GO:0043603),0.2985026406583684,0.8152085672350312,0.8165983606557377,0.9705131155912257,1.0,24/102,22.04%,SMPD3;GPAT4;PLPP3;PLAAT1;ACOT6;PLPP1;ORMDL2;ACOT9;THOP1;CERK;ACOT1;PLA2G4E;DNPEP;ABCB9;ST3GAL1;BTD;PLPP2;GNE;SMPD1;NIT1;MTHFD2L;NSMAF;CPZ;ATF4
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.38835096271701686,0.8147545723948999,0.6988265971316818,0.9708124713895614,1.0,4/12,26.93%,GAS2L1;BRD8;CTSB;CTSL
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.38930442178100405,0.814628575676793,0.7245179063360881,0.9705888352475022,1.0,1/12,2.00%,CDC14B
prerank,lipid oxidation (GO:0034440),-0.3098394628767453,-0.8143276247342816,0.6992753623188406,0.8969930009424727,1.0,4/12,22.73%,ADIPOR2;ADIPOR1;ALOX12;PPARGC1A
prerank,positive regulation of cellular component movement (GO:0051272),0.34156680267891276,0.8142306401385448,0.7107142857142857,0.9707980291577702,1.0,5/24,13.51%,DUOX1;VEGFA;NTN1;CCDC25;TWIST1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.27750622705890005,-0.814212781123212,0.7432432432432432,0.895719147263853,1.0,2/17,4.59%,HMGB1;CXCL12
prerank,T cell receptor signaling pathway (GO:0050852),0.28930162872986687,0.8140640684960518,0.8405650857719476,0.9706431153803516,1.0,40/138,28.26%,PRAM1;PSMC4;FYN;RFTN1;PIK3R2;PTPRJ;CSK;PSMC6;RC3H1;PRKD2;UBE2N;CHUK;PIK3CA;PSMD8;FYB2;PDE4D;ZC3H12A;MOG;BTN3A3;NCK1;RBCK1;VTCN1;CARD11;EIF2B1;RC3H2;TAB2;FBXW11;MAP3K7;RELA;PSMD4;PSMD3;PSMB3;EIF2B2;RNF31;PAK3;BCL10;NFKB1;CUL1;PSMB2;PSMD5
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.2408837037950678,-0.8139592454557996,0.7862068965517242,0.8947097521735168,1.0,7/30,12.83%,ACSL1;ELOVL7;HACD1;HACD4;HACD2;ACSL6;ELOVL1
prerank,actin filament organization (GO:0007015),0.28426625457391075,0.8138338192900085,0.8387096774193549,0.9705902408963524,1.0,33/151,21.44%,DBN1;GSN;SCIN;TLE6;CDC42EP2;COBL;MYO1A;SVIL;SPTA1;MARCKS;GAS2L1;MYO5A;ABI1;MCU;EFS;AVIL;FHOD3;RHOA;RND3;TRIOBP;TMOD2;PLS1;RAC3;CORO7;PPP1R9B;TPM4;ALDOA;RFLNA;SAMD14;CORO1C;FLNA;SHROOM3;ARHGAP17
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3030088637676752,0.8135143274293546,0.7618534482758621,0.9707206803831856,1.0,13/63,14.28%,TRIAP1;RFWD3;MUC1;MDM4;FBXO31;SFN;RPS27L;CDKN1A;CNOT3;CCND1;CNOT10;PLAGL1;TNKS1BP1
prerank,tryptophan metabolic process (GO:0006568),-0.3065093214487477,-0.813386809521817,0.721830985915493,0.8941807077147671,1.0,11/11,69.38%,KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD;ATP7A;KYAT1;KMO
prerank,cardiac muscle cell action potential (GO:0086001),0.33032510851610175,0.81335121688685,0.724824355971897,0.9705438832600726,1.0,6/30,10.18%,ANK2;ATP1A1;SLC4A3;KCNJ2;YWHAE;HCN4
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.40443242908413735,0.8132017260925302,0.7083333333333334,0.9703755802140346,1.0,6/11,37.51%,TENT4B;LARP7;EXOSC10;EXOSC3;FBL;PARN
prerank,cellular response to radiation (GO:0071478),0.3205737916936086,0.8131948890869712,0.7625,0.9699701883089182,1.0,10/40,22.51%,MAPK14;RHNO1;RAD1;CDKN1A;INO80;TNKS1BP1;SPIDR;BLM;OPN3;NSMCE3
prerank,telomere maintenance via telomerase (GO:0007004),0.33556940957089093,0.8130403077644123,0.7260765550239234,0.9697926906668637,1.0,9/28,21.89%,ACD;GAR1;TERF1;TNKS1BP1;HSP90AA1;RAD50;TINF2;PPP6C;TERF2IP
prerank,myeloid dendritic cell activation (GO:0001773),0.3859932029677297,0.8128056821388708,0.7037037037037037,0.9697515645761788,1.0,3/12,21.01%,TGFBR2;IL4;PYCARD
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.3299960513883654,0.8127954725828863,0.7426900584795322,0.9693536240797678,1.0,4/31,7.31%,TGFB2;TNNI3;SMAD4;ZFPM2
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.25871880469561115,-0.8122823248853276,0.7861271676300579,0.8947708975536531,1.0,3/24,6.51%,ABCG2;PGRMC1;FECH
prerank,Rac protein signal transduction (GO:0016601),0.3651918696320938,0.8119434486113949,0.7308673469387755,0.9702512874902679,1.0,7/18,25.32%,FARP2;WASF1;HACD3;HACE1;TIAM1;RAC1;CYFIP1
prerank,regulation of TOR signaling (GO:0032006),0.30231568399919806,0.8117407685076028,0.7824709609292503,0.9701808951704932,1.0,11/67,14.99%,DGKQ;TBCK;FLCN;GAS6;PIK3CA;HDAC3;DEPTOR;SMCR8;TMEM127;RRAGD;GPAT3
prerank,negative regulation of viral process (GO:0048525),0.3040069678601164,0.8116240888202388,0.7494553376906318,0.9699579428761202,1.0,17/57,24.09%,MID2;TRIM11;ZC3HAV1;TNIP1;SLPI;ZFP36;FAM111A;UBP1;PML;PPIA;MBL2;TRIM35;BTBD17;SRPK1;LARP7;TRIM8;HEXIM1
prerank,lipoxygenase pathway (GO:0019372),0.3707759366227844,0.8112379614738435,0.7195121951219512,0.9701288313900741,1.0,2/14,11.01%,PON3;GPX1
prerank,nucleotide metabolic process (GO:0009117),0.34423505115365516,0.8110178710365058,0.727932285368803,0.9700585818315571,1.0,6/23,17.12%,REXO2;FHIT;NME2;NUDT5;CMPK2;AK8
prerank,cellular response to amyloid-beta (GO:1904646),0.322945004919549,0.8109487945191124,0.7439724454649828,0.9697516568707191,1.0,9/35,17.68%,LRP1;FYN;ATP1A3;PSEN1;TLR4;ABCC1;CACNB1;GRIN2A;SNX6
prerank,amyloid precursor protein metabolic process (GO:0042982),0.3577893666223513,0.8103401941472942,0.7280813214739518,0.970296877772643,1.0,5/18,13.86%,ADAM19;TMCC2;PSEN1;KLK6;NSG1
prerank,mismatch repair (GO:0006298),-0.24292414799597362,-0.8103276194637061,0.7734806629834254,0.896856022008944,1.0,12/27,25.64%,MCM9;MSH3;XPC;PCNA;ABL1;MSH2;TDG;POLD2;RPA2;MLH3;MUTYH;POLD4
prerank,negative regulation of cell projection organization (GO:0031345),0.31040607613338045,0.8103162155082388,0.7635135135135135,0.9699203982689141,1.0,11/48,14.62%,FYN;PTPRS;LPAR1;STX1B;SEMA3A;MYLIP;TSKU;KANK1;RTN4RL1;CBFA2T2;DCC
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.3222521433055998,-0.8102534891458152,0.7065217391304348,0.8955151288248925,1.0,1/11,1.73%,H3-3A
prerank,regulation of inclusion body assembly (GO:0090083),-0.3055019545229764,-0.809997540784673,0.7065217391304348,0.8944828780621249,1.0,1/11,0.80%,SNCAIP
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.2868080113283683,-0.809903339463501,0.7004405286343612,0.8931888180628941,1.0,6/15,23.82%,SCARB1;NR1H3;SIK1;CTDNEP1;FITM2;C3
prerank,lysine metabolic process (GO:0006553),0.38719175972414194,0.8098865846378553,0.7082767978290366,0.9697724993976116,1.0,1/12,0.85%,SLC25A21
prerank,lysine catabolic process (GO:0006554),0.38719175972414194,0.8098865846378553,0.7082767978290366,0.9697724993976116,1.0,1/12,0.85%,SLC25A21
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.28299582916125715,0.8095649639258016,0.8422649140546006,0.9698505365851801,1.0,45/149,29.05%,AR;RAB7B;IRAK3;S100A8;S100A9;MID2;CARD16;DHX33;PRKD2;UBE2N;CHUK;TIRAP;TLR4;NPM1;IRAK1;UBA52;FER;EDA;RBCK1;FLOT2;TRIM68;IL6;PPIA;IL18;CARD11;ROR1;PYCARD;TAB2;TERF2IP;FLOT1;TRIM8;TRAF5;MAP3K7;RELA;PRKCZ;TICAM1;RNF31;EDA2R;RHEBL1;BCL10;NFKB1;PRKCI;ZBTB7A;MYD88;RPS6KA5
prerank,regulation of TORC1 signaling (GO:1903432),0.32393636440945,0.8095568342072694,0.7543453070683661,0.9694500342178204,1.0,10/33,22.46%,DGKQ;FLCN;SESN3;SMCR8;RRAGD;PIP4P1;GPR137B;CASTOR2;KLHL22;SESN2
prerank,transcription by RNA polymerase I (GO:0006360),0.32197893966160673,0.8095269931166703,0.7569124423963134,0.9690821721113362,1.0,10/34,23.60%,POLR2H;GTF2H3;POLR1G;UBTF;ERCC3;CCNH;RRN3;POLR1C;TBP;POLR1B
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.337550715426674,0.808576991650296,0.7355072463768116,0.9701103252569557,1.0,6/26,12.33%,WDTC1;PRKAB2;MLXIPL;ACADVL;ELOVL5;EIF6
prerank,regulation of macromolecule metabolic process (GO:0060255),0.28448038695877864,0.8085534841670005,0.8744979919678715,0.9697329794365439,1.0,33/170,20.61%,AFF3;C1D;AFF2;FOXP1;CRIP1;ZFP36L1;CDK4;COQ7;TARDBP;STX1B;PSEN1;HNRNPD;ARF1;SIRPA;TSKU;TRIM11;ALPK2;ZNF462;IGF2BP1;GDNF;PEG3;PIN1;ZC3H12A;SLC8A2;MTMR1;TRIM68;RNF187;CTCF;PRDM9;MKLN1;NOVA1;RASA1;CIAO3
prerank,regulation of interleukin-13 production (GO:0032656),0.3710083918674667,0.8085475455552954,0.6994459833795014,0.9693294874136841,1.0,5/13,25.13%,IRF4;IL4;IL18;RARA;PRKCZ
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.3125694061385076,-0.8080481410169976,0.7256944444444444,0.89496891206049,1.0,4/11,27.89%,PINK1;HIF1A;NR4A3;PARK7
prerank,photoreceptor cell development (GO:0042461),0.37054227084505986,0.8078761680952729,0.7272727272727273,0.9699548296870081,1.0,6/14,31.83%,VEGFA;AHI1;DCX;TOPORS;TULP1;RORB
prerank,positive regulation of histone methylation (GO:0031062),-0.2504889564817113,-0.8076471176594963,0.7604790419161677,0.8942471958419207,1.0,6/24,14.38%,AUTS2;TET1;CTR9;SIRT1;RIF1;CTNNB1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.38674311148774365,0.80729749545126,0.7094133697135061,0.9704511331170309,1.0,7/12,33.89%,SGTA;SEC63;SEC61A1;SEC61B;CHMP4A;CHMP4B;HSPA5
prerank,regulation of ATP biosynthetic process (GO:2001169),0.36161205070875563,0.8068031015402227,0.7216358839050132,0.970794606690012,1.0,4/16,15.09%,PID1;FLCN;ANTKMT;IL4
prerank,nuclear migration (GO:0007097),0.3744414232647123,0.8065184786837093,0.726063829787234,0.9708368181696669,1.0,8/13,23.52%,DCTN1;DOCK7;DYNC1H1;PAFAH1B1;PCM1;FBXW11;TMEM201;SYNE3
prerank,nucleotide catabolic process (GO:0009166),0.3632947736856281,0.8064998553423953,0.7215686274509804,0.9704477454713265,1.0,3/16,11.01%,GDA;SAMHD1;GPX1
prerank,positive regulation of protein modification process (GO:0031401),0.283116827540738,0.8064050152880073,0.9019019019019019,0.9701839915902053,1.0,47/203,23.65%,FGF18;NIBAN1;FGF7;EGFR;EFNA5;TMEM119;NPTN;ITGB3;VEGFA;FGF2;PDE8A;AXIN1;FLCN;GAS6;UBE2N;HDAC3;MUSK;CAMKK2;AKT1;KRAS;GPNMB;CALM2;PIN1;CCND1;NSMF;WDFY2;HSP90AA1;CHP1;HGF;FXR2;CHRNA7;PPIA;PLAUR;ILK;SMPD1;CLIP3;THPO;PTBP1;ACVR2A;ARRB1;TERF2IP;ANKLE2;FLOT1;FGF9;ATG14;ATG10;LEPR
prerank,maintenance of protein location in nucleus (GO:0051457),0.3488433800651341,0.8059038715972529,0.7204433497536946,0.9705426636429675,1.0,6/20,16.96%,TAF8;SYNE1;TAF3;BCL3;BBS4;PML
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.3679308299476866,0.8055912540529696,0.7333333333333333,0.9706038693996393,1.0,3/15,12.13%,IRS1;AKT1;IRS2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.28756879883608155,0.8052408085675685,0.840122199592668,0.9707568941932598,1.0,42/128,28.57%,DCTN1;ODF2;CDK14;YWHAG;SSNA1;YWHAE;PPP1R12B;ALMS1;HAUS3;MAPRE1;SFI1;CDKN1A;FBXL3;CCNH;HSP90AA1;DYNC1H1;TUBB4A;TUBA4A;CDK5RAP2;CCP110;AKAP9;CEP164;CKAP5;PAFAH1B1;PPP2R2A;SKP2;PCM1;FBXW11;DCTN2;CDC25B;NEDD1;LATS1;FBXL12;DYNLL1;CEP78;ACTR1A;CSNK1E;CETN2;WEE1;CUL1;CEP152;FOXM1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.28721552915103676,0.8051473975837994,0.823170731707317,0.970471631080275,1.0,20/107,19.42%,CCL8;NPTN;ANK2;TNNI3;SLC39A14;SLC39A13;ATP2B4;SLC39A7;SLC30A9;ATP13A1;ATP2A2;CCL13;SLC8A2;STC1;SLC30A5;TMEM165;CHRNA7;ATP2B1;HTR2C;STIM1
prerank,mesenchyme morphogenesis (GO:0072132),0.36049490600698864,0.8050477041263859,0.7443408788282291,0.9702113075085268,1.0,3/17,6.84%,TGFB2;ACVR1;MDM4
prerank,cellular response to alcohol (GO:0097306),0.31556318003884476,0.8048732260011137,0.7649043869516311,0.9700775208524218,1.0,10/42,19.41%,LRP6;GRAMD1A;JUP;LARP1;ADCY8;ADAM15;GNB1;SPIDR;BLM;GPLD1
prerank,protein tetramerization (GO:0051262),0.2984936266556821,0.8048441946790001,0.7742616033755274,0.9697106520599957,1.0,12/67,15.19%,PKD1;KRT10;TK1;KCNJ2;OSBPL2;PKD2;CPSF6;SAMHD1;ALDH1A3;GLS;HSD17B8;CRYZ
prerank,pyruvate metabolic process (GO:0006090),-0.21923566946473413,-0.8047893566460609,0.8686868686868687,0.8976543654489314,1.0,17/52,21.45%,BSG;ENO1;HK2;PGAM1;PGAM4;PGK1;PFKM;ALDOC;PFKL;GAPDH;DLD;TPI1;GAPDHS;ENO3;GPI;LDHB;NR4A3
prerank,ion transport (GO:0006811),0.28806825869451724,0.804572653454264,0.8181818181818182,0.9697231330515524,1.0,23/111,18.27%,PIEZO2;SLC1A7;ATP1A4;SLC26A11;SLC1A6;SLC9A9;SLC12A4;SLC17A5;CNGB1;HCN4;SLC9A1;VDAC2;SLC26A6;SLC12A5;SLC8A2;SLC15A4;VDAC1;SLC20A1;SLC9A6;SLC9A7;CHRNA7;SLC26A1;LASP1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.32146878066311635,0.8044888168264324,0.7563805104408353,0.9694319251870229,1.0,6/37,13.21%,ITGB3;DLG4;ATXN2;SIRT2;ITGAV;NCOR1
prerank,regulation of G0 to G1 transition (GO:0070316),0.31665282880394613,0.8034534387850495,0.7377423033067275,0.9706385857355107,1.0,12/38,21.82%,RNF2;RHNO1;RYBP;PHC3;PHC1;EHMT2;UXT;APAF1;RING1;PCGF6;FOXO4;EZH2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.398212886475463,0.8027789982622291,0.71939477303989,0.9712402569753386,1.0,7/10,29.74%,MUC1;ING4;RPS27L;TFAP4;KAT5;FOXM1;TP53
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.31608615179777605,-0.8027606603829351,0.6825938566552902,0.8997864409960149,1.0,4/11,17.51%,GRK3;GTF2H2;ADM;ADRB2
prerank,regulation of gene silencing by miRNA (GO:0060964),0.30194624339779963,0.8025723482512601,0.8002136752136753,0.9711404387603931,1.0,21/62,27.65%,POLR2H;NUP93;TRIM71;NUP107;NUP98;AGO2;PUM1;POLR2D;ZFP36;POLR2G;NUP37;NUP50;TPR;TNRC6A;POLR2C;NUP85;NUP133;NUP188;EIF4G1;NUP88;AGO1
prerank,triglyceride homeostasis (GO:0070328),-0.2457032807957028,-0.8023336022813656,0.7647058823529411,0.8990531680596318,1.0,5/26,10.42%,APOE;SCARB1;NR1H3;C1QTNF3;SIRT1
prerank,protein sumoylation (GO:0016925),0.3099486949310326,0.8019153770083077,0.7863340563991323,0.9717114422992383,1.0,18/49,28.15%,STX1A;RNF212B;NUP93;PIAS3;NUP107;UBA2;NUP98;NUP37;NUP50;SAE1;TPR;NSMCE2;BCL11A;NUP85;NUP133;NUP188;NUP88;TOPORS
prerank,positive regulation of cell motility (GO:2000147),0.2791639812759622,0.8006601354336331,0.8822937625754527,0.9732046069133041,1.0,29/205,15.09%,SEMA3C;HAS2;MYOC;EPHB2;COL1A1;DUOX1;PRKCA;EGFR;VEGFA;F2R;ADAM9;ACVR1;MYADM;RET;NTN1;SEMA3A;STX4;MAPRE1;EGF;MGAT5;GPNMB;SEMA3D;CCDC25;PDGFRA;TWIST1;FER;PPP3CA;SNAI2;IL4
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.31436088152302943,-0.8003545101768628,0.675,0.900889876950046,1.0,2/11,5.23%,SCARB1;NR1H3
prerank,positive regulation of myelination (GO:0031643),-0.30633646280344257,-0.7999555353617434,0.7289377289377289,0.90006614948406,1.0,2/11,8.07%,TENM4;TPPP
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.3370806541346008,0.7995659865599812,0.7289603960396039,0.9744604139485911,1.0,7/22,27.55%,SCAF8;TCERG1;THOC1;ELL;KAT7;ALYREF;THOC5
prerank,response to muramyl dipeptide (GO:0032495),-0.3085938637590656,-0.799023115607337,0.7444444444444445,0.9002575573055484,1.0,4/12,24.68%,NOD1;NOD2;ERBIN;RIPK2
prerank,embryonic hemopoiesis (GO:0035162),-0.30116553667440754,-0.7989369878959298,0.708502024291498,0.8989801069757214,1.0,3/12,4.44%,KITLG;KDR;KIT
prerank,heterocycle biosynthetic process (GO:0018130),0.367743757310636,0.7988418702380289,0.7275132275132276,0.975123119209357,1.0,8/14,35.33%,NFS1;PYCR1;MOCS1;NOXRED1;PYCR3;MOCS2;LIAS;MOCS3
prerank,ceramide metabolic process (GO:0006672),0.30608972036186616,0.7986644003258222,0.7611777535441657,0.974973138006894,1.0,8/49,12.41%,CERS6;PLPP3;PLPP1;ORMDL2;AGK;SGMS2;FA2H;CERK
prerank,smoothened signaling pathway (GO:0007224),0.3183015350636849,0.7980038969586282,0.7345029239766082,0.9755589251081359,1.0,5/32,10.97%,DISP2;GLI2;ARL13B;DYRK2;GLI3
prerank,positive regulation of cytokinesis (GO:0032467),0.3254567914753147,0.7978328038910694,0.7476525821596244,0.975399065867698,1.0,6/32,14.97%,CDC14B;SVIL;CUL3;KIF20B;RHOA;GIPC1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.351395692001385,0.7976693016671851,0.7471116816431322,0.9752364781110285,1.0,3/19,15.79%,CARD16;ZC3H12A;NLRP2B
prerank,negative regulation of GTPase activity (GO:0034260),-0.255212561644499,-0.7974381987719124,0.7772020725388601,0.9001094408398482,1.0,5/22,10.19%,F11R;DAB2IP;LRCH1;CPEB2;ARL2
prerank,regulation of heart contraction (GO:0008016),0.2879591887775426,0.7973890139962849,0.8238341968911918,0.9752461552668797,1.0,17/90,14.25%,ANK2;TGFB2;SRI;ATP1A4;ATP1A3;ATP1A1;ATP2B4;CAMK2D;TNNI3K;HCN4;CELF2;PDE4D;CALM2;ATP2A2;TMEM65;CASQ1;SLC8A2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.30366028875003837,0.7972952162564205,0.7855579868708972,0.9749721982600221,1.0,18/54,26.77%,SDAD1;NOC2L;NPM1;RPL10A;EIF6;SNU13;RSL1D1;RPL6;NOP53;EBNA1BP2;RPF2;MAK16;NOP2;RSL24D1;BRIX1;LTO1;NOP16;NHP2
prerank,visual system development (GO:0150063),0.3179488611023602,0.7972013418144813,0.7595375722543353,0.97470459942603,1.0,5/37,9.24%,ZDHHC16;TGFB2;PBX1;MEIS2;ADAMTS18
prerank,lymphocyte proliferation (GO:0046651),0.33925633198964644,0.7971423654744029,0.7558859975216853,0.9743771997768006,1.0,6/22,21.52%,ELF4;FLT3;CR2;LMBR1L;PPP3CB;PIK3CG
prerank,cholesterol biosynthetic process (GO:0006695),0.31952659742677375,0.7970919306941199,0.7532163742690059,0.9740468100277078,1.0,4/31,9.23%,ACLY;MVK;INSIG2;GGPS1
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.20660920402449087,-0.7967770042116861,0.8987341772151899,0.8999127143163417,1.0,14/55,14.59%,BCL2L1;BCL2;DAB2IP;TPD52L1;CAV1;TNFSF12;ING5;WWOX;FAS;BCL2L11;RIPK1;TNFSF10;DEDD2;GPER1
prerank,kinetochore organization (GO:0051383),0.3727670628953827,0.7966895876375364,0.7194444444444444,0.9742209811699887,1.0,3/13,19.15%,CENPT;CENPC;CENPE
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.3456703829061982,0.7965469592640687,0.7465495608531995,0.9740328575851572,1.0,12/20,33.68%,ADAM9;PSEN1;SPPL2B;RELA;MBTPS1;NFKB1;HM13;ADAM17;TRAF6;PSENEN;SPPL2A;NCSTN
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.2736224013211028,-0.7965326107503914,0.7312775330396476,0.8988875359193246,1.0,5/17,11.89%,IGF1;APOE;GGA3;SORL1;NTRK2
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.29557014752042754,0.7957450557794219,0.8074074074074075,0.9748126615850912,1.0,6/65,9.57%,FHL1;INTS3;PSMC4;PSMC6;PSMD8;AVEN
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.36004154862797705,0.7954267345448842,0.7366412213740458,0.9748689371115794,1.0,5/17,25.32%,WASF1;ARF1;GMFB;PICK1;CYFIP1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.3547253109319971,0.7953447915641646,0.7278401997503121,0.9745818017465581,1.0,6/18,21.55%,COX19;SURF1;BCS1L;COX16;COX14;COX18
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.33091818012952723,0.7948943047311463,0.7493917274939172,0.9748315187686044,1.0,3/25,6.05%,ANK2;F2R;CXCL10
prerank,positive regulation of blood coagulation (GO:0030194),-0.2807669121419399,-0.7947301620702482,0.7440758293838863,0.9004931650305522,1.0,5/17,15.78%,F3;THBS1;ENPP4;USF1;SERPINE1
prerank,regulation of anoikis (GO:2000209),0.3438201312882856,0.7943068778952315,0.7455696202531645,0.9753060809839003,1.0,6/19,19.75%,ITGA5;SRC;PIK3CA;SNAI2;PTRH2;MCL1
prerank,plasma membrane tubulation (GO:0097320),-0.290981793998345,-0.7942315338052262,0.7216117216117216,0.8999690631925771,1.0,2/13,3.88%,FNBP1L;CAVIN2
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.2775788310224901,0.7936948676056027,0.8799192734611504,0.9758209255458612,1.0,43/151,26.33%,CERS6;ST3GAL2;PCSK5;GPAT4;PLPP3;ALDH3A2;INHA;PLPP1;PRKD2;CHKB;SLC44A1;LCAT;SGMS2;LPCAT1;LARGE1;GSTM2;TNIP1;FA2H;ELOVL5;ST3GAL4;PRKD3;NFS1;CEPT1;HACD3;SLC44A2;SLC25A15;PLPP2;GSTO2;TYW5;LPIN3;CSNK2A2;PCTP;CSNK1G2;MOCS1;GSTM1;SLC25A2;SGPP1;ELOVL6;SLC27A1;PAM;LPCAT3;B4GALT5;ESD
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.3131767243137902,-0.7928625141255258,0.75390625,0.9007553530287813,1.0,3/13,12.28%,NOTCH1;TBX3;TGFB1
prerank,Notch signaling involved in heart development (GO:0061314),-0.31975326762651507,-0.7925138651037872,0.7508896797153025,0.8998699219436551,1.0,6/11,24.01%,NOTCH1;HEYL;GALNT11;HEY1;HEY2;DLL4
prerank,positive regulation of insulin secretion (GO:0032024),0.3118810129350811,0.7917899770009775,0.7734741784037559,0.9782367376993195,1.0,10/36,19.43%,TCF7L2;MCU;STX4;IRS2;ADCY8;TRH;GLUD1;CAPN10;GPLD1;PPP3CB
prerank,indolalkylamine catabolic process (GO:0046218),-0.30649008285212154,-0.7916980243483469,0.725752508361204,0.8997954962423821,1.0,10/10,69.38%,KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD;KYAT1;KMO
prerank,regulation of T cell chemotaxis (GO:0010819),-0.3149107107762365,-0.7913559267599358,0.7326388888888888,0.8989698187822728,1.0,2/11,3.53%,ADAM10;WNT5A
prerank,ncRNA processing (GO:0034470),0.2787992150173413,0.791145529914479,0.8997995991983968,0.9788121127659343,1.0,43/200,20.84%,C1D;TARBP2;INTS3;DDX49;RPP21;DGCR8;INTS10;FCF1;HELQ;AGO2;ESF1;EXOSC7;INTS6;RRP36;RPL10A;WDR46;UBA52;RCL1;SBDS;MPHOSPH10;SNU13;NOLC1;EXOSC1;DCAF13;RRP7A;ZCCHC8;RPL6;DDX52;POP4;NOP53;TRPT1;INTS2;AGO4;PWP2;EBNA1BP2;INTS12;AGO3;TBL3;RPL23;RPL17;PDCD11;RPS25;KRR1
prerank,response to amino acid starvation (GO:1990928),0.29035633311371617,0.7910395033558356,0.8055260361317748,0.9785528949019754,1.0,19/72,23.50%,EIF2AK3;MTOR;FLCN;CEBPB;ATP6V1E1;SESN3;LARP1;CDKN1A;RRAGD;EIF2S1;ATP6V1D;ATP6V1B2;DAP;CASTOR2;MAPK1;ATF4;SESN2;SLC38A9;ATP6V0B
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.34601391468468523,0.7910101350916707,0.7538265306122449,0.9781846478178589,1.0,4/21,11.23%,ADAM9;ADAM19;PSEN1;SPPL2B
prerank,"phagocytosis, engulfment (GO:0006911)",0.31027437241084055,0.790726626628564,0.7622950819672131,0.9781869344451798,1.0,1/36,0.45%,GSN
prerank,amyloid fibril formation (GO:1990000),0.30305166458932065,0.7904633274735072,0.8019911504424779,0.978183538245387,1.0,11/51,16.64%,GSN;TGFBI;SIAH1;GGA1;CALCA;HSPG2;MAPT;NAT8;UBA52;GGA2;IAPP
prerank,DNA methylation (GO:0006306),0.33214805972705996,0.7904359782547823,0.7490683229813665,0.9778134732467985,1.0,12/23,32.11%,SPOCD1;EHMT2;DMAP1;N6AMT1;BAZ2A;GATAD2A;PICK1;MTRR;ATF7IP;ATRX;FOS;DNMT3B
prerank,ncRNA export from nucleus (GO:0097064),0.3124015164534231,0.7899035507696284,0.7844243792325056,0.9781828359669233,1.0,19/36,34.17%,NUP93;NUP107;NUP98;NPM1;NUP37;NUP50;XPOT;TPR;NUP85;NUP133;NUP188;NUP88;TSC1;SEC13;AAAS;NUP160;NCBP2;NUP54;RANBP2
prerank,regulation of myoblast differentiation (GO:0045661),0.3207515832843815,0.789803508489376,0.7816901408450704,0.9779241245942513,1.0,6/32,8.29%,ZFP36L1;MAPK14;AKIRIN1;TRIP4;BOC;SOX8
prerank,cellular response to nutrient levels (GO:0031669),0.2968410278018705,0.7894702277725681,0.8051391862955032,0.977990116242424,1.0,12/62,14.40%,MTOR;FOXO1;GAS2L1;FLCN;WIPI2;USP33;WDR45B;RRAGD;FADS1;ULK1;EHMT2;STK24
prerank,histone H2A monoubiquitination (GO:0035518),0.35453408155380955,0.7892548773439475,0.7569620253164557,0.9778896251272825,1.0,7/17,24.78%,RNF2;RYBP;DDB1;RING1;PCGF6;KDM2B;PCGF3
prerank,positive regulation of calcium ion transport (GO:0051928),0.3084234764913202,0.7889583504477248,0.7667057444314185,0.9779280521309136,1.0,3/36,4.41%,ANK2;F2R;P2RX3
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.31283275578422715,0.788744592738491,0.7767441860465116,0.9778369763308151,1.0,4/34,6.77%,TNS2;PTPRS;PTPRJ;PTPRF
prerank,extracellular transport (GO:0006858),-0.3030345953307808,-0.7886336342927749,0.7758007117437722,0.9020143864677914,1.0,9/12,37.39%,WWP2;ARRDC1;CABYR;ROPN1L;ADCY10;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.30843562845766476,0.7885653809974945,0.7909604519774012,0.9777043203445869,1.0,9/43,17.42%,IRS1;GRB10;TNS2;PID1;INPP5K;KANK1;OGT;NCK1;PIP4K2C
prerank,positive regulation of chromosome organization (GO:2001252),0.36128962593309666,0.7885192813092206,0.7409879839786382,0.9773639855283602,1.0,4/15,17.48%,DDX11;NBN;PML;RAD50
prerank,phosphorylation (GO:0016310),0.2723095439376138,0.7880411996693855,0.962,0.9776575487799066,1.0,51/384,12.41%,SYK;EPHB2;DCLK1;PRKCA;TNK1;FGFR1;STK25;EIF2AK3;CDKL2;FYN;IRAK3;DGKQ;TGFB2;SGK3;SGK2;CDK14;LMTK3;TGFBR2;TAOK3;ACVR1;CDK4;MTOR;CAMK2D;CSK;RET;TBCK;PRKD2;GK5;GAS6;STRADA;TNNI3K;CHUK;TESK2;PIK3CA;CDK9;AKT3;AGK;CDK20;NRBP2;BMP2K;ERN1;DYRK2;AMHR2;MAP3K6;CAMKK2;AKT1;IRAK1;STK39;PASK;PXK;CERK
prerank,clathrin coat assembly (GO:0048268),0.3594170762026837,0.7878560021072591,0.7543160690571049,0.9775061485944802,1.0,3/15,13.86%,CLTC;CALY;NSG1
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.31103153524495325,0.7878555762981956,0.7714604236343366,0.9771005086415171,1.0,11/40,21.55%,PID1;PIP5KL1;AKT1;MAPT;NDUFS1;BAK1;TUSC2;SLC25A36;PYCR1;PRELID1;SLC25A33
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.2901927243903489,0.7877975392677958,0.8145416227608009,0.976784398655216,1.0,14/69,21.40%,TGFB3;SIX4;F2R;ZPR1;CLCF1;NFATC4;NRBP2;GDNF;SIX1;SNX6;SET;RASA1;TYRO3;KDM2B
prerank,positive regulation of interferon-alpha production (GO:0032727),0.341038068678483,0.7874432975250452,0.7441860465116279,0.9768937555345445,1.0,3/19,11.66%,CHUK;TLR4;SETD2
prerank,regulation of type I interferon production (GO:0032479),0.28725953407614563,0.7873871428371527,0.8402922755741128,0.9765679126585424,1.0,28/84,29.02%,POLR2H;ITCH;CGAS;POLR3E;DHX33;TIRAP;POLR3D;IRAK1;XRCC5;PIN1;CD14;RNF216;ILRUN;TRAF3;TAX1BP1;POLR3H;POLR1C;POLR3A;CYLD;RELA;G3BP1;UBA7;UFD1;PRKDC;NFKB1;NPLOC4;XRCC6;MYD88
prerank,embryonic heart tube development (GO:0035050),0.3672115207012067,0.787304686582348,0.7387755102040816,0.9762761994122311,1.0,2/14,8.21%,ACVR1;NDRG4
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.3562735729605718,0.786555860403557,0.751358695652174,0.9769650262102876,1.0,2/14,6.98%,UMPS;NT5M
prerank,ear morphogenesis (GO:0042471),0.34120961198725863,0.7855481095153707,0.7512437810945274,0.9779952165694661,1.0,1/20,0.46%,EPHB2
prerank,adherens junction organization (GO:0034332),0.30167906655013194,0.7852743830128759,0.7993311036789298,0.9779677716110166,1.0,7/48,11.99%,CADM3;ANG;NECTIN3;CSK;JAM3;CDH22;JUP
prerank,type I interferon signaling pathway (GO:0060337),-0.21391175238192406,-0.7851233487675942,0.849624060150376,0.9047055844795387,1.0,12/41,18.82%,SP100;IFNAR1;IFITM3;IFIT1;IFIT2;OAS2;STAT1;IFIT3;RNASEL;ADAR;RSAD2;PSMB8
prerank,cellular response to type I interferon (GO:0071357),-0.21391175238192406,-0.7851233487675942,0.849624060150376,0.9047055844795387,1.0,12/41,18.82%,SP100;IFNAR1;IFITM3;IFIT1;IFIT2;OAS2;STAT1;IFIT3;RNASEL;ADAR;RSAD2;PSMB8
prerank,SNARE complex assembly (GO:0035493),-0.31497259526120724,-0.7843204316638066,0.7275747508305648,0.9045441815318775,1.0,2/10,3.51%,SNCA;UVRAG
prerank,regulation of monocyte differentiation (GO:0045655),0.3645376277166468,0.7841126569726068,0.7336010709504686,0.9792212409147929,1.0,2/14,4.06%,FOXP1;ZFP36L1
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.25632100377137795,-0.7839573377344905,0.8412698412698413,0.9037388416682155,1.0,3/22,8.89%,ALDH1A2;RBP1;CUBN
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.3289351848030771,0.783709713689723,0.75,0.9794024806756289,1.0,4/23,10.97%,GPC3;GLIS2;GPR161;GLI3
prerank,cellular metal ion homeostasis (GO:0006875),0.28226561707101205,0.7834846413639668,0.8324873096446701,0.9793222162799425,1.0,10/102,5.78%,CCL8;KCNMA1;NPTN;ANK2;TNNI3;ATP1A4;ATP1A3;ATP1A1;ATP2B4;KCNJ2
prerank,protein kinase B signaling (GO:0043491),0.3353292740699508,0.7833213608114741,0.7652933832709113,0.9791451563924201,1.0,8/23,25.48%,ZFP36L1;GAS6;SIRT2;AKT1;TYRO3;PTEN;TSC2;PAX2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.33048959873082595,0.783246493922422,0.7609756097560976,0.9788416916224512,1.0,4/24,15.59%,CREB3L1;SYVN1;HERPUD1;SELENOS
prerank,response to UV-B (GO:0010224),0.3750563176975745,0.7830959325354426,0.7320441988950276,0.9786585515656505,1.0,2/12,13.19%,CRIP1;CDKN1A
prerank,negative regulation of transmembrane transport (GO:0034763),0.3823673359701251,0.7825028390469415,0.7463768115942029,0.979091338593648,1.0,3/10,12.13%,INPP5K;AKT1;IRS2
prerank,oligosaccharide metabolic process (GO:0009311),0.30257535665843877,0.7814490564350692,0.7950727883538634,0.9801946619945904,1.0,7/46,12.26%,ST3GAL2;B4GALT1;FUT2;GAL3ST3;FUT9;ST3GAL4;GLA
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3613692371704363,0.7814254452178446,0.7645502645502645,0.9798198716816808,1.0,6/14,27.89%,PPP5C;PPP3CA;NCK1;PPP2R2A;DUSP1;PPP2R2D
prerank,UV-damage excision repair (GO:0070914),0.3678662558555078,0.7812815757992733,0.7681940700808625,0.979627809949102,1.0,3/12,14.04%,ACTR5;DDB1;INO80
prerank,response to ethanol (GO:0045471),0.3662919444893826,0.7812725438294943,0.7660130718954249,0.979236330451597,1.0,4/14,30.46%,GRIN3A;GRIN2A;GOT2;GLRA2
prerank,iron-sulfur cluster assembly (GO:0016226),-0.23793681679817053,-0.780882355882333,0.8229166666666666,0.9071050562706517,1.0,7/24,16.36%,NUBPL;HSPA9;CIAO1;NFU1;ISCU;GLRX3;NDOR1
prerank,Rho protein signal transduction (GO:0007266),0.29617717617657396,0.7805003240839046,0.8039003250270856,0.9799343789512703,1.0,6/53,9.40%,COL1A2;CDC42EP2;NTN1;ARHGEF3;MYO9B;RHOJ
prerank,histone H4-K8 acetylation (GO:0043982),0.353683931307662,0.7802068120562395,0.7585301837270341,0.9795175728472043,1.0,4/15,15.80%,ING4;WDR5;KANSL3;OGT
prerank,histone H4-K5 acetylation (GO:0043981),0.353683931307662,0.7802068120562395,0.7585301837270341,0.9795175728472043,1.0,4/15,15.80%,ING4;WDR5;KANSL3;OGT
prerank,histone mRNA metabolic process (GO:0008334),-0.24028971931702287,-0.7798651431244986,0.8245614035087719,0.9071141199722671,1.0,11/27,20.94%,SSB;TUT1;TUT4;TUT7;SNRPB;ATM;LSM11;MTPAP;SNRPE;SNRPF;LSM10
prerank,response to hexose (GO:0009746),0.3279945312895811,0.7793795916574127,0.7714631197097944,0.9802770574515915,1.0,6/25,20.12%,TCF7L2;IRS2;SELENOS;VAMP2;GPLD1;EIF2B1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.27843343810947246,0.7792810296764191,0.8623853211009175,0.9800148942994933,1.0,20/118,13.73%,PHLDB1;ARHGAP44;EFNA5;SPARC;FGF2;PPFIA2;ZRANB1;PID1;RC3H1;LARP4;SRCIN1;EPHB3;HECW2;BCL6;CAMSAP1;MAPT;GPNMB;TANC2;GDNF;NSMF
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.26790878774281257,-0.7784708330972087,0.7674418604651163,0.9078812237832762,1.0,11/18,39.97%,PLCB1;AGRN;OPRM1;RGS10;CDK5R1;CHRM1;GNA15;GNA11;CHRM5;HRH3;GNAQ
prerank,regulation of mitotic cell cycle (GO:0007346),0.2720806598039301,0.7779315812097899,0.9084507042253521,0.9815243087774568,1.0,45/171,26.90%,PRKCA;PSMC4;GAS1;CKS1B;SMOC2;MEIS2;CCDC8;TTC28;PSMC6;CDK9;PSMD8;IQGAP1;CDC23;FBXO5;ANAPC5;KIF20B;ERCC3;DDB1;CDC27;PIN1;CUL9;USP22;TFAP4;TTL;CDC26;ANAPC4;NEK7;PTPN3;TRIM35;ANAPC10;BTG1;SDCBP;ANAPC15;CYLD;CDC25B;PSMD4;PSMD3;MDM2;BTG3;RNF20;CKS2;ANAPC2;PSMB3;GBF1;CUL7
prerank,lipid homeostasis (GO:0055088),0.29660322454793125,0.7779159932686344,0.8053475935828877,0.9811383713617723,1.0,12/57,18.98%,NR1D2;TLCD2;RCN3;ABCA1;MLXIPL;ORMDL2;PNPLA8;IRS2;THADA;ACOX1;POLD1;ANGPTL3
prerank,protein localization to mitochondrion (GO:0070585),0.37614633874628256,0.7777225330261015,0.7779329608938548,0.9810099887581636,1.0,5/11,27.99%,AKT1;MTCH2;RALA;COX18;DNAJA1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.28174195943747454,0.7774780366177894,0.8336776859504132,0.9809659582419309,1.0,11/86,7.56%,TGFB3;TGFB2;SMAD4;ACVR1;BMP15;NUP93;RNF111;SULF1;SH2B1;INHA;FLCN
prerank,positive regulation of response to wounding (GO:1903036),0.32705666925615273,0.7773019119986135,0.7605294825511432,0.9808106126625314,1.0,2/24,1.29%,DUOX1;ANXA1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.23174110848331939,-0.7771798268741316,0.8344370860927153,0.9084095333258203,1.0,7/29,13.30%,WNT5A;MAVS;CNOT7;USP18;PTPN1;PTPN2;RNASEL
prerank,protein K63-linked ubiquitination (GO:0070534),0.30325033318325334,0.7765502875847942,0.7879133409350056,0.9814492942404728,1.0,10/41,17.98%,UBE2B;ITCH;PELI3;STUB1;UBE2N;MAGEL2;TRAF3IP2;TRAF3;UBE2G1;ARIH2
prerank,histone H2B ubiquitination (GO:0033523),-0.3096441706826317,-0.7763396531607233,0.73992673992674,0.9082879422662036,1.0,2/10,8.51%,DTX3L;CTR9
prerank,actin crosslink formation (GO:0051764),-0.2883855039572444,-0.7760130125936454,0.7584905660377359,0.9073857846796148,1.0,4/12,16.93%,EPS8;GAS2L3;BAIAP2L1;LCP1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.3871989078254745,0.7757251936279238,0.7503486750348675,0.9822007049358092,1.0,1/10,3.44%,SRI
prerank,positive regulation of cell division (GO:0051781),0.30805220758268037,0.7756940515453544,0.7806524184476941,0.9818365671358362,1.0,7/38,14.97%,CDC14B;SVIL;SIRT2;CUL3;KIF20B;RHOA;GIPC1
prerank,mitochondrial fusion (GO:0008053),0.34549112329722037,0.7751173344769553,0.7493734335839599,0.9822493137922362,1.0,7/18,30.56%,GDAP1;MIEF2;SPG7;FIS1;CHCHD3;BAX;MFN2
prerank,phospholipid catabolic process (GO:0009395),-0.23152363942571236,-0.7741563686189721,0.8461538461538461,0.9088185980919915,1.0,1/24,0.60%,GPCPD1
prerank,glycerophospholipid metabolic process (GO:0006650),-0.19015474939303828,-0.7736209911705737,0.9591836734693877,0.908242791193884,1.0,14/75,13.00%,GPCPD1;PLCG1;PLA1A;HDHD5;PIGN;PLCB1;PIGG;PIP5K1A;PIGP;PDGFRB;ABCA3;PIGB;PNPLA6;PLA2G15
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.31526546009200973,0.7731607900244228,0.7804014167650531,0.9845866571054049,1.0,8/30,23.69%,MGAT1;LMAN1;MGAT5;MGAT2;TUSC3;DDOST;UGGT1;DPM2
prerank,monocarboxylic acid catabolic process (GO:0072329),0.33496382584772844,0.7730932997210979,0.7714646464646465,0.9842821060708972,1.0,4/21,20.27%,CEL;ACOX1;NUDT19;LPIN3
prerank,vitamin transport (GO:0051180),-0.22697022684033347,-0.7727183042175726,0.8607594936708861,0.9081782280904248,1.0,5/29,8.89%,ABCG2;PDPN;SLC35F3;TCN2;CUBN
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.2898570437588113,-0.7727026002381324,0.7680608365019012,0.9068080418323368,1.0,3/13,9.27%,PTPN1;DNAJB9;PPP1R15B
prerank,stem cell differentiation (GO:0048863),0.3086968600739817,0.7725818731861916,0.7836322869955157,0.9846061889825969,1.0,8/39,18.59%,LRP6;TGFB2;EEF1AKMT4-ECE2;PUM1;SETD2;LMBR1L;UFL1;GPM6A
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3337646395497,0.772549068914826,0.7638709677419355,0.9842422094111417,1.0,6/20,23.59%,AMPD2;PAICS;GART;ATIC;ADSS2;LHPP
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.37166694447225446,0.7721987531602145,0.7558139534883721,0.9843171221397853,1.0,5/13,27.27%,EGF;MGAT5;IL6;HES1;JAK2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.3393653950758313,0.7720961554026992,0.7691326530612245,0.9840676341289427,1.0,9/19,29.07%,PTPRJ;STIMATE;BCAP31;FIS1;DMTN;GRM5;FKBP1B;PTGFR;PRNP
prerank,cognition (GO:0050890),0.3021958877628346,0.7712152891104906,0.8044692737430168,0.9848962581054289,1.0,11/42,18.47%,DGCR2;GPR155;ST3GAL4;SLC8A2;BBS4;LHCGR;TTC8;SETD5;TUSC3;CHRNA7;NIPBL
prerank,regulation of protein targeting to membrane (GO:0090313),0.3233192069531552,0.7704988747966816,0.7761904761904762,0.9854557311171822,1.0,12/28,30.54%,FYN;MIEF2;GDI1;INPP5K;CHP1;ITGAM;FIS1;DMTN;MTCL1;PRNP;MYO1C;AKT2
prerank,sarcomere organization (GO:0045214),0.31766926682103697,0.7701887668736298,0.7853717026378897,0.9854950903346932,1.0,4/27,14.23%,SIX4;CSRP2;FHOD3;CASQ1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.37950928602171574,0.7698013740863774,0.796875,0.9856383855418549,1.0,3/12,17.26%,ZFP36L2;JAG1;YTHDF2
prerank,regulation of nervous system process (GO:0031644),0.3486124827286752,0.7697825218126967,0.7636363636363637,0.9852714551463426,1.0,9/18,26.05%,DLGAP4;DLGAP3;SLC8A2;DLGAP1;CHRNA7;AKAP9;HTR2C;NPTX1;BEGAIN
prerank,axoneme assembly (GO:0035082),0.3109443648434313,0.7695334865284661,0.787363304981774,0.985235109710612,1.0,7/30,22.05%,TOGARAM1;RSPH1;TTLL3;SPAG17;DNAAF3;SPAG16;DCX
prerank,neuromuscular process controlling balance (GO:0050885),0.37068851585695545,0.7693969808972964,0.7424242424242424,0.985036294902881,1.0,5/12,34.12%,TPP1;PAFAH1B1;PCDH15;NRXN1;SHANK1
prerank,macrophage chemotaxis (GO:0048246),-0.30306096167424057,-0.769343723371266,0.7833935018050542,0.9103326917511878,1.0,5/10,36.57%,EDNRB;TAFA4;CCL2;CXCL17;CCL5
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.2800917472212471,0.7689947251354764,0.8624229979466119,0.9852001446670732,1.0,9/86,8.77%,PSMC4;MAPK7;VEGFA;NFE2L2;KLF2;MUC1;PSMC6;EGLN2;PSMD8
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3127176216493414,0.7689379840841453,0.7837837837837838,0.9848830975460298,1.0,2/33,1.29%,EGFR;ANXA1
prerank,megakaryocyte differentiation (GO:0030219),-0.29641718463508904,-0.7683194887937714,0.7377622377622378,0.9104151050069444,1.0,3/11,21.18%,KIT;TAL1;UBA5
prerank,fatty acid biosynthetic process (GO:0006633),0.2881840001938354,0.7683009312155941,0.8317152103559871,0.9853516840649765,1.0,13/63,19.88%,ACLY;TECR;NDUFAB1;ELOVL5;FADS1;HSD17B8;HACD3;FADS3;LIPC;LIPH;SCD5;MCAT;ABCD3
prerank,ruffle organization (GO:0031529),-0.2712356721924426,-0.7682976178850237,0.7772277227722773,0.9090529995741766,1.0,2/16,6.00%,TPM1;PIP5K1A
prerank,actin filament network formation (GO:0051639),0.3704799577998239,0.7674530158692148,0.7634854771784232,0.9861245723722467,1.0,3/11,15.97%,COBL;FHOD3;PLS1
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.2751199025003944,0.7674466375641666,0.8651685393258427,0.9857304074084798,1.0,18/108,17.93%,SYK;GSN;EIF2AK3;F2R;S100A8;S100A9;MTCH1;PDCD2;MAPT;BBC3;ANP32B;RPS27L;DIABLO;GRAMD4;CTSD;DAP;HTRA2;BCAP31
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.32061063880651064,0.7673059596726606,0.7842669845053635,0.9855192247683605,1.0,10/26,32.30%,IRAK3;TLR5;NLRP2B;FLOT2;TYRO3;FLOT1;OTUD4;CACTIN;APPL1;IRF1
prerank,estrogen metabolic process (GO:0008210),0.3469585622932515,0.7670232373159783,0.7711978465679677,0.9855093758981284,1.0,4/15,22.22%,HSD17B8;CYP1B1;HSD17B4;HSD17B11
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.2810375746991951,0.7669090620515779,0.8317460317460318,0.9852577649497476,1.0,11/76,18.81%,ESR1;PLCE1;F2R;LPAR1;GPR20;CALCA;LHCGR;GRM1;TRHR;CXCR2;HTR2C
prerank,AMP metabolic process (GO:0046033),0.3607648520293949,0.7658659949339568,0.7704918032786885,0.9863094907468962,1.0,1/13,2.31%,AMPD2
prerank,DNA conformation change (GO:0071103),-0.2694693837476415,-0.7655029996205488,0.7799043062200957,0.9116893943680283,1.0,6/17,21.19%,HMGB1;ABL1;HHEX;TOP1MT;NAA10;TOP2A
prerank,positive regulation of coagulation (GO:0050820),0.37999529849256375,0.7654800964400511,0.7413554633471646,0.9860212713914821,1.0,2/10,12.02%,F2R;ST3GAL4
prerank,positive regulation of hemostasis (GO:1900048),0.37999529849256375,0.7654800964400511,0.7413554633471646,0.9860212713914821,1.0,2/10,12.02%,F2R;ST3GAL4
prerank,neuron projection regeneration (GO:0031102),0.37212448008139115,0.7652255086045989,0.7538896746817539,0.9859493166531889,1.0,3/10,13.32%,GAP43;MTR;RTN4RL1
prerank,regulation of T cell mediated immunity (GO:0002709),0.3783264468440706,0.7649981883208004,0.7791842475386779,0.9858624389497422,1.0,2/10,13.76%,ZBTB1;TNFRSF1B
prerank,regulation of chemokine production (GO:0032642),0.3029951066036411,0.7649830627912612,0.8062283737024222,0.985480066364399,1.0,8/36,21.01%,FOXP1;IL33;TLR4;ACKR1;SNAI2;IL6;IL18;PYCARD
prerank,epithelial to mesenchymal transition (GO:0001837),0.29127644617093257,0.7646834724425717,0.8094170403587444,0.9854848406548794,1.0,4/47,4.05%,LOXL2;FGFR1;TGFB2;AKNA
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.34615477479964313,0.7646788598403121,0.7711313394018205,0.9850891494415529,1.0,7/16,25.99%,PIGZ;PIGC;PIGW;PIGM;PIGL;DPM2;PIGH
prerank,pharyngeal system development (GO:0060037),0.353136056566664,0.7646704653036118,0.7906976744186046,0.9847004703510612,1.0,2/15,2.88%,SIX4;TGFB2
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.2802734130134009,-0.7642848800814132,0.7569721115537849,0.9120191751679437,1.0,3/14,6.15%,ADAM10;DYRK1A;ABCG1
prerank,positive regulation of intracellular transport (GO:0032388),0.30136325076434156,0.7641529274572277,0.801605504587156,0.9850081166042107,1.0,15/38,27.25%,B3GAT3;EHD2;KIF20B;BCAS3;DYNC1H1;PLA2G4E;CAPN10;VAMP2;NUMA1;PCM1;ICE1;TPR;RAB29;OAZ1;EIPR1
prerank,negative regulation of chemotaxis (GO:0050922),0.30988216820317604,0.763958443924304,0.7935943060498221,0.9848604781280764,1.0,3/31,8.20%,SEMA3C;SLIT2;SEMA3A
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.29893758004427373,-0.7639452610098459,0.7535714285714286,0.9111337183526454,1.0,8/11,42.26%,STAT1;IL12RB2;STAT4;IL27RA;CANX;IL12A;STAT3;EBI3
prerank,macroautophagy (GO:0016236),0.27115550362184365,0.7639119650555567,0.8766564729867482,0.9845218980646471,1.0,45/118,30.73%,VPS4B;PRKAB2;MVB12A;VPS37D;SRC;LIX1L;WIPI2;SQSTM1;TMEM74;VPS33A;PGAM5;STX17;VPS37C;EPG5;ULK1;VDAC1;ILRUN;NBR1;VPS37B;ATG13;PIP4K2B;VPS33B;TOMM5;ATG16L1;ATG3;VPS36;VPS39;CSNK2A2;ATG14;ATG10;UBXN6;STAM;DYNLL1;TOMM40;TECPR1;RB1CC1;WIPI1;VAMP7;ULK3;TBC1D5;CHMP4C;PRKAA1;MFN2;CHMP4A;CHMP4B
prerank,establishment of vesicle localization (GO:0051650),0.3391838013247594,0.7638197204725863,0.7787723785166241,0.9842393938984793,1.0,4/18,16.57%,SYT11;TOR1A;CCDC186;SNAPIN
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3102034575304502,0.7637666037646629,0.7844727694090382,0.9839107664988758,1.0,6/32,14.23%,F2R;CXCL10;PKD2;GSTM2;CALM2;CASQ1
prerank,diol metabolic process (GO:0034311),0.3304672933210544,0.7636353141117171,0.7661691542288557,0.9836978448523672,1.0,5/19,18.06%,PLPP3;PLPP1;AKT1;HSP90AA1;PLPP2
prerank,regulation of actin filament bundle assembly (GO:0032231),0.3170587297469453,0.7630531327205926,0.7802585193889542,0.984086396576751,1.0,5/26,16.22%,ASAP3;PFN2;ALMS1;SLC9A1;ACTG1
prerank,regulation of cellular catabolic process (GO:0031329),0.2870406645174687,0.76267920883641,0.8462365591397849,0.9841725358304145,1.0,16/62,17.56%,PIK3R2;USP10;HDAC6;ABL2;WDR91;FBXL2;USP33;MAPT;DRAM1;SMCR8;RRAGD;CISD2;NUPR1;KEAP1;PIP4K2C;GPR137B
prerank,regulation of membrane repolarization (GO:0060306),-0.27077640807692216,-0.7623261188014985,0.819672131147541,0.9120115989804355,1.0,4/13,12.14%,NEDD4L;CAV1;KCNQ1;AKAP6
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.19761474467454346,-0.7612510043424637,0.9278350515463918,0.9121079882094139,1.0,14/48,19.80%,PRKAG2;NUP35;NDC1;RAE1;PRDM16;PGAM1;NUP153;EP300;NUP214;POM121;NUP155;PNPT1;HIF1A;NUP205
prerank,heart looping (GO:0001947),0.29917789977080544,0.7607999157142904,0.8020361990950227,0.9863093003200435,1.0,9/39,19.13%,TGFBR2;PKD2;TBX6;NDRG4;MICAL2;VANGL2;BBS4;AHI1;BBS5
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.27765843987208105,0.7602358991144533,0.85625,0.9866598694119904,1.0,18/78,25.22%,EGFR;PSRC1;PKD1;GTPBP4;MAPRE3;PKD2;AKT1;CDKN1A;CCND1;CCNH;TFAP4;IPO5;BLM;PTEN;CDKN2C;HEXIM1;LATS1;CCNYL1
prerank,acyl-CoA metabolic process (GO:0006637),0.3076202543949025,0.7602096630603609,0.8015695067264574,0.9862934423055268,1.0,4/35,14.47%,GPAT4;ACOT6;ACOT9;ACOT1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.37869487436328886,0.7601905825899884,0.7485795454545454,0.9859233937975387,1.0,5/10,34.44%,CPEB1;PAF1;HSF1;NCBP2;CPEB3
prerank,protein autoprocessing (GO:0016540),0.34055723637912333,0.7599077902188728,0.7777777777777778,0.9859068170363308,1.0,6/17,30.51%,KLK6;FAM111A;HTRA2;CTSL;MYRF;SPRTN
prerank,acylglycerol homeostasis (GO:0055090),0.3333386095901576,0.7598903232681016,0.7930174563591023,0.9855333087998837,1.0,6/20,19.40%,MLXIPL;PNPLA8;IL18;LIPC;ANGPTL3;RORA
prerank,protein localization to synapse (GO:0035418),0.36348653403847636,0.7588427218426147,0.7591036414565826,0.9865454441125505,1.0,7/12,34.12%,DLG4;NLGN1;ZDHHC15;NRXN1;NLGN2;NRXN2;SHANK1
prerank,phospholipid biosynthetic process (GO:0008654),0.30298527425231286,0.7586764916385733,0.8022727272727272,0.9863620403412537,1.0,8/36,13.90%,FAR1;AGK;SGMS2;AGPAT3;LPCAT1;DHDDS;AGPAT5;FADS1
prerank,protein export from nucleus (GO:0006611),0.3123545606739523,0.7586029152908879,0.7918660287081339,0.9860579917519415,1.0,8/27,24.61%,DESI1;PKD1;STRADA;CHP1;SMURF1;TPR;XPO7;CALR
prerank,peptidyl-asparagine modification (GO:0018196),0.3076375738579567,0.7583947979435886,0.8018757327080891,0.985933936036839,1.0,8/31,23.69%,MGAT1;LMAN1;MGAT5;MGAT2;TUSC3;DDOST;UGGT1;DPM2
prerank,chloride transport (GO:0006821),0.2822950643155982,0.7582149500571268,0.8586497890295358,0.9857689671564965,1.0,12/74,17.70%,SLC4A10;ANO3;SLC4A8;SLC12A8;GABRR3;SLC12A4;SLC26A6;SLC12A5;GABRG3;TTYH3;SLC26A1;ANO5
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.3513423249568364,0.7578098920679008,0.7638522427440633,0.9859145328442381,1.0,3/13,13.85%,RC3H1;ZC3HAV1;ZC3H12A
prerank,negative regulation of cell aging (GO:0090344),0.3390528923931182,0.7573919557890705,0.7777777777777778,0.9860580300891857,1.0,4/16,13.51%,MIF;AKT3;FBXO5;TWIST1
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.3126744552290473,0.7569617057878373,0.8131868131868132,0.986218187572163,1.0,4/28,11.24%,EGFR;BEND6;EGF;AKT1
prerank,microtubule depolymerization (GO:0007019),0.3398800798673686,0.756794742912409,0.7709923664122137,0.986049469822501,1.0,4/17,20.20%,KIF2A;CCSAP;CKAP5;STMN4
prerank,lipid modification (GO:0030258),0.3005428807418876,0.7565649213920266,0.8051341890315052,0.9859245468908757,1.0,6/37,12.90%,DGKQ;PLPP3;PLPP5;PLPP1;MBOAT7;PLPPR3
prerank,regulation of synapse maturation (GO:0090128),0.37395193401908494,0.756540602759779,0.7531734837799718,0.9855546285481054,1.0,1/10,2.60%,NEUROD2
prerank,respiratory chain complex IV assembly (GO:0008535),0.3283633058718734,0.7561295772650319,0.7978075517661388,0.9857010983822808,1.0,8/21,27.29%,COX19;SURF1;BCS1L;COX16;COX14;COX18;SCO1;COX15
prerank,positive regulation of dendrite extension (GO:1903861),0.33745319876769864,0.7546580063212188,0.79204107830552,0.9872234022648706,1.0,5/17,23.14%,SYT2;SYT1;RIMS2;SMURF1;RNF157
prerank,cellular response to zinc ion (GO:0071294),-0.2743140578891191,-0.7546145821655674,0.8166666666666667,0.9199064704278871,1.0,15/15,72.60%,MT3;HVCN1;MT2A;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;ATP13A2;GLRA1;GLRA2;P2RX4
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.2778708249688075,0.753964550900941,0.856544502617801,0.987720525065969,1.0,10/73,11.01%,POLR2H;GLMN;CREBZF;HDAC6;POLR1G;PHF1;KAT2B;MPHOSPH8;DDX21;GPX1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.28242894344738523,0.7537537784071788,0.8586723768736617,0.987603352618101,1.0,9/59,13.22%,CADM3;NPTN;NECTIN3;PKD1;TENM3;DSCAM;L1CAM;PALLD;IGSF9
prerank,cellular response to amino acid starvation (GO:0034198),0.2767315263607327,0.7537364106638021,0.8621420996818664,0.9872268917288268,1.0,18/71,23.50%,EIF2AK3;MTOR;FLCN;CEBPB;ATP6V1E1;SESN3;CDKN1A;RRAGD;EIF2S1;ATP6V1D;ATP6V1B2;DAP;CASTOR2;MAPK1;ATF4;SESN2;SLC38A9;ATP6V0B
prerank,DNA alkylation (GO:0006305),0.3258622099337786,0.7537342599586021,0.7690355329949239,0.9864399027185891,1.0,10/19,32.11%,SPOCD1;EHMT2;DMAP1;BAZ2A;GATAD2A;MTRR;ATF7IP;ATRX;FOS;DNMT3B
prerank,DNA methylation or demethylation (GO:0044728),0.3258622099337786,0.7537342599586021,0.7690355329949239,0.9864399027185891,1.0,10/19,32.11%,SPOCD1;EHMT2;DMAP1;BAZ2A;GATAD2A;MTRR;ATF7IP;ATRX;FOS;DNMT3B
prerank,cellular senescence (GO:0090398),0.31350213520592524,0.7535227403205859,0.7947805456702254,0.9863090587388603,1.0,8/27,24.61%,MAPK14;SMC5;CDKN1A;SMC6;PML;ECRG4;NSMCE2;CALR
prerank,positive regulation of transmembrane transport (GO:0034764),-0.28181540349838774,-0.7535086336890192,0.8235294117647058,0.9199596524026851,1.0,1/13,0.82%,ACSL1
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.275800844971512,0.7534038565777852,0.8696109358569927,0.9860773725618376,1.0,16/72,17.09%,TRIAP1;USP10;MUC1;MDM4;ING4;BCL3;SFN;RPS27L;CDKN1A;CNOT3;CNOT10;PLAGL1;TNKS1BP1;NBN;PML;TFAP4
prerank,negative regulation of neuron differentiation (GO:0045665),-0.24295273292567454,-0.7523934503309881,0.8325123152709359,0.9201020663342229,1.0,2/22,6.91%,BMP7;B2M
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.30569645832912695,0.7522867026468899,0.8016627078384798,0.9870808117110854,1.0,4/29,15.09%,CXCL10;C1QBP;GAS6;IL4
prerank,activation of GTPase activity (GO:0090630),0.27304247751542854,0.7520376475168785,0.8776150627615062,0.9870154315100831,1.0,26/89,23.12%,SGSM2;RABGAP1L;RAP1GAP2;RASGRF1;ARHGAP42;DOCK7;TBCK;TBC1D2B;TBC1D17;ARHGEF10;TIAM2;TBC1D10A;NGEF;BCAS3;EVI5;SGSM1;EVI5L;TBC1D13;ADPRH;TBC1D22B;TBC1D15;CORO1C;TIAM1;RUNDC1;TBC1D8B;TBC1D12
prerank,determination of heart left/right asymmetry (GO:0061371),0.29197447770089446,0.751988548591055,0.8231368186874305,0.9866836905104109,1.0,9/42,19.13%,TGFBR2;PKD2;TBX6;NDRG4;MICAL2;VANGL2;BBS4;AHI1;BBS5
prerank,purine ribonucleotide transport (GO:0015868),0.34335816891708537,0.7519434069367716,0.8038961038961039,0.9863495009143257,1.0,3/16,15.22%,LRRC8D;SLC25A4;SLC25A17
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.3427924337899047,0.7518173302711872,0.7830188679245284,0.9861186483444732,1.0,1/16,0.87%,PARP3
prerank,detection of calcium ion (GO:0005513),0.35422794283139847,0.7517922981842834,0.7736842105263158,0.9857570631359012,1.0,7/13,31.58%,CALM2;SYT1;STIM1;KCNIP2;KCNMB2;KCNMB3;CALM1
prerank,cellular response to heat (GO:0034605),0.3018736373437475,0.7516706431950313,0.814385150812065,0.9855165643701073,1.0,9/35,22.76%,STUB1;YWHAE;MAPT;POLR2D;HSP90AA1;HSBP1;HTRA2;BAG3;TPR
prerank,regulation of dendrite extension (GO:1903859),0.3333521987165761,0.7514450587037765,0.8010204081632653,0.9854128750466526,1.0,5/18,23.14%,SYT2;SYT1;RIMS2;SMURF1;RNF157
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.36699059856357796,0.7512835514203651,0.7909836065573771,0.9852303479078076,1.0,7/11,29.74%,MUC1;ING4;RPS27L;TFAP4;KAT5;FOXM1;TP53
prerank,intracellular pH reduction (GO:0051452),0.3027976944053946,0.7510698369004971,0.8054245283018868,0.9851013322436132,1.0,7/33,16.28%,ATP6V0A2;TMEM9;DMXL2;ATP6V1E1;ATP6V1D;ATP6V0A1;ATP6V1B2
prerank,canonical glycolysis (GO:0061621),0.3145642560766946,0.7506637683737091,0.7936708860759494,0.9848548146394192,1.0,2/24,4.78%,PFKP;FOXK2
prerank,glucose catabolic process to pyruvate (GO:0061718),0.3145642560766946,0.7506637683737091,0.7936708860759494,0.9848548146394192,1.0,2/24,4.78%,PFKP;FOXK2
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.27479545131469224,0.7505965790101452,0.8773388773388774,0.9845600150893078,1.0,24/87,21.55%,NDUFS5;COX19;TMEM126A;NDUFAB1;NDUFAF8;SDHAF1;NDUFAF6;NDUFS1;NDUFB7;NDUFA2;TTC19;SURF1;NDUFV2;ACAD9;BCS1L;DMAC2;UQCC3;COX16;COX14;SDHAF2;NDUFB2;DMAC1;SLC25A33;COX18
prerank,mitochondrial gene expression (GO:0140053),0.2914266756870604,0.7503778746232568,0.8197278911564626,0.9844569534736947,1.0,16/42,34.40%,MRPS11;MRPS18B;MRPS17;MRPS34;MRPL51;HARS1;QRSL1;SLC25A33;NOA1;MRPL12;LARS2;MRPL23;FOXO3;IARS2;GFM2;MRPL16
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.2602590150707683,-0.7498186834750251,0.8251121076233184,0.9221613766083702,1.0,7/17,25.66%,OSR1;CAV1;CEACAM1;APOLD1;MAFG;DSPP;DLL1
prerank,endocrine system development (GO:0035270),0.3225973859083876,0.7496254275467226,0.7958179581795818,0.9850247415228357,1.0,6/21,21.45%,WT1;GLI2;SIX1;DKK3;TGFBR1;NF1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.3000770035540013,0.7495913511295468,0.808,0.9846808448419293,1.0,9/37,14.28%,DGKQ;AXIN1;S1PR2;SIRT2;INPP5K;EGF;PPEF2;CALM2;TNKS1BP1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.3271801331316047,0.7495471867652871,0.8005115089514067,0.9843457052985386,1.0,3/21,8.29%,FOXP1;PRKD2;CD81
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.27697280622492637,0.7495322728071849,0.8354166666666667,0.9839753674383714,1.0,11/76,15.93%,GPSM2;CDC42EP2;BIN1;SORBS3;PFN2;FCHSD1;BCAS3;FER;DYNC1H1;ARF6;NCK1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.3230032505120969,0.7494857264653756,0.8057366362451108,0.9836542603698071,1.0,4/20,17.99%,HOPX;PSMG2;HSP90AA1;PFDN6
prerank,phosphatidylcholine catabolic process (GO:0034638),0.36576186303367947,0.7487939380527161,0.7862165963431786,0.9841615382918882,1.0,3/10,26.30%,PNPLA8;LIPC;PLA2G7
prerank,regulation of adaptive immune response (GO:0002819),-0.2571332417665647,-0.7487123669456289,0.8207547169811321,0.9221955026007831,1.0,7/18,31.68%,AHR;SIRT1;FCGR2B;IRF7;SKAP1;FADD;IL4I1
prerank,cortical cytoskeleton organization (GO:0030865),0.29208526242490157,0.7485443314714838,0.8363844393592678,0.9840881825658097,1.0,16/41,28.94%,LLGL1;FMNL1;RHOQ;FMNL3;FHOD3;RHOA;RND3;ARF6;RAC3;RAC1;STRIP1;RHOBTB2;RND2;NLGN1;EPB41L3;RHOBTB3
prerank,regulation of establishment of planar polarity (GO:0090175),0.2729755466924605,0.7484906749597405,0.8755144032921811,0.9837712613136029,1.0,20/88,24.58%,PSMC4;CLTC;SMURF2;DACT1;AP2A2;PSMC6;FZD7;PARD6A;PSMD8;VANGL2;RHOA;FZD4;DAAM1;TIAM1;SMURF1;AP2M1;PSMD4;DVL1;PSMD3;RAC1
prerank,regulation of neuron projection arborization (GO:0150011),0.33814217724080553,0.7484776046857935,0.7923280423280423,0.9833976527695351,1.0,6/15,27.17%,DLG4;MYO9A;FZD4;NTNG2;DVL1;GRIP1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.3125817740295732,0.7482794988995415,0.8009535160905841,0.9832677708595114,1.0,9/25,29.44%,TCERG1;EAF2;EAF1;LARP7;LDB1;ELL;HEXIM1;NELFA;WDR43
prerank,synaptic vesicle localization (GO:0097479),0.3479572871862865,0.7482203692210945,0.766042780748663,0.9829569325873093,1.0,3/13,16.57%,TOR1A;SYNDIG1;SNAPIN
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3104061359760531,0.7482055812564395,0.8041362530413625,0.9825810157359542,1.0,11/28,27.49%,ITCH;UBE2N;IRAK1;UBA52;AAMP;TAB2;CYLD;MAP3K7;RELA;OTULIN;CASP8
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.2851354002785148,0.7480701821340383,0.8283261802575107,0.982383623470189,1.0,22/52,29.56%,SAMD4B;RC3H1;LSM4;EDC4;EXOSC7;POLR2D;ZFP36;CNOT3;CNOT10;EXOSC1;TNKS1BP1;LSM7;RC3H2;EDC3;DCP1A;DCP1B;LSM5;HBS1L;LSM1;PDE12;EXOSC3;PATL1
prerank,positive regulation of binding (GO:0051099),0.27306362004166734,0.7476753581403965,0.8709338929695698,0.9824766598774516,1.0,18/84,17.82%,LRP1;SKI;PKD1;DACT1;TCF7L2;GPSM1;PSEN1;SIRT2;USP33;EGF;PIN1;DDX11;STK3;AMFR;GMNN;IDE;NME1;PLAUR
prerank,regulation of cilium assembly (GO:1902017),0.28011492395473214,0.7473101989552415,0.8525980911983033,0.9825569571182445,1.0,29/62,31.07%,SAXO1;TBC1D2B;TBC1D17;TBC1D10A;CEP97;BBS4;DYNC2LI1;CCP110;EVI5;EVI5L;TBC1D13;TBC1D22B;ODF2L;TBC1D15;TBC1D19;ENTR1;ATG3;CROCC;CCDC88A;CYLD;CDKL1;FUZ;KCTD17;TCHP;TBC1D5;RABGAP1;SDCCAG8;IFT20;TBC1D9B
prerank,pancreas development (GO:0031016),0.3620249576938445,0.747195257645597,0.7856173677069199,0.9823199082053274,1.0,1/12,5.12%,TCF7L2
prerank,histone acetylation (GO:0016573),0.2762843689942084,0.7470821060584953,0.8604898828541001,0.9820719249333695,1.0,22/69,26.23%,TADA1;MRGBP;MSL3;POLE3;KAT2B;ING4;WDR5;DR1;KAT14;DMAP1;YEATS2;PER1;NAA50;MORF4L1;TAF6L;TRRAP;SGF29;KAT6B;MAP3K7;KAT7;KAT5;BRD8
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.36964434311457195,0.746462688526799,0.7780938833570412,0.9824486180278472,1.0,1/10,3.24%,TGFBR2
prerank,regulation of embryonic development (GO:0045995),0.2985694705169355,0.7463051042131302,0.8159437280187574,0.982261325415903,1.0,2/34,1.74%,PHLDB1;TLE6
prerank,platelet degranulation (GO:0002576),0.2647452725360675,0.7462798857398132,0.9025641025641026,0.9819121505679757,1.0,8/118,3.09%,CD9;TGFB3;CLEC3B;SPARC;ITGB3;VEGFA;TGFB2;ECM1
prerank,regulation of protein kinase C signaling (GO:0090036),0.34215692972157175,0.7460278969360526,0.7831978319783198,0.9818339604074104,1.0,2/14,6.70%,VEGFA;MYADM
prerank,mucosal immune response (GO:0002385),0.3425671213492779,0.7460221613342202,0.787716955941255,0.9814530784733702,1.0,2/15,15.09%,OTUD7B;IL4
prerank,GPI anchor metabolic process (GO:0006505),0.3090175009037051,0.7456012340670732,0.8147699757869249,0.9815985673806491,1.0,9/26,25.99%,PIGZ;PIGC;MPPE1;PIGW;PIGM;GPLD1;PIGL;DPM2;PIGH
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.30355858436333905,0.745181636709346,0.7927710843373494,0.9817492959311791,1.0,8/28,21.89%,DBN1;PFN2;GBA2;FCHSD1;COTL1;RASA1;ABITRAM;CTTN
prerank,membrane lipid metabolic process (GO:0006643),0.31960261711616955,0.7449911638242485,0.8057285180572852,0.9815998037409324,1.0,4/22,12.41%,FUT2;TECR;AGK;CERK
prerank,stem cell development (GO:0048864),0.3373922047518415,0.7449641657085456,0.7779255319148937,0.9812410136654194,1.0,3/16,15.05%,SOX8;NOLC1;SNAI2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.3044540516476579,0.7447742276292256,0.8206896551724138,0.9810937490207831,1.0,3/30,5.78%,ANK2;ATP1A1;KCNJ2
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.25525677244600636,-0.7447500179547434,0.8201754385964912,0.9258746818127015,1.0,5/17,20.42%,COX4I1;COX6C;NDUFA4;COX5A;CYCS
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.3048556880743853,-0.7443653090966215,0.7609427609427609,0.9249701471671767,1.0,3/10,16.30%,ABCA3;PHB2;MTMR3
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.30854781460105296,0.743905218521469,0.8137847642079806,0.9818007866023836,1.0,8/26,23.28%,ITCH;UBE2N;IRAK1;UBA52;AAMP;TAB2;CYLD;MAP3K7
prerank,regulation of neuron apoptotic process (GO:0043523),0.26746806444107213,0.7434366554485787,0.8783505154639175,0.9820003780141017,1.0,21/96,22.04%,TGFB3;SIX4;TGFB2;F2R;CLCF1;NFATC4;EGLN2;NRBP2;GDNF;SIX1;NSMF;NUPR1;FAIM2;SNX6;SET;RASA1;BACE1;TYRO3;KDM2B;NF1;ATF4
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.36905978722321175,0.7433462023789813,0.7777777777777778,0.9817251711658321,1.0,2/10,9.36%,IL33;TLR4
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.2893467361606935,0.7430188404930257,0.8353863381858903,0.9817495753301976,1.0,10/46,20.10%,GPAT4;DGKQ;AGPAT3;LPCAT1;AGPAT5;GPAT3;GPAM;LIPH;DDHD1;PLD2
prerank,ribosome biogenesis (GO:0042254),0.2614223074446026,0.7422076991563185,0.9438877755511023,0.9823870021931358,1.0,47/187,23.98%,C1D;SDAD1;DDX49;RIOK1;ABCE1;NOC2L;FCF1;HELQ;ESF1;EXOSC7;RRP36;NPM1;RPL10A;WDR46;UBA52;EIF6;RCL1;SBDS;MPHOSPH10;SNU13;NOLC1;EXOSC1;MRPL36;DCAF13;RRP7A;RPL6;DDX52;POP4;NOP53;DDX31;PWP2;EBNA1BP2;RPF2;TBL3;RPL23;RPL17;RIOK2;PDCD11;RPS25;KRR1;EIF2A;WDR18;RBIS;NOC4L;TEX10;RRP1B;LTO1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.28333050969026874,0.7420121992153622,0.845054945054945,0.9822434455186456,1.0,7/50,12.27%,GPC3;GAS1;GLIS2;TEDC1;UCHL5;GLI3;TUBD1
prerank,endocardial cushion development (GO:0003197),0.32303859550455105,0.7411025118117656,0.8178391959798995,0.9829636056237381,1.0,3/21,6.84%,TGFB2;ACVR1;MDM4
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.34317073501730627,0.7410933289517541,0.7805519053876478,0.9825884112031791,1.0,6/13,22.76%,RAB23;MDFIC;CABP1;CHP1;UFM1;TPR
prerank,regulation of astrocyte differentiation (GO:0048710),0.3488827301416786,0.7410285172684163,0.773209549071618,0.982283930658666,1.0,2/12,5.13%,BIN1;CLCF1
prerank,regulation of viral genome replication (GO:0045069),0.28057075148917704,0.7409859497378937,0.8487486398258978,0.9819454439165672,1.0,12/56,21.15%,TARBP2;ADARB1;ZC3HAV1;TNIP1;SLPI;LARP1;DDB1;FAM111A;HACD3;PPIA;BTBD17;SRPK1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.33876867872539584,0.7409165388715875,0.792,0.9816483000284746,1.0,4/16,18.67%,ERCC4;TERF1;SMG6;TINF2
prerank,mitotic chromosome condensation (GO:0007076),0.3098769761096456,0.7404748057282301,0.8179611650485437,0.9818110506574332,1.0,7/26,25.97%,TENT4A;NCAPG;SMC2;SET;AKAP8L;CSNK2A2;KMT5A
prerank,positive regulation of immune response (GO:0050778),0.27390484873600773,0.7402215322379583,0.8626609442060086,0.9817342416219873,1.0,10/64,21.01%,CD177;TGFB2;CD81;STX4;POLR3D;AKIRIN2;SLC15A4;IFI35;ITGAM;PYCARD
prerank,cytosolic calcium ion transport (GO:0060401),0.307082264123548,0.7400076694502808,0.793939393939394,0.9816259607777609,1.0,8/28,23.77%,MCU;SLC35G1;MCUB;ATP2A2;SLC8A2;ATP2B1;JPH4;CACNA2D1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.31206714390852147,0.7399420997769273,0.7938021454112039,0.9813195330634469,1.0,1/26,0.59%,UCP1
prerank,regulation of response to interferon-gamma (GO:0060330),-0.2728528377699649,-0.7396240902929604,0.8382978723404255,0.9299121136932458,1.0,14/14,72.74%,STAT1;PTPN2;PIAS1;PARP9;SOCS1;IFNGR2;JAK1;IFNG;HSP90AB1;CDC37;SUMO1;SOCS3;IFNGR1;JAK2
prerank,synapse organization (GO:0050808),0.2611878757887851,0.7392942764537065,0.915736040609137,0.9817304197152228,1.0,21/125,15.49%,SNCB;GPC6;DCTN1;F2R;PTPRS;PPFIA2;PTPRF;FARP1;CAST;PSEN1;DSCAM;MUSK;L1CAM;MAPT;FLRT3;PIN1;CACNB1;SLC8A2;CTNND2;PPFIA1;LRFN5
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.2812234786631259,-0.7392079083905804,0.8212927756653993,0.929043432492142,1.0,8/13,31.68%,SPRED3;ATM;SPRED2;RPL26;PLA2R1;MSX1;ATR;PMAIP1
prerank,negative regulation of centrosome duplication (GO:0010826),0.3515802920425809,0.7388732946885257,0.7809139784946236,0.981862084227563,1.0,4/11,19.70%,KAT2B;NPM1;CDK5RAP2;MDM1
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.2915764960763428,0.738170518508037,0.8132875143184422,0.9823228860277005,1.0,11/36,21.82%,RNF2;RYBP;PHC3;PHC1;EHMT2;UXT;APAF1;RING1;PCGF6;FOXO4;EZH2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.2953432405601938,0.7377000524041868,0.8363636363636363,0.9825217070014232,1.0,12/36,23.95%,TCF7L2;NFATC1;AGO2;GNB1;PPP3CA;FZD4;AGO4;PPP3CB;AGO3;GNAO1;MAP3K7;TNRC6A
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.30507756495493016,0.7375672824275422,0.817016317016317,0.9819247418866823,1.0,4/29,16.18%,CENPT;HJURP;NPM1;CENPC
prerank,CENP-A containing chromatin organization (GO:0061641),0.30507756495493016,0.7375672824275422,0.817016317016317,0.9819247418866823,1.0,4/29,16.18%,CENPT;HJURP;NPM1;CENPC
prerank,regulation of cellular senescence (GO:2000772),0.30579924823237226,0.7366122190583546,0.8241626794258373,0.9827154204712277,1.0,8/28,16.97%,CGAS;AKT3;YPEL3;FBXO5;TWIST1;RSL1D1;EEF1E1;NEK4
prerank,positive regulation of type I interferon production (GO:0032481),0.27035138520688673,0.7365706943514495,0.871413390010627,0.9823811310210779,1.0,12/73,14.68%,POLR2H;CGAS;POLR3E;DHX33;CHUK;TLR4;POLR3D;SETD2;IRAK1;XRCC5;CD14;HSP90AA1
prerank,cell junction organization (GO:0034330),0.2728633576214176,0.7360818207020666,0.8631578947368421,0.9825700813317678,1.0,17/71,17.83%,SNCB;TGFB3;TGFB2;PPFIA2;MYO9A;PSEN1;L1CAM;MAPT;RHOA;PIN1;SLC8A2;CTNND2;PPFIA1;LIMS2;ACTG1;CHRNA7;ILK
prerank,purine nucleotide catabolic process (GO:0006195),0.3480276997976849,0.7353300612697397,0.7991689750692521,0.983116732184796,1.0,2/13,11.01%,GDA;GPX1
prerank,response to interferon-beta (GO:0035456),-0.23315148874031436,-0.7352370749297047,0.8457446808510638,0.9328588369148846,1.0,3/22,4.70%,AIM2;PLSCR1;IFITM3
prerank,apoptotic process (GO:0006915),0.25748576714037436,0.7352283231795449,0.9528112449799196,0.9828635962239396,1.0,40/203,18.18%,FAP;EFNA5;MAGI3;TGFBR2;DPF2;KREMEN1;MTOR;FOXO1;DPF1;AIFM2;PIK3CA;SIAH1;PAEP;ING4;AKT1;BMF;BBC3;ERCC3;NDUFS1;BAK1;TAOK2;DIABLO;ADAM15;NSG1;PLAGL1;CD14;STK3;ATCAY;DCC;THOC1;VDAC1;OGT;PDCD4;CXCR4;IAPP;DAP;PRUNE2;PPIA;AKAP1;SFRP5
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.35888987395394967,0.7351713916298126,0.7907949790794979,0.982539597075225,1.0,2/10,17.76%,SIRT2;RCC2
prerank,response to cytokine (GO:0034097),0.2611383143328304,0.734759721921426,0.9298780487804879,0.9826499802049222,1.0,17/141,14.28%,COL3A1;TIMP2;AFF3;PRKCA;ANXA1;IRAK3;ADAM9;SRC;PID1;CYP27B1;CDK9;SETD2;IRAK1;FLT3;RHOA;HDAC4;GGT7
prerank,regulation of response to oxidative stress (GO:1902882),0.3629151947041369,0.734667503542499,0.806993006993007,0.9823788145465792,1.0,3/11,18.68%,AIFM2;GGT7;SELENON
prerank,regulation of ERAD pathway (GO:1904292),0.3563924890112333,0.734291052971458,0.8085991678224688,0.9824514204330218,1.0,4/11,22.45%,TMEM259;HERPUD1;USP13;USP19
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3138684717566484,0.7336302339196396,0.8084577114427861,0.9828598491927311,1.0,12/22,36.71%,PPP1R1B;MGAT5;FKBP1A;TIPRL;CRY2;FKBP1B;PTPA;BOD1;PPP4R4;NCKAP1L;ROCK2;GSK3B
prerank,regulation of protein modification process (GO:0031399),0.27985448136937224,0.7335983475980417,0.8486842105263158,0.9825168640836809,1.0,16/50,23.68%,CCDC88C;FLCN;CDK9;KAT2B;PARG;PIN1;FER;NOP53;PML;CORO1C;SESN2;STAT2;CCDC88A;ATG14;ATG10;RABL3
prerank,tRNA modification (GO:0006400),0.27343169776817006,0.7324307418546548,0.8562367864693446,0.9835271778845447,1.0,13/62,20.31%,ANKRD16;TRMT6;TYW3;TRMT61A;FTSJ1;THADA;TRMT1;DTWD1;QTRT1;DUS2;TYW5;TRUB1;METTL1
prerank,protein localization to microtubule organizing center (GO:1905508),0.3371152890129525,0.7323834866182222,0.8248663101604278,0.9832041785196965,1.0,6/15,23.69%,PIBF1;BBS4;CEP83;PCM1;DCTN2;NEDD1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.2779580089031674,0.732203453341463,0.8607181719260065,0.9830498624271772,1.0,17/47,27.73%,PKP3;ATXN2;WDR91;SSH1;AKT1;NOLC1;RBM3;KLF4;PCIF1;METAP1;CSF1;EIF2A;CYFIP1;GRM5;EIF4G1;TSC1;NFKB1
prerank,protein localization to Golgi apparatus (GO:0034067),-0.22098375682867916,-0.7321665344248661,0.8797814207650273,0.9351816998391238,1.0,7/27,14.16%,OPTN;PAQR3;VPS13A;GBP5;SORL1;GCC2;RIPOR1
prerank,sphingolipid biosynthetic process (GO:0030148),0.2662979177443164,0.731911636498048,0.8697033898305084,0.9830293805422613,1.0,11/71,12.45%,CERS6;PLPP3;ALDH3A2;PLPP1;PRKD2;AGK;SGMS2;LARGE1;FA2H;ELOVL5;PRKD3
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.30933777683925273,0.7317986677548041,0.8268292682926829,0.9827792407045177,1.0,10/25,32.64%,MPP2;GRIN2D;AKT1;GRIN2A;NPAS4;GRID2;NLGN3;DRD2;GSK3A;RAB3GAP1
prerank,regulation of chromosome segregation (GO:0051983),0.3334451115259384,0.7313072615575826,0.8083670715249662,0.982979807928068,1.0,5/16,21.95%,SMC5;PUM1;SMC6;NUMA1;CSNK2A2
prerank,cardiolipin metabolic process (GO:0032048),0.33886475139323696,0.7311769380174363,0.7879194630872484,0.9827641173969797,1.0,8/13,35.43%,PNPLA8;TAMM41;SLC27A1;PGS1;PLSCR3;CRLS1;PTPMT1;HADHB
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.2839499554289908,0.7309857308618609,0.8548034934497817,0.9826098944921932,1.0,11/46,27.36%,ANXA2;MIF;RAP1B;ARF1;PDCD4;PPIA;RALA;SNRPA1;MTAP;JAK2;PITPNA
prerank,neuron projection extension (GO:1990138),0.29666763926728734,0.730408776917415,0.8454332552693209,0.9829200663055336,1.0,10/32,16.12%,MAP1B;TNN;SEMA3A;IQGAP1;FLRT3;ULK2;ULK1;LLPH;HSP90AA1;SLC9A6
prerank,adenine nucleotide transport (GO:0051503),0.3287906228632693,0.7302171397696043,0.8243589743589743,0.9827572593400428,1.0,3/17,15.22%,LRRC8D;SLC25A4;SLC25A17
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.3175709261238163,0.7301375058145557,0.8280657395701644,0.982469114388849,1.0,1/20,1.08%,PSTPIP1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.3023769908983222,0.729462848535999,0.8446833930704899,0.9829040207500538,1.0,9/29,28.12%,CHUK;TLR4;UBA52;CD14;TRAF3;UBE2D3;TICAM1;CASP8;CD300LF
prerank,presynapse assembly (GO:0099054),0.33291613782201235,0.7292818353677678,0.8076416337285902,0.9827429101857568,1.0,8/16,31.30%,CEL;PTEN;LRRTM3;DVL1;IL1RAPL1;NLGN1;NLGN3;NLGN2
prerank,peptidyl-lysine methylation (GO:0018022),0.30489375078334313,0.7292534024512021,0.8240291262135923,0.9823879430785394,1.0,9/26,28.16%,SETD7;SETD2;ANTKMT;EHMT2;EEF2KMT;N6AMT1;KMT5A;EEF1AKMT3;SUV39H1
prerank,myelin maintenance (GO:0043217),0.3604852842773015,0.7292387131763661,0.8073136427566807,0.9820242487382566,1.0,8/10,39.63%,CXCR4;PTEN;MYRF;EPB41L3;DEGS1;CLU;ABCD1;ABCD2
prerank,cellular response to hypoxia (GO:0071456),0.2603833432168094,0.7288441852363755,0.9129989764585466,0.9820953621796316,1.0,14/126,8.83%,ANGPT4;PSMC4;VEGFA;LMNA;ZFP36L1;MTOR;CARD16;PSMC6;MDM4;EGLN2;STUB1;TIGAR;PSMD8;SIRT2
prerank,regulation of receptor binding (GO:1900120),0.35526572734998996,0.7286034247020866,0.8002894356005789,0.9820003973124352,1.0,3/10,13.12%,PTPRF;ATP2A2;ADAM15
prerank,regulation of neurotransmitter secretion (GO:0046928),0.2929947940974463,0.7283362443530226,0.826945412311266,0.9819354758088462,1.0,7/32,19.18%,SYT11;DTNBP1;STX1B;HCRT;SNAPIN;PREPL;RIMS2
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.25815511924356305,-0.7283057135258802,0.8376068376068376,0.9385068057023632,1.0,5/16,20.05%,SCARB1;NR1H3;CTDNEP1;PNPLA2;ABHD5
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.3037165719836402,0.7276074721977538,0.8245614035087719,0.9824038662167528,1.0,2/25,4.78%,PFKP;FOXK2
prerank,cilium-dependent cell motility (GO:0060285),-0.2331029852049818,-0.72755990207797,0.8789473684210526,0.9379793862130718,1.0,12/22,34.79%,CFAP44;EFHC2;DNAH2;GAS8;RSPH9;DNAH3;DRC1;CCDC65;DNAAF2;TEKT2;DNAH17;CFAP54
prerank,organophosphate catabolic process (GO:0046434),0.3550310714958259,0.7274131530960716,0.7901234567901234,0.9822527416586099,1.0,11/11,64.52%,ANGPTL3;ENPP2;PNLIPRP2;APOA2;LIPG;PLBD2;PON1;PDXP;ABHD12;NUDT15;PLBD1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.31659431898464907,0.7268593529429727,0.8207317073170731,0.9825159652354384,1.0,11/20,34.69%,AGO2;EIF6;AGO4;AGO3;TNRC6A;CELF1;AGO1;CNOT8;LIMD1;TNRC6C;NRDE2
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.3510667854663616,0.7267614567096574,0.8025568181818182,0.98225830999749,1.0,4/10,32.71%,RC3H1;PRNP;LGALS9;CD274
prerank,T cell activation (GO:0042110),0.2657869486384201,0.7266833863331963,0.8759358288770054,0.9819690712737673,1.0,15/69,25.52%,IRF4;DPP4;CD44;PPP3CA;IL4;NCK1;LMBR1L;PPP3CB;DDOST;PIK3CG;FKBP1A;NCK2;LEPR;KIF13B;RAB29
prerank,regulation of protein ubiquitination (GO:0031396),0.2591730231475064,0.7262081234225852,0.9084362139917695,0.9821311846379976,1.0,38/108,31.53%,AXIN1;GTPBP4;GNL3L;USP4;STUB1;MYCBP2;UBE2N;CUL3;SQSTM1;HDAC3;AKT1;DNAJB2;NDFIP1;HSP90AA1;CHP1;OGT;UFL1;TGFBR1;U2AF2;ARRB1;NSMCE3;DERL1;UBE3A;FKBP1A;BAG5;FBXW7;DCUN1D1;PRKCG;BCL10;DNAJA1;HDAC8;LAPTM5;SENP2;SIRT7;TRAF6;SPRTN;GSK3A;CDK5RAP3
prerank,cardiac muscle cell development (GO:0055013),0.3172276060757626,0.7257335551312629,0.8293601003764115,0.9823436115610059,1.0,4/20,13.14%,VEGFA;ALPK2;PDGFRA;FHOD3
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.3413282125486682,0.725712182141859,0.8032128514056225,0.9819881954994639,1.0,7/13,31.56%,IRAK4;IRAK1;EPG5;TNIP2;MYD88;TRAF6;PIK3R4
prerank,purine-containing compound catabolic process (GO:0072523),-0.2673451780530589,-0.724841729592095,0.8243727598566308,0.9397820773983725,1.0,4/13,18.04%,DPYD;NT5E;NT5C2;NT5C1A
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.30120427326505067,0.7245366200265884,0.8235294117647058,0.9829811467061631,1.0,3/24,7.80%,MAPK7;NFE2L2;GAS6
prerank,phosphatidic acid metabolic process (GO:0046473),0.28103199034697435,0.7245030294752502,0.855072463768116,0.9826462840628509,1.0,10/48,20.10%,GPAT4;DGKQ;AGPAT3;LPCAT1;AGPAT5;GPAT3;GPAM;LIPH;DDHD1;PLD2
prerank,cilium movement (GO:0003341),0.278752656950199,0.724459956341885,0.8498871331828443,0.9823127978382343,1.0,1/47,0.46%,CFAP251
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2647422017653518,0.7243455169674358,0.9011328527291452,0.9820578766876888,1.0,20/85,24.58%,PSMC4;CLTC;SMURF2;AP2A2;PSMC6;FZD7;PARD6A;PSMD8;MAGI2;VANGL2;RHOA;FZD4;DAAM1;TIAM1;SMURF1;AP2M1;PSMD4;DVL1;PSMD3;RAC1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.27219856285901484,0.7241968956270437,0.871319520174482,0.9818601830088356,1.0,22/58,29.78%,CYREN;UBE2N;POLB;SMC5;XRCC5;ERCC4;ABRAXAS1;NBN;IFFO1;RAD50;DCLRE1A;SMARCAL1;ERCC1;NSMCE2;KAT5;PRPF19;PRKDC;KDM2A;XRCC6;ZBTB7A;SUMO1;PSMD14
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.2569425984542174,0.7241799960457842,0.9392712550607287,0.9815027898475424,1.0,34/168,21.29%,RPSA;DIS3L2;ZFP36L1;CTIF;SAMD4B;RC3H1;EXOSC7;HELZ2;PNRC2;GSPT2;RPL10A;UBA52;POLR2D;ZFP36;POLR2G;RPS5;CNOT3;CNOT10;SMG7;ZC3H12A;TNKS1BP1;GSPT1;EIF3E;SMG6;RPL6;DDX5;TENT2;TENT4B;PPP2R2A;RPL23;RPL17;RPS25;RC3H2;THRAP3
prerank,negative regulation of hippo signaling (GO:0035331),0.3471240535837778,0.7240136845066059,0.788218793828892,0.9813233393430043,1.0,2/12,4.98%,MAPK14;MAP2K3
prerank,positive regulation of defense response to virus by host (GO:0002230),0.3055512390955413,0.7235718994422986,0.8272506082725061,0.9814727918866575,1.0,5/24,15.09%,CGAS;TRAF3IP2;ZC3H12A;HSP90AA1;IL4
prerank,oligodendrocyte differentiation (GO:0048709),0.3230559054652866,0.7235278862262429,0.8194444444444444,0.9811520601143824,1.0,3/19,8.29%,PRDM8;SOX10;SOX8
prerank,L-glutamate transmembrane transport (GO:0015813),0.35858247359464923,0.7231392438500246,0.8101788170563962,0.9812423090057477,1.0,2/10,10.14%,SLC1A6;PRAF2
prerank,sphingosine metabolic process (GO:0006670),0.32557991348482757,0.7229963311767872,0.8108108108108109,0.9810305059800493,1.0,2/17,7.11%,PLPP3;PLPP1
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.27272803599388756,0.7227585047491173,0.8606911447084233,0.9809062281679665,1.0,7/57,13.69%,GNAI3;LPAR1;HTR1F;AKAP12;GPR37L1;ADCY8;GPR37
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3347724574871627,0.722572147713872,0.8262032085561497,0.9807482284834903,1.0,5/14,23.59%,PAICS;GART;ATIC;ADSS2;LHPP
prerank,regulation of cellular component size (GO:0032535),-0.22156720358299598,-0.7220719017712844,0.9032258064516129,0.941675673077662,1.0,5/30,8.09%,EPS8;RAB22A;RIN3;RPTOR;LAMTOR5
prerank,chloride transmembrane transport (GO:1902476),0.28015882381908436,0.7215755090257421,0.8759521218715995,0.9815338915311251,1.0,5/48,7.45%,ANO3;SLC4A8;SLC12A8;GABRR3;SLC12A4
prerank,regulation of protein localization to cell surface (GO:2000008),0.2844598316579841,0.7211540469904619,0.8436406067677946,0.9816590983023186,1.0,12/33,28.35%,RAB11FIP5;STX4;TOR1A;EGF;GOPC;STX3;MAP1A;LEPROT;GBF1;SNX33;RANGRF;TM9SF4
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.27845287424003007,0.7211304983074566,0.8587319243604005,0.9813131702975686,1.0,8/44,20.57%,KCNMA1;ANK2;KCNJ2;KCNJ3;GNB1;AKAP9;KCNH2;FLNA
prerank,regulation of feeding behavior (GO:0060259),-0.2805396095557482,-0.7209315466459167,0.821917808219178,0.9415825870122232,1.0,3/11,21.45%,SGIP1;CFAP20;NR4A3
prerank,regulation of stem cell population maintenance (GO:2000036),0.31835159761109166,0.7208024763154176,0.8112965340179717,0.9812936572646364,1.0,2/18,6.36%,LOXL2;NCOA3
prerank,regulation of RNA export from nucleus (GO:0046831),0.3553102908818319,0.7208020828775941,0.8217687074829932,0.9809199442911118,1.0,4/11,22.76%,CPSF6;SETD2;AKAP8L;TPR
prerank,regulation of Rac protein signal transduction (GO:0035020),0.32682682697678134,0.7206989441922952,0.8275418275418276,0.9806710934003053,1.0,7/16,23.96%,ARHGAP44;RASGRF1;ARF6;OGT;ARHGAP17;PIK3CG;ALS2
prerank,epithelial cell development (GO:0002064),0.31130201689615755,0.7201490353166533,0.8333333333333334,0.980919807820502,1.0,2/20,5.30%,DACT2;PDZD7
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.29392221275033836,0.7199451498991176,0.8375576036866359,0.9807774749361218,1.0,7/29,14.96%,RASGRF1;RASGEF1A;SRC;ITGAV;IRS2;SHOC2;RAPGEF1
prerank,calcium ion homeostasis (GO:0055074),0.25933728119940025,0.7190197292166287,0.9061855670103093,0.9814381472266134,1.0,27/95,27.37%,CCL8;NPTN;ANK2;TNNI3;ATP2B4;CYP27B1;ATP13A1;ATP2A2;CCL13;SLC8A2;STC1;TMEM165;CHRNA7;ATP2B1;SELENON;HTR2C;STIM1;SLC8B1;HTR2A;RMDN3;CALR;TMEM203;TMCO1;SLC24A4;SLC24A2;FAM20A;SLC10A7
prerank,regulation of interferon-beta production (GO:0032648),0.2757898722687785,0.7188325454455623,0.8632286995515696,0.9812724027456767,1.0,11/46,22.85%,PTPRS;TIRAP;TLR4;POLR3D;SIRPA;HSP90AA1;RNF216;TRAF3;PYCARD;POLR3A;FLOT1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.2872529680673503,-0.7188042396871722,0.8020833333333334,0.9426143770403507,1.0,6/10,24.24%,RAPGEF3;SMARCB1;HDAC5;SPHK2;BRCA1;CHEK1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.27235175300744047,0.7184780943558469,0.8679039301310044,0.9812836720755859,1.0,12/48,22.90%,PAPSS2;AMPD2;SLC25A16;ADCY8;PANK1;SLC26A1;DCAKD;PANK3;ACAT1;NPR2;ADSS2;ADCY2
prerank,I-kappaB phosphorylation (GO:0007252),0.3556851558361932,0.7172745092203586,0.8,0.9822507971013097,1.0,2/10,9.36%,CHUK;TLR4
prerank,positive regulation of neuron death (GO:1901216),0.27368379510353236,0.716723849362944,0.8626799557032115,0.9824809622295777,1.0,11/46,22.04%,FYN;TGFB2;TLR4;MAPT;EIF2S1;NUPR1;SARM1;ITGAM;BACE1;NF1;ATF4
prerank,regulation of intracellular signal transduction (GO:1902531),0.24809671340762118,0.7166002543927011,0.991,0.9822422550853971,1.0,96/420,22.07%,MYOC;TRIP10;ARHGAP21;ARHGAP10;EGFR;ARHGAP44;AKAP13;VEGFA;PIK3R2;TAOK3;MAPK14;TRIO;MTOR;PRKAB2;RCN3;SRGAP1;RASSF2;TBCK;MDM4;RIT2;ARHGEF3;NOC2L;FLCN;MYO9B;PRKD2;MYO9A;ARHGAP9;RHNO1;OCRL;RHOJ;FBXL2;MAPK11;TAGAP;ITGAV;TIAM2;RHOQ;SQSTM1;BRD7;DYRK2;RMI1;AKAP12;TAF3;AKT1;MAPT;BCL3;DNA2;NGEF;RAD1;TAOK2;RHOA;PIN1;TMEM127;BRIP1;EHMT2;NBN;STK3;SLC15A4;USP7;GPAT3;NOP53;RFC4;RAC3;SOS1;TRAF3;PEX5L;CHD3;PML;UFL1;PIP4P1;ARAP1;PPP2R5B;PIP4K2C;RAD50;SRGAP3;SRGAP2;TMBIM4;TCP11;RPF2;DIPK2A;BLM;TTC5;PRKAR2A;CASTOR2;INPP5B;PIP4K2B;RNF41;TIAM1;MAPK1;PYCARD;PTEN;ARHGAP17;NOP2;VAV2;CSNK2A2;TRAF4;CPNE1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.2959814018096054,0.7165389269981483,0.8522050059594756,0.9819416545736149,1.0,9/30,28.12%,CHUK;TLR4;UBA52;CD14;TRAF3;UBE2D3;TICAM1;CASP8;CD300LF
prerank,regulation of cellular biosynthetic process (GO:0031326),0.2914801833017768,0.7158370783499366,0.8424170616113744,0.9823777740064005,1.0,7/28,13.76%,PRKAB2;SIRPA;MITF;CD47;AVIL;EIF6;TNFRSF1B
prerank,dephosphorylation (GO:0016311),0.2504543991475037,0.7158041398164698,0.9350912778904665,0.9820378447418305,1.0,41/147,23.62%,TIMM50;CDC14B;PTPRS;PLPP3;ACP2;PTPRJ;PLPP5;ILKAP;PTPRF;PLPP1;PPP5C;DUSP11;CTDSP2;PPM1G;INPP5K;SSH1;PPP3CC;PPEF2;PLPPR3;PPP3CA;CTDP1;PPP2R1B;MTMR6;PPP1CC;PTPN5;PPP2R5B;PDP2;PLPP2;PPP2R2A;SDHAF2;PPP3CB;PTPN3;ACP3;PPM1A;PTEN;PPP6C;FBXW11;PTPN18;CTDSP1;LHPP;ACP6
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.259663176637697,0.7153621454347721,0.9050104384133612,0.9821680037107424,1.0,20/78,25.21%,NFE2L2;COP1;STUB1;SIRT2;HERPUD1;DNAJB2;USP5;SGTA;RNF14;NOP53;ZER1;KEAP1;BCAP31;ARIH2;RNF19A;ARIH1;ZYG11B;DVL1;MDM2;FBXO22
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.31380254346812275,0.7153058004586796,0.8357050452781372,0.9818490726820919,1.0,4/18,15.93%,C1QBP;PUM1;SEC14L1;NOP53
prerank,C-terminal protein amino acid modification (GO:0018410),0.3469442794777029,0.7152677037471986,0.8224687933425797,0.9815171073773782,1.0,4/11,25.30%,TTL;GPLD1;ICMT;AGBL1
prerank,transcription by RNA polymerase III (GO:0006383),0.3015642846166013,0.7148523175111501,0.8535714285714285,0.9816248279932326,1.0,8/27,23.60%,ZC3H8;GTF3C2;BRF1;POLR3H;ICE1;TBP;ELL;GTF3C5
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.2848197467521948,0.7146199438278851,0.8633177570093458,0.9815113592516859,1.0,10/36,23.97%,UCHL5;RYBP;FHIT;USP7;GIPC1;OGT;NOP53;MAP1A;SDCBP;BAG5
prerank,mRNA modification (GO:0016556),0.3100709185620986,0.7140040340755909,0.8479899497487438,0.9818444445081793,1.0,4/22,20.27%,TRMT6;TRMT61A;PCIF1;TRUB1
prerank,microtubule nucleation (GO:0007020),0.31195185583178797,0.7138991718012243,0.808041504539559,0.9815803711779164,1.0,6/19,22.81%,NDEL1;SLAIN2;AKAP9;CLASP2;TUBGCP5;TUBG2
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.2639533964081007,0.7137156430316871,0.8980021030494216,0.9814158833209835,1.0,25/75,26.99%,MAP1B;LLGL1;DOCK7;FARP1;S100A6;UNK;TAOK2;MAP6;DCC;SDC2;SHTN1;CNTN4;RAB10;SLITRK4;ABITRAM;MAP1A;MAP1S;SPTBN4;NTNG2;DVL1;ATL1;PAX2;NRCAM;SLITRK5;PAK3
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.34510822658319673,0.7135180358870081,0.8184245660881175,0.9812732294149438,1.0,3/12,13.64%,PTPRJ;NDRG4;CBL
prerank,copper ion homeostasis (GO:0055070),-0.2513290938197862,-0.7134073590120499,0.8559670781893004,0.9474271703400245,1.0,3/17,9.43%,APP;XIAP;CUTC
prerank,amide biosynthetic process (GO:0043604),0.2736382805692043,0.7121513802205219,0.8933333333333333,0.9824721038616747,1.0,5/47,11.20%,CERS6;PCSK5;AGK;SGMS2;FA2H
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.30147949414144437,0.7117495333449105,0.8356687898089172,0.9825405714366312,1.0,3/21,11.35%,ZW10;ZWINT;FBXO5
prerank,regulation of protein binding (GO:0043393),0.2550286035158942,0.7115637026295775,0.9258883248730965,0.9823605326542943,1.0,21/114,17.11%,LRP1;PKD1;DACT1;TCF7L2;GNL3L;CARD16;TFIP11;PSEN1;USP33;AKT1;SLPI;DNAJB2;CDKN1A;PIN1;DDX11;HDAC4;STK3;AMFR;GTF2F1;SNAPIN;IDE
prerank,DNA integrity checkpoint signaling (GO:0031570),0.2815191618253256,0.7115375867101534,0.8457207207207207,0.9820237514961292,1.0,15/36,33.09%,TIPIN;RHNO1;DNA2;RAD1;BRIP1;NBN;DONSON;CLSPN;TIPRL;PRPF19;RAD17;RAD9A;USP28;E2F1;CHEK2
prerank,positive regulation of catalytic activity (GO:0043085),0.2835565989871188,0.7110633811585632,0.8623853211009175,0.9821775148762957,1.0,7/37,14.35%,MAPK14;ABL2;PSEN1;B3GAT3;STX4;XRCC5;BCAS3
prerank,regulation of lipid metabolic process (GO:0019216),0.2570331655506648,0.7104330210631151,0.8987473903966597,0.9825147216979895,1.0,20/88,19.40%,NR1D2;MVK;NR1D1;PLPP1;CHD9;SIN3B;GGPS1;HDAC3;HELZ2;IRS2;TGS1;MBOAT7;NCOR2;NCOR1;BBS4;PMVK;OPA3;GPAM;SREBF1;RORA
prerank,lamellipodium organization (GO:0097581),0.28989366298995434,0.7100503262566142,0.8286713286713286,0.9825390061063493,1.0,12/29,30.74%,ABLIM1;WASF1;SNX1;CTTN;CCDC88A;DMTN;RAC1;CYFIP1;ARHGEF7;SPATA13;VCL;WHAMM
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.2690983084598416,0.7097277285502371,0.8786565547128927,0.9821749784642128,1.0,14/56,19.81%,NDUFS5;TMEM126A;NDUFAB1;NDUFAF8;NDUFAF6;NDUFS1;NDUFB7;NDUFA2;NDUFV2;ACAD9;BCS1L;DMAC2;NDUFB2;DMAC1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.2690983084598416,0.7097277285502371,0.8786565547128927,0.9821749784642128,1.0,14/56,19.81%,NDUFS5;TMEM126A;NDUFAB1;NDUFAF8;NDUFAF6;NDUFS1;NDUFB7;NDUFA2;NDUFV2;ACAD9;BCS1L;DMAC2;NDUFB2;DMAC1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.2576753472427579,0.7095493086868804,0.9094693028095734,0.9820036178786865,1.0,37/94,29.74%,CRIP1;C1QBP;CUL3;GSKIP;ERN1;SELENOK;CEBPB;BBC3;BAK1;SFN;QRICH1;DIABLO;CDKN1A;TNFRSF1B;FHIT;STK24;MLLT11;DDX5;PML;HTRA2;CYP1B1;APAF1;MCL1;CUL5;PYCARD;ATF4;DDIT3;SCN2A;MSH6;PRKDC;LGALS12;HIC1;CUL1;TOPORS;BAX;AIFM1;TP53
prerank,regulation of double-strand break repair (GO:2000779),-0.19662568718899254,-0.7093927000515875,0.9236641221374046,0.9503558541739722,1.0,6/39,9.45%,TRIP12;SPIRE1;UBR5;SLF2;MGMT;MRNIP
prerank,cytoskeleton organization (GO:0007010),0.25607732574417663,0.7092977694754508,0.9331275720164609,0.9819119012243366,1.0,41/114,29.22%,ARHGAP10;PLCE1;DIAPH3;BIN1;ZRANB1;DST;MAST4;LARP4;CAMSAP1;MICAL2;PRPF40A;PALLD;FMNL3;CCL13;RHOA;RND3;DIAPH1;ANK1;RAC3;RANBP10;MICAL1;SH3D19;PLD2;ZMYM3;PACSIN3;CNTNAP1;PACSIN2;SYNE3;DMTN;RAC1;STRIP1;RHOBTB2;MAST2;ZMYM6;RND2;SIPA1L3;PRKCI;EPB41L3;LRCH3;RHOBTB3;SH3KBP1
prerank,retinoic acid metabolic process (GO:0042573),0.3306342624448856,0.7091395927026402,0.8232258064516129,0.9817037740155102,1.0,3/14,19.24%,CYP2S1;ALDH1A3;SCPEP1
prerank,tRNA wobble uridine modification (GO:0002098),0.3295029464628383,0.7087994194623958,0.8309114927344782,0.981712564801806,1.0,3/14,13.61%,ELP4;TRMU;ELP1
prerank,regulation of cellular amide metabolic process (GO:0034248),0.28533159530062174,0.7078565630151153,0.8563084112149533,0.9823787072057238,1.0,11/32,27.50%,PKP3;ATXN2;TIGAR;NOLC1;RBM3;PCIF1;METAP1;EIF2A;CYFIP1;GRM5;TSC1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2569909210876236,0.706823773113772,0.9030558482613277,0.9831208153838561,1.0,26/76,31.53%,AXIN1;PIAS3;STUB1;UBA2;MYCBP2;CUL3;HDAC3;TNIP1;NDFIP1;ZC3H12A;HDAC4;SAE1;NSMCE3;DERL1;UBE3A;FKBP1A;FBXW7;DCUN1D1;MUL1;BCL10;LAPTM5;SENP2;TRAF6;SPRTN;GSK3A;CDK5RAP3
prerank,brain development (GO:0007420),0.2517513014599798,0.7063181048057295,0.9362348178137652,0.9833035189031505,1.0,33/136,22.71%,AFF2;UGP2;PBX1;TGFBR2;MEIS2;NFIB;GRIN2D;ZFHX3;NDRG4;EEF1AKMT4-ECE2;HSPG2;SLC6A4;TBC1D23;SLC23A1;MDGA1;BBS4;CHD8;UFC1;CDK5RAP2;GRIN2A;CXCR4;QARS1;NIPBL;CNTN4;UFM1;PAFAH1B1;EML1;PITPNM1;PTEN;NF1;MAP1S;FBXW11;UBE3A
prerank,rRNA processing (GO:0006364),0.24950829150160653,0.7061748748562628,0.9608826479438315,0.9830952595476244,1.0,61/172,31.38%,C1D;DDX49;RIOK1;FCF1;HELQ;ESF1;EXOSC7;RRP36;RPL10A;WDR46;UBA52;EIF6;RCL1;SBDS;MPHOSPH10;SNU13;NOLC1;EXOSC1;DCAF13;RRP7A;RSL1D1;RPL6;DDX52;POP4;NOP53;PWP2;EBNA1BP2;SRFBP1;TBL3;RPL23;RPL17;RIOK2;PDCD11;MAK16;RPS25;KRR1;NOP2;WDR18;NOC4L;TEX10;TSR3;RRP1B;RPL22;EXOSC10;RIOK3;NHP2;PRKDC;NOP56;RPL34;UTP18;NOP58;WDR43;EXOSC3;RPS15;NAT10;RPLP2;RPL31;DDX27;RPS28;NOL11;RPS6
prerank,sensory perception of taste (GO:0050909),0.34855799525028414,0.7061484863305255,0.8191933240611962,0.9827548599390611,1.0,2/10,19.97%,ASIC2;ASIC1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.28588437786566134,0.705933550993927,0.8648339060710195,0.9826207591280173,1.0,15/34,33.61%,MPP2;GRIN2D;AKT1;GABRG3;GRIN2A;GABRG2;GABRA3;NPAS4;GRID2;NLGN3;GABRA1;DRD2;GSK3A;RAB3GAP1;GABRA5
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.24499362683878875,-0.7050171717728801,0.8454545454545455,0.9539279299401757,1.0,3/18,10.96%,SHANK3;CACNG4;CACNG8
prerank,positive regulation by host of viral transcription (GO:0043923),0.3286167917062826,0.7048146300336661,0.8519515477792732,0.9834873701469209,1.0,7/15,23.96%,HPN;CTDP1;SMARCA4;CHD1;TFAP4;JUN;RRP1B
prerank,inorganic anion transmembrane transport (GO:0098661),0.2661825578031388,0.7047551446137797,0.8892405063291139,0.9831771410716963,1.0,14/63,21.53%,ANO3;SLC4A8;SLC12A8;GABRR3;SLC37A3;SLC12A4;SLC12A5;GABRG3;SLC25A3;SLC20A1;ANO5;GABRG2;SLC12A6;SLC37A4
prerank,retinal metabolic process (GO:0042574),0.33931169117509885,0.7045668685118346,0.8259668508287292,0.9830039871675919,1.0,3/12,18.83%,ALDH1A3;RDH13;CYP1B1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.27092323768460036,-0.7044117710346376,0.8333333333333334,0.9532033076865734,1.0,9/13,47.64%,NECTIN2;CYRIB;FADD;IL12A;IL12RB1;IL23A;IL12B;IL23R;XCL1
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.29792114652466517,0.7031376789622312,0.855072463768116,0.9841802658164512,1.0,3/24,7.64%,FGF2;F2R;PKD2
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.2825741809775375,0.7029726080858215,0.8593023255813953,0.9839893626452877,1.0,8/32,20.56%,FGF13;MAPRE1;CAMSAP1;TUBB4A;FKBP4;NAV3;CLIP3;CLASP2
prerank,negative regulation of MAP kinase activity (GO:0043407),0.272580191640352,0.7027415126479274,0.8737430167597765,0.9838576519686936,1.0,10/44,21.45%,UCHL1;IRAK3;AIDA;PTPRJ;INPP5K;PDCD4;SMPD1;STK38;HIPK3;NF1
prerank,aerobic respiration (GO:0009060),0.3039675006760328,0.7024868340125611,0.8337468982630273,0.9837610191096741,1.0,7/20,25.94%,SURF1;MDH2;MTFR1L;UQCRH;UQCR10;SDHC;ME3
prerank,protein homotetramerization (GO:0051289),0.2675509732341803,0.7024581086469162,0.8676957001102535,0.9834244327358402,1.0,10/49,19.31%,TK1;KCNJ2;OSBPL2;PKD2;SAMHD1;ALDH1A3;GLS;CRYZ;ALDOA;HCN1
prerank,modulation of chemical synaptic transmission (GO:0050804),0.25131603654466406,0.7023507400807978,0.9263803680981595,0.9831674706214942,1.0,34/107,26.36%,CEL;SLC4A8;DLG4;DLGAP4;STX1B;NRG3;DLGAP3;HCRT;PXK;LGI1;BTBD9;SLC8A2;DLGAP1;CNTNAP4;GRID1;CHRNA7;AKAP9;SYT1;GRM1;RIMS2;CLSTN3;PTEN;NMU;GRIK5;NPTX1;GRIK2;BCR;DGKI;BAIAP3;GRIK4;GRM5;NPAS4;BEGAIN;EIF4EBP2
prerank,regulation of DNA repair (GO:0006282),0.2735206013241146,0.702304870919406,0.8709677419354839,0.9828568358523755,1.0,7/44,13.53%,EGFR;EYA2;UBE2N;TIGAR;CDK9;PARG;ABRAXAS1
prerank,cellular copper ion homeostasis (GO:0006878),0.32860215317301306,0.702167087421937,0.821917808219178,0.9826493944151008,1.0,2/14,9.87%,COX19;ARF1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.28661373060575557,0.7019214455061773,0.8640093786635404,0.9825384840866512,1.0,10/31,28.15%,CDC14B;AXIN1;UBE2N;PIN1;PTEN;FBXW7;RAB1A;DCUN1D1;GORASP1;TOPORS
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.21960411597123786,-0.7013976072333071,0.883495145631068,0.9549608592767643,1.0,6/22,16.36%,NUBPL;HSPA9;CIAO1;NFU1;ISCU;NDOR1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.27767733166505437,0.7009760333638742,0.8648648648648649,0.9831627464343377,1.0,6/34,13.32%,BTC;CUL3;CDC23;EGF;ANAPC5;CDC27
prerank,peptidyl-lysine trimethylation (GO:0018023),0.29415681929217685,0.7007323845191622,0.8714107365792759,0.9830379174292369,1.0,8/26,19.93%,SETD2;ANTKMT;SETD5;OGT;KMT2A;EEF2KMT;PRDM9;SETD1B
prerank,cellular protein-containing complex assembly (GO:0034622),0.24408116376663364,0.7004543011520519,0.9537223340040242,0.9829676728936049,1.0,39/159,25.05%,BIN1;CLTC;SMAD4;AXIN1;HOPX;NUP93;CENPT;PSMG2;AHCTF1;VAMP1;SRC;SRP19;NUP107;ADRM1;NUP98;MAPT;TBCEL;CALY;NSG1;CASQ1;DNAAF3;HSP90AA1;NCK1;CENPC;PFDN6;VAMP2;CENPE;TIAM1;VAMP4;TPR;FKBP1A;NCK2;AP2M1;PSMD4;EIF4H;RAB5IF;NDUFAF1;RTN4;VBP1
prerank,protein alkylation (GO:0008213),0.29583217403869266,0.6996645655262452,0.8438287153652393,0.9834737808122069,1.0,9/22,35.37%,PRMT2;GSPT1;SNRPD3;EEF2KMT;CAMKMT;PRMT8;ETF1;FAM98A;EEF1AKMT1
prerank,respiratory electron transport chain (GO:0022904),0.32386257903459403,0.6995176073708286,0.848202396804261,0.9832571359735585,1.0,3/14,16.42%,ETFA;ETFDH;ETFB
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.31368609365358846,0.6990821925855857,0.849936948297604,0.9833483638771667,1.0,4/18,17.84%,ABL2;POR;GDNF;PDP2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.30666792341081467,0.6987973866639455,0.8417639429312581,0.9832762946786279,1.0,1/19,2.31%,AMPD2
prerank,regulation of mitochondrial translation (GO:0070129),0.30053003561960845,0.6984113513506419,0.8400503778337531,0.9833105197967967,1.0,5/21,21.70%,C1QBP;MRPS27;RCC1L;RMND1;MPV17L2
prerank,positive regulation of hydrolase activity (GO:0051345),0.24660007624713484,0.6981002741542338,0.9494949494949495,0.983274039626507,1.0,22/137,17.49%,CCL8;SGSM2;MAPK12;S100A10;F2R;RASGRF1;NDEL1;RCN3;ASAP3;ADCYAP1;FLCN;CCL25;CALM2;CCL13;RHOA;PIN1;BCAS3;RAPGEF1;EVI5;EVI5L;ARAP1;SRGAP2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.32907070377260866,0.6975658066721556,0.8333333333333334,0.983470199296496,1.0,3/13,15.59%,IL33;TLR4;SELENOS
prerank,myofibril assembly (GO:0030239),0.27239881206627564,0.6970650475534093,0.903370786516854,0.9836202145284177,1.0,7/42,15.62%,SIX4;CSRP2;PDGFRA;FHOD3;CASQ1;TMOD2;KLHL41
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.28478526189273007,-0.697042325390572,0.8198529411764706,0.9582001161945405,1.0,5/10,29.55%,TBX1;ACTN4;RXRG;RXRB;RXRA
prerank,regulation of potassium ion transport (GO:0043266),0.2761840556731371,0.6964678304352326,0.8548387096774194,0.9838638900743101,1.0,2/31,2.79%,FHL1;ANK2
prerank,peptidyl-lysine monomethylation (GO:0018026),0.34779246016710397,0.6963266011654168,0.8256130790190735,0.9836318213413797,1.0,2/10,11.66%,SETD7;SETD2
prerank,steroid biosynthetic process (GO:0006694),0.26285155429988666,0.6962535752769349,0.8989130434782608,0.983338422091088,1.0,7/56,10.09%,OSBPL3;OSBPL2;INSIG2;SCP2;SRD5A1;HSD3B7;OSBPL6
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.2873589407584952,0.6955333709169216,0.8499413833528722,0.9836980200472608,1.0,4/29,15.10%,LPCAT1;PNPLA8;MBOAT7;PLA2G4E
prerank,carboxylic acid transmembrane transport (GO:1905039),0.2740147528271505,0.695513245633711,0.860730593607306,0.983354202434909,1.0,5/40,13.12%,SLC25A21;SLC7A6;ABCC1;SLC23A1;SLC23A2
prerank,rRNA catabolic process (GO:0016075),-0.23597510147381096,-0.6950496605042816,0.8813559322033898,0.9588787879989857,1.0,6/16,24.75%,EXOSC9;DIS3L;DEDD2;DIS3;PELO;EXOSC4
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.2532663514580135,-0.6949364849408914,0.8842975206611571,0.9575921083052824,1.0,2/14,4.59%,CHKA;ETNK2
prerank,tRNA export from nucleus (GO:0006409),0.28063031901427055,0.6941591557257996,0.8703703703703703,0.9840252606273959,1.0,16/32,34.17%,NUP93;NUP107;NUP98;NUP37;NUP50;XPOT;TPR;NUP85;NUP133;NUP188;NUP88;SEC13;AAAS;NUP160;NUP54;RANBP2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.28063031901427055,0.6941591557257996,0.8703703703703703,0.9840252606273959,1.0,16/32,34.17%,NUP93;NUP107;NUP98;NUP37;NUP50;XPOT;TPR;NUP85;NUP133;NUP188;NUP88;SEC13;AAAS;NUP160;NUP54;RANBP2
prerank,sulfur amino acid catabolic process (GO:0000098),0.34226666498208735,0.6938876469866929,0.8340136054421768,0.9839449557367301,1.0,4/10,25.63%,MPST;TXN2;MTRR;CTH
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.338204399367937,0.6938824652867494,0.8377622377622378,0.9835827867229218,1.0,1/11,2.49%,FYN
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.2902899445743928,0.6934407214888164,0.8576555023923444,0.9836802411285815,1.0,7/26,22.91%,FGF2;F2R;PKD2;IBTK;HTR2C;SLC8B1;HTR2A
prerank,positive regulation of dephosphorylation (GO:0035306),0.28772040739092253,0.6932911919808836,0.8605769230769231,0.9834583949327543,1.0,8/27,22.80%,SRC;CALM2;PIN1;NSMF;PPIA;SMPD1;PTBP1;ANKLE2
prerank,oxoacid metabolic process (GO:0043436),0.2868164036351169,0.6929302088406558,0.8690476190476191,0.9834692849406315,1.0,5/27,17.58%,LIPT2;MIF;BPNT2;SULT4A1;ABHD14B
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.28073662418116285,0.69292768554921,0.8583234946871311,0.9831063884670661,1.0,3/32,6.05%,F2R;P2RX3;CXCL10
prerank,cellular response to interleukin-6 (GO:0071354),0.2911541027714269,0.6922844573597299,0.858682634730539,0.9834070888783744,1.0,6/26,16.45%,SMAD4;SRC;PID1;CBL;FER;IL6
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.3218648644745544,0.6917586621937627,0.8529014844804319,0.9835732210733235,1.0,10/14,38.35%,NME2;CMPK2;AK8;AK3;AK5;ME1;NMNAT2;CMPK1;AK7;PNP
prerank,cristae formation (GO:0042407),0.2904856697205924,0.6912830249967494,0.8745432399512789,0.9836816234937593,1.0,13/27,29.56%,ATP5PO;ATP5ME;SPG7;UQCC3;APOOL;IMMT;ATP5MC3;DNAJC11;ATP5F1B;CHCHD3;LETM1;ATP5F1A;CHCHD6
prerank,microglial cell activation (GO:0001774),-0.23445980879599215,-0.6910169659171663,0.9259259259259259,0.9600806654378518,1.0,3/21,9.30%,APP;SNCA;CX3CL1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.20540836475245533,-0.6908427691652791,0.935251798561151,0.9588988418755992,1.0,3/29,4.55%,KCNIP3;DLG1;CACNA1D
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.3237268798541619,0.6905944662708557,0.8088642659279779,0.9839986919977739,1.0,1/11,4.06%,ZFP36L1
prerank,"transcription, DNA-templated (GO:0006351)",0.2415897345185002,0.6897216517436366,0.9679037111334002,0.9845238348739518,1.0,57/207,27.73%,NFIX;POLR2H;PAX1;GTF2H3;ABT1;BRF2;PPP5C;CDK9;SOX5;TAF3;DDX21;UBTF;BCL3;ERCC3;POLR2D;GTF3C2;POLR2G;GTF2A2;CCNH;CTDP1;EAF2;GTF2F1;NFE2L3;BRF1;BTF3;EAF1;DDX5;POLR3H;TCEA2;HIPK3;GTF2E2;POLR1C;MBD1;PAF1;SLC25A33;SMN1;LHX1;ATF4;POLR3A;BAZ2A;RNMT;TBP;ELL;GTF3C5;RTF1;TAF13;TRIM24;NCOA6;POLR2C;GTF2E1;RBMX;MMS19;SNAPC3;NELFA;MRPL12;CEBPD;NFKB1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.2908302989209612,0.689434650157534,0.8620268620268621,0.9840845913355467,1.0,5/23,14.97%,SMAD4;RNF111;FLCN;SLC2A10;GIPC1
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.2908302989209612,0.689434650157534,0.8620268620268621,0.9840845913355467,1.0,5/23,14.97%,SMAD4;RNF111;FLCN;SLC2A10;GIPC1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.22100802096746472,-0.6893553610841431,0.9221556886227545,0.9590010192519852,1.0,8/23,26.82%,NR1H3;STAT1;PTPN2;PIAS1;PARP9;IRGM;TXK;SOCS1
prerank,negative regulation of bone mineralization (GO:0030502),0.32541970071144666,0.6888809961750275,0.845108695652174,0.9842709476216158,1.0,1/13,3.09%,ECM1
prerank,ganglioside biosynthetic process (GO:0001574),0.3160282942693601,0.6883315367027772,0.8355614973262032,0.98447620583997,1.0,1/15,1.19%,ST3GAL2
prerank,cellular response to catecholamine stimulus (GO:0071870),0.2926948461078271,0.6873593443597313,0.8659286592865929,0.9850878236796915,1.0,7/23,22.04%,ATP2B4;SIRT2;SLC9A1;GNB1;MAPK1;GABPA;ATF4
prerank,regulation of primary metabolic process (GO:0080090),0.24276053615486068,0.6868170685184679,0.9512195121951219,0.98527216650009,1.0,21/126,16.40%,PSMC4;NR1D2;MVK;PRKAB2;NR1D1;PSMC6;PLPP1;CHD9;SIN3B;PSMD8;GGPS1;ODC1;HDAC3;HELZ2;IRS2;TGS1;NCOR2;NCOR1;BBS4;PMVK;OPA3
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.33289490560121676,0.6865633234280173,0.8529819694868238,0.9851592505484787,1.0,4/11,21.49%,UQCRQ;UQCC3;UQCRH;UQCR10
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.2496005513088674,-0.6860873112753522,0.8819188191881919,0.9606959073636641,1.0,4/14,17.24%,ENPP1;ENPP3;AK4;AK1
prerank,negative regulation of secretion (GO:0051048),0.34366212268894675,0.6858722439170372,0.8388969521044993,0.9854811758356019,1.0,2/10,10.98%,SPX;EGF
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.2727223804866369,-0.6854636214612165,0.842809364548495,0.9599312844622978,1.0,2/10,9.07%,ALDH7A1;SARDH
prerank,cardiac conduction system development (GO:0003161),0.29024368081544316,0.6854469343093309,0.8526570048309179,0.9855514997627275,1.0,3/24,10.18%,SMAD4;SMAD5;HCN4
prerank,positive regulation of secretion by cell (GO:1903532),0.2548972757066942,0.685379274080494,0.9259656652360515,0.985245761667278,1.0,7/70,7.19%,TGFB3;ANG;TGFB2;STX1A;ADAM9;DTNBP1;STX1B
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.3355684249887395,0.6848305579338366,0.8231197771587744,0.9854343641736839,1.0,6/10,33.43%,DBF4;INO80;E2F7;ATRX;WIZ;CDC7
prerank,aspartate family amino acid catabolic process (GO:0009068),0.3023041776563707,0.6837952206441855,0.862547288776797,0.986105298425693,1.0,1/19,0.85%,SLC25A21
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.3166122551481666,0.682926283271609,0.8516042780748663,0.9866106769643559,1.0,14/14,68.37%,ATP6AP1;CSF1;TRAF6;POU4F2;IFNG;IL23R;IL12B;TNFSF11;TNF;IL23A;OCSTAMP;CCR1;POU4F1;TYROBP
prerank,cellular amino acid catabolic process (GO:0009063),0.24833761577485958,0.6821024322368043,0.9423274974253347,0.987059131937655,1.0,15/87,20.79%,AMDHD1;SLC25A21;HAL;BCAT1;AUH;HIBADH;CRYM;GLS2;GLS;ALDH5A1;GLUD1;GLDC;BCKDHA;GOT1;ACAT1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.2749595277631863,0.6820912545620013,0.8824228028503563,0.9867072472237332,1.0,7/32,24.13%,HNRNPA1;ACD;CCT7;XRCC5;NEK7;MAPK1;CCT4
prerank,histone H3-K4 trimethylation (GO:0080182),0.3330807315878942,0.6820260457259426,0.8414464534075105,0.9864135616879395,1.0,4/11,19.93%,OGT;KMT2A;PRDM9;SETD1B
prerank,positive regulation of phagocytosis (GO:0050766),0.25900904362243815,0.6815895312502147,0.8994535519125683,0.986484407748831,1.0,5/47,10.32%,PTPRJ;GAS6;SIRPA;C4B;CD47
prerank,negative regulation of cholesterol transport (GO:0032375),-0.27736630680391666,-0.6794577153248058,0.8713235294117647,0.9640198345727681,1.0,10/10,72.29%,ABCA2;APOC1;SHH;ABCG5;APOA2;PLA2G10;ABCG8;APOC3;SREBF2;NFKB1
prerank,regulation of amyloid fibril formation (GO:1905906),0.31303077938516194,0.6793387908922007,0.8672199170124482,0.9882871175754796,1.0,8/15,26.67%,PSEN1;IAPP;CHRNA7;PFDN6;LDLR;CRYAB;VBP1;PFDN2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.2995643734663284,0.679194783537125,0.8609355246523388,0.9880585533912272,1.0,5/19,21.01%,DYRK2;BCL3;RPS27L;PML;PYCARD
prerank,cellular response to mechanical stimulus (GO:0071260),0.25780194137601903,0.6785444252568056,0.902547065337763,0.9883229938829826,1.0,6/46,14.35%,PIEZO2;TLR5;TLR4;SLC9A1;BAK1;MAP3K14
prerank,response to interferon-gamma (GO:0034341),0.24890524786586343,0.6775634550891882,0.9268817204301075,0.9889006829826034,1.0,8/67,13.15%,CCL8;CYP27B1;CCL25;TLR4;SIRPA;CD47;SLC26A6;CCL13
prerank,positive regulation of defense response (GO:0031349),0.24446564935710197,0.6771797940984423,0.9379600420609885,0.9889019666485793,1.0,16/89,19.85%,IL16;S100A8;S100A9;IL33;IL17RA;TLR4;POLR3D;CD47;TNIP1;AKIRIN2;ABCC1;SLC15A4;PDCD4;IL18;IFI35;LRSAM1
prerank,protein acetylation (GO:0006473),0.27706220718503144,0.6762394382643906,0.8680555555555556,0.9894651059486139,1.0,6/30,18.12%,FOXO1;KAT2B;ING4;MAPT;NAA15;NAA50
prerank,folic acid metabolic process (GO:0046655),-0.22313757224844954,-0.6761108000360608,0.8877005347593583,0.9656045938573111,1.0,10/18,35.11%,MTHFS;ALDH1L1;SLC19A1;SHMT2;SHMT1;FPGS;ALDH1L2;MTHFR;MTHFD1L;PM20D2
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.297061229529334,0.6758739387097492,0.8764331210191083,0.9894308776625667,1.0,5/20,20.91%,ACLY;FAR1;HSD17B8;SCD5;HSD17B4
prerank,phosphate ion transmembrane transport (GO:0035435),0.32556590925784085,0.6751846718318518,0.8784153005464481,0.9897335409398512,1.0,4/12,21.53%,SLC37A3;SLC25A3;SLC20A1;SLC37A4
prerank,stress-activated MAPK cascade (GO:0051403),0.25306367813103686,0.6746027418247927,0.9203444564047363,0.9899173203262485,1.0,17/61,24.48%,ZFP36L1;MAPK14;MAP2K3;UBE2N;CHUK;MAPK11;IRAK1;UBA52;ZFP36;TAOK2;MAP2K4;MAPK1;TAB2;FBXW11;MAP3K7;TNIP2;GPS1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.24242021127969723,0.6745893010169455,0.9515962924819773,0.9895641550818358,1.0,14/104,15.56%,LRP6;GTPBP4;ETAA1;SRC;SYAP1;AKT1;PPEF2;CALM2;CDKN1A;RHOA;CCND1;CCNH;SLC8A2;MAP2K2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.3179293557702666,0.6741464940070465,0.8704453441295547,0.9896139756211578,1.0,5/13,17.58%,FUT9;IRAK1;RHOA;IL6;ZDHHC21
prerank,response to glucose (GO:0009749),0.26144755235201783,0.673834225238916,0.9151982378854625,0.9895462962247707,1.0,10/46,20.12%,SLC39A14;TCF7L2;GAS6;ERN1;IRS2;ADCY8;SELENOS;VAMP2;GPLD1;EIF2B1
prerank,sterol transport (GO:0015918),0.29280216940935133,0.6730243687502255,0.8669250645994832,0.9899547526467796,1.0,2/19,8.88%,OSBPL2;LCAT
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.24730541604374195,0.6728258740999543,0.9380252100840336,0.9897866937190638,1.0,5/75,5.31%,LRP6;UCHL1;HEG1;IRAK3;PTPRJ
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.29651247669232983,0.6727377815089126,0.8598726114649682,0.9894957345498877,1.0,10/18,37.51%,CCT7;CCT4;EXOSC10;NHP2;CCT6A;RUVBL1;RUVBL2;TCP1;CCT8;PARN
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.3034407464618884,0.6721341731388466,0.8637566137566137,0.9897018775254774,1.0,7/15,32.51%,CNTNAP4;BAIAP3;NPAS4;NLGN1;DRD2;NLGN2;ZDHHC3
prerank,negative regulation of cell cycle process (GO:0010948),0.24834024901324472,0.6718387755737177,0.9033297529538131,0.9896190119483848,1.0,15/61,21.82%,RNF2;AURKAIP1;RYBP;PHC3;PHC1;FBXO5;TERF1;EHMT2;CCP110;UXT;APAF1;RING1;PCGF6;FOXO4;EZH2
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.30097786222133405,0.6705188097012305,0.8701472556894244,0.9905022654891338,1.0,2/16,14.03%,CLDN10;CLDN12
prerank,regulation of histone methylation (GO:0031060),-0.23750663575681763,-0.6697386212956264,0.9065040650406504,0.9698820302734487,1.0,2/13,8.51%,TET1;CTR9
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.2572408757106816,0.6697254092434736,0.9151251360174102,0.9908626112050325,1.0,9/53,16.92%,EGFR;EYA2;UBE2N;TIGAR;ABRAXAS1;NACC2;EEF1E1;FXR2;DDX5
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.24342261753503533,0.6688766271832225,0.9432989690721649,0.9912904811178157,1.0,20/84,26.18%,PSMC4;PSMC6;PSMD8;CUL3;CDC23;FBXO5;FBXO31;ANAPC5;UBA52;CDC27;CDC26;ANAPC4;SKP2;ANAPC10;ANAPC15;ECRG4;PSMD4;PSMD3;ANAPC2;PSMB3
prerank,calcium ion transmembrane transport (GO:0070588),0.24199348103877583,0.6687740714177038,0.935251798561151,0.9910287022548402,1.0,17/86,17.59%,PKD1;TRPV3;ATP2B4;GRIN2D;PKD2;GAS6;MCU;ITGAV;SLC35G1;MCUB;ATP2A2;SLC8A2;TRPC4AP;GRIN2A;SPG7;TMEM165;ATP2B1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.28525160291917656,0.668625876187278,0.8871165644171779,0.990797969134186,1.0,4/24,11.01%,PKD1;RHBDF1;UCHL5;GPX1
prerank,negative regulation of nuclear division (GO:0051784),0.31930881621171897,0.6685494952655434,0.8538251366120219,0.9905039453755052,1.0,2/11,11.35%,AURKAIP1;FBXO5
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.24417080501801425,0.6681091276144097,0.9296956977964324,0.9905507058150758,1.0,21/76,26.41%,AXIN1;COP1;STUB1;SIRT2;DNAJB2;USP5;RNF14;NOP53;ZER1;KEAP1;ARIH2;RNF19A;ARIH1;PTEN;SMURF1;ZYG11B;DVL1;MDM2;FBXO22;FBXW7;CSNK1E
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.3164864699016633,0.6679062587598029,0.8585164835164835,0.9903855837392573,1.0,2/13,13.62%,ANK2;KCNJ3
prerank,membrane lipid catabolic process (GO:0046466),0.33506967457288306,0.6676782813005435,0.8565022421524664,0.9902411217779485,1.0,3/10,27.10%,PDXDC1;CYP1B1;PPT1
prerank,regulation of histone acetylation (GO:0035065),0.26604153242595774,0.6672373695872701,0.8937426210153483,0.9902847408629969,1.0,9/33,21.25%,NOC2L;FLCN;BRD7;SETD5;SET;KMT2A;GLYR1;CTBP1;ARRB1
prerank,mitotic cytokinesis (GO:0000281),0.25528991890906805,0.66648131321621,0.9258426966292135,0.9906008113049747,1.0,16/47,30.73%,SON;BBS4;TTC19;SPTBN1;RAB35;CIT;RASA1;PDCD6IP;TRIM36;SNX18;SNX33;CUL7;INCENP;MYH10;CKAP2;CHMP4B
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.29264518052332433,0.6661439793843563,0.867515923566879,0.9905480488521727,1.0,5/19,17.16%,BIN1;PIN1;RTN3;FLOT2;CHRNA7
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.2429761207912867,0.6661017756602389,0.9547325102880658,0.990230466083043,1.0,31/88,31.95%,PSMC4;PSMC6;FBXO2;PSMD8;FBXO17;FBXL2;FBXW4;FBXL20;FBXO31;FBXL3;DMAC2;FBXL5;SKP2;CUL5;FBXW11;FBXO38;PSMD4;FBXL12;PSMD3;FBXW7;PSMB3;CUL1;PSMB2;PSMD5;PSMD14;FBXL8;PSMC5;PSMC3;FBXL13;PSME4;FBXW5
prerank,negative regulation of blood pressure (GO:0045776),0.31236683632065554,0.6659464931116128,0.8619756427604871,0.9900099701799343,1.0,3/13,19.24%,PRCP;GPR37L1;SCPEP1
prerank,negative regulation of histone modification (GO:0031057),0.3060473019809209,0.6658540795280402,0.8846694796061885,0.9897306237813088,1.0,4/14,20.18%,NOC2L;TWIST1;SET;CTBP1
prerank,phagosome acidification (GO:0090383),0.27749763721896203,0.6652919728073817,0.898159509202454,0.9898976108377459,1.0,5/26,16.28%,ATP6V0A2;ATP6V1E1;ATP6V1D;ATP6V0A1;ATP6V1B2
prerank,negative regulation of dephosphorylation (GO:0035305),0.29453048722946296,0.6652676890509247,0.8801020408163265,0.9895567155852218,1.0,8/18,28.77%,INPP5K;URI1;CHP1;SH2D4A;YWHAB;PPP1R26;GPATCH2;PTPA
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.24883511313695025,0.6650628980757327,0.9128540305010894,0.9893826717889128,1.0,20/56,30.73%,SON;RHOA;BBS4;TTC19;SPTBN1;RAB35;CIT;RASA1;PDCD6IP;SEPTIN9;TRIM36;IST1;BIN3;SNX18;SNX33;CUL7;INCENP;MYH10;CKAP2;CHMP4B
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.24548706161564834,0.6645185279974302,0.936373276776246,0.989503027638013,1.0,11/73,13.10%,EIF2AK3;F2R;S100A8;S100A9;MTCH1;PDCD2;MAPT;BBC3;ANP32B;RPS27L;DIABLO
prerank,steroid catabolic process (GO:0006706),-0.26493527864105765,-0.6644295768379203,0.8768115942028986,0.9731141360662506,1.0,2/10,10.21%,YWHAH;SPP1
prerank,ceramide catabolic process (GO:0046514),-0.23753419918568508,-0.6640620184299624,0.8858447488584474,0.9720222791034108,1.0,1/14,2.32%,ACER2
prerank,DNA damage checkpoint signaling (GO:0000077),0.27015236533128056,0.6637936914155349,0.8748524203069658,0.9898003601596957,1.0,13/28,33.09%,RHNO1;RAD1;BRIP1;NBN;DONSON;CLSPN;TIPRL;PRPF19;RAD17;RAD9A;USP28;E2F1;CHEK2
prerank,regulation of mitotic nuclear division (GO:0007088),0.24591895768729485,0.663614874773946,0.9200863930885529,0.9895989155209021,1.0,9/55,16.09%,BTC;CCDC8;AURKAIP1;EGF;FBXO5;KIF20B;PIN1;CUL9;CDK5RAP2
prerank,negative regulation of DNA metabolic process (GO:0051053),0.2825715129856905,0.6628824694822378,0.8988095238095238,0.9898769644784021,1.0,10/24,27.80%,XRCC5;ERCC4;CDKN1A;KMT2A;BLM;TERF2IP;ERCC1;H1-0;MSH6;DFFA
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2339223792355236,0.66272157907548,0.9676767676767677,0.9896604878940399,1.0,40/148,26.30%,MAPK14;MTOR;PRKAB2;MDM4;NOC2L;RHNO1;MAPK11;BRD7;DYRK2;RMI1;TAF3;AKT1;DNA2;RAD1;PIN1;BRIP1;EHMT2;NBN;USP7;NOP53;RFC4;CHD3;PML;PIP4P1;RAD50;RPF2;BLM;TTC5;RPL23;PIP4K2B;NOP2;CSNK2A2;TBP;TAF13;HEXIM1;MDM2;MAPKAP1;KAT5;KMT5A;PRR5
prerank,organic cation transport (GO:0015695),0.284791385835658,0.6625939977707209,0.8847117794486216,0.9894240926278475,1.0,4/20,17.43%,SLC47A1;SLC44A1;SEC14L1;SLC44A2
prerank,phosphate ion transport (GO:0006817),0.3030244494719792,0.661922780736503,0.88745148771022,0.9896564844770026,1.0,4/16,21.53%,SLC37A3;SLC25A3;SLC20A1;SLC37A4
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.31934181420266256,0.6618836419374219,0.8686030428769018,0.9893326264018246,1.0,2/11,15.07%,SLC25A4;NUPR1
prerank,liver development (GO:0001889),0.26713290235296905,0.661868811800303,0.896551724137931,0.9889854308804813,1.0,4/32,11.40%,ANXA1;COBL;PKD2;CEBPB
prerank,cellular response to unfolded protein (GO:0034620),0.27206004061762085,0.6612247331032325,0.8976470588235295,0.9892078816293617,1.0,10/26,30.27%,HSPA13;ERN1;BAK1;HSPA14;ABCB10;BAG3;TM7SF3;BAX;HSPA8;HSF1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.250830735595429,-0.6611951446345196,0.9125,0.9730902472771829,1.0,4/13,14.28%,YAE1;CIAO1;NFU1;GLRX3
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.2407988457207789,0.6611637297465816,0.9436913451511991,0.9889080927955448,1.0,23/85,26.41%,TMEM259;COP1;PSMC6;STUB1;SIRT2;DNAJB2;USP5;NUPR1;RNF14;NOP53;ZER1;KEAP1;ARIH2;RNF19A;ARIH1;TMTC3;USP13;ZYG11B;DVL1;MDM2;FBXO22;FBXW7;CSNK1E
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.25973262879462505,0.6603197497039813,0.9155405405405406,0.9892952362369886,1.0,12/36,30.33%,AXL;GAS6;PARP14;CXCR4;CSF1;CPNE1;TRIM44;UBE2K;CD300LF;LAPTM5;AGPAT2;ADAM17
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.27408917553275625,0.6602706534810906,0.895662368112544,0.9889822828049121,1.0,11/28,31.53%,AXIN1;PSMC6;NUPR1;PTEN;TMTC3;SMURF1;FBXW7;LAPTM5;PSMC5;PSMC3;CDK5RAP3
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.26180466347529446,0.6596980486575279,0.9104651162790698,0.9891232887858377,1.0,7/35,24.13%,HNRNPA1;ACD;CCT7;XRCC5;NEK7;MAPK1;CCT4
prerank,negative regulation of lipid storage (GO:0010888),0.29057704059104855,0.6595032400512519,0.8682170542635659,0.988935601022666,1.0,3/19,9.97%,ITGB3;ABCA1;ITGAV
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.3267300421455782,0.6580722789028098,0.8668515950069348,0.9898261142623818,1.0,3/10,27.59%,CCT7;CCT4;CCT6A
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.2565648653316579,0.6576179224661414,0.9108796296296297,0.9898575619172194,1.0,5/39,12.09%,FHL1;ANK2;YWHAE;FXYD5;STK39
prerank,negative regulation of innate immune response (GO:0045824),0.2632856972081315,0.6574813745187823,0.9065743944636678,0.9896207172273124,1.0,7/34,22.59%,IRAK3;SAMHD1;SERPING1;YTHDF2;TYRO3;YTHDF3;STAT2
prerank,inner dynein arm assembly (GO:0036159),0.32695204619633444,0.6571760582086587,0.8828696925329429,0.9895256668177292,1.0,10/10,67.33%,DNAAF5;CCDC39;CFAP73;ZMYND10;DNAI3;DNAAF1;DNAH1;DNAAF4;CCDC40;CFAP100
prerank,negative regulation of lipid catabolic process (GO:0050995),0.29025825738403754,0.6568025075968995,0.8827319587628866,0.9895000693893589,1.0,3/17,19.41%,AKT1;PDE3B;GPLD1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.307711325387652,0.6565045941961092,0.8799454297407913,0.9894054813821984,1.0,4/13,21.46%,BPNT2;SULT4A1;ABHD14B;TPST2
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.308179397219009,0.6563449684490185,0.9088397790055248,0.9892003067989499,1.0,9/13,41.16%,ALG1;SRD5A3;MPDU1;ALG8;DPAGT1;ALG14;ALG2;ALG6;ALG13
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.24766845989111683,0.6560797452105688,0.9271739130434783,0.989073340662265,1.0,9/54,14.28%,TRIAP1;MUC1;MDM4;SFN;CDKN1A;CNOT3;CNOT10;PLAGL1;TNKS1BP1
prerank,regulation of neurogenesis (GO:0050767),0.24909408891785345,0.6558738778777033,0.9195652173913044,0.988895727483306,1.0,4/55,8.01%,NUMBL;BHLHE40;DOCK7;SERPINF1
prerank,nucleic acid-templated transcription (GO:0097659),0.25439516892756875,0.6556405699895862,0.9308390022675737,0.9887497238157615,1.0,5/42,13.20%,POLR2H;PPP5C;BCL3;POLR2D;POLR2G
prerank,receptor clustering (GO:0043113),0.26809384374701856,0.6551822858074436,0.8937947494033412,0.9887881008720676,1.0,9/27,24.11%,DLG4;DLG2;MUSK;MAGI2;DNAJA3;SYNJ2BP;FLNA;PICK1;DVL1
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.23549049786695858,0.6550512894997553,0.9651282051282051,0.9885440194372482,1.0,31/109,28.26%,SYK;PSMC4;PIK3R2;NFATC1;PSMC6;CHUK;PIK3CA;PSMD8;FER;PPP3CA;SOS1;MAP2K4;CARD11;PPP3CB;GAB2;MAPK1;TAB2;VAV2;FBXW11;JUN;MAP3K7;RELA;PSMD4;PSMD3;RAC1;PSMB3;BCL10;NFKB1;CUL1;PSMB2;PSMD5
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.3059526282075154,0.6545962656821076,0.8703448275862069,0.9885929254162035,1.0,4/12,24.61%,KLF2;EZH2;ASXL1;CALR
prerank,regulation of transposition (GO:0010528),0.3107694377360844,0.6545567100335835,0.8836601307189542,0.9882729442011755,1.0,3/13,22.74%,SPOCD1;DDX4;UBR2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.2649794405509713,0.6538355367441112,0.9122807017543859,0.988519889648108,1.0,6/31,12.70%,YWHAG;YWHAE;PPP3CC;BBC3;BAK1;SFN
prerank,negative regulation of chemokine production (GO:0032682),0.29935527967194775,0.6516604112172268,0.8891855807743658,0.9900186660803234,1.0,3/14,16.45%,SIRPA;KLF4;IL6
prerank,early endosome to late endosome transport (GO:0045022),0.2814298484013241,0.651239146929751,0.8847117794486216,0.9900076563148938,1.0,6/20,28.20%,HOOK2;WDR91;ANKRD27;SNX16;PTPN23;STX8
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.2771426578368682,0.6511864482903401,0.9001248439450686,0.9896963464236594,1.0,8/23,33.91%,CNGB1;SAG;METAP2;METAP1;CAMKMT;CALM1;FNTB;NMT1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.2691660470481226,0.6511852215378193,0.9101654846335697,0.9893423743507738,1.0,5/27,15.10%,PLAAT1;CHKB;PNPLA8;CEPT1;PLA2G4E
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.27421263107744487,0.6509389248452764,0.9148418491484185,0.9891960373480136,1.0,12/26,31.43%,DLG4;STX1B;SLC8A2;CHRNA7;RIMS2;PTEN;PRKCZ;NLGN1;NLGN3;NRXN1;NLGN2;CBLN1
prerank,regulation of mRNA processing (GO:0050684),0.2602929870879815,0.6507470269275213,0.9177592371871275,0.9889999821038252,1.0,10/32,26.40%,ZFP36L1;SRSF3;SON;CPSF4;PTCD2;RBM39;SRPK1;LARP7;PABPN1;SAFB
prerank,regulation of telomerase activity (GO:0051972),0.25338444835144713,0.6500867396262369,0.9299435028248587,0.9892091280790553,1.0,10/45,20.94%,SRC;ACD;XRCC5;ERCC4;TERF1;KLF4;HSP90AA1;SMG6;NEK7;MAPK1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.3203877516308986,0.6499174066773827,0.8798842257597684,0.9890072899360326,1.0,2/10,17.27%,ZNHIT6;NUFIP1
prerank,negative regulation of binding (GO:0051100),0.2384299177465507,0.6499024383995827,0.9569779643231899,0.9886635962681828,1.0,15/81,17.09%,DACT1;GTPBP4;GNL3L;CARD16;TFIP11;USP33;AKT1;SLPI;DNAJB2;CDKN1A;PIN1;DDX11;GTF2F1;ILRUN;TFAP4
prerank,regulation of lipid catabolic process (GO:0050994),-0.21567774640738097,-0.6496833932711598,0.9219512195121952,0.9808939196140133,1.0,2/19,8.92%,LONP2;ADRA2A
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.2449568326722233,0.6493534921394637,0.9298056155507559,0.9887693071960203,1.0,11/54,21.25%,GTPBP4;GNL3L;PIAS3;USP4;SQSTM1;AKT1;CHP1;OGT;UFL1;U2AF2;ARRB1
prerank,protein targeting to ER (GO:0045047),0.23503920656690216,0.6492708191083452,0.9495884773662552,0.9884829825937094,1.0,12/99,15.44%,RPSA;EDEM1;SPCS1;SRP19;SRP9;RPL10A;UBA52;RPS5;SGTA;SEC63;SEC61A1;RPL6
prerank,histone H4 acetylation (GO:0043967),0.25117969580693417,0.6486986701231214,0.9252232142857143,0.9886078041155587,1.0,11/47,18.37%,MSL2;MSL3;ING4;MSL1;WDR5;KANSL3;DMAP1;OGT;PER1;KMT2A;MORF4L1
prerank,chromosome condensation (GO:0030261),0.2582497443790907,0.6485361254295271,0.9301260022909508,0.9883912505669793,1.0,11/36,29.71%,TENT4A;NCAPG;SMC2;SET;AKAP8L;CSNK2A2;DFFB;KMT5A;H1-0;INCENP;AIFM1
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.25279662941132297,-0.64844396778408,0.891566265060241,0.9804373329671886,1.0,3/12,14.38%,AXIN2;WAPL;CTNNB1
prerank,regulation of blood circulation (GO:1903522),0.2568252479100551,0.6482106565559425,0.9073226544622426,0.9883179878309533,1.0,4/34,11.34%,SRI;CAMK2D;ECE1;CELF2
prerank,macrophage migration (GO:1905517),-0.2375164020989889,-0.646773952907715,0.9196787148594378,0.9802233737936489,1.0,6/13,36.57%,EDNRB;TAFA4;CCR2;CCL2;CXCL17;CCL5
prerank,T cell differentiation (GO:0030217),0.2550888764528907,0.6467702378469514,0.9255441008018328,0.9891432241500858,1.0,4/40,10.97%,ANXA1;ZFP36L1;ZFP36L2;GLI3
prerank,regulation of p38MAPK cascade (GO:1900744),0.2610931194473921,0.6467588061894184,0.9115566037735849,0.9887982590257847,1.0,5/35,16.32%,GADD45G;VEGFA;EMC10;ZC3H12A;PER1
prerank,regulation of vacuole organization (GO:0044088),0.2769819995768071,0.646259859795072,0.8971141781681304,0.9888668706289876,1.0,8/20,31.04%,ANXA2;RAB1B;ADPRH;TBC1D12;MTM1;PIKFYVE;IFT20;LAPTM4B
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.24111072568520753,-0.6457949403638544,0.9215686274509803,0.9795573812053152,1.0,5/13,20.51%,PHYH;OGDH;ADHFE1;DLST;IDH2
prerank,negative regulation of double-strand break repair (GO:2000780),0.2617847158395664,0.6457815998061397,0.9071925754060325,0.9888816605078665,1.0,5/30,13.51%,CGAS;CYREN;TFIP11;NUDT16L1;TWIST1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.23243693710054045,0.6456899969500913,0.9755351681957186,0.9885968074431362,1.0,22/117,20.32%,CYP2S1;ACOT6;CPT1C;ALKBH7;SLC6A8;SCP2;HAGH;PDHX;PTGR1;FA2H;GBA2;PNPLA8;GAMT;ALDH1A3;ACOT1;VDAC1;PDHA1;GPAM;BTD;ANGPTL3;SCPEP1;LDHA
prerank,negative regulation of protein ubiquitination (GO:0031397),0.24705867871980533,0.645672426279161,0.9316427783902976,0.9882594634878419,1.0,17/50,30.07%,GTPBP4;GNL3L;USP4;SQSTM1;AKT1;FBXO5;CHP1;OGT;UFL1;U2AF2;ARRB1;BAG5;PRKCG;DNAJA1;HDAC8;SENP2;SIRT7
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.31010593856283025,0.6456464315986563,0.8756830601092896,0.9879282516569291,1.0,1/12,8.46%,ZBTB1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.2338601665789042,0.6455297980239533,0.9462025316455697,0.9876776468838104,1.0,9/80,13.43%,SPSB4;AXIN1;STUB1;MYCBP2;UBE2N;CUL3;HDAC3;NDFIP1;PIN1
prerank,DNA replication checkpoint signaling (GO:0000076),0.29243840958191647,0.6452615736518427,0.9039692701664532,0.9875723214043974,1.0,2/16,12.18%,TIPIN;DNA2
prerank,necroptotic process (GO:0070266),0.29066686181325485,0.6447694069874705,0.8954081632653061,0.9876283902320596,1.0,5/16,25.35%,TLR4;PGAM5;CD14;CYLD;TICAM1
prerank,response to light stimulus (GO:0009416),0.24473827551714045,0.6447332650026937,0.9288025889967637,0.9873037583887398,1.0,19/55,31.61%,UBE2B;DTL;UBE2A;ERCC3;ERCC4;PCLAF;UVSSA;TYR;ERCC5;POLD1;OPN3;REV1;CRY2;MSH6;MEN1;SPRTN;DRD2;COPS3;CIRBP
prerank,action potential (GO:0001508),0.24792808583147716,0.6442796380132717,0.9317180616740088,0.9873111065445863,1.0,5/44,10.53%,SRI;SLC4A3;KCNJ2;MYH14;KCNA2
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.21599144191516795,-0.6440671286029099,0.9195402298850575,0.9794298343304587,1.0,5/22,14.65%,RPS7;RPL37;SPRED3;ATM;SPRED2
prerank,heterochromatin assembly (GO:0031507),0.276949028627432,0.643270599567915,0.8929471032745592,0.9877801040952763,1.0,7/20,28.16%,POLE3;SIRT2;EZH1;BAHD1;BAZ2A;MBD2;SUV39H1
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.2103030605273323,-0.6431439092321828,0.9468599033816425,0.978697055630377,1.0,10/20,34.60%,PLCB1;AGRN;LYPD1;RGS10;CDK5R1;CHRM1;LY6H;LY6G6D;CHRNB2;GNA11
prerank,positive regulation of telomerase activity (GO:0051973),-0.181843908183359,-0.6429865283478325,0.9562043795620438,0.9774086447207693,1.0,8/33,14.38%,PARM1;PRKCQ;PNKP;PTGES3;NAF1;MAPK3;CCT2;CTNNB1
prerank,leukotriene metabolic process (GO:0006691),0.28126052935445556,0.6426320840680183,0.8946684005201561,0.9879518237879548,1.0,3/19,12.66%,DPEP1;PTGR1;ABCC1
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.27313742866704493,0.6423719709616965,0.902557856272838,0.9878093048719506,1.0,5/24,25.49%,LPCAT1;PNPLA8;GPAM;SLC27A1;PGS1
prerank,tRNA transport (GO:0051031),0.2571494541580891,0.6422290152265118,0.9247434435575826,0.987571891452763,1.0,11/35,27.08%,NUP93;NUP107;NUP98;NUP37;NUP50;XPOT;TPR;NUP85;NUP133;NUP188;NUP88
prerank,regulation of erythrocyte differentiation (GO:0045646),0.25392205103406706,0.6417973576880746,0.9357476635514018,0.9875653185174962,1.0,10/35,24.28%,ZFP36L1;MAPK14;HOXA5;MAPK11;ZFP36;STAT5B;ACVR2A;ABCB10;LDB1;ACVR1B
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.23670851428636994,0.6415570665131143,0.9631966351209253,0.9874013417692448,1.0,7/74,8.83%,PSMC4;VEGFA;NFE2L2;PSMC6;EGLN2;PSMD8;SIRT2
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.29027238500103353,0.6415287656699884,0.8989637305699482,0.9870715022314487,1.0,3/17,12.36%,MTOR;MAGI2;CALM2
prerank,rRNA metabolic process (GO:0016072),0.22752842759059105,0.6414943223872526,0.9859013091641491,0.9867477611674296,1.0,31/160,20.84%,C1D;DDX49;FCF1;HELQ;ESF1;EXOSC7;RRP36;RPL10A;WDR46;MAPT;UBA52;RCL1;SBDS;MPHOSPH10;SNU13;NOLC1;EXOSC1;DCAF13;RRP7A;RPL6;DDX52;POP4;NOP53;PWP2;EBNA1BP2;TBL3;RPL23;RPL17;PDCD11;RPS25;KRR1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.24956335404603308,0.6412103785920336,0.9227373068432672,0.9866259734183112,1.0,8/44,16.00%,OSBPL3;OSBPL2;INSIG2;SCP2;HSD3B7;OSBPL6;PSAT1;PMVK
prerank,chromatin remodeling at centromere (GO:0031055),0.2615671656161747,0.6408620863004354,0.9218390804597701,0.9865404660439581,1.0,4/31,16.18%,CENPT;HJURP;NPM1;CENPC
prerank,branched-chain amino acid metabolic process (GO:0009081),0.27483173076074346,0.6400257593571878,0.9167701863354037,0.9864953609468496,1.0,5/20,20.79%,BCAT1;AUH;HIBADH;BCKDHA;ACAT1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.27483173076074346,0.6400257593571878,0.9167701863354037,0.9864953609468496,1.0,5/20,20.79%,BCAT1;AUH;HIBADH;BCKDHA;ACAT1
prerank,Fc receptor signaling pathway (GO:0038093),0.23034242305873595,0.6398402686276324,0.9712820512820513,0.9862915388629326,1.0,31/110,28.26%,SYK;PSMC4;PIK3R2;NFATC1;PSMC6;CHUK;PIK3CA;PSMD8;FER;PPP3CA;SOS1;MAP2K4;CARD11;PPP3CB;GAB2;MAPK1;TAB2;VAV2;FBXW11;JUN;MAP3K7;RELA;PSMD4;PSMD3;RAC1;PSMB3;BCL10;NFKB1;CUL1;PSMB2;PSMD5
prerank,inositol phosphate biosynthetic process (GO:0032958),0.3146944552069603,0.6397230267069509,0.8913342503438789,0.986038638519995,1.0,3/11,20.41%,FGF2;IPPK;IP6K1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.2718207553864289,0.6397045975509865,0.8888888888888888,0.9857023027773053,1.0,3/21,12.27%,TEDC1;UCHL5;TUBD1
prerank,peptidyl-arginine modification (GO:0018195),0.28967937181430137,0.6376024485309376,0.8965071151358344,0.9870196751506837,1.0,5/15,31.77%,ART4;PADI2;KRTCAP2;PRMT8;PRMT7
prerank,autophagosome maturation (GO:0097352),0.25787890810406067,0.6369348436609709,0.9153936545240893,0.9871876573631291,1.0,6/32,13.18%,LIX1L;WIPI2;VPS33A;STX17;ATP2A2;EPG5
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.2556928746749122,-0.6364840982404736,0.8916083916083916,0.9804352037237936,1.0,2/10,9.84%,ERLEC1;SVIP
prerank,DNA biosynthetic process (GO:0071897),-0.21671103938434153,-0.6364154244261907,0.9353448275862069,0.9790946322861415,1.0,7/16,28.77%,SIRT1;TERT;WRN;POLD2;POLE;POLD4;POLL
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.2589505750568086,0.6357884279735512,0.9233449477351916,0.9877147161360839,1.0,7/32,21.01%,DYRK2;BCL3;RPS27L;FHIT;DDX5;PML;PYCARD
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.23553135193581987,0.6351136104952742,0.9502164502164502,0.9879022626742274,1.0,17/59,27.68%,CHUK;TLR4;AKT1;BCL3;UBA52;NKIRAS1;CD14;MAP3K14;RBCK1;CARD11;TAB2;AZI2;MAP3K7;RELA;TICAM1;RNF31;BCL10
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.31592825995504015,0.6346735490275301,0.8756983240223464,0.987882211854029,1.0,3/10,16.70%,FLCN;SETD5;DIP2A
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.2074877438367363,-0.6340265722541061,0.9641025641025641,0.9793883832011351,1.0,9/19,34.26%,MTHFS;ALDH1L1;SLC19A1;SHMT2;SHMT1;FPGS;ALDH1L2;MTHFR;MTHFD1L
prerank,positive regulation of cell development (GO:0010720),0.25744644238990083,0.6337981793621171,0.9254437869822485,0.9881876834369995,1.0,3/31,12.88%,NUMBL;SERPINF1;ATP6AP1
prerank,protein-DNA complex assembly (GO:0065004),0.22554417714198194,0.6330688124605518,0.9774590163934426,0.9883872206092951,1.0,17/116,15.46%,PSMC4;GTF2H3;CHAF1B;RAD23B;PSMC6;SPTY2D1;PSMD8;MCM3;NPM1;ERCC3;UBA52;ANP32B;DDB1;CCNH;ORC6;GMNN;GRWD1
prerank,RNA destabilization (GO:0050779),0.2825288240299965,0.6328995605184621,0.9055900621118013,0.9881529125235081,1.0,6/18,27.22%,PUM1;YTHDF2;YTHDF1;YTHDF3;RBM24;CELF1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.27486200026695384,0.6328967624895789,0.9022842639593909,0.987805237218285,1.0,3/18,16.08%,POLE3;MCM3;RFC4
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.23750654167436983,0.6325127809326739,0.9447453954496208,0.9877657120056368,1.0,13/57,22.21%,SDAD1;RIOK1;NOC2L;RRP36;NPM1;TGS1;MRPL36;DDX31;EBNA1BP2;RPF2;RIOK2;RPS25;RBIS
prerank,regulation of steroid metabolic process (GO:0019218),0.26855403139382006,0.6323851589149506,0.9233576642335767,0.9875095922103592,1.0,3/23,10.03%,DGKQ;STUB1;ACADVL
prerank,cellular response to ionizing radiation (GO:0071479),0.24431083039942658,0.6321773566774512,0.918552036199095,0.9873187540321734,1.0,18/47,30.44%,MAPK14;RHNO1;XRCC5;RAD1;CDKN1A;INO80;TNKS1BP1;SPIDR;NIPBL;BLM;CRYAB;MDM2;EEF1D;XRCC6;TP53;TLK2;HSF1;RAD9A
prerank,covalent chromatin modification (GO:0016569),0.29377681483123297,0.6321245991774879,0.9151670951156813,0.9870133078605219,1.0,5/14,30.07%,SETD5;CHD1;UFL1;MBD2;SIRT7
prerank,cellular response to dsRNA (GO:0071359),0.28713269480535736,0.6317706539544685,0.9096945551128818,0.9869409053689124,1.0,6/15,28.97%,CGAS;NPM1;FLOT1;MUL1;RIOK3;PDE12
prerank,phasic smooth muscle contraction (GO:0014821),-0.2483039469922369,-0.6311349689818717,0.9020979020979021,0.9799327903424007,1.0,3/10,16.91%,EDNRB;EDN1;EDN3
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.2931500125596648,0.6309475181105825,0.8878627968337731,0.9872183577744076,1.0,5/13,30.99%,NT5M;OGG1;DUT;SMUG1;UPP2
prerank,meiosis I (GO:0007127),0.27191715197182725,0.630594502891217,0.9062870699881376,0.9871360116112521,1.0,3/23,18.72%,SLC25A31;DDX4;FOXJ2
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.2141537963756995,-0.6303717590289819,0.9511111111111111,0.9790670666790623,1.0,8/18,27.61%,MPV17L;HIP1R;SLC35F6;CHCHD10;HSPA1A;ZNF205;BOK;BID
prerank,magnesium ion transport (GO:0015693),0.30384571930062854,0.6301015465695656,0.9040902679830748,0.9871655681544318,1.0,3/12,15.91%,NIPAL2;CNNM4;TUSC3
prerank,regulation of chromosome organization (GO:0033044),0.271210201200095,0.628948144865382,0.9065656565656566,0.9876624979622028,1.0,8/22,28.00%,HNRNPD;MAPT;XRCC5;SMG6;TERF2IP;SMG5;UPF1;HDAC8
prerank,pseudouridine synthesis (GO:0001522),0.2959612479659751,0.6288856918833541,0.8839634941329857,0.9873555251266811,1.0,4/13,29.66%,GAR1;TRUB1;NHP2;PUS10
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.1921959184146096,-0.6288249653440937,0.9783783783783784,0.978726238844712,1.0,10/25,29.36%,HSPA9;ERO1A;PTGES3;DNAJC18;HSPE1;HSPA1A;ST13;HSPA1B;HSPA2;SDF2L1
prerank,exit from mitosis (GO:0010458),0.3024693508155033,0.628637733589581,0.912303664921466,0.9871898787128767,1.0,6/12,30.73%,CHMP7;CTDP1;CLASP2;PPP2R2D;SIRT7;CHMP4B
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.26269965137968404,0.6281336028572749,0.9210850801479655,0.9872347445403999,1.0,9/24,34.76%,POLB;UBA52;RFC4;POLD1;XRCC1;RFC3;RPA3;LIG1;POLD3
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.23195204858349053,-0.6270312088339336,0.9291338582677166,0.9770920546714268,1.0,2/13,5.51%,PLCB1;SHC1
prerank,cellular response to interleukin-15 (GO:0071350),-0.23195204858349053,-0.6270312088339336,0.9291338582677166,0.9770920546714268,1.0,2/13,5.51%,PLCB1;SHC1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.31003522980071796,0.6265415877246074,0.8898305084745762,0.9880587252374873,1.0,3/10,18.39%,NAGK;ST3GAL1;GNE
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.2707703698768199,0.6257771402249953,0.9180124223602485,0.9882619639196147,1.0,6/22,24.43%,INHA;INPP5K;CDKN1A;CDKN2C;ANKLE2;DYNLL1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.24941882270403576,-0.6254602628991026,0.9194139194139194,0.9767378282605479,1.0,4/11,18.57%,CAV1;PTPRT;ADIPOR1;NF2
prerank,regulation of interleukin-17 production (GO:0032660),0.2539656329544478,0.6254513993971355,0.9194865810968494,0.9881508224546277,1.0,4/31,18.11%,RFTN1;TLR4;IL6;IL18
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.21398524095119964,-0.6248545382420498,0.9179487179487179,0.9757323946490359,1.0,9/17,39.74%,AKAP6;KCNE4;ANK3;NOS1AP;KCNAB1;KCNS2;RNF207;KCNG1;KCNE5
prerank,regulation of neuron differentiation (GO:0045664),0.22811408022199825,0.623848595164872,0.9615795090715048,0.9889722488336811,1.0,27/76,31.63%,FGFR1;NEUROD2;BIN1;BEND6;ZFHX3;YWHAG;RHOA;SIX1;ZEB1;CDK5RAP2;CNTN4;NBL1;KCTD11;TIAM1;CPNE1;PCP4;CALR;NRCAM;HES1;IMPACT;NLGN1;MMD;BRINP2;DISP3;ALK;CDK5RAP3;NGF
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.27114224396269815,0.6238301237112182,0.9081761006289308,0.9886396582712205,1.0,6/21,27.22%,CDC14B;FBXO5;RPL23;PTEN;RAB1A;GORASP1
prerank,sterol biosynthetic process (GO:0016126),0.24760896952204067,0.6232721007485814,0.9293981481481481,0.9886859657311172,1.0,4/33,9.23%,ACLY;MVK;INSIG2;GGPS1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.2970866622439861,0.6231606762255008,0.8868175765645806,0.9884119708673059,1.0,5/12,27.71%,MPHOSPH8;SETDB1;SETDB2;TASOR;ATF7IP
prerank,axonemal dynein complex assembly (GO:0070286),0.25840910855818977,0.6225726815915696,0.9124700239808153,0.9884988562804573,1.0,5/27,22.37%,DNAH8;DNAAF3;DNAAF5;DNAH5;DNAL1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.28294148601117475,0.6206129624234131,0.9099099099099099,0.9895492212029741,1.0,5/16,22.93%,KAT2B;NAA15;NAA50;NAA20;NAA30
prerank,neurotransmitter secretion (GO:0007269),0.23693102716782855,0.6205865924124201,0.9408418657565415,0.9892234780175788,1.0,8/44,19.18%,STX1A;SNAP25;GAD2;SNAPIN;SYT1;SNPH;VAMP2;RIMS2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.2811123337289322,0.620497987665121,0.920881971465629,0.9889449155416933,1.0,6/15,30.45%,SAMHD1;YTHDF2;YTHDF3;STAT2;MUL1;CACTIN
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.22598243825839878,0.6198686819868018,0.9704641350210971,0.9890280913944527,1.0,22/76,24.39%,EGFR;HDAC7;RASSF2;TLR4;BCL3;IRAK1;LRRC19;CD27;RHOA;ZC3H12A;CD14;PDCD4;ILK;IFI35;PPM1A;TSPAN6;TERF2IP;CPNE1;CYLD;RELA;CCN3;TRIM44
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.2374924552312278,-0.6198336967999004,0.9293286219081273,0.9774498599509179,1.0,5/12,26.62%,MFNG;GPR183;DOCK10;DLL1;FCGR2B
prerank,regulation of nervous system development (GO:0051960),0.2447181100525962,0.6198262694479539,0.9299655568312285,0.9887110327678759,1.0,4/37,8.83%,BHLHE40;ZPR1;DOCK7;SIRT2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.2905613772796455,0.6194513122572782,0.8938775510204081,0.9886066197150666,1.0,3/13,16.43%,TBC1D10A;BAK1;GRIN2A
prerank,regulation of ruffle assembly (GO:1900027),0.26159235571363215,0.618710967877698,0.9208899876390606,0.9887883567005888,1.0,4/23,16.64%,NDEL1;PFN2;KANK1;EPS8L2
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.24684862768412252,-0.6183825765975646,0.8858131487889274,0.976943589616527,1.0,4/10,28.39%,SORL1;NAB2;RB1;EGR1
prerank,tryptophan catabolic process (GO:0006569),-0.23344422823426023,-0.6180050452016613,0.9343065693430657,0.9757988163090211,1.0,11/11,76.68%,KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD;KYAT1;KMO;AFMID
prerank,regulation of protein dephosphorylation (GO:0035304),0.2461036871437099,0.6179897421709779,0.9283236994219654,0.9889424557100475,1.0,13/37,28.77%,PPP6R2;CALM2;PIN1;NSMF;PPIA;SMPD1;PTBP1;YWHAB;ANKLE2;TIPRL;HSP90B1;TSC1;PTPA
prerank,RNA stabilization (GO:0043489),0.2467509853903668,0.6175672358179238,0.9480369515011547,0.9888934132328555,1.0,6/33,21.29%,TENT5B;LARP1;GDNF;TENT2;ZCCHC17;THRAP3
prerank,polyol biosynthetic process (GO:0046173),0.28467172783811084,0.6172977581635619,0.9078947368421053,0.9887279899448451,1.0,4/16,20.41%,FGF2;CYP27B1;IPPK;IP6K1
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.3052009375336768,0.6170416352147928,0.906030855539972,0.9885613251205452,1.0,1/10,7.28%,HDAC6
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.26307238309927194,0.616704580484011,0.9344262295081968,0.9884429382255695,1.0,7/22,24.18%,CAMK2N1;CDKN1A;TFAP4;IPO5;PTEN;HEXIM1;LATS1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.24836125742856663,0.6156296879214597,0.9416475972540046,0.9888230332219394,1.0,5/38,16.18%,CENPT;HJURP;NPM1;UBN1;CENPC
prerank,tyrosine metabolic process (GO:0006570),0.30129935346180414,0.6146943039330391,0.9121813031161473,0.9891228756972748,1.0,11/11,69.89%,TYR;GSTZ1;THAP4;TAT;PAH;TH;IYD;DCT;HGD;IL4I1;FAH
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.2981751848732169,0.614300943949415,0.9244264507422402,0.9890474457210802,1.0,2/12,12.43%,TLR4;DUOXA1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.24562578414861355,0.6142696539264623,0.9440559440559441,0.9887238068994578,1.0,5/35,12.36%,PPP1R1B;MTOR;PPP6R2;MAGI2;CALM2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.23777695279881803,0.612657495026587,0.9552071668533034,0.9894658868336047,1.0,17/48,29.74%,CRIP1;DYRK2;BCL3;BAK1;SFN;RPS27L;TNFRSF1B;PML;HTRA2;MCL1;PYCARD;MSH6;PRKDC;HIC1;TOPORS;BAX;TP53
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.27547880690737836,0.6125089526052198,0.9029754204398448,0.9892249110883766,1.0,17/17,72.48%,LPCAT1;CRLS1;PLA2G12A;LPGAT1;PLA2G1B;PLA2G4D;PLA2G2E;PLA2G2F;PLA2G10;PLA2G2D;PLA2G3;SERAC1;PLA2G5;LPCAT4;PLA2G4B;PLA2G4A;PLA2G4F
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.28348040589884904,0.6104105546241465,0.9285714285714286,0.9902572702123684,1.0,2/15,11.91%,MLXIPL;ELOVL5
prerank,histone lysine demethylation (GO:0070076),0.2551202073294645,0.6099231100917908,0.9348612786489746,0.9902373828509888,1.0,10/25,28.33%,KDM3B;KDM5C;KDM5B;JMJD1C;KDM1B;KDM2B;KDM4C;KDM3A;KDM2A;KDM4B
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.27649643247944256,0.6094136160040976,0.9255455712451861,0.9902269762134185,1.0,3/16,14.70%,IRAK3;HDAC6;GSPT1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.21983615336857185,0.6089724958118115,0.9681069958847737,0.9901641891477586,1.0,11/94,12.31%,PSMC4;IRAK3;PSMC6;PELI3;UBE2N;CHUK;PSMD8;SQSTM1;IRAK4;IRAK1;UBA52
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.24753433903872268,0.6083750456926018,0.9342723004694836,0.99022814604394,1.0,4/30,11.97%,INPP5F;SRCIN1;PARP14;PIBF1
prerank,synaptic vesicle transport (GO:0048489),0.29208809601256613,0.6079095753470987,0.8967921896792189,0.9901947864875156,1.0,2/11,16.57%,TOR1A;SNAPIN
prerank,protein localization to cilium (GO:0061512),0.24545420057252684,0.6077927693802665,0.9357060849598163,0.9899207182094301,1.0,10/32,32.24%,BBS9;BBS4;ATP6V1D;TCTN2;TCTN1;RAB29;TULP1;IFT20;ZNF423;ARL6
prerank,DNA-dependent DNA replication (GO:0006261),0.21502316209198746,0.607698918393632,0.9888097660223805,0.9896377275480835,1.0,20/128,19.29%,REV3L;PSMC4;PSMC6;POLE3;PSMD8;POLG2;POLB;MCM3;DDX21;CDC34;DNA2;UBA52;DBF4;ORC6;GMNN;RFC4;RECQL;BLM;POLD1;NOC3L
prerank,detection of visible light (GO:0009584),-0.2127922034758209,-0.6070880593489918,0.9571984435797666,0.9806453104419998,1.0,2/16,10.12%,ABCA4;RP1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.24424009019431792,0.6068864008516076,0.9428238039673279,0.9898330262226679,1.0,2/32,3.76%,CDK14;ZPR1
prerank,neuron maturation (GO:0042551),0.26554111365213484,0.6064635941103651,0.9251870324189526,0.9897607257070143,1.0,2/18,5.95%,MTCH1;FARP2
prerank,regulation of macrophage chemotaxis (GO:0010758),0.2588169985217822,0.6061788625038045,0.9273182957393483,0.98958867500619,1.0,2/21,6.08%,MIF;AKIRIN1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.24196108847456427,0.6058495373273954,0.9363957597173145,0.989460222737243,1.0,8/31,31.45%,SCP2;SRD5A1;NFS1;PYCR1;MOCS1;NOXRED1;PYCR3;MOCS2
prerank,RNA polyadenylation (GO:0043631),0.2537296812473997,0.6048890672039113,0.9345454545454546,0.9893851275461135,1.0,9/26,27.77%,SCAF8;CPSF2;PAPOLB;TENT2;TENT4B;PAF1;CPSF1;WDR33;CPSF3
prerank,mRNA polyadenylation (GO:0006378),0.2537296812473997,0.6048890672039113,0.9345454545454546,0.9893851275461135,1.0,9/26,27.77%,SCAF8;CPSF2;PAPOLB;TENT2;TENT4B;PAF1;CPSF1;WDR33;CPSF3
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.28768287496154776,0.6047685260849355,0.9119669876203577,0.9891168139965976,1.0,4/12,23.01%,ERN1;BAK1;ATF6;TMEM33
prerank,L-serine metabolic process (GO:0006563),-0.24928849111261756,-0.6047577763776034,0.9470198675496688,0.9805732398436643,1.0,1/10,2.06%,SERINC3
prerank,cellular response to starvation (GO:0009267),0.21284570402060896,0.6041653988059726,0.9919191919191919,0.9891516076915808,1.0,32/147,23.50%,EIF2AK3;HNRNPA1;MTOR;FOXO1;GAS2L1;FLCN;WIPI2;USP33;WDR45B;CEBPB;ATP6V1E1;SESN3;CDKN1A;RRAGD;ZC3H12A;FADS1;EIF2S1;EHMT2;STK24;ATP6V1D;ATP6V1B2;DAP;SREBF1;CASTOR2;STK26;MAPK1;ATF4;SESN2;PICK1;SLC38A9;ATG14;ATP6V0B
prerank,nerve growth factor signaling pathway (GO:0038180),0.3033145753958767,0.604112996059823,0.9128571428571428,0.9888452042699252,1.0,3/10,14.96%,MAGI2;KIDINS220;RAPGEF1
prerank,pinocytosis (GO:0006907),0.2995826787883142,0.6037417243831658,0.896011396011396,0.9887233307123794,1.0,5/10,31.16%,PYCARD;SNX33;PPT1;MAPKAPK3;SNX5
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.26889862685326077,0.6037022551198397,0.9235751295336787,0.9884075371206774,1.0,4/18,20.94%,SRC;MAP2K2;VPS11;MAPK1
prerank,microtubule-based transport (GO:0099111),0.28335007288909336,0.603513683492135,0.9199438202247191,0.9881817043550708,1.0,2/12,14.46%,DYNC1I1;SPAG17
prerank,sensory perception (GO:0007600),0.23695983704120643,0.6033896664547657,0.9598623853211009,0.987923436181917,1.0,5/45,17.16%,GNAS;KCNA2;BBS4;TTC8;CHRNA7
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.28837698222155805,0.6027608132344681,0.9127423822714681,0.9879760362485096,1.0,6/12,34.21%,TCERG1;LARP7;HEXIM1;NELFA;NELFB;HNRNPU
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.25972040129882523,0.6023220021820469,0.9365284974093264,0.9872192924634499,1.0,2/20,8.41%,ZW10;ZWINT
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.25972040129882523,0.6023220021820469,0.9365284974093264,0.9872192924634499,1.0,2/20,8.41%,ZW10;ZWINT
prerank,spindle assembly checkpoint signaling (GO:0071173),0.25972040129882523,0.6023220021820469,0.9365284974093264,0.9872192924634499,1.0,2/20,8.41%,ZW10;ZWINT
prerank,regulation of chromatin binding (GO:0035561),0.2956122121876693,0.6018413057633054,0.9020172910662824,0.9871593631258148,1.0,3/10,19.48%,DDX11;GMNN;BTAF1
prerank,calcium ion transport into cytosol (GO:0060402),0.2618491630409048,0.6014410512992336,0.9388004895960832,0.9870582331883846,1.0,5/21,23.77%,ATP2B4;GRIN2D;GRIN2A;JPH4;CACNA2D1
prerank,lipoprotein biosynthetic process (GO:0042158),0.2858147686964554,0.6004874865937443,0.9157303370786517,0.9873185024660365,1.0,5/11,30.62%,WIPI2;WDR45B;ATG10;WIPI1;UGCG
prerank,sphingolipid catabolic process (GO:0030149),0.2756673260928885,0.6002039808096791,0.93048128342246,0.9871631061798638,1.0,3/15,18.60%,PDXDC1;GLA;SMPD1
prerank,DNA catabolic process (GO:0006308),0.29199833127703967,0.5996336953889329,0.9290586630286494,0.9871572064634655,1.0,3/11,25.15%,DNASE1L2;DFFB;DNASE1L1
prerank,cellular response to interferon-beta (GO:0035458),0.2798726670766994,0.5985784531613842,0.9272727272727272,0.9874349187943688,1.0,5/14,27.72%,UBE2G2;CDC34;HTRA2;UBE2K;NDUFA13
prerank,synaptonemal complex organization (GO:0070193),0.27229740769465216,0.5979967822546668,0.9139784946236559,0.9871097516458099,1.0,1/15,8.94%,SYCP2
prerank,synaptonemal complex assembly (GO:0007130),0.27229740769465216,0.5979967822546668,0.9139784946236559,0.9871097516458099,1.0,1/15,8.94%,SYCP2
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.28799677387637534,0.5976657895882499,0.914651493598862,0.9869684090962817,1.0,6/12,26.67%,IAPP;PFDN6;LDLR;CRYAB;VBP1;PFDN2
prerank,regulation of cholesterol metabolic process (GO:0090181),0.2601779255016009,0.5968599734140403,0.9345911949685535,0.9870973405203528,1.0,9/20,29.43%,DGKQ;ACADVL;SREBF1;FMO5;ARV1;LPCAT3;KPNB1;MBTPS1;SREBF2
prerank,natural killer cell mediated immunity (GO:0002228),-0.21127644879763924,-0.5966116989431917,0.944206008583691,0.9834070263015153,1.0,15/15,78.90%,RAET1E;ULBP1;KIF5B;TUBB4B;SLAMF7;KLRD1;KLRK1;TUBB;KLRC2;KIR3DL1;GZMB;CEBPG;ARL8B;PLEKHM2;LYST
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.2504418957656322,0.5965737152119013,0.9424724602203183,0.9869300271237355,1.0,7/25,24.64%,DOK1;AKT1;CBL;ARAP1;PLAUR;CCDC88A;RTN4
prerank,melanosome transport (GO:0032402),0.26699917349626334,0.5957282805621503,0.9248704663212435,0.9867517385801144,1.0,4/18,19.13%,MYO5A;BBS4;RAB27B;BBS5
prerank,pigment granule transport (GO:0051904),0.26699917349626334,0.5957282805621503,0.9248704663212435,0.9867517385801144,1.0,4/18,19.13%,MYO5A;BBS4;RAB27B;BBS5
prerank,regulation of presynapse assembly (GO:1905606),0.26489954073151784,0.5942745590737,0.9458064516129032,0.9868824623083856,1.0,3/18,15.49%,GPC6;MDGA1;LRFN5
prerank,regulation of presynapse organization (GO:0099174),0.26489954073151784,0.5942745590737,0.9458064516129032,0.9868824623083856,1.0,3/18,15.49%,GPC6;MDGA1;LRFN5
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.18863735747319915,-0.5941528510134434,0.9578313253012049,0.9833265712123606,1.0,12/23,36.98%,ABHD4;PLAAT3;PLA2G4C;PLA2G6;PLA2G4F;PLA2G4A;PLA2G4B;LPCAT4;MBOAT2;PLA2G5;PLBD1;MBOAT1
prerank,positive regulation of protein deacetylation (GO:0090312),0.27582291369993633,0.5937530772125187,0.9062087186261559,0.9868539905790409,1.0,6/14,30.10%,AKAP8;NIPBL;CTBP1;AKAP8L;NNMT;BRMS1
prerank,glial cell differentiation (GO:0010001),0.24263910494221852,0.5910061272352348,0.9529553679131484,0.9880934491964083,1.0,3/28,8.29%,SOX10;NFIB;SOX8
prerank,histone H2A acetylation (GO:0043968),0.268279933750248,0.5900359181472392,0.9312581063553826,0.9883033373749476,1.0,8/16,32.83%,MSL3;DMAP1;MORF4L1;TRRAP;BRD8;YEATS4;RUVBL1;RUVBL2
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.21303946300432583,0.5894125682992563,0.9846153846153847,0.9883444094219687,1.0,13/110,15.44%,RPSA;CTIF;HELZ2;PNRC2;GSPT2;RPL10A;UBA52;RPS5;SMG7;GSPT1;EIF3E;SMG6;RPL6
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.21758767926964556,0.5881551795970072,0.9893842887473461,0.9886993554996255,1.0,6/73,9.31%,PSMC4;RUNX1;ITCH;PSMC6;PSMD8;PDCD2
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.26583084984021316,0.5864808817965611,0.9219765929778934,0.9893155534923139,1.0,8/15,36.77%,CCT7;CCT4;NHP2;CCT6A;RUVBL1;RUVBL2;TCP1;CCT8
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.2167139560420705,-0.5858704532047485,0.967032967032967,0.9859905987309818,1.0,7/13,32.91%,SOX11;MAD2L2;TAF1;HEY1;HEY2;SIN3A;PER2
prerank,receptor recycling (GO:0001881),0.2851226999940789,0.5856304459677404,0.9113233287858117,0.9894268323671443,1.0,3/10,16.53%,NSG1;REP15;PHETA2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.26710066118054765,0.5856274752428653,0.9375812743823146,0.9890886377357458,1.0,4/17,21.01%,ACVR1;JAG1;SNAI2;BMPR1A
prerank,regulation of microtubule-based movement (GO:0060632),0.2880905709525081,0.585399613548686,0.9241379310344827,0.9888794579541668,1.0,1/11,7.28%,HDAC6
prerank,protein localization to vacuole (GO:0072665),0.27250401211360253,0.5851946369105484,0.9276315789473685,0.9886607743920622,1.0,2/13,15.04%,CD81;RNF128
prerank,positive regulation of interleukin-1 production (GO:0032732),0.220924630126553,0.5848792007084678,0.9642857142857143,0.9884901270665499,1.0,4/51,11.72%,IL16;TMEM106A;TLR4;USP50
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.2705550823525267,0.5839527133868689,0.931787175989086,0.9886593410326343,1.0,4/14,23.01%,COPS5;BAK1;UFL1;TMEM33
prerank,cytoplasmic translation (GO:0002181),0.21166738098823204,0.5809412663657116,0.9875647668393782,0.9899250859389748,1.0,14/91,20.71%,RPSA;EIF4A1;FTSJ1;GSPT2;RPL10A;UBA52;RPS5;GSPT1;RPL6;RPL22L1;RPL23;RPL17;RWDD1;RPS25
prerank,negative regulation of leukocyte activation (GO:0002695),0.26496426309650245,0.5804317359156456,0.9594771241830066,0.9898528456595151,1.0,6/15,28.12%,ZC3H12A;IL4;LRFN5;IL31RA;HAVCR2;CD300LF
prerank,ribosomal large subunit assembly (GO:0000027),0.24287461942842092,0.580249526622632,0.9542645241038319,0.9896215837312874,1.0,6/24,23.93%,RPL6;NOP53;RPF2;NOP2;RSL24D1;BRIX1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.22957790434136865,0.5798512881214866,0.9659863945578231,0.9894787856431977,1.0,10/38,25.44%,NDUFS5;NDUFAB1;NDUFS1;NDUFB7;NDUFA2;NDUFV2;NDUFB2;NDUFB3;NDUFAF1;NDUFB9
prerank,DNA strand elongation (GO:0022616),0.255812941166497,0.5798297439154236,0.9510939510939511,0.9891535605638626,1.0,4/18,17.48%,MCM3;NBN;RFC4;RAD50
prerank,protein-containing complex subunit organization (GO:0043933),0.20855707202187146,0.5780118168009845,0.9928425357873211,0.9897564611296733,1.0,17/109,18.87%,WIPF1;LLGL1;DLG4;GPAA1;ZW10;WASF1;MDM4;NUP98;MITF;SPG7;PML;NAPG;TFAP4;KMT2A;EPRS1;VAMP2;LAMC1
prerank,regulation of stem cell proliferation (GO:0072091),0.25754538672717664,0.5776506807335469,0.9487836107554417,0.9896034825635203,1.0,3/17,20.81%,ZFP36L1;AGO3;FBLN1
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.24954710350344433,0.5775883545870052,0.9504950495049505,0.9892931350315128,1.0,10/21,32.33%,PPP1R1B;YWHAE;YWHAB;FKBP1A;TIPRL;CRY2;FKBP1B;PTPA;BOD1;PPP4R4
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.24746298337553468,0.5772061020104782,0.9551515151515152,0.989155001052744,1.0,10/24,32.29%,FYN;MIEF2;CHP1;ITGAM;FIS1;MTCL1;PRNP;MYO1C;AKT2;TCAF1
prerank,neurotransmitter biosynthetic process (GO:0042136),0.26934246199059997,0.5767726059001479,0.9380764163372859,0.9890388269186235,1.0,3/14,15.48%,DAGLA;SLC6A4;DAGLB
prerank,glucose metabolic process (GO:0006006),0.2169216411623473,0.5767308940926632,0.9770742358078602,0.9887217034723386,1.0,12/58,23.38%,SLC39A14;CRTC2;IRS2;GAA;MDH2;G6PC3;ALDOA;GALM;GOT1;SLC37A4;ATF4;KCNJ11
prerank,nucleotide biosynthetic process (GO:0009165),0.25930996677819207,0.5765885927372424,0.9434447300771208,0.988449490838493,1.0,8/18,33.05%,GART;PRPSAP1;PRPS1L1;PRPS1;PRPS2;RRM2B;ME1;NMNAT2
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.2518275645479491,0.5765134546253778,0.9375812743823146,0.9881483394553829,1.0,6/19,25.19%,AKIRIN1;JAM3;MPP1;MAPK1;CSF1;CMKLR1
prerank,regulation of mitochondrial fusion (GO:0010635),0.2834205167827454,0.5759049440695476,0.9316005471956225,0.9881203406315936,1.0,1/11,7.05%,PID1
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.15282963083872075,-0.573950998602605,1.0,0.9899148665970988,1.0,16/48,31.53%,IL1R1;SLC7A5;TLR3;SCRIB;CYRIB;TXK;SLC11A1;IL27;FZD5;CCR2;CD276;IL12RB2;RASGRP1;TLR7;LILRB1;FADD
prerank,protein neddylation (GO:0045116),0.27065142612508053,0.57264482211661,0.9455782312925171,0.9893842023438001,1.0,5/13,29.12%,RNF7;NEDD8;UBE2F;DCUN1D1;UBE2M
prerank,signal release from synapse (GO:0099643),0.21882674189513188,0.5716411159231187,0.9669703872437357,0.989563431138103,1.0,7/43,18.69%,STX1A;SNAP25;GAD2;SNAPIN;SYT1;SNPH;VAMP2
prerank,regulation of mRNA polyadenylation (GO:1900363),0.2554448388785809,0.5709158921420049,0.958974358974359,0.9895908350100228,1.0,9/17,34.44%,CDK9;CPSF6;CPEB1;CPSF7;RNF20;HSF1;VIRMA;NCBP2;CPEB3
prerank,positive regulation of interleukin-17 production (GO:0032740),0.24392139249403133,0.5690906410969848,0.9481302774427021,0.9901240549546517,1.0,3/22,18.11%,RFTN1;IL6;IL18
prerank,negative regulation of viral genome replication (GO:0045071),0.22174769575985626,0.5689566316163591,0.9593220338983051,0.9898543254340609,1.0,9/40,22.59%,INPP5K;MPHOSPH8;ZC3HAV1;TNIP1;SLPI;FAM111A;BTBD17;SRPK1;SETDB1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.2605839354659957,0.568483534534707,0.9438356164383561,0.9897419404044665,1.0,2/14,11.93%,TIRAP;IRAK1
prerank,icosanoid biosynthetic process (GO:0046456),-0.2317013893279986,-0.5680472806750412,0.9601328903654485,0.9909071694893377,1.0,6/10,33.48%,MGST3;PLA2G4A;MGST2;ALOX5;PLA2G5;ALOX5AP
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.20989046393225003,0.5679732700120325,0.9852476290832455,0.9896395335175762,1.0,5/70,8.77%,PSMC4;RUNX1;ITCH;PSMC6;PSMD8
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.24462689842068508,0.5672698889921993,0.9593392630241423,0.9896285912456271,1.0,9/20,32.83%,BRD7;DIP2A;GLYR1;ARRB1;TADA2A;RPS6KA5;PRKAA1;TADA2B;RUVBL2
prerank,endothelial tube morphogenesis (GO:0061154),0.2803426972362187,0.5669455493548111,0.9428571428571428,0.9894392162935545,1.0,2/10,13.40%,PRKD2;RHOA
prerank,centromere complex assembly (GO:0034508),0.22592594601793037,0.5667049906925503,0.9681093394077449,0.9892186463731559,1.0,5/36,19.15%,CENPT;HJURP;NPM1;CENPC;CENPE
prerank,cotranslational protein targeting to membrane (GO:0006613),0.20557097256968515,0.5654446121820165,0.9887063655030801,0.9894560543900521,1.0,10/91,15.44%,RPSA;SRP19;SRP9;RPL10A;UBA52;RPS5;SEC63;TRAM1;SEC61A1;RPL6
prerank,neuron fate commitment (GO:0048663),0.2659810416036448,0.5652808231268831,0.9461325966850829,0.9891911462055722,1.0,3/14,25.89%,POU3F2;TGFBR1;MYT1L
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.27419577494175285,0.5646586881783893,0.9518413597733711,0.989151388595449,1.0,3/10,20.18%,NOC2L;SET;CTBP1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.2289701875859748,0.5645891958899139,0.9699421965317919,0.9888472504276051,1.0,4/29,13.43%,AXIN1;UBE2N;FBXO5;PIN1
prerank,ncRNA 3'-end processing (GO:0043628),0.26431064916178554,0.5643144024636356,0.9409448818897638,0.9886364715850119,1.0,4/14,19.51%,INTS6;INTS2;INTS12;PTCD1
prerank,motile cilium assembly (GO:0044458),-0.21850533094597058,-0.5632150859669871,0.9635036496350365,0.9914701109946645,1.0,3/12,17.79%,BBOF1;SPATA6;RSPH9
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.21182647667750604,-0.5619782225805104,0.9923664122137404,0.9905474626667378,1.0,1/12,2.06%,SERINC3
prerank,primary miRNA processing (GO:0031053),0.27516810567164357,0.5617747120270437,0.9504950495049505,0.9894610314888534,1.0,1/10,6.49%,DGCR8
prerank,negative regulation of cellular protein localization (GO:1903828),0.22369087178700045,0.5615339466538474,0.9745958429561201,0.9892297932503773,1.0,12/34,31.50%,FLCN;OTUD7B;MAPT;ILRUN;GOPC;MAP1A;LEPROT;LATS1;SNX33;DNAJA1;TAX1BP3;CTNNA1
prerank,aerobic electron transport chain (GO:0019646),0.20729320936168497,0.5606045227399916,0.9861259338313767,0.9892989321371727,1.0,20/68,27.72%,NDUFS5;NDUFAB1;NDUFS1;NDUFB7;NDUFA2;NDUFV2;UQCRQ;UQCC3;UQCRH;SDHAF2;NDUFB2;COX7B;UQCR10;AFG1L;NDUFB3;NDUFAF1;NDUFB9;SDHC;COX15;NDUFA13
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.24650844862224475,0.5599859233740466,0.9646133682830931,0.9892404819071288,1.0,7/20,31.18%,MCU;MCUB;SPG7;SLC8B1;PARL;LETM1;MICU1
prerank,hydrogen peroxide catabolic process (GO:0042744),0.2729825657125196,0.5596889719562814,0.9583333333333334,0.9890335413055455,1.0,2/11,17.14%,GPX1;PXDN
prerank,autophagy of peroxisome (GO:0030242),0.27401720841283,0.5594210537622603,0.9547325102880658,0.9888188568408305,1.0,3/12,17.51%,SQSTM1;NBR1;PEX5
prerank,ether lipid biosynthetic process (GO:0008611),0.27393883722104323,0.5593095999634715,0.9376731301939059,0.9885369989039458,1.0,1/10,6.89%,FAR1
prerank,lipid droplet organization (GO:0034389),-0.17430904522613067,-0.5582796775852731,0.9883040935672515,0.9905112140418746,1.0,22/22,82.60%,ZFYVE1;PNPLA3;PLA2G4C;FITM2;CDS2;HILPDA;PPID;PLIN5;CIDEA;SMIM22;FAF2;HSD17B13;TSPO2;SQLE;CIDEC;FITM1;BSCL2;CDS1;RAB3GAP1;RAB18;AUP1;PPIA
prerank,glutamate receptor signaling pathway (GO:0007215),0.22263289276761142,0.5579321302212675,0.9724770642201835,0.9887881182491283,1.0,10/37,25.55%,GRIN3A;DAGLA;GRIA2;DAGLB;GRIN2A;GRM1;GRIA3;GRIK2;GRIK4;GRM5
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.2322815549425717,0.5574251569057862,0.9567307692307693,0.9886698858013772,1.0,6/25,21.01%,BMF;BBC3;MLLT11;HRK;PLAUR;PYCARD
prerank,gluconeogenesis (GO:0006094),0.2189440644352313,0.557338399306338,0.9782359679266895,0.9883667124956216,1.0,8/39,22.04%,SLC39A14;CRTC2;MDH2;G6PC3;ALDOA;GOT1;SLC37A4;ATF4
prerank,establishment of epithelial cell polarity (GO:0090162),0.24579914888115648,0.5571626711391443,0.9569074778200254,0.9881214614383734,1.0,8/19,35.30%,MYO9A;RHOA;FBF1;SIPA1L3;PARD3;GOLPH3;CYTH1;CLASP1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.25918683698214207,0.5571205976784431,0.9715832205683356,0.9878029421804683,1.0,2/14,11.36%,TLR5;PUM1
prerank,regulation of store-operated calcium entry (GO:2001256),0.2753102309714302,0.5565716035010745,0.9457579972183588,0.9877048649664032,1.0,4/10,29.47%,CASQ1;STIM1;SLC8B1;EFHB
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.2313297037435808,0.5549168453175568,0.9706601466992665,0.9880746785152822,1.0,7/25,27.04%,MAPK14;MAPK11;STAT5B;ACVR2A;ABCB10;ACVR1B;PRKDC
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.21139674871519915,0.5539377126878332,0.9824368825466521,0.9881386872011826,1.0,10/50,18.91%,EGFR;TLR4;IRAK1;LRRC19;CD27;RHOA;CD14;PDCD4;ILK;IFI35
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.2641815321004588,0.5530432142606242,0.9587217043941412,0.9878221329656665,1.0,3/12,20.12%,STIMATE;SLC9A1;PTBP1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.2641815321004588,0.5530432142606242,0.9587217043941412,0.9878221329656665,1.0,3/12,20.12%,STIMATE;SLC9A1;PTBP1
prerank,cell differentiation in hindbrain (GO:0021533),-0.21651351818465628,-0.5513503977187633,0.9704797047970479,0.9915254564022679,1.0,2/11,9.35%,OPHN1;KNDC1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.2599127468787294,0.5507170315790662,0.9484396200814111,0.9884223883152194,1.0,6/13,34.21%,TCERG1;LARP7;HEXIM1;NELFA;NELFB;HNRNPU
prerank,negative regulation of histone acetylation (GO:0035067),0.2610049942402425,0.5482951448183875,0.9661971830985916,0.9890497120654035,1.0,3/11,20.18%,NOC2L;SET;CTBP1
prerank,endocytic recycling (GO:0032456),0.20911460449223707,0.5459177457171169,0.9826086956521739,0.9896511115548071,1.0,17/50,31.51%,VPS52;EHD2;CMTM6;DENND1A;ARF6;ANKRD27;RAB35;ENTR1;VPS39;RAB11FIP3;EIPR1;MICALL1;PTPN23;ACAP2;CCDC93;SNX27;RAB14
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.23325566865231445,0.5457828604437301,0.9681762545899633,0.9893732431952144,1.0,5/23,26.63%,GSTM2;FADS1;GSTM1;ELOVL6;ACOT7
prerank,NIK/NF-kappaB signaling (GO:0038061),0.1999124024980437,0.545604610335628,0.9947145877378436,0.9891004627224343,1.0,22/72,31.87%,PSMC4;PSMC6;CHUK;TIRAP;PSMD8;AKT1;IRAK1;MAP3K14;FBXW11;MAP3K7;RELA;PSMD4;PSMD3;PSMB3;CUL1;PSMB2;PSMD5;PSMD14;TRAF6;PSMC5;PSMC3;PSME4
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.2019063371263285,0.5455039878719905,0.9882100750267953,0.9888050025997388,1.0,20/69,27.72%,NDUFS5;NDUFAB1;NDUFS1;NDUFB7;NDUFA2;NDUFV2;UQCRQ;UQCC3;UQCRH;SDHAF2;NDUFB2;COX7B;UQCR10;AFG1L;NDUFB3;NDUFAF1;NDUFB9;SDHC;COX15;NDUFA13
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.21917571355594997,-0.5452844411254869,0.9591078066914498,0.9920218317409818,1.0,1/10,4.04%,MTHFS
prerank,positive regulation of ruffle assembly (GO:1900029),0.25584333269380743,0.5448122342731007,0.9405255878284924,0.9887706200078927,1.0,2/13,16.64%,NDEL1;EPS8L2
prerank,glycerophospholipid catabolic process (GO:0046475),0.22415758549588302,0.5441445303822255,0.9633569739952719,0.9886948081206066,1.0,5/27,20.05%,INPP5F;PNPLA8;PLA2G4E;LIPC;GDPD3
prerank,tRNA metabolic process (GO:0006399),0.2396164567625722,0.5437966250118575,0.9697368421052631,0.988491468866999,1.0,5/17,31.02%,RPP21;TRPT1;RPP30;SARS1;AARS1
prerank,presynapse organization (GO:0099172),0.2718702982552986,0.5426208349766087,0.9355742296918768,0.9886040061838357,1.0,5/10,31.30%,LRRTM3;DVL1;NLGN1;NLGN3;NLGN2
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.20797237915881983,-0.5397772890255095,0.975,0.9922979626929497,1.0,12/12,79.22%,ACSL3;APOC1;MTTP;P4HB;APOC4;DGAT1;APOB;APOC3;MFSD2A;SOAT2;LPCAT3;SOAT1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.24432257681017017,0.5392823141649689,0.9674479166666666,0.9895238125848718,1.0,3/16,21.55%,MLXIPL;NUPR1;SLC25A33
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.23505400653102249,0.5367401749091776,0.9835234474017744,0.9900984631514077,1.0,18/18,76.52%,SPAG17;SPEF2;NPHP3;CCDC39;NEK10;RFX3;DNAAF1;DNAAF4;CCDC40;OFD1;AQP4;ODAD4;DNAAF2;SPA17;ADCY10;ROPN1L;CFAP53;CABYR
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.24135659022892159,0.5356924879331681,0.9591836734693877,0.9901419195666782,1.0,6/16,33.00%,VAMP2;LYST;VAMP7;PLEKHM2;ARL8B;CEBPG
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.20376513260188614,0.5351013741236536,0.9869706840390879,0.9900407182783878,1.0,5/50,13.94%,CAMK2N1;GTPBP4;CDKN1A;CCND1;CCNH
prerank,regulation of cell projection organization (GO:0031344),0.2519253659219789,0.5340556380746541,0.9663394109396914,0.9900714653135557,1.0,1/13,7.99%,MYO9A
prerank,negative regulation of cell division (GO:0051782),0.25642989509508207,0.5339699836414104,0.942008486562942,0.9897698342054738,1.0,4/11,30.00%,ORC6;BLM;E2F7;CHMP4C
prerank,positive regulation of DNA repair (GO:0045739),0.20801897043257067,0.5329571357704203,0.9899328859060402,0.9897814520748608,1.0,6/46,13.53%,EGFR;EYA2;UBE2N;TIGAR;DDX11;ABRAXAS1
prerank,regulation of cellular amine metabolic process (GO:0033238),0.20283603113384546,0.5322339824161719,0.9869706840390879,0.9896970976363072,1.0,4/50,9.94%,PSMC4;PSMC6;PSMD8;ODC1
prerank,snRNA 3'-end processing (GO:0034472),0.23909071414455313,0.5291584021207986,0.972972972972973,0.9903750556702393,1.0,4/19,18.86%,EXOSC7;INTS6;INTS2;INTS12
prerank,regulation of stem cell differentiation (GO:2000736),0.19184313871276315,0.5268493395581028,0.9979188345473465,0.9907872898684916,1.0,9/89,13.00%,PSMC4;RUNX1;ITCH;PSMC6;ZFP36L2;JAG1;PSMD8;PDGFRA;GDNF
prerank,regulation of mRNA metabolic process (GO:1903311),0.2538008078861826,0.524989685489942,0.9634317862165963,0.9910393595248689,1.0,4/11,29.45%,PTCD2;SRPK1;SAFB;SLTM
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.14372049579128138,-0.5247064636019465,0.991869918699187,0.9950558126358903,1.0,3/45,3.83%,APP;WNT5A;AIM2
prerank,establishment of skin barrier (GO:0061436),0.23887064373361638,0.5217772607219516,0.9652406417112299,0.991353658232656,1.0,2/15,12.70%,FA2H;SFN
prerank,regulation of water loss via skin (GO:0033561),0.23887064373361638,0.5217772607219516,0.9652406417112299,0.991353658232656,1.0,2/15,12.70%,FA2H;SFN
prerank,positive regulation of telomere maintenance (GO:0032206),0.21055929074558838,0.5208650262945195,0.9882491186839013,0.9912939454847182,1.0,7/31,23.30%,HNRNPD;NBN;PML;RAD50;NEK7;MAPK1;ERCC1
prerank,DNA replication initiation (GO:0006270),0.20416367611776928,0.5204593777272809,0.9873271889400922,0.9910846586055653,1.0,6/37,15.15%,POLE3;MCM3;CDC34;DBF4;ORC6;GMNN
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.2508756156667729,0.5199318483015007,0.9643835616438357,0.9909134703512986,1.0,2/12,18.75%,TLR4;STRAP
prerank,response to histamine (GO:0034776),0.2562651773119166,0.5197393035001909,0.9684931506849315,0.9906373149554583,1.0,2/10,19.52%,DIAPH1;GABRG2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.2306366530742735,0.5152390043088196,0.9743260590500642,0.9915868854222449,1.0,2/17,15.10%,MBOAT7;PLA2G4E
prerank,response to gamma radiation (GO:0010332),0.21527307119277458,0.5105992719484408,0.9748110831234257,0.992543600615229,1.0,10/24,30.27%,FANCD2;XRCC5;CRYAB;MDM2;MEN1;XRCC6;TP53;TLK2;PRKAA1;HSF1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.21402954109530006,0.5096574057494196,0.98661800486618,0.9924544502819649,1.0,5/24,25.50%,GGCX;TTLL3;TTLL11;VKORC1;TPGS1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.19303020838007062,0.5092299251802233,0.9935205183585313,0.9922267332685568,1.0,4/53,9.94%,PSMC4;PSMC6;PSMD8;ODC1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.23231004777626613,0.5086755529308108,0.966931216931217,0.9920308990354851,1.0,3/15,17.39%,DAGLA;DAGLB;GRM1
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.17343654225014804,-0.5074888499394542,0.9915966386554622,0.9975270258201477,1.0,6/17,26.18%,GJA1;TERT;SOX11;HMGA2;PTPRC;N4BP2L2
prerank,pre-replicative complex assembly (GO:0036388),0.18882690071554853,0.5068891526635989,0.9957264957264957,0.9921744088053827,1.0,7/64,15.15%,PSMC4;PSMC6;PSMD8;MCM3;UBA52;ORC6;GMNN
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.20743616776923807,0.5007423192166374,0.9904306220095693,0.9933742760347102,1.0,5/27,18.15%,AK2;NME2;AK8;NME1;AK9
prerank,glycine metabolic process (GO:0006544),-0.18330194601381042,-0.4996798986968083,0.985663082437276,0.9976403574211237,1.0,12/12,81.69%,DLD;GCSH;SHMT2;SHMT1;AMT;GLYAT;RIDA;BAAT;SDS;SDSL;GCAT;GLDC
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.19433149048532405,-0.4912962620989563,0.9859154929577465,0.9975776743673663,1.0,1/12,2.52%,APOE
prerank,endoderm development (GO:0007492),-0.18877518990520434,-0.4894393725807752,0.992619926199262,0.9964965273596607,1.0,13/13,81.14%,SOX17;SOX7;DUSP4;TBX20;GATA4;DUSP5;DUSP2;KIF16B;EOMES;APELA;DUSP1;LHX1;LAMC1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.19564478629573018,0.4887720849983325,0.9942922374429224,0.9956456181353867,1.0,11/35,29.00%,ACLY;FAR1;GGT7;HSD17B8;BDH2;SCD5;ACAT1;BDH1;PAM;PPT1;HMGCL
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.22759341194300808,0.4876881930430647,0.9840848806366048,0.9955358883822318,1.0,3/13,21.68%,CBL;SNX6;CBLB
prerank,B cell mediated immunity (GO:0019724),0.24203695225947508,0.48763266254320314,0.9735744089012517,0.9952164450578005,1.0,1/10,12.41%,CD27
prerank,fibrinolysis (GO:0042730),-0.17829116705380124,-0.47993465355059917,1.0,0.9964867436830003,1.0,13/13,82.19%,SERPINE1;PLAT;HRG;PLG;SERPINB2;CPB2;GP1BA;F2;KRT1;FGG;SERPINF2;PLAU;PLAUR
prerank,neuronal action potential (GO:0019228),0.20695408003651328,0.477629643089379,0.9861111111111112,0.9967643079533717,1.0,11/22,36.16%,MYH14;KCNA2;SCN9A;SCN2A;CACNA1H;KCNMB2;KCNMB3;CACNA1I;SCN1A;CACNA1G;SCN8A
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.18233743409490333,-0.46880636220760163,0.9965277777777778,0.9963794262211306,1.0,10/10,81.78%,QDPR;KYNU;IL4I1;PCBD1;IYD;PAH;ATP7A;KYAT1;THAP4;ASRGL1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.22104655398088988,0.46583448468867783,0.9823129251700681,0.998362825942649,1.0,5/12,29.87%,CDYL;LRIF1;PCGF3;RBM15;RLIM
prerank,mitotic DNA replication (GO:1902969),0.22658245368403013,0.4612306548515721,0.9801980198019802,0.9987121815419073,1.0,1/10,10.42%,MCM3
prerank,'de novo' posttranslational protein folding (GO:0051084),0.18703086168769764,0.4608521316773591,0.9939759036144579,0.9984308449938197,1.0,5/30,20.54%,HSPA13;HSPA14;SELENOF;DNAJB1;UGGT1
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.19971406400611377,0.4571277779503578,0.9886363636363636,0.9986173005321652,1.0,3/19,18.10%,CHRNA7;CHRFAM7A;CHRNA5
prerank,negative regulation of inclusion body assembly (GO:0090084),0.22445346157971,0.45488768840972943,0.9792817679558011,0.9985829726755707,1.0,2/10,20.00%,DNAJB2;DNAJB1
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.22059009534041796,0.45411147403653906,0.9932065217391305,0.9983561384200292,1.0,3/11,28.05%,VPS11;EIPR1;PTPN23
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.18597541641941173,0.43997972232030463,0.99265605875153,0.9996298457605133,1.0,4/23,21.68%,SRCIN1;CBL;SNX6;CBLB
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.18042532478456774,0.43465040422252055,0.9917061611374408,0.9998027646054343,1.0,1/29,3.98%,CD160
prerank,innate immune response in mucosa (GO:0002227),0.21250977241791638,0.4326422427106446,0.9927007299270073,0.9996717591179347,1.0,1/10,15.09%,IL4
prerank,ether lipid metabolic process (GO:0046485),0.202856104510226,0.4321291530751047,0.9973787680209698,0.9993875368218101,1.0,4/14,26.30%,FAR1;PAFAH1B1;PEDS1;PLA2G7
prerank,glutathione derivative biosynthetic process (GO:1901687),0.1839755734887763,0.42871859788828626,0.9962640099626401,0.9990185626984912,1.0,8/20,33.88%,GSTM2;GSTO2;GSTM1;ESD;GSTM5;GSTT1;GSTZ1;HPGDS
prerank,glutathione derivative metabolic process (GO:1901685),0.1839755734887763,0.42871859788828626,0.9962640099626401,0.9990185626984912,1.0,8/20,33.88%,GSTM2;GSTO2;GSTM1;ESD;GSTM5;GSTT1;GSTZ1;HPGDS
prerank,sensory perception of pain (GO:0019233),0.18472457760190944,0.42611028347510016,0.9987357774968394,0.9988941038677782,1.0,21/21,81.55%,KCNA2;SCN9A;P2RX4;PTGES;RETREG1;TRPA1;NIPSNAP1;MME;P2RX7;MRGPRX2;PRDM12;PROK2;ALOXE3;CHRNB2;OPRL1;KCNK4;CCL2;CCR2;CHRNA4;OPRM1;OPRK1
prerank,positive regulation of telomere capping (GO:1904355),0.1894044957699782,0.42147520605275995,0.9934383202099738,0.9989376235154235,1.0,3/17,20.94%,HNRNPD;NEK7;MAPK1
prerank,negative regulation of transposition (GO:0010529),0.19214207687977827,0.4192401078340276,0.9961190168175937,0.9987663300328565,1.0,3/16,22.74%,SPOCD1;DDX4;UBR2
prerank,double-strand break repair via break-induced replication (GO:0000727),0.1988034755214809,0.4191188078763421,0.9943977591036415,0.9984440792789031,1.0,1/12,10.42%,MCM3
prerank,positive regulation of lipid storage (GO:0010884),0.18086896326815213,0.41855607087088065,0.9962216624685138,0.9981557804580151,1.0,7/21,33.13%,PLIN2;ZC3H12A;NFKB1;SREBF2;PLIN3;VSTM2A;OSBPL11
prerank,dendritic cell chemotaxis (GO:0002407),0.18986575018834473,0.41446155675988544,0.996078431372549,0.9980989466772414,1.0,3/14,21.52%,CXCR4;CXCR2;PIK3CG
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.20808761268931708,0.41321670182237763,0.9971949509116409,0.997847558983401,1.0,5/10,33.61%,GABRG3;GABRG2;GABRA3;GABRA1;GABRA5
prerank,positive regulation of acute inflammatory response (GO:0002675),0.16818284557808755,0.371724467672794,0.9959946595460614,0.9992963637542589,1.0,4/14,33.06%,IL6;OSMR;PTGER3;IL6ST
